Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6561129649631011,-2.333688416356707,0.0,0.0,0.0,63/87,18.55%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPS21;RPLP2;RPL27A;RPS19;RPL34;RPS29;RPS8;RPS3;RPS23;RPS5;RPS4X;RPL13;RPS16;RPL9;RPS15;RPS27;RPL30;RPL37;RPL19;RPS11;RPS24;RPL18A;RPL18;RPS7;RPL23;RPL17;RPS20;RPL22;RPL23A;RPL26;RPS25;RPS18;RPL35A;RPL11;RPL13A;RPL7;RPL36;SRP14;RPL32;RPS17;RPL39;RPS2;RPL8;RPL14;RPL24;RPL29;RPL10A;RPL3;RPL12;RPS12;RPL27;RPS27A;RPL5;RPS28;RPS10
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.6448453874816822,-2.305337015564768,0.0,0.0,0.0,66/91,18.55%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPS21;RPLP2;RPL27A;RPS19;RPL34;RPS29;RPS8;RPS3;RPS23;RPS5;RPS4X;RPL13;RPS16;RPL9;RPS15;RPS27;RPL30;RPL37;RPL19;RPS11;RPS24;RPL18A;RPL18;RPS7;RPL23;RPL17;RPS20;RPL22;RPL23A;RPL26;RPS25;RPS18;RPL35A;RPL11;RPL13A;RPL7;RPL36;SRP14;RPL32;RPS17;RPL39;RPS2;RPL8;RPL14;RPL24;RPL29;SSR1;RPL10A;RPL3;TRAM1;RPL12;RPS12;RPL27;RPS27A;RPL5;RPS28;ARL6IP1;RPS10
prerank,cytoplasmic translation (GO:0002181),-0.6241952748246299,-2.2558278118945445,0.0,0.0,0.0,64/91,18.88%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPS21;RPL27A;RPS19;RPL34;RPS29;RPS8;RPS3;RPS23;RPS5;RPS4X;RPL13;RPS16;RPL9;RPS15;RPS27;RPL30;RPL37;RPL19;RPS11;RPS24;RPL18A;RPL18;RPS7;RPL23;RPL17;RPS20;RPL22;RPL23A;RPL26;RPS25;RPS18;RPL35A;RPL11;RPL13A;RPL7;RPL36;RPL32;RPS17;RPL39;RPS2;RPL8;RPL14;EIF3M;RPL24;RPL29;RPL10A;RPL3;RPL12;EIF3I;RPS12;RPL27;RPS27A;RPL5;RPS28;RPS10;GSPT2
prerank,protein targeting to ER (GO:0045047),-0.6193226788946227,-2.255814748703837,0.0,0.0,0.0,66/99,18.55%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPS21;RPLP2;RPL27A;RPS19;RPL34;RPS29;RPS8;RPS3;RPS23;RPS5;RPS4X;RPL13;RPS16;RPL9;RPS15;RPS27;RPL30;RPL37;RPL19;RPS11;RPS24;RPL18A;RPL18;RPS7;RPL23;RPL17;RPS20;RPL22;RPL23A;RPL26;RPS25;RPS18;RPL35A;RPL11;RPL13A;RPL7;RPL36;SRP14;RPL32;RPS17;SPCS3;ZFAND2A;RPL39;RPS2;RPL8;RPL14;RPL24;RPL29;RPL10A;RPL3;RPL12;SEC61G;RPS12;RPL27;RPS27A;RPL5;RPS28;RPS10
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5388112842166474,-2.017014044002032,0.0,0.019881389866169833,0.094,66/110,18.88%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPS21;RPLP2;RPL27A;RPS19;RPL34;RPS29;RPS8;RPS3;RPS23;RPS5;RPS4X;RPL13;RPS16;RPL9;RPS15;RPS27;RPL30;RPL37;RPL19;RPS11;RPS24;RPL18A;RPL18;RPS7;RPL23;RPL17;RPS20;RPL22;RPL23A;RPL26;RPS25;RPS18;RPL35A;RPL11;RPL13A;RPL7;RPL36;RPL32;RPS17;RPL39;RPS2;RPL8;RPL14;RPL24;RPL29;RPL10A;RPL3;SMG7;RPL12;CTIF;RPS12;RPL27;RPS27A;RPL5;RPS28;RPS10;MAGOH;GSPT2
prerank,bicarbonate transport (GO:0015701),0.8640665230505813,2.0100759336146163,0.0,0.05370220639230943,0.039,3/25,0.03%,SLC4A10;SLC26A7;SLC4A4
prerank,organic anion transport (GO:0015711),0.7390325029867387,2.0076897430300584,0.0,0.02788383793446836,0.039,9/76,2.45%,SLC4A10;SLC26A7;SLC4A4;SLC23A1;SLCO3A1;LRRC8D;SLCO2A1;SLCO4A1;ABCG2
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.6254245594212602,-2.0026001180757778,0.0,0.021987206861340466,0.122,19/41,17.69%,IL34;TGFA;GRM5;NEDD9;ACE;DOCK3;EPHA4;GPRC5B;ADRA2A;LRP8;GAS6;NTRK2;HBEGF;CSF1R;NOX4;AGT;FCGR1A;RELN;ERBB3
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.6281390663361686,-1.98910216288901,0.0,0.023889520533448397,0.153,16/46,9.33%,ATP1A2;CDH2;SHANK3;GRM7;GRM3;NRXN1;DGKI;GRM5;GRM1;MEF2C;GRIK1;OPHN1;GRM8;CACNG4;CACNG7;SYT1
prerank,response to glucocorticoid (GO:0051384),0.8447834642259383,1.9500654856958706,0.0,0.07848784011183686,0.161,7/26,7.30%,SLIT3;SLIT2;ANXA1;ADAM9;FAM107A;ISL1;IL10
prerank,regulation of intracellular pH (GO:0051453),0.8009173257177249,1.9421168629798258,0.0,0.07332416642026864,0.197,10/34,8.43%,SLC4A10;SLC4A4;SLC9A2;SLC9B1;SLC26A6;SLC4A2;SLC9A8;SLC9C1;SLC9A1;SLC4A8
prerank,cation transport (GO:0006812),0.6489397446705563,1.9027191431726644,0.0,0.15800841496198734,0.431,18/167,3.26%,SLC47A1;SLC4A4;PIEZO2;SLC23A1;SLC9B2;KCNB2;KCNK5;KCNJ2;SLC12A2;SLC5A6;KCNMB2;KCNMB3;ATP1B1;KCNS3;KCNJ15;ANO6;TRPM6;FGF13
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.7994751400353117,-1.9022014109790575,0.0,0.09650370898824259,0.524,7/12,14.20%,IL34;LYN;CSF1;BST2;PTK2;MAPK3;CSF1R
prerank,regulation of cellular pH (GO:0030641),0.7997373476857087,1.9001186352043695,0.0,0.13873069984679937,0.444,11/29,8.94%,SLC4A10;SLC4A4;SLC9A2;SLC9B1;SLC26A6;SLC4A2;SLC9A8;SLC9C1;SLC9A1;SLC4A8;ATP1A4
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.6929937732405091,1.8919358093691012,0.0,0.14414026276177558,0.507,21/79,9.41%,SLIT2;BMPER;THBS1;CRIM1;HTRA3;SMAD9;VWC2;NEDD4;SMAD6;SULF1;SKIL;BMPR1A;FGF2;ATP2B4;NOG;SKI;BAMBI;NBL1;CHRD;UBE2D3;NIBAN2
prerank,regulation of BMP signaling pathway (GO:0030510),0.7064133521958705,1.8886722669540243,0.0,0.1347718833499304,0.526,22/73,9.08%,BMPER;BMP4;CRIM1;FSTL1;HTRA3;SMAD9;FOXD1;VWC2;CCN1;SMAD6;SULF1;SKIL;BMPR1A;ZNF423;SFRP4;NOG;SKI;BAMBI;GDF5;NBL1;CHRD;UBE2D3
prerank,ion homeostasis (GO:0050801),0.8062454233032045,1.885369710004473,0.0,0.12782961094237758,0.55,5/30,1.93%,SLC4A10;SLC4A4;FHL1;CAMK2D;WNK1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.9263922384190959,1.8841233787703517,0.001669449081803005,0.11866122143223758,0.559,3/11,1.53%,EGFR;BMP4;DDX5
prerank,endoderm formation (GO:0001706),0.7519208267236591,1.8836801385457815,0.004213483146067416,0.10956376723745646,0.565,12/35,8.15%,COL8A1;COL12A1;COL6A1;FN1;INHBA;ITGB5;ITGA5;COL11A1;ITGAV;SETD2;DUSP5;MMP14
prerank,response to ketone (GO:1901654),0.8248832754005839,1.8798742614169415,0.0015552099533437014,0.10946988226124615,0.596,4/24,1.76%,SLIT3;SLIT2;THBS1;TGFB3
prerank,positive regulation of blood coagulation (GO:0030194),0.8736130001533875,1.8754709947800325,0.0,0.11058205813327622,0.622,5/17,3.01%,F3;ST3GAL4;THBS1;ANO6;THBD
prerank,chloride transport (GO:0006821),0.6876885862693022,1.8751036726390333,0.0,0.1034947741324315,0.625,11/74,4.01%,SLC4A10;SLC26A7;SLC12A7;SLC12A2;CLIC4;SLC12A8;ANO6;GLRB;ANO9;SLC26A6;GABRA3
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.6919515341300055,-1.8687941853338035,0.0,0.13976844173828637,0.679,5/19,2.80%,TJP1;PRKCH;CLDN5;OCLN;F11R
prerank,cellular response to drug (GO:0035690),-0.6584925851222128,-1.865916567959352,0.0031545741324921135,0.1316445300951526,0.696,11/25,13.74%,PDE4B;PPM1E;ACER2;TFRC;RAP2A;MEF2C;AIM2;GAS6;KCNQ1;CERS1;PPM1F
prerank,cellular component maintenance (GO:0043954),-0.7870036342328295,-1.857537615964017,0.0,0.1336968570864352,0.73,4/12,7.66%,IGF1R;ITGA3;INSR;CLDN1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.8267433597885866,-1.8518934797826268,0.0022471910112359553,0.13316195704755496,0.753,6/10,13.41%,LYN;RAPGEF2;CXCL12;GAS6;AXL;CCL19
prerank,endodermal cell differentiation (GO:0035987),0.765078814472888,1.8511980463740945,0.001466275659824047,0.15766417004921612,0.783,11/31,8.15%,COL8A1;COL12A1;COL6A1;FN1;INHBA;ITGB5;ITGA5;COL11A1;ITGAV;SETD2;MMP14
prerank,cellular response to copper ion (GO:0071280),-0.7256396548230115,-1.8470497228036062,0.002638522427440633,0.13142299052439368,0.775,11/16,19.01%,SNCA;MT2A;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;MT3
prerank,ion transport (GO:0006811),0.6485903432043003,1.8310227932032936,0.0,0.21964976965508293,0.887,11/111,3.93%,SLC26A7;PIEZO2;SLC9A2;SLC26A2;SLC12A7;SLC12A2;SLC24A3;WNK1;ANO6;GLRB;SLC26A6
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.716538561981649,1.8286569081279105,0.0013698630136986301,0.21559856389853638,0.895,15/51,9.08%,BMPER;CRIM1;FSTL1;HTRA3;SMAD9;VWC2;SMAD6;SKIL;BMPR1A;NOG;SKI;BAMBI;NBL1;CHRD;UBE2D3
prerank,regulation of phagocytosis (GO:0050764),-0.542992837202849,-1.8233322029527141,0.0,0.16862019909858994,0.876,28/53,24.22%,CAMK1D;MERTK;TGM2;DYSF;IL15RA;CD47;SYT7;SIRPA;GATA2;SYT11;GAS6;SPHK1;DOCK2;CALR;SCARB1;CYBA;HCK;RACK1;LYAR;SNX3;SYK;PRTN3;TREM2;RAB27A;AHSG;PYCARD;PLA2G5;TULP1
prerank,collagen fibril organization (GO:0030199),0.6532903281742071,1.8213756414699838,0.0,0.23248006442482672,0.918,22/88,6.16%,COL25A1;COL8A1;COL12A1;COL6A2;TLL1;COL8A2;ADAMTS2;COL6A1;CYP1B1;COL5A2;PLOD2;BMP1;DDR2;COL3A1;COL23A1;LOXL1;COL6A3;TGFBR1;P3H2;P4HA1;COL11A1;P4HA2
prerank,inorganic anion transport (GO:0015698),0.6959440303496413,1.8203088703018773,0.001321003963011889,0.22339683023521434,0.918,6/53,3.93%,SLC4A10;SLC26A7;CLIC4;ANO6;ANO9;SLC26A6
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.7831029279367318,1.8071235088086568,0.001557632398753894,0.2678397543816433,0.95,4/23,3.14%,SLC12A7;SLC12A2;SLC12A8;ATP6V0A4
prerank,response to copper ion (GO:0046688),-0.6655312690498182,-1.783550737277845,0.0079155672823219,0.26037807787345163,0.964,14/20,25.27%,SNCA;MT2A;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;ATP5F1D;MT3;AQP1;IL1A
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.8396355517973989,1.77530593473382,0.004807692307692308,0.42661780261289767,0.992,8/15,10.37%,BMP4;SIX1;SOX9;SMO;NOG;GDNF;SIX4;VEGFA
prerank,regulation of acrosome reaction (GO:0060046),-0.7528338035535409,-1.7699858983746461,0.007194244604316547,0.28411109992747957,0.977,2/10,8.20%,PLCB1;GLRA1
prerank,carbohydrate transport (GO:0008643),0.8624157838439389,1.7682078585089256,0.008403361344537815,0.4543563423698977,0.995,3/11,3.93%,SLC23A1;SLC23A2;SLC26A6
prerank,sulfate transport (GO:0008272),0.8279026461962594,1.7668716345664315,0.006369426751592357,0.44295339971582987,0.996,3/14,3.93%,SLC26A7;SLC26A2;SLC26A6
prerank,monosaccharide transmembrane transport (GO:0015749),0.8378108670007116,1.7657524484247522,0.008038585209003215,0.43181221245739193,0.996,2/16,0.16%,SLC23A1;SLC23A2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.6257017520733297,1.7637439459292974,0.0,0.4261889718072741,0.996,27/104,10.17%,BMPER;CRIM1;CCN3;HTRA3;SMAD9;VWC2;CD109;SMAD6;SKIL;BMPR1A;SPRED2;TGFBR1;PMEPA1;TGFBR2;HTRA4;NOG;SKI;IL17RD;TGFB1I1;BAMBI;NBL1;IGSF1;CHRD;UBE2D3;ACVR1;LDLRAD4;SMAD2
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.6166430947063857,-1.7636697367324259,0.003367003367003367,0.2860887189373256,0.982,12/26,16.03%,LYN;PICALM;MBP;GRIN2B;EPHA4;AIM2;GRIN1;ROCK2;APH1B;PSME2;TTBK1;VSIR
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.7964184077341501,1.7628572968438387,0.007704160246533128,0.4148018797003604,0.997,6/20,7.14%,SMOC2;THBS1;SULF1;FGF2;NOG;LRIT3
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.5054960904381256,-1.7610051511077698,0.0,0.279278817668341,0.984,38/69,28.18%,COX4I1;SDHA;UQCRH;COX7C;UQCR10;COX5B;NDUFB9;COX6B1;NDUFA8;NDUFC1;COX8A;COX6C;CYCS;NDUFB11;AFG1L;NDUFB3;NDUFA1;NDUFB8;NDUFA4;NDUFA3;NDUFS4;COX6A1;NDUFA11;UQCR11;NDUFA13;COX10;COX4I2;NDUFB7;CYC1;NDUFA6;UQCRB;NDUFA2;UQCRC1;NDUFA10;SDHC;COA6;NDUFS6;NDUFV3
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.8091253735873061,1.760887151791864,0.004975124378109453,0.41007218998002093,0.997,7/18,12.88%,EGFR;BMP4;DDX5;ESR1;NCOR1;ZC3H12A;NCOR2
prerank,carboxylic acid transmembrane transport (GO:1905039),0.707417180342902,1.7598077204661111,0.0014005602240896359,0.4013280959853838,0.997,7/40,3.57%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC5A6;SLC16A1;SLC38A6
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.6997295476099112,1.7583254018678873,0.0041265474552957355,0.3951812893471205,0.997,7/39,2.80%,STK39;FHL1;PTPN3;NEDD4;ANK2;FXYD5;WWP2
prerank,acute inflammatory response (GO:0002526),0.7700186361114401,1.7547491958654475,0.004594180704441042,0.40280097243359786,0.998,5/23,6.58%,F3;LBP;ANO6;VNN1;PLSCR1
prerank,positive regulation of RNA metabolic process (GO:0051254),0.6875951744988592,1.75341493666349,0.006896551724137931,0.3979027004651016,0.998,4/45,1.53%,SLC38A2;EGFR;BMP4;DDX5
prerank,negative regulation of calcium ion transport (GO:0051926),-0.6926279915049414,-1.7515433449340083,0.005154639175257732,0.29450470035401105,0.993,9/15,26.75%,ATP1A2;ADRA2A;SLC30A1;TMBIM6;STC1;INPP5K;TRIM27;NOS1;PLN
prerank,organic cation transport (GO:0015695),0.7783069875334024,1.7503887504001532,0.00463678516228748,0.4019274509674409,0.998,1/20,0.02%,SLC47A1
prerank,extracellular matrix organization (GO:0030198),0.5749657355638986,1.748561109122293,0.0,0.3997622287035902,0.998,53/276,6.16%,COL25A1;COL8A1;ADAMTSL3;COL12A1;SH3PXD2A;SMOC2;THBS1;CDH1;VIT;ADAMTS17;ADAMTSL1;COL6A2;THSD4;TLL1;COL8A2;ADAMTS2;COL6A1;CYP1B1;ITGB8;COL5A2;MFAP5;MMP28;PLOD2;BMP1;DDR2;FN1;DSPP;CD44;COL3A1;GSN;SMOC1;COL23A1;ITGB1;CAPN2;FGF2;LOXL1;COL6A3;ADAMTSL5;HTRA1;ITGB5;TGFBR1;P3H2;ADAM12;P4HA1;ITGA5;ITGA10;MMP16;COL11A1;TIMP2;ITGAV;ADAMTS5;FLRT2;P4HA2
prerank,aerobic electron transport chain (GO:0019646),-0.5029955484274939,-1.74246486855876,0.0,0.3066286320247361,0.997,37/68,28.18%,COX4I1;SDHA;UQCRH;COX7C;UQCR10;COX5B;NDUFB9;COX6B1;NDUFA8;NDUFC1;COX8A;COX6C;CYCS;NDUFB11;AFG1L;NDUFB3;NDUFA1;NDUFB8;NDUFA4;NDUFA3;NDUFS4;COX6A1;NDUFA11;UQCR11;NDUFA13;COX10;COX4I2;NDUFB7;CYC1;NDUFA6;UQCRB;NDUFA2;UQCRC1;NDUFA10;SDHC;NDUFS6;NDUFV3
prerank,positive regulation of chemotaxis (GO:0050921),0.6860207908622827,1.7406615562875756,0.005434782608695652,0.43180461881961024,0.998,7/43,3.76%,SMOC2;F3;THBS1;MET;NTRK3;FGF2;NRP1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.82556056345149,1.7364952377918779,0.01565217391304348,0.441331813741633,0.998,1/13,0.01%,SLC4A10
prerank,mesonephric tubule development (GO:0072164),0.8191978556882968,1.7364072364173042,0.006462035541195477,0.4296463382145397,0.998,5/15,2.06%,SLIT2;BMP4;SIX1;PKD1;WNT11
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.7441792660732509,-1.7344511008360861,0.004640371229698376,0.31600526883411467,0.998,5/11,6.52%,PLCB1;IGF1;IGF1R;PIK3R1;GHR
prerank,cGMP-mediated signaling (GO:0019934),-0.7388143828194824,-1.734006807422866,0.007832898172323759,0.3028238035902801,0.998,6/13,7.46%,IRAG1;APOE;GUCY1B1;KCNC2;PDE2A;HTR2C
prerank,ceramide transport (GO:0035627),-0.7377408296284347,-1.7322160328410372,0.002457002457002457,0.29559530890010327,0.998,6/12,20.69%,PLTP;CERT1;ABCB4;PSAP;ABCA2;SGPP1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.6789349633156492,-1.7293161763481886,0.010498687664041995,0.2916014600114045,0.998,12/17,21.08%,COX4I1;COX7C;COX5B;COX6B1;COX8A;COX6C;CYCS;AFG1L;NDUFA4;COX6A1;COX10;COX4I2
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.8398426031827301,1.7284217274574194,0.01309328968903437,0.46277680976324864,1.0,6/11,6.32%,BMP4;ZFPM2;BMPR1A;ISL1;JAG1;GATA4
prerank,positive regulation of heart contraction (GO:0045823),-0.6647897792511283,-1.725838814222671,0.008241758241758242,0.2890791248017479,0.998,8/19,13.85%,ATP1A2;RYR2;KCNQ1;EDN1;ADM;ATP2A2;GSK3A;CHGA
prerank,sprouting angiogenesis (GO:0002040),0.6685783113018404,1.7228550181925875,0.004166666666666667,0.48315679415105106,1.0,11/51,3.76%,RSPO3;SLIT2;BMPER;THBS1;BMP4;PGF;PTK2B;SEMA3E;PARVA;FGF2;NRP1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.5540773797123406,-1.7224223473396532,0.0,0.28889474670737436,0.998,17/37,9.69%,PLCB1;GRM7;GRM3;GRM5;GRIA4;GRID2;GRIK2;GRM1;GRIN2A;APP;GRIN2B;GRIK1;GRIA3;GRM8;GRIN1;CPEB4;GRIA2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.8582638810899713,1.7213982769745377,0.008802816901408451,0.4798509280251672,1.0,2/11,0.41%,SLIT2;CCN3
prerank,positive regulation of phosphatase activity (GO:0010922),-0.6395381098218731,-1.7150113495680166,0.005780346820809248,0.29990687793966125,0.999,9/21,9.54%,ITGA1;PDGFRB;CALM1;MEF2C;BMP2;HSP90AB1;CD300A;PPP1R15B;PLEK
prerank,transepithelial transport (GO:0070633),0.7970747847156701,1.7131676530335311,0.009569377990430622,0.5193364815294731,1.0,6/15,3.93%,SLC23A1;SLC23A2;SLC12A2;CXADR;ABCG2;SLC26A6
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.7475332550569764,-1.7125636218558185,0.023696682464454975,0.29649549373179845,1.0,2/10,1.92%,LYN;KIT
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.6626277529355737,-1.710866928805885,0.007792207792207792,0.29184573264712727,1.0,6/16,6.25%,APOE;NOS3;GUCY1B1;KCNC2;NDNF;GUCY1A1
prerank,chemical homeostasis (GO:0048878),0.6518600652298764,1.7098412947954995,0.003896103896103896,0.5271229236265758,1.0,7/61,6.46%,SLC4A10;SLC4A4;WNK1;PNPLA3;RBP1;SLC4A2;ACOX3
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.6765912768560349,-1.7087075170328951,0.005115089514066497,0.2894259652480113,1.0,5/15,12.03%,PLTP;APOE;ABCA5;ABCG1;SCARB1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.6968739561643599,1.7080905339604016,0.012413793103448275,0.5254898593452586,1.0,10/35,6.13%,NR3C2;NEDD4;DDX5;RBFOX2;ESR2;PMEPA1;DDX17;UBR5;ESR1;TADA3
prerank,aorta development (GO:0035904),-0.6827547822082918,-1.7070491835734378,0.010050251256281407,0.28515439339253235,1.0,7/14,9.74%,ROBO1;PDGFRB;ADAMTS9;ROBO2;TBX1;PDE2A;EFEMP2
prerank,positive regulation of phagocytosis (GO:0050766),-0.5240328088347431,-1.7070181886219085,0.0076045627376425855,0.27630138340586785,1.0,24/47,24.22%,CAMK1D;MERTK;IL15RA;CD47;SIRPA;GATA2;GAS6;C4B;DOCK2;CALR;CYBA;MYO18A;C2;RAB31;LYAR;CCL2;TREM2;RAB27A;AHSG;C3;PTPRJ;PYCARD;PLA2G5;TULP1
prerank,ureteric bud development (GO:0001657),0.7885985807699967,1.7060489429344579,0.009554140127388535,0.525878135584082,1.0,5/17,2.25%,SLIT2;BMP4;SIX1;WNT11;GPC3
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.7302884320569242,1.7039581679315179,0.011730205278592375,0.5270467852007465,1.0,5/27,5.81%,EGFR;BMP4;DDX5;EIF4G1;STAT3
prerank,renal water homeostasis (GO:0003091),-0.6136374088369696,-1.7031579547372429,0.005291005291005291,0.2788236834247324,1.0,10/23,14.70%,ADCY5;ADCY1;PRKAR2B;ADCY7;PRKAR1B;PRKACB;PRKAR1A;AQP4;ADCY2;ADCY4
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.7544522143599067,-1.7029329463717644,0.01240694789081886,0.2711694791532015,1.0,3/10,12.09%,ATP1A2;ADRA2A;BIN1
prerank,embryonic skeletal system development (GO:0048706),0.7117809814773335,1.701846900056171,0.010218978102189781,0.5283241424604083,1.0,11/35,6.85%,KIAA1217;SIX1;PCSK5;WNT9A;WNT11;SULF1;HOXA3;NOG;HOXB3;XYLT1;HOXC4
prerank,response to interferon-alpha (GO:0035455),-0.6674197001887522,-1.7002723110593176,0.00516795865633075,0.27082753111419333,1.0,8/16,15.89%,IFNAR1;IFITM1;BST2;IFITM3;GAS6;IFNAR2;AXL;ADAR
prerank,digestive tract development (GO:0048565),0.7067775372662496,1.7000430142219032,0.007363770250368188,0.5284907769544165,1.0,15/32,11.69%,PCSK5;RARB;PKD1;COBL;SMO;GLI3;STRA6;CLMP;EPHB3;GATA4;AGR2;GLI2;MEGF8;CCDC40;NIPBL
prerank,neuron cell-cell adhesion (GO:0007158),-0.7204930563117231,-1.6989765516837652,0.012953367875647668,0.26704649835815863,1.0,6/14,7.41%,NRXN1;NCAM2;NRXN3;ASTN2;CNTN4;ASTN1
prerank,sulfur compound transport (GO:0072348),0.7213553420316161,1.6954763697792676,0.013595166163141994,0.5438996378186723,1.0,5/27,3.93%,SLC26A7;SLC5A6;LRRC8D;ABCG2;SLC26A6
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.5704173094899051,-1.6954155867966432,0.003663003663003663,0.2690189581032376,1.0,15/35,7.46%,KSR1;IRAG1;APOE;PDE7B;ADCY1;RAPGEF3;RAPGEF2;GUCY1B1;RIMS2;CAP2;AHR;AKAP6;PDE4D;PDE2A;HTR2C
prerank,negative regulation of leukocyte migration (GO:0002686),0.8556537387604762,1.6920181869267616,0.008532423208191127,0.5529864217528594,1.0,2/10,1.17%,SLIT2;BMP5
prerank,ventricular septum morphogenesis (GO:0060412),0.7024855609796188,1.6897066222116335,0.01337295690936107,0.5565597190744564,1.0,9/27,5.56%,SLIT3;SLIT2;BMP4;ZFPM2;HES1;BMPR1A;TGFBR1;TGFBR2;NOG
prerank,cellular response to glucagon stimulus (GO:0071377),-0.6577429854259953,-1.6875694694591297,0.0024390243902439024,0.2827939456246759,1.0,10/17,14.70%,ADCY5;ADCY1;PRKAR2B;ADCY7;PRKAR1B;PRKACB;PRKAR1A;CYSLTR2;ADCY2;ADCY4
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.7512943371492156,-1.6859937586413438,0.014018691588785047,0.2802118248211787,1.0,5/10,14.04%,PDE4B;CALM1;CACNA2D1;NOS1AP;CALM3
prerank,response to glucagon (GO:0033762),-0.6399982751892924,-1.6829552632632387,0.0024691358024691358,0.28121947254624335,1.0,10/19,14.70%,ADCY5;ADCY1;PRKAR2B;ADCY7;PRKAR1B;PRKACB;PRKAR1A;CYSLTR2;ADCY2;ADCY4
prerank,regulation of cell junction assembly (GO:1901888),-0.579106226753018,-1.681857432550329,0.009868421052631578,0.27705693400234616,1.0,7/27,5.39%,TJP1;PRKCH;CLDN5;OCLN;RAPGEF2;F11R;MEF2C
prerank,positive regulation of hemostasis (GO:1900048),0.8680551912684016,1.6811622124874603,0.008561643835616438,0.5898535331831001,1.0,2/10,0.27%,ST3GAL4;THBS1
prerank,positive regulation of coagulation (GO:0050820),0.8680551912684016,1.6811622124874603,0.008561643835616438,0.5898535331831001,1.0,2/10,0.27%,ST3GAL4;THBS1
prerank,circulatory system development (GO:0072359),0.5898622927884157,1.6793281869998893,0.003416856492027335,0.5896915355770901,1.0,31/118,9.60%,MICAL2;PLCE1;NXN;ZFPM2;PCSK5;NTRK3;PKD1;SOX9;CACNA1C;FN1;AKAP13;CXADR;HDAC9;COL3A1;PDLIM7;FOXC2;MEF2A;TGFBR1;STRA6;FOXL1;TCF25;TGFBR2;ISL1;PDLIM5;ID2;GLI2;CDKN1B;FOXC1;NF1;TNNI3;ACVR1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6633728667553654,1.6789054659632308,0.008344923504867872,0.581819368892586,1.0,13/43,8.73%,BMP4;KLF5;NFIB;SOX9;DDX5;FOXO3;KLF4;FGF2;NFATC4;STAT3;TEAD1;IL10;ATOH8
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.6759803363530198,1.6784579490793716,0.012482662968099861,0.5738562695896142,1.0,11/39,6.07%,SLIT2;BMP4;SIX1;MET;PKD1;LRP6;SEMA3E;FGF2;NRP1;TGFBR2;GDNF
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.7529765657940344,-1.6726865376405002,0.016548463356973995,0.29550009704290475,1.0,3/10,2.93%,ENG;ERRFI1;ENPP1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.8178296564963623,1.6701464550371163,0.025806451612903226,0.6170496176447805,1.0,7/12,10.37%,SIX1;SOX9;SMO;NOG;GDNF;SIX4;VEGFA
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.5828761292839754,-1.6699905772833772,0.008982035928143712,0.2956065813398562,1.0,8/25,9.88%,ERRFI1;PPARA;SLC6A9;CBLB;CNRIP1;SOCS5;ZFYVE28;ACE2
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.7763040975057008,1.6694867949612147,0.013333333333333334,0.609792979590695,1.0,6/17,8.73%,BMP4;SOX9;FGF2;TMEM100;SFRP4;ATOH8
prerank,regulation of T cell chemotaxis (GO:0010819),0.8161574932864286,1.6679864316213082,0.01929824561403509,0.6075560347345856,1.0,2/11,1.93%,STK39;WNK1
prerank,xenobiotic transport (GO:0042908),0.7545213365512055,1.6622752608587825,0.021996615905245348,0.6321939117901015,1.0,2/17,2.45%,SLC47A1;ABCG2
prerank,response to zinc ion (GO:0010043),-0.5777335466927702,-1.660858811494147,0.005698005698005698,0.31502797026683715,1.0,13/25,13.58%,PAM;CRIP1;GLRA1;MT2A;SLC30A4;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X
prerank,negative regulation of cartilage development (GO:0061037),0.799466872303049,1.6601978009737457,0.02254428341384863,0.6342741691107315,1.0,7/13,7.37%,WNT9A;SOX9;WNT11;TGFBR1;EFEMP1;PTHLH;GDF5
prerank,positive regulation of wound healing (GO:0090303),0.6819961351793707,1.659739447032018,0.0111731843575419,0.6268183494194655,1.0,8/36,3.72%,SMOC2;ST3GAL4;THBS1;ANXA1;PLPP3;ITGB1;PRKCE;FOXC2
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.7349655854698603,1.6591505283502814,0.018072289156626505,0.6200979550854722,1.0,7/21,4.08%,BMP4;CCN3;TGFB3;BMP6;BMPR1A;NUP93;TGFBR1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.6350296516426216,-1.658674885477034,0.008,0.31430350916154676,1.0,4/18,7.42%,IGF1;IGFBP2;RPS3;IL18
prerank,regulation of cellular senescence (GO:2000772),-0.5741971737050728,-1.6583643554260497,0.0060790273556231,0.30829887881662177,1.0,10/28,13.89%,SLC30A10;B2M;AKT3;CDK6;NUAK1;YPEL3;ABI3;YBX1;RBL1;VASH1
prerank,peptide biosynthetic process (GO:0043043),-0.42383252217665873,-1.6566670065177849,0.0,0.30632521252339817,1.0,71/153,18.88%,RPS14;EEF1A1;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;GGT5;RPL37A;RPS21;RPLP2;RPL27A;RPS19;RPL34;RPS29;RPS8;RPS3;RPS23;RPS5;RPS4X;RPL13;RPS16;RPL9;RPS15;RPS27;RPL30;RPL37;RPL19;RPS11;RPS24;RPL18A;RPL18;RPS7;RPL23;RPL17;EIF4EBP2;RPS20;RPL22;RPL23A;RPL26;RPS25;RPS18;RPL35A;MRPL3;RPL11;RPL13A;RPL7;RPL36;RPL32;RPS17;RPL39;RPS2;RPL8;RPL14;RPL24;RPL29;MRPS11;MRPL51;RPL10A;RPL3;RPL12;GGT1;PCSK1;RPS12;RPL27;RPS27A;RPL5;RPS28;RPS10;GSPT2
prerank,regulation of smooth muscle contraction (GO:0006940),0.7151594570626881,1.654280823365362,0.032357473035439135,0.6405287359211745,1.0,3/20,2.73%,KCNB2;PLCE1;ADRB2
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.6206599118430373,1.6531691627323526,0.01303780964797914,0.6370334073905789,1.0,17/56,10.79%,BMPER;BMP4;BMP5;TGFB3;SMAD6;BMP6;INHBA;BMPR1A;TGFBR1;PMEPA1;NOG;GDF6;GDF5;GDF10;ACVR1;LDLRAD4;INHBB
prerank,organic acid transport (GO:0015849),0.5908579717781424,1.6525102638533338,0.001184834123222749,0.6312268358336419,1.0,9/94,2.45%,SLC26A7;SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC5A6;LRRC8D;SLC16A1;ABCG2
prerank,axon extension (GO:0048675),0.7265679416693521,1.6523346548290634,0.0182370820668693,0.6225483884822072,1.0,5/23,3.76%,SLIT3;SLIT2;ULK2;ALCAM;NRP1
prerank,regulation of fibrinolysis (GO:0051917),0.8203664349187642,1.6517325273500585,0.022108843537414966,0.6162922788366839,1.0,2/13,3.01%,THBS1;THBD
prerank,heart development (GO:0007507),0.5707661221683588,1.6508534957711296,0.0011160714285714285,0.6123654579660359,1.0,37/150,9.60%,MICAL2;BMP4;PLCE1;ZFPM2;SGCD;PCSK5;NTRK3;PKD1;SOX9;BMP5;CACNA1C;CSRP3;FN1;AKAP13;GPC3;CXADR;HDAC9;COL3A1;PDLIM7;FOXC2;MEF2A;TGFBR1;STRA6;FOXL1;TCF25;TGFBR2;ISL1;FLRT2;GATA4;PDLIM5;ID2;GLI2;CDKN1B;FOXC1;NF1;TNNI3;ACVR1
prerank,epiboly involved in wound healing (GO:0090505),0.7823378094005728,1.6506827490905165,0.0192,0.604180196464608,1.0,5/16,8.86%,TMEFF2;CCN1;CD44;MRTFA;RHOA
prerank,regulation of multicellular organism growth (GO:0040014),-0.6599956074300887,-1.6503593934768765,0.019230769230769232,0.31773062309486366,1.0,6/15,11.48%,IGF1;PTCH1;APP;GHR;MFSD2A;PPIB
prerank,carboxylic acid transport (GO:0046942),0.6323778387020935,1.6473944104406213,0.006631299734748011,0.6154500353544492,1.0,8/55,3.57%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC16A9;SLC16A1;SLC6A7;SLC38A6
prerank,negative regulation of T cell differentiation (GO:0045581),0.8263146956685916,1.6461352905647377,0.015985790408525755,0.6135919680923486,1.0,3/10,6.67%,BMP4;GLI3;IRF1
prerank,secretion (GO:0046903),-0.6772776713158857,-1.6449552892270969,0.02072538860103627,0.3269830723173421,1.0,6/14,9.86%,RIMS1;SLC22A6;NPR1;SLC22A4;FBLN5;SLC22A2
prerank,central nervous system neuron development (GO:0021954),-0.6554519792035228,-1.644419973072388,0.02962962962962963,0.32200419287918053,1.0,6/15,8.14%,RAPGEF2;MAP2;LHX6;NTRK2;HSP90AB1;MAPT
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.7814483241593233,1.6421261649499572,0.028428093645484948,0.6290663656702594,1.0,3/14,1.93%,STK39;PTK2B;WNK1
prerank,extracellular structure organization (GO:0043062),0.5509095866065171,1.6406154580565961,0.0,0.6291506087034905,1.0,39/204,6.00%,COL8A1;ADAMTSL3;SH3PXD2A;SMOC2;THBS1;CDH1;VIT;ADAMTS17;ADAMTSL1;COL6A2;THSD4;COL8A2;ADAMTS2;COL6A1;ITGB8;COL5A2;MFAP5;MMP28;DDR2;FN1;DSPP;CD44;COL3A1;SMOC1;COL23A1;ITGB1;FGF2;LOXL1;COL6A3;ADAMTSL5;ITGB5;TGFBR1;ADAM12;ITGA5;ITGA10;MMP16;COL11A1;ITGAV;ADAMTS5
prerank,regulation of membrane depolarization (GO:0003254),0.7348670931598846,1.6399634398747875,0.027156549520766772,0.6240830170680554,1.0,3/18,1.69%,FHL1;PTPN3;CAMK2D
prerank,regulation of T cell migration (GO:2000404),-0.6240721678708827,-1.6381449101757088,0.022900763358778626,0.3336517654285932,1.0,5/18,4.57%,APOD;LRCH1;CXCL12;RIPOR2;APP
prerank,positive regulation of potassium ion transport (GO:0043268),0.6750882815357815,1.6369454423172523,0.013850415512465374,0.6340712175748926,1.0,6/38,2.75%,KCNJ2;FHL1;KCNMB2;KCNMB3;ANK2;KCNJ15
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.7472365218641552,1.634993781106718,0.032520325203252036,0.6371284845569635,1.0,5/17,7.14%,SLIT2;FSTL1;SULF1;SFRP4;LRIT3
prerank,skeletal system development (GO:0001501),0.5570261636788878,1.6344721268129248,0.002254791431792559,0.631775476163371,1.0,31/148,6.15%,KIAA1217;TNFRSF11B;CDH11;TLL1;EXT1;PCSK5;PKD1;SOX9;BMP5;ITGB8;BMP1;AKAP13;WNT11;SULF1;DSPP;ZBTB16;CD44;ALPL;FGFR1;PAPSS2;BMP6;CMKLR1;HHIP;TGFBR1;NPR3;PHEX;MMP16;NOG;SLC10A7;XYLT1;PTHLH
prerank,negative regulation of interleukin-12 production (GO:0032695),0.7780180094894922,1.63419026363976,0.023529411764705882,0.6251934687240539,1.0,6/14,15.37%,THBS1;CMKLR1;IL10;IRAK3;PIBF1;TLR8
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.635800020548811,-1.6291440760163305,0.013297872340425532,0.35312335613303986,1.0,7/18,13.84%,CAMK1D;PRKD1;RPS6KA5;ADCY1;LRP8;CD200;EPHA5
prerank,external encapsulating structure organization (GO:0045229),0.5453234465551309,1.6260141076511574,0.0010775862068965517,0.6673452437849043,1.0,38/205,6.00%,COL8A1;ADAMTSL3;SH3PXD2A;SMOC2;THBS1;CDH1;VIT;ADAMTS17;ADAMTSL1;COL6A2;THSD4;COL8A2;ADAMTS2;COL6A1;ITGB8;COL5A2;MFAP5;MMP28;DDR2;FN1;DSPP;CD44;COL3A1;SMOC1;COL23A1;ITGB1;FGF2;LOXL1;COL6A3;ADAMTSL5;ITGB5;ADAM12;ITGA5;ITGA10;MMP16;COL11A1;ITGAV;ADAMTS5
prerank,cellular response to estradiol stimulus (GO:0071392),0.7325873715906515,1.6252782235033272,0.025356576862123614,0.663381734562837,1.0,4/18,7.26%,EGFR;ESR1;LCOR;MYOG
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.7110235041215456,-1.6241126428424992,0.00963855421686747,0.36237698175218563,1.0,7/11,19.56%,MERTK;CXCL12;GAS6;AXL;CCL19;SELENOS;IRF7
prerank,negative regulation of leukocyte activation (GO:0002695),-0.6761792016024246,-1.624048919594145,0.017721518987341773,0.3558555451642929,1.0,8/15,13.65%,IL31RA;NR1H3;LRFN5;GRN;CD300A;CD84;CD200;HAVCR2
prerank,ureteric bud morphogenesis (GO:0060675),0.7762263889240009,1.6234573281951103,0.011272141706924315,0.6661139062122996,1.0,5/16,6.07%,BMP4;SIX1;WNT11;FGF2;GDNF
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.8198205196138214,1.6233385527523354,0.029982363315696647,0.65843851963866,1.0,2/10,1.93%,STK39;WNK1
prerank,nucleotide biosynthetic process (GO:0009165),0.7373947768165328,1.6231864262236375,0.02564102564102564,0.6512777900935988,1.0,4/18,8.34%,ME1;NMNAT2;PRPS2;NMNAT1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.6840662223746552,-1.6204875386259596,0.027160493827160494,0.35997646511295267,1.0,8/12,20.85%,MAP2;SNCA;ARHGEF7;STMN1;TUBB4A;STMN2;CDH5;DYRK1A
prerank,detection of mechanical stimulus (GO:0050982),0.7377947324534866,1.6199620010723899,0.0219435736677116,0.6634138647880339,1.0,5/19,7.59%,PIEZO2;PKD1;CSRP3;PKD2L2;JUP
prerank,histone H4 deacetylation (GO:0070933),0.8258976383515235,1.6189418040669934,0.03368794326241135,0.661737078035637,1.0,3/10,5.43%,HDAC4;HDAC9;HDAC8
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.7783041538382418,1.6178672904496998,0.04,0.6604156404208984,1.0,7/12,17.95%,FOXP1;PIAS2;NCOR1;SMARCA4;NCOR2;ZBTB7A;HEYL
prerank,cartilage development (GO:0051216),0.6402257263372112,1.6157352297003789,0.007978723404255319,0.665585530299674,1.0,11/49,3.46%,BMP4;CCN3;NFIB;PKD1;SOX9;ITGB8;SULF1;ZBTB16;CD44;FGF2;SLC39A14
prerank,base conversion or substitution editing (GO:0016553),-0.7050473652669994,-1.614042293044074,0.024830699774266364,0.37222859181179285,1.0,5/11,20.78%,APOBEC1;ADARB2;ADARB1;ADAR;METTL3
prerank,mesenchyme development (GO:0060485),0.744334432222949,1.6136019123878298,0.03514376996805112,0.6710639106476651,1.0,5/15,6.32%,BMP4;WNT11;TGFBR1;ISL1;GATA4
prerank,negative regulation of endocytosis (GO:0045806),-0.569578031288204,-1.6119701137150968,0.039755351681957186,0.3714680738152784,1.0,7/24,8.57%,PRKD1;MCTP1;PICALM;NR1H3;SYT11;CD300A;RAC1
prerank,vesicle transport along actin filament (GO:0030050),-0.6209283242231125,-1.6118272051377593,0.014492753623188406,0.3655920418187724,1.0,7/19,16.92%,MYO1B;FNBP1L;MYO6;MYO5A;ACTN4;MYO5C;MYO1F
prerank,amino acid transmembrane transport (GO:0003333),0.6369308244048462,1.6111081747760945,0.02086230876216968,0.6774387814676708,1.0,5/45,3.57%,SLC47A1;SLC38A2;SLC38A1;LRRC8D;SLC38A6
prerank,peptide cross-linking (GO:0018149),0.6903606538333754,1.6102987786631742,0.027820710973724884,0.6749791796962504,1.0,7/25,8.35%,THBS1;ANXA1;FN1;DSP;COL3A1;TGM3;SPRR1A
prerank,protein hydroxylation (GO:0018126),0.7644255366592801,1.6100796833996496,0.016181229773462782,0.6686268940755294,1.0,7/15,14.50%,EGLN3;PLOD2;P3H2;P3H1;P3H4;JMJD4;P3H3
prerank,cellular response to zinc ion (GO:0071294),-0.6410380404779068,-1.608936528740073,0.020151133501259445,0.36833951508747403,1.0,12/15,20.94%,GLRA1;MT2A;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;MT3;HVCN1
prerank,negative regulation of cell growth (GO:0030308),0.5563554857627486,1.6088714309023668,0.008064516129032258,0.6678048674871209,1.0,12/121,4.06%,SLIT3;SLIT2;CCN3;FHL1;NDRG3;OSGIN2;WNT11;ULK2;ESR2;INHBA;FGF13;IP6K2
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.7578750427002761,1.607156765408176,0.015463917525773196,0.67072753640194,1.0,4/13,6.03%,BMP4;NR3C2;ESR2;ESR1
prerank,pharyngeal system development (GO:0060037),0.7527902491021431,1.6062786143065535,0.03231017770597738,0.668712400069992,1.0,8/15,8.09%,BMP4;BMP5;HES1;BMPR1A;TGFBR1;NOG;ISL1;SIX4
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.7652107137731629,1.6031828785366717,0.01757188498402556,0.6790230904412201,1.0,5/16,6.07%,BMP4;SIX1;FOXD1;FGF2;GDNF
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.6099983490818461,-1.6008450859272123,0.01876675603217158,0.38689742101712277,1.0,8/19,16.99%,CAMK1D;RIPOR2;DAPK2;RAC1;MDK;CCL19;CD74;THBS4
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.577721589872668,1.6004722941137048,0.009650180940892641,0.6876056596612056,1.0,23/86,10.89%,THBS1;BMP4;BMP5;FOXD1;CCN1;TGFB3;SULF1;GIPC1;BMP6;INHBA;BMPR1A;ZNF423;NUP93;TGFBR1;CREBBP;TGFB1I1;GDF6;GDF5;GDF10;ACVR1;SMAD2;INHBB;RNF111
prerank,response to hydrogen peroxide (GO:0042542),0.6292034444620853,1.5998595208202149,0.024226110363391656,0.6838640345270655,1.0,7/45,3.58%,MAP3K5;CYP1B1;ANXA1;ADAM9;PRKCD;NFE2L2;ABL1
prerank,neutral amino acid transport (GO:0015804),0.6728860356307982,1.5994041475417533,0.03167420814479638,0.6797098058084494,1.0,4/28,3.57%,SLC38A2;SLC38A1;SLC6A7;SLC38A6
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.7007304108780162,1.5985751867289903,0.04451038575667656,0.6776742124156676,1.0,8/23,8.09%,BMP4;SIX1;SOX9;SMO;FGF2;NOG;GDNF;SIX4
prerank,positive regulation of epithelial cell migration (GO:0010634),0.5689158174483596,1.5962484764196176,0.014201183431952662,0.6845779515336647,1.0,15/92,3.76%,SMOC2;FOXP1;THBS1;BMP4;DOCK5;SOX9;PTK2B;ADAM9;ANXA3;MAPRE2;FGF2;PRKCE;ABL1;FOXC2;NRP1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6856317535639296,1.5956480259171975,0.0382262996941896,0.6812124880864451,1.0,10/26,12.88%,FOXP1;CRY2;ISL1;PIAS2;STRN3;KANK2;NCOR1;PER1;SMARCA4;NCOR2
prerank,activation of protein kinase A activity (GO:0034199),-0.628409444452888,-1.5951117465704558,0.014778325123152709,0.39922695921702905,1.0,7/16,6.67%,ADCY5;ADCY1;PRKAR2B;ADCY7;PRKAR1B;PRKACB;PRKAR1A
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.669366793310874,1.5920619641100138,0.025449101796407185,0.6959814128520437,1.0,2/27,0.30%,SLC47A1;SLC38A1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.6909240531837184,-1.5918938030507757,0.03044496487119438,0.40284239159037516,1.0,5/11,16.35%,NOS3;CALM1;QDPR;AKT1;GCH1
prerank,sensory perception of sound (GO:0007605),-0.43180103854932494,-1.5911780808013365,0.0,0.39858632746825723,1.0,19/88,9.33%,COL4A3;CACNA1D;CEMIP;GRM7;DCDC2;KIT;ADGRV1;USP53;RIPOR2;PCDH15;TBX1;EPS8L2;CLIC5;ALDH7A1;EYA1;KCNQ1;GRAP;CCDC50;NDUFB9
prerank,response to hexose (GO:0009746),0.6864045513284122,1.5909654001060025,0.031914893617021274,0.6953949734986041,1.0,2/25,0.73%,THBS1;TCF7L2
prerank,sodium ion transport (GO:0006814),0.5733084070679748,1.5904618340960617,0.0072992700729927005,0.6915813453901313,1.0,11/85,4.42%,SLC4A4;SLC23A1;SLC9B2;SLC12A2;SLC5A6;SLC24A3;ATP1B1;SLC6A7;ANO6;FGF13;NALCN
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.624393884213943,1.5900890481433791,0.030054644808743168,0.6870466449465801,1.0,10/38,7.59%,KCNJ2;ANK2;CACNA1C;CAMK2D;DSP;CACNA1G;DSG2;TRPM4;ISL1;JUP
prerank,gland development (GO:0048732),0.6071815088273086,1.5899753837813368,0.0076726342710997444,0.6811328199780609,1.0,18/59,9.89%,SIX1;MET;SOX9;IGSF3;COBL;EZR;TGFB3;ANXA1;WNT11;HES1;TGFBR1;STRA6;EPHB3;GLI2;RIPK3;NF1;DKK3;FOXE1
prerank,embryonic digestive tract development (GO:0048566),0.7221239329594412,1.5896907447128719,0.029850746268656716,0.6764899674981867,1.0,6/18,8.12%,PCSK5;RARB;GLI3;STRA6;ID2;GLI2
prerank,cellular response to amyloid-beta (GO:1904646),-0.5175452477768524,-1.5884232466424058,0.025089605734767026,0.40141652597049826,1.0,14/35,10.85%,IGF1;IGF1R;VCAM1;GRM5;GRIN2A;CASP4;APP;GJA1;EPHA4;ITGA4;CACNA2D1;GRIN1;LGMN;CACNB1
prerank,regulation of sensory perception of pain (GO:0051930),0.7805446591836637,1.588086840493694,0.03880070546737213,0.6792209508350093,1.0,6/11,12.77%,CCN3;MGLL;TMEM100;ACP3;CCL3;SCN11A
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.6396582336685303,1.5867309004237928,0.018641810918774968,0.6803618206575527,1.0,8/44,2.87%,KCNJ2;KCNMB2;KCNMB3;ANK2;ATP1B1;WNK1;KCNJ15;ANO6
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.7313419433598763,1.5856396182307482,0.042993630573248405,0.6802974282605154,1.0,4/13,5.37%,BMP4;NFIB;SOX9;NFATC4
prerank,positive regulation of DNA replication (GO:0045740),0.7312661652800009,1.5836968051911862,0.03322784810126582,0.685491765302112,1.0,4/16,8.57%,EGFR;GLI2;BCAR3;STN1
prerank,response to estradiol (GO:0032355),0.6546005530172846,1.583638486704647,0.04129793510324484,0.6796418008925522,1.0,8/31,8.60%,EGFR;ANXA1;STAT3;ESR1;LCOR;MYOG;SOCS2;STRN3
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.7794398298484388,1.5817321740353965,0.03697183098591549,0.6840576722904992,1.0,2/12,1.49%,BMP4;NEDD4
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.6591390952802009,1.5816603998141936,0.030303030303030304,0.6783056596716838,1.0,11/30,17.95%,FOXP1;DDX5;KDM1A;PIAS2;NCOR1;SMARCA4;NCOR2;EP300;ZBTB7A;RNF14;HEYL
prerank,cellular response to peptide (GO:1901653),-0.46467004904626874,-1.581561227835439,0.017543859649122806,0.4166802004086622,1.0,17/56,10.85%,IGF1;IGF1R;VCAM1;GRM5;GRIN2A;NOD1;CASP4;APP;GJA1;EPHA4;VIM;ITGA4;CACNA2D1;GRIN1;RPL23;LGMN;CACNB1
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.6981543421920645,-1.581013022741034,0.027586206896551724,0.41236570102622855,1.0,4/11,4.96%,MECOM;WNT5A;ETV6;CD34
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.5974988170767208,1.5809519983985816,0.02838709677419355,0.6763778400588729,1.0,22/59,18.33%,STK39;CAMK2D;CIT;WNK1;PRKCD;HIPK1;GSK3B;TGFBR1;TGFBR2;MARK2;NLK;ACVR1;PRKDC;CHEK1;PRKCA;CDC42BPG;DYRK2;CAD;CDC42BPA;CDK10;CSNK2A2;CSNK2A1
prerank,B cell receptor signaling pathway (GO:0050853),-0.5326297977548052,-1.5805677013533046,0.028938906752411574,0.4075976113237984,1.0,9/32,11.51%,BCL2;RFTN1;TEC;PRKCB;MEF2C;VAV3;CD38;BMX;BLNK
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.7535685957767598,1.580109923620306,0.031496062992125984,0.6749684840555801,1.0,6/14,7.37%,WNT9A;SOX9;TGFBR1;EFEMP1;PTHLH;GDF5
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.635588003208539,1.578587413558256,0.029829545454545456,0.6779013268461553,1.0,10/39,5.55%,STK39;PTPN3;NEDD4;FXYD5;CAMK2D;WNK1;SLMAP;FGF13;PRKCE;DMD
prerank,vitamin transport (GO:0051180),0.6713194779956587,1.5772079692267775,0.025280898876404494,0.6796012453588232,1.0,3/29,2.45%,SLC23A1;SLC5A6;ABCG2
prerank,maintenance of blood-brain barrier (GO:0035633),-0.5317721560145322,-1.577054033098305,0.03125,0.4127792963349293,1.0,14/30,7.66%,TJP1;GJB6;PECAM1;CLDN5;ESAM;LAMA2;OCLN;MBP;F11R;SLC1A1;ACTB;GJA1;JAM3;CLDN1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.552650193100962,1.5762873695207937,0.005847953216374269,0.6786992668368337,1.0,37/128,11.45%,BMP4;SMAD9;BMP5;DDX5;TGFB3;ADAM9;SMAD6;COL3A1;ITGB1;BMP6;INHBA;BMPR1A;ID1;ITGB5;TGFBR1;LTBP2;PDCD4;TMEM100;TGFBR2;GCNT2;SKI;TGFB1I1;BAMBI;GDF6;GDF5;NLK;RHOA;GDF10;ACVR1;USP15;PARD3;SMAD2;JUN;INHBB;RNF111;MEGF8;RGMB
prerank,regulation of activated T cell proliferation (GO:0046006),-0.5269255955133817,-1.5747630737925182,0.024691358024691357,0.4149428910304903,1.0,5/30,7.42%,IGF1;IGFBP2;RPS3;PRKAR1A;IL18
prerank,regulation of mononuclear cell migration (GO:0071675),0.68405502136339,1.574548915643271,0.02607361963190184,0.6829240506502284,1.0,4/23,3.61%,SLIT2;THBS1;BMP5;CMKLR1
prerank,negative regulation of growth (GO:0045926),0.5492523195712207,1.573948472852414,0.009378663540445486,0.6801418864077265,1.0,11/121,4.06%,SLIT3;SLIT2;CCN3;FHL1;NDRG3;OSGIN2;WNT11;ESR2;INHBA;NOTCH2;IP6K2
prerank,glycine transport (GO:0015816),-0.7080746465742632,-1.5738441615949967,0.03736263736263736,0.4118553339966503,1.0,6/10,19.46%,SLC6A9;SLC38A5;SLC6A17;SLC6A5;SLC25A38;SLC36A2
prerank,melanocyte differentiation (GO:0030318),-0.6882542216195747,-1.5738177232531072,0.03712871287128713,0.40615923485975486,1.0,6/11,8.89%,LRMDA;KIT;ENPP1;MITF;MEF2C;SLC24A5
prerank,cellular response to chemokine (GO:1990869),0.6282274257164712,1.5734979206990574,0.02351313969571231,0.6768680034873011,1.0,11/46,13.07%,STK39;SLC12A2;PTK2B;WNK1;CXCL2;FOXC1;RHOA;CCL3;CCL1;ZC3H12A;CCL7
prerank,neurotransmitter secretion (GO:0007269),-0.48717175991816164,-1.5725968111597675,0.015748031496062992,0.40468589717853354,1.0,21/44,25.25%,NRXN1;RIMS1;LIN7A;RIMS2;HSPA8;SYN2;SNAP25;SNCA;SYT1;SYN1;PIP5K1C;SYT10;PTPRN2;RAB3A;LIN7C;SLC32A1;CPLX1;OTOF;STXBP2;SNAPIN;PPFIA3
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.618893212714418,-1.5721646722266087,0.04922279792746114,0.4005167203163685,1.0,5/15,7.26%,GRM7;GRM3;GRM5;GRM1;GRM8
prerank,regulation of protein import into nucleus (GO:0042306),0.6354983573195756,1.5720252497792497,0.03857142857142857,0.6792262513733475,1.0,8/36,7.59%,BMP4;CDH1;PRKCD;ZIC1;MDFIC;UBR5;MAVS;JUP
prerank,sodium ion import across plasma membrane (GO:0098719),0.720537736982547,1.5706080218765612,0.03241491085899514,0.6810591731570012,1.0,5/17,8.27%,SLC9A2;SLC12A2;TRPM4;SLC9C1;SLC9A1
prerank,ganglioside biosynthetic process (GO:0001574),-0.6260148497832617,-1.5686642892770664,0.031026252983293555,0.4053614018684589,1.0,4/15,5.23%,ST6GALNAC3;ST3GAL1;ST8SIA4;ST8SIA6
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.5633420184809104,-1.5675608978747348,0.02531645569620253,0.40320201878120127,1.0,12/23,18.58%,ACSL1;ELOVL7;FAR2;ELOVL6;ACOT7;ACSL5;HSD17B12;DGAT1;HACD2;ACSBG1;HACD1;ACSL4
prerank,peptidyl-threonine modification (GO:0018210),0.5862777668865833,1.567476141938634,0.015113350125944584,0.6926651831941052,1.0,24/66,18.33%,STK39;CAMK2D;CIT;WNK1;PRKCD;HIPK1;GSK3B;GALNT13;TGFBR1;TGFBR2;MARK2;NLK;ACVR1;GALNT11;PRKDC;CHEK1;PRKCA;CDC42BPG;DYRK2;CAD;CDC42BPA;CDK10;CSNK2A2;CSNK2A1
prerank,negative chemotaxis (GO:0050919),0.6425057868273133,1.5669855582762668,0.041726618705035974,0.6898007101702613,1.0,7/33,2.46%,SLIT3;SLIT2;NTN1;SEMA3E;UNC5C;SEMA3D;SEMA3C
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.7423477265981375,1.56658382033713,0.0333889816360601,0.6863915708360135,1.0,4/15,3.27%,SMOC2;THBS1;MET;FGF2
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.678183232330384,-1.5662512450976573,0.03278688524590164,0.40185736009620454,1.0,5/12,18.23%,SERINC3;SERINC5;CBS;GGT1;SEPHS2
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.6185841389317329,1.5660468290142637,0.031292517006802724,0.6837679779987479,1.0,15/43,19.19%,FZR1;FOXN3;RAD17;ATM;CLSPN;NABP1;UIMC1;CHEK1;MRNIP;TRIM39;CHFR;NBN;TICRR;CDKN1A;TOPBP1
prerank,regulation of endothelial cell migration (GO:0010594),0.5722070209292425,1.5657833854352519,0.020606060606060607,0.6798057097350985,1.0,13/85,3.76%,SLIT2;SMOC2;BMPER;FOXP1;THBS1;BMP4;RHOJ;PTK2B;ANXA3;FGF2;ABL1;FOXC2;NRP1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.6276885747316502,1.5647692177045738,0.030598052851182198,0.6802119362446277,1.0,8/42,13.07%,STK39;PTK2B;WNK1;CXCL2;FOXC1;CCL3;CCL1;CCL7
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.5658995630139114,1.5633774114360552,0.01097560975609756,0.6822404563567358,1.0,14/76,9.53%,EGFR;NR3C2;CCN3;RASSF2;TCIM;EZR;NFAT5;PDCD4;TRIM44;DLG1;IFI35;TLR4;RHOA;LIMS1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.676435924053341,1.5633348786110446,0.043740573152337855,0.6773084354367681,1.0,7/26,3.07%,STK39;FHL1;NEDD4;ANK2;ATP1B1;WWP2;ITGB1
prerank,vasculature development (GO:0001944),-0.6238905845249869,-1.5628331044235628,0.031007751937984496,0.4065441385730019,1.0,11/16,18.15%,ERRFI1;PDGFRB;NOTCH4;ACVR2B;SOX18;FLT4;PDGFRA;APLNR;ACVRL1;CDH5;FOXF1
prerank,import into cell (GO:0098657),0.6211785405814516,1.5624301781587202,0.03943661971830986,0.6770358584447682,1.0,6/41,3.46%,SLC47A1;SLC12A7;SLC38A1;SLC5A6;LRRC8D;SLC39A14
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.5264477967889035,-1.5623623541257805,0.01557632398753894,0.4027732325152163,1.0,14/32,26.32%,CEMIP;CALM1;AKAP6;SNCA;JPH2;PLCG1;TRPC1;CALM3;APLNR;GPER1;CX3CL1;F2R;HAP1;CASQ1
prerank,regulation of interleukin-13 production (GO:0032656),-0.6446368484942494,-1.5622519382679683,0.047244094488188976,0.3979335563063142,1.0,4/13,7.42%,LEF1;TNFRSF21;PRKCZ;IL18
prerank,regulation of sequestering of calcium ion (GO:0051282),0.7658694753336331,1.5618390562987703,0.04522613065326633,0.6748882690265433,1.0,4/12,3.88%,ANK2;PTK2B;UBASH3B;DIAPH1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.6818848331331954,1.5604129651672842,0.04510108864696734,0.6774971092607268,1.0,3/24,2.87%,SLIT2;CCN3;ANO6
prerank,entry into host (GO:0044409),0.7552256405222116,1.558874041229248,0.053726169844020795,0.6808093390441552,1.0,3/13,5.86%,CDH1;MET;ITGAV
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.6108639664705138,-1.5578494073420137,0.02894736842105263,0.4056291277076204,1.0,8/17,16.99%,CAMK1D;RIPOR2;DAPK2;RAC1;MDK;CCL19;CD74;THBS4
prerank,epidermal cell differentiation (GO:0009913),0.62273148461333,1.5571150782870984,0.029661016949152543,0.6854473080045536,1.0,11/41,8.35%,CLIC4;ANXA1;ADAM9;DSP;BCR;WNT16;PIP5K1A;JAG1;TGM3;PITX2;SPRR1A
prerank,L-serine metabolic process (GO:0006563),-0.678484958892559,-1.557103774271927,0.030434782608695653,0.4029152789942772,1.0,2/10,2.79%,SERINC3;SERINC5
prerank,response to progesterone (GO:0032570),0.7165331048997516,1.556936240044818,0.04807692307692308,0.6813787809939429,1.0,2/18,1.76%,THBS1;TGFB3
prerank,response to alcohol (GO:0097305),0.6711258329820932,1.556427629996882,0.03259259259259259,0.6791802457274854,1.0,5/27,5.03%,SLIT3;SLIT2;ADH7;TGFBR1;TGFBR2
prerank,regulation of cholesterol storage (GO:0010885),-0.6156966867314292,-1.555904996694782,0.05093833780160858,0.4016385176405975,1.0,9/15,17.20%,PPARA;NR1H3;PPARD;ABCA1;ABCG1;SCARB1;MSR1;LPL;NR1H2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.7716183705975845,1.5554962129529755,0.046153846153846156,0.6793388546597693,1.0,2/12,2.67%,BDH2;GCLC
prerank,water-soluble vitamin metabolic process (GO:0006767),0.5681138948867156,1.5550173634452886,0.02064516129032258,0.6770092577015085,1.0,8/68,6.83%,SLC23A1;SLC23A2;AOX1;SLC5A6;VNN1;RFK;PNPO;MMACHC
prerank,positive regulation of organelle organization (GO:0010638),0.6339718515136329,1.5550120602644244,0.05217391304347826,0.6722736928429505,1.0,9/32,10.71%,SORBS3;ANXA1;ANXA2;ATL3;ADRB2;GSK3B;RAB3GAP2;C2CD5;SMCR8
prerank,thymus development (GO:0048538),0.7491022877762447,1.5548606794031843,0.05140961857379768,0.668339376845567,1.0,6/13,9.89%,SIX1;HES1;TGFBR1;EPHB3;RIPK3;FOXE1
prerank,hippo signaling (GO:0035329),-0.5375731572426872,-1.5541694533528256,0.041176470588235294,0.40187002610353306,1.0,7/26,12.65%,TJP1;AMOTL1;TEAD2;TEAD4;AMOTL2;YWHAB;CASP3
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.5580655035373904,-1.5539217169834478,0.02932551319648094,0.3976941571026562,1.0,11/24,16.44%,RAPGEF2;PEX5L;PRKAR2B;PRKAR1B;PDE4D;PRKAR1A;PDE2A;RNF157;MGRN1;APLNR;PDE3B
prerank,negative regulation of myoblast differentiation (GO:0045662),0.7372787326968975,1.552304234194949,0.054982817869415807,0.6767951277365365,1.0,3/13,3.19%,BMP4;SOX9;PRICKLE1
prerank,keratinocyte differentiation (GO:0030216),0.6544917822889205,1.5522922032273367,0.0319634703196347,0.6721812227998922,1.0,10/29,8.35%,CLIC4;ANXA1;ADAM9;DSP;BCR;WNT16;PIP5K1A;JAG1;TGM3;SPRR1A
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.723348740539664,1.552029841441924,0.056179775280898875,0.668784771914835,1.0,4/16,6.63%,DPYSL3;NT5E;NT5C1A;UPP2
prerank,regulation of response to stress (GO:0080134),0.79949203767332,1.5516754545107663,0.05272727272727273,0.6661209797379045,1.0,3/10,7.30%,SLC38A2;EIF4G1;IL10
prerank,purine nucleotide metabolic process (GO:0006163),0.6749988165277934,1.551346716865714,0.03484848484848485,0.6630789306548065,1.0,4/24,2.84%,NT5E;NT5C1A;FHIT;PRPS2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.658191537055833,-1.550760152358203,0.04884318766066838,0.40239321017751983,1.0,4/10,12.42%,SEMA6A;DCN;DAB2IP;CADM4
prerank,negative regulation of myotube differentiation (GO:0010832),0.7571204077316644,1.5504444004541509,0.0451505016722408,0.6631413048709375,1.0,2/12,1.25%,CCN3;HDAC4
prerank,ventricular septum development (GO:0003281),0.6210357401427067,1.550344490906731,0.035919540229885055,0.6591758694804073,1.0,10/37,6.32%,SLIT3;SLIT2;ZFPM2;HES1;BMPR1A;TGFBR1;STRA6;TGFBR2;NOG;GATA4
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.7663821656314445,1.550222847783077,0.052901023890784986,0.6554560837129029,1.0,3/12,1.17%,SLIT2;CCN3;BMP5
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.608989372868832,1.5500710006166658,0.0274869109947644,0.6518881561746017,1.0,8/54,2.80%,STK39;KCNJ2;FHL1;KCNMB2;KCNMB3;NEDD4;KCNJ15;WWP2
prerank,regulation of interleukin-1 production (GO:0032652),0.7247761731700412,1.5498384320943392,0.04873949579831933,0.6488155993455461,1.0,4/15,8.33%,FOXP1;ANXA1;IL10;TLR4
prerank,anterior/posterior pattern specification (GO:0009952),0.5989228506236679,1.5497992238874092,0.023968042609853527,0.6447707216204843,1.0,18/53,10.73%,PCSK5;HOXA5;HES1;HOXA3;HOXB6;TGFBR1;HOXA6;HOXC6;BHLHE40;SKI;HOXB3;HOXB5;GATA4;DDIT3;HOXC4;HOXB4;SMAD2;LRP5
prerank,negative regulation of coagulation (GO:0050819),-0.6165461448915766,-1.5495234328462246,0.0405727923627685,0.401689633114355,1.0,6/14,8.58%,VTN;APOE;HS3ST5;CD34;TFPI;EDN1
prerank,nucleotide metabolic process (GO:0009117),0.6734190730929341,1.5493756293557661,0.058734939759036146,0.6427030167872807,1.0,6/23,10.58%,ME1;FHIT;NMNAT2;CTPS2;NMNAT1;NUDT5
prerank,regulation of regulated secretory pathway (GO:1903305),-0.4971368942302141,-1.5492520367299205,0.03205128205128205,0.39790544053777005,1.0,22/34,25.19%,RIMS1;RIMS2;SYT7;SYT11;SYT12;SYT1;SYN1;SYT13;RAB15;SYT10;SYT9;SYT6;SYT15;RAB3A;RIMS4;SYT2;SYT4;RAB27A;SYT5;SYT17;SNAPIN;DOC2A
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.7351464329355799,1.5487096302670142,0.05289256198347107,0.6417946688262042,1.0,3/14,8.34%,ME1;NMNAT2;NMNAT1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.758350281956832,1.5486394687558742,0.06375838926174497,0.6380380855380167,1.0,3/11,3.13%,RSPO3;MLLT3;PLEKHA4
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7485172393114372,1.5479721687579504,0.04770017035775128,0.6372433790374042,1.0,3/11,2.04%,MAP3K5;CYP1B1;PRKCD
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.6470589255172711,1.5479127323199866,0.042028985507246375,0.6334520360391777,1.0,12/32,19.19%,FZR1;FOXN3;ATM;CLSPN;UIMC1;CHEK1;MRNIP;TRIM39;NBN;TICRR;CDKN1A;TOPBP1
prerank,response to prostaglandin E (GO:0034695),-0.6830256574011486,-1.5463610346165555,0.0514018691588785,0.40159731866456055,1.0,3/10,13.41%,TGFBR3;GNG2;CCL19
prerank,positive regulation of cytokinesis (GO:0032467),0.6303500009467675,1.5461436877065826,0.036414565826330535,0.638100164537163,1.0,9/32,14.03%,CIT;GIPC1;PRKCE;CDC25B;CDC14A;RHOA;DRD3;PKN2;CUL3
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.6071475614392906,-1.5457815599677736,0.049868766404199474,0.3989535016775937,1.0,6/17,9.19%,ITGA1;PDGFRB;CALM1;HSP90AB1;CD300A;PPP1R15B
prerank,atrioventricular valve morphogenesis (GO:0003181),0.6928375017485454,1.5454247947813224,0.04234527687296417,0.6379589754090239,1.0,7/19,9.60%,SLIT3;SMAD6;BMPR1A;TGFBR2;GATA4;MDM4;ACVR1
prerank,regulation of cell death (GO:0010941),0.5517075866167863,1.5428614887624108,0.01694915254237288,0.64617122111033,1.0,18/94,6.77%,BMP4;CCN3;ACER3;CCN5;CCN1;WNT11;FGF2;LRPAP1;SRGAP2;EIF4G1;BECN1;LRP1;WNT16;CLU;RIPK2;SRSF6;CELF1;AGR2
prerank,lymphocyte mediated immunity (GO:0002449),0.7709265723629724,1.5421600376716629,0.04318936877076412,0.6455994593734521,1.0,5/12,9.13%,CD55;GNL1;JAG1;KLRC2;CD46
prerank,inorganic anion transmembrane transport (GO:0098661),0.5863604985720096,1.541774212813777,0.028205128205128206,0.6433620629896967,1.0,9/63,4.01%,SLC26A2;SLC12A7;SLC12A2;SLC5A6;SLC12A8;ANO6;GLRB;ANO9;GABRA3
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.5602513325263802,-1.5414204487131173,0.028169014084507043,0.4073310717129084,1.0,8/23,10.44%,IGF1;EFNB2;PIEZO1;AKAP6;MEF2C;EDN1;PROX1;MYOCD
prerank,L-glutamate transmembrane transport (GO:0015813),-0.6912121724687987,-1.5406517680613454,0.03579952267303103,0.40544804207921775,1.0,3/10,4.89%,SLC1A3;SLC1A1;SLC1A2
prerank,cellular response to osmotic stress (GO:0071470),0.6829617140413222,1.5404571997507293,0.05530642750373692,0.6454214284677958,1.0,3/21,2.91%,STK39;LRRC8D;YBX3
prerank,cellular response to hydrogen peroxide (GO:0070301),0.6289288862605935,1.539315743915156,0.048295454545454544,0.6465482771700666,1.0,8/33,9.15%,MAP3K5;CYP1B1;ANXA1;PRKCD;NFE2L2;ABL1;ANKZF1;RIPK3
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.6647695780090584,1.5389196558483944,0.05007587253414264,0.6444638044693389,1.0,4/25,3.76%,EGFR;THBS1;FZD7;NRP1
prerank,atrioventricular valve development (GO:0003171),0.7042373177630066,1.5386166545644144,0.05930807248764415,0.6421383817785153,1.0,5/14,9.60%,SLIT3;BMPR1A;TGFBR2;MDM4;ACVR1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7598461654664725,1.5376197133391538,0.05140961857379768,0.6431724416683323,1.0,3/14,3.27%,THBS1;SULF1;FGF2
prerank,aortic valve morphogenesis (GO:0003180),0.6460509382381969,1.5364693583807272,0.04061624649859944,0.6446770218217419,1.0,5/30,2.16%,SLIT3;SLIT2;BMP4;SOX9;SMAD6
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.6920125623645481,1.5364515722754493,0.03987240829346093,0.6409455531485736,1.0,3/19,4.64%,SLC26A2;PAPSS2;SULT1A1
prerank,regulation of ion transmembrane transport (GO:0034765),0.6280255090899708,1.5361326221462668,0.04796511627906977,0.6386951008792942,1.0,6/33,2.87%,KCNJ2;NEDD4;WNK1;KCNJ15;WWP2;ANO6
prerank,cellular response to reactive oxygen species (GO:0034614),0.5780432357459507,1.5359965152528297,0.0196078431372549,0.6355701758995003,1.0,11/59,10.62%,EGFR;MAP3K5;CYP1B1;ANXA1;PRKCD;NFE2L2;ABL1;ANKZF1;CHUK;RIPK3;JUN
prerank,skin development (GO:0043588),0.5689880068275065,1.53434257536637,0.02442159383033419,0.6395254638744444,1.0,16/65,8.35%,CLIC4;MET;PKD1;COL5A2;ANXA1;ADAM9;DSP;COL3A1;BCR;WNT16;PIP5K1A;JAG1;TGM3;ASPRV1;PDGFA;SPRR1A
prerank,heterochromatin organization (GO:0070828),-0.6367376922831054,-1.5340289920320918,0.03865979381443299,0.4207426395641843,1.0,3/14,9.75%,MECOM;PRDM16;HP1BP3
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.7535858708784943,1.5338264546932194,0.05360134003350084,0.6382063272493643,1.0,1/12,0.33%,FZR1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.5885943042084576,-1.5337879210171244,0.03651685393258427,0.4168179038116452,1.0,7/19,12.09%,IGF1;APOE;PICALM;RTN1;NTRK2;RTN4;BIN1
prerank,translation (GO:0006412),-0.3723854495823328,-1.5336327961195608,0.014285714285714285,0.4128185391330521,1.0,76/208,18.91%,RPS14;EEF1A1;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPS21;RPLP2;EEF1B2;RPL27A;RPS19;RPL34;RPS29;RPS8;RPS3;RPS23;RPS5;RPS4X;RPL13;RPS16;RPL9;RPS15;RPS27;RPL30;RPL37;RPL19;RPS11;RPS24;RPL18A;RPL18;RPS7;RPL23;RPL17;EIF4EBP2;RPS20;RPL22;RPL23A;RPL26;RPS25;RPS18;RPL35A;LARS2;MRPL3;RPL11;RPL13A;RPL7;RPL36;RPL32;RPS17;RPL39;RPS2;RPL8;RPL14;FASTKD2;RPL24;RPL29;IARS1;MRPS11;MRPL51;RPL10A;RPL3;EEF2;RPL12;EEF1G;RPS12;RPL27;RPS27A;DARS2;RPL5;RPS28;RPS10;GSPT2;PPA1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.7479220763048942,1.5323289291065605,0.048939641109298535,0.6411748376173656,1.0,6/13,4.08%,BMP4;TGFB3;BMP6;BMPR1A;NUP93;TGFBR1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.693177113493662,1.5319179029655228,0.04746317512274959,0.6394564407795787,1.0,3/18,3.53%,CCN3;KCNB1;IRS1
prerank,rRNA metabolic process (GO:0016072),-0.3840160441034383,-1.5318753932930758,0.0,0.413372528107722,1.0,70/160,23.21%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPL41;RPL37A;RPLP2;RPL27A;RPS19;RPL34;RPL13;RPS16;RPL9;RPS15;RPS27;RPL30;RPL37;RPL19;RPS24;RPL18A;RPL18;MAPT;RPS7;RPL23;RPL17;RPL22;RPL23A;RPL26;RPS25;RPL35A;SNU13;RPL11;RPL13A;RPL7;RPL36;RPL32;RPS17;RPL39;RPS2;RPL8;RPL14;RPL24;RPL29;RPL10A;RPL3;DDX10;LYAR;NIFK;RPL12;RPL27;PIH1D1;RPL5;RPS28;EXOSC9;DDX27;DDX54;LAS1L;POP5;MTREX;EMG1;NOLC1;DIS3L;RPL4;RPL31;NOC4L;RPL36A;RPL7A;RRP9;WDR36
prerank,negative regulation of insulin secretion (GO:0046676),0.7021944588527642,1.5316072216644379,0.05723905723905724,0.6371623255822867,1.0,4/17,3.98%,CCN3;KCNB1;IRS1;KLF7
prerank,positive regulation of nuclear division (GO:0051785),-0.5361815727954993,-1.5307932535600899,0.03216374269005848,0.4122698061179425,1.0,6/25,9.28%,IGF1;TGFA;PDGFRB;INSR;EDN1;RGCC
prerank,cAMP-mediated signaling (GO:0019933),-0.5525109692398588,-1.529845941103118,0.03468208092485549,0.41061515865807546,1.0,11/24,7.22%,KSR1;PDE7B;ADCY1;RAPGEF3;RAPGEF2;RIMS2;CAP2;AHR;AKAP6;PDE4D;PDE2A
prerank,positive regulation of DNA metabolic process (GO:0051054),0.5849581657290583,1.5292372836499515,0.017834394904458598,0.6450472779268118,1.0,22/61,18.49%,SMOC2;EGFR;EYA2;FGF2;EYA4;EYA3;WRN;APLF;STPG4;USP7;UIMC1;ATRX;RNF168;ERCC8;DHX9;PML;PARP3;USP9X;NBN;SIRT6;RAD51;DHX36
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6987394188601039,1.5283544620209122,0.046948356807511735,0.6455976786735101,1.0,2/17,1.11%,EGFR;PKD1
prerank,transition metal ion transport (GO:0000041),-0.5058168941707663,-1.528266947226601,0.025396825396825397,0.4108239134275872,1.0,14/35,13.34%,CP;SLC30A10;TRPC3;FTH1;TFRC;SLC39A8;ATP2C1;ATOX1;TRPC4;TRPC6;SLC30A1;SLC31A1;TRPC1;TTYH1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.6645283893066537,1.5279166965631048,0.05143721633888049,0.6441453433622832,1.0,4/25,3.14%,SLIT2;PRKCD;LIMK2;ARHGAP44
prerank,BMP signaling pathway (GO:0030509),0.5796205817114218,1.5271321199225185,0.018842530282637954,0.6441411908683999,1.0,19/62,11.45%,BMP4;SMAD9;BMP5;DDX5;TGFB3;SMAD6;BMP6;BMPR1A;PDCD4;TMEM100;NOG;GDF6;GDF5;CHRD;ACVR1;USP15;SMAD2;MEGF8;RGMB
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.6491215657592238,1.526733999195267,0.049107142857142856,0.6424801689316605,1.0,16/27,25.13%,USP2;CRY2;BHLHE40;ID2;PER3;FBXL6;PER1;ATOH7;MTA1;CRTC1;PML;PER2;FBXL8;FBXL17;RBM4;RBM4B
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5608131310359422,1.5258537712404303,0.030562347188264057,0.6430043501828222,1.0,12/74,6.80%,THBS1;BMP4;EYA2;TCF7L2;BMP5;GSK3B;EYA4;TGFBR1;ITGAV;GDNF;BIRC6;EYA3
prerank,photoperiodism (GO:0009648),0.6397278554386282,1.525616730629538,0.04671532846715328,0.6407221021028925,1.0,16/28,25.13%,USP2;CRY2;BHLHE40;ID2;PER3;FBXL6;PER1;ATOH7;MTA1;CRTC1;PML;PER2;FBXL8;FBXL17;RBM4;RBM4B
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.7182899728490624,1.5246340377478262,0.06880733944954129,0.6415738958899927,1.0,6/16,6.13%,DDX5;RBFOX2;ESR2;DDX17;ESR1;TADA3
prerank,aortic valve development (GO:0003176),0.6232633042229591,1.5245777124926738,0.04054054054054054,0.6383411150238865,1.0,5/34,2.16%,SLIT3;SLIT2;BMP4;SOX9;SMAD6
prerank,response to amyloid-beta (GO:1904645),-0.47878743335013124,-1.523179047288274,0.023715415019762844,0.4217921411850918,1.0,15/44,10.85%,IGF1;IGF1R;VCAM1;GRM5;GRIN2A;CASP4;APP;GJA1;EPHA4;CACNA1B;ITGA4;CACNA2D1;GRIN1;LGMN;CACNB1
prerank,cellular response to purine-containing compound (GO:0071415),-0.6607361584736997,-1.5210514534155979,0.06142506142506143,0.4239195418660418,1.0,5/10,16.61%,SLC8A1;RYR2;P2RY1;CASQ2;RYR3
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.5401556351398684,-1.5209410890485846,0.03488372093023256,0.420127047629981,1.0,5/26,14.04%,ATP1A2;CALM1;ADRA2A;CASQ2;CALM3
prerank,regulation of muscle cell differentiation (GO:0051147),0.636799526138632,1.5205343195024574,0.0424597364568082,0.653605113793688,1.0,8/31,7.56%,CDON;BOC;HDAC9;CTNNA1;ABL1;MEF2A;MYOG;ID2
prerank,positive regulation of endothelial cell migration (GO:0010595),0.5450176519298043,1.5183988288636359,0.03274853801169591,0.6601537083874576,1.0,14/84,5.01%,SMOC2;FOXP1;THBS1;BMP4;MET;PTK2B;ANXA3;PLPP3;FGFR1;FGF2;ABL1;FOXC2;NRP1;BCAS3
prerank,regulation of viral life cycle (GO:1903900),-0.5656261745594454,-1.5170613300528997,0.03977272727272727,0.4273114374067059,1.0,8/21,15.47%,HS3ST5;TRIM14;PPIA;TRIM62;NECTIN2;AXL;TYRO3;TRIM21
prerank,potassium ion transmembrane transport (GO:0071805),0.5236981943826637,1.5165684865508884,0.012585812356979404,0.6652068481881724,1.0,13/135,3.03%,SLC9A2;KCNB2;KCNK5;SLC12A7;KCNJ2;SLC12A2;SLC24A3;ATP1B1;KCNQ5;SLC12A8;KCNS3;KCNJ15;KCNB1
prerank,epithelial tube morphogenesis (GO:0060562),0.6313416519976265,1.514268795354394,0.05027932960893855,0.6722559601822702,1.0,5/32,2.31%,SLIT2;BMP4;MET;PKD1;HES1
prerank,alcohol catabolic process (GO:0046164),-0.6632300890268763,-1.5136621479150656,0.05827505827505827,0.4334002282322205,1.0,2/10,1.91%,APOE;CYP27A1
prerank,skeletal system morphogenesis (GO:0048705),0.6051567878959339,1.5133370736227156,0.0443213296398892,0.6733538633568126,1.0,18/42,17.42%,SIX1;LRP6;HOXA3;FGFR1;HHIP;TGFBR1;SFRP4;SKI;HOXB3;HOXC4;HOXB4;LRP5;MEGF8;MMP13;HOXD3;TFAP2A;ANKRD11;DYNC2I1
prerank,cardiac muscle cell contraction (GO:0086003),0.685009877774416,1.5131256239496522,0.0630048465266559,0.6709171985108106,1.0,5/19,3.30%,KCNJ2;CACNA1C;CAMK2D;GSN;CACNA1G
prerank,membrane repolarization during action potential (GO:0086011),0.7282279832521001,1.511369356370462,0.05150976909413854,0.6757188743743359,1.0,2/13,1.56%,KCNJ2;ATP1B1
prerank,chordate embryonic development (GO:0043009),0.5827810382949317,1.511236298060156,0.035856573705179286,0.6728639456359167,1.0,18/55,10.37%,KIAA1217;PCSK5;MBNL1;PKD1;BMP5;FUT8;TGFB3;WNT11;SULF1;FGFR1;TGFBR1;NOG;ISL1;XYLT1;SIX4;GRHL2;DACT1;VEGFA
prerank,postsynaptic membrane organization (GO:0001941),-0.5791985836274839,-1.510770760400193,0.04065040650406504,0.4380319698452722,1.0,5/17,13.47%,SHANK3;APOE;NRXN1;GPHN;MUSK
prerank,histone deacetylation (GO:0016575),0.6132619645913494,1.5101063479850783,0.035422343324250684,0.6746882525780934,1.0,17/43,19.11%,HDAC4;HDAC9;RCOR3;HDAC8;TBL1X;MIER1;PER1;MTA1;REST;HDAC10;BAZ2A;PRDM5;SIRT6;RBM14;MIER2;BRMS1L;PER2
prerank,stem cell development (GO:0048864),-0.5926481543954708,-1.509979779483046,0.06285714285714286,0.43623149291133567,1.0,8/16,29.14%,CDH2;TAPT1;NRG1;NOLC1;WNT7A;SHH;SNAI2;CYP26C1
prerank,dopaminergic neuron differentiation (GO:0071542),0.6710344453604293,1.509322886318705,0.056074766355140186,0.6748341918853051,1.0,6/19,13.77%,LRP6;NR4A2;PITX3;PHOX2A;VEGFA;CDNF
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.7142442626124444,1.508841873638159,0.06655844155844155,0.6738725225204428,1.0,4/15,5.78%,PIEZO2;TMEM120A;TMC1;COL11A1
prerank,Rac protein signal transduction (GO:0016601),-0.5828745495782908,-1.5088192710845802,0.053475935828877004,0.43559560763033,1.0,7/18,11.85%,EPS8;ELMO1;CDH13;RHOH;RAC1;HACD3;HACE1
prerank,cellular response to BMP stimulus (GO:0071773),0.5673236344510039,1.5087189416011737,0.024193548387096774,0.6711576157675991,1.0,18/66,11.45%,BMP4;SMAD9;SOX9;BMP5;DDX5;TGFB3;SMAD6;BMP6;BMPR1A;PDCD4;TMEM100;GDF6;GDF5;ACVR1;USP15;SMAD2;MEGF8;RGMB
prerank,regulation of RNA splicing (GO:0043484),0.5609486401789907,1.5082255613812612,0.028423772609819122,0.669969795210124,1.0,12/69,7.90%,SLC38A2;AHNAK2;MBNL1;AHNAK;CLK1;SON;CLK2;CELF1;HNRNPH1;MBNL2;RBM39;FUS
prerank,positive regulation of positive chemotaxis (GO:0050927),0.715433933454031,1.5079199069630749,0.06197654941373534,0.6679728287412642,1.0,3/15,1.54%,F3;NTRK3;PGF
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.6545113697282378,1.5073652771951298,0.06746626686656672,0.6670490192589319,1.0,6/25,3.51%,BMP4;FOXD1;CCN1;SULF1;BMPR1A;ZNF423
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.6520768586293388,1.5072003637446847,0.059854014598540145,0.6645187911709439,1.0,13/25,12.60%,ANK2;CACNA1C;CAMK2D;CXADR;DSP;FGF13;DSG2;TRPM4;DLG1;JUP;AKAP9;RANGRF;DSC2
prerank,negative regulation of complement activation (GO:0045916),0.7624299006852964,1.5049760453370942,0.06206896551724138,0.6716286079676296,1.0,4/10,9.13%,CD55;SERPING1;CR1L;CD46
prerank,signal release from synapse (GO:0099643),-0.46953978539636543,-1.504020172514074,0.04669260700389105,0.44563382604645235,1.0,20/43,25.25%,NRXN1;RIMS1;LIN7A;HSPA8;SYN2;SNAP25;SNCA;SYT1;SYN1;PIP5K1C;SYT10;PTPRN2;RAB3A;LIN7C;SLC32A1;CPLX1;OTOF;STXBP2;SNAPIN;PPFIA3
prerank,sensory perception (GO:0007600),-0.463807081290015,-1.5021595085762973,0.02127659574468085,0.4472796588271749,1.0,17/45,20.29%,RETREG1;ADGRV1;PCDH15;ADORA2A;TTC8;P2RX7;TRPV2;WHRN;MME;PENK;KCNA2;SCN9A;NTSR2;TRPA1;CHRNA7;CCL2;KCNK4
prerank,inorganic cation import across plasma membrane (GO:0098659),0.5491213671437858,1.502033892063125,0.0323785803237858,0.6817770497433899,1.0,15/75,8.95%,SLC9A2;SLC12A7;KCNJ2;SLC12A2;ATP1B1;SLC12A8;KCNJ15;SLC39A14;TRPM4;ATP2B4;SLC9C1;SLC9A1;ATP1A4;ATP1A3;ATP1A1
prerank,positive regulation of cellular senescence (GO:2000774),-0.6664209521512489,-1.5016578008496018,0.045023696682464455,0.4449319702451332,1.0,3/10,9.85%,B2M;YPEL3;ABI3
prerank,positive regulation of nervous system development (GO:0051962),-0.46994676790416395,-1.5004955219182887,0.0078125,0.4442147754465032,1.0,15/42,24.11%,IL1RAPL1;TGM2;NRXN1;GRID2;EPHB1;SRPX2;LRRC4B;CUX2;MME;CLSTN3;GPER1;SYNDIG1;BDNF;CX3CR1;WNT7A
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.5654426993075689,1.4992161570249052,0.0472972972972973,0.6912723319837061,1.0,23/57,24.20%,FZR1;FOXN3;CHEK2;RAD17;ATM;WAC;CLSPN;UIMC1;PRKDC;CHEK1;MRNIP;ATF2;CCND1;TRIM39;NBN;TICRR;CDKN1A;TOPBP1;RAD9B;TAOK3;CDK2;BRCC3;MDC1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.5930270080776885,1.4985074467978254,0.05434782608695652,0.6912404426609792,1.0,9/43,7.56%,FOXP1;THBS1;BMP4;IGFBP5;BMPR1A;FGF2;NR4A3;IL10;ID2
prerank,positive regulation of neutrophil migration (GO:1902624),-0.5772553714043773,-1.4983413258744098,0.04450261780104712,0.44654033516034897,1.0,8/18,16.99%,CAMK1D;RIPOR2;DAPK2;RAC1;MDK;CCL19;CD74;THBS4
prerank,rRNA processing (GO:0006364),-0.3682541863770466,-1.4978288426922302,0.01,0.4440962327499167,1.0,69/172,23.21%,NSA2;RPS14;RPL38;RPLP1;RPS9;RPL21;RPL41;RPL37A;RPLP2;RPL27A;RPS19;RPL34;RPL13;RPS16;RPL9;RPS15;RPS27;RPL30;RPL37;RPL19;RPS24;RPL18A;RPL18;RPS7;RPL23;RPL17;RPL22;RPL23A;RPL26;RPS25;RPL35A;SNU13;RPL11;RPL13A;RPL7;RPL36;RPL32;RPS17;RPL39;RPS2;RPL8;RPL14;RPL24;RPL29;RPL10A;RPL3;DDX10;LYAR;RPL12;RPL27;PIH1D1;RPL5;RPS28;EXOSC9;DDX27;TSR3;DDX54;LAS1L;POP5;MTREX;EMG1;NOLC1;RPL4;RPL31;NOC4L;RPL36A;RPL7A;RRP9;WDR36
prerank,negative regulation of heart contraction (GO:0045822),-0.6501702471962859,-1.497773635857697,0.07,0.4403388304698495,1.0,2/11,5.65%,ATP1A2;PDE4D
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.522102867843302,1.4975126984152272,0.023310023310023312,0.6925908301554422,1.0,15/113,4.34%,F3;EGFR;BMP4;TCF7L2;SOX9;BMP5;PGF;NRAS;BMP6;FGF2;FZD7;NOTCH2;NRP1;TGFBR1;NR4A3
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5986732696314183,1.4971299850720783,0.05405405405405406,0.691023666703259,1.0,9/45,4.80%,EGFR;PLCE1;REPS2;SOX9;PTK2B;SHC1;GAREM1;EFEMP1;NCK2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.6266523913912492,-1.49705362846499,0.04785894206549118,0.43844022577469133,1.0,8/12,24.73%,APOE;PICALM;ROCK2;RANBP9;ABCA2;CHRNA7;TMED10;FKBP1A
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.673185992684079,1.4964062042361435,0.06912442396313365,0.6913887300710283,1.0,5/20,4.96%,THBS1;GSN;ANO6;PDCD4;SFRP4
prerank,spinal cord development (GO:0021510),0.732741536223338,1.4948580260018989,0.06289308176100629,0.6953796415823209,1.0,4/12,9.42%,VIT;PKD1;GLI2;NF1
prerank,response to chemokine (GO:1990868),0.7234339131016803,1.4937646175983945,0.07107438016528926,0.6972378882072592,1.0,3/13,1.93%,STK39;SLC12A2;WNK1
prerank,negative regulation of protein processing (GO:0010955),0.7295788133452574,1.4932455939312885,0.07370184254606366,0.6963116545274235,1.0,5/12,15.25%,THBS1;GAS1;SNX12;SERPINE2;ACP4
prerank,inositol phosphate-mediated signaling (GO:0048016),0.6665917945809849,1.492813955755853,0.08763693270735524,0.6950110848054889,1.0,4/19,5.37%,PLCE1;PPP3CA;NFAT5;NFATC4
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.6776635722665889,-1.492079047404506,0.058823529411764705,0.4489510276443137,1.0,5/10,15.26%,APOD;LRCH1;RIPOR2;CD200;AKT1
prerank,nucleoside catabolic process (GO:0009164),0.7405530307121799,1.489505321746924,0.07718696397941681,0.70747638024074,1.0,4/11,7.91%,NT5E;NT5C1A;UPP2;DERA
prerank,neuron remodeling (GO:0016322),-0.6547825466021815,-1.4892108363187124,0.07311320754716981,0.4531217347962821,1.0,7/10,23.08%,APP;EPHA8;ADGRB3;C1QA;CX3CL1;C3;RND1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.7118583949111985,1.488575102426607,0.06386554621848739,0.708475244152709,1.0,6/14,11.29%,THBS1;MEOX2;KLF4;RHOA;STARD13;ITGB1BP1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.5874469543268516,1.4875124093511674,0.05307262569832402,0.7101150997155424,1.0,17/46,18.30%,CDH1;TCF7L2;NEDD4;PRKCD;ZIC1;GSK3B;UBR5;MAVS;JUP;EMD;ZC3H12A;BAG3;DHX9;KHDRBS1;XPO4;HCLS1;EFCAB7
prerank,regulation of interleukin-12 production (GO:0032655),0.570419687250819,1.4853074382575637,0.052269601100412656,0.717165268138062,1.0,10/47,11.03%,FOXP1;THBS1;CMKLR1;ISL1;RIPK2;IL10;TLR4;IRAK3;PLCG2;MAST2
prerank,negative regulation of nuclear division (GO:0051784),0.7218656508979602,1.4852083705169128,0.07116788321167883,0.714263979057345,1.0,1/11,0.28%,BMP4
prerank,regulation of DNA repair (GO:0006282),0.5955241549173454,1.4840302743319886,0.050824175824175824,0.7164915555703117,1.0,13/44,15.73%,EGFR;EYA2;EYA4;UBR5;EYA3;TRIP12;USP1;RAD52;UIMC1;RNF168;ERCC8;DHX9;PML
prerank,motor neuron axon guidance (GO:0008045),0.6989750720594129,1.483781223586563,0.07890222984562607,0.7144036437260834,1.0,4/15,6.98%,SLIT2;NTN1;TMEFF1;NTN5
prerank,establishment of endothelial barrier (GO:0061028),-0.5004539119609491,-1.482332790649695,0.04377104377104377,0.4706088078913202,1.0,11/29,9.93%,TJP1;PECAM1;RAPGEF3;PPP1R16B;RAPGEF2;F11R;PDE4D;ROBO4;PDE2A;SOX18;RAPGEF1
prerank,negative regulation of peptidase activity (GO:0010466),-0.4482901372279563,-1.4801969330953142,0.012987012987012988,0.47312385602239176,1.0,9/47,7.78%,VTN;TIMP3;SPOCK2;SPOCK3;SERPINI1;CST3;SPOCK1;SERPIND1;GAPDH
prerank,catecholamine biosynthetic process (GO:0042423),-0.6326566136278485,-1.4782162476458298,0.07177033492822966,0.47545610784560155,1.0,3/11,8.26%,MOXD1;SNCA;DDC
prerank,positive regulation of protein sumoylation (GO:0033235),0.7507355579399453,1.4781056192891115,0.09705372616984402,0.7379941132020754,1.0,3/10,8.98%,HDAC4;SAE1;PIAS3
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.667435678664811,-1.477922451242235,0.05432098765432099,0.4723765586777073,1.0,5/10,17.28%,SNCA;KLF15;NOC2L;SET;CTBP1
prerank,visual perception (GO:0007601),0.5316314649826812,1.477496021028516,0.036057692307692304,0.7375726373620106,1.0,14/84,13.86%,SLC4A10;PITPNA;EYA4;EFEMP1;COL11A1;EYA3;CACNA1F;TULP2;MYO9A;ATF6;CRYBG3;RDH12;PAX6;CRYBB3
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.690766429284513,1.4769239055155827,0.08796296296296297,0.7370345330398114,1.0,2/16,2.14%,ST3GAL4;NFAT5
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.7438946030399061,1.4767635387892972,0.08571428571428572,0.7345003096650062,1.0,4/10,3.47%,STK39;NEDD4;CAMK2D;PRKCE
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6091769276926711,1.4756272522784895,0.07264957264957266,0.7365464153652901,1.0,13/32,11.29%,THBS1;RHOJ;ANXA1;MEOX2;HDAC9;KLF4;FGF2;FOXC2;MAP3K3;RHOA;STARD13;VEGFA;ITGB1BP1
prerank,peptidyl-proline hydroxylation (GO:0019511),0.7271452353806727,1.475311089006314,0.10210696920583469,0.7347633485737415,1.0,4/11,6.16%,EGLN3;P3H2;P4HA1;P4HA2
prerank,regulation of synapse maturation (GO:0090128),-0.6510244273024334,-1.4751028174408298,0.08314087759815242,0.47710268204755046,1.0,5/10,17.22%,NRXN1;ARHGEF15;DAB2IP;CAMK2B;RELN
prerank,negative regulation of cell death (GO:0060548),0.5290517338167492,1.4737922925987461,0.037484885126964934,0.7384644812933652,1.0,16/88,6.77%,BMP4;CCN3;CCN5;CCN1;WNT11;GSK3B;FGF2;LRPAP1;SRGAP2;EIF4G1;BECN1;WNT16;GATA4;CLU;SRSF6;AGR2
prerank,histone modification (GO:0016570),0.5190052050782689,1.473442040451231,0.0304093567251462,0.7369468265533028,1.0,45/109,24.39%,EYA2;HDAC4;CCNA2;PRKCD;HDAC9;RCOR3;EYA4;KAT6B;UBE2B;CREBBP;TBL1X;EYA3;TRRAP;EHMT1;SGF29;CPA4;PRMT8;CTCFL;MIER1;MTA1;KAT2A;PRMT6;EP300;HDAC10;BAZ2A;PRDM5;NSD1;BRD8;CARM1;EHMT2;RBM14;USP22;MIER2;BRMS1L;PHF20;USP21;UBE2N;USP36;HUWE1;PHF20L1;CDK2;PARP2;USP3;BRMS1;NAA50
prerank,cell differentiation in spinal cord (GO:0021515),-0.6454924284988361,-1.4726731076953143,0.07729468599033816,0.48014455103483233,1.0,4/10,8.04%,SOX13;SOX6;MDGA2;ZC4H2
prerank,lung epithelium development (GO:0060428),0.7462895249048057,1.4719004823689437,0.08377896613190731,0.74074590265052,1.0,4/10,8.73%,BMP4;PKD1;STRA6;GRHL2
prerank,regulation of endopeptidase activity (GO:0052548),-0.41868824251229664,-1.4706730053588322,0.017857142857142856,0.4828046203310698,1.0,15/59,16.03%,VTN;TIMP3;SPOCK2;PICALM;SPOCK3;SERPINI1;SPOCK1;SERPIND1;GAPDH;APH1B;PSME2;PSMB8;AGT;AKT1;VSIR
prerank,positive regulation of macrophage activation (GO:0043032),0.6634728169197108,1.4703302412164425,0.09905660377358491,0.7448217637249076,1.0,5/17,11.16%,THBS1;LBP;TLR4;IL33;CCL3
prerank,regulation of cell killing (GO:0031341),0.689523838071256,1.4697008059922647,0.08,0.7443826813796458,1.0,5/16,9.02%,CFH;CD55;FZD7;IL10;CR1L
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6547765555228734,1.4694186648171612,0.07655502392344497,0.742558534061697,1.0,1/21,0.11%,SLIT2
prerank,ganglion development (GO:0061548),0.7161438518628609,1.4687757639817955,0.08376068376068375,0.7424919534681824,1.0,2/11,3.76%,UNC5C;NRP1
prerank,muscle cell migration (GO:0014812),0.7449429787517773,1.4686388420662733,0.08896797153024912,0.7398838256606439,1.0,2/10,0.70%,CCN3;SIX1
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.5099665919749335,-1.4681857426630243,0.03691275167785235,0.4865456202551511,1.0,15/28,22.88%,PRKAG2;MITF;CD47;PRKAA2;SIRPA;RAC1;FGFR4;NOS1AP;MED1;SIRT5;NR1H4;PDK4;MFSD12;C3;CX3CR1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.5375874005352177,-1.4669756616665435,0.05325443786982249,0.4863694029316463,1.0,4/23,3.55%,ENG;TGFBR3;NREP;ITGA3
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.5180405496201238,-1.4664837141119618,0.06647398843930635,0.48414620286027427,1.0,8/22,12.00%,SLC16A2;TOX;NES;TAFA1;GATA2;KDM2B;PROX1;MDK
prerank,metal ion homeostasis (GO:0055065),0.5997624480640434,1.4659033851289018,0.06025824964131994,0.7499148369565671,1.0,7/40,7.20%,SLC12A7;SLC12A2;CNNM2;SLC12A8;CNNM4;FAM20A;CLDN16
prerank,response to purine-containing compound (GO:0014074),-0.566756714521748,-1.465584309263428,0.06944444444444445,0.4829675184871089,1.0,8/17,17.83%,TRPC3;ABCC9;RYR2;P2RY1;P2RX7;STAT1;VGF;NDUFS4
prerank,sodium ion transmembrane transport (GO:0035725),0.523579511207537,1.4651576635936907,0.044171779141104296,0.7501723875185148,1.0,16/84,8.95%,SLC4A4;SLC9A2;SLC12A2;SLC24A3;ATP1B1;SLC6A7;ANO6;NALCN;TRPM4;SLC6A19;SLC9C1;SLC9A1;SLC4A8;ATP1A4;ATP1A3;ATP1A1
prerank,endothelial cell proliferation (GO:0001935),0.6771551510131629,1.4650371223506273,0.06862745098039216,0.7475474369701282,1.0,2/17,0.28%,BMPER;BMP4
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.4420059076518766,-1.4649493682009902,0.009259259259259259,0.4812048286861835,1.0,14/57,15.34%,ADCY5;GRM7;ADCY1;LPAR1;ADCY7;CHRM2;ADRA2A;PDE2A;GRM8;CHRM3;GPR37;ADCY2;ADCY4;PSAP
prerank,eye development (GO:0001654),0.564740033900762,1.4639147032733741,0.06241699867197875,0.7496612786975554,1.0,15/54,11.69%,PBX3;COL5A2;CACNA1C;PBX1;SMOC1;HIPK1;STRA6;EFEMP1;TSKU;SKI;PITX2;FOXC1;SCO2;ATF6;NIPBL
prerank,histone H3 deacetylation (GO:0070932),0.6925241671207718,1.4637463964380726,0.09508196721311475,0.7472289543613528,1.0,6/15,19.11%,HDAC4;HDAC9;HDAC8;PER1;SIRT6;PER2
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.6379790339117335,-1.4628276181694937,0.08068459657701711,0.4841866703225618,1.0,6/11,10.44%,EFNB2;SOX6;MEF2C;BMP2;FRS2;MYOCD
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.7179483786923828,1.4625691771985183,0.09743589743589744,0.7496191159277769,1.0,2/11,1.56%,KCNJ2;ATP1B1
prerank,endothelial cell migration (GO:0043542),0.5881469217304389,1.4608349400074594,0.05172413793103448,0.7548005375157817,1.0,11/37,10.37%,CCN3;FSTL1;CYP1B1;GIPC1;ABL1;NRP1;ID1;RHOA;STARD13;S100A2;VEGFA
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.5461880832393166,-1.4606413323256644,0.04788732394366197,0.48725841978978846,1.0,13/20,32.03%,PLCB1;CHRM2;CHRM3;GRK2;LYPD1;CHRNA7;CDK5R1;LY6G6D;AGRN;RGS8;CHRM1;RGS10;LY6H
prerank,mesenchymal to epithelial transition (GO:0060231),0.7450930342794247,1.459814653530088,0.06821963394342762,0.756665965767164,1.0,2/10,3.34%,BMP4;FZD7
prerank,aorta morphogenesis (GO:0035909),-0.5801670821230646,-1.4593620196925543,0.05181347150259067,0.487169934888589,1.0,9/17,9.74%,ENG;MYLK;PDGFRB;ADAMTS9;TBX1;RBPJ;HEY2;PROX1;EFEMP2
prerank,amino sugar metabolic process (GO:0006040),-0.6584655212163424,-1.4591641668201005,0.07654320987654321,0.48408453518661887,1.0,3/10,3.15%,ST6GAL1;ST3GAL1;CSGALNACT1
prerank,sulfation (GO:0051923),0.7087245039293442,1.4590433949294148,0.09715242881072027,0.7570625621790155,1.0,3/11,4.64%,UST;CHST5;SULT1A1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.7375549853959117,1.4587113901441704,0.09930313588850175,0.7555343439842355,1.0,3/10,6.63%,NT5E;NT5C1A;UPP2
prerank,regulation of histone acetylation (GO:0035065),-0.4812159660382934,-1.4581595299175087,0.04195804195804196,0.48337161736669465,1.0,12/33,20.42%,RPS6KA5;RAPGEF3;PPARGC1A;SNCA;MYOCD;NOC2L;MAPK3;SET;ARRB1;CTBP1;RUVBL2;SPI1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5520996594146573,1.4580645444661011,0.06504065040650407,0.7554517839421745,1.0,12/55,19.04%,FBXL7;FHL1;PSMB2;AURKA;PSMC6;USP47;PSMD11;PSMD1;CUL1;PSMD7;PSMC1;PSMD14
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.7020713652332446,1.4575127205592169,0.1040268456375839,0.7550928199462739,1.0,3/11,9.13%,THBS1;BMPR1A;CD46
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.6924763109914711,1.4573280468984626,0.10101010101010101,0.75278836420923,1.0,4/14,5.58%,SLIT2;IGFBP5;BMPR1A;LRP1
prerank,metanephros development (GO:0001656),0.6294088803093094,1.4571000876920521,0.07584269662921349,0.7509439036082158,1.0,8/26,9.42%,BMP4;SIX1;PKD1;FOXD1;GDNF;GDF6;SIX4;NF1
prerank,positive regulation of T cell migration (GO:2000406),0.6460222025178394,1.456535350709579,0.08217054263565891,0.7504456147831081,1.0,2/20,1.93%,STK39;WNK1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.52834885246105,-1.4561406065697733,0.0782608695652174,0.48566444417812693,1.0,9/22,21.49%,APOD;ADRA2A;PPP2R5A;ASXL3;PDE3B;CCDC3;GPER1;APOC1;ALK
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.3681627297039304,-1.4559120389372504,0.0,0.4827619870203115,1.0,74/168,18.88%,RPS14;RPL38;CNOT6L;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPS21;RPLP2;RPL27A;RPS19;RPL34;RPS29;RPS8;RPS3;RPS23;RPS5;RPS4X;RPL13;RPS16;RPL9;RPS15;RPS27;RPL30;RPL37;RPL19;RPS11;RPS24;RPL18A;RPL18;RPS7;RPL23;RPL17;RPS20;RPL22;RPL23A;RPL26;RPS25;RPS18;RPL35A;RPL11;RPL13A;DCP2;RPL7;RPL36;RPL32;RPS17;RPL39;RPS2;RPL8;RPL14;POLR2G;RPL24;NBDY;RPL29;CNOT9;RPL10A;PAN2;RPL3;SMG7;RPL12;CTIF;RPS12;RPL27;RPS27A;RPL5;RPS28;EXOSC9;AGO1;RPS10;MAGOH;GSPT2
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.5615121416015383,1.455793996150546,0.05555555555555555,0.7511203679923721,1.0,19/53,20.47%,EGFR;EYA2;DDX5;PRKCD;EYA4;SPRED2;EYA3;BCLAF1;ATM;UIMC1;RNF168;ERCC8;DHX9;NSMCE1;ATR;FXR2;FMR1;RNF8;UBE2N
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.6967215906584747,1.4556584042627663,0.09917355371900827,0.748728570796362,1.0,3/14,4.50%,THBS1;ANO6;PDCD4
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.6310647303517806,-1.4547758611996073,0.06997742663656885,0.4825595318636968,1.0,9/11,32.45%,UQCRH;UQCR10;CYCS;UQCR11;CYC1;UQCRB;UQCRC1;UQCRC2;UQCRQ
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.6984956204402161,1.4547700263927967,0.0846286701208981,0.7499334443183667,1.0,3/13,8.12%,BMP4;VNN1;GLI2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.691865008025892,1.453863378590493,0.08223684210526316,0.751116547282036,1.0,4/15,3.27%,SMOC2;MET;FGFR1;FGF2
prerank,actin filament-based transport (GO:0099515),-0.5441132314373833,-1.453811862539534,0.05454545454545454,0.4818853418650299,1.0,7/21,16.92%,MYO1B;FNBP1L;MYO6;MYO5A;ACTN4;MYO5C;MYO1F
prerank,regulation of integrin activation (GO:0033623),-0.5774076597215547,-1.4529898826926777,0.06166219839142091,0.48106608325096983,1.0,5/15,12.28%,RASIP1;PIEZO1;JAM3;PLEK;FBLIM1
prerank,regulation of ossification (GO:0030278),0.5948975787008879,1.4527204513475118,0.07475317348377997,0.7534043869085816,1.0,8/36,4.63%,BMP4;SOX9;LRP6;DDR2;SMAD6;ZBTB16;SGMS2;TXLNG
prerank,glucose transmembrane transport (GO:1904659),-0.5512663769106583,-1.452345680898078,0.07008086253369272,0.4794966685903618,1.0,4/18,6.17%,SLC2A1;SORT1;PPARD;SLC5A3
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.6097099672856843,1.452222219786411,0.09104258443465492,0.75277047560719,1.0,1/29,0.01%,SLC4A10
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.6876102396551187,1.45178807024917,0.08514190317195326,0.7518792989331905,1.0,2/15,2.10%,CD55;GLI3
prerank,regulation of cell growth (GO:0001558),0.4870711776251699,1.451391600376171,0.014099783080260303,0.7508544126775062,1.0,19/204,5.18%,SLIT3;SLIT2;EGFR;CCN3;PLCE1;FHL1;NDRG3;OSGIN2;CAMK2D;WNT11;ESR2;INHBA;FAM107A;IP6K2;TGFBR1;AGTR1;EIF4G1;SGK3;KLHL22
prerank,positive regulation of cell cycle (GO:0045787),0.536816683740837,1.4507636947454718,0.0625,0.7508501917757163,1.0,15/62,14.98%,SMOC2;EGFR;PKD1;LRP6;USP2;CDC25B;CDKN1B;RARA;CCNYL1;PKN2;CHEK1;PRKCA;HCFC1;CCND1;TGM1
prerank,cellular response to organic substance (GO:0071310),0.5115836382009747,1.4504620964366781,0.03550295857988166,0.7492590211285781,1.0,25/116,12.50%,SLIT3;SLIT2;DPYSL3;RAMP1;CYP1B1;PID1;NFAT5;IGFBP5;SHC1;KLF4;BMPR1A;TGFBR1;PTPN2;TGFBR2;STAT3;SOCS2;RHOA;ACVR1;IL18BP;EMD;CCL3;ERBB2;ARL6IP5;PTPN9;CPNE3
prerank,anion transport (GO:0006820),0.5996278700688952,1.4504574142491917,0.08228730822873083,0.7463971159461279,1.0,3/33,2.45%,SLC26A7;LRRC8D;ABCG2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.5464960267985947,-1.4503350756951747,0.07317073170731707,0.48161273395431964,1.0,5/19,6.40%,VCAM1;GRM5;KDR;RYR2;PTGFR
prerank,cellular response to ketone (GO:1901655),-0.4628641530262295,-1.4488254262898403,0.049342105263157895,0.48247983506997816,1.0,8/35,12.05%,ADCY5;ADCY1;GNG2;AHR;PTGFR;SPP1;ROCK2;ADCY2
prerank,response to laminar fluid shear stress (GO:0034616),0.7259817936749169,1.4481318345461343,0.08919382504288165,0.7543632658621432,1.0,3/10,3.21%,SMAD6;KLF4;NFE2L2
prerank,basement membrane organization (GO:0071711),-0.5904738282509365,-1.4480231252054383,0.08354430379746836,0.4815224472687355,1.0,7/14,14.70%,NID1;NID2;COL4A1;LAMB1;CTSS;RAMP2;LAMB2
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.6357914648832859,1.4477288379135518,0.08446455505279035,0.7532893316800269,1.0,5/24,3.95%,CDON;BOC;CTNNA1;ABL1;MEF2A
prerank,potassium ion transport (GO:0006813),0.5057392034668754,1.44760332150424,0.0265282583621684,0.7510180526450662,1.0,11/120,3.03%,SLC9A2;KCNB2;KCNK5;KCNJ2;SLC24A3;KCNMB2;KCNMB3;KCNQ5;KCNS3;KCNJ15;KCNB1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.6935760801303629,1.4473279413565088,0.08732876712328767,0.7493116426306882,1.0,4/13,11.22%,GLI3;ZBTB7B;TGFBR2;CBFB
prerank,odontogenesis (GO:0042476),0.6000923470196776,1.4471161240109718,0.06392045454545454,0.7475050949280748,1.0,9/35,9.93%,BMP4;LRP6;EDA;TGFB3;INHBA;GLI2;PITX2;FOXC1;AQP6
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.6447358849087337,1.4467286914705948,0.09292035398230089,0.7463333241184519,1.0,4/21,7.94%,LRP6;GSK3B;FZD1;CSNK1A1
prerank,positive regulation of leukocyte activation (GO:0002696),0.6531536312829653,1.44667234613383,0.09120521172638436,0.7438242943301251,1.0,5/18,9.25%,THBS1;LBP;CD2;TLR4;IL33
prerank,regulation of B cell differentiation (GO:0045577),0.6591377013642146,1.446207061124395,0.09508716323296355,0.7431913697785291,1.0,4/17,8.15%,PPP2R3C;INHBA;ID2;MMP14
prerank,atrial septum development (GO:0003283),0.6812766209839356,1.4460173518535193,0.10543657331136738,0.7413231014671854,1.0,5/13,8.46%,ANK2;NOTCH2;ISL1;GATA4;MDM4
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.7055463397664754,1.4459539485273611,0.12110726643598616,0.738849031337382,1.0,3/12,9.05%,TMEFF2;IL10;AP2A1
prerank,outflow tract septum morphogenesis (GO:0003148),0.6193542908324118,1.445839136466599,0.09822866344605476,0.7366714105660896,1.0,9/24,5.76%,BMP4;ZFPM2;SMAD6;SEMA3C;PARVA;BMPR1A;NRP1;TGFBR2;ISL1
prerank,potassium ion homeostasis (GO:0055075),0.6335179422897368,1.44571155951531,0.07435508345978756,0.7344604430666521,1.0,5/23,2.58%,SLC12A7;KCNJ2;SLC12A2;ATP1B1;SLC12A8
prerank,B cell homeostasis (GO:0001782),-0.6232264185108085,-1.4451884156836206,0.08705882352941176,0.48701674025805153,1.0,4/10,5.39%,DOCK10;LYN;DOCK11;MEF2C
prerank,regulation of fibroblast migration (GO:0010762),0.6507433361340856,1.4442542839618764,0.09921259842519685,0.7380119151368019,1.0,9/20,11.89%,THBS1;DDR2;ITGB1;FGF2;PRKCE;DMTN;HAS1;ITGB1BP1;CORO1C
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.6501557636454615,1.4433639962532263,0.08620689655172414,0.7393023848567314,1.0,4/20,3.47%,STK39;NEDD4;CAMK2D;PRKCE
prerank,negative regulation of potassium ion transport (GO:0043267),0.7122388167066538,1.4428324803653887,0.08455284552845528,0.7390287341362912,1.0,2/13,1.68%,STK39;PTK2B
prerank,positive regulation of synapse assembly (GO:0051965),-0.49474480804538684,-1.4427280846323236,0.06688963210702341,0.4908992320635373,1.0,7/27,11.72%,IL1RAPL1;NRXN1;GRID2;EPHB1;SRPX2;LRRC4B;CUX2
prerank,cellular zinc ion homeostasis (GO:0006882),-0.5042573575411874,-1.442072427428655,0.03592814371257485,0.4892756866710258,1.0,13/26,13.58%,SLC30A10;SLC39A10;SLC39A8;SLC30A1;MT2A;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.5338679005420248,1.4420041770129581,0.06842105263157895,0.7400741773626891,1.0,16/65,19.62%,FBXL7;FHL1;PSMB2;AURKA;PSMC6;USP47;NABP1;PSMD11;CHEK1;PSMD1;CUL1;CHFR;PSMD7;PSMC1;PSMD14;ZFYVE19
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.6656358560200364,1.441818049770022,0.08077544426494346,0.7382301085343241,1.0,4/18,5.76%,ANXA1;FAM107A;KLF9;ISL1
prerank,regulation of neuron projection development (GO:0010975),-0.3624281429546834,-1.439936912740872,0.0,0.49253591723567525,1.0,55/163,13.40%,CAMK1D;EFNB2;LYN;IL1RAPL1;CDH2;SHANK3;APOE;PRKD1;ITGA6;LRRC4C;PTK7;CSMD3;CTNNA2;PPFIA2;RAPGEF2;PAK1;WNT5A;SERPINI1;DCC;TENM3;FUT9;LPAR1;SPOCK1;TOX;CHN1;ATP1B2;NDNF;RIT2;EPHA4;ROR2;LRRC7;DAB2IP;CCDC88A;DENND5A;SETX;NTRK2;MAG;PLK5;CRMP1;CFL1;PAK3;ABI3;RAPGEF1;TWF2;PTPRO;MFSD2A;BRSK2;FES;CAMK2B;MDK;KNDC1;RTN4RL1;NDRG4;GSK3A;KIF1A
prerank,androgen receptor signaling pathway (GO:0030521),0.7208933661125164,1.4396421461301627,0.10374149659863946,0.7449286551621638,1.0,9/11,25.98%,DDX5;PMEPA1;DDX17;PLPP1;ZMIZ1;RNF14;TMF1;ARID1A;AR
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.6109426468335659,1.4387025408253973,0.08221225710014948,0.7463488817954055,1.0,9/27,11.41%,PTPN3;FXYD5;CAMK2D;SLMAP;ATP2B4;SNTA1;DLG1;COMMD1;RANGRF
prerank,regulation of interleukin-8 production (GO:0032677),0.5290388632330896,1.4380369891573386,0.05472636815920398,0.7466266440789014,1.0,11/69,8.33%,F3;LBP;ANXA1;ANXA4;KLF4;CD2;STAT3;MAVS;DDIT3;IL10;TLR4
prerank,positive regulation of transporter activity (GO:0032411),0.7002898206126479,1.4374366694114233,0.09523809523809523,0.7465863611237428,1.0,1/13,0.13%,STK39
prerank,positive regulation of cell communication (GO:0010647),-0.4917190163432852,-1.4373253173355562,0.0621301775147929,0.49692098703265797,1.0,10/28,18.07%,WLS;RIMS1;ANK3;GRIK2;RIMS2;EDN1;SYT1;CLSTN3;LGI1;KCTD13
prerank,negative regulation of actin filament polymerization (GO:0030837),0.6319558699817505,1.4365896709529544,0.09908536585365854,0.747872072995463,1.0,3/22,2.48%,SLIT2;PRKCD;GSN
prerank,protein localization to cilium (GO:0061512),0.597434160316871,1.4363115352044518,0.07215007215007214,0.7463752766521239,1.0,8/32,9.86%,BBS9;ZNF423;INVS;ARL3;RABEP1;WDR35;TULP2;EHD1
prerank,negative regulation of transmembrane transport (GO:0034763),0.7160342935122659,1.435414005247962,0.11363636363636363,0.7480090436825868,1.0,1/10,0.27%,THBS1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6420179273293638,1.4350805917845335,0.07339449541284404,0.7468701391177658,1.0,2/20,1.11%,EGFR;PKD1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.6119624615828526,1.4346112951189178,0.09315866084425037,0.7462375114865704,1.0,12/27,12.60%,ANK2;CACNA1C;CAMK2D;DSP;FGF13;DSG2;TRPM4;DLG1;JUP;AKAP9;RANGRF;DSC2
prerank,regulation of cholesterol efflux (GO:0010874),-0.4876388825302599,-1.4343897760088407,0.051118210862619806,0.502533640795053,1.0,6/30,7.33%,PLTP;APOE;PTCH1;ABCA5;NR1H3;EEPD1
prerank,negative regulation of macrophage activation (GO:0043031),-0.5580918996774851,-1.4342347841307916,0.0873015873015873,0.49960986238363425,1.0,6/16,11.26%,IL31RA;NR1H3;SYT11;LRFN5;GRN;CD200
prerank,limb morphogenesis (GO:0035108),0.6386924982657965,1.4338295420800031,0.1015625,0.7472105710115142,1.0,5/20,5.80%,PCSK5;MBNL1;LRP6;GLI3;SKI
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.6142781575674321,-1.4336937684264712,0.11386138613861387,0.4977532018643629,1.0,3/11,2.80%,TJP1;RAPGEF2;F11R
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5617615463212976,1.432741408179964,0.07601572739187418,0.749360215066297,1.0,6/46,4.34%,FOXP1;THBS1;BMP4;TCF7L2;IGFBP5;NR4A3
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.589076898744757,-1.4323897297598653,0.09549071618037135,0.49853597185921744,1.0,4/12,5.64%,SEMA6A;DCN;ADAMTS12;DAB2IP
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.5515446460478134,1.4321905207219845,0.07180156657963446,0.7490864594611041,1.0,10/50,9.53%,EGFR;NR3C2;TCIM;NFAT5;PDCD4;TRIM44;IFI35;TLR4;RHOA;LIMS1
prerank,activation of phospholipase C activity (GO:0007202),0.6053201800922793,1.43185688247372,0.09899569583931134,0.748048943657542,1.0,2/29,0.88%,EGFR;EDNRA
prerank,hexose transmembrane transport (GO:0008645),-0.5312871251021629,-1.4314733222982534,0.07336956521739131,0.49796989564881167,1.0,8/21,23.42%,SLC2A1;PPARD;SLC2A12;SLC5A3;SLC50A1;SLC2A4;SLC45A1;SLC2A8
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.6023943417497883,1.431351323345868,0.1151603498542274,0.747746086455222,1.0,7/26,11.24%,EGFR;SOX9;GAREM1;FOXC1;IQGAP1;SYAP1;ERBB2
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.502795655063337,-1.4313482300153244,0.05325443786982249,0.49501272514504224,1.0,18/27,23.96%,RIMS1;RIMS2;SYT7;SYT11;SYT12;SYT1;SDF4;PPP3CB;SYT13;SYT10;SYT9;SYT6;SYT15;SYT2;DOC2B;SYT4;SYT5;SYT17
prerank,potassium ion import across plasma membrane (GO:1990573),0.5735758344102879,1.4309308797404778,0.07112970711297072,0.7469572303505643,1.0,6/41,2.75%,SLC12A7;KCNJ2;SLC12A2;ATP1B1;SLC12A8;KCNJ15
prerank,angiogenesis involved in wound healing (GO:0060055),-0.6117747847515888,-1.4294797757317435,0.0997624703087886,0.49714936809114874,1.0,6/11,9.51%,KDR;NDNF;CD34;GATA2;MCAM;PRCP
prerank,positive regulation of cholesterol transport (GO:0032376),-0.5001552914173486,-1.4290486840382375,0.08064516129032258,0.4950088468125921,1.0,8/27,13.29%,PLTP;APOE;PTCH1;ABCA5;NR1H3;EEPD1;ABCB4;SCP2
prerank,regulation of cell communication (GO:0010646),0.5728074367333422,1.4284942626851678,0.06853146853146853,0.7551758221430476,1.0,6/35,2.26%,GRK5;ANK2;CAMK2D;ANXA1;MGLL;CXADR
prerank,response to UV (GO:0009411),0.5150072957954043,1.4282241633402089,0.04436450839328537,0.7538612319370438,1.0,30/95,19.50%,EGFR;SCARA3;NEDD4;PRKCD;UBE4B;UBE2B;CREBBP;KDM1A;ERCC5;WRN;USP1;UVSSA;USP47;EP300;EIF2AK4;ERCC8;CCND1;ZBTB1;YY1;ERCC3;XPA;USP28;ATR;INO80;EIF2S1;DHX36;MAP3K4;REV1;CIRBP;FMR1
prerank,regulation of peptide hormone secretion (GO:0090276),-0.4091271034083753,-1.428164339981735,0.02564102564102564,0.4945573148952215,1.0,13/67,7.46%,ITPR1;RAPGEF4;CHD7;SLC2A1;CACNA1D;RAPGEF3;CACNA1E;KCNC2;DPP4;SYT7;ADRA2A;SNAP25;HTR2C
prerank,regulation of NMDA receptor activity (GO:2000310),-0.4804490618925443,-1.4270152630625625,0.04713804713804714,0.49495772783079633,1.0,14/32,11.55%,GRIA4;SLC6A9;GRIN2A;APP;GRIN2B;MEF2C;LRRC7;GRIA3;GRIN1;ACTN2;GRIA2;CAMK2A;GRIA1;CAMK2B
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.6313929643743491,-1.4270016823732836,0.11302211302211303,0.4918780038077324,1.0,3/10,2.90%,BCL2;DCN;KDR
prerank,"wound healing, spreading of cells (GO:0044319)",0.6221349508683666,1.4269869020779777,0.09278350515463918,0.7565884708800209,1.0,6/24,8.86%,TMEFF2;CCN1;CD44;ITGA5;MRTFA;RHOA
prerank,cardiac muscle tissue development (GO:0048738),0.5474136502203476,1.4255910471535806,0.07723577235772358,0.7601241681172359,1.0,8/50,3.37%,BMP4;SGCD;BMP5;CSRP3;AKAP13;BMPR1A;CACNA1G;NOTCH2
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.6006053284310607,1.4251956863820552,0.09691629955947137,0.7591782581861257,1.0,13/31,17.42%,SIX1;HOXA3;TGFBR1;TGFBR2;NOG;HOXB3;HOXC4;HOXB4;MEGF8;TWIST1;HOXD3;TFAP2A;DYNC2I1
prerank,cAMP biosynthetic process (GO:0006171),-0.6280665037822949,-1.4247102778527145,0.10238095238095238,0.4955155668020139,1.0,5/10,14.70%,ADCY5;ADCY1;ADCY7;ADCY2;ADCY4
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6871238286232968,1.4246528677172365,0.11647254575707154,0.7589491349705072,1.0,4/13,7.30%,MET;NFE2L2;NR4A3;IL10
prerank,regulation of lipid storage (GO:0010883),0.6159065074479935,1.4245948290963113,0.11216429699842022,0.7566698907243634,1.0,8/22,12.36%,FTO;PTPN2;ITGAV;IKBKE;NFKB1;HILPDA;ITGB3;ZC3H12A
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5434703023925888,-1.4235675833474986,0.0947075208913649,0.49575732090349894,1.0,6/18,9.69%,UNC13C;CDH8;GRID2;GRIK2;GRIK1;GRIA2
prerank,linoleic acid metabolic process (GO:0043651),-0.5552483389691052,-1.4234142219492056,0.08564231738035265,0.4931858794571903,1.0,4/17,10.56%,ACSL1;FADS2;PNPLA8;ALOX12
prerank,positive regulation of phospholipid transport (GO:2001140),-0.6280945152933243,-1.4225263550800742,0.09352517985611511,0.49257881036544526,1.0,5/10,19.29%,APOE;DBI;ABCB4;TMEM30A;TRIAP1
prerank,skeletal muscle organ development (GO:0060538),0.61014258119299,1.4222269830400485,0.09626436781609195,0.7643441920715657,1.0,7/26,8.09%,SIX1;CSRP3;DISP1;LARGE1;STRA6;MYOG;SIX4
prerank,zinc ion homeostasis (GO:0055069),-0.48725229852300694,-1.421473033582897,0.042682926829268296,0.49257194972023666,1.0,13/28,13.58%,SLC30A10;SLC39A10;SLC39A8;SLC30A1;MT2A;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.5578364240346958,-1.4211433854332085,0.09065934065934066,0.4906844394853444,1.0,6/17,12.09%,IGF1;APOE;RTN1;NTRK2;RTN4;BIN1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.6050390668675627,1.421005641039969,0.08955223880597014,0.7670988947597597,1.0,6/28,7.59%,CDH1;PRKCD;ZIC1;UBR5;MAVS;JUP
prerank,chondrocyte differentiation (GO:0002062),0.5970799315791714,1.4205474727784917,0.0855457227138643,0.7666790160941791,1.0,6/32,3.46%,BMP4;CCN3;NFIB;SOX9;SULF1;SLC39A14
prerank,integrin-mediated signaling pathway (GO:0007229),0.5285204601463731,1.4203223136215406,0.05170239596469105,0.7650792060858143,1.0,15/73,6.27%,ITGBL1;ITGB8;PTK2B;ADAM9;FN1;PLPP3;COL3A1;ITGB1;ABL1;NRP1;ITGB5;ITGA5;ITGA10;ITGAV;PTPRA
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.382217367623215,-1.418044782029039,0.007042253521126761,0.4965899350429664,1.0,29/107,10.07%,ATP1A2;CDH2;GRM7;LRRC4C;GRM3;MCTP1;NRG3;DGKI;GRM5;GRID2;RIMS1;GRIK2;GRM1;RIMS2;APP;MEF2C;MCTP2;GRIK1;DLGAP1;OPHN1;CACNA1B;LRP8;GRM8;EIF4EBP2;ABR;SYT1;TMEM108;CAMK2A;SYN1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.6233312862147337,1.4178104569595165,0.10229007633587786,0.7737289425290744,1.0,5/22,7.30%,WNK1;CD44;KLF4;GCNT2;IL10
prerank,actin filament depolymerization (GO:0030042),0.7202100947220946,1.4176514471529416,0.100169779286927,0.771838855291333,1.0,2/11,2.48%,MICAL2;GSN
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5422380713439758,1.417235234531719,0.07898259705488621,0.7712807270639057,1.0,15/50,13.29%,SMO;GLI3;GPC3;ZIC1;HHIP;VCP;CREBBP;GLIS2;RORA;GAS1;KIF7;MEGF8;EVC;HERC4;ARMC9
prerank,vascular transport (GO:0010232),0.5111054952455094,1.417003876455209,0.061893203883495146,0.7697372315511056,1.0,10/81,2.45%,SLC4A4;SLC38A2;SLC38A1;SLC12A2;SLCO3A1;SLC5A6;SLC24A3;SLC2A13;SLC16A1;ABCG2
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5765737708323999,1.4168893321393865,0.0860655737704918,0.7677879824132237,1.0,5/41,2.75%,KCNJ2;KCNMB2;KCNMB3;ANK2;KCNJ15
prerank,regulation of MAPK cascade (GO:0043408),-0.35802936244929984,-1.4166019969403585,0.0,0.4977455158561948,1.0,33/157,7.93%,FLT1;IGF1;IGF1R;PHLPP1;KSR1;LYN;TEK;TGFBR3;KIT;TNIK;JCAD;EPHA7;PAK1;KDR;EPHB1;LPAR1;PELI2;INSR;TBX1;NRK;RIT2;ROR2;LBH;DAB2IP;EPHA8;PAK5;MAP4K4;FAS;SPRED1;ADRA2A;BMP2;NTRK2;ZDHHC17
prerank,modulation by symbiont of host process (GO:0044003),-0.6294841107491657,-1.4163553509208031,0.10273972602739725,0.4955939049800228,1.0,5/10,19.67%,B2M;UBC;MRC1;RPS27A;ENO1
prerank,sensory perception of light stimulus (GO:0050953),0.5072269360752355,1.416354299555736,0.0535279805352798,0.7676561289289504,1.0,14/87,13.86%,SLC4A10;PITPNA;EYA4;EFEMP1;COL11A1;EYA3;CACNA1F;TULP2;MYO9A;ATF6;CRYBG3;RDH12;PAX6;CRYBB3
prerank,positive regulation of dendrite extension (GO:1903861),-0.5635187037253441,-1.4161728578627666,0.07823960880195599,0.4932079993836101,1.0,9/17,23.96%,NEDD4L;RIMS1;RIMS2;SYT1;RNF157;CPNE5;SYT2;SYT4;SYT17
prerank,positive regulation of DNA repair (GO:0045739),0.5623187057384055,1.4159673755802804,0.05298913043478261,0.7668988224645663,1.0,11/46,14.67%,EGFR;EYA2;EYA4;EYA3;DDX11;SPIDR;UIMC1;RNF168;ERCC8;HDAC10;DHX9
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.6482943845955212,1.4159654041885747,0.09763779527559055,0.7644362305426169,1.0,3/18,2.92%,SLIT2;PTK2B;MTUS1
prerank,negative regulation of hemostasis (GO:1900047),-0.593199130799426,-1.4158464757825768,0.10638297872340426,0.4913340882205738,1.0,5/12,8.58%,VTN;APOE;CD34;TFPI;EDN1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.6700005396864777,1.4150143528460473,0.09546925566343042,0.7661005031361464,1.0,4/16,14.52%,SOX9;NCOR1;ERLIN1;WDTC1
prerank,transport across blood-brain barrier (GO:0150104),0.5076708024344816,1.4143019576242475,0.06159420289855073,0.7667939950458539,1.0,10/83,2.45%,SLC4A4;SLC38A2;SLC38A1;SLC12A2;SLCO3A1;SLC5A6;SLC24A3;SLC2A13;SLC16A1;ABCG2
prerank,organic substance transport (GO:0071702),0.49449245667919106,1.4142716940631177,0.04728950403690888,0.7644506448773939,1.0,7/121,2.45%,SLC47A1;SLC23A1;ABCD3;RAMP1;SLCO2A1;DISP1;ABCG2
prerank,supramolecular fiber organization (GO:0097435),0.46150853655479607,1.4135029629458098,0.007231404958677686,0.7654957732678598,1.0,51/333,9.42%,COL25A1;COL8A1;COL12A1;COL6A2;TLL1;COL8A2;ADAMTS2;SNCAIP;COL6A1;CYP1B1;COL5A2;PLOD2;BMP1;DDR2;CLIP4;DSP;COL3A1;GSN;COL23A1;SHROOM3;MAP7D3;FGF13;LOXL1;RHOBTB1;COL6A3;TGFBR1;LTBP2;LTBP3;FAT1;TMOD3;P3H2;CLIP1;HDGFL3;NLRP5;P4HA1;TLE6;COL11A1;PCM1;P4HA2;DLG1;TNXB;P3H1;ARHGAP17;PLK3;P3H4;SHROOM4;RND3;OPTC;RHOA;RIPK3;NF1
prerank,endothelial tube morphogenesis (GO:0061154),0.7224675546884046,1.4124390137063818,0.11584327086882454,0.7676552616534544,1.0,3/10,8.91%,BMP4;RHOA;STARD13
prerank,negative regulation of cell aging (GO:0090344),-0.5616440265568453,-1.4124086841342736,0.07297297297297298,0.49793099402589286,1.0,6/16,13.67%,SLC30A10;AKT3;CDK6;MIF;YBX1;RBL1
prerank,pulmonary valve development (GO:0003177),0.6205248640424985,1.4122928361759992,0.12063492063492064,0.7659242979401075,1.0,6/18,6.28%,SLIT2;BMP4;SMAD6;NOTCH2;STRA6;JAG1
prerank,ERBB signaling pathway (GO:0038127),0.5370661656172132,1.412163617626602,0.07251908396946564,0.7641197833595611,1.0,9/64,4.80%,EGFR;PLCE1;REPS2;SOX9;PTK2B;SHC1;GAREM1;EFEMP1;NCK2
prerank,T cell migration (GO:0072678),0.6665247708321879,1.4116951052294175,0.12199036918138041,0.7636377346040243,1.0,1/13,0.49%,SLC12A2
prerank,mesonephros development (GO:0001823),0.7023563962644969,1.4114011686801826,0.11148086522462562,0.762403511375818,1.0,2/11,2.42%,BMP4;ZBTB16
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.5476103164359695,1.4109591960138332,0.09302325581395349,0.7617689505722411,1.0,12/45,10.79%,BMP4;BMP5;TGFB3;BMP6;INHBA;BMPR1A;TGFBR1;GDF6;GDF5;GDF10;ACVR1;INHBB
prerank,vasculogenesis (GO:0001570),-0.48370690254733373,-1.4106583509722026,0.06291390728476821,0.4998924859201379,1.0,12/32,9.70%,ENG;TGFBR3;PDGFRB;KDR;RASIP1;NOTCH1;SOX17;SPRED1;HEY2;RAMP2;SOX18;ADM
prerank,positive regulation of angiogenesis (GO:0045766),0.49899208410285,1.410422341720865,0.05035128805620609,0.7617380870285148,1.0,18/108,6.32%,SMOC2;BMPER;F3;THBS1;CYP1B1;ITGB8;PGF;ANXA3;PTGIS;KLF4;HIPK1;ITGB1;FGF2;FOXC2;ADAM12;ITGA5;ISL1;GATA4
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.6797171395173893,1.4104138446558057,0.12111292962356793,0.7594277245952212,1.0,3/13,6.50%,CYFIP2;PERP;RIPK2
prerank,negative regulation of phosphorylation (GO:0042326),0.5046583591428494,1.4098767806979342,0.06313131313131314,0.7594807764428034,1.0,9/85,3.18%,SLIT2;BMP4;NTRK3;HDAC4;LRP6;PID1;PLPP3;NIBAN1;INHBA
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5839269215087368,1.40899486123563,0.09869375907111756,0.7610269951313464,1.0,10/33,12.47%,KLF5;FOXO3;KLF4;FGF2;STAT3;TEAD1;IL10;ATOH8;JUN;SMARCA4
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.5754313490049452,-1.4083904826235984,0.09511568123393316,0.5032571333978416,1.0,7/13,17.91%,ELOVL7;ELOVL6;HACD3;ELOVL4;TECRL;HACD2;HACD1
prerank,gastrulation (GO:0007369),0.6570740855835272,1.4083065495461227,0.12140575079872204,0.7616482053022522,1.0,5/15,10.95%,GPC3;NR4A3;SMAD2;LRP5;MEGF8
prerank,retina homeostasis (GO:0001895),-0.5081884144625074,-1.407713046823222,0.07142857142857142,0.5022491676904003,1.0,10/23,24.22%,B2M;ACTB;POTEF;ATP1B2;WHRN;ACTG1;HSPB1;CDH3;JCHAIN;TULP1
prerank,osteoclast differentiation (GO:0030316),0.6249854802842525,1.4076341263249919,0.11861861861861862,0.7621929771877665,1.0,3/22,3.24%,FOXP1;ANXA2;GAB2
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.45827491337990367,-1.4068641678180809,0.0744336569579288,0.5019095207835328,1.0,15/32,26.32%,CEMIP;TRPC3;AKAP6;SNCA;GRIN1;P2RX7;PLCG1;TRPC1;APLNR;GPER1;CX3CL1;F2R;P2RX3;RAMP3;CASQ1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.6471395607043898,1.4067740534486293,0.12101910828025478,0.7635876928852074,1.0,7/17,9.95%,BMP4;BMPR1A;NOTCH2;NOG;JAG1;ACVR1;GALNT11
prerank,regulation of dendrite extension (GO:1903859),-0.5538300540274641,-1.4055000705983562,0.08740359897172237,0.5028160106233404,1.0,9/18,23.96%,NEDD4L;RIMS1;RIMS2;SYT1;RNF157;CPNE5;SYT2;SYT4;SYT17
prerank,AMP metabolic process (GO:0046033),0.6687323594167045,1.4053851219773452,0.1282051282051282,0.767208906157981,1.0,7/13,20.84%,NT5E;NT5C1A;AMPD3;XDH;AK4;AK3;AK9
prerank,regulation of macrophage chemotaxis (GO:0010758),0.6233547368732378,1.4052421968760933,0.10161290322580645,0.7655005420285562,1.0,4/21,3.61%,THBS1;PTK2B;MTUS1;CMKLR1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.4451658181070107,-1.405100256640822,0.058823529411764705,0.501078168658676,1.0,16/38,19.24%,IL34;GRM5;NEDD9;ACE;APP;EPHA4;GPRC5B;LRP8;GAS6;CSF1R;NOX4;AGT;FCGR1A;RELN;ERBB3;HYAL2
prerank,regulation of neutrophil migration (GO:1902622),-0.6159826103785341,-1.4048788163666117,0.09523809523809523,0.49882458612421887,1.0,7/10,30.84%,JAM3;RHOH;RAC1;RHOG;BST1;RAC2;OLFM4
prerank,negative regulation of cell motility (GO:2000146),0.4955809595202104,1.404704810340944,0.04953917050691244,0.7655122847415928,1.0,19/108,6.79%,SLIT2;CDH1;TMEFF2;CLIC4;DPYSL3;CYP1B1;PTPRU;WNT11;FOXO3;SULF1;IGFBP5;SRGAP2;SRGAP3;CCDC125;VCL;NOG;ZMYND8;JAG1;SLURP1
prerank,regulation of B cell proliferation (GO:0030888),-0.44360430828890796,-1.404697160871153,0.048,0.4965493509655044,1.0,14/44,16.10%,LYN;BCL2;TFRC;AHR;TNFRSF21;MEF2C;CD81;VAV3;CD38;CD300A;MIF;CD74;TYROBP;CD40
prerank,regulation of DNA replication (GO:0006275),0.5504605984033801,1.4042852076972114,0.09055118110236221,0.7649858148186223,1.0,13/49,17.81%,EGFR;CCNA2;GLI2;BCAR3;STN1;RAD17;WAPL;GTPBP4;DHX9;ANKRD17;EGF;ATR;EHMT2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.5405727299699711,-1.4041711202485503,0.10140845070422536,0.4953790886979706,1.0,10/18,30.00%,PLCB1;CHRM2;CHRM3;GRK2;CDK5R1;GNA15;AGRN;RGS8;CHRM1;RGS10
prerank,response to fatty acid (GO:0070542),0.6492794167217575,1.4033326424570751,0.11021069692058347,0.7668505121279265,1.0,7/17,13.12%,SOX9;PID1;FOXO3;IRS1;SCD;PPP5C;PDK3
prerank,Wnt signaling pathway (GO:0016055),0.5013701281903115,1.4029180417200304,0.04767580452920143,0.7663077279497705,1.0,22/92,11.40%,TCF7L1;NXN;TCF7L2;WNT9A;LRP6;WNT11;PLPP3;GSK3B;FZD7;STRN;NR4A2;SFRP4;WNT16;FZD1;CSNK1A1;GPC4;USP34;CSNK1G3;RARG;PLCG2;LRP5;BCL9L
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6912138687792185,1.4028014401578457,0.10810810810810811,0.7645073230563489,1.0,3/12,8.33%,FOXP1;KLF4;TLR4
prerank,dendritic spine organization (GO:0097061),-0.4807085809359991,-1.4027632638121004,0.0736196319018405,0.49669409978738,1.0,8/26,9.89%,IGF1R;DOCK10;SHANK3;EPHB1;ITGA3;INSR;PAK3;LGMN
prerank,regulation of myotube differentiation (GO:0010830),0.6055334104235259,1.4026074903802717,0.1263318112633181,0.7630004074656409,1.0,5/24,8.15%,CCN3;HDAC4;HDAC9;MYOG;MMP14
prerank,negative regulation of histone acetylation (GO:0035067),-0.6161604326793637,-1.402453473012401,0.12039312039312039,0.49482250959318336,1.0,5/11,20.42%,SNCA;NOC2L;SET;CTBP1;SPI1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.6462449491186498,1.4015788954947668,0.1182108626198083,0.7650603134249729,1.0,5/17,9.10%,ADRA1B;AKAP13;ADRB2;ADCY9;DRD3
prerank,positive regulation of embryonic development (GO:0040019),-0.525240629094288,-1.4006796222527687,0.09090909090909091,0.49700922366222294,1.0,9/19,18.13%,PLCB1;WNT4;TENM4;OSR1;CFL1;NR2C2;RBM19;RACK1;LHX1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.6173512858747902,-1.3999975552636088,0.10772833723653395,0.49626816428618703,1.0,5/10,15.49%,LYN;FAS;RNF13;MAPK3;GREM1
prerank,positive regulation of protein import (GO:1904591),0.5853517310565817,1.3986079352962435,0.10802919708029197,0.7755043473398294,1.0,9/30,13.34%,CDH1;PRKCD;ZIC1;UBR5;MAVS;JUP;ARHGEF5;ZC3H12A;BAG3
prerank,lipid phosphorylation (GO:0046834),-0.6118329130582004,-1.3972108812811477,0.11722488038277512,0.5016496365205805,1.0,6/10,19.13%,DGKB;DGKI;DGKD;DGKG;DGKE;DGKZ
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.5178574216873525,-1.3971393521340354,0.09144542772861357,0.4991238242456393,1.0,5/21,7.33%,PLTP;APOE;PTCH1;NR1H3;EEPD1
prerank,pulmonary valve morphogenesis (GO:0003184),0.6320116265353386,1.396927778299923,0.10927152317880795,0.7801625504549188,1.0,6/17,6.28%,SLIT2;BMP4;SMAD6;NOTCH2;STRA6;JAG1
prerank,primary neural tube formation (GO:0014020),0.5913756167951901,1.3964988286471325,0.09572901325478646,0.7796448659592085,1.0,14/30,23.81%,COBL;LRP6;LMO4;PRICKLE1;SKI;GRHL2;STIL;BCL10;TGFB2;SCRIB;FUZ;MTHFR;PHACTR4;CELSR1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.6107748406828266,1.3960338685026954,0.13509316770186336,0.7792604452838471,1.0,4/19,8.33%,LBP;PIK3AP1;PRKCE;TLR4
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.3363491276729579,-1.3951816821478833,0.0,0.5019646360618204,1.0,58/224,11.24%,SLC1A3;UNC13C;DTNA;GRM7;NOVA1;PDE7B;GRM3;NRXN1;CACNA1E;MBP;GRM5;GRIA4;SLC6A1;GABRG3;GRIK2;PRKAR2B;KCND2;GRM1;GRIN2A;SLC1A1;PLP1;CALM1;APBA1;GRIN2B;RIT2;SLC1A2;KCNQ3;GABRA2;GABRB1;PRKAR1B;GRIK1;APBA2;GABRB2;DLGAP1;PRKACB;CHRM2;PRKAR1A;CACNB4;GRIA3;CACNA1B;SYN2;SNAP25;SNCA;HTR2C;GABRB3;CHRM3;GRIN1;GLRA1;RPS6KA1;GABRA1;SYT1;GRIA2;SYN1;HTR2A;GRIA1;GLRA3;CACNB1;SDCBP
prerank,response to UV-A (GO:0070141),0.6658766122100197,1.3938550413825395,0.1272430668841762,0.7864727986090984,1.0,1/14,0.24%,EGFR
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.6396867791981083,1.3934458979302016,0.13793103448275862,0.7858870487490831,1.0,7/17,10.39%,CD55;STAT3;GNL1;JAG1;TLR4;CD46;IL18BP
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.5804599721043779,-1.3932241607987559,0.10287081339712918,0.5047800329757408,1.0,5/13,16.35%,NOS3;CALM1;QDPR;AKT1;GCH1
prerank,NAD biosynthetic process (GO:0009435),0.6105970282452178,1.3921563235181318,0.1111111111111111,0.7889793187129512,1.0,5/20,8.36%,PTGIS;NMNAT2;QPRT;NMNAT1;NNMT
prerank,myoblast differentiation (GO:0045445),0.665480317167621,1.391400411081458,0.11967213114754098,0.7900570419800572,1.0,10/14,15.51%,TCF7L2;MBNL1;DDX5;DDX17;PLEKHM3;JAG1;MAPK12;RB1;REST;HINFP
prerank,early endosome to Golgi transport (GO:0034498),0.6936047608445124,1.3911413735400744,0.1206896551724138,0.7889048726847995,1.0,8/11,23.08%,RAB6A;SNX2;STX5;EHD3;TRAPPC10;SNX8;RBSN;SURF4
prerank,positive regulation of cell junction assembly (GO:1901890),-0.4211369967914129,-1.3911094122514382,0.05092592592592592,0.5083363818262309,1.0,17/56,15.54%,TEK;IL1RAPL1;CLDN5;CNTNAP2;NRXN1;GRID2;KDR;EPHB1;MAP4K4;SRPX2;RAC1;LRRC4B;ACE2;CUX2;PPM1F;AGT;CLSTN3
prerank,kidney development (GO:0001822),0.526912969396473,1.390837693921887,0.08220858895705521,0.7878694628244355,1.0,17/65,10.37%,BMP4;SIX1;PCSK5;PKD1;SULF1;ZBTB16;TGFBR1;STRA6;AGTR1;GDNF;ARL3;GDF6;GLI2;FOXC1;KANK2;NF1;VEGFA
prerank,protein deacetylation (GO:0006476),0.5662345833667127,1.3901578695394894,0.10096818810511757,0.78852264898805,1.0,13/41,19.08%,HDAC4;HDAC9;RCOR3;TBL1X;MIER1;MTA1;HDAC10;BAZ2A;PRDM5;SIRT6;RBM14;MIER2;BRMS1L
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.6912279330243746,1.3899470135368004,0.13859649122807016,0.7871332546157754,1.0,4/11,13.47%,DDIT3;ATF6;CREB3L1;CREB3L3
prerank,activin receptor signaling pathway (GO:0032924),0.6404380690609044,1.3898438825414423,0.129783693843594,0.7852826430016513,1.0,6/15,10.79%,INHBA;TGFBR1;GDF6;ACVR1;SMAD2;INHBB
prerank,neuron maturation (GO:0042551),-0.5352717624748823,-1.389756729752044,0.09695290858725762,0.509574287164704,1.0,10/18,27.31%,APP;EPHA8;ADGRB3;C1QA;ACTL6B;CX3CL1;C3;RND1;SRRM4;B4GALT6
prerank,regulation of axon regeneration (GO:0048679),-0.5764447507329216,-1.3896722342621965,0.10696517412935323,0.5071416902974758,1.0,5/12,12.80%,EPHA4;GRN;INPP5F;CERS2;RTN4RL1
prerank,regulation of protein catabolic process (GO:0042176),0.500516564487539,1.3896292952075107,0.06929510155316607,0.7840192599685464,1.0,25/99,15.47%,EGFR;WWP1;FZR1;NEDD4;GPC3;WWP2;GSK3B;VCP;STX5;IDE;ASB9;CHEK2;NSF;CDKN1B;MDM4;IRAK3;DACT1;ASB11;SNX12;ZDHHC2;SMURF1;AZIN1;MAD2L1;HMGCR;SEC22B
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.4642663697124447,-1.3894637932520595,0.0875,0.5051577395290571,1.0,9/35,10.05%,VTN;SGIP1;B2M;PICALM;TNK2;HIP1R;SNAP91;RAC1;HIP1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5308508571418866,-1.3888745485217644,0.10810810810810811,0.5040654270172581,1.0,7/17,4.86%,ATP1A2;GJC1;GJD3;SLC8A1;RYR2;ATP1B2;GJA1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.7068886404893425,1.3885043950878986,0.1356521739130435,0.7866563478553517,1.0,3/10,5.03%,CD55;ZBTB7B;TGFBR2
prerank,positive regulation of vasoconstriction (GO:0045907),0.686923014826802,1.3877301304665004,0.1477832512315271,0.7876313852224851,1.0,2/13,4.92%,ADRA1B;TRPM4
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.6394542278028471,1.3875874080113648,0.14715719063545152,0.7859869864306828,1.0,2/16,1.76%,BMP4;TGFB3
prerank,establishment of epithelial cell polarity (GO:0090162),0.6245735427554165,1.3875700718424044,0.13166144200626959,0.7838602119397494,1.0,7/19,10.48%,CYTH3;EZR;GOLPH3;RHOA;SYNE4;PARD3;MYO9A
prerank,embryonic organ morphogenesis (GO:0048562),0.559505540828251,1.3874811623227312,0.09822646657571624,0.7820586871699392,1.0,14/42,11.69%,SIX1;MFAP5;HES1;HOXA3;EFEMP1;HOXB3;HOXC4;ID2;ACVR1;RARG;HOXB4;FOXE1;MEGF8;NIPBL
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.5214084835134565,-1.3874056723504875,0.09497206703910614,0.505357569538999,1.0,5/18,11.77%,APOE;TMCC2;ABCG1;NSG1;APH1B
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.5054904552850839,-1.3867739570121804,0.08695652173913043,0.5044861973315173,1.0,10/20,30.30%,RPS6KA5;PRKAA2;PPARGC1A;MAPK3;ARRB1;RUVBL2;NOS1;RPS6KA4;DIP2A;SOX4
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.4297050532314024,-1.3866758084454434,0.05150214592274678,0.5022373533481967,1.0,10/49,7.42%,IGF1;LYN;IL31RA;KIT;PARP14;IL6R;ERBB4;GHR;ARL2BP;IL18
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.6596333323522514,1.3864806790033852,0.1167192429022082,0.7840250208724231,1.0,3/17,4.65%,EZR;UBASH3A;PTPN2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.606988922396755,1.3862488307662646,0.10914454277286136,0.7827898537704941,1.0,6/25,5.55%,STK39;ANK2;ATP1B1;WNK1;COA8;DMD
prerank,tube closure (GO:0060606),0.5852611561952499,1.3861772491876387,0.09738372093023256,0.7809056805790618,1.0,6/31,8.73%,COBL;LRP6;LMO4;PRICKLE1;SKI;GRHL2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.6443493557248834,1.385997180349841,0.12305295950155763,0.7795139178943504,1.0,4/15,5.14%,BMPER;KLF4;FGF2;ITGA5
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.6499466546930983,1.3856676825252539,0.11754966887417219,0.7787191825821101,1.0,2/15,1.56%,KCNJ2;ATP1B1
prerank,positive regulation of protein catabolic process (GO:0045732),0.5095786643220772,1.3854854090693016,0.06601466992665037,0.777301209226211,1.0,21/84,12.98%,WWP1;FZR1;NEDD4;EZR;ADAM9;GPC3;WWP2;GSK3B;VCP;STX5;IDE;ASB9;RDX;NSF;PLK3;CDKN1B;DACT1;ASB11;SH3D19;TNFRSF1B;SMURF1
prerank,protein localization to centrosome (GO:0071539),0.6415782642464342,1.3854645413489617,0.1254125412541254,0.7752338535622163,1.0,10/17,20.71%,GOLGB1;PCM1;CEP131;PIBF1;STIL;NUDCD3;HOOK3;C2CD3;CSNK1D;CCDC14
prerank,regulation of Wnt signaling pathway (GO:0030111),0.49027243836664597,1.3850092105977478,0.05448354143019296,0.7749340734870793,1.0,21/108,9.40%,RSPO3;TCF7L1;NXN;TRABD2B;CTNND2;GPC3;SULF1;GRB10;MDFIC;FZD7;FOXL1;MDFI;SFRP4;TSKU;LRP1;SKI;ESR1;RSPO4;NLK;DISC1;DACT1
prerank,action potential (GO:0001508),0.5457932426984693,1.3850085432558297,0.1085383502170767,0.7728109664364297,1.0,6/44,5.55%,KCNJ2;KCNMB2;KCNMB3;KCNB1;CACNA1G;DMD
prerank,cellular response to mechanical stimulus (GO:0071260),0.5416442098233436,1.3845091251263448,0.0850480109739369,0.772739535423764,1.0,9/46,11.92%,PIEZO2;SOX9;CRADD;IRF1;SLC9A1;TLR4;NFKB1;MAP2K4;MYD88
prerank,regulation of amyloid-beta formation (GO:1902003),-0.45140493897761147,-1.384232247723319,0.0625,0.5063156357821211,1.0,13/34,13.30%,IGF1;APOE;PICALM;RTN1;EPHA4;LRRTM3;ABCG1;NTRK2;RTN4;ROCK2;BIN1;CASP3;GSK3A
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.4912539641431749,1.384167313239985,0.05785123966942149,0.7721056954584077,1.0,22/101,15.46%,THBS1;SAMD4A;CYFIP2;PERP;EZR;NIBAN1;KLF4;INHBA;AGTR1;EIF4G1;RDX;LARP4B;FBXW11;DACT1;ERBB2;EIF3E;EIF6;PRKDC;MTOR;TBC1D10A;PLD1;IST1
prerank,epithelial cell differentiation (GO:0030855),0.4992577169719217,1.3841269169543282,0.07001166861143523,0.7701815755081823,1.0,10/88,6.28%,BMP4;SIX1;FSTL1;BDH2;ANXA1;ANXA4;FZD7;EHF;CASP6;JAG1
prerank,metal ion export (GO:0070839),0.5794245776874756,1.3835806667555959,0.0970724191063174,0.770285775303823,1.0,8/31,8.95%,SLC4A4;KCNK5;ATP1B1;ATP2B4;SLC9A1;ATP1A4;ATP1A3;ATP1A1
prerank,cell-cell junction maintenance (GO:0045217),-0.5983018163499307,-1.382916451972367,0.11320754716981132,0.5072635845070192,1.0,5/11,23.54%,TJP1;CSF1R;MYADM;PRTN3;F2R
prerank,regulation of T cell mediated immunity (GO:0002709),0.7163486618965469,1.3824956397648944,0.15789473684210525,0.772594440082373,1.0,4/10,15.68%,TRPM4;RIPK3;TNFRSF1B;ZBTB1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.603525013074155,1.3822617925147092,0.12401883830455258,0.7714612004750484,1.0,3/22,8.41%,BMP4;INHBA;CDKN1B
prerank,negative regulation of protein catabolic process (GO:0042177),0.5523784728442145,1.3821654976438618,0.1095890410958904,0.7697788198235086,1.0,14/40,15.31%,EGFR;PTPN3;NELL1;TIMP2;IL10;RGP1;MDM4;IRAK3;TIMP1;SNX12;SNRNP70;AZIN1;MAD2L1;HMGCR
prerank,reverse cholesterol transport (GO:0043691),-0.5737445237575751,-1.3817812755492174,0.1038961038961039,0.507742131643059,1.0,5/13,12.03%,APOE;ABCA5;ABCA1;ABCG1;SCARB1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.6359108436092843,-1.3813954197149665,0.13365155131264916,0.5061663858263278,1.0,3/10,9.94%,TGFA;ADRA2A;HBEGF
prerank,protein K11-linked ubiquitination (GO:0070979),0.5904633642644402,1.3811955667520364,0.12205882352941176,0.7717850966210892,1.0,5/27,9.08%,FZR1;ANAPC5;UBE2B;CDC16;UBE2D3
prerank,purine-containing compound catabolic process (GO:0072523),0.6691068903116824,1.3808437438118388,0.13705583756345177,0.7711546266546819,1.0,2/13,1.27%,NT5E;NT5C1A
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.567542873649258,-1.3805487998061534,0.11658031088082901,0.5059349202485406,1.0,4/13,8.34%,ERRFI1;CBLB;SOCS5;ZFYVE28
prerank,regulation of protein localization to membrane (GO:1905475),0.5935789667761265,1.3796831304444317,0.1199421965317919,0.7737110961480703,1.0,6/28,9.20%,GPC6;GPC3;GSN;MMP14;GPC4;STX8
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.6176241724331273,-1.3796583182705604,0.12064965197215777,0.5061402327834955,1.0,6/10,14.67%,SHANK3;APP;SYP;NETO1;CAMK2B;SYNGR1
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.46302617448296096,-1.3795887953364838,0.08185053380782918,0.5037909606158919,1.0,15/34,15.26%,GRID2;GABRG3;GRIN2A;GRIN2B;GABRA2;MEF2C;GRIN1;GLRA1;GABRA1;GABRG1;GABRA4;GSK3A;GABRA5;ARRB2;AKT1
prerank,potassium ion export across plasma membrane (GO:0097623),0.6624795399046386,1.3791198115512195,0.13028169014084506,0.7739165810635553,1.0,1/13,0.20%,KCNK5
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.6405994634549739,1.3787147153172097,0.14533965244865718,0.7735895420823194,1.0,7/16,18.48%,DDX5;DDX17;SRSF6;DHX9;HNRNPM;CDK13;SCNM1
prerank,carboxylic acid metabolic process (GO:0019752),0.57316653810887,1.378367510072893,0.10359712230215827,0.7728790070160577,1.0,5/33,5.60%,SLC23A1;SLC23A2;PTGIS;CYP2S1;PON3
prerank,embryonic organ development (GO:0048568),0.5191883634962624,1.3782753552140246,0.07901554404145078,0.7711749103558903,1.0,13/61,8.14%,PBX3;PCSK5;RARB;COBL;PBX1;GLI3;BMPR1A;STRA6;TGFBR2;GDNF;TEAD1;GLI2;PDGFA
prerank,response to nitric oxide (GO:0071731),-0.5779308294118749,-1.3782311321730771,0.09090909090909091,0.5049018128988814,1.0,8/13,24.57%,FOXO1;GUCY1B1;KCNC2;EGLN1;CCL19;MT3;AQP1;TXN
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.6135207518633626,1.3778400056482796,0.13312202852614896,0.77096365938109,1.0,4/21,6.57%,RASSF2;NCK2;DMD;DMTN
prerank,blood vessel morphogenesis (GO:0048514),-0.41736456637592095,-1.3766604867544252,0.03571428571428571,0.5068124047178949,1.0,20/54,10.70%,FLT1;EFNB2;ENG;LAMA1;TGFBR3;CDH2;CCBE1;KDR;RASIP1;SLC1A1;TBX1;SOX17;RBPJ;COL4A1;HEY2;PROX1;RAMP2;SOX18;ADM;FLT4
prerank,aminoglycan biosynthetic process (GO:0006023),0.5394610157476711,1.3765644200924045,0.09517601043024772,0.774271862979205,1.0,11/49,8.51%,GPC6;EXT1;GPC3;B3GNT2;HS3ST1;HS6ST2;HEXA;GCNT2;XYLT1;GPC4;HAS1
prerank,negative regulation of cellular component movement (GO:0051271),-0.5500974643189862,-1.3763864905734837,0.10344827586206896,0.5050924423875601,1.0,4/15,3.30%,FRMD5;TGFBR3;SPOCK3;FBLN1
prerank,purine nucleotide catabolic process (GO:0006195),0.6664017718935809,1.3759291038578798,0.1505922165820643,0.7747186703681522,1.0,2/13,1.27%,NT5E;NT5C1A
prerank,signal peptide processing (GO:0006465),0.6801505940122307,1.3746597448131281,0.12962962962962962,0.7777085795278308,1.0,1/11,0.87%,PCSK5
prerank,dicarboxylic acid transport (GO:0006835),0.5768693441098051,1.3746282415242197,0.11061285500747384,0.775801630957409,1.0,3/28,3.93%,SLC26A7;GIPC1;SLC26A6
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.543817858180909,1.3741935977487068,0.08064516129032258,0.7754630792184182,1.0,5/44,3.74%,THBS1;NGF;CD44;KLF4;CAST
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4700109933638873,1.3728955140474792,0.056856187290969896,0.77887195166885,1.0,28/136,12.46%,TCF7L2;PKD1;HDAC4;CYP1B1;PTGIS;HES1;ANXA4;WWP2;TAX1BP1;KLF4;CMKLR1;ID1;MDFI;SFRP4;BHLHE40;GLIS2;ESR1;KDM1A;DDIT3;ID2;CHUK;IRAK3;ERBIN;COMMD1;USP7;RB1;ZC3H12A;CHP1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5837367813577323,1.3727445540409446,0.12663755458515283,0.7775291725154855,1.0,7/26,9.80%,EYA2;FGFR1;INHBA;EYA4;GDNF;EYA3;GATA1
prerank,pancreas development (GO:0031016),0.6823325873935094,1.3723061957889313,0.1384083044982699,0.7772846067667994,1.0,5/12,13.27%,TCF7L2;MET;ISL1;CCDC40;SELENOT
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.4136316694836144,-1.3720434566506352,0.04132231404958678,0.5146999776010264,1.0,8/47,7.78%,VTN;TIMP3;SPOCK2;SPOCK3;SERPINI1;SPOCK1;SERPIND1;GAPDH
prerank,calcineurin-mediated signaling (GO:0097720),0.6888556333109653,1.3714855946159288,0.1549053356282272,0.7764285125287305,1.0,6/10,15.08%,PPP3CA;NFAT5;NFATC4;PPP3CC;NFATC3;NFATC1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.6888556333109653,1.3714855946159288,0.1549053356282272,0.7764285125287305,1.0,6/10,15.08%,PPP3CA;NFAT5;NFATC4;PPP3CC;NFATC3;NFATC1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.628522691569061,1.3705046825368623,0.15422885572139303,0.7780692191353185,1.0,4/14,8.89%,PKD1;MDFI;IL10;G3BP2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.5862727746387807,-1.3701309041432368,0.1053921568627451,0.5173389156358144,1.0,2/12,7.42%,IL1R1;IL18
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.5693844433360593,-1.3698601118582938,0.1359447004608295,0.5155752861344919,1.0,2/11,3.49%,IL34;CSF1
prerank,actin polymerization or depolymerization (GO:0008154),0.5414115634885711,1.3693438463290073,0.12010443864229765,0.7809108028635208,1.0,7/50,3.95%,MICAL2;VILL;COBL;ABI1;GSN;DIAPH1;FAM107A
prerank,regulation of stem cell proliferation (GO:0072091),-0.532450659936182,-1.3690776305868375,0.12886597938144329,0.5151843050371934,1.0,3/17,4.86%,FBLN1;ACE;GJA1
prerank,positive regulation of collagen metabolic process (GO:0010714),0.62347961913262,1.3689780508910308,0.1461038961038961,0.7803427773058258,1.0,2/17,1.76%,BMP4;TGFB3
prerank,regulation of microtubule-based movement (GO:0060632),-0.5943288275647627,-1.368536377796083,0.1475826972010178,0.5144165848349715,1.0,6/11,28.29%,MAP2;LAMP1;NEFH;CFAP298;HAP1;DYNLT2B
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.554707422398837,-1.3677839329664185,0.10540540540540541,0.5141889068435087,1.0,7/15,20.00%,GGT5;ABHD12;ALDH4A1;SARDH;GGT1;GOT2;GGT7
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6922855067293627,1.3674029607293874,0.14634146341463414,0.7846189068567111,1.0,1/11,0.13%,STK39
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.44514329977765627,-1.3673440090022728,0.08280254777070063,0.5130299575984179,1.0,11/32,14.86%,ITGA1;PDGFRB;PPP1R16B;CALM1;PPIA;HSP90AB1;CD300A;PPP1R15B;PPP2R5A;CALM3;SMPD1
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5354715886074988,1.3668098328731948,0.10843373493975904,0.7850875625843561,1.0,7/49,8.33%,F3;LBP;CD2;STAT3;MAVS;DDIT3;TLR4
prerank,regulation of protein phosphorylation (GO:0001932),0.450407303773673,1.36630434055525,0.0328042328042328,0.7852669806032391,1.0,21/256,3.58%,SLIT2;BMPER;EGFR;BMP4;PLCE1;SLCO3A1;CARD14;NTRK3;SOX9;LRP6;PGF;CCN1;EFNA5;PID1;FN1;PLPP3;KRAS;NIBAN1;LIMK2;FGF2;ABL1
prerank,regulation of protein sumoylation (GO:0033233),0.6414272914975397,1.3655493708405146,0.14171974522292993,0.7862154934495857,1.0,5/17,18.78%,HDAC4;SAE1;PIAS3;ZMIZ1;PIAS1
prerank,endocardial cushion morphogenesis (GO:0003203),0.6118697722837846,1.3655303107507013,0.13192182410423453,0.7843257063966078,1.0,8/18,9.60%,BMP4;SOX9;BMPR1A;TGFBR2;NOG;ISL1;MDM4;ACVR1
prerank,neuromuscular junction development (GO:0007528),-0.48786650140081994,-1.365466989523976,0.11048158640226628,0.5160254823563439,1.0,9/24,10.85%,UNC13C;PDZRN3;PPFIBP2;ANK3;PPFIBP1;CACNB4;ZC4H2;GPHN;CACNB1
prerank,regulation of blood coagulation (GO:0030193),0.5934184573608899,1.3650179236452389,0.1163141993957704,0.7843943875943972,1.0,3/27,3.01%,ST3GAL4;THBS1;THBD
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.5170445198172967,-1.3643072777376575,0.09912536443148688,0.5167268561033126,1.0,9/18,18.58%,ACSL1;ELOVL7;ELOVL6;ACSL5;HSD17B12;HACD2;ACSBG1;HACD1;ACSL4
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.3590025520486865,-1.3640380078517922,0.006622516556291391,0.5150234938859052,1.0,34/124,14.80%,PTPRM;LYN;FRYL;APOE;CNTNAP2;RAPGEF2;MAP2;GPM6A;CNTN4;PLP1;RASGRF1;APP;ATP1B2;SH3GL2;EPHA8;OPHN1;STMN4;LAMB1;GPM6B;STMN3;MICALL1;MAPT;RAC1;UHMK1;PLEK;TMEM108;BICDL1;STMN1;FRY;BLOC1S6;ATXN10;CSF1R;PRMT1;WDPCP
prerank,fatty acid beta-oxidation (GO:0006635),0.5289576716549793,1.363871297178614,0.10851648351648352,0.7870936171320513,1.0,9/51,8.49%,ABCD3;EHHADH;BDH2;AUH;ECHDC1;ACOX3;DECR1;ACOT8;ACADM
prerank,defense response to symbiont (GO:0140546),-0.36607225395951437,-1.363673524245731,0.023923444976076555,0.5137014967692095,1.0,23/92,13.08%,SERINC3;BCL2;AGBL4;SERINC5;ABCC9;BCL2L1;SAMHD1;IFIT2;IRF2;IFITM1;BST2;IFITM3;OAS2;IFNAR2;NLRC5;IFIT3;NDUFAF4;RTP4;MLKL;RNASEL;TLR7;STAT1;TLR3
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5887303801504938,1.362713552220119,0.1409295352323838,0.7898720985188428,1.0,12/25,23.97%,RNF185;VCP;ZYG11B;OMA1;YME1L1;CLPP;CUL3;UFD1;UBE2W;UGGT2;FBXL17;POMT2
prerank,urogenital system development (GO:0001655),0.6802367453558763,1.362161607121371,0.15091210613598674,0.7900317988423914,1.0,3/11,6.25%,SOX9;ANXA1;EPHB3
prerank,fatty acid oxidation (GO:0019395),0.5103282889390622,1.3612418204275647,0.09617918313570488,0.7918666582681981,1.0,9/57,8.66%,ABCD3;EHHADH;BDH2;ADH7;AUH;ECHDC1;DECR1;ACADM;PECR
prerank,T-helper cell differentiation (GO:0042093),0.6407971919306928,1.3605064727488232,0.15325077399380804,0.7929127706295562,1.0,1/14,0.25%,FOXP1
prerank,regulation of plasminogen activation (GO:0010755),0.6639488181414277,1.3602849584640844,0.1558872305140962,0.7918219485070798,1.0,1/12,0.27%,THBS1
prerank,positive regulation of catabolic process (GO:0009896),0.5168420140603065,1.359986518992544,0.10532994923857868,0.7910570037769002,1.0,13/65,9.40%,WWP1;FZR1;NEDD4;GPC3;WWP2;GSK3B;VCP;STX5;IDE;ASB9;NSF;CDKN1B;DACT1
prerank,negative regulation of cellular senescence (GO:2000773),-0.5724262242157454,-1.3592354049262472,0.14430379746835442,0.524126661696479,1.0,5/13,13.67%,SLC30A10;AKT3;CDK6;YBX1;RBL1
prerank,histone deubiquitination (GO:0016578),0.6145513344012828,1.3591065237695956,0.14192495921696574,0.7927317525067733,1.0,11/18,23.68%,TRRAP;USP49;USP15;USP7;UIMC1;KAT2A;USP22;USP21;USP36;USP3;BRCC3
prerank,activation of protein kinase B activity (GO:0032148),-0.47128159730421226,-1.3582902376708736,0.08615384615384615,0.5242836549120461,1.0,10/29,7.77%,IGF1;OSBPL8;WNT5A;INSR;PPIA;FGF1;CCDC88A;ADRA2A;IL18;GAS6
prerank,muscle tissue development (GO:0060537),0.6521086455786065,1.358196330749781,0.15307820299500832,0.7944514471485211,1.0,6/13,9.42%,BMP4;SMO;CSRP3;STRA6;CSRP2;NF1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.621428444128457,-1.3570899253363076,0.12987012987012986,0.5251009941160688,1.0,2/10,3.16%,KCNAB1;ANK3
prerank,nucleotide catabolic process (GO:0009166),0.6344250493691426,1.356985349334341,0.1402936378466558,0.7973191934305234,1.0,7/16,18.28%,NT5E;NT5C1A;VCP;DERA;NUDT15;XDH;DNPH1
prerank,positive regulation of locomotion (GO:0040017),0.5766254554498611,1.3569460237039164,0.13411078717201166,0.795528163249076,1.0,2/27,0.86%,THBS1;NTN1
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.6782913191313822,1.3561694898379304,0.1611785095320624,0.7967108777186579,1.0,2/10,1.37%,BMP5;LRP6
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.4060117571269492,-1.3558387797933436,0.034782608695652174,0.526138939296056,1.0,18/57,16.10%,IGF1;LYN;IL31RA;KIT;PARP14;IL6R;ERBB4;GHR;ARL2BP;IL18;INPP5F;NF2;IL6ST;CSF1R;SH2B3;FLT3;TNFRSF1A;CD40
prerank,protein localization to Golgi apparatus (GO:0034067),0.5763588396787206,1.3556089141296912,0.11504424778761062,0.797155912643272,1.0,8/27,11.39%,VPS13A;VPS13C;RAB6A;GAK;GOLPH3;GBF1;VPS13D;ZDHHC15
prerank,regulation of lamellipodium assembly (GO:0010591),0.5617096566687169,1.3549294814243258,0.1492753623188406,0.7978838572296744,1.0,2/34,0.44%,SLIT2;PLCE1
prerank,regulation of cardiac conduction (GO:1903779),-0.40189190783291573,-1.3545355172231397,0.07264957264957266,0.5273692730792218,1.0,13/54,10.71%,ATP1A2;ITPR1;ATP1B3;ABCC9;NPR1;SLC8A1;RYR2;ATP1B2;DMPK;ATP2B1;FXYD6;ACE2;ATP2A2
prerank,positive regulation of cell division (GO:0051781),0.539189523442024,1.3541457686028655,0.12380952380952381,0.7992144555654423,1.0,10/38,14.30%,CIT;GIPC1;PRKCE;CDC25B;CDC14A;RHOA;DRD3;PKN2;CUL3;HTR2B
prerank,regulation of mRNA metabolic process (GO:1903311),0.6828773634481735,1.35254630653159,0.1644518272425249,0.8034651378905724,1.0,4/11,17.22%,SLTM;DHX9;CDK11B;SRPK1
prerank,inorganic cation transmembrane transport (GO:0098662),0.4417904814870403,1.3521575680245925,0.028662420382165606,0.8031771697628634,1.0,36/268,8.95%,SLC4A4;SLC9A2;KCNB2;KCNK5;KCNJ2;SLC12A2;SLC24A3;PKD1;ATP1B1;CACNA1C;ATP2C2;SLC6A7;KCNQ5;KCNS3;ANO6;TRPM6;KCNB1;ATP6V0A4;CACNA1G;SLC39A14;SLC39A11;SCARA5;NALCN;TRPM4;ATP2B4;ITGAV;TRPM7;SLC9A8;SLC6A19;SLC9C1;SLC9A1;SLC4A8;P2RX4;ATP1A4;ATP1A3;ATP1A1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.48711825011869797,1.3515933130626734,0.07859733978234583,0.8034725795722267,1.0,15/93,10.37%,EGFR;RASSF2;NTRK3;NGF;CD44;DOCK7;NCK2;EIF4G1;ATP2B4;DMD;RIPK2;DMTN;BCAR3;AKAP9;VEGFA
prerank,axon development (GO:0061564),-0.37077131358873777,-1.3510560709577029,0.041666666666666664,0.5347235142585914,1.0,28/78,18.61%,NREP;GRM7;CTNNA2;ANK3;DCC;CNTN4;ACTB;PLP1;APP;BAIAP2;ZDHHC17;MAPT;PLPPR4;PAK3;RTN4;DSCAML1;BRSK2;ADGRB1;LMTK2;RTN4RL1;CAMSAP2;NRCAM;APBB1;SLITRK5;RAB3A;NEFH;S100A6;SPTBN4
prerank,negative regulation of cell differentiation (GO:0045596),0.4572849510349266,1.3507492374515633,0.05888767720828789,0.8050513177172464,1.0,30/181,7.56%,EGFR;BMP4;CRIM1;ZFPM2;WNT9A;SOX9;BMP5;COL5A2;PTK2B;SMAD6;HES1;ZBTB16;TWIST2;SPRED2;TGFBR1;EFEMP1;PDCD4;TRPM4;TSKU;NOG;TRIO;SKI;ITGAV;PTHLH;JAG1;IL17RD;RORA;BAMBI;GDF5;ID2
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.6361400377727133,1.3505893585564097,0.13725490196078433,0.8037239615220587,1.0,3/15,5.76%,ANXA1;FAM107A;ISL1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.604457848656075,1.350419266129044,0.16534181240063592,0.8024963639755525,1.0,2/19,1.76%,BMP4;TGFB3
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.660117302702396,1.3498439055690774,0.15023474178403756,0.8029083306352457,1.0,4/12,4.34%,DOCK5;IGFBP5;DOCK7;NR4A3
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4982750063623858,1.3497754913163478,0.10240202275600506,0.8012284029825236,1.0,9/63,9.79%,THBS1;BMP4;TCF7L2;FGFR1;TGFBR1;ITGAV;BIRC6;ACVR1;FEM1B
prerank,cellular response to organonitrogen compound (GO:0071417),0.4880685961223936,1.3496576759151582,0.07429245283018868,0.7998542755505574,1.0,15/99,8.71%,SLIT2;CDH1;SOX9;EZR;IGFBP5;CTNNA1;CAPN2;DIAPH1;SLC26A6;RAP1A;GOLPH3;DMTN;JUP;RRAGB;P2RX4
prerank,regulation of glycogen metabolic process (GO:0070873),0.664590589076528,1.3493054769404929,0.17504051863857376,0.7994803934678738,1.0,2/12,3.25%,PPP1R3B;PPP1R3C
prerank,regulation of autophagosome maturation (GO:1901096),0.6592969564437773,1.3492975940776308,0.1539708265802269,0.7976454324480153,1.0,8/13,25.27%,ADRB2;CLEC16A;TMEM39A;SMCR8;TBC1D25;CLN3;RUBCN;PHF23
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5238681063534388,-1.3488843379917834,0.12359550561797752,0.538270653970651,1.0,4/17,5.05%,PPARA;PRKAG2;PPARD;PRKAA2
prerank,embryonic eye morphogenesis (GO:0048048),0.6792013303260053,1.3487560025183665,0.13367174280879865,0.7978336462863218,1.0,4/11,9.77%,LRP6;MFAP5;EFEMP1;RARG
prerank,PERK-mediated unfolded protein response (GO:0036499),0.6703984024975612,1.3480106413477415,0.16928446771378708,0.7989352027555556,1.0,6/10,23.05%,NFE2L2;DDIT3;EIF2S1;QRICH1;EIF2AK3;HERPUD1
prerank,microglial cell activation (GO:0001774),-0.48545744718239614,-1.3475727386461618,0.1048158640226629,0.5395796601320434,1.0,9/21,22.88%,APP;SNCA;GRN;MAPT;C1QA;TYROBP;CX3CL1;TREM2;CX3CR1
prerank,regulation of sprouting angiogenesis (GO:1903670),0.5624753227878464,1.34733526125976,0.13861386138613863,0.7996648461566537,1.0,6/33,5.14%,BMPER;THBS1;RHOJ;KLF4;FGF2;ITGA5
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.648149909607744,1.3472973272366557,0.17003367003367004,0.7979308201186869,1.0,2/12,4.40%,SOAT1;ACSL3
prerank,endocardial cushion development (GO:0003197),0.588402211836724,1.3472391924336506,0.13270142180094788,0.7962793122876124,1.0,8/21,9.60%,BMP4;SOX9;BMPR1A;NOG;ISL1;GATA4;MDM4;ACVR1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.5361280923098624,1.3469168471985435,0.11126564673157163,0.7956897680308307,1.0,22/45,21.23%,BMP4;PTPN3;GAS1;IL10;CDKN1B;FOXC1;BTG3;NABP1;ANGEL2;CHEK1;BCL6;MAD2L1;CHFR;PRCC;HECA;TRIM35;ZWILCH;SCRIB;ZW10;TOM1L1;WEE1;FZD3
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6318367993931893,1.3461717100442931,0.1536,0.7967572411986475,1.0,5/17,5.01%,NTRK3;BAIAP2L1;ABL1;NRP1;BCAS3
prerank,regulation of leukocyte activation (GO:0002694),-0.5338892994713966,-1.3458964108615485,0.10817307692307693,0.5418391000161998,1.0,6/14,13.49%,LYN;MFHAS1;CD200;MIF;MYO18A;CD74
prerank,regulation of epidermal cell differentiation (GO:0045604),0.5977343263517154,1.3456452940822239,0.14953271028037382,0.7970136305607238,1.0,3/21,4.96%,BMP4;KLF7;SFRP4
prerank,smoothened signaling pathway (GO:0007224),0.5567401762099524,1.3455397384049137,0.12973760932944606,0.795700699712494,1.0,8/32,14.78%,SMO;GLI3;HIPK1;GLI2;TMEM231;EVC2;DYRK2;STIL
prerank,protein localization to nucleus (GO:0034504),0.4732947476532425,1.3452179556713182,0.09903381642512077,0.7949849569367621,1.0,30/102,20.44%,BMP4;SIX1;PRICKLE1;NUP93;LMNA;STAT3;TOR1AIP1;E2F3;IPO7;SIX4;TNPO2;WRN;MORC3;CNEP1R1;TBRG1;NUP153;SEC13;NUP214;PML;ZBTB7A;NUP188;XPA;TOR1B;NUP88;ABCA7;DVL1;HEATR3;TNPO3;RAN;NUTF2
prerank,negative regulation of chemotaxis (GO:0050922),0.5585464105488008,1.344725684030924,0.1531791907514451,0.7950304678349105,1.0,6/31,4.65%,SLIT2;THBS1;SEMA3E;SEMA3D;SEMA3C;PTPN2
prerank,protein localization to organelle (GO:0033365),0.459718319845891,1.3446767244417464,0.06720741599073002,0.7933813292383971,1.0,24/133,12.62%,BMP4;SIX1;BBS9;ANK2;CSRP3;CNTLN;ZNF423;LMNA;RAB6A;STX5;GAK;TOR1AIP1;ARL3;GBF1;SIX4;WDR35;TULP2;EHD1;TRAM2;EMD;CNEP1R1;COG3;DDRGK1;FAM83H
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.46845050564515045,1.3445047100764143,0.06064073226544622,0.7922702353754765,1.0,24/122,14.92%,SMOC2;EGFR;THBS1;SAMD4A;NIBAN1;KLF4;SORBS1;FGF2;IRS1;GLI2;TLR4;BCAR3;LARP4B;STN1;NFKB1;IL33;ERBB2;EIF3E;EIF6;PRKDC;MTOR;DYRK2;DHX9;PLD1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.4335973623646457,1.3443332308236668,0.0010030090270812437,0.7910983342575514,1.0,142/572,16.65%,FOXP2;FOXP1;BMP4;KLF12;ZFHX3;ZFPM2;TCF7L2;RARB;NFIB;SOX9;HDAC4;PRDM6;NEDD4;DDX5;EZR;FOXP4;CUX1;GLI3;FOXO3;HES1;HDAC9;ZBTB16;SKIL;WWP2;USP2;ESR2;KLF4;BMP6;ZNF148;CRY2;NR2F1;FOXC2;ID1;MEF2A;GLIS1;KLF7;JDP2;NR4A3;MDFI;NR4A2;TCF25;KLF10;ZBTB7B;SMYD2;BHLHE40;NFATC4;HDAC8;CREBBP;FRK;NOG;GLIS2;TLE6;ISL1;SKI;STAT3;ESR1;KDM1A;TBL1X;PHF21A;NFIL3;DDIT3;DLG1;NFIX;LCOR;SOX14;ID2;GLI2;PLK3;ZNF8;MDM4;RXRA;ZMYM5;FOXC1;PHF12;KANK2;NFKB1;UBE2D3;PER3;IL33;DACT1;CBX5;RARG;GATA1;FOXE1;RARA;ZNF25;SMAD2;MTDH;VEGFA;TCERG1;JUN;ZBTB32;NCOR1;MIER1;MXD1;GTF2IRD1;CBFB;PER1;OTUD7B;EED;BPTF;NIPBL;DCAF1;RB1;MTA1;NCOA5;ID4;NKX2-1;SMARCA4;ATRX;NR6A1;TCF3;NCOR2;MXD4;NFATC3;BAG3;PPM1A;CTR9;HCFC1;PAX6;CHD3;EP300;BCL6;RNF2;DNMT3A;REST;VPS72;HDAC10;CCND1;PCGF1;TWIST1;URI1;ZBTB1;PRDM5;ZBTB7A;TFAP2A;POU6F1;NSD1;YY1;ZNF219;EPC1;KMT5A
prerank,negative regulation of cell migration (GO:0030336),0.46355535774790557,1.3443135586208022,0.07377979568671963,0.7893614087324119,1.0,30/137,10.12%,SLIT2;CDH1;TMEFF2;CLIC4;DPYSL3;CYP1B1;PTPRU;WNT11;ARHGDIB;FOXO3;PHLDB2;SULF1;COL3A1;IGFBP5;BMPR1A;FGF2;SRGAP2;SRGAP3;VCL;NOG;LRP1;ZMYND8;JAG1;SLURP1;RAP2C;HAS1;CHRD;NF1;LDLRAD4;TIMP1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.5095265611639587,1.3442535785135494,0.09462915601023018,0.787826729997137,1.0,12/66,9.40%,EGFR;FHL1;PKD1;ANXA1;KLF4;FAM107A;EIF4G1;DLG1;ID2;RDX;KANK2;DACT1
prerank,retinol metabolic process (GO:0042572),0.6375551954606338,1.3442453322500618,0.1646655231560892,0.7860793641398465,1.0,2/14,2.13%,CYP1B1;ADH7
prerank,neural tube closure (GO:0001843),0.5564004810994861,1.3441929717934546,0.13191489361702127,0.7845077356028114,1.0,15/34,23.81%,COBL;LRP6;LMO4;PRICKLE1;SKI;GRHL2;STIL;BCL10;DVL1;TGFB2;SCRIB;FUZ;MTHFR;PHACTR4;CELSR1
prerank,regulation of filopodium assembly (GO:0051489),0.5363341364486705,1.3440521385226367,0.12181303116147309,0.7833665146771436,1.0,10/38,6.57%,DPYSL3;ARAP1;TGFB3;PRKCD;PALM;ARHGAP44;NRP1;BCAS3;RHOQ;DMTN
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.5643008614005967,1.3438223346411937,0.11353711790393013,0.7825181961096831,1.0,11/33,19.60%,PKD1;TCIM;ATP2B4;ID2;CDKN1B;PLCG2;DDRGK1;TRIM39;INO80;CDKN1A;E2F1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.6336676758944947,1.3434206059168434,0.13782051282051283,0.7822757243339189,1.0,3/17,3.98%,SOX9;DSPP;KLF7
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.4924330579041409,1.3430784203263773,0.0941320293398533,0.7820019922834681,1.0,24/87,10.62%,SMAD9;TGFB3;ADAM9;SMAD6;COL3A1;ITGB1;BMPR1A;ID1;ITGB5;TGFBR1;LTBP2;TGFBR2;GCNT2;SKI;BAMBI;GDF5;NLK;RHOA;GDF10;ACVR1;USP15;PARD3;SMAD2;JUN
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.534737221210143,-1.3423305140292972,0.13089005235602094,0.549402008564993,1.0,5/15,6.03%,PPARA;LPGAT1;NR1H3;PPARD;PPARGC1A
prerank,protein targeting to peroxisome (GO:0006625),0.5631433838742512,1.3423069824410254,0.14074074074074075,0.7833269937994287,1.0,12/29,24.53%,ABCD3;PXMP2;ACBD5;HACL1;LONP2;PEX13;ZFAND6;ABCD1;PEX2;SLC25A17;PEX7;PEX26
prerank,engulfment of apoptotic cell (GO:0043652),0.62708404782669,1.3415295415783528,0.13993174061433447,0.784556390286823,1.0,2/15,3.34%,THBS1;RHOBTB1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5232519169580978,1.340543404225386,0.12872628726287264,0.7865629062248622,1.0,2/48,0.11%,SLIT3;SLIT2
prerank,regulation of telomere maintenance (GO:0032204),0.5818110075620558,1.3404807626747184,0.1321928460342146,0.785077620458132,1.0,13/26,21.89%,SMG6;HDAC8;USP7;ATRX;SMG1;XRCC5;PML;YLPM1;NBN;SIRT6;DHX36;ERCC1;RAD50
prerank,cellular response to hormone stimulus (GO:0032870),0.4951016508501527,1.3402341517115737,0.11713933415536375,0.7843391856355322,1.0,14/69,9.94%,SLIT3;SLIT2;RAMP1;NR4A3;SERPINB9;BCAS3;KLF9;STAT3;RDX;SOCS2;ATP1A3;ATP1A1;GATA1;RARA
prerank,canonical Wnt signaling pathway (GO:0060070),0.49930100902041585,1.340232836905257,0.09762202753441802,0.7826077525546591,1.0,16/68,11.40%,TCF7L1;TCF7L2;WNT9A;LRP6;WNT11;PLPP3;GSK3B;FZD7;NR4A2;SFRP4;WNT16;FZD1;CSNK1A1;RARG;LRP5;BCL9L
prerank,glucose import (GO:0046323),-0.534143201912651,-1.3391199356011707,0.13144329896907217,0.5559978953639311,1.0,2/13,1.81%,SLC2A1;SORT1
prerank,acidic amino acid transport (GO:0015800),-0.5099330965954616,-1.3388402100674044,0.11734693877551021,0.5543783274844245,1.0,6/17,4.89%,SLC1A3;SLC6A13;SLC6A1;SLC1A1;GJA1;SLC1A2
prerank,adrenergic receptor signaling pathway (GO:0071875),0.5992302506996876,1.3385134787121555,0.16744186046511628,0.787687712576116,1.0,5/20,9.10%,ADRA1B;AKAP13;ADRB2;ADCY9;DRD3
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.4283066970208185,-1.3382235085248408,0.07581227436823104,0.553734396650081,1.0,18/38,28.18%,NDUFB9;NDUFA8;NDUFC1;NDUFB11;NDUFB3;NDUFA1;NDUFB8;NDUFA4;NDUFA3;NDUFS4;NDUFA11;NDUFA13;NDUFB7;NDUFA6;NDUFA2;NDUFA10;NDUFS6;NDUFV3
prerank,lipid catabolic process (GO:0016042),-0.5149279804281391,-1.3380907268762645,0.12602739726027398,0.551759059922606,1.0,8/18,29.34%,PLA1A;LIPE;LPL;PLAAT3;MT3;HSD11B1;HSD17B14;PPT1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.5338852440313772,-1.338022597676481,0.1491442542787286,0.5495595173894033,1.0,4/17,12.19%,KCNAB1;ANK3;AKAP6;NOS1AP
prerank,protein import into peroxisome membrane (GO:0045046),0.5882038606028079,1.3365490926053794,0.1582952815829528,0.7937054459476032,1.0,8/22,24.53%,ABCD3;PXMP2;ACBD5;PEX13;ABCD1;PEX2;SLC25A17;PEX26
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.5685492489959365,1.335898924737925,0.15701219512195122,0.7945829369816887,1.0,4/26,6.79%,SMOC2;HES1;USP2;CDC25B
prerank,regulation of muscle contraction (GO:0006937),0.576897175310245,1.3358633368003363,0.1457725947521866,0.7929685332040641,1.0,3/26,4.02%,KCNB2;PLCE1;PPP1R12B
prerank,response to cholesterol (GO:0070723),0.6293355415769237,1.3353354151564913,0.1737012987012987,0.7932800815440381,1.0,8/17,12.43%,LRP6;SMO;TGFBR1;TGFBR2;GRAMD1C;SMAD2;CCL3;GRAMD1A
prerank,visual system development (GO:0150063),0.5403272692005414,1.3352902911449573,0.14965034965034965,0.7917183000387901,1.0,7/37,11.18%,PBX3;PBX1;SMOC1;HIPK1;FOXC1;SCO2;ATF6
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.4651645700560242,-1.3347636765554916,0.11079545454545454,0.5560365993548876,1.0,8/26,9.94%,ERRFI1;TGFA;CBLB;APP;ADRA2A;SOCS5;ZFYVE28;HBEGF
prerank,dendrite self-avoidance (GO:0070593),-0.515771729286024,-1.3346579591091394,0.13705583756345177,0.5539332732657423,1.0,7/16,13.16%,BSG;CNTN4;ROBO4;CNTN2;DSCAML1;PALLD;NEXN
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.6494470866686604,1.334478484342639,0.17868852459016393,0.7932772286314801,1.0,3/12,7.30%,CD44;GCNT2;IL10
prerank,positive regulation of integrin activation (GO:0033625),-0.5552265870154633,-1.3343492603567337,0.14004914004914004,0.552368026182325,1.0,3/11,9.54%,RASIP1;PIEZO1;PLEK
prerank,heterotypic cell-cell adhesion (GO:0034113),0.5797303046957444,1.333691219515657,0.15304606240713226,0.794578490959796,1.0,11/25,12.60%,CXADR;DSP;PARVA;ITGB1;DSG2;ITGA5;CD2;ITGAV;JUP;ITGB3;DSC2
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.36077984853760536,-1.333628145455625,0.04597701149425287,0.5520218716589299,1.0,25/91,13.58%,CP;SLC30A10;SLC39A10;FTH1;TFRC;APP;SLC39A8;SLC40A1;FTL;ATOX1;SLC30A1;MT2A;SLC31A1;ABCB7;BOLA2;ATP6AP1;SLC22A17;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X
prerank,autonomic nervous system development (GO:0048483),0.6253951782400806,1.3336226513216574,0.15031645569620253,0.7931291022419956,1.0,5/17,9.42%,FN1;NRP1;GDNF;PHOX2A;NF1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.49966028428299447,1.333596044344076,0.10101010101010101,0.7915119931523745,1.0,19/65,13.35%,HTRA3;CD109;SMAD6;SKIL;SPRED2;TGFBR1;PMEPA1;TGFBR2;HTRA4;SKI;IL17RD;TGFB1I1;BAMBI;LDLRAD4;SMAD2;BCL9L;NKX2-1;SMURF1;PPM1A
prerank,negative regulation of wound healing (GO:0061045),0.5626524704023037,1.333379831839228,0.15529753265602322,0.7906074080503067,1.0,5/28,3.27%,SLC12A2;CD109;PHLDB2;THBD;FGF2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.4380401374797913,-1.3328897765919097,0.09740259740259741,0.5517101434250428,1.0,3/33,3.49%,IL34;LEF1;CSF1
prerank,neuron differentiation (GO:0030182),0.45440148482259407,1.3324760363101578,0.05771365149833518,0.7923851611517021,1.0,25/165,9.35%,VSX1;PBX3;MET;WNT9A;LRP6;PBX1;WNK1;WNT11;INHBA;FZD7;TGFBR1;ACSL3;NR4A2;ITM2C;WNT16;THOC2;PITX3;LHX2;PHOX2A;ID2;FZD1;GLI2;PITX2;ATOH8;CTF1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.674266387258987,1.332332459356619,0.1903914590747331,0.7912343737138269,1.0,5/10,10.73%,SOX9;TGFBR2;PDGFA;CHRD;LRP5
prerank,neuron projection development (GO:0031175),-0.33380929895340117,-1.3322404397720542,0.010416666666666666,0.5512246463959414,1.0,40/168,9.67%,PTPRM;DOCK10;LYN;FRYL;SHANK3;APOE;GRM7;CNTNAP2;ADGRV1;TNIK;RAPGEF2;PAK1;MAP2;EPHB1;EPB41L3;GPM6A;CNTN4;PLP1;RASGRF1;BMP7;APP;NRK;EPHA4;SH3GL2;DAB2IP;SGK1;EPHA8;MAP4K4;OPHN1;STMN4;MYO16;LAMB1;GPM6B;STMN3;MICALL1;NYAP2;MAPT;PAK3;UHMK1;TMEM108
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.6618746628688665,1.3321768571930355,0.1639871382636656,0.7901769716387101,1.0,6/12,7.59%,CACNA1C;DSP;DSG2;TRPM4;DLG1;JUP
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.5255055060629584,1.3321242901353747,0.11559139784946236,0.7887335028017745,1.0,4/48,4.28%,SLC26A2;GUCY2C;PAPSS2;ADCY9
prerank,organelle disassembly (GO:1903008),0.5595822489950468,1.3318573629271124,0.11790393013100436,0.7880911089716727,1.0,17/33,19.87%,ULK2;VCP;STX5;GBF1;KIF9;PLK3;KLC1;MRRF;EIF2D;RB1CC1;MTIF3;DDRGK1;GFM2;UBA5;MTIF2;ATG2A;DYRK3
prerank,endocrine system development (GO:0035270),0.5937887676860829,1.3309847792665652,0.1448170731707317,0.7897366490043504,1.0,9/21,12.34%,SIX1;WNT11;TGFBR1;STRA6;GLI2;NF1;DKK3;FOXE1;NKX2-1
prerank,regulation of cartilage development (GO:0061035),0.6113243006694882,1.3304152429308373,0.14423076923076922,0.7902657243711002,1.0,5/18,2.42%,BMP4;SOX9;BMP1;WNT11;ZBTB16
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.47682471468417215,1.3299457036554232,0.0885478158205431,0.7902936945025344,1.0,26/95,13.97%,THBS1;HTRA3;CD109;SMAD6;SKIL;GIPC1;SPRED2;TGFBR1;PMEPA1;TGFBR2;HTRA4;CREBBP;SKI;IL17RD;TGFB1I1;BAMBI;LTBP4;DKK3;LDLRAD4;SMAD2;RNF111;BCL9L;NKX2-1;SMURF1;PPM1A;EP300
prerank,cGMP biosynthetic process (GO:0006182),0.6794652241535413,1.3293978438459968,0.1824561403508772,0.7906163015248976,1.0,1/10,0.24%,GUCY2C
prerank,in utero embryonic development (GO:0001701),0.5754528861672001,1.3284559811729961,0.16886930983847284,0.7926544143695107,1.0,5/25,4.08%,MBNL1;PKD1;FUT8;TGFB3;TGFBR1
prerank,artery morphogenesis (GO:0048844),0.5483258080720161,1.327625038153782,0.15195369030390737,0.7941795362983807,1.0,11/30,10.37%,BMP4;HES1;BMPR1A;NRP1;TGFBR1;STRA6;NOG;LRP1;JAG1;NF1;VEGFA
prerank,regulation of protein localization to nucleus (GO:1900180),0.5276788323799698,1.3271616424239971,0.15654520917678813,0.7942315932546503,1.0,4/43,3.23%,BMP4;CTNNA1;LIMK2;GSK3B
prerank,negative regulation of telomere maintenance (GO:0032205),0.6210616678868517,1.3271470738981967,0.16779661016949152,0.7926228291245486,1.0,7/15,21.89%,SMG6;TNKS2;ATM;SLX4;NBN;ERCC1;RAD50
prerank,response to estrogen (GO:0043627),0.5560071964730967,1.3251495941555778,0.14002828854314003,0.798530808673607,1.0,14/31,26.50%,SERPINB9;BCAS3;KRT19;ESR1;SLC34A2;RARA;KMT2D;EP300;CYP27B1;TRIM25;GATA3;SRA1;AR;CITED2
prerank,embryonic limb morphogenesis (GO:0030326),0.5444422111609126,1.324709285087405,0.15306122448979592,0.7985217109806833,1.0,14/34,16.13%,MBNL1;LRP6;CACNA1C;GLI3;AFF3;CREBBP;NOG;SKI;RARG;MEGF8;NIPBL;ECE1;TWIST1;TFAP2A
prerank,cellular protein metabolic process (GO:0044267),-0.30064835282117447,-1.3241036429981887,0.0,0.572029104250424,1.0,113/396,15.37%,CP;IGF1;LTBP1;IGFBP2;IGFBP7;SPARCL1;CDH2;APOE;ST3GAL1;ST3GAL6;ST8SIA4;MSRA;IGFBP3;PAPPA;RPS14;CTSH;CST3;ITIH2;CSF1;IGFBP4;EEF1A1;RPL38;TNC;RPLP1;APP;RPS9;RPL21;RPS13;LGALS1;RPL41;VWA1;RPL37A;PLAT;RPS21;NOTUM;RPLP2;DAB2IP;RPL27A;RPS19;RPL34;RPS29;RPS8;RPS3;RPN2;RPS23;RPS5;RPS4X;RPL13;LAMB1;RPS16;RPL9;RPS15;SERPIND1;RPS27;RPL30;RPL37;RPL19;RPS11;QSOX1;RPS24;RPL18A;ADORA2A;GAS6;RPL18;CHRM3;SPP1;GATA6;F5;RPS7;RPL23;RPL17;EIF4EBP2;RPS20;RPL22;RPL23A;RPL26;RPS25;RPS18;PDIA6;RPL35A;MRPL3;LGMN;RPL11;RPL13A;RPL7;RPL36;CSF2RA;RPL32;RPS17;APH1B;SPCS3;RPL39;ERO1A;HSP90B1;MSRB1;RPS2;RPL8;RPL14;LTA4H;FAM20C;RPL24;MFGE8;RPL29;PENK;MATN3;MRPS11;LAMB2;LAMC1;MRPL51;MMP2;SFTPA1;SFTPA2;RPL10A
prerank,regulation of cell morphogenesis (GO:0022604),0.5592310861870211,1.3239009600139617,0.15373352855051245,0.8000983293242658,1.0,9/30,13.13%,FMNL2;EFNA5;CD44;MOV10;MYO9A;BCL9L;ZMYM4;SH3D19;ZRANB1
prerank,respiratory tube development (GO:0030323),0.5576430845347531,1.3238048017247628,0.1618075801749271,0.7987741583457405,1.0,8/28,12.34%,BMP4;PCSK5;FGF2;STRA6;GLI2;VEGFA;CCDC40;NKX2-1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.4585320131671333,-1.3237806714061897,0.128125,0.5705025190060641,1.0,12/27,17.20%,PRKCH;PPARA;CSF1;ABCA5;NR1H3;ABCA1;IL18;ABCG1;MSR1;AGT;LPL;NR1H2
prerank,negative regulation of vascular permeability (GO:0043116),0.6662524149096796,1.3229969491782707,0.17269736842105263,0.8002472938111564,1.0,1/12,0.11%,SLIT2
prerank,regulation of osteoblast differentiation (GO:0045667),0.48250137993793557,1.3227072579274983,0.1116564417177914,0.7997215575435721,1.0,16/82,6.42%,BMP4;CRIM1;SOX9;DDX5;CCN1;DDR2;SMAD6;TWIST2;SMOC1;BMP6;BMPR1A;NELL1;TRPM4;NOG;SKI;BAMBI
prerank,calcium-mediated signaling (GO:0019722),0.4732324804902992,1.3215509727281258,0.09608540925266904,0.8024306241707818,1.0,23/93,15.03%,EGFR;PLCE1;ANK2;ATP1B1;CACNA1C;PPP3CA;AGTR1;TRPM4;DMTN;NUDT4;SLC9A1;P2RX4;TNNI3;PLCG2;MCU;TNFSF11;CCL3;PPP3CC;SAMD14;RCAN1;CXCR4;HTR2B;BCAP31
prerank,regulation of intracellular protein transport (GO:0033157),0.5550774988647462,1.320801144895229,0.15873015873015872,0.803648621155966,1.0,6/32,10.81%,BMP4;NDEL1;BCAS3;PCM1;PLK3;CEP131
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.47262042387816505,1.320482020252221,0.13043478260869565,0.803214755144929,1.0,18/87,17.86%,FBXL7;FHL1;KLF4;FAM107A;DLG1;PSMB2;KANK2;DACT1;AURKA;PSMC6;USP47;RB1;PSMD11;PSMD1;CUL1;PSMD7;CDKN1A;PSMC1
prerank,chemical synaptic transmission (GO:0007268),-0.3179875918761572,-1.3200724941546018,0.0,0.5786312842299844,1.0,64/284,10.85%,SLC1A3;UNC13C;DTNA;APOE;GRM7;NOVA1;PDE7B;GRM3;NRXN1;CDH8;CACNA1E;MBP;GRM5;GRIA4;GRID2;SLC6A1;GABRG3;RIMS1;LIN7A;GRIK2;PRKAR2B;KCND2;GRM1;GRIN2A;SLC1A1;HSPA8;PLP1;CALM1;APBA1;GRIN2B;RIT2;SLC1A2;KCNQ3;GABRA2;GABRB1;PRKAR1B;GRIK1;APBA2;GABRB2;DLGAP1;PRKACB;CHRM2;PRKAR1A;CACNB4;GRIA3;CACNA1B;SYN2;SNAP25;SNCA;HTR2C;GABRB3;CHRM3;GRIN1;GLRA1;RPS6KA1;GABRA1;SYT1;GRIA2;SYN1;HTR2A;GRIA1;GLRA3;NSG1;CACNB1
prerank,detection of calcium ion (GO:0005513),0.6283269190675564,1.3200544629371995,0.17398373983739837,0.8032704101232849,1.0,3/13,6.44%,KCNMB2;KCNMB3;CASR
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.5131383288372601,-1.3199849866569793,0.1346153846153846,0.5764808946652387,1.0,7/18,12.28%,FLT1;COL4A3;AKT3;MEF2C;ITGA4;MDK;PLCG1
prerank,integrated stress response signaling (GO:0140467),0.6384338839129511,1.319458484925315,0.18524871355060035,0.8038739482722688,1.0,8/14,23.05%,NFE2L2;DDIT3;OMA1;EIF2AK4;EIF2S1;QRICH1;EIF2AK3;HERPUD1
prerank,regulation of cell cycle (GO:0051726),0.43185490661653425,1.3194368966759182,0.038702928870292884,0.8023123996148493,1.0,65/271,18.33%,THBS1;BMP4;TCF7L2;PLAGL1;GRK5;PKD1;SOX9;LRP6;INHBA;NOTCH2;TTC28;NEK7;ABL1;TGFBR1;SON;PDCD4;TXLNG;GADD45G;STAT3;IRF1;GBF1;MYOG;BIRC7;ID2;CDKN1B;CDC14A;IQGAP1;ATM;RARA;PIM2;JUN;FBXL6;MAPK12;TBRG1;RB1;CDKN3;NR4A1;TMEM8B;CHEK1;HCFC1;EP300;BAP1;PUM1;CDK11B;CCND1;TGM1;PML;EIF4G2;NEK6;ADAM10;KAT2B;ANKRD17;PRCC;CDK10;UHRF2;BIRC3;BARD1;WHAMM;NBN;SMIM22;CDKN1A;GAS2L1;WDR12;CSNK2A2;CSNK2A1
prerank,extracellular matrix disassembly (GO:0022617),0.5142117634374608,1.3193224131221708,0.11228533685601057,0.8011007669975525,1.0,12/53,10.12%,TLL1;BMP1;CD44;GSN;CAPN2;HTRA1;MMP16;TIMP2;ADAMTS5;KIF9;MMP14;TIMP1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.6807918289091907,1.3188181724332744,0.16785714285714284,0.8014231902254462,1.0,4/10,16.65%,SMYD2;SETD2;EHMT1;KMT5A
prerank,regulation of bone mineralization (GO:0030500),0.5024821444064117,1.3187291562872119,0.13516896120150187,0.8000839508019946,1.0,12/55,4.92%,BMP4;CCN1;PTK2B;TGFB3;DDR2;ANO6;SGMS2;BMP6;BMPR1A;NELL1;TXLNG;TRPM4
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.5959587323795859,1.318416308899047,0.15730337078651685,0.7995650202873685,1.0,3/20,2.42%,HOXA5;PTK2B;ZBTB16
prerank,renal system development (GO:0072001),0.5158975521570619,1.3177762758471343,0.14360313315926893,0.8002209927063925,1.0,11/52,8.70%,BMP4;SIX1;PCSK5;PKD1;SULF1;TGFBR1;STRA6;AGTR1;ARL3;GLI2;FOXC1
prerank,mitochondrion localization (GO:0051646),0.585540901283123,1.3175593203133236,0.1629032258064516,0.7993909321076811,1.0,4/19,7.79%,MARK1;MEF2A;TLE6;MARK2
prerank,positive regulation of cartilage development (GO:0061036),0.605195679080393,1.317191450392225,0.1779935275080906,0.7991347211853717,1.0,6/17,7.37%,BMP4;SOX9;BMP1;ZBTB16;GDF6;GDF5
prerank,ncRNA processing (GO:0034470),-0.3233031751496393,-1.3169497517934736,0.013888888888888888,0.5828862028945246,1.0,76/200,23.21%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPL41;RPL37A;RPLP2;RPL27A;RPS19;RPL34;LIN28B;RPL13;RPS16;RPL9;RPS15;RPS27;RPL30;RPL37;RPL19;RPS24;RPL18A;RPL18;RPS7;RPL23;RPL17;RPL22;RPL23A;AGO4;RPL26;RPS25;RPL35A;SNU13;RPL11;RPL13A;RPL7;RPL36;RPL32;RPS17;RPL39;RPS2;RPL8;RPL14;RPL24;RPL29;RPL10A;TARBP2;RPL3;ADAR;DDX10;LYAR;RPL12;RPL27;PIH1D1;RPL5;RPS28;EXOSC9;AGO1;DDX27;DDX54;LAS1L;POP5;METTL3;MTREX;EMG1;POP7;NOLC1;RPL4;RPL31;NOC4L;RPL36A;SMAD3;RPL7A;RRP9;SARS1;WDR36
prerank,cellular component disassembly (GO:0022411),0.5122274355303322,1.3167945743676002,0.11624834874504623,0.7990956467512498,1.0,12/53,10.12%,TLL1;BMP1;CD44;GSN;CAPN2;HTRA1;MMP16;TIMP2;ADAMTS5;KIF9;MMP14;TIMP1
prerank,mesenchymal cell development (GO:0014031),-0.5006217183063562,-1.3158162220165632,0.14326647564469913,0.5837792669945265,1.0,4/18,7.33%,CDH2;NOTCH1;TAPT1;HEY2
prerank,positive regulation of RNA splicing (GO:0033120),0.557081090178723,1.3157832617836247,0.1615720524017467,0.8013814192860393,1.0,1/29,0.05%,SLC38A2
prerank,DNA double-strand break processing (GO:0000729),0.5944237387221283,1.315557392321739,0.1858974358974359,0.8006570978015414,1.0,10/18,21.89%,RNF138;ATM;RAD52;SLX4;RBBP8;BARD1;NBN;EXD2;UBE2N;RAD50
prerank,positive regulation of ossification (GO:0045778),0.5235144346729759,1.3155456296517443,0.1622002820874471,0.7991074203428539,1.0,8/39,3.75%,BMP4;CCN1;TGFB3;ZBTB16;ANO6;BMP6;BMPR1A;NELL1
prerank,response to sterol (GO:0036314),0.6599819594199388,1.3154559650007256,0.19658119658119658,0.7978195362224266,1.0,5/11,11.16%,TGFBR1;TGFBR2;RORA;SMAD2;CCL3
prerank,cytosolic transport (GO:0016482),0.4657879913789925,1.31472878682385,0.1053864168618267,0.7988120911235445,1.0,50/108,25.52%,VPS13A;VPS13C;ERC1;EEA1;RAB6A;SNX2;STX5;BECN1;GAK;ANKRD27;EHD3;VPS54;DOP1B;GBF1;RGP1;AP2A1;RNF126;STX8;SNX32;KIF16B;VTI1A;WDR81;TBC1D10A;MON2;TBC1D5;HOOK3;TMEM87B;AP4M1;TMEM87A;BET1L;SNF8;TBC1D17;WASHC1;RBSN;CLN3;VPS52;RAB5A;VPS51;EMP2;HOOK2;VPS53;CORO7;SYS1;RAB7A;TBC1D23;UBE2O;PHETA2;SPAG9;ARL1;VPS29
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5787110346693234,1.3138182972207018,0.1573208722741433,0.8006424912193073,1.0,6/21,6.08%,EXT1;HS3ST4;SULF1;HS6ST2;GLCE;XYLT1
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.5549206731948136,1.313362515200972,0.15602836879432624,0.8007300597207382,1.0,5/28,9.41%,EGFR;TCIM;WWP2;MMP14;NIBAN2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.43709574714956034,-1.312892163996771,0.13588850174216027,0.5896833332203386,1.0,14/33,18.81%,IGF1;IGF1R;PIK3R1;PIK3C2A;MYO16;NYAP2;EDN1;HTR2A;PIK3R5;TYRO3;AKT1;ERBB3;PIK3CG;TPTE
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.4601054232454843,-1.3124676681224274,0.14018691588785046,0.5884861064487179,1.0,9/26,11.72%,SHANK3;NRXN1;RIMS1;RIMS2;APP;PRKCZ;GRIN1;TMEM108;CUX2
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.6015352572428327,1.312432357421781,0.18167456556082148,0.8026087183088225,1.0,3/18,3.34%,CCN3;HDAC4;FZD7
prerank,Golgi to endosome transport (GO:0006895),0.6189046180793969,1.3114859142982473,0.17411402157164868,0.8044697464801722,1.0,6/16,10.93%,VPS13A;VPS13C;DOP1B;GBF1;AP2A1;KIF16B
prerank,carnitine shuttle (GO:0006853),-0.5782122461719483,-1.3109325609421605,0.1625,0.5905426892661988,1.0,3/11,5.12%,PRKAG2;PRKAA2;ACACB
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.45608054170502943,-1.310608853456072,0.14136125654450263,0.5891560907463854,1.0,14/25,28.76%,TNFSF10;PDCD5;BMF;BIK;GPER1;DNM1L;PMAIP1;PLAUR;MFF;PYCARD;MLLT11;PINK1;HRK;BCL2L11
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.5522635939335234,-1.3105943258907307,0.18610421836228289,0.5868254147470677,1.0,5/12,7.73%,PPARA;ABCA5;NR1H3;ABCA1;ABCG1
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.522507362272745,-1.310189530929147,0.15306122448979592,0.5857111331252248,1.0,2/15,1.98%,OSBPL8;PPARA
prerank,nitrogen compound transport (GO:0071705),0.44573959741039965,1.309806756126087,0.07597765363128492,0.8092973834515125,1.0,7/141,2.45%,SLC38A2;SLC23A1;SLC38A1;SLC12A2;RAMP1;LRRC8D;ABCG2
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.5609358359486973,1.309611597867377,0.17673716012084592,0.8083995446661814,1.0,17/27,29.22%,KAT6B;CREBBP;TRRAP;ATAT1;SGF29;CPA4;KAT2A;EP300;KAT2B;BRD8;PHF20;PHF20L1;NAA50;KAT5;MORF4L2;KAT6A;TAF6L
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.5310753214055284,1.309606729738939,0.14203730272596843,0.8068275649672427,1.0,16/38,22.10%,ABLIM3;NPEPPS;HPS4;SAE1;UBE2D3;HSPA1L;ARIH2;SH3GLB1;BAP1;SREBF1;CSNK2A2;RNF31;USP36;ATP5IF1;HUWE1;PARL
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.6186138880497195,1.3095788740659964,0.18225039619651348,0.8037909875785233,1.0,7/16,11.89%,THBS1;PHLDB2;FAM107A;BCAS3;DMTN;ITGB1BP1;CORO1C
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.6186138880497195,1.3095788740659964,0.18225039619651348,0.8037909875785233,1.0,7/16,11.89%,THBS1;PHLDB2;FAM107A;BCAS3;DMTN;ITGB1BP1;CORO1C
prerank,epithelial cell-cell adhesion (GO:0090136),0.6540643728876386,1.3094338467107982,0.18394648829431437,0.8027757748157455,1.0,5/11,7.59%,CCN3;DSP;ITGB5;VCL;JUP
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.6133437030547451,1.3094012306590468,0.2042483660130719,0.8013296843181719,1.0,3/15,8.70%,BMP4;SFRP4;FOXC1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.5083602338555956,1.3092029426203957,0.14659685863874344,0.8005341775404307,1.0,14/54,12.05%,GPC6;EXT1;GPC3;HS3ST1;HS6ST2;HEXA;GCNT2;XYLT1;GPC4;NAGLU;HAS1;B3GALT6;SGSH;GLB1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.41828689090795595,-1.3089519774999185,0.1111111111111111,0.5869357903257189,1.0,9/34,6.25%,FLT1;TEK;PIK3R1;PDGFRB;PRKD1;KIT;DAB2IP;EPHA8;PTK2
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.4230504302006685,-1.3088898413028471,0.0996309963099631,0.5847972732053783,1.0,14/41,14.22%,ITPR1;SLC24A2;GRIN2A;SLC8A1;RYR2;GRIN2B;HTR2C;CACNA2D1;GRIN1;HTR2A;TRPV2;ERO1A;CCL19;TRPV4
prerank,regulation of axon guidance (GO:1902667),0.6654283639560086,1.3087962308900003,0.20309810671256454,0.8003974965354739,1.0,3/10,10.37%,NRP1;MYCBP2;VEGFA
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.6166761166286201,1.3079129743205502,0.1919191919191919,0.8020386097352313,1.0,1/14,0.58%,CARD14
prerank,regulation of heart contraction (GO:0008016),-0.35999082708723595,-1.307792567073143,0.055900621118012424,0.5855291989512976,1.0,25/90,15.45%,ATP1A2;ITPR1;ATP1B3;ABCC9;NPR1;SLC8A1;CALM1;RYR2;ATP1B2;DMPK;PDE4D;ATP2B1;DES;FXYD6;KCNQ1;ACE2;ATP2A2;KCNJ12;CELF2;CASQ2;TRPC1;GSK3A;CALM3;AGT;ATP2A3
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.5317248771121167,-1.3077647617558774,0.155,0.5832919680269932,1.0,4/13,9.89%,SHANK3;ADCY1;APP;LGMN
prerank,protein localization to cell surface (GO:0034394),0.5673594605195491,1.306772551345972,0.15875370919881307,0.8046821384406925,1.0,9/26,15.18%,ANK2;PTPRU;WNT11;VCL;RIC3;USP4;SMURF1;GGA2;PIGU
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.6386118881533314,1.3060618169411122,0.19458544839255498,0.8057583835785207,1.0,3/12,8.33%,SOX9;MUC6;TLR4
prerank,positive regulation of synaptic transmission (GO:0050806),-0.37062147090070563,-1.3058859736295911,0.07476635514018691,0.5862808119891755,1.0,15/72,9.89%,SHANK3;ADCY1;NRXN1;SLC24A2;RIMS1;GRIK2;RIMS2;GRIN2A;APP;GRIN2B;CACNG4;PRKCZ;CACNG7;SYT1;LGMN
prerank,regulation of nervous system process (GO:0031644),-0.4870649628988931,-1.3053782569421815,0.1424802110817942,0.5854389843494283,1.0,12/18,22.90%,NOS3;APP;DLGAP1;HTR2C;TMEM108;ROCK2;DLGAP2;NPTXR;CHRNA7;BEGAIN;DLGAP3;SLC8A3
prerank,positive regulation of histone acetylation (GO:0035066),-0.46276929330473787,-1.304913209382402,0.16718266253869968,0.584523894378695,1.0,10/23,26.14%,RPS6KA5;PPARGC1A;MAPK3;ARRB1;PIH1D1;RUVBL2;SPHK2;MUC1;NOS1;RPS6KA4
prerank,myelination in peripheral nervous system (GO:0022011),0.6250304600499252,1.3048552895344567,0.20701168614357263,0.8085934928548271,1.0,5/13,10.26%,SKI;ARHGEF10;NF1;PARD3;ADGRG6
prerank,protein modification by small protein removal (GO:0070646),0.43120915981571567,1.304828879094096,0.05844845908607864,0.8071278766439989,1.0,101/252,25.98%,CCNA2;USP46;ADRB2;USP2;USP13;OTUD1;TGFBR1;USP24;FOXK1;VCP;BECN1;ESR1;TADA3;MYSM1;TRRAP;PSMB2;MDM4;USP34;RHOA;USP49;IL33;USP15;USP25;RAD23B;PSMC6;USP1;SMAD2;USP32;USP10;CLSPN;USP7;COPS7B;FOXK2;USP47;OTUD7B;DESI2;DESI1;COPS5;USP4;USP33;ZC3H12A;UIMC1;TNIP1;KAT2A;IFIH1;ZRANB1;PSMD11;JOSD1;HCFC1;SENP5;EP300;OTUD3;BAP1;POLB;PSMD1;VCPIP1;OTUD5;YY1;KAT2B;IKBKG;USP28;BIRC3;BARD1;PSMD7;USP9X;INO80;PSMC1;USP22;USP40;PSMD14;TRAF3;UFD1;WDR48;USP21;SENP1;RNF123;USP36;SMAD4;PSMD3;HGS;SENP3;ASXL2;GATA3;USP48;RHOT1;USP3;BRCC3;CDC20;TOMM20;ASXL1;SMAD7;PSMD12;COPS3;OGT;STAMBP;MCRS1;ADRM1;TRAF6;PSMD4;MAP3K7;AR
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.48807812061843686,1.3042653002895432,0.13434727503168567,0.8077115516954029,1.0,13/67,10.85%,DOCK5;VIT;PTK2B;FN1;GSK3B;ABL1;NRP1;DMTN;AGR2;JUP;S100A10;LIMS1;LIMS2
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.5697430226078605,-1.3040072734057973,0.1751269035532995,0.5848594615163492,1.0,4/11,8.30%,NEDD4L;PICALM;GPM6B;ACTN2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.5463893056099748,1.3039251478043785,0.18233618233618235,0.8074501839333501,1.0,13/29,15.66%,TCF7L1;TCF7L2;TLE2;CREBBP;TRRAP;BCL9L;SMARCA4;KMT2D;EP300;TLE3;PYGO1;TLE4;PYGO2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.6217810124410404,1.3034286485026942,0.1891025641025641,0.8077407391684553,1.0,6/15,16.13%,SIX1;TGFBR1;TGFBR2;NIPBL;TWIST1;TFAP2A
prerank,connective tissue development (GO:0061448),0.5395301497146022,1.303388139802137,0.14486638537271448,0.8063549477660856,1.0,6/35,2.44%,PKD1;SOX9;ITGB8;SULF1;ZBTB16;CD44
prerank,sodium-independent organic anion transport (GO:0043252),0.6580802366658988,1.3032842485396057,0.2010221465076661,0.8051849167442957,1.0,3/10,1.51%,SLCO3A1;SLCO2A1;SLCO4A1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.619162293248194,1.3026793137240513,0.18357487922705315,0.8059375509342472,1.0,3/14,6.61%,FOXO3;EARS2;FASTKD1
prerank,pyroptosis (GO:0070269),-0.5133263447394146,-1.3025968199486666,0.17866004962779156,0.5867624277172792,1.0,6/15,23.02%,CASP4;AIM2;GSDMD;CASP1;TREM2;ZBP1
prerank,embryonic appendage morphogenesis (GO:0035113),0.6338381774303553,1.3023012826836702,0.1972318339100346,0.8057506168636791,1.0,4/12,10.95%,MBNL1;LRP6;SKI;MEGF8
prerank,regulation of cytokinesis (GO:0032465),0.47569606626051547,1.3005031511975496,0.13157894736842105,0.8112346522524146,1.0,20/78,14.25%,CIT;KIF13A;GIPC1;PRKCE;BECN1;RAB11FIP3;SETD2;BIRC6;CDC25B;PLK3;KLHL13;CDC14A;RHOA;DRD3;AURKA;ENTR1;SH3GLB1;PKN2;CUL3;PDXP
prerank,positive regulation of vasculature development (GO:1904018),0.46692223580654113,1.3002555280901944,0.11750599520383694,0.8106206322325533,1.0,14/94,6.32%,SMOC2;F3;THBS1;CYP1B1;ITGB8;PGF;ANXA3;PTGIS;HIPK1;ITGB1;FGF2;ADAM12;ISL1;GATA4
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.5740173275196212,1.2999323909780893,0.1588785046728972,0.8102096305487032,1.0,9/22,20.62%,NEDD4;RNF115;RNF126;VPS37A;MVB12B;VPS37B;TSG101;SNF8;TOM1L1
prerank,positive regulation of B cell proliferation (GO:0030890),-0.44302672745949995,-1.2997033571234982,0.11824324324324324,0.5928152237239364,1.0,9/29,16.10%,BCL2;TFRC;MEF2C;CD81;VAV3;CD38;MIF;CD74;CD40
prerank,cation transmembrane transport (GO:0098655),-0.4113691060002732,-1.2996792454977353,0.09797297297297297,0.5906030563299329,1.0,6/44,5.71%,ATP1A2;TRPM3;SLC6A9;ABCC9;SLC7A5;SLC38A5
prerank,regulation of interleukin-4 production (GO:0032673),-0.4882137556499619,-1.2991983192655117,0.12044817927170869,0.5897996160104695,1.0,4/21,7.28%,LEF1;SLC7A5;PRKCQ;PRKCZ
prerank,regulation of DNA biosynthetic process (GO:2000278),0.560557055317313,1.2989764110828517,0.1748148148148148,0.8122585134460135,1.0,6/27,9.52%,SMOC2;FGF2;SMG6;PDGFA;NIBAN2;ATM
prerank,muscle cell differentiation (GO:0042692),-0.44341425620165376,-1.2982926902641092,0.09966777408637874,0.5901405563346377,1.0,13/32,10.97%,WNT5B;MRTFB;SGCZ;SPEG;TBX1;TMEM204;TBX18;MEF2C;HEY2;GATA6;MEGF10;MYOCD;NINJ1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.45904080245290035,1.2981998838268154,0.13523131672597866,0.8136202630271502,1.0,15/85,9.50%,PLCE1;ARHGEF28;NGF;AKAP13;ARHGDIB;SHC1;ARHGAP44;NOTCH2;BCR;SHOC2;RDX;ARHGAP17;KANK2;STARD13;ERBIN
prerank,base-excision repair (GO:0006284),0.5101729675907187,1.2977323383458799,0.15824468085106383,0.8138414759182041,1.0,18/48,24.04%,MPG;APEX2;SMUG1;ERCC5;WRN;APEX1;USP47;PRMT6;POLB;XPA;RPA1;RFC1;NEIL3;TDG;POLD3;HUWE1;MBD4;RFC5
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.4984928783060843,1.2974911077980256,0.14933333333333335,0.8132167196961022,1.0,14/55,16.21%,THBS1;CYP1B1;PID1;COQ7;AGTR1;TGFBR2;ARF4;AATF;ZC3H12A;EIF6;PDK3;XDH;TFAP2A;ACOD1
prerank,cardiac conduction system development (GO:0003161),0.5661763130113477,1.2972933104613138,0.16199376947040497,0.8124649658758271,1.0,5/24,6.32%,BMP4;BMPR1A;CACNA1G;NOTCH2;GATA4
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5450759251574703,-1.2967895435344192,0.1741424802110818,0.5921038354336475,1.0,4/14,6.49%,ZEB1;OSR1;NOTCH4;SPRED1
prerank,regulation of chromatin organization (GO:1902275),0.6193951776300155,1.2962272571428006,0.21252059308072488,0.8148739503834186,1.0,5/14,17.97%,MLLT3;TLK1;SETD5;TLK2;ALKBH4
prerank,regulation of neuroinflammatory response (GO:0150077),-0.48084698850965557,-1.2955548583997185,0.13411078717201166,0.5933202727318926,1.0,7/19,21.57%,IGF1;IL18;SPHK1;CD200;NUPR1;PTGS2;TREM2
prerank,positive regulation of glucose import (GO:0046326),-0.483740778190786,-1.295348298802066,0.13043478260869565,0.5916773142485187,1.0,5/21,3.80%,IGF1;OSBPL8;PIK3R1;OCLN;INSR
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.3733715943439621,-1.294762988784751,0.07172995780590717,0.5910001940858095,1.0,15/66,7.04%,ROBO1;FLT1;IL34;SASH1;PDGFD;PDGFRB;KIT;PAK1;TPD52L1;DAB2IP;FGF1;PIK3R6;RPS3;TNFRSF11A;ADRA2A
prerank,superoxide anion generation (GO:0042554),-0.5299341310364631,-1.2946265995349173,0.16751269035532995,0.5891451027285306,1.0,5/13,17.78%,ALOX12;CYBA;NCF2;NOX4;TAFA4
prerank,negative regulation of lipid storage (GO:0010888),-0.4822721993569715,-1.2944529514904262,0.15760869565217392,0.5874702500069865,1.0,6/19,7.73%,OSBPL8;PPARA;NR1H3;PPARD;ABCA1;ABCG1
prerank,cellular response to heat (GO:0034605),0.5288737836859456,1.2941915113269797,0.16572237960339944,0.8209991159321617,1.0,4/35,8.50%,THBS1;TCIM;VCP;CLPB
prerank,oligosaccharide biosynthetic process (GO:0009312),0.5855022123685232,1.294128279069598,0.18210361067503925,0.8196880883759515,1.0,2/20,1.55%,ST3GAL4;FUT8
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.6454661230907403,1.293584705323348,0.21565217391304348,0.8186851640242394,1.0,3/10,7.30%,WNK1;KLF4;IL10
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.6454661230907403,1.293584705323348,0.21565217391304348,0.8186851640242394,1.0,3/10,7.30%,WNK1;KLF4;IL10
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.46600754607408673,1.2935175621653363,0.12033694344163658,0.8173799568568678,1.0,19/95,8.51%,ST3GAL4;GPC6;EXT1;UST;DSE;GPC3;B3GNT2;HS3ST1;CHST13;HS6ST2;GLCE;HEXA;CHST5;GCNT2;SLC10A7;XYLT1;B4GALT1;GPC4;HAS1
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.48765102868545934,-1.2934301651639053,0.15204678362573099,0.5882012422067048,1.0,4/18,4.17%,SLC2A1;OCLN;PRKAG2;PRKCB
prerank,"phagocytosis, engulfment (GO:0006911)",0.5298893238306919,1.2933829306155493,0.15616045845272206,0.8163463240025933,1.0,4/36,3.34%,THBS1;GULP1;GSN;RHOBTB1
prerank,response to glucose (GO:0009749),0.5076977084239654,1.2933663853001458,0.1568627450980392,0.8149132942812582,1.0,5/46,3.48%,THBS1;TCF7L2;KCNB1;SLC39A14;UNC13B
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.5415379045829334,1.2912823689931638,0.18651362984218078,0.8211000533371632,1.0,11/31,10.73%,CRIM1;SOX9;SMAD6;TWIST2;TRPM4;NOG;SKI;BAMBI;CHRD;GDF10;LRP5
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.61444002451087,1.2912223255529558,0.20812182741116753,0.8198018896084979,1.0,3/15,4.96%,RSPO3;GPC3;SFRP4
prerank,cAMP metabolic process (GO:0046058),-0.5406515283604634,-1.2910035648752414,0.1875,0.5928735060766114,1.0,6/13,14.70%,ADCY5;ADCY1;ADCY7;PDE4D;ADCY2;ADCY4
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5045169316535694,-1.290819432262322,0.1736842105263158,0.5911314444241236,1.0,8/16,19.76%,ATP5PF;ATP5F1B;ATP5F1E;ATP5F1A;ATP5MC1;ATP5F1D;ATP5MC2;ATP5ME
prerank,neuron projection regeneration (GO:0031102),-0.5910957108050596,-1.2906546702058785,0.21052631578947367,0.5894124387791133,1.0,3/10,18.52%,NREP;RTN4RL1;OMG
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6181205775379037,1.2901735488873127,0.20565149136577707,0.8221854706760579,1.0,9/14,25.36%,SEC24B;SEC23A;SEC31A;SEC13;SEC24D;SEC24A;RAB1A;MIA3;TBC1D20
prerank,protein kinase B signaling (GO:0043491),-0.4675865479828575,-1.2898378169460976,0.1636904761904762,0.5895300697452895,1.0,10/23,21.95%,IGF1;KDR;SETX;GAS6;THEM4;TYRO3;AKT1;MT3;CCL2;EPHA2
prerank,defense response to virus (GO:0051607),-0.34087058923489694,-1.2898058815849502,0.053763440860215055,0.5874734382260358,1.0,24/100,13.08%,SERINC3;BCL2;AGBL4;SERINC5;ABCC9;BCL2L1;SAMHD1;IFIT2;IRF2;IFITM1;BST2;ZDHHC1;IFITM3;OAS2;IFNAR2;NLRC5;IFIT3;NDUFAF4;RTP4;MLKL;RNASEL;TLR7;STAT1;TLR3
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.49775226847069154,-1.28956860226047,0.14814814814814814,0.5860026994368427,1.0,6/16,8.09%,RANBP3L;PLCB1;IGFBP3;RIPOR2;MEF2C;BTG1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.4180034874269492,1.2894149197156084,0.024193548387096774,0.8233841140761505,1.0,100/417,15.80%,FOXP2;FOXP1;BMP4;WWP1;ZFPM2;TCF7L2;SOX9;FOXD1;HDAC4;FOXN3;RBFOX2;WNT11;GLI3;HES1;HDAC9;ZBTB16;TWIST2;GCLC;WWP2;SHC1;KLF4;PRICKLE1;ZNF148;MDFIC;CRY2;RCOR3;ZNF423;L3MBTL3;ID1;BTAF1;PDCD4;PHC2;FOXK1;KAT6B;KLF10;ARID4A;SAMD7;BHLHE40;TLE2;GLIS2;SCMH1;SPINDOC;MBD1;KDM1A;NFIL3;DDIT3;IRF1;EHMT1;DMBX1;SOX14;ID2;MBTD1;SIX4;ATP8B1;CDKN1B;ATOH8;CIPC;PHF12;FBXW11;NIBAN2;BCLAF1;LIMS1;DKK3;CBX5;FOXE1;RARA;SMAD2;JUN;ELF3;ERN2;NCOR1;FOXK2;USP47;PER1;EED;NIPBL;CREB3L1;RB1;ID4;NKX2-1;SMARCA4;UIMC1;NCOR2;HNF4A;XRCC5;SP3;PRMT6;BCL6;GCFC2;BAP1;REST;HDAC10;SBNO2;CNOT7;RUNX2;TWIST1;HINFP;PML;PRDM5;ZBTB7A
prerank,regulation of actin nucleation (GO:0051125),0.6320109652638808,1.2884388720248325,0.20672268907563024,0.8253453957092606,1.0,5/12,17.44%,GSN;WASHC5;ARFIP1;ARFIP2;WHAMM
prerank,regulation of gene expression (GO:0010468),0.4128725256061823,1.287985305355528,0.0,0.8254560350713077,1.0,194/903,16.38%,SLC38A2;BNC2;F3;FOXP1;BMP4;CDH1;VSX1;TCF7L1;ZFHX3;AHNAK2;SLC24A3;SIX1;PRRX2;MBNL1;NTRK3;SOX9;FOXD1;HDAC4;HOXA5;ITGB8;PRDM6;NGF;FOXN3;ANK2;ATP1B1;SMO;EZR;AHNAK;PID1;FN1;NFIA;WNT11;AFF3;GSN;KRAS;WWP2;YBX3;USP13;COQ7;CLK1;ESR2;KLF4;JMJD1C;BMP6;INHBA;BMPR1A;NFE2L2;GSK3B;FGF2;ZNF148;FZD7;NOTCH2;ZNF423;ABL1;ERC1;NELL1;TGFBR1;EFEMP1;SERPINB9;SON;CLK2;ZFP64;KAT6B;SFRP4;ZBTB7B;GCNT2;ATP2B4;BHLHE40;TSKU;CREBBP;NOG;C1D;WNT16;UBR5;ZC3H7A;STAT3;HMG20A;ESR1;GDNF;TADA3;PTHLH;GATA4;NFIL3;CLU;RORA;TRIM44;DDIT3;PLSCR1;CELF1;REL;TOB2;AGR2;TRRAP;AFF4;MOV10;HNRNPH1;MBNL2;IL10;PITX3;PKP1;SOX14;ID2;TNRC6C;RDX;FUS;CHEK2;CRABP2;TLR4;IGSF1;NLK;FOXC1;ATOH8;PHF12;NFKB1;NFYA;RBMS3;CD46;SERTAD3;IL33;ATM;LIMS1;AURKA;PCBP4;TOB1;CTCFL;PLCG2;ATF7;GON4L;VEGFA;NFKB2;TRIM26;SMCR8;MEGF8;FOXK2;GTF2IRD1;CCL3;BRCA2;PER1;CREB3L1;TCF19;MYD88;RB1;MTA1;FGF22;SNX12;NKX2-1;DDRGK1;ZC3H12A;ATRX;TCF3;KMT2D;SNRNP70;ANXA7;MTOR;CTR9;PUM2;HCFC1;SP3;PAX6;TDRD7;CHD3;PIK3R3;EP300;GPBP1;BCL6;GCFC2;REST;HDAC10;ZNF507;ATF2;PUM1;CDK11B;SBNO2;CNOT7;GPBP1L1;BAZ2A;PCGF1;TWIST1;MAP2K2;HINFP;CLK4;CALCOCO1;TRIM39;HOXD3;PML;PRDM5;ZNF462;XDH;TFAP2A;AGO2;ADAM10;NSD1;YY1;ZNF219
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.5655629055252335,1.2873074351666556,0.19099378881987578,0.8264732009785937,1.0,1/21,0.33%,FZR1
prerank,regulation of response to biotic stimulus (GO:0002831),0.5518943842875468,1.2863161800077723,0.18154761904761904,0.8285906326373356,1.0,2/28,1.42%,FOXP1;CD55
prerank,response to calcium ion (GO:0051592),0.4548702364446175,1.2860243741538957,0.10377358490566038,0.8282158422022403,1.0,16/102,10.65%,THBS1;CLIC4;KCNMB2;KCNMB3;NEDD4;PPP3CA;CAMK2D;ADAM9;MEF2A;CASR;DMTN;SYT8;IQGAP1;PLCG2;CARF;SEC31A
prerank,positive regulation of neuron migration (GO:2001224),-0.5475959423515724,-1.284959778212482,0.19617224880382775,0.5972192594855497,1.0,4/11,12.00%,SEMA6A;RAPGEF2;DAB2IP;MDK
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.4409400107481879,1.284563781854945,0.09933035714285714,0.8320629868294581,1.0,17/150,6.03%,F3;EGFR;THBS1;TCF7L2;MET;TNFAIP8L3;FGFR1;ITGB1;GAB2;FGF2;PIK3AP1;IRS1;STRN;TGFBR1;GCNT2;CD80;ESR1
prerank,regulation of protein binding (GO:0043393),0.44853249776251225,1.28371417785662,0.1111111111111111,0.8337468869755746,1.0,25/114,12.50%,BMP4;TCF7L2;PKD1;HDAC4;PRKCD;GSK3B;LRPAP1;LRP1;KDM1A;BAMBI;RIPK2;IDE;SLPI;MARK2;DISC1;PRMT8;DACT1;AURKA;MARK3;DDX11;ITGB1BP1;TIAM1;USP33;CARD16;ADD1
prerank,positive regulation of binding (GO:0051099),0.4673125636636457,1.283273007390233,0.12054120541205413,0.8338393316309965,1.0,20/84,12.50%,BMP4;TCF7L2;MET;PKD1;NGF;HES1;GSK3B;LRP1;SKI;BAMBI;RIPK2;IDE;FOXC1;DACT1;RARA;MARK3;DDX11;TIAM1;USP33;ADD1
prerank,chloride transmembrane transport (GO:1902476),0.5035696002781826,1.283258426999543,0.17876344086021506,0.8323897713905352,1.0,7/48,4.01%,SLC12A7;SLC12A2;SLC12A8;ANO6;GLRB;ANO9;GABRA3
prerank,positive regulation of bone mineralization (GO:0030501),0.5217687854115892,1.2823250506419752,0.17335243553008595,0.8344292734369182,1.0,7/35,3.75%,BMP4;CCN1;TGFB3;ANO6;BMP6;BMPR1A;NELL1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.43992448366058395,1.2818402556878896,0.11247216035634744,0.8346347464675155,1.0,45/153,16.12%,STK39;PKD1;MARK1;CAMK2D;WNK1;PRKCD;ULK2;HIPK1;GSK3B;TLK1;PRKCE;TGFBR1;MKNK2;SGK3;TGFBR2;IKBKE;VRK3;MARK2;CSNK1A1;NLK;CSNK1G3;CHUK;ATM;AURKA;TOP1;MARK3;CAB39;CLSPN;MORC3;MAPK12;MAST2;PRKDC;PDK3;SMG1;MTOR;CSNK1G1;PKN2;PAK2;PRKCA;DYRK2;CSNK1E;MAPKAPK2;MAP2K2;TLK2;NEK6
prerank,macromolecule catabolic process (GO:0009057),0.5538629048308537,1.2809826700557745,0.1874062968515742,0.8362250855225744,1.0,8/26,13.30%,NEDD4;BECN1;IDE;LRSAM1;KIF16B;SMURF1;MTOR;SH3GLB1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.5597962870994474,1.2807349113653288,0.18906942392909898,0.8341275142272899,1.0,4/23,6.31%,THBS1;GIPC1;CREBBP;TGFB1I1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.5597962870994474,1.2807349113653288,0.18906942392909898,0.8341275142272899,1.0,4/23,6.31%,THBS1;GIPC1;CREBBP;TGFB1I1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.6556784371322448,1.2805374409050059,0.20552677029360966,0.833332403929497,1.0,8/11,27.58%,UBN1;CABIN1;ATRX;HIRA;IPO4;RBBP4;NASP;HAT1
prerank,regulation of protein kinase activity (GO:0045859),0.45217925309937235,1.2803867252963128,0.13445378151260504,0.8324135485582616,1.0,19/106,14.15%,PLCE1;RASSF2;LRP6;CCN1;PTK2B;DDR2;UBASH3B;RAP1A;RAP2C;IQGAP1;NF1;SMCR8;ITGB1BP1;CEP85;RB1;CHP1;PAK2;XRCC5;MRNIP
prerank,positive regulation of mRNA processing (GO:0050685),0.5606557263855053,1.2803556314816482,0.1849624060150376,0.8310658143084808,1.0,15/21,30.99%,CELF3;RBMX;THRAP3;DHX36;CIRBP;SNW1;DAZAP1;TRA2B;NUP98;RBM3;PAF1;CELF4;NCBP2;RBMXL1;PRDX6
prerank,peptidyl-serine modification (GO:0018209),0.4388512592733122,1.2800957375197937,0.10514541387024609,0.8305362436463978,1.0,43/166,14.20%,STK39;PKD1;MARK1;CAMK2D;WNK1;PRKCD;ULK2;HIPK1;GSK3B;TLK1;PRKCE;GALNT13;TGFBR1;MKNK2;SGK3;TGFBR2;IKBKE;VRK3;POGLUT3;MARK2;CSNK1A1;CSNK1G3;CHUK;ATM;AURKA;TOP1;MARK3;MBOAT4;CAB39;CLSPN;MORC3;MAPK12;MAST2;PRKDC;PDK3;SMG1;MTOR;CSNK1G1;PKN2;PAK2;PRKCA;DYRK2;CSNK1E
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.5738537790450509,1.2800934956477747,0.17925925925925926,0.8290779882224493,1.0,3/22,4.65%,EZR;UBASH3A;PTPN2
prerank,positive regulation of phosphorylation (GO:0042327),0.42325298545066004,1.2798390265391624,0.08191489361702127,0.8286047906469324,1.0,22/240,3.76%,SLC4A4;EGFR;THBS1;BMP4;SLCO3A1;CARD14;MET;NTRK3;SOX9;PGF;CCN1;EFNA5;LMO4;DDR2;KRAS;FGFR1;NIBAN1;LIMK2;FGF2;FZD7;ABL1;NRP1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.4382740628680092,-1.2798219308583276,0.1501597444089457,0.6093677185472967,1.0,6/29,8.97%,ENG;TGFBR3;NOTCH1;BMP2;S1PR1;PROX1
prerank,cell junction maintenance (GO:0034331),-0.5158100228311264,-1.2796719949609707,0.1897810218978102,0.6076335830727375,1.0,6/14,23.54%,CLDN1;CSF1R;MYADM;CHCHD10;PRTN3;F2R
prerank,positive regulation of filopodium assembly (GO:0051491),0.5493585327532913,1.2790004842535403,0.19637462235649547,0.8301750922021851,1.0,7/24,6.13%,DPYSL3;ARAP1;TGFB3;PALM;NRP1;BCAS3;RHOQ
prerank,lung development (GO:0030324),0.5289173404709085,1.2788914887789287,0.19313304721030042,0.8290772699187444,1.0,9/33,12.34%,BMP4;PKD1;WNT11;FGF2;STRA6;GLI2;VEGFA;CCDC40;NKX2-1
prerank,clathrin coat assembly (GO:0048268),-0.5169720788189143,-1.2785562133287913,0.16923076923076924,0.6086323917778207,1.0,6/15,10.81%,SGIP1;PICALM;PIK3C2A;HIP1R;HIP1;NSG1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5556844782737969,-1.278500682176671,0.18518518518518517,0.6066179681345514,1.0,2/11,1.42%,LYN;MFHAS1
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.4125783212616132,-1.2783367951072244,0.13043478260869565,0.6049617248681095,1.0,11/39,7.18%,ROBO1;EPN2;MAML3;MAML2;NOS3;ROBO2;TSPAN5;NOTCH1;RBPJ;NOTCH4;JAG2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.6417299361940487,1.2779277333609524,0.21035058430717862,0.8312409436073297,1.0,3/11,7.57%,LRP6;NR4A2;FZD1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.49665703103547076,-1.27726260499976,0.1557377049180328,0.6059857382801659,1.0,7/17,6.00%,MAML3;MAML2;NOTCH3;NOTCH1;PLXND1;RBPJ;NOTCH4
prerank,regulation of hippo signaling (GO:0035330),0.5836605561272975,1.2772400928224812,0.21077654516640254,0.8322612114061808,1.0,2/17,1.74%,MOB3B;CIT
prerank,ribosome biogenesis (GO:0042254),-0.31252266102229237,-1.2772323507444217,0.0,0.6039265163171293,1.0,69/187,23.21%,RPS14;RPL38;RPLP1;RPS9;RPL21;RPL41;RPL37A;RPLP2;RPL27A;RPS19;RPL34;RPL13;RPS16;RPL9;RPS15;RPS27;RPL30;RPL37;RPL19;RPS24;RPL18A;RPL18;RPS7;RPL23;RPL17;RPL22;RPL23A;RPL26;RPS25;RPL35A;SNU13;RPL11;RPL13A;RPL7;RPL36;RPL32;RPS17;RPL39;NOC2L;NPM1;RPS2;RPL8;RPL14;RPL24;RPL29;RPL10A;RPL3;DDX10;LYAR;RPL12;RPL27;PIH1D1;RPL5;RPS28;EXOSC9;DDX27;DDX54;LAS1L;POP5;MTREX;EMG1;NOLC1;RPL4;RPL31;NOC4L;RPL36A;RPL7A;RRP9;WDR36
prerank,response to interferon-gamma (GO:0034341),-0.3632430343484169,-1.2771562733283506,0.088,0.6020322737265199,1.0,24/67,20.21%,WNT5A;CD47;GBP4;GBP7;SIRPA;IFITM1;BST2;SNCA;IFITM3;GAPDH;AQP4;RPL13A;STAT1;CCL19;CD74;TRIM21;CD40;GCH1;GBP3;SP100;GBP5;CASP1;CX3CL1;CCL2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.4712107574548866,1.2770963819303758,0.15365239294710328,0.831259384846584,1.0,15/69,15.16%,THBS1;LBP;CD2;ISL1;STAT3;MAVS;CLU;TLR4;IL33;PLCG2;CCL3;IFIH1;TLR1;DHX9;TWIST1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.3369093196286031,-1.2765017574372979,0.07518796992481203,0.6018072916105607,1.0,24/121,7.77%,IGF1;IL34;VTN;LYN;IL31RA;PECAM1;ENPP2;KIT;GRM5;NEDD9;PARP14;ACE;TEC;IL6R;ERBB4;EPHA4;TNK2;GPRC5B;GHR;CD81;LRP8;ARL2BP;IL18;GAS6
prerank,muscle organ development (GO:0007517),0.4871885566392607,1.2762589961651816,0.15214564369310793,0.8329267002260534,1.0,13/54,11.25%,FHL1;MKX;SGCD;MRAS;LARGE1;COL6A3;MEF2A;DMD;COPRS;CTF1;EMD;MAPK12;EVC
prerank,substantia nigra development (GO:0021762),-0.40354353284606725,-1.2757108986982144,0.1388888888888889,0.6020321593469141,1.0,12/37,14.25%,MBP;GNB4;MAOB;ACTB;PLP1;CALM1;ATP5PF;BASP1;COX6B1;DYNLL1;CALM3;TTBK1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.6281210129744766,1.2750471350812462,0.20642978003384094,0.8359052128140362,1.0,3/14,6.63%,NT5E;NT5C1A;UPP2
prerank,estrogen metabolic process (GO:0008210),0.605331521512168,1.2746738820146801,0.22276422764227644,0.8357033187267154,1.0,2/15,4.64%,CYP1B1;SULT1A1
prerank,regulation of microtubule-based process (GO:0032886),0.5203889038369693,1.274666418002874,0.17107093184979139,0.8342811319855459,1.0,9/36,11.24%,EFNA5;PHLDB2;GSK3B;DIAPH1;FAM107A;MEMO1;MARK2;AURKA;ERBB2
prerank,positive regulation of intracellular protein transport (GO:0090316),0.4381272838296765,1.274306782270641,0.11738148984198646,0.8342259391947039,1.0,33/144,13.34%,CDH1;TCF7L2;ABLIM3;PRKCD;KCNB1;NPEPPS;ZIC1;GSK3B;BCAS3;HPS4;UBR5;PCM1;MAVS;JUP;SEC16A;PLK3;SAE1;UBE2D3;HSPA1L;C2CD5;EMD;CEP131;ERBB2;ITGB1BP1;MIEF1;TMEM30B;PPP3CC;ZC3H12A;CHP1;ARIH2;ZDHHC2;SH3GLB1;BAG3
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.4669475109647065,1.2742044374931671,0.13209876543209875,0.8331810843633012,1.0,9/77,6.61%,THBS1;BMP4;TCF7L2;TGFBR1;NR4A2;ITGAV;GATA4;CLU;BIRC6
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.6335996123100687,1.2739309240681096,0.21428571428571427,0.8312944858741618,1.0,2/11,2.99%,PTK2B;SHC1
prerank,cellular response to interleukin-2 (GO:0071352),0.6335996123100687,1.2739309240681096,0.21428571428571427,0.8312944858741618,1.0,2/11,2.99%,PTK2B;SHC1
prerank,cellular response to fatty acid (GO:0071398),0.6220764013037958,1.273294611737603,0.20860927152317882,0.8320837994753314,1.0,4/12,13.12%,PID1;IRS1;ZC3H12A;PDK3
prerank,striated muscle tissue development (GO:0014706),0.5353984348291003,1.2731591453355056,0.2028169014084507,0.8311154613868198,1.0,4/29,1.79%,SIX1;SGCD;BMP5;CSRP3
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.6248318993551859,1.2725788878561188,0.20933977455716588,0.8317429469791331,1.0,6/12,11.00%,NFIB;PAFAH1B1;TSKU;MYCBP2;GLI2;EPHB6
prerank,regulation of RNA metabolic process (GO:0051252),0.47897767436345445,1.2723750746075422,0.16883116883116883,0.8310402292158674,1.0,11/59,9.62%,AHNAK2;MBNL1;AHNAK;CLK1;SON;CLK2;CELF1;HNRNPH1;MBNL2;FUS;PCBP4
prerank,positive regulation of gene expression (GO:0010628),0.4112279273170552,1.2723165800278189,0.04356636271529889,0.8298067756313297,1.0,81/442,13.97%,SLC38A2;F3;EGFR;THBS1;BMP4;SLC24A3;SAMD4A;NTRK3;SOX9;FOXD1;HOXA5;ITGB8;NGF;ANK2;DDX5;SMO;EZR;PID1;FN1;WNT11;GSN;KRAS;NIBAN1;KLF4;BMP6;INHBA;NFE2L2;GSK3B;FGF2;POLR1G;TGFBR1;SERPINB9;SFRP4;ZBTB7B;NOG;WNT16;UBR5;STAT3;TADA3;CLU;PLSCR1;CELF1;AGR2;MOV10;IL10;PKP1;ID2;TNRC6C;RDX;TLR4;LARP4B;POLR1A;RBMS3;CD46;IL33;ATM;LIMS1;CTCFL;PLCG2;HILPDA;VEGFA;U2AF2;TAF1D;CCL3;ERBB2;EIF3E;MYD88;TAF1C;FGF22;NKX2-1;DDRGK1;ZC3H12A;EIF6;KAT2A;PRKDC;MTOR;HCFC1;PAX6;PIK3R3;POLR1F;EP300
prerank,endothelial cell development (GO:0001885),-0.44911168750384406,-1.2722560693601919,0.13694267515923567,0.6093025449118417,1.0,12/25,9.93%,COL22A1;PECAM1;RAPGEF3;COL18A1;PPP1R16B;RAPGEF2;COL15A1;PDE4D;ROBO4;PDE2A;SOX18;RAPGEF1
prerank,cell-cell junction assembly (GO:0007043),-0.36477844480579874,-1.272063092616692,0.07929515418502203,0.6076965910465998,1.0,16/63,6.59%,TJP1;GJB6;TLN2;CDH2;CLDN5;CDH8;CDH10;EPB41L3;GJB2;GJC1;GJD3;ARVCF;ACTB;GJA1;JAM3;TLN1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.6042013795430177,1.272017542534545,0.20727848101265822,0.8295010010741731,1.0,5/14,12.46%,ATP1B1;WNK1;DMD;SLC9A1;CHP1
prerank,protein deubiquitination (GO:0016579),0.42157316908116116,1.2715367254596572,0.08226495726495726,0.8298243540309728,1.0,95/242,25.98%,CCNA2;USP46;ADRB2;USP2;USP13;OTUD1;TGFBR1;USP24;FOXK1;VCP;BECN1;ESR1;TADA3;MYSM1;TRRAP;PSMB2;MDM4;USP34;RHOA;USP49;IL33;USP15;USP25;RAD23B;PSMC6;USP1;SMAD2;USP32;USP10;CLSPN;USP7;FOXK2;USP47;OTUD7B;DESI2;COPS5;USP4;USP33;ZC3H12A;UIMC1;TNIP1;KAT2A;IFIH1;ZRANB1;PSMD11;JOSD1;HCFC1;EP300;OTUD3;BAP1;POLB;PSMD1;VCPIP1;OTUD5;YY1;KAT2B;IKBKG;USP28;BIRC3;BARD1;PSMD7;USP9X;INO80;PSMC1;USP22;USP40;PSMD14;TRAF3;UFD1;WDR48;USP21;RNF123;USP36;SMAD4;PSMD3;HGS;ASXL2;GATA3;USP48;RHOT1;USP3;BRCC3;CDC20;TOMM20;ASXL1;SMAD7;PSMD12;OGT;STAMBP;MCRS1;ADRM1;TRAF6;PSMD4;MAP3K7;AR
prerank,regulation of calcium ion import (GO:0090279),-0.4621406778307105,-1.2715160702064252,0.1762820512820513,0.6070468612615064,1.0,8/21,21.94%,PDGFRB;CXCL12;SLC30A1;PLPP4;STC1;CCL2;SPHK2;TRIM27
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.5046574469451535,-1.2713809431608765,0.17447916666666666,0.6052931752310227,1.0,4/14,11.26%,IGF1;SYT11;GRN;CD200
prerank,type I interferon signaling pathway (GO:0060337),-0.40863969927501864,-1.2712601466538718,0.12167300380228137,0.6014782214232827,1.0,20/41,22.58%,IFNAR1;SAMHD1;IFIT2;IRF2;IFITM1;BST2;IFITM3;OAS2;IFNAR2;IFIT3;RNASEL;STAT1;PSMB8;ADAR;IFIT1;SP100;IRF7;OASL;XAF1;RSAD2
prerank,cellular response to type I interferon (GO:0071357),-0.40863969927501864,-1.2712601466538718,0.12167300380228137,0.6014782214232827,1.0,20/41,22.58%,IFNAR1;SAMHD1;IFIT2;IRF2;IFITM1;BST2;IFITM3;OAS2;IFNAR2;IFIT3;RNASEL;STAT1;PSMB8;ADAR;IFIT1;SP100;IRF7;OASL;XAF1;RSAD2
prerank,purine ribonucleotide catabolic process (GO:0009154),0.5529952734707482,1.2710995525786912,0.20948012232415902,0.8300025863169299,1.0,4/21,11.42%,NT5E;NT5C1A;NUDT4;AMPD3
prerank,negative regulation of protein polymerization (GO:0032272),0.5370492965074326,1.2710889358417612,0.17851739788199697,0.828626727868222,1.0,2/27,2.04%,SLIT2;PRKCD
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.5366229321763398,1.2701405551068277,0.191800878477306,0.8306408028106939,1.0,3/26,6.49%,ST3GAL4;LARGE1;GOLPH3
prerank,regulation of vasculature development (GO:1901342),0.5473735579119797,1.2698290339746574,0.19664634146341464,0.8303064975514308,1.0,6/26,11.42%,BMPER;FGF2;NF1;PROK2;ERBB2;HTATIP2
prerank,regulation of myeloid cell differentiation (GO:0045637),0.48209612136493163,1.2696069526770046,0.16233766233766234,0.8296680369396571,1.0,16/62,13.97%,THBS1;HOXA5;PTK2B;ZBTB16;NR4A3;CREBBP;KMT2C;MOV10;TNRC6C;GATA1;CBFB;EIF6;KMT2D;CTR9;PRMT6;EP300
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.43571393237581035,-1.2694629064940157,0.15673981191222572,0.6042735088410548,1.0,5/28,8.89%,ARHGAP28;ESAM;CXCL12;COTL1;PAK3
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.4560707202087408,-1.2691865522123944,0.17210682492581603,0.6029797142369079,1.0,6/23,8.10%,CEMIP;PRKAG2;CALM1;BMP7;APP;SPHK1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5244564623547894,1.2683396242666658,0.19676945668135096,0.8327063844544691,1.0,8/31,20.47%,FZR1;DCUN1D5;UBE2S;DCUN1D2;DCUN1D1;DCUN1D4;RAB1A;UBE2N
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.5707009272449819,-1.268313795203123,0.22790697674418606,0.6034960779429946,1.0,7/10,14.92%,GABRG3;GABRA2;GABRB2;GABRA1;GABRG1;GABRA4;GABRA5
prerank,regulation of signal transduction (GO:0009966),0.4259264234561676,1.268186776399394,0.08881578947368421,0.831848706994263,1.0,37/190,11.29%,RSPO3;PLCE1;TCF7L1;GRK5;CD55;MGLL;SULF1;IGFBP5;UBASH3B;ZIC1;MDFIC;ELF1;HHIP;FOXL1;PTPN2;NCK2;CD80;CREBBP;ESR1;GDNF;CLU;RORA;PLSCR1;GAS1;LRIT3;GDF5;SOCS2;FRMPD1;CD46;ACVR1;GALNT11;TIMP1;IGFBP6;SIK2;SRMS;CBFB;ITGB1BP1
prerank,negative regulation of cellular protein localization (GO:1903828),-0.40737768248951034,-1.2677385937913956,0.15162454873646208,0.6030642226044461,1.0,8/34,8.30%,MFHAS1;NEDD4L;PICALM;RIPOR2;ANKRD13A;GPM6B;MAPT;ACTN2
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.4900524079900379,-1.267483439507094,0.1935483870967742,0.6016937261914103,1.0,8/17,19.76%,ATP5PF;ATP5F1B;ATP5F1E;ATP5F1A;ATP5MC1;ATP5F1D;ATP5MC2;ATP5ME
prerank,negative regulation of protein phosphorylation (GO:0001933),0.4325094670673183,1.2674408351081463,0.10738255033557047,0.8330732674692172,1.0,33/150,13.44%,SLIT2;RASSF2;NTRK3;LRP6;PID1;PRKCD;SMAD6;PLPP3;UBASH3B;NIBAN1;SPRED2;PMEPA1;NCK2;EIF4G1;DNAJC3;DMD;NOG;DMTN;KLHL31;IBTK;NF1;PARD3;LDLRAD4;PPEF2;SMCR8;ITGB1BP1;CEP85;CORO1C;RB1;ZC3H12A;CHP1;PRKDC;PAK2
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5805497977546242,1.2671548500442074,0.21884984025559107,0.8327255560328898,1.0,5/18,9.40%,EZR;NELL1;RDX;RGP1;DACT1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.4157969405784819,1.2671484766982872,0.03941908713692946,0.8313618435860838,1.0,52/348,9.97%,SLC38A2;F3;BMP4;SLC24A3;NTRK3;SOX9;FOXD1;HOXA5;ITGB8;NGF;ANK2;SMO;EZR;PID1;FN1;ANXA2;WNT11;GSN;KRAS;KLF4;BMP6;INHBA;NFE2L2;GSK3B;FGF2;TGFBR1;SERPINB9;SFRP4;ZBTB7B;NOG;WNT16;UBR5;STAT3;TADA3;CLU;PLSCR1;CELF1;AGR2;MOV10;PKP1;ID2;TNRC6C;RDX;NSF;TLR4;RBMS3;CD46;IL33;ATM;LIMS1;CTCFL;PLCG2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.4690261148863709,-1.266881276754192,0.16091954022988506,0.6013425215620909,1.0,3/21,3.39%,OSBPL8;PLA1A;OSBPL10
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.528925823962754,1.2662847330097555,0.20512820512820512,0.8329920964518436,1.0,7/31,11.96%,FHL1;KLF4;FAM107A;DLG1;KANK2;DACT1;RB1
prerank,nucleosome assembly (GO:0006334),0.5491817725388642,1.266179009268006,0.1836734693877551,0.832027310782247,1.0,7/31,12.95%,SOX9;CHAF1B;KAT6B;UBN1;CABIN1;ATRX;HIRA
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5145286500063403,1.2660838443804046,0.18922651933701656,0.8310054982051475,1.0,3/38,3.23%,THBS1;BMP5;GSK3B
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4644267649163611,1.2659245899351645,0.1435523114355231,0.8301503302624804,1.0,9/75,4.32%,F3;BMP4;PGF;NRAS;FGFR1;FGF2;NRP1;TGFBR1;AGTR1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.40413712714090905,1.2658934949230625,0.0,0.8288914284375959,1.0,339/1646,15.80%,BNC2;FOXP2;ZBTB7C;EGFR;FOXP1;BMP4;KLF12;WWP1;CDH1;VSX1;PBX3;NR3C2;TBX15;MKX;TCF7L1;KLF5;ZFHX3;TFCP2L1;ZFPM2;SIX1;TCF7L2;SLTM;PLAGL1;MAP3K5;PRRX2;ZFHX4;NFIB;SMAD9;SOX9;ZIC4;FOXD1;HDAC4;HOXA5;LRP6;MLLT3;FOXN3;DDX5;TCIM;RBFOX2;CAMK2D;TGFB3;FOXP4;PBX1;KLF3;CUX1;NFIA;WNT11;GLI3;NFAT5;SMAD6;FOXO3;HES1;MEOX2;HOXA3;HDAC9;ZBTB16;GRHL1;TWIST2;ANXA4;PURG;GCLC;HOXB6;WWP2;TCF20;USP13;SHC1;ESR2;KLF4;JMJD1C;INHBA;PRICKLE1;ZIC1;NFE2L2;FGF2;ZNF148;MDFIC;PRRX1;FZD7;ELF1;CRY2;RCOR3;ZNF423;ABL1;ERC1;NR2F1;FOXC2;L3MBTL3;ID1;MEF2A;GLIS1;KLF7;TGFBR1;HOXA6;JDP2;BTAF1;EFEMP1;EHF;NR4A3;FOXL1;SP140;NR4A2;PDCD4;PHC2;FOXK1;DDX17;HDGFL3;KAT6B;KLF10;ARID4A;SAMD7;ZBTB7B;HOXC6;CD80;ATP2B4;BHLHE40;FOXO6;NFATC4;BRD3;ARID4B;KLF9;TLE2;CREBBP;GLIS2;CCNL2;SCMH1;ISL1;STAT3;MNAT1;HOXB3;HMG20A;ESR1;SPINDOC;MBD1;ATF1;KDM1A;TBL1X;TADA3;HOXB5;E2F3;TGFB1I1;E2F5;GATA4;NFIL3;RORA;TRIM44;BAMBI;DDIT3;TASP1;HIF3A;IRF1;NFIX;REL;HOXC4;TRRAP;LCOR;ELP3;EHMT1;TEAD1;DMRT3;GDF6;MYOG;DMBX1;NOBOX;IL10;PITX3;BARHL2;LHX2;PHOX2A;SOX14;SP8;ID2;FZD1;SRCAP;MBTD1;MLXIP;FUS;CHEK2;SIX4;CRABP2;GLI2;CAMTA2;PITX2;PIAS2;ATP8B1;CDKN1B;HIVEP3;IGSF1;ZNF8;MDM4;NLK;RXRA;FOXC1;GRHL2;ATOH8;CIPC;PHF12;BAZ2B;NFKB1;PIAS3;EGR2;NFYA;MED13;CHUK;SERTAD3;FBXW11;CCNL1;NIBAN2;BCLAF1;LIMS1;ACVR1;DKK3;TOX4;CBX5;MED27;GATA1;CTCFL;HOXB4;FOXE1;RARA;PIM2;ATF7;ZNF25;CARF;SMAD2;GON4L;MTDH;NFE2L1;NRF1;VEGFA;LBX1;NFKB2;JUN;ELF3;ERN2;WAC;PRDM15;ZBTB32;MYNN;LRP5;NCOR1;RNF111;SP110;MXD1;FOXK2;GTF2IRD1;ATF6;USP47;BRCA2;CBFB;PER1;ERBB2;HTATIP2;EED;RGMB;BPTF;NIPBL;CREB3L1;BAZ1A;KDM3B;RB1;AATF;ATOH7;BCL11B;ELOA;ID4;BRD9;NKX2-1;SMARCA4;UIMC1;ATRX;NR6A1;TCF3;KMT2D;KAT2A;CDC45;NR4A1;NCOR2;CC2D1B;HIRA;MXD4;NFATC3;SETD5;PPM1A;CREB3L3;CTR9;HNF4A;HNF1A;XRCC5;HCFC1;SP3;PAX6;RFX2;CHD3;PRMT6;EP300;STAT5A;MED14;GPBP1;ZXDC;E2F2;BCL6;GCFC2;BAP1;EBF4;REST;ETV3;HDAC10;DHX9;ZNF691;ATF2;CDK11B;SBNO2;ELP4;ZMIZ1;CNOT7;FOXD2;KDM2A;RUNX2;CDK16;GPBP1L1;BAZ2A;NFATC1;PCGF1;RFX7;TWIST1;MAP2K2;HSF2;THRAP3;ZNF585B;ZNF585A;HINFP;CALCOCO1;URI1;BRWD1;ZBTB1;HOXD3;PML;PRDM5;ZBTB7A
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.6243884687854192,1.2649529362937966,0.22110552763819097,0.8308821951579087,1.0,1/12,0.19%,F3
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.500181814033004,-1.2639613257028475,0.20994475138121546,0.6074037100894064,1.0,2/15,4.67%,IGF1;BCL2L1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.6238230265965761,1.2636241418920122,0.2294022617124394,0.8341453195782516,1.0,5/12,11.60%,SORBS1;IRS1;ZBTB7B;C1QTNF12;ERFE
prerank,epithelial cell migration (GO:0010631),0.5027526553401697,1.2633807582036822,0.1888111888111888,0.8336183597680702,1.0,10/37,10.03%,FSTL1;CYP1B1;FAT2;GIPC1;ABL1;NRP1;RHOA;KANK2;STARD13;S100A2
prerank,positive regulation of protein modification process (GO:0031401),0.42020225433900976,1.2630887215576914,0.1064516129032258,0.8332891201138729,1.0,17/203,3.58%,EGFR;BMP4;SLCO3A1;CARD14;TRABD2B;NTRK3;SOX9;RAMP1;PGF;CCN1;EFNA5;PRKCD;KRAS;NIBAN1;LIMK2;FGF2;ABL1
prerank,cGMP metabolic process (GO:0046068),0.6219405455582988,1.2629471403078474,0.23679727427597955,0.8324386430867698,1.0,1/12,0.24%,GUCY2C
prerank,DNA geometric change (GO:0032392),0.555252394091952,1.2623703452294823,0.18960244648318042,0.8331230800202145,1.0,10/24,21.89%,ANXA1;WRN;DDX11;DHX9;MCM9;RECQL5;NBN;DHX36;DDX1;RAD50
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.5212885840580583,1.2620724882137158,0.19826338639652677,0.8328318870461735,1.0,2/29,3.18%,THBS1;INHBA
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.5839286825601272,1.261684101224361,0.21226415094339623,0.8328836363722757,1.0,12/16,30.99%,CELF3;RBMX;THRAP3;CIRBP;SNW1;DAZAP1;TRA2B;NUP98;RBM3;CELF4;RBMXL1;PRDX6
prerank,positive regulation of dendrite development (GO:1900006),0.6320218195407497,1.2616829776621148,0.24385964912280703,0.8315238685050161,1.0,2/10,1.27%,BMP5;COBL
prerank,phosphatidylserine metabolic process (GO:0006658),-0.42067253650967107,-1.2613418647909833,0.16040955631399317,0.6127215194315833,1.0,6/32,8.09%,OSBPL8;PLA1A;SERINC5;OSBPL10;ABHD12;SERINC1
prerank,ATP transport (GO:0015867),-0.5590597001665418,-1.2611596114130814,0.20623501199040767,0.6111797399834432,1.0,2/10,5.01%,CD47;ABCC6
prerank,nuclear migration (GO:0007097),0.6083089522928744,1.2603845458308918,0.22988505747126436,0.834669040315562,1.0,8/13,18.66%,DOCK7;PAFAH1B1;CLMN;PCM1;FBXW11;SYNE2;HOOK3;TMEM201
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.39842167314416466,-1.2598094080800262,0.1310344827586207,0.612890571335471,1.0,17/40,26.55%,IGF1;BCL2L1;TNFSF10;PDCD5;BMF;AKT1;BIK;GPER1;TRIAP1;DNM1L;PMAIP1;PLAUR;MFF;PYCARD;MLLT11;PINK1;HRK
prerank,negative regulation of signal transduction (GO:0009968),0.41650732340709956,1.2597467906301845,0.07255520504731862,0.8355784324639,1.0,42/249,9.72%,EGFR;THBS1;NXN;TRABD2B;NTN1;BMP5;NEDD4;TCIM;PID1;PRKCD;GLI3;GPC3;SULF1;GRB10;IGFBP5;WWP2;UBASH3B;PALM;FGF2;IRS1;LRPAP1;HHIP;MDFI;NR4A2;PTPN2;VCP;SFRP4;TSKU;NOG;LRP1;GLIS2;GATA4;IL10;MMP14;NLK;KANK2;IRAK3;DACT1;NIBAN2;ACVR1;DKK3;KIF7
prerank,myeloid cell development (GO:0061515),0.5669958304173714,1.2591021174367167,0.22009569377990432,0.8365925090405041,1.0,4/18,9.80%,FOXP1;ANXA2;DMTN;GATA1
prerank,positive regulation of lipid localization (GO:1905954),0.605811888872565,1.2589644972959966,0.2322357019064125,0.835734289817277,1.0,5/11,12.36%,LRP1;IKBKE;NFKB1;HILPDA;ZC3H12A
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5338441604630366,-1.2584773676112644,0.20192307692307693,0.6146483665111917,1.0,5/12,9.33%,UNC13C;RIMS1;RIMS2;SYT7;SYT1
prerank,cell differentiation in hindbrain (GO:0021533),-0.5360406351063524,-1.2580450485944858,0.20902612826603326,0.6137725128092233,1.0,7/11,19.04%,GRID2;OPHN1;PROX1;FAIM2;KNDC1;LHX1;ATP7A
prerank,DNA replication (GO:0006260),0.44821121668734903,1.257738240181999,0.14723203769140164,0.8386074317895953,1.0,45/105,26.57%,REV3L;EXO1;MCM7;RAD17;WRN;MCM2;ATM;MCMBP;TOP1;CLSPN;IGHMBP2;TBRG1;BAZ1A;CDC45;CHEK1;POLG2;POLB;MCM9;RNASEH2A;POLE2;KIN;RBBP8;RPA1;TOP3A;RECQL5;ATR;BARD1;RMI2;NBN;TICRR;RFC1;REV1;TOPBP1;HELB;POLA1;RAD50;RAD9B;TOP1MT;CDK2;RFC5;BRIP1;KAT5;FAM111A;ORC3;CDK2AP1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.44894969181207944,-1.257698195134599,0.15168539325842698,0.6127683774134189,1.0,14/23,35.94%,ELOVL6;ALOX12;ACOT7;LTA4H;ACSBG1;GPX4;PTGS2;GSTM1;CYP2E1;ASAH2;GSTM2;LTC4S;GSTP1;CYP1A1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4660652560607595,1.2571227203126885,0.1702127659574468,0.8393639460155902,1.0,11/73,10.37%,EGFR;NTRK3;NGF;CD44;DOCK7;EIF4G1;ATP2B4;RIPK2;BCAR3;AKAP9;VEGFA
prerank,gene expression (GO:0010467),-0.29210772365947735,-1.2567464181725376,0.0,0.6134254622350728,1.0,102/348,18.94%,RBPMS;NOVA1;RBMS1;ATXN1;TSPAN5;RPS14;PTMA;EEF1A1;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;APOBEC1;RPS21;RPLP2;RPL27A;RPS19;RPL34;RPS29;RPS8;RPS3;RPS23;ADARB2;RPS5;RPS4X;RPL13;RPS16;ELAVL4;RPL9;ANGPT2;RPS15;RPS27;RPL30;DTX1;SETX;RPL37;RPL19;RPS11;RPS24;RPL18A;RPL18;RPS7;RPL23;RPL17;EIF4EBP2;RPS20;RPL22;RPL23A;RPL26;RPS25;RPS18;RPL35A;MRPL3;RPL11;RPL13A;RPL7;RPL36;RNASEL;RPL32;RPS17;RPL39;CELF2;NUP160;RPS2;RPL8;RPL14;HHEX;FASTKD2;POLR2G;RPL24;NUP210;HNRNPH3;RPL29;MRPS11;MRPL51;ADARB1;NOX4;RPL10A;RPL3;ADAR;SMG7;TFIP11;DDX20;PABPN1;RPL12;RPS12;RPL27;RPS27A;NUP62;RPL5;NUP205;RPS28;PWP1;DDX54;POLR2K;RPS10;MAGOH;GSPT2;RBM15B
prerank,amino acid import (GO:0043090),0.5534164638301875,1.2562594607243838,0.192,0.8411206670612228,1.0,1/21,0.02%,SLC47A1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5297048640529574,-1.255891721312083,0.20192307692307693,0.6118733610165499,1.0,2/12,5.28%,IGF1;AKAP6
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5297048640529574,-1.255891721312083,0.20192307692307693,0.6118733610165499,1.0,2/12,5.28%,IGF1;AKAP6
prerank,regulation of actin filament polymerization (GO:0030833),0.46339706652585094,1.2558576746190053,0.17076326002587322,0.8411866360425777,1.0,15/69,13.56%,SLIT2;BAIAP2L1;CDC42EP5;PTK2B;PRKCD;PRKCE;NCK2;WASHC5;CTTN;KANK4;NCKAP1;ARHGAP40;FCHSD2;FCHSD1;SSH3
prerank,actin filament bundle organization (GO:0061572),0.5210214596799883,1.255217767103605,0.20710059171597633,0.8420136176649755,1.0,8/33,6.57%,DPYSL3;BAIAP2L1;EZR;PAWR;CALD1;FAM107A;PLS1;DMTN
prerank,regulation of B cell apoptotic process (GO:0002902),0.5894490830365957,1.2550082609046274,0.24217462932454695,0.8413595120963818,1.0,1/12,0.25%,FOXP1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.4024149956808845,1.2537110165285263,0.012,0.8445030589762162,1.0,178/807,14.92%,FOXP2;FOXP1;BMP4;KLF12;WWP1;ZFHX3;ZFPM2;TCF7L2;RARB;SOX9;FOXD1;HDAC4;PRDM6;FOXN3;DDX5;RBFOX2;EZR;FOXP4;CUX1;WNT11;GLI3;FOXO3;HES1;HDAC9;ZBTB16;TWIST2;SKIL;GCLC;WWP2;USP2;SHC1;ESR2;KLF4;BMP6;PRICKLE1;ZNF148;MDFIC;CRY2;RCOR3;ZNF423;NR2F1;FOXC2;L3MBTL3;ID1;MEF2A;GLIS1;KLF7;JDP2;BTAF1;NR4A3;MDFI;NR4A2;PDCD4;PHC2;TCF25;FOXK1;KAT6B;KLF10;ARID4A;SAMD7;ZBTB7B;SMYD2;BHLHE40;HDAC8;TLE2;CREBBP;FRK;NOG;GLIS2;TLE6;SCMH1;ISL1;SKI;STAT3;ESR1;SPINDOC;MBD1;KDM1A;TBL1X;PHF21A;NFIL3;DDIT3;DLG1;IRF1;NFIX;LCOR;EHMT1;DMBX1;SOX14;ID2;MBTD1;SIX4;GLI2;ATP8B1;PLK3;CDKN1B;ZNF8;MDM4;RXRA;ZMYM5;FOXC1;ATOH8;CIPC;PHF12;KANK2;NFKB1;UBE2D3;PER3;IL33;FBXW11;DACT1;NIBAN2;BCLAF1;LIMS1;DKK3;CBX5;RARG;GATA1;FOXE1;RARA;ZNF25;SMAD2;MTDH;VEGFA;TCERG1;JUN;ELF3;ERN2;ZBTB32;NCOR1;MIER1;MXD1;FOXK2;GTF2IRD1;USP47;CBFB;PER1;OTUD7B;EED;BPTF;NIPBL;CREB3L1;DCAF1;RB1;MTA1;NCOA5;ID4;NKX2-1;SMARCA4;UIMC1;NR6A1;TCF3;NCOR2;MXD4;PPM1A;CTR9;HNF4A;XRCC5;HCFC1;SP3;PAX6;CHD3;PRMT6;PRDX5;EP300;BCL6;GCFC2;RNF2;BAP1;DNMT3A;REST;VPS72;HDAC10;SBNO2;CCND1;CNOT7;KDM2A;RUNX2
prerank,O-glycan processing (GO:0016266),0.4783072773772048,1.2536592050755597,0.17997465145754118,0.8433182574016898,1.0,6/54,6.87%,ST3GAL4;B3GNT2;GXYLT2;GALNT15;GALNT13;MUC6
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5941955140908859,1.253613091901223,0.21489001692047377,0.8421041527957257,1.0,3/14,6.89%,EHHADH;ACOX3;ACOT8
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.402286506135887,1.2533057697406653,0.01,0.8418440492837491,1.0,198/834,16.36%,MICAL2;EGFR;BMP4;KLF5;ZFHX3;ZFPM2;SIX1;TCF7L2;MET;PLAGL1;RARB;NFIB;SMAD9;PKD1;SOX9;BMP5;HDAC4;HOXA5;LRP6;PPP3CA;CCN1;TGFB3;CSRP3;PID1;PBX1;NFIA;GLI3;NFAT5;FOXO3;HES1;MEOX2;GRHL1;TCF20;KLF4;DCAF6;BMP6;INHBA;BMPR1A;NFE2L2;FGF2;ELF1;ABL1;NR2F1;FOXC2;MEF2A;GLIS1;KLF7;EHF;NR4A3;NR4A2;ZFP64;MLLT10;DDX17;NCK2;KAT6B;KLF10;BCAS3;MRTFA;HDAC8;CREBBP;GLIS2;ISL1;SKI;STAT3;CDK12;HOXB3;ESR1;ATF1;GDNF;KDM1A;TBL1X;RHOQ;E2F3;MAVS;KMT2C;JAG1;E2F5;GATA4;RORA;DDIT3;CEBPZ;MYSM1;RIPK2;PLSCR1;IRF1;NFIX;REL;HOXC4;TEAD1;MYOG;IL10;PHOX2A;JUP;MLXIP;GABPB2;GABPB1;GLI2;CAMTA2;PITX2;SLC9A1;TLR4;RXRA;FOXC1;GRHL2;ATOH8;THAP3;PAXBP1;NFKB1;EGR2;MED13;CHUK;IL33;BCLAF1;ATM;LPIN2;SSBP3;ACVR1;RBMX;RARG;GATA1;CTCFL;HOXB4;RARA;SLC30A9;PPP1R12A;SMAD2;NRF1;VEGFA;NFKB2;APEX1;TCERG1;JUN;ELF3;PRDM15;LRP5;ARF4;RNF111;TNFSF11;FOXK2;ATF6;PER1;ITGB1BP1;KANSL3;BCL9L;HTATIP2;ZBED4;BPTF;COPS5;AATF;BCL11B;NKX2-1;DDRGK1;ZC3H12A;PPRC1;SMARCA4;ATRX;TCF3;TNIP1;KMT2D;KAT2A;NR4A1;PRKDC;NFATC3;CREB3L3;HNF4A;HNF1A;HCFC1;CRTC1;SP3;PAX6;EP300;MED14;E2F2;REST;DHX9;ZNF507;ATF2;SBNO2;ZMIZ1;FOXD2;SQSTM1;RUNX2;NFATC1;TWIST1;HSF2;THRAP3;HINFP;CALCOCO1;GALR1;HOXD3;CAPRIN2;MED24;ZNF462;TFAP2A;AGO2;CDK13;YY1;KAT2B
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.5925576119752964,1.2532687873336972,0.22098569157392686,0.8406460769873053,1.0,3/16,4.32%,THBS1;FGF2;AGTR1
prerank,positive regulation of ERAD pathway (GO:1904294),0.6096547889255579,1.253104512367574,0.2463295269168026,0.8399098211212349,1.0,3/13,4.85%,USP13;NFE2L2;RNF185
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.35331631632961613,-1.2519540009399572,0.10344827586206896,0.6208612357263513,1.0,16/72,7.80%,FLT1;IGF1;IGF1R;LYN;TEK;PDGFD;PIK3R1;PDGFRB;KIT;DCN;KDR;INSR;ROR2;PTK2;IL18;NTRK2
prerank,early endosome to late endosome transport (GO:0045022),0.5637545125720393,1.2514834518528368,0.22442748091603054,0.8441554017190909,1.0,12/20,23.94%,EEA1;BECN1;ANKRD27;STX8;KIF16B;WDR81;HOOK3;SNF8;RAB5A;EMP2;HOOK2;RAB7A
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.3744903139258947,-1.2512819202060448,0.12133891213389121,0.6207465002984259,1.0,20/57,13.02%,GRIA4;GRIN2A;APP;GRIN2B;MEF2C;LRRC7;DLGAP1;GRIA3;CACNG4;CACNG7;GRIN1;ACTN2;GRIA2;CAMK2A;GRIA1;NETO1;CAMK2B;DLGAP2;NPTXR;GSG1L
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6046458987703294,1.2508157164932376,0.2408026755852843,0.8451759897742804,1.0,5/12,12.88%,STAT3;ESR1;NCOR1;ZC3H12A;NCOR2
prerank,metal ion transport (GO:0030001),-0.3398969681677311,-1.2507630621223247,0.07865168539325842,0.6202740318856124,1.0,27/86,15.45%,ITPR1;CACNA1D;CACNA1E;TRPC3;CALCRL;SLC8A1;RYR2;SLC39A8;ATP2C1;TPT1;SLC41A1;CACNA1B;CACNA2D1;CACNG7;TRPC4;MMGT1;RAMP2;SLC30A1;CAMK2A;NDFIP2;TRPC1;GRIN3A;SELENOK;SLC3A2;TRPV4;CCR5;ATP2A3
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.4028479782462882,1.2501759203444804,0.035175879396984924,0.846049082856324,1.0,104/497,14.92%,FOXP2;FOXP1;BMP4;WWP1;ZFPM2;TCF7L2;SAMD4A;SOX9;FOXD1;HDAC4;FOXN3;RBFOX2;WNT11;GLI3;HES1;HDAC9;ZBTB16;TWIST2;IGFBP5;GCLC;WWP2;SHC1;KLF4;PRICKLE1;GSK3B;ZNF148;MDFIC;CRY2;RCOR3;ZNF423;L3MBTL3;ID1;BTAF1;PDCD4;PHC2;PAIP2;FOXK1;KAT6B;KLF10;ARID4A;SAMD7;BHLHE40;TLE2;GLIS2;SCMH1;SPINDOC;MBD1;KDM1A;SYNCRIP;NFIL3;DDIT3;IRF1;EHMT1;DMBX1;SOX14;ID2;MBTD1;SIX4;ATP8B1;CDKN1B;ATOH8;CIPC;PHF12;RAD17;FBXW11;NIBAN2;BCLAF1;LIMS1;DKK3;TOB1;CBX5;FOXE1;RARA;SMAD2;JUN;ELF3;ERN2;NCOR1;FOXK2;USP47;PER1;EED;NIPBL;CREB3L1;RB1;WAPL;ID4;NKX2-1;SMARCA4;UIMC1;NCOR2;GTPBP4;HNF4A;XRCC5;SP3;PRMT6;BCL6;GCFC2;BAP1;REST;HDAC10;SBNO2;CNOT7;RUNX2
prerank,superoxide metabolic process (GO:0006801),0.5267945323510365,1.2498629018773895,0.21021897810218979,0.845857213923582,1.0,1/29,0.12%,SH3PXD2A
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.4301794965556045,1.2494926155044106,0.12345679012345678,0.8458195551225917,1.0,15/142,6.03%,SLC35G1;PLCE1;EDNRA;PTGDR;CD55;ADRA1B;CACNA1C;ABL1;CMKLR1;AGTR1;PLCZ1;TRPM4;ATP2B4;PTGER1;ESR1
prerank,protein depolymerization (GO:0051261),0.5301043768244603,1.2494281628280333,0.20884146341463414,0.844724808181277,1.0,2/27,2.48%,MICAL2;GSN
prerank,regulation of mitotic cell cycle (GO:0007346),0.42459887198849233,1.2485794691443344,0.11666666666666667,0.8464938967200276,1.0,41/171,18.06%,SMOC2;FZR1;PTPN3;USP2;TTC28;NEK7;ANAPC5;CCDC8;CDC16;GAS1;CDC25B;GBF1;PSMB2;IL10;ANAPC16;CDKN1B;FOXC1;IQGAP1;PIM2;PSMC6;BTG3;RB1;TMEM8B;ANGEL2;PSMD11;PKN2;PRKCA;UBE2S;PDXP;CDK11B;MAD2L1;PSMD1;CUL1;NEK6;CDK13;ERCC3;HECA;CDK10;PSMD7;PSMC1;USP22
prerank,glycerophospholipid catabolic process (GO:0046475),-0.4372024052040427,-1.248541200221067,0.16666666666666666,0.624440843617433,1.0,6/27,10.13%,GPCPD1;ENPP2;ENPP6;ABHD12;INPP5F;PNPLA8
prerank,long-chain fatty acid import into cell (GO:0044539),-0.5468501727531705,-1.248348126134564,0.20417633410672853,0.6229949362201962,1.0,2/10,1.22%,ACSL1;SLC2A1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.5051170355736717,-1.2476556454369845,0.18181818181818182,0.6229074130445761,1.0,1/14,0.60%,AUTS2
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.397932892052251,1.2476555620358882,0.0,0.8483322256066286,1.0,368/1668,16.38%,FOXP2;ZBTB7C;EGFR;FOXP1;BMP4;KLF12;PBX3;NR3C2;TBX15;MKX;TCF7L1;KLF5;ZFHX3;TFCP2L1;ZFPM2;SIX1;TCF7L2;SLTM;MET;PLAGL1;PRRX2;RARB;ZFHX4;NFIB;SMAD9;PKD1;SOX9;BMP5;ZIC4;FOXD1;HDAC4;HOXA5;LRP6;PRDM6;DDX5;PPP3CA;CCN1;CAMK2D;EZR;TGFB3;CSRP3;PID1;FOXP4;PBX1;KLF3;CUX1;NFIA;GLI3;NFAT5;SMAD6;FOXO3;HES1;MEOX2;HOXA3;HDAC9;ZBTB16;GRHL1;TWIST2;ANXA4;SKIL;PURG;HOXB6;WWP2;TCF20;USP2;ESR2;KLF4;JMJD1C;DCAF6;BMP6;INHBA;ZIC1;BMPR1A;NFE2L2;FGF2;ZNF148;PRRX1;ELF1;CRY2;RCOR3;ABL1;NR2F1;FOXC2;ID1;MEF2A;GLIS1;KLF7;HOXA6;JDP2;EHF;NR4A3;FOXL1;MDFI;SP140;NR4A2;TCF25;ZFP64;FOXK1;MLLT10;DDX17;HDGFL3;NCK2;KAT6B;KLF10;ARID4A;BCAS3;ZBTB7B;SMYD2;HOXC6;ATP2B4;BHLHE40;FOXO6;NFATC4;BRD3;ARID4B;MRTFA;HDAC8;KLF9;CREBBP;FRK;NOG;GLIS2;TLE6;CCNL2;ISL1;MED15;SKI;STAT3;CDK12;MNAT1;HOXB3;ESR1;ATF1;GDNF;KDM1A;TBL1X;TADA3;RHOQ;HOXB5;E2F3;MAVS;KMT2C;JAG1;PHF21A;E2F5;GATA4;NFIL3;RORA;DDIT3;CEBPZ;MYSM1;RIPK2;PLSCR1;HIF3A;DLG1;IRF1;NFIX;REL;HOXC4;MOV10;LCOR;ELP3;TEAD1;DMRT3;MYOG;DMBX1;NOBOX;PITX3;BARHL2;LHX2;PHOX2A;SOX14;SP8;ID2;JUP;SRCAP;TNRC6C;MLXIP;FUS;GABPB2;GABPB1;SIX4;GLI2;CAMTA2;PITX2;PIAS2;PLK3;SLC9A1;TLR4;HIVEP3;ZNF8;MDM4;RXRA;ZMYM5;FOXC1;GRHL2;ATOH8;THAP3;PHF12;BAZ2B;KANK2;PAXBP1;NFKB1;PIAS3;EGR2;NFYA;MED13;CHUK;UBE2D3;PER3;IL33;CCNL1;DACT1;BCLAF1;ATM;LPIN2;SSBP3;ACVR1;TOX4;RBMX;CBX5;MED27;RARG;GATA1;CTCFL;HOXB4;FOXE1;RARA;SLC30A9;ATF7;ZNF25;PPP1R12A;CARF;SMAD2;MTDH;NFE2L1;NRF1;VEGFA;LBX1;NFKB2;APEX1;TCERG1;JUN;ELF3;PRDM15;ZBTB32;MYNN;LRP5;NCOR1;ARF4;RNF111;SP110;MIER1;MXD1;TNFSF11;FOXK2;GTF2IRD1;ATF6;CBFB;PER1;OTUD7B;ERBB2;ITGB1BP1;KANSL3;BCL9L;HTATIP2;EED;ZBED4;BPTF;NIPBL;CREB3L1;BAZ1A;DCAF1;COPS5;KDM3B;RB1;AATF;ATOH7;BCL11B;MTA1;ELOA;NCOA5;ID4;BRD9;NKX2-1;DDRGK1;ZC3H12A;PPRC1;SMARCA4;ATRX;NR6A1;TCF3;TNIP1;KMT2D;KAT2A;NR4A1;NCOR2;CC2D1B;HIRA;MXD4;PRKDC;NFATC3;PPM1A;CREB3L3;CTR9;HNF4A;HNF1A;HCFC1;CRTC1;SP3;PAX6;RFX2;CHD3;EP300;STAT5A;MED14;ZXDC;E2F2;BCL6;RNF2;EBF4;DNMT3A;REST;ETV3;VPS72;HDAC10;DHX9;ZNF691;ZNF507;ATF2;SBNO2;ELP4;CCND1;ZMIZ1;FOXD2;SQSTM1;KDM2A;RUNX2;NFATC1;PCGF1;RFX7;TWIST1;HSF2;THRAP3;ZNF585B;ZNF585A;HINFP;CALCOCO1;URI1;GALR1;BRWD1;ZBTB1;HOXD3;PRDM5;CAPRIN2;ZBTB7A;MED24;RBBP8;ZNF462;ZKSCAN1;TFAP2A;AGO2;POU6F1;CDK13;NSD1;YY1;KAT2B;ZNF219
prerank,macrophage activation (GO:0042116),0.506147878005132,1.247405981215963,0.2059238363892807,0.8478508632041255,1.0,6/34,9.97%,FOXP1;LBP;CLU;IFI35;TLR4;PLCG2
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.49649089520200773,-1.247371597580433,0.21024258760107817,0.621690854662484,1.0,9/16,20.52%,AUTS2;ARHGAP24;RASGRF1;STMN3;CADM4;GABARAP;PIK3CG;ARF6;KBTBD7
prerank,T cell differentiation in thymus (GO:0033077),0.591334398135486,1.2473434811850321,0.23491027732463296,0.8467743930168589,1.0,2/14,9.15%,GLI3;RIPK3
prerank,response to X-ray (GO:0010165),0.5856218583192109,1.2472417229227013,0.23615635179153094,0.8457984197334687,1.0,4/14,13.64%,ANXA1;ATM;NIPBL;XRCC5
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.4660042749008025,-1.2472209857128176,0.19161676646706588,0.620199756955833,1.0,8/19,5.64%,ROBO1;SEMA6A;CCBE1;JCAD;DCN;TSPAN12;CD63;DAB2IP
prerank,positive chemotaxis (GO:0050918),0.5723414560460091,1.247219655454167,0.20673076923076922,0.8445345899456506,1.0,2/17,3.76%,MET;NRP1
prerank,relaxation of muscle (GO:0090075),0.5915288094393203,1.2470194605939706,0.22895622895622897,0.8439734192223096,1.0,4/13,2.48%,KCNJ2;ATP1B1;CAMK2D;GSN
prerank,protein localization to chromosome (GO:0034502),0.5044406353982034,1.2461374562703615,0.2028985507246377,0.8458258619852435,1.0,12/34,17.21%,ESR1;TNKS2;RB1;WAPL;ATRX;XRCC5;MRNIP;MCM9;LEMD2;PARP3;RPA1;ATR
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.483916074903584,1.2458188941995958,0.17608409986859397,0.8455571971681022,1.0,10/52,6.77%,EGFR;EPB41L2;SORBS1;ITGB1;PRKCE;ATP2B4;LRP1;PLS1;DLG1;AGR2
prerank,double-strand break repair via homologous recombination (GO:0000724),0.4525770676433361,1.2451463260190259,0.1590909090909091,0.8466577816926053,1.0,34/95,21.89%,REV3L;RNF138;MCM7;ERCC5;WRN;MCM2;SMC5;BRCA2;RAD52;NABP1;NIPBL;SPIDR;SLX4;CDC45;KDM4D;MCM9;RBBP8;YY1;NSMCE1;RPA1;RECQL5;INO80;NBN;RAD51;FANCM;PSMD14;SWSAP1;EXD2;UBE2N;RAD51B;RAD51C;SMC6;ZFYVE26;RAD50
prerank,regulation of establishment of cell polarity (GO:2000114),0.5836582227209784,1.2450612624943658,0.2404870624048706,0.8456574062687185,1.0,4/16,5.62%,PTK2B;GSN;BCAS3;SHTN1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.5148768615519977,1.2447362686522385,0.21306818181818182,0.845443089818294,1.0,8/33,11.96%,FHL1;KLF4;FAM107A;DLG1;PLK3;KANK2;DACT1;RB1
prerank,positive regulation of phospholipase C activity (GO:0010863),0.5000395082252399,1.2447245939682214,0.21875,0.844171123578608,1.0,5/40,3.27%,EGFR;EDNRA;NTRK3;FGFR1;FGF2
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.5996631298694186,1.244008467762468,0.24496644295302014,0.8453484518544954,1.0,5/12,17.93%,ESR1;NCOR1;ZC3H12A;NCOR2;PPARG
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.45560827756062094,1.2439809017154981,0.17167919799498746,0.8441251818233217,1.0,23/78,19.78%,FZR1;PRICKLE1;NFE2L2;GSK3B;RNF144A;VCP;ARIH1;CLU;RNF19A;CSNK1A1;PLK3;ZYG11B;DDRGK1;COP1;ARIH2;ANKIB1;CSNK1E;BCAP31;RNF14;SIRT6;PIAS1;CSNK1D;DVL1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5800547801450313,1.243864144000498,0.21859706362153344,0.8432478047178797,1.0,8/16,28.52%,SMG6;TNKS2;ATM;SLX4;DHX36;NAF1;HNRNPA2B1;PINX1
prerank,carbohydrate biosynthetic process (GO:0016051),0.5597311290473532,1.243377461407985,0.21293375394321767,0.8436251195016716,1.0,2/21,1.55%,ST3GAL4;FUT8
prerank,cytoplasmic sequestering of protein (GO:0051220),0.6120732639366886,1.2432056106494542,0.24738675958188153,0.8429637812156866,1.0,2/13,4.44%,PKD1;MDFI
prerank,peptidyl-lysine modification (GO:0018205),0.44278331585942,1.2425548574311973,0.1650602409638554,0.8439660340601663,1.0,43/99,28.55%,HDAC4;PLOD2;HDAC9;LOXL1;NUP93;TRPM4;PIAS2;SAE1;P3H4;PIAS3;EGR2;RANBP2;NUP153;IFIH1;SENP5;EP300;P3H3;HDAC10;ETFBKMT;LOXL4;NUP214;NUP188;KAT2B;LIPT2;LOX;NUP88;PIAS1;NDUFAB1;SENP1;NUP98;SENP3;EEF1AKMT1;AAAS;NUP54;METTL21A;KAT5;METTL21C;ESCO1;RAE1;SENP7;NUP155;SIRT3;SENP6
prerank,keratan sulfate catabolic process (GO:0042340),-0.5293069994517363,-1.242533261641978,0.18048780487804877,0.6315194334343397,1.0,7/11,17.49%,FMOD;OGN;LUM;OMD;HEXB;PRELP;GALNS
prerank,glycolipid biosynthetic process (GO:0009247),0.4966739632716697,1.2420945130627494,0.19831223628691982,0.844259857809735,1.0,11/38,19.17%,ST3GAL4;LARGE1;PGAP2;PIGB;A4GALT;DPM1;ST3GAL2;PIGU;ST6GALNAC5;PIGL;PIGN
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.5468611386046257,1.2414048547848082,0.23179791976225855,0.8441384547664881,1.0,5/21,9.80%,EYA2;EYA4;GDNF;EYA3;GATA1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5468611386046257,1.2414048547848082,0.23179791976225855,0.8441384547664881,1.0,5/21,9.80%,EYA2;EYA4;GDNF;EYA3;GATA1
prerank,bile acid and bile salt transport (GO:0015721),-0.4380356784336568,-1.240752769343366,0.15853658536585366,0.6344854652846399,1.0,3/24,1.57%,SLCO2B1;NCOA1;SLCO1C1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5839544740459525,1.2405921472096757,0.22128378378378377,0.8458711480184988,1.0,5/13,17.19%,LARGE1;CHST5;MGAT3;RENBP;OGA
prerank,nerve growth factor signaling pathway (GO:0038180),0.6279806835055721,1.2404811268821367,0.2596491228070175,0.8449546400279716,1.0,3/10,4.54%,NGF;RAP1A;KIDINS220
prerank,peroxisomal membrane transport (GO:0015919),0.5243746561903039,1.2401828724754012,0.2303206997084548,0.844739347804208,1.0,9/27,24.53%,ABCD3;PXMP2;ACBD5;PEX13;ABCD1;PEX2;SLC25A17;PEX7;PEX26
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.6346954973285539,1.240039938004197,0.2357142857142857,0.8439730813111896,1.0,4/10,9.94%,RARB;RXRA;RARG;RARA
prerank,sulfur compound biosynthetic process (GO:0044272),0.44039720005866945,1.2396197897240777,0.16686674669867949,0.8440900908646211,1.0,12/104,6.56%,SLC26A2;ST3GAL4;UST;DSE;GCLC;B3GNT2;CHST13;PAPSS2;GLCE;CHST5;SLC10A7;B4GALT1
prerank,sphingosine metabolic process (GO:0006670),0.5724566215751256,1.2395950330343495,0.24088748019017434,0.8428990323468337,1.0,2/17,2.20%,ACER3;PLPP3
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.550174435522528,1.2391582389787497,0.2119309262166405,0.8419155774574797,1.0,1/20,0.03%,SLC4A4
prerank,positive regulation of glycolytic process (GO:0045821),0.550174435522528,1.2391582389787497,0.2119309262166405,0.8419155774574797,1.0,1/20,0.03%,SLC4A4
prerank,ceramide biosynthetic process (GO:0046513),-0.40136765501969457,-1.2388658800976478,0.15985130111524162,0.6379279993635835,1.0,9/40,12.54%,ST6GALNAC3;CERS4;ST8SIA4;SGMS1;DEGS2;ST8SIA6;SPTSSA;CERS1;CERS2
prerank,peptidyl-proline modification (GO:0018208),0.5351855899041785,1.2387640054744182,0.22660818713450293,0.8420085402866468,1.0,3/25,6.47%,FKBP5;P3H2;NKTR
prerank,positive regulation of protein metabolic process (GO:0051247),0.4419747304599437,1.238753196062565,0.1595744680851064,0.8407625508299722,1.0,20/110,9.40%,WWP1;FZR1;NEDD4;GPC3;WWP2;KLF4;INHBA;GSK3B;AGTR1;EIF4G1;VCP;STX5;CD80;ISL1;CLU;IDE;ASB9;NSF;CDKN1B;DACT1
prerank,regulation of dopamine secretion (GO:0014059),-0.4416308536305334,-1.2379456804102322,0.16224188790560473,0.6385241647511773,1.0,15/25,23.96%,SYT7;SYT11;SYT12;SNCA;SYT1;SYT13;KCNA2;SYT10;SYT9;SYT6;SYT15;SYT2;SYT4;SYT5;SYT17
prerank,regulation of platelet activation (GO:0010543),-0.4574131950144285,-1.237933447210275,0.1967654986522911,0.6365581464662112,1.0,7/21,10.78%,LYN;APOE;NOS3;TEC;PRKCQ;PLEK;PDGFRA
prerank,substrate-dependent cell migration (GO:0006929),0.5908769738821267,1.237633234035159,0.24242424242424243,0.8434170934698375,1.0,4/14,11.29%,NTN1;NRP1;SHTN1;ITGB1BP1
prerank,negative regulation of interleukin-8 production (GO:0032717),0.5753766110507964,1.2371435782349234,0.23102866779089376,0.8438263425832516,1.0,5/17,11.23%,ANXA1;ANXA4;KLF4;IL10;OTUD7B
prerank,regulation of DNA metabolic process (GO:0051052),0.4863564140834534,1.236906334500085,0.20445062586926285,0.8434258031242634,1.0,17/44,22.16%,SMG6;HDAC8;KPNA1;PDGFA;GRHL2;USP1;SMG1;XRCC5;WDR18;YLPM1;NBN;TICRR;HELB;UBE2N;TOM1L1;WDR70;MPV17
prerank,positive regulation of protein export from nucleus (GO:0046827),0.5810455952126528,1.2354899665895098,0.22061191626409019,0.8472052547198834,1.0,4/15,13.34%,TCF7L2;GSK3B;EMD;BAG3
prerank,relaxation of cardiac muscle (GO:0055119),0.5854745418409119,1.2354785684537182,0.2540983606557377,0.8459654315871863,1.0,4/13,2.48%,KCNJ2;ATP1B1;CAMK2D;GSN
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5928685087985713,1.235440709246589,0.23958333333333334,0.8448201106837383,1.0,2/12,2.74%,FUT8;GMDS
prerank,positive regulation of actin filament polymerization (GO:0030838),0.48681528365008486,1.235116776850523,0.19919786096256684,0.8446171879453446,1.0,10/44,13.20%,BAIAP2L1;CDC42EP5;PTK2B;GSN;PRKCE;NCK2;CTTN;NCKAP1;FCHSD2;FCHSD1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.4831572738062547,-1.2348877060103471,0.19525065963060687,0.6432570776488309,1.0,7/16,16.35%,APOE;HIF1A;NUS1;SCARB1;NOS1AP;AKT1;GCH1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.48551599127700057,1.2345590215567284,0.20540540540540542,0.8452895469993961,1.0,12/49,13.97%,THBS1;NR4A3;RAB7B;KMT2C;MOV10;TNRC6C;GATA1;CBFB;EIF6;KMT2D;PRMT6;EP300
prerank,actin filament bundle assembly (GO:0051017),0.5113418533851926,1.2344723767432657,0.23248882265275708,0.8443188739720794,1.0,8/33,6.57%,DPYSL3;BAIAP2L1;EZR;PAWR;CALD1;FAM107A;PLS1;DMTN
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.45221823857205073,1.233955134163137,0.19254658385093168,0.8447326465962471,1.0,15/73,15.16%,THBS1;LBP;CD2;ISL1;STAT3;MAVS;CLU;TLR4;IL33;PLCG2;CCL3;IFIH1;TLR1;DHX9;TWIST1
prerank,sodium ion export across plasma membrane (GO:0036376),0.6015410518137004,1.2338206695760596,0.2495755517826825,0.8439505226070869,1.0,6/13,8.95%,SLC4A4;ATP1B1;SLC9A1;ATP1A4;ATP1A3;ATP1A1
prerank,T cell proliferation (GO:0042098),-0.5111430525753446,-1.2337076749059948,0.20393120393120392,0.6446078015229671,1.0,5/13,18.72%,CADM1;CTPS1;PPP3CB;DOCK8;PIK3CG
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.5779143374882634,1.233414425814734,0.2598684210526316,0.8440692036531484,1.0,2/14,5.03%,CD55;TGFBR2
prerank,negative regulation of protein modification process (GO:0031400),0.4460292437990562,1.2333710914666622,0.2071156289707751,0.8429659221295644,1.0,13/79,8.29%,SLIT2;NTRK3;LRP6;PID1;PLPP3;NIBAN1;GSK3B;ATP2B4;DMD;SNTA1;KLHL31;P3H1;IBTK
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.559254732047642,1.2324560571134666,0.24405705229793978,0.8448180819758095,1.0,4/18,6.07%,ABL1;RFK;AGTR1;GDNF
prerank,regulation of cellular response to stress (GO:0080135),0.43275219602507825,1.2322500232709799,0.1536643026004728,0.8442712796642974,1.0,28/115,18.23%,SLC38A2;CAMK2D;GSK3B;ABL1;NUP93;EIF4G1;CREBBP;HSPA1L;ATM;MLST8;RANBP2;HSPB8;NUP153;CHORDC1;SEC13;SMG1;MTOR;BAG3;EP300;MAPKAPK2;NUP214;NEK6;NUP188;RPA1;AIFM2;ATR;ABCD1;NUP88
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.553827588016893,1.2320553176267013,0.2378716744913928,0.8436684563315917,1.0,5/17,4.92%,KCNJ2;ANK2;CACNA1C;CACNA1G;TRPM4
prerank,protein localization to microtubule organizing center (GO:1905508),0.5852018659686087,1.2318391441762815,0.23679727427597955,0.8431643143330759,1.0,11/15,30.94%,PCM1;CEP131;PIBF1;STIL;HOOK3;C2CD3;CSNK1D;CCDC14;CEP192;BBS4;CEP83
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5903856320075201,1.2318310693772643,0.25333333333333335,0.8407170397544117,1.0,6/12,14.19%,GSK3B;ATP2B4;HOMER2;CHP1;RCAN1;DYRK2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5903856320075201,1.2318310693772643,0.25333333333333335,0.8407170397544117,1.0,6/12,14.19%,GSK3B;ATP2B4;HOMER2;CHP1;RCAN1;DYRK2
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5229717206381261,1.2318118951222128,0.23964497041420119,0.8395439907191196,1.0,8/33,8.91%,THBS1;MEOX2;KLF4;FGF2;ATP2B4;JUP;RHOA;STARD13
prerank,amino acid import across plasma membrane (GO:0089718),0.5355230107942196,1.2316179672831158,0.2089783281733746,0.8390201972243626,1.0,1/24,0.02%,SLC47A1
prerank,respiratory electron transport chain (GO:0022904),-0.5120266676004414,-1.2313137482563505,0.21761658031088082,0.6496089872765628,1.0,3/14,6.03%,GPD2;SDHA;PPARGC1A
prerank,gliogenesis (GO:0042063),0.591869896303981,1.2309482156775169,0.22719734660033167,0.840026736794896,1.0,3/15,2.65%,NFIB;ANXA1;CD9
prerank,negative regulation of protein metabolic process (GO:0051248),0.48072555168341163,1.2306242368161495,0.21912350597609562,0.8399135558357108,1.0,13/48,15.31%,EGFR;LDLR;ITGAV;CLU;MDM4;NFKB1;IRAK3;INHBB;ITGB3;SNX12;AZIN1;MAD2L1;HMGCR
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.4888792512238436,-1.2305731658195345,0.21158690176322417,0.6497741317483058,1.0,4/16,6.18%,CXCL12;BCL2L1;TPT1;RPS3
prerank,negative regulation of cell projection organization (GO:0031345),-0.3786769757756371,-1.2304060056298167,0.14173228346456693,0.6483224227945701,1.0,17/48,16.77%,EFNB2;APOE;RAPGEF2;DCC;LPAR1;SPOCK1;GRIN2B;EPHA4;DENND5A;MAG;CRMP1;PTPRO;RTN4RL1;TRPV4;FKBP4;MYLIP;STMN2
prerank,protein localization to chromatin (GO:0071168),0.5707313588328005,1.230274369546838,0.22838499184339314,0.8399281090052266,1.0,8/18,19.05%,ESR1;SGF29;NIPBL;WAPL;MRNIP;MCM9;LEMD2;TASOR
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.5084057201265133,-1.229398721235664,0.20430107526881722,0.6492263343462328,1.0,3/14,11.07%,MOXD1;SLC22A2;ALDH9A1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.40079665569328343,-1.2293300545792956,0.1715210355987055,0.6474225964012664,1.0,10/36,13.49%,WNT5A;CSF1;PARP14;CASP4;HIF1A;GAS6;EDN1;NLRC5;AXL;CD74
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.4942246563776404,1.229078568096781,0.20133333333333334,0.8429360540157398,1.0,8/39,7.72%,CDH1;FXYD5;WNK1;KLF4;BMP6;JAG1;IL10;RDX
prerank,regulation of ruffle assembly (GO:1900027),-0.4430295005192261,-1.2290410993486236,0.19692307692307692,0.646205882788991,1.0,5/23,9.85%,EPS8;ARHGAP24;EVL;EPS8L2;ABI3
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.4760506786158029,1.228879254873348,0.18469656992084432,0.8424141308157062,1.0,4/50,3.02%,THBS1;NGF;CD44;KLF4
prerank,protein localization to plasma membrane (GO:0072659),0.4302564335512563,1.227590369302746,0.1775486827033219,0.8455739528629,1.0,27/129,10.50%,KCNB2;CDH1;RAMP1;LRP6;ANK2;ATP1B1;EZR;SLMAP;NECTIN3;KCNB1;FGF13;TTC7A;MRAP;RAP1A;GAK;PIP5K1A;EHD3;DLG1;JUP;RDX;RAPGEF6;SEC16A;S100A10;FCHO2;C2CD5;EHD1;EHD2
prerank,extracellular matrix assembly (GO:0085029),-0.4381499122826172,-1.2274106041851967,0.20241691842900303,0.648906944009159,1.0,9/23,9.74%,FBLN5;MYH11;LAMB1;GPM6B;MFAP4;QSOX1;GAS6;RAMP2;EFEMP2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.42037805767906894,1.2272111645947155,0.1610738255033557,0.8456681780956993,1.0,33/152,13.35%,RSPO3;EGFR;WNK1;GPC3;SULF1;PLEKHA4;TMEM198;VCP;TRPM4;SFRP4;UBE2B;UBR5;SKI;TBL1X;BAMBI;PSMB2;RSPO4;JUP;USP34;CSNK1G3;DISC1;NFKB1;DACT1;TNKS2;PSMC6;PRDM15;USP47;RNF146;SMARCA4;ZRANB1;PSMD11;CSNK1G1;PPM1A
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4915502913152602,1.2271157804605177,0.2011251758087201,0.844785944482966,1.0,7/40,3.75%,BMP4;CCN1;TGFB3;ANO6;BMP6;BMPR1A;NELL1
prerank,synaptic membrane adhesion (GO:0099560),0.5853495000447946,1.2260043378673742,0.25774877650897227,0.8471991132404897,1.0,3/14,8.16%,GPC6;PTPRF;GPC4
prerank,L-amino acid transport (GO:0015807),0.5178168125313377,1.2251971366409853,0.22388059701492538,0.8486349330664442,1.0,1/28,0.05%,SLC38A2
prerank,positive regulation of calcium ion transport (GO:0051928),-0.38457888812111457,-1.225088026797332,0.15483870967741936,0.6535844828226802,1.0,10/36,10.92%,MYLK;PDGFRB;CACNA1D;TRPC3;CXCL12;ATP2B1;GRIN1;TRPC6;CAMK2A;P2RX7
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5425173857456269,1.2250550659746307,0.25538971807628524,0.8479137439764423,1.0,6/20,8.14%,SLIT2;IGFBP5;BMPR1A;NRP1;LRP1;PDGFA
prerank,recombinational repair (GO:0000725),0.4525901173189689,1.2243034497140552,0.193390452876377,0.8492201426155683,1.0,29/77,21.89%,REV3L;RNF138;ERCC5;WRN;SMC5;BRCA2;RAD52;NABP1;SPIDR;SLX4;KDM4D;MCM9;RBBP8;YY1;NSMCE1;RPA1;RECQL5;INO80;NBN;RAD51;PSMD14;SWSAP1;EXD2;UBE2N;RAD51B;RAD51C;SMC6;ZFYVE26;RAD50
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5195247942662652,1.2240162622503339,0.2314540059347181,0.8489744399628046,1.0,4/27,5.55%,ANK2;CAMK2D;AHNAK;DMD
prerank,positive regulation of programmed cell death (GO:0043068),0.40513356174448567,1.2236836237094764,0.12225705329153605,0.848919757576538,1.0,38/272,11.79%,SLIT2;BMP4;RASSF2;MAP3K5;CYP1B1;HOXA5;NGF;TGFB3;AKAP13;PAWR;FOXO3;VAV2;ANO6;ITGB1;CRADD;UNC13B;ABL1;IP6K2;TIAM2;SFRP4;TRIO;GADD45G;CLU;CALHM2;ARHGEF6;NF1;BCLAF1;ATM;GNA13;RARG;JUN;DIABLO;ATF6;HTATIP2;UBE2Z;ARHGEF5;TIAM1;ARL6IP5
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5524800303022275,1.2236445379986902,0.2536115569823435,0.8478369161566475,1.0,2/17,2.35%,PCSK5;HDAC9
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6002609765918689,1.2235307295932356,0.2637931034482759,0.8469895986277731,1.0,2/11,7.72%,EZR;RDX
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.4460649523904657,1.2234454036837719,0.2,0.8460594873865738,1.0,29/80,23.65%,PLPP3;ERGIC1;RAB6A;ERGIC2;GOLPH3;GBF1;ARF3;KIF1C;NSF;KLC1;COPA;ARF4;ARCN1;COG3;ATP9B;COPG1;ARFGAP3;ARFGAP1;SEC22B;KIF3B;BNIP1;ZW10;RAB1A;PITPNB;NBAS;TMED3;SURF4;KIF2C;ATP9A
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.4611856302971916,-1.2232634408998184,0.24574209245742093,0.656809506983699,1.0,7/18,16.87%,MSRA;ASPA;ASPG;ASS1;SMS;ASNS;GOT2
prerank,amino acid transport (GO:0006865),0.4797704526601653,1.222960175338299,0.2234185733512786,0.8465065532366846,1.0,5/49,7.17%,SLC38A2;SLC38A1;SLC38A6;SLC7A2;SLC6A19
prerank,negative regulation of neuron projection development (GO:0010977),-0.36290588368050475,-1.2228974615292332,0.1572052401746725,0.6558219409840508,1.0,23/56,19.01%,EFNB2;APOE;DCC;LPAR1;SPOCK1;EPHA4;ARHGDIA;DENND5A;MAG;CRMP1;RTN4;LINGO1;PTPRO;EFNB3;NGEF;RTN4RL1;TRPV4;FKBP4;MYLIP;STMN2;BCL11A;OMG;MT3
prerank,regulation of dendritic spine development (GO:0060998),-0.4511258910098448,-1.2217111142548214,0.20680628272251309,0.6571823516607834,1.0,7/19,13.71%,SHANK3;APOE;PPFIA2;MEF2C;CAMK2B;KIF1A;GRIN3A
prerank,regulation of endothelial cell proliferation (GO:0001936),0.44784536988328816,1.2215837841810888,0.18899521531100477,0.8500549496457287,1.0,9/88,4.08%,F3;THBS1;BMP4;PGF;SULF1;NRAS;FGF2;NRP1;TGFBR1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.4273499059913124,-1.2206804514893856,0.18404907975460122,0.6581214270512804,1.0,4/23,8.34%,ERRFI1;CBLB;SOCS5;ZFYVE28
prerank,negative regulation of cellular process (GO:0048523),0.3941905623891466,1.220380806256964,0.059475806451612906,0.8529847703551177,1.0,57/521,7.30%,SLIT3;SLIT2;ZBTB7C;BMP4;CCN3;FHL1;NDRG3;WNT9A;OSGIN2;TES;BMP5;CYP1B1;NGF;CCN5;CCN1;PTK2B;TGFB3;ABI1;PTPRU;WNT11;ARHGDIB;SMAD6;VPS13C;CD9;ESR2;KLF4;INHBA;FGF2;LRPAP1;SRGAP2;LMNA;STRN;IP6K2;PDCD4;PTPN2;P3H2;NCK2;KLF10;SFRP4;SMYD2;BECN1;CLMN;FRK;WNT16;SKI;PTHLH;TGFB1I1;CLU;PLSCR1;IRF1;SRSF6;CELF1;AGR2;SLURP1;IFI35;MYOG;IL10
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5505522046297949,1.2201928618696982,0.24324324324324326,0.8524195451496928,1.0,7/19,9.65%,CLIC4;DLG2;DLG1;MARK2;PATJ;ERBIN;PARD3
prerank,regulation of protein kinase B signaling (GO:0051896),0.41169370217716955,1.220014031631108,0.12012987012987013,0.8518165326737543,1.0,21/193,6.42%,F3;EGFR;THBS1;TCF7L2;MET;TNFAIP8L3;NTRK3;FGFR1;ITGB1;GAB2;FGF2;PIK3AP1;IRS1;PHLPP2;STRN;TGFBR1;GCNT2;CD80;ESR1;GATA4;DDIT3
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5072749410931833,1.2198466024071968,0.23242467718794835,0.8512574628386662,1.0,7/34,10.85%,DOCK5;ABL1;NRP1;DMTN;S100A10;LIMS1;LIMS2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5085516236188625,1.219675518308033,0.24123422159887797,0.8506592402810392,1.0,7/32,6.57%,THBS1;SEMA3E;PHLDB2;FAM107A;BCAS3;JAG1;DMTN
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.4763546371277435,1.2196303418092795,0.20080321285140562,0.8495906346786348,1.0,14/52,12.92%,EGFR;SORBS1;ITGB1;PRKCE;ACSL3;ATP2B4;LRP1;PLS1;DLG1;AGR2;CNST;RANGRF;PTPN9;ZDHHC2
prerank,fat cell differentiation (GO:0045444),0.46586365003644264,1.219525825499728,0.20725388601036268,0.8487208442460019,1.0,14/57,13.97%,TCF7L2;BBS9;PID1;SMAD6;TMEM120A;KLF4;NR4A3;NR4A2;GDF6;EGR2;INHBB;ERAP1;NR4A1;EP300
prerank,negative regulation of phagocytosis (GO:0050765),-0.4693576610008899,-1.2194584731601876,0.18559556786703602,0.6595609060241645,1.0,8/17,21.48%,DYSF;CD47;SIRPA;SYT11;CD300A;RACK1;SNX3;PRTN3
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.41472979214669436,1.2193192223830616,0.1291390728476821,0.8482112572653027,1.0,29/166,13.21%,SMOC2;EGFR;THBS1;SAMD4A;NIBAN1;KLF4;GIPC1;SORBS1;FGF2;IRS1;PTPN2;LDLR;CLU;GLI2;TLR4;BCAR3;NNMT;LARP4B;STN1;P2RX4;STARD4;CNEP1R1;ERBB2;ELOVL5;EIF3E;CHP1;EIF6;PRKDC;MTOR
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.42556812091112367,1.2192409441895407,0.16477272727272727,0.8472850860193216,1.0,18/140,9.10%,PLCE1;EDNRA;PTGDR;CD55;ADRA1B;CACNA1C;GPR4;ABL1;CMKLR1;AGTR1;PLCZ1;TRPM4;PTGER1;ESR1;LPAR4;P2RX2;P2RX4;DRD3
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5904497419513927,1.2189848929844083,0.25963149078726966,0.847008589605867,1.0,1/15,0.24%,EGFR
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.5109045153824194,1.2186431249851302,0.22734026745913818,0.8469578747734233,1.0,13/30,21.97%,ABLIM3;NPEPPS;HPS4;SAE1;UBE2D3;HSPA1L;ARIH2;SH3GLB1;BAP1;CSNK2A2;RNF31;USP36;HUWE1
prerank,polyamine metabolic process (GO:0006595),0.5796766649903529,1.2186403644374404,0.25779967159277506,0.8457809435732023,1.0,6/13,25.04%,SMOX;SRM;HDAC10;SAT1;ODC1;OAZ2
prerank,apoptotic cell clearance (GO:0043277),0.5019291628449671,1.2183641300005277,0.23929098966026588,0.8455796148040404,1.0,7/30,10.80%,THBS1;ANXA1;RHOBTB1;LRP1;ITGAV;RARA;ITGB3
prerank,proteolysis (GO:0006508),0.40280968188506083,1.2182303871742068,0.12260127931769722,0.8448215427512522,1.0,48/252,14.45%,F3;TRABD2B;CAPN5;HTRA3;PCSK5;BMP1;NPEPPS;CPQ;CAPN2;HTRA1;DDI2;CASP6;PHEX;HTRA4;MMP16;SPPL2A;XPNPEP1;TBL1X;TASP1;IDE;XPNPEP3;CPA5;CNDP1;ASPRV1;MMP14;NLN;CAPN6;CPA4;CPA3;BACE2;USP25;FBXL6;CAPN10;PGPEP1;LONP2;DESI2;DESI1;ADAMTS3;CAPN12;ERAP1;OLR1;YME1L1;TMPRSS2;LAP3;CLPP;PITRM1;ECE1;PCSK7
prerank,regulation of chondrocyte differentiation (GO:0032330),0.5327833181134238,1.2181865760420785,0.23467862481315396,0.8438317767842421,1.0,8/24,7.37%,WNT9A;SOX9;ZBTB16;TGFBR1;EFEMP1;PTHLH;GDF6;GDF5
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.43344708584636704,-1.2180817613081694,0.18541033434650456,0.6616893089738783,1.0,7/24,10.75%,TEK;KDR;NDNF;GATA2;GAS6;RAMP2;TNIP2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.4200966031512027,1.217933331294499,0.16987542468856173,0.843538020727465,1.0,27/140,9.63%,SLIT2;PLCE1;ARHGAP20;RHOJ;ARHGAP21;ARHGAP10;ARAP1;AKAP13;ARHGDIB;VAV2;ARHGAP44;ARHGAP31;BCR;SRGAP2;SRGAP3;TIAM2;ARAP2;TRIO;ITGAV;RHOQ;ARHGEF6;OCRL;ARHGAP17;RHOA;STARD13;ARHGAP5;GNA13
prerank,negative regulation of locomotion (GO:0040013),-0.524894337028592,-1.2175844942034544,0.24688279301745636,0.6611526899599935,1.0,3/12,3.30%,FRMD5;SPOCK3;FBLN1
prerank,non-motile cilium assembly (GO:1905515),0.5018399180712263,1.2174420972462963,0.2434017595307918,0.8440260661654703,1.0,20/30,33.16%,PCM1;ARL13A;TOGARAM1;DISC1;RPGRIP1;PIBF1;CEP89;C2CD3;CSNK1D;GORAB;FUZ;IFT88;TMEM80;CEP290;BBS4;RPGRIP1L;DCTN1;IFT122;TMEM17;TMEM107
prerank,response to lipid (GO:0033993),0.42637368096839884,1.2171959935779864,0.19696969696969696,0.8436457214554363,1.0,19/105,9.94%,FOXP1;SOX9;LBP;ANXA1;SMAD6;FOXO3;ALPL;STAT3;ESR1;SLPI;SOCS2;TLR4;STRN3;RXRA;SCD;IRAK3;ERBIN;RARG;RARA
prerank,vesicle transport along microtubule (GO:0047496),0.5335265844503206,1.216939528258994,0.25,0.8433391753104215,1.0,6/23,9.35%,KIF13A;NDEL1;PAFAH1B1;KIF1C;FBXW11;DYNC1I1
prerank,fatty acid transport (GO:0015908),-0.48376906945992626,-1.2167772216971176,0.19321148825065274,0.6614660580939103,1.0,7/17,17.95%,ACSL1;APOE;PPARD;MFSD2A;FABP5;GOT2;SLC27A1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.5324847747607673,1.2161855046577301,0.23148148148148148,0.8447499511681076,1.0,8/23,13.10%,GLI3;GPC3;HHIP;VCP;GLIS2;KIF7;MEGF8;HERC4
prerank,central nervous system neuron differentiation (GO:0021953),-0.40640640971609615,-1.2159294898246982,0.19594594594594594,0.6619005436533144,1.0,11/33,9.42%,MAP2;GRID2;SPOCK1;TOX;MDGA2;OPHN1;NTRK2;ZC4H2;MAPT;PROX1;FAIM2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.4277370088830865,-1.2157792862915062,0.175,0.6604226425711575,1.0,9/25,15.26%,GRID2;GRIN2A;GRIN2B;MEF2C;GRIN1;GLRA1;GSK3A;ARRB2;AKT1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.527458170792456,-1.215704831803274,0.2397094430992736,0.658719766716883,1.0,5/14,9.88%,NOS3;ACE;ENPEP;EDN1;ACE2
prerank,camera-type eye development (GO:0043010),0.5288261386286861,1.2154455521658991,0.2610619469026549,0.8459832956348987,1.0,9/25,10.37%,CYP1B1;CACNA1C;STRA6;EFEMP1;TSKU;SKI;PITX2;NF1;VEGFA
prerank,protein localization to cell periphery (GO:1990778),0.4251384810085797,1.215026082235667,0.18088737201365188,0.846207502710136,1.0,28/133,10.50%,KCNB2;CDH1;RAMP1;LRP6;ANK2;ATP1B1;EZR;SLMAP;KCNB1;FGF13;TTC7A;MRAP;RAP1A;GAK;PIP5K1A;ARL3;EHD3;DLG1;JUP;RDX;RAPGEF6;SEC16A;RABEP1;S100A10;FCHO2;C2CD5;EHD1;EHD2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.5466788613412285,1.2145260203726607,0.25617283950617287,0.8466949518831424,1.0,4/20,12.26%,PLOD2;GCLC;PLSCR1;FPGS
prerank,DNA repair (GO:0006281),0.3985816291632251,1.214477572152603,0.12852664576802508,0.8456822525630322,1.0,111/284,26.56%,MPG;ABL1;FTO;APEX2;HERC2;VCP;UBE2B;MNAT1;SMUG1;SETD2;EXO1;EYA3;TRRAP;CHEK2;CHD1L;ERCC5;RAD17;WRN;APLF;ATM;COMMD1;RAD23B;SLC30A9;USP1;APEX1;IGHMBP2;SMC1A;USP47;BRCA2;RAD52;NABP1;MTA1;PPP5C;UIMC1;SLX4;RNF168;PRKDC;CHEK1;XRCC5;PRMT6;CSNK1E;MLH3;ERCC8;BAP1;POLB;EID3;FANCL;RNASEH2A;POLE2;HINFP;ZBTB1;RBBP8;VCPIP1;ERCC3;XPA;NSMCE1;PARP3;RPA1;RECQL5;TNKS1BP1;ATR;BARD1;RMI2;SMARCAL1;INO80;NBN;TICRR;RAD51;FANCM;ERCC1;NEIL3;SMARCA5;TOPBP1;WDR48;RNF8;PARP4;EXD2;ASCC1;UBE2N;MAPK8;RAD51B;KMT5B;POLA1;ALKBH5;DDX1;TDG;FAAP24;RAD51C;POLD3;NUDT1;RAD50;HUWE1;RAD9B;MBD4;PARP2;USP3;BRCC3;PWWP3A;RFC5;ERCC2;MDC1;UBE2V1;ASCC2;BRIP1;KAT5;POLK;POLQ;FAM111A;TDP2;XPC;RAD51AP1
prerank,mitochondrion morphogenesis (GO:0070584),0.6135563288500289,1.2143297529973218,0.28596491228070176,0.8449948805291904,1.0,1/11,1.83%,PID1
prerank,sensory organ development (GO:0007423),0.4705303836150281,1.214265800580464,0.2248995983935743,0.8441031247364892,1.0,11/51,14.30%,PBX3;PBX1;SMOC1;HIPK1;STRA6;SIX4;FOXC1;SCO2;ATF6;PAX6;ECE1
prerank,sphingosine biosynthetic process (GO:0046512),0.5893297831638313,1.2138026542125218,0.2533112582781457,0.8433864167772371,1.0,1/11,0.61%,ACER3
prerank,sphingoid biosynthetic process (GO:0046520),0.5893297831638313,1.2138026542125218,0.2533112582781457,0.8433864167772371,1.0,1/11,0.61%,ACER3
prerank,cell-matrix adhesion (GO:0007160),0.43162140212014555,1.2130642296110707,0.18427230046948356,0.8447263641005336,1.0,16/95,6.01%,MSLN;ITGBL1;PKD1;ITGB8;ADAM9;FN1;CD44;COL3A1;SORBS1;ITGB1;BCR;ITGB5;ITGA10;VCL;ITGAV;PIP5K1A
prerank,endochondral bone morphogenesis (GO:0060350),0.5997689038273463,1.2117583753241652,0.29292929292929293,0.8478752201555008,1.0,1/11,0.28%,BMP4
prerank,fatty acid elongation (GO:0030497),-0.49736616934556344,-1.2116747101965761,0.22448979591836735,0.6681183832726965,1.0,6/13,17.91%,ELOVL7;ELOVL6;HACD3;ELOVL4;HACD2;HACD1
prerank,regulation of protein transport (GO:0051223),0.5181292979197977,1.21151997135026,0.25181950509461426,0.8475623127551694,1.0,9/27,14.59%,DISP1;WWP2;NDEL1;P3H1;DNAJC1;GAPVD1;SNX12;CHP1;ARFIP1
prerank,central nervous system development (GO:0007417),0.40218920773927713,1.2113147322367266,0.12343096234309624,0.847065287077149,1.0,30/250,9.42%,SLC23A1;WWP1;PBX3;DCLK1;VIT;ZFHX3;NFIB;PKD1;SOX9;ZIC4;ADGRL2;PDGFC;SMO;PBX1;ZBTB16;GSN;ZIC1;ECRG4;NR4A2;TGFBR2;GLIS2;STAT3;ELP3;DMBX1;SNTG2;SHROOM4;PAFAH1B2;GRHL2;EGR2;NF1
prerank,negative regulation of ion transport (GO:0043271),0.5279774020034605,1.2111036872258942,0.23802395209580837,0.8466045925912884,1.0,3/24,1.93%,NEDD4;PTK2B;WNK1
prerank,skeletal muscle tissue development (GO:0007519),0.5041229031422281,1.2110917938393613,0.24162011173184358,0.8455078958703812,1.0,6/32,9.00%,SIX1;CSRP3;SKI;MYOG;SIX4;EGR2
prerank,cell projection assembly (GO:0030031),0.5482959707894941,1.2104113512652233,0.2917981072555205,0.8465759282077034,1.0,6/22,10.47%,RHOJ;PARVA;GSN;RHOQ;PDGFA;NCKAP1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4228176634699531,1.2103570700382738,0.18828932261768083,0.8456118446966325,1.0,23/114,19.21%,TNFRSF11B;CARD14;EDA;PTK2B;FOXO3;PSMB2;CHUK;TNFRSF13B;LIMS1;PSMC6;CDIP1;TNFSF11;TRAF5;TNFRSF1B;PSMD11;TRADD;PSMD1;BIRC3;PSMD7;PSMC1;TNFRSF4;PSMD14;TRAF3
prerank,ether lipid metabolic process (GO:0046485),0.5916704761734015,1.210070142516756,0.2707993474714519,0.8454116885021111,1.0,5/14,10.36%,NCEH1;PAFAH1B1;AGPS;PEDS1;GNPAT
prerank,regulation of transport (GO:0051049),-0.3954009324866375,-1.2100354489987226,0.17482517482517482,0.6707403425576061,1.0,6/36,7.45%,LEPR;EPB41;ICA1;ACTB;MYO6;SNCA
prerank,synaptic vesicle cycle (GO:0099504),-0.40426734992403224,-1.2099876881141216,0.18095238095238095,0.6689200392395932,1.0,16/30,26.74%,RIMS1;SYT7;SNAP25;SNCA;PIP5K1C;SYT10;RAB3A;PLD2;SLC32A1;CPLX1;SYNDIG1;OTOF;WNT7A;SNAPIN;SLC17A8;SLC18A2
prerank,mitochondrion disassembly (GO:0061726),0.49466303587569666,1.2099241039506687,0.240981240981241,0.844771456130394,1.0,16/34,26.50%,ULK2;WIPI2;BECN1;ATG3;MARK2;RB1CC1;CISD2;SQSTM1;AMBRA1;ATG2A;WDR45B;ULK1;BNIP3;ATG7;USP30;ATG5
prerank,positive regulation of protein binding (GO:0032092),0.4603169451356294,1.2098743215293781,0.2103861517976032,0.843812297334205,1.0,14/56,12.50%,BMP4;TCF7L2;PKD1;GSK3B;ABL1;LRP1;BAMBI;RIPK2;IDE;DACT1;MARK3;TIAM1;USP33;ADD1
prerank,monocarboxylic acid transport (GO:0015718),0.4671154863489871,1.209668749696752,0.23107569721115537,0.8433644566139269,1.0,10/51,8.67%,SLCO3A1;SLC5A6;SLC16A9;SLCO2A1;SLC16A1;ABCG2;SLC26A6;SLC10A2;ATP8B1;RXRA
prerank,regulation of vasoconstriction (GO:0019229),0.523613001657184,1.2095985621805183,0.24622356495468278,0.8424609767754141,1.0,4/27,4.92%,KCNMB2;ADRA1B;AGTR1;TRPM4
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.5690854870799676,1.209403751218438,0.25375626043405675,0.8420092315414918,1.0,3/15,3.58%,EGFR;PTK2B;ABL1
prerank,regulation of tissue remodeling (GO:0034103),-0.47868838546048326,-1.2093135210851083,0.23575129533678757,0.6689307406365167,1.0,6/18,12.00%,LEPR;CST3;SYT7;IL18;FLT4;MDK
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.4743810342022863,1.2090486206367619,0.23677248677248677,0.8420571129532901,1.0,10/47,11.89%,DOCK5;EFNA5;ABL1;NRP1;DMTN;S100A10;LIMS1;LIMS2;ITGB1BP1;CORO1C
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.5868390735246131,1.2088531340253486,0.2724358974358974,0.8416140072760852,1.0,5/13,11.60%,SORBS1;IRS1;ZBTB7B;C1QTNF12;ERFE
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.5041680077261415,1.2086810686704075,0.24118476727785615,0.8410550399436775,1.0,9/35,5.01%,NTRK3;BAIAP2L1;PTK2B;SEMA3E;ARHGDIB;NOTCH2;ABL1;NRP1;BCAS3
prerank,macrophage differentiation (GO:0030225),0.5892609106019906,1.2083724467238257,0.282793867120954,0.8408688506592185,1.0,1/13,0.28%,BMP4
prerank,negative regulation of mRNA processing (GO:0050686),0.5605342945589289,1.2081012152126156,0.2763578274760383,0.8406460769873053,1.0,7/15,20.62%,SRSF6;PCBP4;RBMX;U2AF2;BARD1;SFSWAP;SRSF12
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.3477797206626435,-1.207896465534398,0.136986301369863,0.671045769434531,1.0,11/66,5.70%,ROBO1;MCC;PTPRM;MTSS1;NR2F2;TGFBR3;APOE;B2M;CDK6;DAB2IP;AQP11
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.5355556789904194,-1.2077833021565456,0.2535211267605634,0.6694218166709212,1.0,2/10,1.27%,ST6GAL1;ST3GAL1
prerank,protein methylation (GO:0006479),0.47879375433645865,1.2072966610110607,0.2313937753721245,0.8420175706636847,1.0,19/40,27.59%,RAB6A;EHMT1;PRMT8;ETF1;CTCFL;GSPT1;PCMT1;PRMT6;METTL22;ETFBKMT;NSD1;CARM1;EHMT2;PRMT5;EEF1AKMT1;METTL21A;PRMT2;METTL21C;FAM98A
prerank,calcium ion import across plasma membrane (GO:0098703),-0.4947940983181033,-1.207075132680645,0.24860335195530725,0.669454946292958,1.0,5/14,14.22%,SLC24A2;SLC8A1;CACNA2D1;TRPV2;TRPV4
prerank,morphogenesis of an epithelium (GO:0002009),0.5183964931071416,1.2070584728880998,0.24776119402985075,0.8416199157126912,1.0,4/25,8.24%,SOX9;LRP6;VCL;RIPK4
prerank,regulation of cytoskeleton organization (GO:0051493),0.4250520627805504,1.2062532533645893,0.2037037037037037,0.8432915193500848,1.0,24/108,9.67%,CLIC4;SORBS3;EZR;EFNA5;PRKCD;PHLDB2;ARHGAP44;CAPN2;GSK3B;RHOBTB1;ABL1;DIAPH1;FAM107A;LRP1;RHOQ;DMTN;MARK2;ARHGAP17;PDGFA;CAPN6;RND3;RHOA;IQGAP1;MLST8
prerank,cognition (GO:0050890),0.4859184140082886,1.2059659335811619,0.23045267489711935,0.8431309241949674,1.0,10/42,13.34%,ST3GAL4;SOBP;FAM107A;STRA6;MGAT3;DOP1B;SHROOM4;NF1;NIPBL;SETD5
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.4199459849394398,-1.2058228558080164,0.2006269592476489,0.6710858300874396,1.0,6/28,14.83%,SH3KBP1;CD47;PRKCQ;SIRPA;TNIP2;TYROBP
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.5239561036790286,1.2058042278847214,0.23932926829268292,0.8425696648089991,1.0,4/23,8.90%,SLC4A4;PFKFB2;PFKFB1;NFKB1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.5957975399977814,1.2056025047018808,0.2657580919931857,0.8420711964283029,1.0,5/11,23.97%,RNF185;VCP;UFD1;UGGT2;POMT2
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.4428413186482766,1.2055551756523437,0.21099744245524296,0.8410978133945781,1.0,10/76,5.01%,NTRK3;BAIAP2L1;CDC42EP5;SORBS3;PTK2B;PRKCE;ABL1;NRP1;NCK2;BCAS3
prerank,T cell differentiation (GO:0030217),-0.3821386181183356,-1.2054020469744504,0.16845878136200718,0.670312041030617,1.0,8/40,9.03%,LEPR;CHD7;SOX13;KIT;RHOH;JAG2;TCF7;LFNG
prerank,regulation of phosphorylation (GO:0042325),0.4186102033423625,1.2049157418359417,0.1902552204176334,0.842056575222002,1.0,27/120,18.23%,EGFR;THBS1;BMP4;FN1;INHBA;FZD7;NRP1;NUP93;MCM7;CDKN1B;RAD17;RANBP2;CORO1C;NUP153;EIF6;SEC13;EP300;KDM4D;NUP214;PML;ZBTB7A;NUP188;EGF;BARD1;BCL10;CDKN1A;NUP88
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.41698475053288997,1.2044788644667246,0.17792792792792791,0.8423749916477673,1.0,16/151,6.37%,BMPER;EGFR;TNFAIP8L3;NTRK3;PDGFC;PTK2B;CD44;SHC1;FGF2;NOTCH2;NRP1;GAREM1;RAP1A;GCNT2;GATA4;ROR1
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.43232216862424455,-1.2042557660395763,0.1844380403458213,0.6716936856654574,1.0,8/23,12.85%,PDE4B;TGM2;GNG2;RYR2;SNCA;KCNQ1;APLP1;MAPK3
prerank,autophagy of peroxisome (GO:0030242),0.5931370899232483,1.203897624799808,0.27104377104377103,0.8431289773030409,1.0,5/12,17.50%,ACBD5;ATM;RB1CC1;SQSTM1;NBR1
prerank,ameboidal-type cell migration (GO:0001667),0.4677297263469136,1.203857982363846,0.23138297872340424,0.8421390080703459,1.0,9/51,6.07%,CCN3;FAT2;SEMA3E;GPC3;SEMA3D;SEMA3C;SRGAP2;PDXDC1;GDNF
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.5011018440421584,1.2037019312381034,0.23502994011976047,0.8415287678042148,1.0,5/30,5.95%,KCNJ2;ANK2;CACNA1C;CACNA1G;SNTA1
prerank,regulation of osteoblast proliferation (GO:0033688),0.5641993792725997,1.2033153451549254,0.27821939586645467,0.8416275124837158,1.0,7/17,18.81%,CCN1;NELL1;NPR3;RHOA;HPSE;PLXNB1;TMEM119
prerank,thyroid hormone generation (GO:0006590),0.6091590326810663,1.2032612870283002,0.2736660929432014,0.8407121396533332,1.0,3/10,9.89%,CPQ;IYD;FOXE1
prerank,regulation of angiogenesis (GO:0045765),0.406419003885561,1.2032080178270588,0.1457663451232583,0.8398099253934426,1.0,22/192,6.32%,SMOC2;BMPER;F3;THBS1;RHOJ;CYP1B1;HOXA5;ITGB8;PGF;SEMA3E;ANXA3;PTGIS;SULF1;KLF4;HIPK1;ITGB1;FGF2;ISM1;ADAM12;ATP2B4;ISL1;GATA4
prerank,negative regulation of protein secretion (GO:0050709),0.48121571604679136,1.20319763877602,0.24366197183098592,0.8387446617269206,1.0,9/38,15.31%,CCN3;KCNB1;IRS1;RAB11FIP3;DRD3;INHBB;REST;SERGEF;HMGCR
prerank,calcium ion transmembrane transport (GO:0070588),0.43681384692010095,1.2031614040123122,0.2210144927536232,0.8377694608501559,1.0,13/86,6.14%,SLC35G1;SLC24A3;PKD1;CACNA1C;ATP2C2;ANO6;TRPM6;CACNA1G;NALCN;TRPM4;ATP2B4;ITGAV;TRPM7
prerank,regulation of inclusion body assembly (GO:0090083),0.6076045765496292,1.2030775879058235,0.2597623089983022,0.8369376204269972,1.0,1/11,1.18%,SNCAIP
prerank,aminoglycan catabolic process (GO:0006026),0.5148167849477264,1.2030298234910528,0.24696969696969698,0.8359967614533408,1.0,9/28,15.89%,GPC6;GPC3;GPC4;NAGLU;SGSH;GLB1;IDUA;SDC4;HPSE
prerank,inner ear morphogenesis (GO:0042472),0.5357379846611072,1.202962146915175,0.2648809523809524,0.8351399420353636,1.0,3/22,3.19%,SIX1;SOX9;ZIC1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.41462760530316767,-1.2028677645536954,0.2006269592476489,0.6738623157321387,1.0,7/27,6.25%,FLT1;TEK;PDGFRB;PRKD1;KIT;EPHA8;PTK2
prerank,epithelial to mesenchymal transition (GO:0001837),-0.37709882562879316,-1.2027127473586559,0.14814814814814814,0.6723734047603592,1.0,14/47,7.33%,LEF1;WNT4;ENG;TGFBR3;TBX3;WNT5A;NOTCH1;BMP7;LOXL3;RBPJ;HIF1A;NOTCH4;BMP2;HEY2
prerank,mesoderm development (GO:0007498),-0.4565415701353663,-1.2024426117729028,0.23015873015873015,0.6712278587079508,1.0,8/18,16.42%,TIE1;TBX3;TBX1;BMX;IKZF1;HCK;GDF11;BTK
prerank,stress fiber assembly (GO:0043149),0.5755199042941602,1.2022121495012246,0.2661290322580645,0.8354143548827474,1.0,5/15,8.86%,PHACTR1;SORBS1;ITGB1;ITGB5;RHOA
prerank,contractile actin filament bundle assembly (GO:0030038),0.5755199042941602,1.2022121495012246,0.2661290322580645,0.8354143548827474,1.0,5/15,8.86%,PHACTR1;SORBS1;ITGB1;ITGB5;RHOA
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.5451873170544443,1.2015130728617338,0.2617960426179604,0.8365777683988258,1.0,2/20,6.47%,FKBP5;NKTR
prerank,somite development (GO:0061053),0.6042914178257662,1.2014537178206388,0.28546712802768165,0.8356953382933275,1.0,2/11,2.31%,SMO;MEOX2
prerank,response to nutrient levels (GO:0031667),0.5588901170122745,1.2014344031775404,0.2859504132231405,0.8346756208167714,1.0,3/17,4.80%,KCNB1;FAM107A;EIF4G1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.4460677314871341,1.2013310039664953,0.22053231939163498,0.8339465754136949,1.0,7/66,7.59%,CDH1;PRKCD;LIMK2;ZIC1;UBR5;MAVS;JUP
prerank,positive regulation of chemokine production (GO:0032722),-0.36558470055759973,-1.1999772393979007,0.15416666666666667,0.6762083875016007,1.0,11/44,15.52%,MBP;WNT5A;IL6R;APP;HIF1A;IL18;TLR7;TLR3;CD74;CSF1R;LPL
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.5636559556057491,1.1999255083340012,0.26865671641791045,0.8374723068159023,1.0,8/14,30.05%,TNKS2;BRCA2;ATRX;XRCC5;ATR;PINX1;ACD;TPP1
prerank,regulation of cell cycle phase transition (GO:1901987),0.4320031791498516,1.1991249582580836,0.193390452876377,0.8390731425397199,1.0,33/91,27.63%,FZR1;TCIM;ANAPC5;ATP2B4;CDC16;PSMB2;ANAPC16;CDKN1B;PSMC6;PSMD11;UBE2S;MAD2L1;PSMD1;TRIM39;CUL1;ERCC3;PSMD7;CDKN1A;PSMC1;PSMD14;ANAPC11;PSMD3;ANAPC10;CCNB1;CDC20;ERCC2;PSMD12;BUB3;PSMD4;XPC;TAF1;PSMD2;PSME3
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.41885726239194715,-1.1986759031184295,0.2208955223880597,0.6781579088686259,1.0,9/26,12.39%,SLC30A10;PPARA;SLC5A3;SNCA;GRIN1;SLC25A33;ABCB7;CYBA;ADGRB1
prerank,cell junction assembly (GO:0034329),-0.3219510068657074,-1.1985528031810393,0.11764705882352941,0.6765620466779535,1.0,22/100,6.79%,TJP1;ADGRL3;DNM3;TLN2;CDH2;SHANK3;SPOCK2;ITGA6;CLDN5;NRXN1;CDH8;CDH10;GPM6A;GJC1;VASP;ARVCF;ACTB;PLXND1;KIRREL3;OPHN1;TLN1;OBSL1
prerank,regulation of sodium ion transport (GO:0002028),0.4951635742110893,1.198318552984608,0.24522760646108663,0.8406275644567849,1.0,10/34,11.41%,NEDD4;WNK1;SLMAP;ATP2B4;SNTA1;DLG1;P2RX4;ATP1A1;PER1;RANGRF
prerank,regulation of lipase activity (GO:0060191),0.5739993898838818,1.1982331759704588,0.2884012539184953,0.8398325672701682,1.0,2/13,8.86%,PCSK5;RHOA
prerank,response to ATP (GO:0033198),-0.457848999264015,-1.1982154359839865,0.22857142857142856,0.6756686179584881,1.0,6/18,16.61%,TRPC3;ABCC9;P2RY1;P2RX7;HSP90B1;RYR3
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5890809132421615,1.1981386891281474,0.26411960132890366,0.8390646607021992,1.0,9/11,39.23%,RESF1;SIRT6;TASOR;ATF7IP;MPHOSPH8;TPR;SETDB1;TRIM28;PPHLN1
prerank,regulation of chromatin binding (GO:0035561),0.6028965875790279,1.198112352835898,0.2864406779661017,0.8380629228778244,1.0,4/10,13.99%,BTAF1;DDX11;WAPL;KDM4D
prerank,negative regulation of programmed cell death (GO:0043069),0.38933836474394035,1.1980286734736776,0.12422997946611909,0.8372610750998136,1.0,79/355,17.23%,EGFR;THBS1;BMP4;CARD14;MET;FSTL1;GRK5;SOX9;NGF;ARHGAP10;TCIM;PTK2B;ANXA1;WNT11;SMAD6;CD44;ANXA4;GCLC;SHC1;TAX1BP1;GSK3B;NOTCH2;ERC1;SERPINB9;SON;DNAJC3;GDNF;GOLPH3;RIPK2;BIRC6;IL10;BIRC7;SOCS2;SIX4;PLK3;ERCC5;KANK2;NFKB1;RIPK3;NIBAN2;NTSR1;GATA1;PIM2;MTDH;VEGFA;PROK2;ARF4;USP47;KRT18;HTATIP2;UBE2Z;COPS5;MYD88;AATF;DDRGK1;PRKDC;YME1L1;BAG3;PAK2;PRDX5;FATE1;HTR2B;CEACAM5;MAD2L1;STIL;SQSTM1;PIDD1;ZFAND6;DPEP1;TFAP2A;ADAM10;CLEC5A;NAA15;CASP2;TMBIM4;BFAR;AIFM2;BIRC3;BARD1
prerank,cellular response to increased oxygen levels (GO:0036295),-0.5133120289270134,-1.1979726234533608,0.24154589371980675,0.6744059573099725,1.0,3/11,12.75%,FOXO1;FAS;ATP6AP1
prerank,monoacylglycerol metabolic process (GO:0046462),0.5903933036988104,1.197748954250189,0.2646566164154104,0.8370590975527045,1.0,4/13,12.01%,MGLL;MOGAT3;ABHD6;DGAT2L6
prerank,positive regulation of ATP metabolic process (GO:1903580),0.49314167710604756,1.1972936445451796,0.25755395683453236,0.8374756994424949,1.0,5/32,8.27%,SLC4A4;PID1;VCP;PFKFB2;PFKFB1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.411676676054365,-1.1971350849298232,0.20754716981132076,0.674799911565536,1.0,8/29,6.89%,FLT1;TEK;PDGFRB;PRKD1;KIT;EPHA8;PTK2;CD81
prerank,regulation of striated muscle contraction (GO:0006942),-0.4207271393320639,-1.1965763082604912,0.22186495176848875,0.6745526556028397,1.0,3/27,4.62%,ATP1A2;CALM1;RYR2
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.5200440536561312,1.1964705603859498,0.28923076923076924,0.8389934392905877,1.0,5/24,3.53%,PPP1R3B;SORBS1;GSK3B;PPP1R3C;IRS1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3955624396057562,1.1963842987347761,0.12655601659751037,0.8382141110255984,1.0,74/327,17.16%,BNC2;VSX1;TCF7L1;ZFHX3;SIX1;PRRX2;FOXN3;NFIA;USP13;ESR2;JMJD1C;FZD7;ZNF423;ABL1;ERC1;TGFBR1;EFEMP1;KAT6B;BHLHE40;CREBBP;STAT3;HMG20A;ESR1;GATA4;NFIL3;RORA;DDIT3;TRRAP;PITX3;SOX14;FUS;CHEK2;CRABP2;IGSF1;NLK;FOXC1;PHF12;NFYA;SERTAD3;ATF7;GON4L;NFKB2;FOXK2;GTF2IRD1;BRCA2;RB1;ATRX;TCF3;KMT2D;CTR9;HCFC1;SP3;CHD3;EP300;GPBP1;GCFC2;REST;HDAC10;ATF2;CDK11B;SBNO2;ZMIZ1;GPBP1L1;BAZ2A;PCGF1;HINFP;PML;NSD1;ZNF219;RNF14;WWTR1;CREBL2;CARM1;POU6F2
prerank,modulation by symbiont of entry into host (GO:0052372),-0.4738786878073995,-1.1963458306162824,0.22284122562674094,0.6733418943977008,1.0,5/16,15.47%,HS3ST5;TRIM14;TRIM62;NECTIN2;TRIM21
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3889844028488621,1.1962234144997395,0.12746113989637306,0.8376563752828453,1.0,97/341,22.49%,FBXL7;WWP1;FZR1;NEDD4;FBXO10;UBE4B;WWP2;NFE2L2;RNF144A;RNF115;ANAPC5;UBR4;RNF185;VCP;KLHL22;UBE2B;ARIH1;TBL1X;TGFB1I1;DDIT3;CDC16;BIRC6;RNF19A;TRIP12;RNF114;PSMB2;CBLC;ANAPC16;UBE2D3;RNF126;FBXW11;AURKA;UBE4A;FEM1B;RAD23B;PSMC6;PPP2R5C;RNF111;OTUD7B;RNF146;SPSB2;VPS37A;MTA1;USP33;WDR81;COP1;MVB12B;RNF122;ARIH2;RNF168;SMURF1;ZRANB1;ANKIB1;PSMD11;UBE2S;CUL3;ERCC8;NPLOC4;SPOP;NTAN1;MAD2L1;SQSTM1;APPBP2;PSMD1;UBE2K;PML;CHFR;RNF14;BFAR;OS9;PSMD7;USP9X;VPS37B;TSG101;UBE3C;PSMC1;FBXL19;PSMD14;CNOT4;UFD1;UBE2W;TRIM25;TRPC4AP;RNF8;MIB1;FBXL4;TOM1L1;ANAPC11;RBCK1;PSMD3;CUL4A;HUWE1;RMND5A;ANAPC10;KCTD17;RNF130;FBXL17
prerank,protein stabilization (GO:0050821),0.40562582803687025,1.1949927999917724,0.18403547671840353,0.8405181275507,1.0,43/168,17.83%,RASSF2;ANK2;ATP1B1;PRKCD;PLPP3;PARVA;USP2;USP13;TELO2;HPS4;UBE2B;COA8;TBL1X;CLU;TRIM44;P3H1;CHEK2;SEC16A;MDM4;NLK;AAK1;PER3;IFT46;PIM2;MORC3;USP7;TBRG1;USP33;COG3;WDR81;CHP1;GTPBP4;BAG3;HCFC1;EP300;OTUD3;GOLGA7;TRIM39;NAA15;CREBL2;USP9X;RAB21;CDKN1A
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4455811255619937,1.1946938902348163,0.2380352644836272,0.8403357349826099,1.0,22/76,19.97%,HDAC4;TANK;PRICKLE1;FAM107A;RIPK2;BIRC7;MYCBP2;SAE1;PIAS3;DCUN1D5;COMMD1;ZC3H12A;TNIP1;FBXO4;CUL3;BIRC3;BCL10;PIAS1;WDR48;DCUN1D2;DCUN1D1;DCUN1D4
prerank,dendritic cell differentiation (GO:0097028),-0.44291425773226045,-1.194636378024923,0.209375,0.6760989540886125,1.0,9/22,26.11%,LYN;GAS6;AXL;CCL19;FLT3;PRTN3;TREM2;IRF8;BATF
prerank,negative regulation of histone modification (GO:0031057),-0.49288437268556284,-1.1944830028534739,0.24802110817941952,0.6747251458281265,1.0,7/14,20.41%,JARID2;SNCA;NOC2L;SET;CTBP1;AASS;SPHK2
prerank,response to organophosphorus (GO:0046683),-0.4686422619961546,-1.1942263807077411,0.23316062176165803,0.6736202949944528,1.0,6/16,17.83%,TRPC3;ABCC9;P2RX7;STAT1;VGF;NDUFS4
prerank,peptidyl-lysine acetylation (GO:0018394),0.5973429353597268,1.1941635028638702,0.284452296819788,0.8410758404975744,1.0,6/10,26.59%,CREBBP;KAT2A;EP300;KAT2B;KAT5;ESCO1
prerank,stabilization of membrane potential (GO:0030322),0.5532538011558099,1.1940740066425828,0.27419354838709675,0.8403079018840792,1.0,1/16,0.20%,KCNK5
prerank,DNA metabolic process (GO:0006259),0.391711769447435,1.1937927799922379,0.16091954022988506,0.8402329830919799,1.0,85/270,24.04%,TCF7L2;NT5E;MPG;VCP;UBE2B;MNAT1;SMUG1;EXO1;TRRAP;MCM7;STN1;CHD1L;ERCC5;RAD17;WRN;MCM2;ATM;TOP1;APEX1;USP7;IGHMBP2;SMC1A;RAD52;NABP1;SLX4;CDC45;PRKDC;CHEK1;XRCC5;CSNK1E;PRIM2;POLB;EID3;NUDT15;FANCL;RNASEH2A;POLE2;HINFP;ZBTB1;RBBP8;DFFB;DDX21;ERCC3;XPA;PARP3;RPA1;TOP3A;RECQL5;UHRF2;ATR;BARD1;RMI2;SMARCAL1;INO80;NBN;TICRR;RAD51;PRIM1;ERCC1;RFC1;NEIL3;TOPBP1;HELB;PARP4;EXD2;RAN;UBE2N;RAD51B;KMT5B;POLA1;TDG;RAD51C;POLD3;NUDT1;RAD50;RAD9B;TOP1MT;MBD4;DNASE2;CDK2;NOC3L;PARP2;USP3;PWWP3A;RFC5
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.4915666226657584,1.193786263726452,0.2536656891495601,0.8391929828831455,1.0,8/32,17.14%,DDX5;FHIT;HIPK1;CDIP1;EP300;DYRK2;PML;USP28
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.5473465067506831,1.1935069543859433,0.2750759878419453,0.8390613409961416,1.0,11/20,25.55%,MCUB;MCU;SLC8B1;PMPCB;YME1L1;SPG7;MICU3;PARL;MICU1;STOML2;MICU2
prerank,regulation of DNA recombination (GO:0000018),0.4941815043235505,1.1930781418027823,0.27835051546391754,0.8393816887174652,1.0,9/32,17.91%,KDM1A;SETD2;KPNA1;IL10;SPIDR;PPP4R2;CHEK1;SIRT6;RAD51
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.5962904213084395,1.1926206514427062,0.289568345323741,0.8398201477034724,1.0,5/11,10.73%,SOX9;TGFBR2;PDGFA;CHRD;LRP5
prerank,atrial septum morphogenesis (GO:0060413),0.5931736502438222,1.192517075926048,0.30155979202772965,0.8390982657982576,1.0,4/10,9.60%,NOTCH2;ISL1;GATA4;ACVR1
prerank,DNA duplex unwinding (GO:0032508),0.4676369883464758,1.1918998575403497,0.23473541383989144,0.8400658889320729,1.0,18/50,21.95%,ANXA1;MCM7;CHD1L;WRN;MCM2;RAD23B;DDX11;DHX9;MCM9;ERCC3;XPA;RPA1;RECQL5;NBN;RAD51;DDX1;RAD50;CUL4A
prerank,positive regulation of chromosome organization (GO:2001252),0.5581725871046583,1.1913936299690817,0.27906976744186046,0.8406074460120567,1.0,7/15,21.89%,DDX11;ATRX;PML;NBN;SIRT6;DHX36;RAD50
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.5441147428254487,1.1906091313805527,0.2304,0.8420556377260249,1.0,5/15,17.19%,LARGE1;CHST5;MGAT3;RENBP;OGA
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.5766963760024557,1.1902974573705238,0.27958833619210977,0.8420076426870721,1.0,5/12,19.19%,CHEK2;RAD17;CLSPN;TICRR;TOPBP1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.478924248138207,-1.1900244335407502,0.26804123711340205,0.6835610563258516,1.0,4/16,5.77%,APOD;PPARA;ADCY7;SIRPA
prerank,protein neddylation (GO:0045116),0.5616171037887445,1.1896077798645344,0.2789115646258503,0.8431015481539292,1.0,6/13,21.57%,UBE2F;DCUN1D5;DCUN1D2;DCUN1D1;DCUN1D4;UBE2M
prerank,positive regulation of apoptotic process (GO:0043065),0.39308962768645367,1.1886658368268497,0.1524896265560166,0.8450204645761424,1.0,45/293,13.16%,SLIT2;BMP4;RASSF2;MAP3K5;CYP1B1;HOXA5;NGF;TGFB3;AKAP13;PAWR;FOXO3;PTGIS;VAV2;ANO6;ITGB1;CRADD;UNC13B;ABL1;IP6K2;TGFBR1;TIAM2;SFRP4;TRIO;GADD45G;CLU;DDIT3;CALHM2;ARHGEF6;NF1;BCLAF1;ATM;GNA13;RARG;JUN;CCL3;DIABLO;ATF6;UBE2Z;ARHGEF5;TIAM1;ARL6IP5;ZC3H12A;SOS2;RNF122;OMA1
prerank,ERBB2 signaling pathway (GO:0038128),0.5001757395432466,1.1883426953218996,0.27153284671532846,0.845008645417183,1.0,8/31,16.70%,EGFR;SHC1;ERBIN;ERBB2;CPNE3;PRKCA;GAB1;EGF
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.38928405917522446,1.1883388583243693,0.13230769230769232,0.8439666770493583,1.0,84/366,18.18%,BNC2;VSX1;TCF7L1;ZFHX3;SIX1;PRRX2;FOXN3;CCNA2;NFIA;FOXO3;USP13;ESR2;JMJD1C;FZD7;ZNF423;ABL1;ERC1;TGFBR1;EFEMP1;KAT6B;BHLHE40;CREBBP;STAT3;HMG20A;ESR1;GATA4;NFIL3;RORA;DDIT3;TRRAP;PITX3;SOX14;FUS;CHEK2;CRABP2;PDGFA;IGSF1;NLK;FOXC1;PHF12;NFYA;SERTAD3;GATA1;ATXN2;ATF7;GON4L;NFKB2;FOXK2;GTF2IRD1;BRCA2;RB1;ATRX;TCF3;KMT2D;CTR9;HCFC1;SP3;CHD3;EP300;GPBP1;GCFC2;REST;HDAC10;ATF2;CDK11B;SBNO2;GPBP1L1;BAZ2A;PCGF1;HINFP;PML;NSD1;ZNF219;ANKRD17;RNF14;WWTR1;CREBL2;CARM1;POU6F2;PUM3;UTP4;EHMT2;HCLS1;TGFBRAP1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.4465944126545449,1.1882690239098324,0.23203026481715006,0.843162171139612,1.0,13/63,7.87%,MET;PTPN3;EIF4G3;DAPL1;NELL1;FOXK1;EIF4G1;TAB3;KLHL22;STAT3;TIMP2;IL10;RGP1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.6113625584198643,1.1882160126040173,0.2832764505119454,0.8422920776628151,1.0,3/10,7.87%,ANXA2;NELL1;RGP1
prerank,organelle transport along microtubule (GO:0072384),0.5050739136438427,1.188214796639082,0.2543859649122807,0.841258586739622,1.0,14/31,24.80%,ARHGAP21;NDEL1;RAB6A;PAFAH1B1;FBXW11;DYNC1I1;COPG1;TMEM201;CLN3;RAB1A;CDC42;RHOT1;TRAK1;MAP1S
prerank,intestinal absorption (GO:0050892),-0.489525379363641,-1.1882091265958243,0.2617283950617284,0.6869445334130108,1.0,4/13,8.47%,F11R;UGCG;ADRA2A;KCNQ1
prerank,regulation of myoblast differentiation (GO:0045661),0.49564980906884115,1.1881456649799256,0.25327510917030566,0.8404324077311025,1.0,3/32,1.12%,BMP4;BOC;SOX9
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.4938978662198007,-1.1880796880589612,0.2660098522167488,0.6854529992458107,1.0,6/13,18.15%,NOTCH1;RYR2;RBPJ;HEY2;GSK3A;FOXF1
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.430623887098624,-1.187898605207743,0.2417910447761194,0.684145291165121,1.0,4/22,5.11%,APOE;PPARA;PPARD;ZBTB20
prerank,positive regulation of cell development (GO:0010720),0.5000850932404305,1.1878481208316423,0.2624633431085044,0.8403323187088754,1.0,3/31,9.41%,BMP4;MYOG;NIBAN2
prerank,cellular response to estrogen stimulus (GO:0071391),0.565361339962684,1.1876480082202638,0.28365384615384615,0.8399698514154119,1.0,3/14,9.94%,SERPINB9;BCAS3;RARA
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.3850211352864649,-1.1876132343072656,0.2179930795847751,0.6831351132668543,1.0,5/35,1.26%,FLT1;PTPRM;NR2F2;COL4A3;APOE
prerank,cellular response to tumor necrosis factor (GO:0071356),0.4000198158579798,1.1875520118647418,0.1843817787418655,0.8392357288109333,1.0,33/175,17.93%,TNFRSF11B;CARD14;EDA;PTK2B;PID1;TANK;FOXO3;YBX3;NFE2L2;PSMB2;CHUK;TNFRSF13B;ERBIN;LIMS1;PSMC6;CDIP1;TNFSF11;CCL3;CCL1;TRAF5;ZC3H12A;TNFRSF1B;CCL7;PSMD11;TRADD;DHX9;PSMD1;ZFAND6;ACOD1;BIRC3;PSMD7;PSMC1;TNFRSF4
prerank,calcium ion import into cytosol (GO:1902656),-0.4802108915983123,-1.187533254748602,0.2514124293785311,0.681525992959085,1.0,5/15,14.22%,SLC24A2;SLC8A1;CACNA2D1;TRPV2;TRPV4
prerank,modification-dependent protein catabolic process (GO:0019941),0.4015979457363726,1.1872052920178675,0.1714922048997773,0.8393146591629108,1.0,53/193,20.76%,FBXL7;FZR1;NEDD4;FBXO10;UBE4B;RNF144A;ANAPC5;UBR4;RNF185;UBE2B;ARIH1;CDC16;BIRC6;RNF19A;TRIP12;RNF114;CBLC;ANAPC16;RNF126;AURKA;UBE4A;RNF111;RNF146;SPSB2;USP33;WDR81;ARIH2;RNF168;SMURF1;ANKIB1;PSMD11;UBE2S;CUL3;NPLOC4;NTAN1;MAD2L1;SQSTM1;UBE2K;CHFR;RNF14;BFAR;OS9;UBE3C;PSMD14;PCYOX1L;CNOT4;UFD1;TRIM25;TRPC4AP;RNF8;MIB1;FBXL4;ANAPC11
prerank,positive regulation of lipid transport (GO:0032370),-0.5053884167351378,-1.187079886960334,0.2674698795180723,0.6809242775879882,1.0,4/12,11.70%,APOE;SPP1;DBI;ABCB4
prerank,regulation of keratinocyte migration (GO:0051547),0.5743518566311834,1.186907873945651,0.3148148148148148,0.8392252766863695,1.0,2/12,2.36%,ADAM9;MAPRE2
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5897655428220571,1.1868088753092407,0.3018867924528302,0.8385099068439964,1.0,2/10,2.36%,ADAM9;MAPRE2
prerank,mesenchymal cell differentiation (GO:0048762),-0.36705280961554093,-1.186758099225187,0.1693548387096774,0.6800450816285319,1.0,15/51,7.33%,RANBP3L;LEF1;WNT4;ENG;TGFBR3;WNT5A;NOTCH1;BMP7;LOXL3;RBPJ;MEF2C;HIF1A;NOTCH4;BMP2;HEY2
prerank,response to interleukin-4 (GO:0070670),-0.52707671153902,-1.1866811845809866,0.26932668329177056,0.6784347774817626,1.0,4/10,19.18%,LEF1;TCF7;JAK3;XBP1
prerank,glutathione biosynthetic process (GO:0006750),0.5997052867235677,1.1865951759205604,0.31316725978647686,0.8381430507900494,1.0,1/11,2.67%,GCLC
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5484783198324158,1.1865459259930475,0.2934426229508197,0.8372569438399858,1.0,4/17,8.43%,KCNB1;CACNA1G;CLTRN;SLC4A8
prerank,regulation of protein polymerization (GO:0032271),-0.3863082694377119,-1.1861855062387154,0.20618556701030927,0.6781351729617768,1.0,8/35,14.25%,ARHGAP28;ESAM;MAP2;MAPT;COTL1;PAK3;CAMSAP2;TTBK1
prerank,heart morphogenesis (GO:0003007),-0.35935827205889115,-1.1855427205412399,0.17670682730923695,0.6780860510330724,1.0,14/50,7.33%,ENG;TGFBR3;CHD7;NOS3;TBX3;INSR;NOTCH1;TBX1;RYR2;SOX17;EPHB4;PTK2;BMP2;HEY2
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.47320505200013263,-1.185532596337873,0.25721153846153844,0.6763265813656169,1.0,4/14,6.52%,LYN;PIK3R1;PTK2;GHR
prerank,cellular response to alcohol (GO:0097306),0.47963596834131694,1.1852246647108473,0.2763337893296854,0.8402800284990601,1.0,8/42,7.59%,CDH1;LRP6;SMO;CTNNA1;KLF9;GOLPH3;GRAMD1C;JUP
prerank,cellular response to metal ion (GO:0071248),0.4100111096585127,1.184855476525261,0.207909604519774,0.8404438016918447,1.0,17/123,10.62%,EGFR;CDH1;SLC12A2;CLIC4;CAMK2D;BMP6;MEF2A;DLG2;DMTN;SYT8;CDKN1B;P2RX4;IQGAP1;CHUK;PLCG2;CARF;JUN
prerank,double-strand break repair (GO:0006302),0.4048036247211225,1.1847313425278014,0.20417124039517015,0.8398241556585138,1.0,54/158,21.89%,REV3L;HERC2;RNF138;VCP;EYA3;CHEK2;ERCC5;WRN;APLF;ATM;SMC5;BRCA2;RAD52;NABP1;MTA1;PPP5C;SPIDR;UIMC1;SLX4;RNF168;PRKDC;XRCC5;KDM4D;BAP1;POLB;MCM9;KDM2A;RBBP8;YY1;NSMCE1;PARP3;RPA1;RECQL5;TNKS1BP1;BARD1;SMARCAL1;INO80;NBN;RAD51;ERCC1;PSMD14;SMARCA5;SWSAP1;RNF8;EXD2;UBE2N;MAPK8;RAD51B;POLA1;DDX1;RAD51C;SMC6;ZFYVE26;RAD50
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.41614167189978846,-1.1843374917685405,0.2112676056338028,0.6779469129912531,1.0,11/29,20.23%,ACSL1;ELOVL7;ELOVL6;ACSL5;HSD17B12;ACLY;HACD2;ACSBG1;HACD1;ACSL4;GCDH
prerank,amide transport (GO:0042886),0.5090266640543439,1.184078125496062,0.2811550151975684,0.840891727483312,1.0,3/26,2.45%,SLC5A6;DISP1;ABCG2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.4752481834373873,1.1835987590587345,0.2580213903743315,0.8414184373915956,1.0,10/43,11.60%,PID1;PRKCD;GRB10;SORBS1;IRS1;PTPN2;ZBTB7B;C1QTNF12;SIK2;ERFE
prerank,cellular response to misfolded protein (GO:0071218),0.5341955860521524,1.1835959861751522,0.2916666666666667,0.840404772139249,1.0,8/20,23.97%,RNF185;VCP;RNF126;CUL3;UFD1;UBE2W;UGGT2;POMT2
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3867871857658797,1.1835790955778387,0.15104166666666666,0.8394460067533036,1.0,80/314,23.42%,FBXL7;WWP1;FZR1;NEDD4;UBE4B;WWP2;NFE2L2;ECRG4;ANAPC5;RNF185;VCP;KLHL22;UBE2B;TBL1X;DDIT3;CDC16;FBXL20;PSMB2;ANAPC16;ANKZF1;UBE2D3;RNF126;FBXW11;AURKA;UBE4A;FEM1B;RAD23B;PSMC6;PPP2R5C;FBXL6;FBXO17;SPSB2;RB1;MTA1;COP1;RNF122;UBXN4;SMURF1;FBXO4;PSMD11;ERLIN1;UBE2S;CUL3;ERCC8;NPLOC4;SPOP;MAD2L1;APPBP2;AMN1;PSMD1;UBE2K;CUL1;PML;BFAR;OS9;PSMD7;PSMC1;FBXL19;PSMD14;UFD1;UBE2W;TRIM25;FBXL8;FBXL4;ECPAS;ANAPC11;RBCK1;PSMD3;CUL4A;HUWE1;RMND5A;ANAPC10;KCTD17;FBXL17;FAF2;HERPUD1;ANKRD9;CDK2;FBXO27;CCNB1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.5933579643248729,1.1832530893950903,0.29914529914529914,0.8374334009700451,1.0,6/10,18.66%,EXO1;WRN;SLX4;SMARCAL1;NBN;ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.5933579643248729,1.1832530893950903,0.29914529914529914,0.8374334009700451,1.0,6/10,18.66%,EXO1;WRN;SLX4;SMARCAL1;NBN;ERCC1
prerank,t-circle formation (GO:0090656),0.5933579643248729,1.1832530893950903,0.29914529914529914,0.8374334009700451,1.0,6/10,18.66%,EXO1;WRN;SLX4;SMARCAL1;NBN;ERCC1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.4633971866999386,1.1831787402875986,0.25833333333333336,0.8366381714144274,1.0,7/47,9.97%,THBS1;PID1;PRKCD;AGTR1;TGFBR2;TLR4;PLCG2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4532109460868931,1.1831524789732122,0.2449255751014885,0.8357132790906004,1.0,6/48,5.55%,ANK2;PTK2B;CAMK2D;UBASH3B;DIAPH1;DMD
prerank,actin crosslink formation (GO:0051764),0.5874247394809006,1.1830053243789616,0.2933104631217839,0.8352071726691996,1.0,4/12,9.44%,DPYSL3;BAIAP2L1;GAS2L2;GAS2
prerank,regulation of catecholamine secretion (GO:0050433),-0.408187193907266,-1.1827526522861336,0.19710144927536233,0.6806588918434265,1.0,17/29,23.96%,SYT7;SYT11;SYT12;SNCA;SYT1;SYT13;GRK2;CHGA;KCNA2;SYT10;SYT9;SYT6;SYT15;SYT2;SYT4;SYT5;SYT17
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.5059103223555177,1.1826371325289786,0.2702702702702703,0.8353821017204331,1.0,4/23,7.30%,CYP1B1;PTK2B;HES1;IL10
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.45270377265727085,-1.1819830323239933,0.24935064935064935,0.680937724837171,1.0,1/19,0.18%,IGF1
prerank,negative regulation of catabolic process (GO:0009895),0.4621095657561805,1.1818767119680391,0.2677165354330709,0.8367835253852053,1.0,10/47,15.31%,EGFR;HDAC4;PFKFB1;MDM4;IRAK3;NCOR1;SNX12;AZIN1;MAD2L1;HMGCR
prerank,positive regulation of vascular permeability (GO:0043117),-0.49763703383863034,-1.180961724634924,0.2669902912621359,0.6819106596376378,1.0,3/12,7.22%,TJP1;OCLN;PDE2A
prerank,negative regulation of response to stimulus (GO:0048585),0.44503515150743056,1.1806826713987328,0.23834196891191708,0.8394527495265266,1.0,9/60,6.70%,SLIT2;VPS13C;COL3A1;UBASH3B;KLF4;HHIP;KLF7;CLU;MAP3K3
prerank,actin nucleation (GO:0045010),-0.43968594571208336,-1.1795118391830663,0.23380281690140844,0.6841665519561587,1.0,10/21,26.19%,IQGAP2;LMOD1;SPIRE1;ARPC4;ARPC5;ARPC3;ARPC5L;TRIM27;ARPC1A;SPIRE2
prerank,positive regulation of neuron projection development (GO:0010976),-0.3235894450837641,-1.179325065925724,0.140625,0.6829776131303883,1.0,29/85,12.00%,CAMK1D;LYN;APOE;PRKD1;ITGA6;PTK7;RAPGEF2;WNT5A;SERPINI1;TENM3;FUT9;TOX;BMP7;ATP1B2;NDNF;RIT2;ROR2;LRRC7;DAB2IP;LRP8;SETX;NTRK2;PLK5;RAPGEF1;TWF2;FES;CAMK2B;CUX2;MDK
prerank,neuronal action potential (GO:0019228),0.5250448443691339,1.179310205129445,0.26633986928104575,0.8427226511385382,1.0,3/22,3.30%,KCNMB2;KCNMB3;CACNA1G
prerank,protein K63-linked ubiquitination (GO:0070534),0.4724583214636932,1.1793060182262067,0.26580459770114945,0.8417268745595023,1.0,15/41,20.47%,NEDD4;TRAF3IP2;WWP2;RNF115;UBE2B;RNF126;TRAF5;ARIH2;RNF168;UBE2S;RNF135;BFAR;TRAF3;RNF8;UBE2N
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5143685500744875,1.179078711827094,0.29591836734693877,0.8414375530739985,1.0,6/23,7.40%,ANK2;PTK2B;CAMK2D;UBASH3B;DIAPH1;CACNG6
prerank,Golgi localization (GO:0051645),0.595386395470749,1.1785638681640187,0.303236797274276,0.8419874027009959,1.0,5/11,20.93%,ARHGAP21;ARCN1;COPG1;HOOK3;CDC42
prerank,positive regulation of metabolic process (GO:0009893),-0.3161076622417256,-1.1785449512441684,0.1223021582733813,0.683512965622309,1.0,15/103,7.42%,CAMK1D;LEPR;IGF1R;ACSL1;PPARGC1B;ESRRG;GATM;EBF2;INSR;PRDM16;GJA1;ACACB;PPARGC1A;ELOVL6;IL18
prerank,regulation of glucose import (GO:0046324),-0.4035011223400347,-1.178387770631372,0.19269102990033224,0.6822548617262721,1.0,7/30,3.80%,IGF1;OSBPL8;PIK3R1;OCLN;ENPP1;PRKAG2;INSR
prerank,protein localization to mitochondrion (GO:0070585),-0.5129946334856648,-1.1781730875005376,0.28354430379746837,0.6810896816972608,1.0,5/11,25.69%,HK2;AKT1;COX18;RALA;PINK1
prerank,microtubule polymerization (GO:0046785),0.49885626255211823,1.1781055371034617,0.2891566265060241,0.8423615709580832,1.0,9/28,16.55%,MAP7D3;FGF13;NDEL1;HDGFL3;AKAP9;SLAIN2;TUBGCP6;TUBGCP5;TUBGCP4
prerank,activation of protein kinase activity (GO:0032147),-0.3098583006814238,-1.177357646801062,0.14634146341463414,0.6817023822692475,1.0,24/106,7.77%,IGF1;ADCY5;OSBPL8;ADCY1;TNIK;PAK1;WNT5A;PRKAR2B;INSR;CARD10;ADCY7;NRK;PPIA;PRKAR1B;FGF1;PAK5;CCDC88A;MAP4K4;GHR;PRKACB;PRKAR1A;ADRA2A;IL18;GAS6
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.5001793424085887,1.1771717175932706,0.27205882352941174,0.8443391462237215,1.0,2/26,1.29%,ACER3;CYP1B1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.42417157912754344,1.177065643658098,0.2218091697645601,0.8437099792180555,1.0,28/88,27.63%,FBXL7;FBXL20;PSMB2;FBXW11;PSMC6;FBXL6;FBXO17;FBXO4;PSMD11;AMN1;PSMD1;CUL1;PSMD7;PSMC1;PSMD14;FBXL8;FBXL4;PSMD3;CUL4A;FBXL17;FBXO27;PSMD12;FBXW5;PSMD4;CCNF;FBXO48;PSMD2;PSME3
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.4731170893458754,-1.1770281612433195,0.24742268041237114,0.6807977697259335,1.0,11/16,39.34%,TNFRSF21;JAK3;TYROBP;VSIR;DLL1;TRIB2;IL23A;FOXP3;FCGR2B;CD274;IL12B
prerank,regulation of cellular protein localization (GO:1903827),0.4712514908965322,1.1767513345704386,0.26536312849162014,0.8437455048216044,1.0,13/45,16.70%,GPC6;GPC3;NDEL1;VCP;KDM1A;SETD2;GBF1;GPC4;SPIDR;CCDC66;CSNK1E;VCPIP1;EGF
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5984702085567611,1.1764992016399538,0.3067375886524823,0.8435426229397354,1.0,4/10,3.47%,STK39;NEDD4;CAMK2D;PRKCE
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.4932112927922619,1.1763986973983254,0.2732919254658385,0.8428641372940616,1.0,9/27,17.21%,DDX5;CD44;SPRED2;SMYD2;KDM1A;ATM;TWIST1;KMT5A;ATR
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.4850462845189844,1.1759446110181204,0.2679083094555874,0.8433077770271385,1.0,10/33,17.04%,DDX5;ESR1;KDM1A;CBFB;DNAAF4;DDRGK1;UBA5;EP300;RNF14;CARM1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5367634348151045,1.1757619783717816,0.2828438948995363,0.8428832629711285,1.0,6/18,6.70%,RHOJ;ANXA1;HDAC9;FGF2;FOXC2;MAP3K3
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.3195436526046452,-1.1751974230642175,0.1375,0.6842118624862965,1.0,36/102,20.09%,TBC1D4;ADCY5;PIK3R1;SLC30A10;ADCY1;FOXO1;CPEB2;ENPP1;PRKAR2B;INSR;ADCY7;PRKAR1B;INSIG2;PRKACB;LPIN3;PRKAR1A;MYO5A;CYSLTR2;SLC25A33;ADCY2;GSK3A;ADCY4;AKT1;LPIN1;RAB15;DENND4C;RAB31;PDE3B;RAB13;LHCGR;SELENOS;TSHR;XBP1;GPER1;SLC2A4;INPP5K
prerank,protein O-linked glycosylation (GO:0006493),0.4186319941451134,1.174983625108368,0.2186761229314421,0.844295316345304,1.0,8/96,4.00%,ST3GAL4;TMTC1;PLOD2;B3GNT2;GXYLT2;LARGE1;GALNT15;GALNT13
prerank,7-methylguanosine mRNA capping (GO:0006370),0.4918605383977515,1.1748011788764232,0.2546230440967283,0.8429093558203898,1.0,2/31,5.85%,RNMT;MNAT1
prerank,7-methylguanosine RNA capping (GO:0009452),0.4918605383977515,1.1748011788764232,0.2546230440967283,0.8429093558203898,1.0,2/31,5.85%,RNMT;MNAT1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.4161642610387444,-1.1745228378246955,0.24025974025974026,0.6841655903679368,1.0,5/26,3.80%,IGF1;OSBPL8;PIK3R1;OCLN;INSR
prerank,regulation of feeding behavior (GO:0060259),-0.5176575910715127,-1.1742197294400758,0.27411167512690354,0.6833137570122328,1.0,2/11,1.17%,LEPR;SGIP1
prerank,homeostasis of number of cells (GO:0048872),0.572147857275509,1.173464097577687,0.2921739130434783,0.8460097521246737,1.0,1/12,0.41%,CCN3
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.4990673183319366,-1.1734130125254918,0.2635294117647059,0.6836553313721967,1.0,4/12,10.34%,NKD1;PROM1;RORB;SDK2
prerank,wound healing (GO:0042060),0.4410252496944211,1.1733369653693666,0.25259067357512954,0.8453823704178832,1.0,16/62,11.30%,AHNAK2;PPP3CA;DSP;COL3A1;FGF2;FZD7;TGFBR1;SYTL4;TSKU;NOG;GATA4;PDGFA;NF1;ITGB3;ERBB2;PLEC
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.37485635280000856,1.1730387618649556,0.041,0.8453139412611819,1.0,253/1082,16.99%,EGFR;BMP4;CDH1;KLF5;ZFHX3;ZFPM2;SIX1;TCF7L2;MET;PLAGL1;MAP3K5;RARB;NFIB;PKD1;SOX9;BMP5;HDAC4;HOXA5;LRP6;MLLT3;PPP3CA;CCN1;TGFB3;CSRP3;PID1;PBX1;NFIA;WNT11;GLI3;NFAT5;FOXO3;HES1;MEOX2;ZBTB16;GRHL1;TCF20;SHC1;ESR2;KLF4;DCAF6;BMP6;INHBA;ZIC1;BMPR1A;NFE2L2;FGF2;MDFIC;FZD7;ELOF1;ELF1;ZNF423;ABL1;NR2F1;FOXC2;MEF2A;GLIS1;KLF7;TGFBR1;EHF;NR4A3;NR4A2;ZFP64;FOXK1;MLLT10;DDX17;NCK2;KAT6B;KLF10;BCAS3;CD80;MRTFA;HDAC8;CREBBP;GLIS2;ISL1;SKI;STAT3;HOXB3;ESR1;ATF1;GDNF;KDM1A;TBL1X;TADA3;RHOQ;E2F3;MAVS;KMT2C;JAG1;TGFB1I1;E2F5;GATA4;NFIL3;RORA;TRIM44;BAMBI;DDIT3;CEBPZ;MYSM1;RIPK2;PLSCR1;TASP1;IRF1;NFIX;REL;HOXC4;TEAD1;GDF6;MYOG;IL10;PITX3;LHX2;PHOX2A;ID2;FZD1;JUP;SCAF8;MLXIP;GABPB2;GABPB1;CHEK2;SIX4;GLI2;CAMTA2;PITX2;SLC9A1;TLR4;HIVEP3;RXRA;FOXC1;GRHL2;ATOH8;THAP3;PAXBP1;NFKB1;EGR2;NFYA;MED13;CHUK;WDR43;SERTAD3;IL33;FBXW11;NIBAN2;BCLAF1;ATM;LPIN2;SSBP3;ACVR1;RBMX;RARG;GATA1;CTCFL;HOXB4;FOXE1;RARA;SLC30A9;PIM2;PPP1R12A;SMAD2;NRF1;VEGFA;NFKB2;APEX1;TCERG1;JUN;ELF3;WAC;PRDM15;LRP5;ARF4;RNF111;TNFSF11;FOXK2;ATF6;BRCA2;PER1;ERBB2;ITGB1BP1;KANSL3;BCL9L;HTATIP2;RGMB;ZBED4;BPTF;COPS5;AATF;BCL11B;NKX2-1;DDRGK1;ZC3H12A;PPRC1;SMARCA4;ATRX;TCF3;TNIP1;KMT2D;KAT2A;NR4A1;PRKDC;NFATC3;MTOR;PPM1A;CREB3L3;CHEK1;HNF4A;HNF1A;HCFC1;CRTC1;SP3;PAX6;EP300;MED14;ZXDC;E2F2;REST;DHX9;ZNF507;ATF2;SBNO2;ZMIZ1;FOXD2;SQSTM1;RUNX2;NFATC1;TWIST1;MAP2K2;HSF2;THRAP3;HINFP;CALCOCO1;GALR1;HOXD3;PML;CAPRIN2;MED24;ZNF462;TFAP2A;AGO2;NSD1;YY1;KAT2B;NAA15;RNF14;EPC1;TRIM16;EGF;WWTR1;JMJD6;NRIP1;BRD8;CREBL2;IKBKG
prerank,positive regulation of axonogenesis (GO:0050772),0.4671251729160946,1.1725884472770587,0.3,0.8457010417590511,1.0,5/43,5.62%,SLIT2;NTN1;NGF;TIAM2;SHTN1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.3159492942244707,-1.1725776285438034,0.12598425196850394,0.684330002413501,1.0,26/110,12.39%,ADGRL4;ADGRL3;ADCY5;ADCY1;LGR4;RAPGEF2;LPAR1;GNG2;CALCRL;ADGRE5;ADCY7;ABCA1;PTGFR;ADGRB3;ADRA2A;ADGRG1;ADORA2A;S1PR1;PTH1R;RAMP2;ADM;TBXA2R;LPAR2;S1PR3;ADCY2;ADGRB1
prerank,bone morphogenesis (GO:0060349),0.5580187117543316,1.1724278756360262,0.2964824120603015,0.845195659578638,1.0,6/14,16.13%,LRP6;SFRP4;SKI;LRP5;MMP13;TFAP2A
prerank,positive regulation of protein polymerization (GO:0032273),0.43637839414094387,1.1723208136831536,0.25949367088607594,0.8445384144490943,1.0,14/65,13.20%,MET;BAIAP2L1;CDC42EP5;PTK2B;PRKCE;CLIP1;NCK2;TOGARAM1;AKAP9;CTTN;NCKAP1;SLAIN2;FCHSD2;FCHSD1
prerank,protein insertion into membrane (GO:0051205),0.48321641317539066,1.1723031007706,0.2557471264367816,0.8436178975804246,1.0,4/32,10.57%,EGFR;STX5;TRAM2;EMD
prerank,regulation of tumor necrosis factor production (GO:0032680),0.41110444084964126,1.1721222195909378,0.23130841121495327,0.8432357284731349,1.0,21/112,15.16%,FOXP1;THBS1;LBP;CD2;ISL1;STAT3;MAVS;CLU;IL10;TLR4;IL33;IRAK3;RARA;PLCG2;CCL3;ZC3H12A;IFIH1;TLR1;DHX9;MAPKAPK2;TWIST1
prerank,regulation of epithelial cell migration (GO:0010632),0.4514916144719023,1.1721068224230604,0.24370860927152319,0.8422948500055664,1.0,5/51,3.47%,BMPER;DOCK5;SOX9;RHOJ;PRKCE
prerank,response to cadmium ion (GO:0046686),0.5030709107746406,1.171641458730991,0.27089337175792505,0.842741532954592,1.0,1/26,0.24%,EGFR
prerank,ceramide catabolic process (GO:0046514),0.5536785398490639,1.1714466666266454,0.32676518883415434,0.8423724931797762,1.0,2/14,3.89%,ACER3;HEXA
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4964375286899014,1.1711027215253382,0.27074235807860264,0.8425009308046704,1.0,9/26,17.14%,EGFR;ANXA1;EIF4G1;RDX;LSM11;CCND1;ANKRD17;ADAMTS1;CDK10
prerank,neuropeptide signaling pathway (GO:0007218),-0.33676844310033255,-1.171049417522414,0.16379310344827586,0.686965170866101,1.0,11/58,14.54%,SORT1;RAPGEF2;GLRA1;CYSLTR1;CYSLTR2;SORCS2;GLRA3;SORCS3;GPR37;PENK;SORCS1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.33006885438009886,-1.170927074428104,0.1694915254237288,0.685542435356291,1.0,26/75,18.61%,DCDC2;CTNNA2;MAP2;ANK3;DCC;CNTN4;ACTB;APP;BAIAP2;MEF2C;OPHN1;ZDHHC17;PLPPR4;PAK3;MFSD2A;DSCAML1;BRSK2;ADGRB1;LMTK2;NRCAM;APBB1;SLITRK5;RAB3A;NEFH;S100A6;SPTBN4
prerank,acylglycerol biosynthetic process (GO:0046463),0.5119375964980414,1.1708207781445374,0.31210191082802546,0.8424151133446017,1.0,7/23,14.55%,PLCE1;PNPLA3;MOGAT3;PLA2G15;LPIN2;DGAT2L6;MOGAT1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.3434919170545466,-1.17051256859101,0.19724770642201836,0.6849716590288425,1.0,13/61,8.57%,ROBO1;IGF1;AUTS2;LYN;ARHGEF3;F11R;LPAR1;RASGRF1;NOTCH1;MAP4K4;NET1;ADGRG1;RAC1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.5255728897476557,-1.1705123202744698,0.28672985781990523,0.6832506247096746,1.0,7/10,19.83%,PDE4D;PDE2A;RNF157;MGRN1;APLNR;PDE3B;PDE11A
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.43626742351820513,1.1699616526929968,0.25718015665796345,0.844070219449136,1.0,26/63,23.42%,PLAGL1;CRADD;CHEK2;PLK3;CDKN1B;MDM4;ATM;AURKA;PCBP4;WAC;PRKDC;EP300;CCND1;CNOT7;PIDD1;PML;CASP2;CARM1;TNKS1BP1;CDKN1A;CNOT4;E2F1;CNOT11;CDK2;CNOT3;CCNB1
prerank,apoptotic mitochondrial changes (GO:0008637),-0.38207700926752197,-1.1692088527425424,0.23129251700680273,0.6850331655032865,1.0,12/32,23.28%,BCL2;BCL2L1;ERBB4;IFIT2;CAMK2A;HK2;BOK;THEM4;BIK;DNM1L;CCAR2;MFF
prerank,B cell proliferation (GO:0042100),-0.45896586930448946,-1.168636589027974,0.2545454545454545,0.6848836871899876,1.0,5/17,16.83%,BCL2;MEF2C;CTPS1;CD40;CD180
prerank,cytosolic calcium ion transport (GO:0060401),0.5073634738932677,1.168538338483877,0.2888243831640058,0.8474268272437157,1.0,2/28,1.59%,SLC35G1;CACNA1C
prerank,glial cell differentiation (GO:0010001),0.5038776618680572,1.168484573135906,0.272992700729927,0.8466114005968495,1.0,5/28,10.26%,NFIB;SOX9;STAT3;EGR2;ADGRG6
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3802339075121495,-1.168428870990529,0.22672064777327935,0.6837688486904274,1.0,8/39,5.68%,TJP1;APOE;RAPGEF2;TIE1;HSPA8;NOTCH1;DAB2IP;GFAP
prerank,eye morphogenesis (GO:0048592),0.5261321574465945,1.1676224351546811,0.2942073170731707,0.8483094922516811,1.0,9/19,11.69%,COL5A2;MFAP5;EFEMP1;SKI;STAT3;NF1;RARG;VEGFA;NIPBL
prerank,triglyceride homeostasis (GO:0070328),-0.41053595403310394,-1.1664441036287676,0.23880597014925373,0.6876005539465806,1.0,9/26,19.18%,APOE;NR1H3;C1QTNF3;IL18;PNPLA8;SCARB1;LPL;NR1H4;XBP1
prerank,regulation of complement activation (GO:0030449),0.4654712603620404,1.1662137843318823,0.2863070539419087,0.8517090547536593,1.0,6/40,9.13%,CFH;CD55;CLU;SERPING1;CR1L;CD46
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.4248382757432973,1.1661860581804955,0.24472049689440994,0.8508202947368296,1.0,37/80,26.78%,SGSM2;ERC1;RAB6A;SNX2;RAB7B;STX5;EHD3;VPS54;GBF1;RGP1;RNF126;SNX32;VTI1A;SNX12;TBC1D10A;TRAPPC10;TBC1D5;TMEM87B;TMEM87A;BET1L;SNX8;TBC1D17;WASHC1;RBSN;VPS52;VPS51;VPS53;SURF4;RAB7A;TBC1D23;UBE2O;PHETA2;SPAG9;ARL1;VPS29;PIKFYVE;STX16
prerank,erythrocyte differentiation (GO:0030218),-0.36693585859002503,-1.1660757597191869,0.1936619718309859,0.6869386511329769,1.0,17/44,19.95%,LYN;TGFBR3;MFHAS1;KIT;RPS14;RPS19;ALAS1;TAL1;CASP3;IKZF1;MED1;JAK3;SH2B3;LYAR;ABCB10;SLC25A38;HSPA9
prerank,positive regulation of vacuole organization (GO:0044090),0.5909958129936398,1.1652535243784083,0.32088285229202035,0.852657102129805,1.0,4/10,13.30%,ANXA2;RAB3GAP2;LRSAM1;SH3GLB1
prerank,positive regulation of type 2 immune response (GO:0002830),-0.4898811213662354,-1.1650426533025706,0.2650918635170604,0.6879587303729872,1.0,4/14,13.49%,CD81;PRKCZ;IL18;CD74
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.4413746746091494,1.1648095910747718,0.251604621309371,0.8530223132434721,1.0,13/60,17.21%,SMOC2;KLF4;FGF2;NEK7;GRHL2;TNKS2;ATM;CHTF18;FBXO4;XRCC5;POLG2;CHTF8;ATR
prerank,positive regulation of protein acetylation (GO:1901985),-0.48451274647052445,-1.163924172270497,0.2911694510739857,0.6892673937264621,1.0,2/12,5.05%,RAPGEF3;PRKAA2
prerank,response to iron ion (GO:0010039),-0.4956775353186257,-1.16377759343348,0.2938271604938272,0.687915219292049,1.0,4/12,7.45%,B2M;BCL2;HIF1A;SNCA
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.4930653471302808,-1.1635785564897803,0.2804878048780488,0.6867751275867168,1.0,6/12,24.70%,ACLY;ASS1;IDH2;GLUD1;IDH3A;ACO1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.448271801071724,1.1628787596609156,0.27636849132176233,0.857923386097352,1.0,4/51,3.61%,THBS1;PGF;ANO6;CMKLR1
prerank,regulation of chromosome segregation (GO:0051983),0.5487652779155262,1.1624213073072578,0.315955766192733,0.8583892632922454,1.0,9/16,23.34%,SMC5;PUM2;PUM1;IHO1;RMI2;CSNK2A2;CSNK2A1;SMC6;KIF2C
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.47790220773716935,1.1624151979298356,0.29036827195467424,0.8574306720885148,1.0,10/39,11.89%,THBS1;EFNA5;SEMA3E;FZD7;GCNT2;JAG1;DMTN;RHOA;ITGB1BP1;CORO1C
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5126771940518583,-1.162288135954785,0.2964705882352941,0.68869870439376,1.0,5/11,12.78%,PARP14;PARP16;TIPARP;PARP8;PARP11
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.4749636934440463,1.161777295880542,0.26857142857142857,0.8583770478368912,1.0,10/33,17.12%,EGFR;ANXA1;EIF4G1;RDX;PLCG2;DDRGK1;LSM11;CCND1;ANKRD17;ADAMTS1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.4172265561546905,1.1616125156258201,0.25,0.8578763788014505,1.0,42/96,28.50%,NUP93;SMG6;SRSF11;THOC2;SRSF5;SRSF6;DDX19B;RANBP2;U2AF2;NUP153;SEC13;SRRM1;SMG1;FYTTD1;CASC3;NUP214;CHTOP;NUP188;U2AF1L4;NUP88;SRSF2;THOC5;ZC3H11A;NXF1;ALKBH5;NUP98;UPF2;FIP1L1;AAAS;NUP54;CDC40;HNRNPA2B1;CPSF3;UPF3B;SRSF3;RBM8A;RAE1;ALYREF;NUP155;NCBP2;CPSF4;SRSF7
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.47750738520938246,1.161571899787986,0.2609289617486339,0.8570333894863778,1.0,5/35,9.37%,PCDHB16;CDH11;PCDHB13;PCDHB9;PCDHB3
prerank,protein-containing complex assembly (GO:0065003),0.3877195453528097,1.1615233421514202,0.1921858500527983,0.8561958429276705,1.0,61/259,16.19%,FBXL7;TCF7L1;TCF7L2;REPS2;SOX9;PTK2B;FN1;HES1;ANO6;GSK3B;SEC24B;STX5;TLE2;CREBBP;DMD;MNAT1;DMTN;TRRAP;TEAD1;CSNK1A1;SEC16A;NSF;SLC9A1;MDM4;SHANK1;SAMM50;PARD3;SEC23A;ANKRD28;PPP6R3;MCU;SEC31A;CAPZA1;MATN1;ITGB1BP1;BCL9L;TIAM1;CNIH2;BIN2;ZC3H12A;SMARCA4;SEC13;KMT2D;SEC24D;SLC7A9;EP300;CUL3;TLE3;MAGI1;TRADD;PYGO1;DHX9;TLE4;TRAPPC10;SEC22B;PYGO2;CUL1;PML;SEC23IP;ADAM10;SAR1B
prerank,diterpenoid metabolic process (GO:0016101),0.4426381290270523,1.1610698466893563,0.28456375838926173,0.8565795310124011,1.0,9/55,8.66%,GPC6;ADH7;GPC3;STRA6;RBP1;RLBP1;LRP1;GPC4;PECR
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.4956345482872496,1.160473247825954,0.28160919540229884,0.8574312401177401,1.0,9/29,15.19%,RAB6A;TRAPPC3L;NSF;COG5;COPA;VTI1A;COG3;COPG1;TRAPPC10
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.33853660272224034,-1.1599938271955166,0.1821705426356589,0.6915342885453506,1.0,24/56,31.73%,NDUFB9;NDUFAF4;NDUFA8;NDUFC1;NDUFB11;NDUFAF8;NDUFB3;NDUFA1;NDUFB8;NDUFA3;NDUFS4;NDUFA11;NDUFA13;NDUFB7;FOXRED1;NDUFA6;NDUFA2;NDUFA10;NDUFS6;NDUFV3;BCS1L;DMAC1;TIMMDC1;NDUFS1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.33853660272224034,-1.1599938271955166,0.1821705426356589,0.6915342885453506,1.0,24/56,31.73%,NDUFB9;NDUFAF4;NDUFA8;NDUFC1;NDUFB11;NDUFAF8;NDUFB3;NDUFA1;NDUFB8;NDUFA3;NDUFS4;NDUFA11;NDUFA13;NDUFB7;FOXRED1;NDUFA6;NDUFA2;NDUFA10;NDUFS6;NDUFV3;BCS1L;DMAC1;TIMMDC1;NDUFS1
prerank,positive regulation of calcium ion import (GO:0090280),-0.4817619675446872,-1.1598473644865095,0.2691358024691358,0.6902066109450274,1.0,5/12,20.41%,PDGFRB;CXCL12;STC1;CCL2;SPHK2
prerank,chromatin assembly or disassembly (GO:0006333),0.57319742232234,1.1598259178782617,0.30594405594405594,0.8583992789173636,1.0,2/11,5.43%,CHAF1B;HDAC8
prerank,neurogenesis (GO:0022008),0.4609258003366001,1.1590341781347357,0.2749003984063745,0.8597873416840676,1.0,8/43,9.84%,SIX1;CIT;ANXA1;THOC2;NTN5;DAGLB;SIX4;BTBD3
prerank,cellular response to cadmium ion (GO:0071276),0.5037252974403811,1.1587787329762471,0.29013254786450665,0.8595717588432793,1.0,1/24,0.24%,EGFR
prerank,regulation of membrane repolarization (GO:0060306),0.565111273214807,1.1585527150816277,0.3094017094017094,0.8592936488723358,1.0,1/13,0.28%,KCNJ2
prerank,negative regulation of cell junction assembly (GO:1901889),0.497192143314994,1.158420713356154,0.2979942693409742,0.8587037819150197,1.0,5/25,6.57%,THBS1;PHLDB2;FAM107A;BCAS3;DMTN
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.5675797739516293,1.1584102820235658,0.2932454695222405,0.8577659547687753,1.0,2/12,6.21%,DPYSL3;CTPS2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3739008060315408,1.1582302097114467,0.14545454545454545,0.8573803339125249,1.0,115/476,16.75%,EGFR;BMP4;CDH1;ZFHX3;SIX1;MAP3K5;NFIB;SOX9;HDAC4;LRP6;MLLT3;TGFB3;WNT11;GLI3;FOXO3;HES1;ZBTB16;SHC1;ESR2;KLF4;INHBA;ZIC1;FGF2;MDFIC;FZD7;ELF1;ZNF423;FOXC2;TGFBR1;EHF;FOXK1;KAT6B;CD80;CREBBP;GLIS2;STAT3;ESR1;TBL1X;TADA3;TGFB1I1;GATA4;NFIL3;RORA;TRIM44;BAMBI;DDIT3;TASP1;IRF1;TEAD1;GDF6;IL10;PITX3;LHX2;ID2;FZD1;CHEK2;SIX4;GLI2;HIVEP3;RXRA;FOXC1;ATOH8;NFKB1;EGR2;NFYA;MED13;CHUK;SERTAD3;FBXW11;NIBAN2;ACVR1;GATA1;CTCFL;FOXE1;RARA;PIM2;SMAD2;JUN;WAC;LRP5;RNF111;FOXK2;BRCA2;RGMB;NKX2-1;SMARCA4;TCF3;KAT2A;PPM1A;HNF4A;HNF1A;HCFC1;SP3;PAX6;EP300;MED14;ZXDC;REST;ZMIZ1;RUNX2;NFATC1;MAP2K2;THRAP3;HINFP;CALCOCO1;PML;MED24;TFAP2A;NSD1;NAA15;RNF14;EPC1;TRIM16;EGF;JMJD6
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.5504720997575511,1.1579728441320956,0.32059800664451826,0.8572058449228069,1.0,2/14,3.61%,THBS1;CMKLR1
prerank,protein monoubiquitination (GO:0006513),0.469839763298155,1.1576712414616073,0.2733812949640288,0.8571675120481026,1.0,14/36,24.52%,KLHL22;UBE2B;UBE2D3;RNF126;WAC;CTR9;CUL3;FANCL;UBE2W;TRIM25;HUWE1;PAF1;UBE2O;UBE2R2
prerank,embryonic heart tube morphogenesis (GO:0003143),0.45905170545892443,1.1575994250261148,0.2656675749318801,0.8564419344662484,1.0,8/43,11.12%,MICAL2;SMO;HES1;TGFBR2;GATA4;ACVR1;MEGF8;CCDC40
prerank,regulation of interferon-alpha production (GO:0032647),0.5053966426076927,1.1572421434381501,0.30381679389312977,0.8565805256458374,1.0,12/23,21.37%,MAVS;RIPK2;SETD2;IL10;TLR4;CHUK;IFIH1;DHX9;TLR8;PTPRS;DHX36;IRF3
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.38578517148772795,-1.1570331997497563,0.2703583061889251,0.6962815945553853,1.0,5/32,5.11%,APOE;PPARA;PRKAG2;PRKAA2;ZBTB20
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.4662789935603383,1.1568757999685553,0.29346314325452016,0.8567558137227018,1.0,7/37,7.79%,EFNA5;PHLDB2;MAPRE2;GSK3B;FAM107A;GAS2L2;MARK2
prerank,RNA export from nucleus (GO:0006405),0.412769419337208,1.1563660555363993,0.2645631067961165,0.8574043352073456,1.0,43/100,28.50%,NUP93;SMG6;SRSF11;THOC2;SRSF5;SRSF6;DDX19B;RANBP2;U2AF2;NUP153;SEC13;SRRM1;SMG1;FYTTD1;CASC3;NUP214;CHTOP;NUP188;U2AF1L4;NUP88;SRSF2;THOC5;ZC3H11A;NXF1;RAN;ALKBH5;NUP98;UPF2;FIP1L1;AAAS;NUP54;CDC40;HNRNPA2B1;CPSF3;UPF3B;SRSF3;RBM8A;RAE1;ALYREF;NUP155;NCBP2;CPSF4;SRSF7
prerank,myotube differentiation (GO:0014902),-0.4509565948584334,-1.1561958425371544,0.29110512129380056,0.6969014038479265,1.0,5/17,8.79%,IGF1;SORT1;MEF2C;ADGRB3;ADAMTS15
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5329042985764086,1.156127751697051,0.31006493506493504,0.8571352159934528,1.0,4/17,10.75%,HDAC4;PID1;PFKFB1;NCOR1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.426559472943936,1.15611587086072,0.2711864406779661,0.8562120174347672,1.0,17/78,12.92%,EGFR;PID1;SORBS1;ITGB1;PRKCE;MRAP;ATP2B4;LRP1;RHOQ;PLS1;DLG1;AGR2;MMP14;STX8;RANGRF;PTPN9;ZDHHC2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.4585704145280466,1.1556337681374995,0.28898426323319026,0.856693185998025,1.0,13/42,19.51%,KDM1A;SETD2;FUS;SPIDR;PPP4R2;CHEK1;MRNIP;SHLD1;RMI2;SIRT6;RAD51;HELB;WDR48
prerank,autophagy of nucleus (GO:0044804),0.5448483557837092,1.1555433226618756,0.3180327868852459,0.8560347446191259,1.0,9/16,26.50%,ULK2;WIPI2;ATG3;RB1CC1;ATG2A;WDR45B;ULK1;ATG7;ATG5
prerank,SNARE complex assembly (GO:0035493),0.5793564480309757,1.1552101100852818,0.32460732984293195,0.856134800543126,1.0,2/10,7.32%,STXBP6;CLTRN
prerank,cardiac muscle cell action potential (GO:0086001),0.4802288953336795,1.1551582768254036,0.29172714078374457,0.8553384498643808,1.0,6/30,5.55%,KCNJ2;ANK2;ATP1B1;CACNA1C;CACNA1G;DMD
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.49214164074090194,-1.1551397302535384,0.2925,0.6981286006304086,1.0,5/12,25.35%,PCGF5;RBM15B;CDYL;METTL3;SMCHD1
prerank,striated muscle contraction (GO:0006941),-0.35371676295484356,-1.1550494028399265,0.21777777777777776,0.6966724659972583,1.0,11/53,14.48%,ATP1A2;DTNA;SLC8A1;RYR2;RCSD1;KCNQ1;STAC;ARHGEF11;CASQ2;GRK2;MYH14
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.5405521407012343,1.1549766083173234,0.31017770597738287,0.8549198235979821,1.0,6/14,20.62%,SRSF6;PCBP4;RBMX;U2AF2;SFSWAP;SRSF12
prerank,regulation of focal adhesion assembly (GO:0051893),0.44405755909241174,1.1547968197737637,0.26007802340702213,0.8545089951818746,1.0,17/54,11.89%,THBS1;EFNA5;PHLDB2;ABL1;NRP1;FAM107A;BCAS3;VCL;PTPRA;DMTN;SLC9A1;RHOA;S100A10;LIMS1;VEGFA;ITGB1BP1;CORO1C
prerank,phospholipid biosynthetic process (GO:0008654),0.4748299889238406,1.1547919343114925,0.2926829268292683,0.8535775627969535,1.0,13/36,20.17%,DHDDS;SGMS2;PIP5K1A;GNPAT;MBOAT1;MVD;CPNE3;AGK;HDHD5;CPNE1;FDPS;CLN3;LPCAT1
prerank,fatty acid catabolic process (GO:0009062),0.4297327354495893,1.1543154257746964,0.2742782152230971,0.8540727709910667,1.0,13/67,11.13%,ABCD3;EHHADH;BDH2;AUH;ECHDC1;PLA2G15;DECR1;ACOT8;ACADM;PECR;ACBD5;LPIN2;HACL1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.42090153892873766,1.1537249707733843,0.25953259532595324,0.8549137923830351,1.0,19/86,10.80%,EGFR;PTK2B;EFNA5;PRKCD;CD44;BMP6;ABL1;NRP1;ITGA5;CD80;RIPK2;DMTN;RAP2C;PDGFA;ACVR1;GATA1;PLCG2;VEGFA;ITGB3
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5543568577665654,1.1534456622334959,0.3486394557823129,0.8547874756225361,1.0,4/14,15.88%,PAICS;RFK;PFAS;GMPS
prerank,heart trabecula morphogenesis (GO:0061384),-0.43454962612049175,-1.1534401186686387,0.27676240208877284,0.6994665294351923,1.0,8/18,7.98%,ENG;TEK;TGFBR3;RBP4;NOTCH1;BMP7;RBPJ;S1PR1
prerank,regulation of viral entry into host cell (GO:0046596),-0.3835903666438869,-1.1534183415622594,0.2523076923076923,0.6978359376981831,1.0,12/30,19.06%,LY6E;HS3ST5;TRIM14;LGALS1;IFITM1;TRIM62;IFITM3;NECTIN2;CD74;TRIM21;SNX3;P4HB
prerank,anion transmembrane transport (GO:0098656),0.42384281571297955,1.1529425115354535,0.2775,0.8554459514400073,1.0,4/67,1.34%,SLC23A1;SLC23A2;SLC5A6;LRRC8D
prerank,inositol lipid-mediated signaling (GO:0048017),0.45420229202269363,1.1528672947704641,0.2826666666666667,0.8547472281829137,1.0,10/50,4.57%,PLCE1;TNFAIP8L3;NGF;EZR;FGFR1;PLCB3;GAB2;IRS1;PIK3C2B;PLCZ1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.4492966839844969,-1.1528254842332133,0.2768361581920904,0.6977978447651048,1.0,7/18,11.72%,SHANK3;NRXN1;RIMS1;RIMS2;PRKCZ;GRIN1;CUX2
prerank,regulation of apoptotic process (GO:0042981),0.371619185981202,1.1527059158405482,0.11088709677419355,0.8542761305137615,1.0,118/676,14.85%,SLIT2;EGFR;THBS1;BMP4;RASSF2;CARD14;FSTL1;MAP3K5;GRK5;PERP;SOX9;CYP1B1;HOXA5;NGF;ARHGAP10;EGLN3;TCIM;PTK2B;TGFB3;NDRG1;ANXA1;AKAP13;WNT11;PAWR;SMAD6;FOXO3;FBXO10;CD44;ANXA4;GCLC;VAV2;ANO6;SHC1;TAX1BP1;ITGB1;CRADD;GSK3B;NOTCH2;UNC13B;ABL1;ERC1;IP6K2;SERPINB9;SON;TIAM2;VCP;CASP6;SFRP4;DNAJC3;CREBBP;TRIO;GADD45G;GDNF;CLU;GOLPH3;RIPK2;BIRC6;GAS1;CALHM2;ARHGEF6;IL10;BIRC7;SOCS2;SIX4;PLK3;ERCC5;NFKB1;RIPK3;WRN;NIBAN2;NF1;BCLAF1;RBM25;ATM;GNA13;NTSR1;RARG;GATA1;PIM2;MTDH;VEGFA;PROK2;APEX1;JUN;ARF4;DIABLO;ATF6;USP47;KRT18;HTATIP2;UBE2Z;ARHGEF5;DDX42;TIAM1;ARL6IP5;COPS5;MYD88;AATF;DDRGK1;SOS2;RNF122;PRKDC;OMA1;YME1L1;BAG3;PAK2;PLSCR3;PRDX5;FATE1;TMEM219;HTR2B;BCL6;TRADD;REST;CEACAM5;MAD2L1;STIL;SQSTM1
prerank,cellular response to sterol (GO:0036315),0.5627133508846704,1.1526446309749503,0.3163934426229508,0.8535064616626572,1.0,4/13,7.16%,LRP6;SMO;RORA;GRAMD1C
prerank,positive regulation of ion transport (GO:0043270),0.4503575959852337,1.152339247810792,0.2774725274725275,0.8534900776295594,1.0,8/48,8.71%,FHL1;ANK2;ANO6;STIM2;GDNF;DLG1;CRACR2A;P2RX4
prerank,blood vessel diameter maintenance (GO:0097746),0.4812543567538191,1.1523195055360058,0.2865583456425406,0.8526165143981753,1.0,4/34,4.32%,EDNRA;KCNMB2;GCLC;AGTR1
prerank,response to molecule of bacterial origin (GO:0002237),0.4256448240594958,1.1522732064169943,0.2855313700384123,0.8518251760220847,1.0,9/69,9.50%,FOXP1;LBP;SMAD6;SLPI;IL10;TLR4;CXCL2;IRAK3;ERBIN
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.4947819830806876,1.1521085623202192,0.31563845050215206,0.8514005291090442,1.0,5/27,4.65%,PID1;PRKCD;GRB10;IRS1;PTPN2
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3760989462826316,1.1519213359261729,0.18575851393188855,0.8509993838228803,1.0,52/348,10.80%,EGFR;BMP4;SLCO3A1;RASSF2;CARD14;NTRK3;SOX9;BMP5;NGF;PGF;CCN1;PDGFC;PTK2B;EFNA5;TGFB3;DDR2;CD44;KRAS;NIBAN1;LIMK2;BMP6;INHBA;BMPR1A;FGF2;DOCK7;ABL1;NRP1;TGFBR1;RAP1A;EIF4G1;ITGA5;CD80;ATP2B4;MAVS;RIPK2;FAM20A;GDF6;GDF5;RAP2C;PDGFA;BCAR3;IQGAP1;GDF10;ACVR1;GATA1;AKAP9;RB1CC1;PLCG2;VEGFA;CAB39;INHBB;ITGB3
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.46626269901508144,1.1518460255882061,0.3047619047619048,0.8502642648176041,1.0,13/40,13.21%,TCF7L2;TGFB3;TGFBR1;TGFBR2;GCNT2;JAG1;TGFB1I1;BAMBI;FOXC1;SMAD2;BCL9L;TIAM1;MTOR
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5504857652630346,1.1510274970913048,0.3350253807106599,0.8517820432822294,1.0,4/15,8.70%,LRP6;EDA;GLI2;FOXC1
prerank,autophagy of mitochondrion (GO:0000422),0.4618239443851945,1.1503581899678472,0.27932960893854747,0.8527531480698014,1.0,16/38,26.50%,ULK2;WIPI2;BECN1;ATG3;MARK2;RB1CC1;CISD2;SQSTM1;AMBRA1;ATG2A;WDR45B;ULK1;BNIP3;ATG7;USP30;ATG5
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.4156771731033432,1.149997599613138,0.2638717632552404,0.8529591069412799,1.0,26/84,25.47%,FZR1;ECRG4;ANAPC5;CDC16;PSMB2;ANAPC16;AURKA;PSMC6;RB1;PSMD11;UBE2S;CUL3;MAD2L1;PSMD1;PSMD7;PSMC1;PSMD14;ANAPC11;PSMD3;ANAPC10;CDK2;CCNB1;CDC20;PSMD12;BUB3;PSMD4
prerank,cellular metal ion homeostasis (GO:0006875),0.4084532837260672,1.1496574791690408,0.2577937649880096,0.8530220557806835,1.0,25/102,14.30%,KCNJ2;SLC12A2;SLC24A3;ANK2;ATP1B1;ATP2C2;CSRP3;STIM2;ATP2B4;SLC10A7;CASR;CLDN16;SLC9A1;ATP1A4;ATP1A3;ATP1A1;DRD3;TNNI3;CCL3;CCL1;SLC8B1;CCL7;RMDN3;NPTN;HTR2B
prerank,establishment of skin barrier (GO:0061436),0.5335311566337481,1.1493707669930975,0.3122977346278317,0.8520408822941,1.0,1/15,0.77%,MET
prerank,regulation of water loss via skin (GO:0033561),0.5335311566337481,1.1493707669930975,0.3122977346278317,0.8520408822941,1.0,1/15,0.77%,MET
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4174749204678982,1.1493131623804558,0.2675709001233046,0.8512945455729293,1.0,17/85,13.09%,EGFR;BMP4;TCF7L2;SOX9;BMP5;BMP6;FGF2;NR4A3;SRSF6;GDF5;SIX4;LIMS1;VEGFA;ERBB2;DUSP10;NR4A1;PRKDC
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4916997567387675,1.149292597846912,0.3208092485549133,0.8504402918269616,1.0,5/28,4.65%,PID1;PRKCD;GRB10;IRS1;PTPN2
prerank,cellular potassium ion homeostasis (GO:0030007),0.566412232120074,1.149204051887485,0.3174872665534805,0.8498167614635305,1.0,6/13,8.95%,KCNJ2;SLC12A2;ATP1B1;ATP1A4;ATP1A3;ATP1A1
prerank,acute-phase response (GO:0006953),0.557151113726602,1.1491959332443216,0.3088235294117647,0.8489257991225542,1.0,2/12,6.58%,LBP;PLSCR1
prerank,regulation of histone deacetylation (GO:0031063),0.5584062543463386,1.1487004087653472,0.3,0.8495151182512912,1.0,4/13,13.88%,CAMK2D;ZBTB7B;NIPBL;PRMT6
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3836096911573906,-1.1486878907137663,0.23310810810810811,0.7073429826418229,1.0,11/34,11.25%,FLT1;SEMA6A;PRKD1;KDR;NOTCH1;DAB2IP;ERN1;SPHK1;RAMP2;FLT4;NUS1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5567482861777159,1.148639380085684,0.3230769230769231,0.846956863565624,1.0,5/12,20.76%,ANAPC5;CDC16;RB1;CUL3;ANAPC11
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5567482861777159,1.148639380085684,0.3230769230769231,0.846956863565624,1.0,5/12,20.76%,ANAPC5;CDC16;RB1;CUL3;ANAPC11
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5567482861777159,1.148639380085684,0.3230769230769231,0.846956863565624,1.0,5/12,20.76%,ANAPC5;CDC16;RB1;CUL3;ANAPC11
prerank,response to ionizing radiation (GO:0010212),0.42370640392309594,1.1483841277372075,0.25625,0.8468313926702664,1.0,22/70,20.13%,ANXA1;TANK;CLK2;EYA3;ATM;NABP1;MTA1;SPIDR;COP1;UIMC1;RNF168;KDM4D;MRNIP;USP28;TNKS1BP1;INO80;TICRR;CDKN1A;RAD51;BRAT1;TOPBP1;RNF8
prerank,negative regulation of immune system process (GO:0002683),0.5341260407941131,1.1483399342790306,0.32643312101910826,0.8460513130962044,1.0,2/16,2.47%,SOX9;COL3A1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.35111361203272246,-1.1483136819270823,0.208,0.7066387454235517,1.0,10/47,6.42%,IGF1R;PHLPP1;TGFBR3;FOXO1;EPHB1;RAP2A;PPIA;DAB2IP;MAP4K4;FAS
prerank,UV protection (GO:0009650),0.5837331419318897,1.1480777895928214,0.3185689948892675,0.8459171196709597,1.0,2/10,8.66%,SCARA3;ERCC5
prerank,positive regulation of T cell proliferation (GO:0042102),-0.3369765456503353,-1.1476814192970821,0.2151394422310757,0.7066837313641708,1.0,10/55,14.82%,IGF1;IGFBP2;VCAM1;TFRC;RPS3;IL18;IL6ST;ICOSLG;CCL19;JAK3
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.4930166029989325,1.1475129855472468,0.28763040238450077,0.8466346116154708,1.0,1/23,0.11%,SLIT2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.500800060346163,-1.147342752859033,0.31009615384615385,0.7059976030254542,1.0,5/11,19.26%,EFNB2;MEF2C;MYOCD;GREM1;GPER1
prerank,positive regulation of B cell activation (GO:0050871),-0.3487449631247018,-1.1472426735648855,0.22127659574468084,0.7045921345293091,1.0,19/50,23.70%,BCL2;TFRC;SH3KBP1;MEF2C;CD81;VAV3;CD38;TNIP2;RIF1;MIF;CD74;CD40;BTK;XBP1;SYK;SHLD3;IL7;NFATC2;BST1
prerank,dorsal/ventral pattern formation (GO:0009953),0.5207544740622088,1.1470689718096487,0.3338557993730408,0.8470545550105094,1.0,6/20,9.60%,BMPR1A;MDFI;NOG;NBL1;GLI2;ACVR1
prerank,regulation of immune effector process (GO:0002697),0.4607699660020575,1.1469936059558046,0.2984441301272984,0.8463834922001588,1.0,6/41,9.13%,CFH;CD55;CLU;SERPING1;CR1L;CD46
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.543567587893141,1.1468285211890887,0.33060556464811786,0.8459596460090877,1.0,2/13,1.59%,ANK2;CACNA1C
prerank,negative regulation of gluconeogenesis (GO:0045721),0.565933576520343,1.1464331959621308,0.3128205128205128,0.8462336343401216,1.0,4/11,13.97%,CLK2;C1QTNF12;ERFE;EP300
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.5721695645396849,1.1463374512891393,0.32367972742759793,0.8456084828864224,1.0,2/12,1.66%,UST;DSE
prerank,chromatin organization (GO:0006325),0.3954274803203863,1.1459661383059205,0.2494279176201373,0.8458009614470581,1.0,34/132,18.40%,TCF7L1;SOX9;HDAC4;HDAC8;HMG20A;ESR1;MYSM1;SETD2;EHMT1;CHD1L;BAZ2B;TOP1;NUDT5;DDX11;BPTF;BAZ1A;RB1;SMARCA4;ATRX;KAT2A;PBRM1;SETD5;HCFC1;KDM4D;HDAC10;BAZ2A;BRWD1;ZBTB1;ZBTB7A;KAT2B;INO80;SMARCC1;SATB2;EZH1
prerank,ephrin receptor signaling pathway (GO:0048013),-0.3148755152428704,-1.1458950712060911,0.24571428571428572,0.7065742011476869,1.0,27/82,12.61%,EFNB2;LYN;EPHA7;PAK1;EPHB1;ACTB;CHN1;GRIN2B;EPHA4;EPHB4;EPHA8;PTK2;EPHA6;VAV3;GRIN1;RAC1;DNM1;PAK3;ARPC4;SDCBP;ARHGEF7;EFNB3;ROCK2;APH1B;ARPC5;ARPC3;NGEF
prerank,synapse assembly (GO:0007416),-0.3299848753355856,-1.1457753632288585,0.24519230769230768,0.7052920322562248,1.0,17/67,8.53%,ADGRL3;DNM3;CDH2;SHANK3;SPOCK2;NRXN1;GRID2;WNT5A;GPM6A;PLXND1;KIRREL3;GABRA2;GABRB2;OBSL1;LRRTM3;GABRB3;GABRA1
prerank,membrane assembly (GO:0071709),-0.37978775238034024,-1.1454170533937298,0.24271844660194175,0.7045719965801142,1.0,6/34,3.53%,IL1RAPL1;NRXN1;PICALM;RFTN1;ANK3;UGCG
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.41548793667994477,1.1452169901996896,0.2770935960591133,0.847159658997817,1.0,16/76,12.46%,CYP1B1;PTGIS;ANXA4;TAX1BP1;KLF4;CMKLR1;DDIT3;IL10;G3BP2;CHUK;IRAK3;ERBIN;COMMD1;USP7;ZC3H12A;CHP1
prerank,androgen metabolic process (GO:0008209),-0.43809263204964943,-1.1447702763750358,0.27717391304347827,0.7047169227015848,1.0,14/18,44.21%,SPP1;HSD17B7;MED1;SRD5A1;SHH;HSD17B10;HSD17B11;HSD17B4;SRD5A2;HSD3B2;DHRS9;HSD17B6;HSD17B3;AKR1D1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.44004552580478873,-1.1447359777146056,0.28055555555555556,0.7031463604799392,1.0,7/18,12.00%,IL34;DAAM2;TNFRSF21;NOTCH1;TENM4;OPALIN;MDK
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.3808142649661726,-1.1447028728166875,0.22666666666666666,0.7015831202266926,1.0,6/34,9.28%,IGF1;TGFA;PDGFRB;INSR;EDN1;RGCC
prerank,cellular response to DNA damage stimulus (GO:0006974),0.37162231336365614,1.1445073378006725,0.1919917864476386,0.8484036470598183,1.0,115/336,21.99%,FOXP1;TANK;ABL1;HERC2;VCP;UBE2B;SUSD6;UBR5;MNAT1;GNL1;DDIT3;EXO1;TRRAP;TRIP12;IKBKE;MCM7;CHEK2;PLK3;CHD1L;RAD17;CEP63;DCUN1D5;WRN;APLF;ATM;CBX5;USP10;BOD1L1;APEX1;WAC;IGHMBP2;SMC1A;MAPK12;DDX11;SMC5;USP47;RAD52;NABP1;NIPBL;AATF;ZC3H12A;SPIDR;TNFRSF1B;ALKBH8;SLX4;MACROD2;RNF168;PRKDC;CHEK1;XRCC5;MRNIP;DYRK2;CSNK1E;BCL6;ERCC8;POLB;ATF2;CCND1;MCM9;EID3;MAPKAPK2;FANCL;POLE2;KIN;HINFP;ZBTB1;PIDD1;PML;TLK2;RBBP8;VCPIP1;YY1;ERCC3;XPA;CASP2;PARP3;RPA1;IKBKG;RECQL5;USP28;ATR;BARD1;RMI2;SMARCAL1;INO80;NBN;TICRR;CDKN1A;RAD51;BRAT1;ERCC1;ALKBH7;NCOA6;TOPBP1;MOAP1;HELB;FMR1;WDR48;E2F1;RNF8;PARP4;RAD51B;KMT5B;POLA1;WDR76;RAD51C;NRDE2;SMC6;MCL1;IRF3;NUDT1;RAD50;CBX1;CUL4A;RAD9B
prerank,phospholipid metabolic process (GO:0006644),0.43083342541228076,1.1443206243847657,0.28169014084507044,0.848092061595783,1.0,14/71,15.02%,TNFAIP8L3;PLPPR2;PLPP3;PNPLA3;PLA2G4F;PIP5K1A;PLA2G15;GNPAT;MBOAT1;LCAT;PLPP1;PDXP;PLA2G2C;PLCD1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.43469289654936005,1.1442217416909446,0.2862694300518135,0.8474595006633829,1.0,17/56,21.22%,EGFR;ANXA1;ANAPC5;EIF4G1;CDC16;CDC25B;RDX;RB1;LSM11;CUL3;CCND1;ANKRD17;ADAMTS1;KLHL18;RAD51B;ANAPC11;RAD51C
prerank,negative regulation of neurogenesis (GO:0050768),-0.3773389918479203,-1.1442065337155816,0.2701612903225806,0.7013169997770695,1.0,8/34,11.52%,B2M;RAPGEF2;NOTCH1;ARHGDIA;MAG;RTN4;LINGO1;EFNB3
prerank,sarcomere organization (GO:0045214),0.48868923510880286,1.1441018423892009,0.29300291545189505,0.8469014988308051,1.0,4/27,8.09%,CSRP3;KRT19;CSRP2;SIX4
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.4060550025427112,1.143645775978933,0.2589073634204275,0.8472824347824519,1.0,26/112,10.62%,SMAD9;SOX9;TGFB3;ADAM9;SMAD6;COL3A1;ITGB1;BMPR1A;ID1;ITGB5;TGFBR1;LTBP2;TGFBR2;GCNT2;SKI;BAMBI;GDF5;NLK;RHOA;GDF10;LIMS1;ACVR1;USP15;PARD3;SMAD2;JUN
prerank,regulation of macromolecule metabolic process (GO:0060255),0.39174423069236564,1.1435043777392233,0.24551569506726456,0.8468152220925221,1.0,37/170,17.67%,FOXP1;CDH1;PRDM6;ATP1B1;AFF3;YBX3;COQ7;NELL1;ZFP64;TSKU;C1D;LDLR;HMG20A;GDNF;PTHLH;TRIM44;TOB2;AFF4;IL10;PCBP4;TOB1;TRIM26;KIF16B;MEGF8;MKLN1;TCF19;ZC3H12A;REST;ZNF507;HINFP;TRIM39;PRDM5;ZNF462;SCARB2;GNB3;HMG20B;ZUP1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.498550727765829,-1.1434673662803727,0.3251231527093596,0.7016707536521894,1.0,3/11,5.39%,LYN;RAPGEF2;MEF2C
prerank,zymogen activation (GO:0031638),0.4609151430255367,1.1429412876389733,0.3131868131868132,0.8476246621493698,1.0,5/39,8.15%,CYFIP2;PERP;PRSS12;RIPK2;MMP14
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.5078904423774079,-1.1426562374246638,0.3248730964467005,0.70231534436055,1.0,4/11,17.04%,NOVA1;NOVA2;PCBP3;PCBP1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.503532033865477,1.142366921535756,0.3090062111801242,0.8484508963162678,1.0,11/21,23.35%,SAMD4A;PAN3;TUT7;CNOT7;TUT4;TNKS1BP1;CNOT4;PNLDC1;CNOT11;SAMD4B;CNOT3
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.45005228964687777,-1.141357102068894,0.27807486631016043,0.7041928128484316,1.0,4/17,13.65%,SLC7A5;PRKCQ;PRKCZ;HAVCR2
prerank,negative regulation of ossification (GO:0030279),0.5084072535253326,1.1407484047941976,0.32589285714285715,0.8523225020654388,1.0,4/23,4.92%,SOX9;PTK2B;SMAD6;TRPM4
prerank,protein import (GO:0017038),0.4146719348402666,1.1396359758622294,0.2904761904761905,0.8545950546041703,1.0,22/84,20.44%,ABCD3;PRICKLE1;NUP93;PXMP2;STAT3;E2F3;IPO7;CLU;TNPO2;ACBD5;SAMM50;NUP153;SEC13;PEX13;NUP214;NUP188;ABCD1;NUP88;HEATR3;TNPO3;RAN;NUTF2
prerank,positive regulation of immune system process (GO:0002684),0.5437607559440429,1.1390688507550137,0.32682926829268294,0.8554590946886422,1.0,5/16,25.86%,ANXA1;VEGFA;TGFB2;MIA3;IL15
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.38080332958520163,-1.138908425036377,0.27009646302250806,0.7091291637200224,1.0,7/30,8.57%,ROBO1;ARHGEF3;F11R;LPAR1;NET1;ADGRG1;RAC1
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.522841693906956,1.1388658946446217,0.3333333333333333,0.8551748016846517,1.0,2/18,1.69%,STK39;CAMK2D
prerank,negative regulation of viral transcription (GO:0032897),-0.4668919009691339,-1.138773044294765,0.3012345679012346,0.7078641893472118,1.0,6/13,26.09%,TRIM14;TRIM62;IFITM3;TRIM21;TRIM27;TRIM32
prerank,calcium ion transport (GO:0006816),0.40167030855866936,1.138183306419355,0.2727272727272727,0.8562810747079175,1.0,19/113,7.40%,SLC24A3;PKD1;RAMP1;ANK2;CACNA1C;ATP2C2;ANO6;TRPM6;CACNA1G;NALCN;TRPM4;STIM2;ATP2B4;ITGAV;TRPM7;CASR;CRACR2A;CACNG6;CACNA1F
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.42771992600073305,-1.1380080155946393,0.2765957446808511,0.708318195763602,1.0,9/17,32.49%,ADRA2A;MFSD2A;AKT1;PDE3B;APOC1;ALK;GPLD1;PLIN5;CIDEA
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.521969561759603,1.1379789837926422,0.3375594294770206,0.8559500162717186,1.0,5/17,4.34%,DOCK5;IGFBP5;DOCK7;NRP1;NR4A3
prerank,regulation of neuron death (GO:1901214),-0.31983962390121284,-1.1377316979372651,0.1702127659574468,0.707458417772493,1.0,17/82,9.42%,EFNB2;PICALM;GRID2;WNT5A;EPHB1;DCC;CSF1;TRIM2;GRIN2B;CD34;MEF2C;PPARGC1A;SNCA;CTSZ;MAPT;C1QA;FAIM2
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.33490088917493194,-1.1377133616655828,0.21551724137931033,0.7058856376821281,1.0,15/57,12.58%,RPL38;RPS19;RPS16;RPS15;RPS24;RPS7;RPL26;RPS25;RPL35A;RPL11;RPL7;RPS17;NOC2L;NPM1;RPL14
prerank,sympathetic nervous system development (GO:0048485),0.5284358222947321,1.1372428341552125,0.3166926677067083,0.857260575183188,1.0,3/15,9.42%,NRP1;GDNF;NF1
prerank,microvillus organization (GO:0032528),0.5532117535548989,1.1371923136168698,0.3480392156862745,0.856521271068112,1.0,5/13,8.03%,FXYD5;EZR;RAP1A;RAPGEF6;RAP2C
prerank,oxoacid metabolic process (GO:0043436),-0.38848220592227206,-1.1371225000945016,0.2668621700879765,0.7059008670033292,1.0,6/27,15.12%,DDO;ENPP1;TPST1;SULT4A1;MIF;AGXT
prerank,fibrinolysis (GO:0042730),-0.4774777956537173,-1.136985974649553,0.30927835051546393,0.7046871646425995,1.0,8/13,40.54%,PLAT;HRG;PLAUR;PLG;CPB2;SERPINE1;GP1BA;F2
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.5541584406634007,1.1369602609011789,0.3397212543554007,0.8563138919003016,1.0,3/13,7.32%,KCNB1;CACNA1G;CLTRN
prerank,mitochondrial transcription (GO:0006390),0.5732404668064482,1.136689358038555,0.35343383584589616,0.8561801735464025,1.0,1/10,2.21%,FOXO3
prerank,diol biosynthetic process (GO:0034312),0.5291262732185835,1.136532008352913,0.3218210361067504,0.8557562771272568,1.0,1/15,0.61%,ACER3
prerank,cell projection organization (GO:0030030),0.4868262521627552,1.136328146230883,0.3260233918128655,0.8554708175856784,1.0,7/30,10.47%,RHOJ;PARVA;GSN;ITGB1;RHOQ;PDGFA;NCKAP1
prerank,sulfur compound catabolic process (GO:0044273),-0.37173219794815276,-1.1356932222057634,0.2491349480968858,0.7065336231065658,1.0,18/38,23.89%,FMOD;OGN;DCN;GGT5;LUM;OMD;CSPG5;NCAN;IDS;HEXB;PRELP;GGT1;GALNS;GGT7;CSPG4;ACAN;BCAN;TXN2
prerank,mRNA transport (GO:0051028),0.4041500108726462,1.135390861858668,0.2815533980582524,0.8573244209524205,1.0,43/101,28.50%,NUP93;SMG6;SRSF11;THOC2;SRSF5;SRSF6;DDX19B;RANBP2;U2AF2;NUP153;SEC13;SRRM1;SMG1;FYTTD1;CASC3;NUP214;CHTOP;NUP188;U2AF1L4;NUP88;SRSF2;THOC5;ZC3H11A;FMR1;NXF1;ALKBH5;NUP98;UPF2;FIP1L1;AAAS;NUP54;CDC40;HNRNPA2B1;CPSF3;UPF3B;SRSF3;RBM8A;RAE1;ALYREF;NUP155;NCBP2;CPSF4;SRSF7
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3753681188897405,1.1351336981800932,0.24866023579849947,0.857132298308277,1.0,52/234,14.72%,SLCO3A1;CARD14;HDAC4;LRP6;EDA;SMO;DDR2;ANXA3;PLPP3;ESR2;ERC1;RAB7B;TAB3;STAT3;ESR1;KDM1A;MAVS;CLU;ROR1;DDIT3;RIPK2;IKBKE;IL10;FZD1;JUP;RIPK4;TLR4;NFKB1;CHUK;RIPK3;IRAK3;PLCG2;MTDH;VEGFA;NFKB2;TRIM26;TRIM41;TNFSF11;ARHGEF5;COPS5;MYD88;TRAF5;DDRGK1;CARD16;PPRC1;SMARCA4;TCF3;CRTC1;EP300;TRADD;DHX9;ATF2
prerank,hyaluronan metabolic process (GO:0030212),0.49814459125206767,1.134952921604363,0.3159509202453988,0.8567916633370198,1.0,7/23,12.46%,CD44;FGF2;HEXA;SPAM1;SLC9A1;HAS1;CHP1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.34210505695293125,-1.1343403981062634,0.25555555555555554,0.7086197499832221,1.0,17/51,10.34%,LIMCH1;PPM1E;RAPGEF3;PAK1;CCN2;LPAR1;EVL;CD47;ARHGEF15;SYNPO2;CCDC88A;FHOD1;SYNPO;RAC1;RGCC;PLEK;NF2
prerank,DNA replication checkpoint signaling (GO:0000076),0.5317663006366605,1.134007671700551,0.33878887070376434,0.8585760643507321,1.0,6/16,21.99%,RAD17;CLSPN;CDC45;TICRR;TOPBP1;RAD9B
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.44513056994344563,1.1332354940923082,0.3024193548387097,0.8599302066039736,1.0,7/48,3.72%,THBS1;RHOJ;ANXA1;HDAC9;FGFR1;FGF2;FOXC2
prerank,nucleosome organization (GO:0034728),0.4432226742595168,1.133170822151757,0.31048387096774194,0.8592278264308616,1.0,15/55,20.67%,SOX9;CHAF1B;KAT6B;SETD2;SRCAP;BPTF;SMARCA4;ATRX;VPS72;INO80;SMARCC1;NAP1L2;SMARCA5;RNF8;CHAF1A
prerank,regulation of RNA export from nucleus (GO:0046831),0.5592494318619602,1.1329746908116125,0.34271523178807944,0.8588907017392697,1.0,7/11,27.79%,SETD2;NUP153;DHX9;KHDRBS1;NRDE2;AKAP8L;NCBP2
prerank,smooth muscle tissue development (GO:0048745),0.5757838295082773,1.1327980060571359,0.34205933682373474,0.8585137734659721,1.0,3/10,4.11%,BMP4;SMO;STRA6
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.4432021881557797,1.1323881463256107,0.2898550724637681,0.8588232730566133,1.0,10/49,13.97%,SMAD6;GSK3B;PMEPA1;ISL1;ANKRD27;CLU;DACT1;LDLRAD4;PPM1A;EP300
prerank,ether lipid biosynthetic process (GO:0008611),0.5840686473872023,1.1323168002997424,0.35478260869565215,0.8581504521913896,1.0,5/10,22.81%,AGPS;PEDS1;GNPAT;PLA2G4A;PEX7
prerank,regulation of double-strand break repair (GO:2000779),0.45248566274319296,1.1322714166508803,0.3155680224403927,0.857391892018747,1.0,13/39,17.91%,UBR5;KDM1A;SETD2;TRIP12;DDX11;SPIDR;PPP4R2;CHEK1;MRNIP;TWIST1;PML;SIRT6;RAD51
prerank,body fluid secretion (GO:0007589),-0.4585584707574439,-1.1321665021870713,0.29484029484029484,0.7129173392380931,1.0,4/15,9.86%,NPR1;SLC22A4;ERBB4;SLC22A2
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.5364966417232699,1.1319858827965397,0.315359477124183,0.8573481467119748,1.0,3/15,9.39%,TGFB3;IL10;IRAK3
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5473152566908918,1.1312796454460494,0.34003350083752093,0.8586224473706415,1.0,5/13,20.32%,RHOQ;ENTPD7;AK4;AK3;RAN
prerank,excitatory postsynaptic potential (GO:0060079),-0.4236197918301481,-1.131136713465722,0.2784090909090909,0.7140820408802495,1.0,8/19,15.26%,GRID2;GRIN2A;GRIN2B;MEF2C;GRIN1;GSK3A;ARRB2;AKT1
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.36674793918560805,-1.13082352118858,0.25,0.7133980481527628,1.0,8/33,19.29%,IGF1;TFRC;BCL2L1;MAPT;VAT1;AKT1;TMEM14A;TRIAP1
prerank,response to acidic pH (GO:0010447),0.5345945524536635,1.1308136851735957,0.334453781512605,0.8591643348641641,1.0,6/13,23.02%,GPR4;SLC9A1;CHP1;GPR65;RAB11B;PKD2L1
prerank,synaptic vesicle endocytosis (GO:0048488),-0.3840450793896838,-1.130760390586047,0.26490066225165565,0.7119609782666612,1.0,8/33,9.33%,DNAJC6;DNM3;PICALM;OPHN1;SNCA;SNAP91;DNM1;SYT1
prerank,retinoid metabolic process (GO:0001523),0.4167953862325321,1.1306944496127913,0.3053435114503817,0.8586078312730371,1.0,9/71,5.58%,GPC6;CYP1B1;ADH7;GPC3;STRA6;RBP1;CYP2S1;RLBP1;LRP1
prerank,regulation of defense response to virus by host (GO:0050691),0.47825819486581783,1.13069353852255,0.315028901734104,0.8577300676123053,1.0,8/30,14.67%,TRAF3IP2;MAVS;TRIM44;ZDHHC11;ZC3H12A;EIF2AK4;IFNLR1;DHX9
prerank,positive regulation of signal transduction (GO:0009967),0.3761780871246141,1.1305433563523126,0.2426470588235294,0.8573049964470557,1.0,44/238,11.77%,RSPO3;SMOC2;F3;CCN3;NTRK3;PTK2B;SMO;PTGIS;SULF1;GRB10;SORBS1;CRADD;BMP6;SLC39A14;IRS1;NRP1;TGFBR1;ZBTB7B;ITGA5;CD80;CREBBP;SKI;STAT3;ITGAV;JAG1;TRIM44;DMTN;RSPO4;SHANK1;DISC1;DRD3;AAK1;DACT1;LIMS1;KIF7;C1QTNF12;ELF3;ITGB3;LIMS2;TNFSF11;EVC;ITGB1BP1;ERFE;ADAMTS3
prerank,regulation of cation transmembrane transport (GO:1904062),-0.3868166933051579,-1.1304249935683648,0.2785923753665689,0.7112827126334897,1.0,10/29,11.00%,KCNIP4;CACNA1D;KCNIP3;FGF12;KCNAB1;DPP10;CD63;KCNIP1;KCNN2;DPP6
prerank,cell cycle G1/S phase transition (GO:0044843),0.4271550276247763,1.1302057292422298,0.2928388746803069,0.8574103471214016,1.0,19/61,19.76%,CCNA2;INHBA;MNAT1;E2F3;PLK3;CDKN1B;ACVR1;GSPT1;PIM2;RB1;CDKN3;CUL3;CCND1;HINFP;CUL1;KHDRBS1;CDKN1A;E2F1;PPP6C
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.40627742142089684,1.1299955016327148,0.2973621103117506,0.8571498103921317,1.0,20/87,9.67%,PTK2B;EZR;EFNA5;SEMA3E;PRKCD;ARHGDIB;ARHGAP44;RHOBTB1;NOTCH2;ABL1;FAM107A;LRP1;RHOQ;DMTN;ARHGAP17;PDGFA;RND3;RHOA;IQGAP1;MLST8
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.38555012038850195,1.1297278160073991,0.2786127167630058,0.8570508735491214,1.0,37/145,23.42%,FBXL7;FHL1;SFI1;PAFAH1B1;PCM1;CDC25B;PSMB2;CEP164;CEP63;AURKA;AKAP9;PSMC6;CEP131;USP47;PSMD11;CSNK1E;CCND1;PSMD1;SDCCAG8;CUL1;CEP43;HAUS2;CEP57;PSMD7;PSMC1;CEP70;PSMD14;CSNK1D;RAD51B;RAD51C;PSMD3;OFD1;CNTRL;HAUS5;PLK4;CDK2;CCNB1
prerank,regulation of protein export from nucleus (GO:0046825),0.4961550210211393,1.1294592632396208,0.33037037037037037,0.8569910498008192,1.0,6/23,17.46%,TCF7L2;GSK3B;EMD;BAG3;BARD1;XPO4
prerank,cortical cytoskeleton organization (GO:0030865),0.4530786754112322,1.1294060684057554,0.3021978021978022,0.8562715742029094,1.0,9/41,10.47%,FMNL2;EZR;PPP2R3C;RHOBTB1;RHOQ;DLG1;RND3;RHOA;NCKAP1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.5102104903727831,1.1293216757153979,0.35331230283911674,0.855657464143911,1.0,10/19,21.37%,MAVS;RIPK2;SETD2;TLR4;CHUK;IFIH1;DHX9;TLR8;DHX36;IRF3
prerank,smooth muscle contraction (GO:0006939),-0.45635176950201845,-1.128994430584326,0.29873417721518986,0.7134754616817698,1.0,8/14,11.65%,MYLK;SLC8A1;PIK3C2A;MYH11;SMTN;ACTA2;BDKRB2;ROCK2
prerank,regulation of humoral immune response (GO:0002920),0.4442773152725713,1.128718160024175,0.31636863823933975,0.8565931788855292,1.0,6/44,9.13%,CFH;CD55;CLU;SERPING1;CR1L;CD46
prerank,positive regulation of defense response to virus by host (GO:0002230),0.4957436255607387,1.1286690983562773,0.32515337423312884,0.8558511583220916,1.0,6/24,14.27%,TRAF3IP2;MAVS;TRIM44;ZDHHC11;ZC3H12A;EIF2AK4
prerank,iron ion transport (GO:0006826),-0.34271547291384846,-1.1284448041857058,0.27125506072874495,0.7135251760932363,1.0,15/47,20.15%,CP;FTH1;TFRC;SLC40A1;ABCB7;LMTK2;ATP6AP1;TTYH1;ATP6V1D;STEAP3;ATP6V0C;ATP6V0E2;ATP6V1F;ATP6V1E1;ATP6V0D2
prerank,icosanoid metabolic process (GO:0006690),0.4576586203703806,1.1283797989121094,0.3234463276836158,0.8558211042515026,1.0,6/40,7.92%,CYP1B1;MGLL;PTGIS;CYP2S1;PON3;DAGLB
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.3953826410637628,-1.12831714961909,0.27218934911242604,0.7122698888253434,1.0,11/26,20.20%,SHANK3;SYNPO2;FHOD1;SYNPO;RAC1;PLEK;ROCK2;LIMK1;ALMS1;ACTG1;CX3CL1
prerank,regulation of cell population proliferation (GO:0042127),0.3632843100108474,1.128258614902422,0.15515515515515516,0.8552841511526335,1.0,109/691,11.29%,ZBTB7C;EGFR;THBS1;BMP4;ACER3;SIX1;TCF7L2;WNT9A;GRK5;NTRK3;SOX9;TES;BMP5;HDAC4;CYP1B1;NGF;EGLN3;PGF;RBFOX2;PDGFC;PTK2B;TGFB3;ABI1;PTPRU;FN1;SMAD6;HES1;KRAS;FGFR1;SHC1;KLF4;BMP6;INHBA;BMPR1A;GAB2;FGF2;IRS1;ECRG4;LMNA;STRN;GAREM1;TGFBR1;CLCF1;AGTR1;NR4A3;PTPN2;P3H2;NCK2;KLF10;NPR3;TRPM4;SFRP4;SGK3;TGFBR2;SMYD2;GCNT2;CLMN;FRK;SKI;STAT3;ITGAV;GDNF;PTHLH;JAG1;TGFB1I1;CLU;BAMBI;BIRC6;IRF1;CELF1;SLURP1;CDC25B;IFI35;MYOG;IL10;BIRC7;ID2;P3H1;JUP;SIX4;PDGFA;CDKN1B;MDM4;RHOA;KANK2;RNF126;RAB25;CTF1;NIBAN2;LIMS1;TOB1;RARG;RARA;HILPDA;PIM2;TIMP1;BTG3;IGFBP6;VEGFA;PROK2;PPP2R5C;JUN;LRP5;CEP131;MVD;ELN;ERBB2;TBRG1;ITGB1BP1
prerank,actin filament capping (GO:0051693),0.5150594714011958,1.1281336096841186,0.3425324675324675,0.8539099377930204,1.0,3/18,2.48%,VILL;ADD3;GSN
prerank,barbed-end actin filament capping (GO:0051016),0.5150594714011958,1.1281336096841186,0.3425324675324675,0.8539099377930204,1.0,3/18,2.48%,VILL;ADD3;GSN
prerank,positive regulation of TORC1 signaling (GO:1904263),0.5297899807091637,1.1279954273794894,0.324459234608985,0.8534338549629327,1.0,5/16,9.38%,TELO2;KLHL22;CLEC16A;RRAGB;SIK3
prerank,regulation of cellular component movement (GO:0051270),0.45100966670564985,1.1277215312724642,0.3188976377952756,0.8534043070458069,1.0,11/49,11.24%,EGFR;ARAP1;CD9;ABL1;DIAPH1;TGFBR1;MEMO1;MYCBP2;RHOA;VEGFA;ERBB2
prerank,polyol biosynthetic process (GO:0046173),0.5271215306838815,1.127074365698061,0.3360258481421648,0.8544044333348896,1.0,3/16,4.06%,ACER3;FGF2;IP6K2
prerank,arachidonic acid metabolic process (GO:0019369),0.44701752651093,1.1266872014394835,0.31223628691983124,0.854634749539272,1.0,6/35,7.92%,CYP1B1;MGLL;PTGIS;CYP2S1;PTGES2;DAGLB
prerank,positive regulation of cell population proliferation (GO:0008284),0.3663467217091474,1.1264217116601485,0.2006079027355623,0.8545355807743538,1.0,43/423,6.79%,EGFR;FOXP1;THBS1;BMP4;ACER3;ZFPM2;TCF7L2;GRK5;NTRK3;SOX9;BMP5;HDAC4;PGF;CCN1;PDGFC;PTK2B;TGFB3;PID1;DDR2;FN1;HES1;KRAS;FGFR1;SHC1;BMP6;BMPR1A;GAB2;FGF2;IRS1;GAREM1;TGFBR1;CLCF1;NR4A3;TRPM4;TGFBR2;GCNT2;ITGAV;GDNF;KDM1A;PTHLH;BAMBI;MAP3K3;CDC25B
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.38650165355276844,1.126401032789885,0.26480086114101187,0.8537460475534243,1.0,54/173,21.62%,CD55;ANK2;ATL3;SPTAN1;ERGIC1;GOLGB1;SEC24B;TMED5;ATL2;ERGIC2;STX5;LMAN2L;TRAPPC3L;GBF1;SEC16A;NSF;COG5;DYNC1I1;SEC23A;COPA;SEC31A;ARF4;CAPZA1;RANGRF;ARCN1;VTI1A;CNIH2;COG3;SEC13;SEC24D;GOPC;DCTN6;CUL3;COPG1;ARFGAP3;ARFGAP1;BCAP31;TRIP11;SEC22B;SAR1B;DYNC1LI2;WHAMM;NRBP2;BET1L;USO1;BCAP29;DCTN5;ZW10;SEC24A;TRAPPC3;RAB1A;BET1;TMED3;CAPZA2
prerank,positive regulation of cell adhesion (GO:0045785),0.4116546481380597,1.1263018949924184,0.29314720812182743,0.8531828759219191,1.0,15/74,14.41%,VIT;ZFHX3;PPP3CA;ADAM9;FOXC2;ITGAV;AGR2;CHRD;ATM;LIMS1;VEGFA;ERBB2;PRKCA;RSU1;MAGI1
prerank,membrane depolarization (GO:0051899),-0.38186045328802176,-1.1257729684740552,0.25748502994011974,0.7176717429227373,1.0,11/32,15.68%,SCN7A;CACNA1E;SCN1A;CACNB4;CACNA1B;CACNG4;SCN3A;P2RX7;CACNA1I;SCN2A;SCN9A
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.5743906352549218,1.1255602014726511,0.3526405451448041,0.85453936015023,1.0,2/10,7.57%,LRP6;FZD1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.4277177023186825,1.1254679527839815,0.29389312977099236,0.8539444750590436,1.0,37/58,35.83%,HERC2;ATM;SMC5;UIMC1;RNF168;PRKDC;XRCC5;ERCC8;POLB;KDM2A;ZBTB7A;BARD1;SMARCAL1;NBN;ERCC1;PSMD14;RNF8;UBE2N;POLA1;RAD50;BRCC3;MDC1;KAT5;POLQ;POLM;IFFO1;XRCC4;BABAM2;PIAS4;PAXIP1;NSMCE2;LIG4;SUMO1;MRE11;ERCC4;BRCA1;ABRAXAS1
prerank,inhibitory synapse assembly (GO:1904862),-0.4793206224606388,-1.125459601507256,0.3076923076923077,0.7169554595306181,1.0,5/11,8.53%,WNT5A;GABRA2;GABRB2;GABRB3;GABRA1
prerank,chromosome organization (GO:0051276),0.3983253329901284,1.1252253664149001,0.2985781990521327,0.8537917574712995,1.0,15/99,16.38%,TCF7L1;TCF7L2;ABL1;HDAC8;HMG20A;EHMT1;RAD23B;COPS7B;COPS5;SMARCA4;HDAC10;BRWD1;CENPT;ZBTB7A;XPA
prerank,regulation of macrophage migration (GO:1905521),0.5624024581060457,1.1234671691655522,0.34956521739130436,0.8580333682408515,1.0,2/10,2.92%,PTK2B;MTUS1
prerank,regulation of cell migration (GO:0030334),0.36940077929641807,1.1232949879208358,0.23319755600814665,0.8576892921896551,1.0,50/382,8.15%,SLIT2;F3;EGFR;THBS1;CDH1;TMEFF2;CLIC4;DPYSL3;NTRK3;CYP1B1;PPP3CA;CCN1;PDGFC;PTK2B;SMO;PHACTR1;LMO4;PTPRU;ANXA1;ADAM9;SEMA3E;WNT11;FOXO3;SULF1;SEMA3D;SEMA3C;TWIST2;IGFBP5;ITGB1;FGF2;SRGAP2;SRGAP3;LMNA;FAM107A;TGFBR1;SGK3;GCNT2;VCL;NOG;STAT3;ZMYND8;MGAT3;JAG1;SLURP1;ELP3;RDX;ARSB;RAP2C;PDGFA;MMP14
prerank,protein polyubiquitination (GO:0000209),0.36552844897514825,1.1231683096966714,0.25467775467775466,0.8571996925285501,1.0,88/297,24.54%,FBXL7;WWP1;FZR1;NEDD4;TRAF3IP2;FBXO10;UBE4B;WWP2;NPEPPS;RNF144A;FBXO40;RNF115;ANAPC5;FBXW8;UBE2B;ARIH1;UBR5;MKRN3;CDC16;RNF19A;FBXL20;TRIP12;RNF114;PSMB2;UBE2D3;RNF126;FBXW11;LRSAM1;TNKS2;UBE4A;PSMC6;CBFB;FBXO17;RNF146;TRAF5;HECTD2;ARIH2;RNF168;SMURF1;FBXO4;ANKIB1;PSMD11;HERC6;UBE2S;CUL3;ERCC8;SPOP;RNF135;PSMD1;UBE2K;CUL1;CHFR;RNF14;MKRN1;BFAR;BARD1;PSMD7;UBE3C;PSMC1;FBXL19;PSMD14;TRAF3;UBE2W;FBXL8;RNF8;FBXL4;UBE2N;RNF31;ANAPC11;RBCK1;PSMD3;PPIL2;HUWE1;RMND5A;ANAPC10;FBXL17;FBXO11;FBXO27;FBXW9;RNF166;UBE2Q2;UBE2O;RNF26;RC3H2;UBE2V1;PSMD12;UBE2R2;TPP2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.3855418039924448,1.122919238213919,0.2762008733624454,0.8570618276733087,1.0,24/159,9.60%,CDH1;PCDHB16;GPC6;HMCN1;CDH11;PKD1;FAT2;MPZL2;CXADR;NECTIN3;ITGB1;DSG2;ALCAM;PTPRF;TGFBR2;CLDN11;PCDHB13;CLDN16;EMB;GPC4;PCDHB9;PVR;PCDHB3;ACVR1
prerank,Golgi organization (GO:0007030),0.3981362239529874,1.1226891312855725,0.30536130536130535,0.8568584709836978,1.0,39/112,21.97%,ARHGAP21;ATL3;GOLGB1;RAB43;TMED5;ATL2;BCAS3;STX5;FBXW8;RAB30;LMAN2L;GAK;GOLPH3;GBF1;CSNK1A1;SEC16A;ATP8B1;PLK3;PLEKHM2;VTI1A;COG3;NPLOC4;TRIP11;GORASP2;SEC22B;SEC23IP;VCPIP1;ARFGEF1;CSNK1D;DYNC2H1;ZW10;RAB1A;BET1;CDC42;CUL7;VPS51;TMED3;PRMT5;HUWE1
prerank,peroxisome organization (GO:0007031),0.4835021456571993,1.1225079205697477,0.32786885245901637,0.856546701601361,1.0,4/25,11.50%,ABCD3;TMEM135;ACOT8;LONP2
prerank,cellular response to alkaloid (GO:0071312),-0.42861038585487127,-1.1222828857167289,0.315035799522673,0.7242058050278884,1.0,7/17,16.61%,TGM2;SLC8A1;RYR2;BLM;CASP3;CASQ2;RYR3
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.4549019607480421,-1.1221808313124222,0.3048128342245989,0.7229053105564334,1.0,4/14,6.17%,KIT;SEMA7A;WNT5A;GPRC5B
prerank,positive regulation of axon extension (GO:0045773),0.4959861013986901,1.1220178839026118,0.32457496136012365,0.8571370150132073,1.0,6/22,12.53%,NTN1;NRP1;SHTN1;VEGFA;MEGF8;ZFYVE27
prerank,protein localization to synapse (GO:0035418),0.5518918829856772,1.1215479892503257,0.36688311688311687,0.857657513093416,1.0,5/12,11.39%,BSN;NPHS1;SHANK1;PCLO;ZDHHC15
prerank,negative regulation of dephosphorylation (GO:0035305),-0.4310220493355922,-1.1214570655318117,0.30708661417322836,0.7232133764432327,1.0,8/18,24.08%,MFHAS1;PPP1R16B;YWHAB;INPP5K;SH3RF2;PPP1R35;ENSA;SH2D4A
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.42690835718781023,-1.1213974006239467,0.3313953488372093,0.7217924084898052,1.0,4/18,13.14%,BCL2;BCL2L1;CAMK2A;THEM4
prerank,purine nucleotide biosynthetic process (GO:0006164),0.542058531183524,1.1213521987519144,0.35691318327974275,0.8573878432059339,1.0,2/12,6.52%,PRPS2;ADA
prerank,positive regulation of endocytosis (GO:0045807),-0.35344515178272023,-1.1213336739559694,0.2964426877470356,0.720353264372245,1.0,5/45,1.80%,VTN;SGIP1;APOE;NEDD4L;B2M
prerank,negative regulation of cell division (GO:0051782),-0.47433665258297425,-1.1211706066642881,0.32439024390243903,0.71925104450033,1.0,7/11,33.31%,TXNIP;BLM;CHMP4C;E2F7;E2F8;MYC;AURKB
prerank,negative regulation of autophagy (GO:0010507),0.43108841744392157,1.1210543403528292,0.31209362808842656,0.8573835373154797,1.0,17/54,16.08%,MET;EIF4G3;DAPL1;FOXK1;EIF4G1;TAB3;KLHL22;STAT3;IL10;SMCR8;FOXK2;SNRNP70;SMG1;MTOR;HTR2B;TLK2;EIF4G2
prerank,"phototransduction, visible light (GO:0007603)",0.547401251678007,1.1210422975995515,0.3494983277591973,0.856568170326667,1.0,2/14,4.50%,RP1;PDE6A
prerank,axonal transport of mitochondrion (GO:0019896),-0.47785451741667584,-1.1209626432624347,0.3207070707070707,0.7182568536526743,1.0,9/11,42.79%,HIF1A;MAPT;TRAK2;HAP1;NEFL;SYBU;SPAST;ACTR10;OPA1
prerank,negative regulation of inflammatory response (GO:0050728),-0.2772141044149703,-1.1207757930720692,0.15151515151515152,0.7171781209738697,1.0,57/182,19.77%,IGF1;LYN;ADCY5;TEK;APOE;MFHAS1;ADCY1;PPARA;PRKAR2B;GNG2;CALCRL;ADCY7;NR1H3;PPARD;GGT5;PRKAR1B;SIRPA;MYH9;RPS19;C1QTNF3;ENPP3;PRKACB;PRKAR1A;ADORA2A;LRFN5;GRN;CYSLTR1;CYSLTR2;PTH1R;RAMP2;ADM;CD200;MDK;ADCY2;PLCG1;TYRO3;ADCY4;HCK;TNFRSF1A;METRNL;PLK2;GGT1;FCGR1A;AOAH;GPR176;CDH5;RHBDF2;LHCGR;NR1H4;VIPR2;SELENOS;GPS2;TSHR;GPER1;RXFP1;OTULIN;FNDC4
prerank,mRNA export from nucleus (GO:0006406),0.3972223991416754,1.1207743894964806,0.2843488649940263,0.8564983511226454,1.0,42/102,28.50%,NUP93;SMG6;SRSF11;THOC2;SRSF5;SRSF6;DDX19B;RANBP2;U2AF2;NUP153;SEC13;SRRM1;SMG1;FYTTD1;CASC3;NUP214;CHTOP;NUP188;U2AF1L4;NUP88;SRSF2;THOC5;ZC3H11A;NXF1;ALKBH5;NUP98;UPF2;FIP1L1;AAAS;NUP54;CDC40;HNRNPA2B1;CPSF3;UPF3B;SRSF3;RBM8A;RAE1;ALYREF;NUP155;NCBP2;CPSF4;SRSF7
prerank,respiratory system development (GO:0060541),0.4661884273490531,1.1207109664785166,0.3242074927953891,0.855827175692368,1.0,8/32,12.34%,BMP4;DISP1;FGF2;STRA6;GLI2;VEGFA;CCDC40;NKX2-1
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.531946939029683,1.1206357315996007,0.35334476843910806,0.8551695457923868,1.0,4/13,13.39%,SAE1;DESI2;DESI1;UBA5
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.49980994391387223,1.1205984101511843,0.3365695792880259,0.8544491109380077,1.0,7/19,19.78%,HIPK1;CDIP1;EP300;DYRK2;PML;USP28;SNW1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.36585439864276986,1.1202633060759424,0.2523461939520334,0.854544287692977,1.0,39/291,9.90%,SLIT2;EGFR;WNT9A;SOX9;LBP;PTK2B;EZR;PID1;ADAM9;PRKCD;WNT11;IGFBP5;CAPN2;FZD7;IRS1;SLC26A6;IP6K2;RAP1A;NR4A3;PDCD4;VCP;CD80;ATP2B4;ESR1;RORA;DMTN;LCOR;MYOG;IL10;RRAGB;TLR4;CXCL2;P2RX4;RHOA;NFKB1;CHUK;ATM;SHPK;AKAP9
prerank,regulation of cell-matrix adhesion (GO:0001952),0.42459193165150677,1.1199516909267435,0.3054862842892768,0.8546504474652634,1.0,12/64,9.42%,THBS1;PTK2B;EFNA5;SEMA3E;GSK3B;VCL;PTPRA;JAG1;JUP;SLC9A1;RHOA;NF1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.49225930582680566,1.1198186040196727,0.31076923076923074,0.8542207562931745,1.0,5/24,6.37%,CYP1B1;SULF1;ISL1;GATA4;RORA
prerank,response to organic cyclic compound (GO:0014070),0.42982953780941696,1.1195399423366965,0.29305555555555557,0.8541739899284343,1.0,11/52,11.79%,CYP1B1;ANXA1;IGFBP5;ALPL;STAT3;ESR1;SOCS2;STRN3;DRD3;CCL3;ARL6IP5
prerank,microtubule depolymerization (GO:0007019),-0.43282330108524686,-1.119012789618219,0.30886075949367087,0.7204026273267509,1.0,7/17,25.39%,STMN4;STMN3;NCKAP5;STMN1;STMN2;KIF19;KIF18B
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.4483802970557728,1.1189538734724969,0.33105335157318744,0.8549484406279116,1.0,13/37,22.60%,ENTPD6;SIDT2;PABPC4;NUDT5;ENTPD2;EXOSC7;ENTPD7;NUDT15;RNASEH2A;DFFB;RNASE6;NUDT1;RNASE3
prerank,positive regulation of proteolysis (GO:0045862),0.4300937612453197,1.1189486598231646,0.3203631647211414,0.8541242262410069,1.0,13/55,15.46%,CYFIP2;PERP;TANK;ADAM9;TNP2;FBXW11;MAPK12;SH3D19;ZC3H12A;TNFRSF1B;TNIP1;TBC1D10A;IST1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.4943963757293671,1.1189463025918471,0.33024691358024694,0.8533046563090813,1.0,7/22,12.44%,PTPN3;ADAM9;TIMP2;IL10;TIMP1;SH3D19;TNFRSF1B
prerank,regulation of transferase activity (GO:0051338),0.522610124362529,1.1185202328792108,0.3665594855305466,0.8537011362599075,1.0,11/17,28.52%,SMG6;SPTSSB;ATM;FEM1B;PPP1R3F;PARP4;EMP2;LDB2;LDB1;FEM1A;PINX1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.4032890122230465,-1.1184997378041568,0.2905027932960894,0.7202529568642547,1.0,6/21,5.65%,ATP1A2;SLC8A1;CALM1;RYR2;AKAP6;PDE4D
prerank,regulation of cellular metabolic process (GO:0031323),0.441048197637097,1.1183156673110173,0.31994459833795014,0.8534554167444552,1.0,10/45,13.12%,CYP1B1;PID1;COQ7;CNDP1;ARF4;KIF16B;MKLN1;EIF6;NCOR2;PDK3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.4281463619988715,1.118248386107583,0.31585845347313235,0.8528474600906987,1.0,19/54,19.60%,PLAGL1;CRADD;CHEK2;PLK3;CDKN1B;MDM4;ATM;AURKA;PCBP4;EP300;CNOT7;PIDD1;PML;CASP2;CARM1;TNKS1BP1;CDKN1A;CNOT4;E2F1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.4690898879615052,1.1179747711269277,0.31805157593123207,0.8527902725211788,1.0,6/31,5.76%,ZFPM2;DSP;BMPR1A;TGFBR1;NOG;ISL1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.498738960717388,1.1177338779092842,0.3557993730407524,0.8526165485792094,1.0,4/22,4.54%,NTRK3;NGF;RAP1A;KIDINS220
prerank,sensory perception of pain (GO:0019233),-0.4317953188674679,-1.1176092453892996,0.31767955801104975,0.7211353043552724,1.0,8/21,20.29%,RETREG1;P2RX7;MME;KCNA2;SCN9A;TRPA1;CCL2;KCNK4
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.36884989892624404,-1.1172359932172413,0.27205882352941174,0.7205382016364142,1.0,15/34,23.43%,LYN;MFHAS1;LGR4;DAB2IP;CD300A;GRAMD4;TLR3;TYRO3;LRRC14;SARM1;GPS2;TREM2;CACTIN;TNFAIP3;SMPDL3B
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.43663862572240636,1.1172315149415133,0.3265856950067476,0.8532116860406389,1.0,6/43,3.75%,BMP4;CCN1;DDR2;BMP6;BMPR1A;NELL1
prerank,Golgi inheritance (GO:0048313),0.559588620425345,1.1168532456227382,0.35906040268456374,0.8534102367558892,1.0,4/11,16.03%,STX5;GBF1;PLK3;VCPIP1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3722092053340732,1.1168134795029727,0.271474019088017,0.8527009990831741,1.0,66/259,16.43%,NTN1;PKD1;BBS9;ABLIM3;FXYD5;EZR;EXOC4;PARVA;GSN;ANO6;ITGB1;EMP1;NRP1;SRGAP2;PMP22;PDE6D;RAP1A;PTPDC1;DZIP1;VCL;RAB11FIP3;SHTN1;ABLIM2;PIP5K1A;PCM1;ARL3;EHD3;GOLPH3;DMTN;GBF1;ATAT1;ARHGEF6;CEP164;OCRL;RAPGEF6;EXOC5;RAP2C;FGD6;CFAP70;CDC14A;DISC1;WDR35;TMEM231;IFT46;EHD1;GALNT11;DYNC2I2;EHD2;ARF4;CEP131;CCDC66;ABCC4;ARMC9;PIBF1;RFX2;ATP6V0D1;CEP20;ARFIP2;S1PR2;SSTR3;IFT52;MKS1;NUDCD3;FAM161A;CEP89;KIF3B
prerank,cell junction organization (GO:0034330),-0.3198838182619746,-1.1166442497462086,0.26865671641791045,0.7206709131982971,1.0,19/71,12.28%,TJP1;OCLN;PPFIA2;PPFIBP2;GRM5;SLC6A1;VASP;PPFIBP1;ACTB;APP;OPHN1;SNCA;CLDN1;MAPT;PAK3;C1QA;SDK2;FLNC;FBLIM1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.5737249978377355,1.116354037720287,0.36379310344827587,0.8531731193125724,1.0,2/10,8.33%,DDIT3;TLR4
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.513727296953444,1.116013631411118,0.35139573070607555,0.8533070846512046,1.0,5/18,19.85%,NUP93;THOC2;DDX19B;ZC3H11A;NXF1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.46702065068867615,1.1159129282610087,0.34011627906976744,0.8527549667747737,1.0,8/30,16.35%,POLR1G;MNAT1;POLR1A;TAF1D;TAF1C;TTF1;POLR1F;ERCC3
prerank,regulation of mast cell activation (GO:0033003),-0.49410529576355944,-1.115751792735257,0.36009732360097324,0.7214170967452519,1.0,7/10,28.92%,LYN;NECTIN2;CD84;CRLF2;TSLP;CD300LF;CD226
prerank,positive regulation of cell migration (GO:0030335),0.3703476622275795,1.1150569337634444,0.2717842323651452,0.8543143312366498,1.0,48/253,13.21%,F3;EGFR;THBS1;DOCK5;NTRK3;SOX9;PPP3CA;CCN1;PDGFC;PTK2B;SMO;DDR2;ADAM9;SEMA3E;FN1;WNT11;SEMA3D;SEMA3C;TWIST2;ITGB1;PRKCE;NRP1;FAM107A;TGFBR1;GCNT2;SHTN1;STAT3;DMTN;ELP3;RDX;PDGFA;MMP14;RAB25;ATM;ACVR1;PLCG2;ELP5;VEGFA;CCL3;NIPBL;TIAM1;SYNE2;DDRGK1;CPNE3;FAM83H;TRIP6;CCL7;MTOR
prerank,histone methylation (GO:0016571),0.48170824434602194,1.1146342251640158,0.3447251114413076,0.8547102278438569,1.0,9/26,17.81%,SMYD2;CREBBP;EHMT1;PRMT8;CTCFL;PRMT6;NSD1;CARM1;EHMT2
prerank,peripheral nervous system development (GO:0007422),0.49093892996218785,1.1145660896386995,0.32448377581120946,0.8541085119688938,1.0,6/23,10.26%,NGF;PMP22;GDNF;EGR2;NF1;ADGRG6
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.41603025987849745,-1.1145288420245327,0.3116531165311653,0.7231149833961263,1.0,5/20,7.42%,IL1R1;B2M;CD81;PRKCZ;IL18
prerank,cellular component assembly (GO:0022607),0.37148520181905753,1.1144819882616503,0.2692713833157339,0.8535338496473986,1.0,49/253,13.22%,REPS2;DPYSL3;BAIAP2L1;SOX9;RHOJ;PTK2B;EZR;PAWR;CALD1;CHAF1B;HES1;RP1;PARVA;GSN;BSN;FAM107A;CREBBP;MNAT1;RHOQ;PLS1;DMTN;TEAD1;KRT14;PKP1;FZD1;TOGARAM1;PDGFA;MDM4;P3H4;HAS1;SHANK1;GRHL2;RHOA;LIMS1;PARD3;PCLO;SPAG17;NCKAP1;MYO9A;CAPZA1;LIMS2;MATN1;CCDC40;LIMA1;RTN3;ADD1;ZFYVE27;SLC7A9;TLCD1
prerank,cellular response to growth factor stimulus (GO:0071363),0.3769529877141293,1.1142252738387348,0.28058361391694725,0.8534438293369472,1.0,30/151,11.29%,EGFR;BMP4;NTRK3;SMAD9;SOX9;ANXA1;CD44;SHC1;KLF4;BMP6;BMPR1A;NRP1;GAREM1;TGFBR1;RAP1A;KIDINS220;TMEM100;TGFBR2;GAS1;HAS1;FOXC1;IQGAP1;LIMS1;ACVR1;EHD1;SYAP1;VEGFA;EMD;ERBB2;ITGB1BP1
prerank,response to metal ion (GO:0010038),0.4155778993506978,1.1140456906751695,0.3075,0.8531005199815977,1.0,5/67,1.96%,THBS1;NEDD4;PPP3CA;NDRG1;ADAM9
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.4435882212790508,1.1140249285269386,0.3492753623188406,0.8523408048845358,1.0,14/40,21.36%,PRKCD;ABL1;SMYD2;BCLAF1;FEM1B;USP1;SMG1;NSMCE1;KMT5A;FXR2;FMR1;UBE2N;WDR76;MCL1
prerank,positive regulation of telomere maintenance (GO:0032206),0.4699359546857178,1.1139665252981379,0.3313782991202346,0.85168969188347,1.0,13/31,22.53%,NEK7;TNKS2;ATM;ATRX;SLX4;PML;NBN;SIRT6;DHX36;MAP3K4;ERCC1;RAD50;NAF1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.36602651538937164,-1.1139433430549865,0.2958801498127341,0.7231262012460344,1.0,12/40,15.49%,VTN;SGIP1;B2M;INSR;CD63;DGKD;HIP1;ARRB1;CCL19;NTF3;ARRB2;GREM1
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.5050714675810284,-1.1136696791175213,0.3515439429928741,0.722299455239919,1.0,3/10,5.14%,CST3;NOTCH1;DPP4
prerank,negative regulation of cell cycle process (GO:0010948),0.4163298131575179,1.1132961958903262,0.319693094629156,0.8527613835527046,1.0,21/61,23.13%,BMP4;EHMT1;CBX5;EED;WAPL;CHEK1;RNF2;SUZ12;RBBP8;EPC1;RRM2;EHMT2;RAD51;RBBP7;E2F1;ZFYVE19;TOM1L1;YAF2;NANOS2;E2F6;MGA
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.40797089802317876,-1.1131359578474098,0.3282208588957055,0.7222194568296221,1.0,5/22,8.10%,RFTN1;SLC7A5;PRKCQ;IL18;SPHK1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.40364337853916477,1.1131014901867073,0.3097560975609756,0.8525121298194728,1.0,5/80,3.02%,THBS1;MAP3K5;NGF;CD44;KLF4
prerank,regulation of mast cell degranulation (GO:0043304),-0.4559547575223116,-1.1129196888832875,0.33665835411471323,0.7212659905761248,1.0,7/14,23.27%,LYN;CD300A;CD84;FES;SYK;SPHK2;STXBP2
prerank,protein deacylation (GO:0035601),0.5023429486936641,1.1124825626829924,0.36180124223602483,0.8533930308550348,1.0,6/23,17.75%,HDAC4;ABHD17B;LYPLA2;LYPLAL1;HDAC10;SIRT6
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.4056161996602932,1.1120763063234795,0.3204488778054863,0.8537356191968404,1.0,10/80,6.13%,PLCE1;DPYSL3;CDC42EP5;ARAP1;TGFB3;PALM;NRP1;NDEL1;BCAS3;RHOQ
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.43910192024605266,1.1120714158480167,0.3220108695652174,0.8529362127641009,1.0,12/48,15.79%,DOCK5;CUX1;ABL1;NRP1;FBXW8;DMTN;S100A10;LIMS1;LIMS2;PRKDC;TRIOBP;CAPRIN2
prerank,cellular response to unfolded protein (GO:0034620),-0.3847971594675324,-1.1117884942730525,0.28104575163398693,0.7228084303821695,1.0,9/26,19.95%,HSPA8;DAB2IP;OPTN;ERN1;TMBIM6;HSPA13;PACRG;ABCB10;HSPA9
prerank,protein modification by small protein conjugation (GO:0032446),0.35913198534960156,1.1117119968136788,0.26605504587155965,0.8531335858574588,1.0,113/361,23.10%,FBXL7;WWP1;NEDD4;FBXO10;WWP2;NFE2L2;RNF144A;NUP93;HERC2;RNF138;VCP;TRPM4;FBXW8;UBE2B;ARIH1;MKRN3;ATG3;TRIM44;CDC16;BIRC6;HIF3A;ASB9;CBLC;BIRC7;ANAPC16;MYCBP2;PIAS2;SAE1;KLHL13;UBE2F;TRIM47;PIAS3;EGR2;UBE2D3;FBXW11;DCUN1D5;COMMD1;RANBP2;UVSSA;TRIM7;TRIM26;WAC;USP7;RNF111;TRIM41;TRIM55;UBE2Z;ASB11;SPSB2;NUP153;DDRGK1;ARIH2;RNF168;SMURF1;FBXO4;PRKDC;IFIH1;PEX13;UBA5;CTR9;UBE2S;CUL3;RNF135;CCDC22;UBE2K;NUP214;ASB1;TRIM39;CUL1;CHFR;VCPIP1;NUP188;RNF14;MKRN1;UHRF2;BARD1;OS9;USP9X;BCL10;DTX3;MKRN2;NUP88;PIAS1;FBXO25;TRIM35;CNOT4;RTF1;UBE2W;DCUN1D2;DCUN1D1;GAN;DCUN1D4;TSPAN17;TRPC4AP;RNF8;MOCS3;MIB1;UBE2N;KLHL18;ANAPC11;NFX1;CUL7;NUP98;UBE2M;DET1;CUL4A;HUWE1;FBXL17;PEX2;PAF1;FBXO11;AAAS;ANKRD9
prerank,protein maturation (GO:0051604),0.3978194203505298,1.1111822185644074,0.2988095238095238,0.8538164012025361,1.0,21/95,16.65%,F3;PCSK5;DDI2;PHEX;NAA40;MMP16;TASP1;XPNPEP3;ASPRV1;MMP14;CCS;LONP2;ADAMTS3;PITRM1;ECE1;NFU1;PCSK7;ADAM10;NAA15;CASP2;LIPT2
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.37012139741772143,1.11113157224342,0.27282377919320594,0.8531294673417542,1.0,22/214,6.66%,BMPER;EGFR;TNFAIP8L3;NTRK3;CCN1;PDGFC;PTK2B;EZR;FN1;CD44;SHC1;FGF2;NOTCH2;NRP1;SPRED2;GAREM1;RAP1A;PTPN2;GCNT2;GATA4;ROR1;DLG1
prerank,microvillus assembly (GO:0030033),0.529854690824417,1.1106893161173845,0.37540453074433655,0.8536634524745252,1.0,5/14,8.03%,FXYD5;EZR;RAP1A;RAPGEF6;RAP2C
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.4962916382613957,-1.1106808829372856,0.3270588235294118,0.7243247068717057,1.0,3/11,5.69%,LYN;ANK3;PRKCQ
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.36586191444312893,-1.110541454120971,0.32867132867132864,0.7231631144565788,1.0,15/39,18.27%,RPS14;RPS19;RPS5;RPS16;RPS15;RPS27;RPS24;RPS7;RPS25;SNU13;RPS17;NPM1;MRPS11;RPS28;TSR3
prerank,cellular response to interleukin-4 (GO:0071353),-0.49569300848692666,-1.1101714114258456,0.3251231527093596,0.722612731782119,1.0,4/10,19.18%,LEF1;TCF7;JAK3;XBP1
prerank,muscle contraction (GO:0006936),-0.28432629042417135,-1.1099191376680573,0.192,0.721808981313934,1.0,27/126,11.82%,ITGA1;MYLK;DTNA;SNTB1;DYSF;GJC1;SLC8A1;CALM1;MYH11;SMTN;MYL6;TLN1;LMOD1;TMOD1;ACTA2;MYL9;TPM2;VIM;DES;GLRA1;ACTN2;BDKRB2;ARHGEF11;MYOM1;KCNJ12;ROCK2;MYL12A
prerank,cytoplasmic microtubule organization (GO:0031122),0.4353404753136201,1.109682544077436,0.31763122476446837,0.8556919707199965,1.0,14/54,16.55%,EZR;CLIP4;LIMK2;CLIP1;PCM1;DLG1;PLK3;RHOA;SLAIN2;CHP1;TUBGCP6;TUBGCP5;HOOK3;TUBGCP4
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.41944464070225435,1.1096099741386238,0.32313829787234044,0.8550984732016147,1.0,16/59,15.95%,TCF7L2;SOX9;MED15;MOV10;TNRC6C;NFKB1;MED13;BCLAF1;MED27;JUN;CBFB;MED14;CCND1;RUNX2;TWIST1;MED24
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.48199700880046314,1.10958065020349,0.3409436834094368,0.8543678165160291,1.0,5/26,6.37%,CYP1B1;SULF1;ISL1;GATA4;RORA
prerank,cilium organization (GO:0044782),0.3732435538781046,1.1090923570873361,0.27705627705627706,0.8548505888481525,1.0,65/209,22.99%,PKD1;BBS9;ABLIM3;EXOC4;PARVA;GSN;PDE6D;PTPDC1;DZIP1;RAB11FIP3;PCM1;ARL3;EHD3;GBF1;ATAT1;CEP164;OCRL;EXOC5;CFAP70;CDC14A;DISC1;WDR35;TMEM231;IFT46;EHD1;GALNT11;DYNC2I2;EHD2;ARF4;CEP131;CCDC66;ABCC4;ARMC9;PIBF1;RFX2;ATP6V0D1;CEP20;SSTR3;IFT52;MKS1;FAM161B;NUDCD3;FAM161A;CEP89;TTC17;KIF3B;DYNC2I1;LZTFL1;HYLS1;TEKT2;IQCB1;RILPL1;POC1B;FUZ;DYNC2H1;RAB1A;IFT80;CLUAP1;OFD1;TRAPPC14;TSGA10IP;FLNA;TRAF3IP1;PLK4;BBS2
prerank,positive regulation of transport (GO:0051050),-0.30526671640971764,-1.1088819109123675,0.2,0.7231744059913456,1.0,37/85,24.22%,CAMK1D;APOE;MERTK;NEDD4L;IL15RA;ACTB;NR1H3;CD47;SGK1;SIRPA;GATA2;SNCA;GAS6;HIP1R;DOCK2;CALR;BOK;CYBA;GSK3A;CCL19;SMPD1;LYAR;CHCHD10;DLL1;INPP5K;CDH3;SGK2;DOC2B;SPAG5;TREM2;RAB27A;AHSG;MLC1;PYCARD;CD151;PLA2G5;TULP1
prerank,lipid oxidation (GO:0034440),-0.4732352331473302,-1.1087693113738624,0.3397590361445783,0.7219899558485355,1.0,2/12,10.56%,PPARGC1A;ALOX12
prerank,catecholamine metabolic process (GO:0006584),0.5278756762945882,1.108745994618083,0.3567921440261866,0.8549731913284982,1.0,2/14,9.10%,SNCAIP;DRD3
prerank,positive regulation of leukocyte migration (GO:0002687),-0.39043678295711826,-1.108685038082366,0.3126934984520124,0.7207309303132217,1.0,4/27,12.00%,CSF1;IL6R;JAM3;MDK
prerank,ubiquinone metabolic process (GO:0006743),0.5128127823674861,1.1082059769493766,0.3544891640866873,0.8557243953540854,1.0,6/15,22.83%,COQ7;COQ10B;PDSS2;AIFM2;UBIAD1;COQ8A
prerank,Rap protein signal transduction (GO:0032486),-0.4708123870052668,-1.1080953427421958,0.3431372549019608,0.7208842545370214,1.0,4/10,9.93%,RAPGEF3;RAPGEF2;RAP2A;RAPGEF1
prerank,monocyte differentiation (GO:0030224),0.5729388977679094,1.1080853165390605,0.3771106941838649,0.8552479886846538,1.0,1/10,0.28%,BMP4
prerank,hyaluronan catabolic process (GO:0030214),0.5062950759142059,1.1080559675574462,0.36450079239302696,0.8545313810066925,1.0,6/18,12.46%,CD44;FGF2;HEXA;SPAM1;SLC9A1;CHP1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.5328132066504626,1.1078721747478466,0.367003367003367,0.8542491146310607,1.0,3/13,3.27%,ZFPM2;BMPR1A;FGF2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.43358191303118476,-1.1078157213148825,0.3258145363408521,0.7201581225397589,1.0,5/16,7.08%,IGF1;IGFBP2;IGFBP3;IGFBP4;BMP2
prerank,negative regulation of nervous system development (GO:0051961),-0.4330963927791119,-1.1074567782239695,0.3418079096045198,0.7196316047100836,1.0,3/17,4.43%,B2M;ROBO2;NOTCH1
prerank,response to interleukin-1 (GO:0070555),0.40733633089572785,1.1072265117142104,0.31337579617834393,0.8552427108075081,1.0,15/73,13.66%,SOX9;HDAC4;ANXA1;TANK;PTGIS;NFKB1;IRAK3;RBMX;USP10;CCL3;CCL1;MYD88;ZC3H12A;CCL7;PRKCA
prerank,regulation of chromosome organization (GO:0033044),0.4900790435373383,1.106919124893395,0.35758513931888547,0.8552931951231617,1.0,8/22,17.41%,SMG6;HDAC8;RB1;WAPL;SMG1;XRCC5;RMI2;YLPM1
prerank,artery development (GO:0060840),-0.4068288190695304,-1.1065071235782191,0.33633633633633636,0.7206383506810877,1.0,7/23,9.74%,ROBO1;ENG;ROBO2;TBX1;PDE2A;ACVR2B;EFEMP2
prerank,neuromuscular synaptic transmission (GO:0007274),0.5108931577916807,1.1058122888420412,0.36378205128205127,0.8575500581135822,1.0,6/18,16.16%,ERC1;ERC2;KIF1B;FCHSD2;FCHSD1;CHRNB1
prerank,tyrosine metabolic process (GO:0006570),0.5450435554244386,1.1052467306454485,0.3747841105354059,0.8582132543515455,1.0,1/11,4.56%,IYD
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.4716933502864874,-1.10520234997953,0.36261261261261263,0.722646753364295,1.0,5/11,21.84%,PTPRT;NF2;SH2B3;BCL3;LEPROT
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.402472137364704,1.1049387706639284,0.341645885286783,0.8582986584588375,1.0,12/80,13.21%,THBS1;SAMD4A;SLC2A13;PRKCD;NIBAN1;CLU;LARP4B;ERBB2;EIF3E;EIF6;PRKDC;MTOR
prerank,digestive tract morphogenesis (GO:0048546),0.5244267321917219,1.1045469784497992,0.37152209492635024,0.8586263281777387,1.0,5/14,11.69%,STRA6;EPHB3;AGR2;ID2;NIPBL
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.40688690350678824,-1.1039386613665074,0.3438395415472779,0.7244668132127143,1.0,12/22,19.82%,LYN;PICALM;EPHA4;LRRTM3;ABCG1;ROCK2;CASP3;GSK3A;RANBP9;ABCA2;GSAP;CHRNA7
prerank,positive regulation of histone methylation (GO:0031062),-0.39592161060317616,-1.1038314259606972,0.3115727002967359,0.7232705269387862,1.0,2/24,2.97%,AUTS2;JARID2
prerank,protein deneddylation (GO:0000338),0.5556388121342108,1.103453103264242,0.38392857142857145,0.8607940923275575,1.0,4/10,27.60%,COPS7B;COPS5;COPS3;COPS2
prerank,spindle assembly (GO:0051225),0.4121715384502223,1.1034413078728278,0.3333333333333333,0.8600270333134462,1.0,26/67,22.95%,MAPRE2;NEK7;MISP;TOGARAM1;CHEK2;ARHGEF10;RHOA;SPICE1;CEP63;NCOR1;SMC1A;TUBGCP6;PIBF1;STAG2;TUBGCP5;NEK6;KIF3B;TUBGCP4;HAUS2;INO80;STAG1;CSNK1D;OFD1;FLNA;HAUS5;AAAS
prerank,exit from mitosis (GO:0010458),-0.4674691765993836,-1.1031497387120504,0.35507246376811596,0.7236014768587716,1.0,2/12,4.67%,EPS8;CLASP2
prerank,regulation of telomere capping (GO:1904353),0.48562174330686947,1.1031339301465035,0.3504531722054381,0.8600891456982345,1.0,8/23,21.89%,NEK7;SMG6;TNKS2;ATM;USP7;NBN;MAP3K4;RAD50
prerank,calcium ion transport into cytosol (GO:0060402),-0.40438062915531003,-1.102708437767692,0.311046511627907,0.7232914056691728,1.0,9/21,14.22%,GRIN2A;SLC8A1;RYR2;GRIN2B;CACNA2D1;GRIN1;JPH1;JPH2;TRPV4
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3874842646479077,1.1026098567798714,0.3286549707602339,0.8607472104766335,1.0,25/107,18.83%,THBS1;MAP3K5;TMEM117;NIBAN1;GSK3B;ERP27;RNF185;VCP;DDIT3;AGR2;SEC16A;JUN;ERN2;ATF6;CREB3L1;DDRGK1;UBA5;CREB3L3;BCAP31;GORASP2;OS9;MBTPS1;EIF2S1;QRICH1;AIFM1
prerank,eye photoreceptor cell development (GO:0042462),0.5072807411462243,1.1024733093162857,0.3652312599681021,0.8603220866838117,1.0,3/15,10.54%,RP1;VEGFA;RPGRIP1
prerank,regulation of monocyte differentiation (GO:0045655),0.5285080071664011,1.1024155829501256,0.35081967213114756,0.8596750100646923,1.0,1/14,0.25%,FOXP1
prerank,mitochondrial fission (GO:0000266),-0.4301837373237816,-1.1017082446188589,0.32,0.7244493030616125,1.0,6/16,23.28%,DNM3;DNM1;MTFP1;MTFR2;DNM1L;MFF
prerank,negative regulation of endothelial cell migration (GO:0010596),0.46049554926666947,1.1013994238655607,0.36427566807313644,0.8618113588909906,1.0,4/36,5.23%,SLIT2;THBS1;FGF2;ATP2B4
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.46332458131157167,-1.1010960091331783,0.34405940594059403,0.7245672617857967,1.0,4/12,11.92%,PIK3R1;DAB2IP;ERN1;BOK
prerank,protein polyglutamylation (GO:0018095),-0.4967413432935049,-1.1007638472963794,0.3469387755102041,0.7239732983196128,1.0,5/11,16.63%,TTLL7;TTLL11;TTLL5;TTLL4;CEP41
prerank,regulation of transmembrane transport (GO:0034762),0.4567906066030653,1.1006210842096216,0.36661698956780925,0.8632209076370225,1.0,4/31,2.80%,KCNJ2;NEDD4;KCNJ15;WWP2
prerank,dermatan sulfate metabolic process (GO:0030205),0.5435313337264913,1.0997814560997576,0.35223367697594504,0.8647951460915966,1.0,2/13,1.66%,UST;DSE
prerank,hematopoietic stem cell differentiation (GO:0060218),0.5506357326931237,1.099730478118444,0.37410071942446044,0.8641540016817564,1.0,2/10,9.87%,MLLT3;HOXB4
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.5095253306250134,1.0996246856694765,0.3704918032786885,0.8636436207277637,1.0,5/17,17.33%,DHDDS;ALG13;MVD;ALG14;ALG12
prerank,secretory granule organization (GO:0033363),-0.48529032159640323,-1.0996031899220848,0.3480278422273782,0.7255778264242354,1.0,2/10,5.88%,SRGN;ABCA1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.49776173481749175,1.0989564327002175,0.3684210526315789,0.864752809876075,1.0,5/19,5.56%,ZFPM2;BMPR1A;FGF2;TGFBR1;NOG
prerank,mammary gland epithelium development (GO:0061180),-0.4431437236214526,-1.0987565390766618,0.3480392156862745,0.7264296006294172,1.0,4/14,15.26%,WNT4;ERBB4;CSF1R;AKT1
prerank,natural killer cell mediated immunity (GO:0002228),0.5232946942621646,1.098658827328913,0.380718954248366,0.8648137942817749,1.0,4/15,15.90%,RAET1E;KLRC2;PLEKHM2;LYST
prerank,inflammatory response (GO:0006954),0.3696413151967695,1.0985950456301252,0.31394072447859495,0.8641941518406238,1.0,34/195,14.99%,THBS1;PTGDR;HDAC4;TRAF3IP2;ANXA1;MGLL;HDAC9;CD44;CMKLR1;VNN1;AGTR1;NFATC4;PTGER1;STAT3;RIPK2;REL;TLR4;CXCL2;NFKB1;CHUK;PROK2;ELF3;CDO1;CCL3;CCL1;OLR1;CCL7;NFATC3;FOLR2;ABCF1;CXCR4;PRDX5;TLR1;MAPKAPK2
prerank,liver development (GO:0001889),0.4601988965650716,1.0984339671435106,0.32947976878612717,0.8638118471450704,1.0,7/32,11.20%,MET;COBL;ANXA1;NF1;AURKA;CCDC40;PRKCSH
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.3925157969419982,-1.0983467505958242,0.33815028901734107,0.7260479868036049,1.0,6/22,14.84%,SASH1;MFHAS1;BMP2;SPHK1;PRMT1;RELL1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.4671531806871323,-1.0983448626323564,0.35731414868105515,0.7245924842473508,1.0,3/12,8.29%,LYN;ELF2;CD300A
prerank,heart looping (GO:0001947),0.4419500499083264,1.0981383658491524,0.34492350486787204,0.8637990153619872,1.0,4/39,6.32%,MICAL2;SMO;TGFBR2;GATA4
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.27479866011154797,-1.0980216521414565,0.21551724137931033,0.7240325533386546,1.0,30/163,14.11%,PDE4B;PIK3R1;BCL2;PAK1;FYB1;RFTN1;INPP5D;TEC;PRKCB;TNFRSF21;MEF2C;PDE4D;PRKCQ;VAV3;CD38;BMX;PAG1;MOG;BTRC;PAK3;THEMIS;PSMB4;BLNK;PSMB3;PLCG1;ICOSLG;PSME2;PSMB8;PSMB10;MALT1
prerank,gonad development (GO:0008406),-0.34775185322094876,-1.0979843605850093,0.26334519572953735,0.7226972512175027,1.0,8/41,8.91%,NR2F2;WNT4;KIT;WNT5A;SALL1;MAMLD1;GATA6;BASP1
prerank,extracellular transport (GO:0006858),0.5384174165930279,1.0979022008767123,0.37181663837011886,0.8636115395922632,1.0,5/12,17.54%,WWP2;SPAG17;CCDC40;DNAAF4;TSG101
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.47585070833691856,-1.0978177818148054,0.3544600938967136,0.7217310912682806,1.0,3/10,10.44%,PRKAA2;KLF15;MYOCD
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.3690811398219677,-1.097585755583121,0.2981366459627329,0.7208376902079461,1.0,10/33,10.41%,LRRC4C;NRG3;GRID2;GRIK2;GRIK1;CACNA1B;LRP8;EIF4EBP2;ABR;FABP5
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.4208687944345877,1.0970622545740052,0.3373333333333333,0.8650769763368856,1.0,10/52,9.72%,MBNL1;DDX5;RBFOX2;DDX17;SRSF6;CELF1;MBNL2;CELF3;RBM25;RBMX
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5307425772129744,1.096867788051383,0.3747841105354059,0.8648181671907128,1.0,5/13,26.85%,SMUG1;UPP2;TDG;MBD4;NT5C
prerank,establishment of spindle orientation (GO:0051294),0.4741234385965857,1.096802892354836,0.35526315789473684,0.8641933808501083,1.0,10/28,21.28%,ITGB1;NDEL1;PAFAH1B1;MISP;FBXW11;MAD2L1;SPDL1;ZW10;LLGL1;GPSM2
prerank,positive regulation of secretion by cell (GO:1903532),0.4107059382019756,1.0965226939742392,0.35107731305449935,0.8642268535121336,1.0,9/70,6.49%,SLC12A2;EZR;TGFB3;ADAM9;KCNB1;BMP6;UNC13B;SYTL4;GOLPH3
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.49573556534906954,1.0959194105446552,0.3632075471698113,0.8651466873199936,1.0,3/17,3.76%,SLIT2;FGF2;NRP1
prerank,ncRNA 3'-end processing (GO:0043628),0.5187558343138436,1.0957504823099287,0.362012987012987,0.8648090324087317,1.0,7/14,26.03%,INTS8;INTS5;INTS6;SSB;ERI1;PTCD1;INTS2
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.4991926874876502,1.0955102578297047,0.36507936507936506,0.8646692509000335,1.0,6/18,12.46%,CTNNA1;GSK3B;MDFIC;POLR1A;OTUD7B;CHP1
prerank,blood vessel endothelial cell migration (GO:0043534),0.48000045611358233,1.095427502476599,0.3480916030534351,0.8641185269019679,1.0,4/22,3.94%,SLIT2;FGF2;NRP1;ID1
prerank,cell part morphogenesis (GO:0032990),0.5404212801632039,1.0949029623104103,0.3884007029876977,0.8647719342516498,1.0,1/13,1.83%,PID1
prerank,chromatin assembly (GO:0031497),0.4483470805272328,1.0945790814120289,0.35774647887323946,0.8648879172319881,1.0,3/38,4.81%,SOX9;CHAF1B;KAT6B
prerank,quinone biosynthetic process (GO:1901663),0.5132575049937242,1.094100780370438,0.36932707355242567,0.8654326555693563,1.0,3/14,10.56%,COQ7;COQ10B;PDSS2
prerank,sodium ion homeostasis (GO:0055078),-0.4138245438283136,-1.0934425494176094,0.3628808864265928,0.7305890515148019,1.0,5/21,4.72%,ATP1A2;ATP1B3;NEDD4L;SLC8A1;ATP1B2
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.4024503585043541,1.0933560729632856,0.3381294964028777,0.8667070531487538,1.0,19/74,15.44%,BMP5;TGFB3;PHLDB2;SPRED2;TGFBR1;TGFBR2;GCNT2;IL17RD;TGFB1I1;BAMBI;FOXC1;LDLRAD4;SMAD2;BCL9L;TIAM1;NKX2-1;MTOR;TWIST1;PHLDB1
prerank,neural crest cell development (GO:0014032),-0.3371437573530811,-1.09327225664167,0.29615384615384616,0.7296221966835409,1.0,12/44,11.99%,SEMA6A;CDH2;SEMA7A;RADIL;SEMA6D;TBX1;ERBB4;TAPT1;SEMA5B;SEMA3G;SEMA6B;SEMA3B
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.5563674822465017,1.0932552312544985,0.39100346020761245,0.8653808277908939,1.0,1/10,1.17%,CDC42EP5
prerank,regulation of pseudopodium assembly (GO:0031272),0.5563674822465017,1.0932552312544985,0.39100346020761245,0.8653808277908939,1.0,1/10,1.17%,CDC42EP5
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5009599435995842,1.0931874366589207,0.3591331269349845,0.8647868398811766,1.0,7/20,8.95%,KCNJ2;SLC12A2;ATP1B1;SLC9A1;ATP1A4;ATP1A3;ATP1A1
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.4373392389057326,-1.0930881323635502,0.3484848484848485,0.7286351351388084,1.0,4/16,8.57%,ST6GALNAC3;ST8SIA4;ST8SIA6;ST8SIA1
prerank,cellular response to light stimulus (GO:0071482),0.4093963874168967,1.0927868630293724,0.33073929961089493,0.8651401371468352,1.0,16/66,19.50%,NEDD4;PRKCD;PDE6A;CREBBP;KDM1A;USP47;EP300;EIF2AK4;ZBTB1;YY1;USP28;ATR;INO80;EIF2S1;DHX36;FMR1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.36516339670586,1.092745710176025,0.2988133764832794,0.8644600567310218,1.0,26/199,7.47%,EGFR;BMP4;NFIB;SOX9;BMP5;WNT11;ARHGDIB;SMAD6;HDAC9;GSK3B;DOCK7;ZNF423;LRPAP1;FOXC2;ID1;KLF7;SPRED2;NPR3;ATP2B4;RAB11FIP3;ADAMTS5;IL17RD;DDIT3;SRSF6;IL10;ABHD6
prerank,myotube cell development (GO:0014904),0.5490678488036816,1.0925597032795984,0.4028520499108734,0.8642215333634816,1.0,2/10,5.80%,SIX1;SKI
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.5047761178408352,1.0920857583784278,0.3713355048859935,0.8647685468013034,1.0,9/16,28.54%,NAA40;CREBBP;EP300;KAT2B;NAA15;NAA35;NAA50;NAA80;NAA60
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5484986953079805,1.0916814051103203,0.3976510067114094,0.8650662238212227,1.0,2/10,1.93%,CYP1B1;WNK1
prerank,cellular response to superoxide (GO:0071451),-0.4985251165827119,-1.091611566088128,0.350253807106599,0.7310615452805053,1.0,4/10,19.04%,NOS3;SOD3;MT3;ATP7A
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3939860790227813,1.09121792132511,0.3333333333333333,0.865519722552165,1.0,30/84,21.38%,MBNL1;DDX5;RBFOX2;SON;DDX17;SRSF6;CELF1;MBNL2;CELF3;RBM39;RBM25;PCBP4;RBMX;U2AF2;REST;THRAP3;ZBTB7A;JMJD6;KHDRBS1;SRPK1;SFSWAP;FXR2;CIRBP;FMR1;SNW1;DAZAP1;SRSF12;TRA2B;NUP98;RBM3
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.41450553141256835,1.0910462816582005,0.3354591836734694,0.8652343311508688,1.0,23/62,28.21%,MLLT3;ELOF1;CDK12;MNAT1;SETD2;AFF4;ELOA;NELFE;CTR9;ELP4;CDK13;ERCC3;CCNT1;RTF1;PAF1;ERCC2;EAF2;ADRM1;GTF2F2;GTF2H3;NCBP2;CCNT2;EAF1
prerank,positive regulation of response to wounding (GO:1903036),-0.39141234781756373,-1.0907394494898743,0.33518005540166207,0.7320368449388345,1.0,9/24,12.00%,VTN;MYLK;OCLN;PTK2;ADRA2A;CLDN1;GRN;HBEGF;MDK
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.565977154675104,1.090605513220204,0.4097222222222222,0.8656111542088747,1.0,2/10,6.87%,LBP;IFI35
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.45000471487551524,1.0906037075648307,0.3562043795620438,0.8648331727617522,1.0,5/35,3.76%,MET;SEMA3E;SEMA3D;SEMA3C;NRP1
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.3229416463542299,-1.0904447667068562,0.2882882882882883,0.7313580917115035,1.0,24/57,26.55%,DCN;KDR;PPARGC1A;TNFSF10;PDCD5;HIP1R;SPIRE1;BOK;GSK3A;BMF;BIK;CAMKK2;CHCHD10;GPER1;DNM1L;TREM2;PMAIP1;PLAUR;MFF;PYCARD;RALA;MLLT11;PINK1;HRK
prerank,inositol phosphate biosynthetic process (GO:0032958),0.5410626194605085,1.0900498770093594,0.40266222961730447,0.8655977692284405,1.0,6/11,22.41%,FGF2;IP6K2;PPIP5K2;IP6K1;IP6K3;PPIP5K1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.4064478767308254,-1.089821995418721,0.345679012345679,0.7315082398987772,1.0,6/22,9.74%,AEBP1;APOE;MAP2;HSPA8;MAPT;EFEMP2
prerank,cellular response to hydroxyurea (GO:0072711),0.543099890791361,1.0898122371759607,0.3895870736086176,0.865481110473196,1.0,5/10,19.50%,DDI2;DDX11;SPIDR;ATRX;FMR1
prerank,B cell differentiation (GO:0030183),0.42735700855119035,1.0898079685285678,0.33967391304347827,0.8647053508367833,1.0,9/46,12.66%,HDAC4;HDAC9;ITGB1;CLCF1;PTPN2;IL10;PLCG2;DCAF1;TCF3
prerank,ubiquinone biosynthetic process (GO:0006744),0.5085442649778786,1.0896542977217103,0.3546875,0.8643654818688981,1.0,3/15,10.56%,COQ7;COQ10B;PDSS2
prerank,regulation of brown fat cell differentiation (GO:0090335),0.5046208339928915,1.0891579131647915,0.39232053422370616,0.8649409060787233,1.0,3/16,5.02%,SIX1;FTO;ZBTB7B
prerank,membrane lipid catabolic process (GO:0046466),0.548383668127638,1.088801614072252,0.38879159369527144,0.8651540239381674,1.0,2/10,3.97%,CYP1B1;PDXDC1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.5240421317238342,1.0887000149063166,0.4,0.8646467209596509,1.0,5/14,10.48%,EZR;PATJ;RHOA;SYNE4;MYO9A
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4491468862604673,1.088498224479929,0.36403508771929827,0.8644369850567336,1.0,8/33,13.09%,HOXA5;FOXO3;INHBA;RAB7B;STAT3;GATA1;BRD1;PRKDC
prerank,histone H3-K9 demethylation (GO:0033169),0.5435861973267005,1.0878021185062605,0.4045138888888889,0.8655808320457283,1.0,5/11,17.15%,JMJD1C;KDM1A;KDM3B;KDM4D;HR
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.36658298326244554,1.087465866055826,0.32216216216216215,0.8657389400375854,1.0,30/186,10.57%,NXN;TRABD2B;TCF7L2;SOX9;LRP6;MLLT3;PTPRU;WNT11;GLI3;GRB10;PRICKLE1;GSK3B;MDFI;SFRP4;TSKU;TLE2;NOG;LRP1;TLE6;INVS;DDIT3;PSMB2;CSNK1A1;NLK;RBMS3;DACT1;DKK3;PSMC6;IGFBP6;EMD
prerank,phospholipid dephosphorylation (GO:0046839),0.4427709069799687,1.0873829959766872,0.36049723756906077,0.8651913248232502,1.0,7/37,14.23%,PLPPR2;PLPP3;MTMR12;OCRL;PIP4P2;PLPP1;SYNJ1
prerank,positive regulation of translation (GO:0045727),0.3869229196395968,1.0871619142102333,0.3407755581668625,0.8650705306686568,1.0,28/94,24.02%,THBS1;SAMD4A;NIBAN1;YBX3;LARP4B;MRPS27;ERBB2;JMJD4;EIF3E;EIF6;PRKDC;MTOR;DHX9;PLD1;RPUSD4;AGO2;KHDRBS1;DHX36;FXR2;CIRBP;FMR1;LARP4;YTHDF2;RBM3;CDC123;TRUB2;YTHDF3;MPV17L2
prerank,protein polymerization (GO:0051258),0.4216422340479147,1.0869773254426671,0.33462033462033464,0.8647976724894766,1.0,14/55,16.34%,COBL;GSN;MAP7D3;FGF13;DIAPH1;FAM107A;HDGFL3;WASHC5;MSRB2;PSTPIP1;UBE2S;RNF135;UBE2K;TTC17
prerank,positive regulation of protein processing (GO:0010954),-0.41616374881284457,-1.086940238413751,0.34210526315789475,0.737812894364328,1.0,4/19,5.92%,CCBE1;CLEC3B;NKD2;MYH9
prerank,protein dephosphorylation (GO:0006470),0.37660144619685615,1.0867873801174017,0.330672748004561,0.8645704837018462,1.0,32/135,14.88%,EYA2;PTPN3;PPP3CA;PTPRU;UBASH3B;PPM1H;PPTC7;EYA4;PTPRF;PTPN2;PTPRA;EYA3;PPP2R2D;DUSP5;PTPN21;DUSP16;DUSP11;FBXW11;PPEF2;PPP1R12A;PPP2R5C;DUSP10;PTPN9;PPP5C;PPP3CC;ILKAP;DAPP1;PPP4R2;PPM1A;PDXP;PPP4R1;SBF1
prerank,actin filament network formation (GO:0051639),0.5410928949371125,1.0867343350311667,0.39663865546218485,0.8639374236902897,1.0,2/11,6.19%,COBL;PLS1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.404868279561759,1.0865773132352805,0.34564643799472294,0.8636073967573339,1.0,16/60,18.49%,TCF7L2;SOX9;MED15;MOV10;TNRC6C;NFKB1;MED13;MED27;CBFB;HNF1A;MED14;CCND1;RUNX2;MED24;CDKN1A;DHX36
prerank,regulation of Notch signaling pathway (GO:0008593),0.4019469113221065,1.0865194390730335,0.34591194968553457,0.8629763217920532,1.0,21/76,16.70%,EGFR;CCN3;TCIM;WWP2;CREBBP;STAT3;JAG1;MMP14;CD46;AAK1;NIBAN2;GALNT11;ELF3;ITGB1BP1;EP300;NEPRO;ZMIZ1;SYNJ2BP;ZBTB7A;KAT2B;EGF
prerank,ganglioside metabolic process (GO:0001573),-0.4089709376549032,-1.0862263178841947,0.36752136752136755,0.7382405263500357,1.0,9/20,22.10%,ST6GALNAC3;ST8SIA4;ST8SIA6;HEXB;ABCA2;GM2A;ST3GAL5;NEU2;ST6GALNAC4
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.5440230819112136,1.0854641272733547,0.36795774647887325,0.8650513262035748,1.0,2/10,5.28%,FN1;TSKU
prerank,miRNA metabolic process (GO:0010586),0.4913202764861485,1.0853230641450577,0.3940809968847352,0.8646964035731535,1.0,8/20,20.32%,DDX17;DGCR8;TUT7;DIS3L2;AGO2;TUT4;DROSHA;RAN
prerank,histone H3-K4 trimethylation (GO:0080182),0.5491222561436624,1.08526887652346,0.39195979899497485,0.8640687943470333,1.0,6/11,29.09%,KMT2D;CTR9;WDR82;OGT;KMT2A;SETD1B
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4743080110556526,1.0840644268021027,0.3570391872278665,0.8666385533424663,1.0,5/24,4.88%,TMEFF2;MET;ARAP1;PHLDB2;RHPN2
prerank,small GTPase mediated signal transduction (GO:0007264),0.38828595668530425,1.0836421016854567,0.3442240373395566,0.8670311677882457,1.0,22/103,12.46%,PLCE1;NTN1;CCNA2;NRAS;KRAS;MRAS;SHC1;FGF2;ARHGAP31;BCR;TIAM2;SHOC2;SHTN1;ARL3;RAPGEF6;G3BP2;NF1;JUN;TIAM1;RB1;RIT1;CHP1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.3930707054784966,1.0824436553983259,0.35049019607843135,0.8696339989157015,1.0,20/73,19.19%,HDAC4;POLR1G;POLR1A;CTCFL;TAF1D;EED;TAF1C;MTA1;KAT2A;POLR1F;EP300;DNMT3A;SUZ12;SF3B1;DDX21;KAT2B;EPC1;RBBP7;TASOR;SMARCA5
prerank,protein-containing complex disassembly (GO:0032984),0.42140036948807497,1.082410229117216,0.36328125,0.8689649430062315,1.0,7/54,8.84%,LRP6;GSK3B;WIPI2;VCP;FZD1;CSNK1A1;LIX1L
prerank,negative regulation of cation channel activity (GO:2001258),-0.3810575404247136,-1.0822583990413528,0.3168604651162791,0.7475041926235174,1.0,5/26,14.04%,KCNAB1;SLC6A9;CALM1;CASQ2;CALM3
prerank,positive regulation of lipid catabolic process (GO:0050996),0.4914459959534824,1.0818271038049447,0.383206106870229,0.8698119304589905,1.0,6/19,17.78%,PRKCD;IRS1;DAGLB;TWIST1;ABCD1;ANGPTL3
prerank,regulation of glycolytic process (GO:0006110),0.3972527891045733,1.0817948036848686,0.34347275031685676,0.869151197922473,1.0,15/68,16.82%,SLC4A4;HDAC4;NUP93;PFKFB2;PFKFB1;RANBP2;NCOR1;NUP153;EIF6;SEC13;EP300;NUP214;ZBTB7A;NUP188;PRXL2C
prerank,establishment of mitotic spindle orientation (GO:0000132),0.48492333380980995,1.0817251321743575,0.36874051593323215,0.868559994574346,1.0,9/23,21.28%,ITGB1;NDEL1;PAFAH1B1;MISP;FBXW11;MAD2L1;SPDL1;ZW10;GPSM2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4558768410487002,1.0811446367289175,0.38705035971223023,0.8694315087409363,1.0,9/29,22.14%,BMP5;SPRED2;IL17RD;LDLRAD4;NKX2-1;ADIPOR1;FUZ;FOXA1;GATA3
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.46462271423019735,-1.0810819484188336,0.37644341801385683,0.7477874446005373,1.0,3/11,14.04%,CALM1;CASQ2;CALM3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.46462271423019735,-1.0810819484188336,0.37644341801385683,0.7477874446005373,1.0,3/11,14.04%,CALM1;CASQ2;CALM3
prerank,acylglycerol homeostasis (GO:0055090),-0.3994770100002649,-1.081048375995797,0.3674033149171271,0.7464212775589366,1.0,6/20,15.52%,APOE;NR1H3;IL18;PNPLA8;SCARB1;LPL
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.5489831059055188,1.0810083780550461,0.4017241379310345,0.8690194402867187,1.0,4/10,10.48%,EZR;RHOA;SYNE4;MYO9A
prerank,negative regulation of apoptotic process (GO:0043066),0.35019073085363045,1.080734607083312,0.28484848484848485,0.868959008932763,1.0,78/444,14.85%,EGFR;THBS1;BMP4;CARD14;SIX1;FSTL1;GRK5;SOX9;NGF;ARHGAP10;TCIM;PTK2B;TGFB3;ANXA1;PRKCD;WNT11;SMAD6;CD44;ANXA4;GCLC;SHC1;TAX1BP1;KLF4;ITGB1;GSK3B;NOTCH2;ERC1;CLCF1;SERPINB9;SON;NR4A2;ITGA5;NFATC4;DNAJC3;ISL1;GDNF;GATA4;GOLPH3;RIPK2;BIRC6;IL10;BIRC7;SOCS2;SIX4;PLK3;ERCC5;NFKB1;NIBAN2;NTSR1;GATA1;PIM2;MTDH;VEGFA;PROK2;ARF4;USP47;KRT18;HTATIP2;UBE2Z;COPS5;MYD88;RB1;AATF;DDRGK1;ZC3H12A;CARD16;PRKDC;YME1L1;BAG3;PAK2;PRKCA;PRDX5;FATE1;HTR2B;CEACAM5;MAD2L1;STIL;SQSTM1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.47332080020121353,1.080452148574281,0.39109697933227344,0.868992238564519,1.0,12/25,28.21%,CDK12;WDR43;TCERG1;RNF168;NELFE;CDK13;RECQL5;RNF8;LDB1;EAF2;HEXIM1;EAF1
prerank,regulation of developmental growth (GO:0048638),-0.3576556869266624,-1.080430013272344,0.3560371517027864,0.746572611791464,1.0,9/29,10.52%,PLCB1;IGF1;APOE;INSR;APP;GHR;SPAAR;MFSD2A;OLFM1
prerank,phospholipid catabolic process (GO:0009395),-0.39068358168856776,-1.080183853954584,0.364741641337386,0.7457057544897713,1.0,4/24,7.68%,GPCPD1;ENPP2;ENPP6;ABHD12
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.3929885062027802,-1.0800032462109925,0.349862258953168,0.7447971647450933,1.0,8/21,13.42%,DCN;CSGALNACT1;CHSY3;CHST3;CHSY1;UGDH;CSPG5;NCAN
prerank,positive regulation of type I interferon production (GO:0032481),0.3990955197158761,1.0795576335623458,0.34465408805031444,0.8706652618806945,1.0,23/73,18.52%,CREBBP;POLR3D;MAVS;RIPK2;SETD2;IRF1;TLR4;NFKB1;CHUK;NFKB2;MYD88;PRKDC;IFIH1;XRCC5;EP300;DHX9;RNF135;TLR8;POLR3K;POLR3A;POLR3F;DHX36;POLR3E
prerank,negative regulation of cell cycle (GO:0045786),0.3982079964485011,1.0792754059705796,0.3577749683944374,0.870667920639898,1.0,13/73,13.17%,BMP4;PTPN3;INHBA;PDCD4;IPO7;GAS1;IL10;CDKN1B;FOXC1;BTG3;RB1;NR4A1;ANGEL2
prerank,regulation of monooxygenase activity (GO:0032768),0.47277864508091105,1.0790261548393003,0.3799126637554585,0.8705836075987535,1.0,1/23,0.24%,EGFR
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.3710506844796535,-1.0786899929703135,0.3651315789473684,0.7469348725910567,1.0,7/28,10.81%,SHANK3;APOE;ADCY1;APP;EPHA4;LGMN;NSG1
prerank,heart process (GO:0003015),0.5230512375149249,1.0783648786703772,0.3979933110367893,0.8715864839062479,1.0,1/14,0.75%,SGCD
prerank,negative regulation of cell population proliferation (GO:0008285),0.35332616866194616,1.0778775211581562,0.3312945973496432,0.8720857056319744,1.0,57/351,11.29%,ZBTB7C;BMP4;CCN3;WNT9A;SOX9;TES;BMP5;CYP1B1;NGF;PTK2B;TGFB3;ABI1;PTPRU;SMAD6;HES1;IGFBP5;KLF4;INHBA;NELL1;LMNA;STRN;PTPN2;P3H2;NCK2;KLF10;SFRP4;SMYD2;CLMN;FRK;NOG;SKI;PTHLH;E2F3;TGFB1I1;IRF1;CELF1;SLURP1;IFI35;MYOG;IL10;GDF5;P3H1;CDKN1B;MDM4;KANK2;NIBAN2;NF1;TOB1;RARG;PIM2;BTG3;IGFBP6;PPP2R5C;EMD;MORC3;TBRG1;ITGB1BP1
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.35381910456130694,-1.0775858701825223,0.3187919463087248,0.7485198268600162,1.0,11/32,12.70%,IL1RAPL1;NEDD4L;TNIK;RAPGEF2;HECW2;RAP2A;ADGRB3;OBSL1;HECW1;CUX2;KNDC1
prerank,bile acid biosynthetic process (GO:0006699),-0.36872694650045557,-1.0775631023837842,0.3554913294797688,0.7471375806534084,1.0,7/24,21.44%,CYP7B1;CYP27A1;OSBPL1A;SCP2;CH25H;OSBPL7;SLC27A2
prerank,negative regulation of type I interferon production (GO:0032480),0.4360397781786957,1.0770063723342207,0.37202797202797205,0.8738074333876442,1.0,17/40,22.43%,TAX1BP1;MAVS;REL;IKBKE;IL10;IFIH1;NPLOC4;RNF135;OTUD5;ACOD1;YY1;PTPRS;UFD1;TRIM25;GPATCH3;IRF3;TRAF3IP1
prerank,organophosphate ester transport (GO:0015748),0.4674381360313201,1.0766917660318696,0.3810930576070901,0.8739039270696592,1.0,4/24,5.84%,TNFAIP8L3;PITPNC1;PITPNA;LDLR
prerank,protein localization to cell-cell junction (GO:0150105),-0.43550173071263104,-1.076541428789692,0.39641943734015345,0.7483508660472896,1.0,4/15,4.13%,TJP1;F11R;CGNL1;ACTB
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.463623033249303,-1.0760644676085027,0.3783783783783784,0.748262406504282,1.0,5/11,25.61%,RPS6KA6;SP100;ING4;MUC1;HIPK2
prerank,positive regulation of cell differentiation (GO:0045597),0.3575058546132362,1.0756592458038627,0.34285714285714286,0.8759295269681713,1.0,45/237,10.99%,BMP4;CDON;BOC;SOX9;VWC2;HOXA5;NGF;CCN1;TGFB3;DDR2;ZBTB16;FGFR1;CTNNA1;BMP6;BMPR1A;ABL1;CMKLR1;NELL1;MEF2A;TGFBR1;AGTR1;RAP1A;TMEM100;TRPM4;TGFBR2;GCNT2;ISL1;GDNF;TGFB1I1;BAMBI;GDF6;MYOG;GDF5;ID2;NBL1;FOXC1;RHOA;NFKB1;ACVR1;HOXB4;CDS1;SMAD2;SYAP1;LRP5;MAPK12
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.278217534489715,-1.0755554350659642,0.2653061224489796,0.7481832024384995,1.0,30/152,12.39%,ADGRL4;ADGRL3;ADCY5;CACNA1D;ADCY1;LGR4;LPAR1;CALCRL;ADGRE5;ADCY7;ABCA1;PTGFR;PRKACB;CHRM2;ADGRB3;ADRA2A;PDE2A;GRM8;ADGRG1;ADORA2A;S1PR1;PTH1R;RAMP2;ADM;TBXA2R;LPAR2;S1PR3;GPR37;ADCY2;ADGRB1
prerank,nucleic acid metabolic process (GO:0090304),0.3991522112544998,1.0755060975715545,0.3706467661691542,0.875597749609901,1.0,21/69,25.89%,NT5E;RBFOX2;HNRNPH1;DXO;DUSP11;WRN;RBMX;ATXN2;HNRNPM;RECQL5;LSM8;TOPBP1;EXD2;RAN;DDX1;RAD50;DDX24;DNASE2;GTF2F2;HNRNPA2B1;WTAP
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.507923198794744,1.0745302997440132,0.3853820598006645,0.8774805827801658,1.0,4/15,9.60%,SKI;IGSF1;DACT1;ACVR1
prerank,cellular calcium ion homeostasis (GO:0006874),0.3712475424672205,1.07448593037071,0.3521288837744534,0.8768385717537116,1.0,22/133,14.30%,SLC35G1;SLC24A3;ANK2;ATP1B1;CAMK2D;ATP2C2;CSRP3;STIM2;ATP2B4;SLC10A7;CASR;DRD3;TNNI3;MCUB;MCU;CCL3;CCL1;SLC8B1;CCL7;RMDN3;NPTN;HTR2B
prerank,protein localization to membrane (GO:0072657),0.36448291032019164,1.0743007286592616,0.3365800865800866,0.8765473160233904,1.0,37/187,13.39%,KCNB2;CDH1;RAMP1;LRP6;ANK2;ATP1B1;EZR;SLMAP;KCNB1;FGF13;TTC7A;MRAP;RAP1A;DLG2;GAK;PIP5K1A;ARL3;EHD3;DLG1;JUP;RDX;RAPGEF6;SEC16A;RABEP1;FRMPD1;S100A10;FCHO2;C2CD5;EHD1;EHD2;ITGB1BP1;ZDHHC15;ZFYVE27;ZDHHC2;SMURF1;SH3GLB1;PRAM1
prerank,signal transduction in response to DNA damage (GO:0042770),0.41176720175243375,1.0741880703521474,0.3761840324763194,0.87607965487395,1.0,15/49,17.56%,NDRG1;ABL1;CHEK2;MDM4;RAD17;CEP63;ATM;USP10;CLSPN;ATRX;CHEK1;HINFP;USP28;ATR;NBN
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.45615122146907416,1.0737665220342512,0.3953147877013177,0.8764616048320192,1.0,11/25,28.21%,SCAF8;WDR43;SETD5;CCNT1;THOC5;HTATSF1;LDB1;EAF2;ALYREF;CCNT2;EAF1
prerank,protein heterooligomerization (GO:0051291),0.4858857832898965,1.073506998351629,0.3767441860465116,0.876386587878875,1.0,2/17,2.18%,PKD1;TMEM120A
prerank,neurotransmitter uptake (GO:0001504),-0.45793810396992457,-1.0733993218031335,0.37623762376237624,0.7523490394409331,1.0,5/12,9.86%,ATP1A2;SLC1A3;SLC29A1;SNAP25;SLC22A2
prerank,regulation of receptor binding (GO:1900120),-0.48008400468060747,-1.073063971792061,0.37259615384615385,0.7518484322685544,1.0,4/10,15.45%,B2M;GREM2;ATP2A2;ATP2A3
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.48313969940677187,1.0728070184276781,0.37059724349157736,0.8775253658991231,1.0,5/18,17.60%,EZR;RDX;SNX12;MAP2K2;RAB21
prerank,"base-excision repair, AP site formation (GO:0006285)",0.49376012149065684,1.072682571742521,0.3886178861788618,0.877106803770992,1.0,6/17,23.04%,MPG;SMUG1;ERCC5;NEIL3;TDG;MBD4
prerank,carbohydrate derivative transport (GO:1901264),-0.40765745501572775,-1.0724547664436541,0.36338028169014086,0.7520075081263645,1.0,7/18,12.03%,PLTP;SLC29A1;ABCG1;NPC2;MFSD2A;SLC15A2;SCARB1
prerank,bicellular tight junction assembly (GO:0070830),-0.3315874601767579,-1.072211575795933,0.33201581027667987,0.7511803140596378,1.0,6/46,2.80%,PECAM1;PARD6G;CLDN5;ESAM;OCLN;F11R
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.47589545005516143,1.0720870280369976,0.3671875,0.8779962029516668,1.0,1/21,0.25%,FOXP1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.37190700196582366,1.072073033919402,0.35,0.8772697453239556,1.0,32/138,16.73%,NR3C2;RARB;HDAC9;ESR2;NOTCH2;NR2F1;NR4A3;NR4A2;CREBBP;MNAT1;ESR1;TBL1X;E2F3;RORA;TEAD1;RXRA;MED27;RARG;RARA;NCOR1;GTF2E1;NR6A1;NR4A1;NCOR2;HNF4A;E2F2;HDAC10;TAF4;ERCC3;KAT2B;TAF12;WWTR1
prerank,tRNA wobble base modification (GO:0002097),0.512757980060539,1.0720040100438781,0.37738853503184716,0.8766971775454294,1.0,9/14,30.11%,ELP3;MTO1;ALKBH8;ELP4;CTU2;MOCS3;GTPBP3;DPH3;URM1
prerank,signal transduction by p53 class mediator (GO:0072331),0.451107616527443,1.0717121013260187,0.3825701624815362,0.8767186630799739,1.0,6/30,12.57%,DDX5;NDRG1;FHIT;MDM4;USP10;ATRX
prerank,neuron migration (GO:0001764),-0.32666360235535996,-1.0716573444112538,0.3320754716981132,0.7511510686573004,1.0,14/48,8.57%,AUTS2;ADGRL3;DCDC2;RAPGEF2;ASTN2;GPM6A;SPOCK1;SH3RF1;NDNF;MEF2C;DCX;ASTN1;NTRK2;RAC1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.4305069899445226,-1.0716113544900179,0.38903394255874674,0.7498614761969297,1.0,6/15,15.52%,PRKCH;CSF1;IL18;MSR1;AGT;LPL
prerank,DNA methylation or demethylation (GO:0044728),0.4875243336337603,1.0715156344805932,0.40275650842266464,0.8757305688558088,1.0,8/19,25.49%,EHMT1;ATRX;DNMT3A;BAZ2A;EHMT2;TEX15;DMAP1;ATF7IP
prerank,DNA alkylation (GO:0006305),0.4875243336337603,1.0715156344805932,0.40275650842266464,0.8757305688558088,1.0,8/19,25.49%,EHMT1;ATRX;DNMT3A;BAZ2A;EHMT2;TEX15;DMAP1;ATF7IP
prerank,acylglycerol catabolic process (GO:0046464),0.44412278547754597,1.0711874945129938,0.386066763425254,0.8758924863507332,1.0,4/30,12.02%,MGLL;PNPLA3;ABHD6;LYPLA2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.3513767964662607,-1.070156836973066,0.3622291021671827,0.7522489277049813,1.0,11/35,14.04%,ITGA1;PDGFRB;CALM1;NUAK1;PPP4R4;HSP90AB1;CD300A;PPP1R15B;TIPRL;HSP90B1;CALM3
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.38183393025495077,1.0700268959017263,0.37824474660074164,0.8782795707559394,1.0,25/94,19.60%,MAP3K5;CYP1B1;DDX5;TMEM117;PRKCD;FHIT;ABL1;DDIT3;IKBKE;CHEK2;ATM;ERN2;DIABLO;ARL6IP5;TNFRSF1B;PRKDC;CUL3;CUL1;PML;CASP2;CDKN1A;QRICH1;AIFM1;MOAP1;E2F1
prerank,secondary palate development (GO:0062009),-0.4267634812098633,-1.06971098541438,0.3569553805774278,0.7520580126689671,1.0,4/14,2.82%,LEF1;TGFBR3;CHD7;WNT5A
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.5281185280189943,1.0692204670885923,0.40932642487046633,0.8789619553453921,1.0,4/12,11.89%,EFNA5;DMTN;ITGB1BP1;CORO1C
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.5281185280189943,1.0692204670885923,0.40932642487046633,0.8789619553453921,1.0,4/12,11.89%,EFNA5;DMTN;ITGB1BP1;CORO1C
prerank,response to ethanol (GO:0045471),-0.4426878727331892,-1.0691280812200785,0.3937007874015748,0.7521412704404529,1.0,8/14,16.87%,GRIN2A;ADCY7;GRIN2B;GRIN1;GLRA1;SDF4;GRIN3A;GOT2
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.4685971714912027,1.069090699461354,0.4009216589861751,0.87856561446894,1.0,10/23,23.08%,VCP;SEC16A;RANGRF;SEC13;NPLOC4;OS9;UFD1;FAF2;HERPUD1;SURF4
prerank,mismatch repair (GO:0006298),0.46171773287292034,1.068560545249343,0.4051355206847361,0.8792478592342379,1.0,10/27,21.45%,ABL1;SETD2;EXO1;MLH3;MCM9;RNASEH2A;RPA1;ERCC1;TDG;POLD3
prerank,regulation of blood circulation (GO:1903522),0.4326072368805439,1.0683311179594954,0.3832599118942731,0.8790988532077032,1.0,3/34,4.32%,KCNMB2;CAMK2D;AGTR1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.2812326433319715,-1.0683261499132366,0.29411764705882354,0.7528978101227977,1.0,32/117,19.52%,LYN;ADCY5;ADCY1;PRKAR2B;GNG2;CALCRL;ADCY7;GGT5;PRKAR1B;MYH9;PRKACB;PRKAR1A;CD81;ADORA2A;CYSLTR1;CYSLTR2;PTH1R;RAMP2;ADM;ADCY2;PLCG1;ADCY4;HCK;PLK2;GGT1;FCGR1A;GPR176;RHBDF2;LHCGR;VIPR2;TSHR;RXFP1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.36472153035677074,1.0681341214019446,0.3444075304540421,0.878896166695737,1.0,37/166,16.73%,NR3C2;RARB;HDAC9;ESR2;NOTCH2;NR2F1;POLR1G;NR4A3;NR4A2;CREBBP;MNAT1;ESR1;TBL1X;E2F3;RORA;TEAD1;RXRA;POLR1A;MED27;RARG;RARA;NCOR1;TAF1D;TAF1C;GTF2E1;NR6A1;NR4A1;NCOR2;HNF4A;POLR1F;E2F2;HDAC10;TAF4;ERCC3;KAT2B;TAF12;WWTR1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.4104536402615589,-1.0676494424822527,0.39195979899497485,0.7532812879551292,1.0,10/18,18.72%,PTGDS;PTGS1;EDN1;PNPLA8;HPGDS;MIF;CD74;CBR1;PTGES3;PTGS2
prerank,determination of heart left/right asymmetry (GO:0061371),0.42518426326107467,1.0676213666188317,0.37637362637362637,0.8795295558342999,1.0,6/42,11.12%,MICAL2;SMO;TGFBR2;GATA4;MEGF8;CCDC40
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.3800464485040499,-1.0674842115494367,0.36908517350157727,0.7522776151330071,1.0,4/26,5.05%,LPGAT1;PRKAG2;NR1H3;PRKAA2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.5110745501501153,1.0674354649436766,0.3872549019607843,0.8792774176343437,1.0,5/14,15.19%,PGF;NRP1;FOXC1;VEGFA;GAB1
prerank,regulation of amyloid fibril formation (GO:1905906),-0.43053462328529113,-1.0672854267673515,0.3716577540106952,0.7513786080157595,1.0,4/15,8.77%,APOE;APP;PFDN5;PFDN2
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.4676464444230748,1.0669885930586591,0.37962962962962965,0.8797021469157593,1.0,7/20,9.51%,ANK2;ATP1B1;CACNA1C;CAMK2D;DMD;SLC9A1;TNNI3
prerank,regulation of Rho protein signal transduction (GO:0035023),0.39413358808821825,1.0669848418180803,0.34895191122071517,0.87895595367922,1.0,10/72,4.67%,ARHGEF28;MET;AKAP13;ARHGDIB;GPR4;COL3A1;ABL1;BCR;NRP1;CCDC125
prerank,regulation of cell division (GO:0051302),0.39527456618823753,1.0669177812939277,0.3682266009852217,0.8783959212964904,1.0,16/72,14.30%,MLLT3;KIF13A;NLRP5;BECN1;RAB11FIP3;TLE6;SETD2;BIRC6;PLK3;KLHL13;AURKA;PRDM15;ENTR1;SH3GLB1;PDXP;HTR2B
prerank,epithelial structure maintenance (GO:0010669),0.5381607680650861,1.0662423791109754,0.41724137931034483,0.8794132149067961,1.0,2/11,6.87%,CXADR;MUC6
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5461342070597304,1.0660811882875085,0.4116666666666667,0.8791068764884684,1.0,2/10,2.55%,PID1;GRB10
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.44938139022850326,-1.065745460920683,0.4023529411764706,0.7542060553816707,1.0,5/12,10.15%,PROM1;PODXL;BASP1;KLF15;PTPRO
prerank,regulation of lymphocyte differentiation (GO:0045619),0.49111360465796283,1.0657407064322268,0.4075286415711948,0.8792752739847037,1.0,3/18,13.09%,ABL1;CD2;PRKDC
prerank,regulation of protein localization to centrosome (GO:1904779),0.534909065812636,1.0655898373198647,0.4033898305084746,0.8789520247108046,1.0,1/10,3.23%,GSK3B
prerank,cilium assembly (GO:0060271),0.3498698934164572,1.0654507651526957,0.3492723492723493,0.8785626961995845,1.0,88/296,23.09%,PKD1;BBS9;ABLIM3;EXOC4;RP1;PARVA;GSN;PDE6D;DNAAF3;PTPDC1;DZIP1;SFI1;PAFAH1B1;RAB11FIP3;PCM1;ARL3;EHD3;GBF1;ARL13A;ATAT1;CEP164;OCRL;EXOC5;TOGARAM1;CFAP70;CDC14A;DISC1;WDR35;TMEM231;CEP63;IFT46;EHD1;AKAP9;GALNT11;DYNC2I2;EHD2;RPGRIP1;ARF4;CEP131;CCDC40;CCDC66;ABCC4;ARMC9;PIBF1;RFX2;ATP6V0D1;NPHP1;CSNK1E;CEP20;TRIP11;SSTR3;IFT52;SDCCAG8;MKS1;NUDCD3;FAM161A;CEP89;CEP43;KIF3B;HAUS2;CEP57;DYNC2I1;C2CD3;CEP97;LZTFL1;HYLS1;TEKT2;IQCB1;RSPH9;CEP70;RILPL1;CSNK1D;GORAB;POC1B;FUZ;DYNC2H1;RAB1A;IFT80;CLUAP1;OFD1;TRAPPC14;FLNA;TRAF3IP1;CNTRL;HAUS5;PLK4;BBS2;RSPH6A
prerank,cellular protein modification process (GO:0006464),0.33811327448858197,1.0646012293934146,0.2832832832832833,0.8800616815289823,1.0,188/982,15.75%,STK39;FBXL7;ST3GAL4;THBS1;BMP4;DCLK1;MSLN;FSTL1;MAP3K5;GRK5;MARK1;PTP4A2;PTPN3;UST;EGLN3;PPP3CA;CCN1;PTK2B;CAMK2D;PLOD2;PTPRU;ANXA1;WNK1;FN1;PRKCD;WNT11;FBXO10;GPC3;DSP;ZBTB16;COL3A1;IGFBP5;B3GNT2;WWP2;FGFR1;LIMK2;HIPK1;DCAF6;PPM1H;BMPR1A;GSK3B;LOXL1;LARGE1;TLK1;PRKCE;NEK7;ABL1;BCR;PTPRF;TGFBR1;FBXO40;PHKA2;CLK2;CHST5;WIPI2;MKNK2;SGK3;TGFBR2;FBXW8;GCNT2;KLHL22;PHEX;DNAJC3;FRK;CCDC8;CDK12;ATG3;PTPRA;BIRC6;HIF3A;FBXL20;CDC25B;PSMB2;IKBKE;FAM20A;MPI;DUSP5;ASB9;TGM3;ASB16;P3H1;KTN1;MARK2;SOCS2;CSNK1A1;DCAF4;CHEK2;SPRR1A;PTPN21;NLK;KLHL13;DUSP16;UBE2F;CSNK1G3;DUSP11;CHUK;UBE2D3;RIPK3;AAK1;FBXW11;SIK3;IRAK3;TNKS2;ATM;AURKA;ACVR1;COMMD1;USP25;FEM1B;RARA;PIM2;PPEF2;PSMC6;PPP1R12A;TIMP1;MARK3;SIK2;PPP2R5C;ERN2;MORC3;ARF4;STRADA;COPS7B;MAST2;PRKCSH;ERBB2;FBXO17;JMJD4;CKAP4;ASB11;SPSB2;MAN2A1;COPS5;DUSP10;PTPN9;LRRC41;PPP5C;CDKL2;COG3;PPP3CC;COP1;ILKAP;CSK;YES1;DAPP1;MACROD2;FBXO4;PRKDC;PDK3;PSMD11;MTOR;PPP4R2;PPM1A;PKN2;PAK2;CHEK1;PRKCA;RCN1;UBE2S;CUL3;DCAF5;CDC42BPG;DYRK2;CSNK1E;PDXP;EIF2AK4;ERCC8;BMP15;BAP1;WDTC1;TRIOBP;MGAT1;CDK11B;ST3GAL2;PPP4R1;SBF1;CDK16;TGM1;MAPKAPK2;PIGU;CCDC22;CALU;PSMD1;MXRA8;ASB1;CUL1;TLK2;DDOST
prerank,myeloid leukocyte differentiation (GO:0002573),0.3935859451367189,1.06445556754459,0.37182741116751267,0.8796808244987687,1.0,8/65,11.08%,FOXP1;BMP4;GAB2;TGFBR2;RXRA;RARA;VEGFA;TNFSF11
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.47275414968301893,1.0644032665664507,0.3964968152866242,0.8790653832767295,1.0,6/22,18.96%,CDK12;SCAF8;TCERG1;CDK13;CCNT1;THOC5
prerank,response to hydroxyurea (GO:0072710),0.5239160897407706,1.0637798304401989,0.4166666666666667,0.8800883310411909,1.0,5/11,19.50%,DDI2;DDX11;SPIDR;ATRX;FMR1
prerank,regulation of peptidase activity (GO:0052547),-0.3987921258058995,-1.0637704333619933,0.3924731182795699,0.7581183841508597,1.0,2/19,3.19%,CTSH;CST3
prerank,glial cell development (GO:0021782),-0.3642701731544546,-1.063719819408317,0.3463855421686747,0.7568450220812506,1.0,15/25,33.68%,CDK6;APP;NRROS;CSPG5;MDK;MYRF;MT3;DLL1;TPPP;SOX10;EIF2B1;SOX4;EIF2B5;S100A9;HES5
prerank,axon guidance (GO:0007411),0.3576245956594678,1.0634360770528775,0.35714285714285715,0.8802618863065556,1.0,24/201,6.27%,SLIT3;SLIT2;NTN1;NFIB;SMO;EZR;EFNA5;SEMA3E;UNC5C;SEMA3D;SEMA3C;PDLIM7;GRB10;SPTAN1;SHC1;GAB2;NOTCH2;ALCAM;NRP1;KLF7;TMEFF1;GDNF;EPHB3;PTPRA
prerank,protein localization to vacuole (GO:0072665),-0.43227011661469195,-1.0633957532307414,0.38072289156626504,0.7562533127862062,1.0,5/13,14.46%,CD81;RTN4;SH3BP4;GLMP;MFSD1
prerank,cellular response to interleukin-7 (GO:0098761),0.49059576606157074,1.0629218905549058,0.4066666666666667,0.8801950241811223,1.0,6/17,15.60%,IRS1;STAT3;SOCS2;SMARCA4;STAT5A;BRWD1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.49059576606157074,1.0629218905549058,0.4066666666666667,0.8801950241811223,1.0,6/17,15.60%,IRS1;STAT3;SOCS2;SMARCA4;STAT5A;BRWD1
prerank,positive regulation of cell motility (GO:2000147),0.35884787037505844,1.0627787859621562,0.38354700854700857,0.8798464584792138,1.0,19/205,4.08%,F3;EGFR;THBS1;NTN1;NTRK3;PPP3CA;CCN1;PDGFC;PTK2B;SMO;ADAM9;SEMA3E;WNT11;SEMA3D;SEMA3C;TWIST2;ITGB1;FAM107A;TGFBR1
prerank,plasma membrane repair (GO:0001778),0.5119836490549059,1.062564653119712,0.39303482587064675,0.8796698775075932,1.0,2/13,4.49%,AHNAK2;SYTL4
prerank,endoplasmic reticulum organization (GO:0007029),0.3923792090775347,1.0625501948363751,0.38471177944862156,0.8789572324184673,1.0,15/72,12.38%,ATL3;ATL2;STX5;SPTSSB;SHTN1;TLE6;LMAN2L;GAK;DOP1B;SEC16A;TRAM2;EMD;SEC31A;SEC61A1;RTN3
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.46236786113045686,1.062488721904738,0.39280125195618154,0.8783630435781645,1.0,7/22,18.49%,ESR1;MED13;PSMC6;HNF1A;MED14;MED24;DHX36
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5458901312520584,1.0624081569958794,0.423728813559322,0.8778549021177233,1.0,4/10,26.50%,JUN;BAG3;NCK1;CITED2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3787779952041906,1.0623049803203997,0.37545126353790614,0.8774247872522701,1.0,25/100,16.54%,FHIT;GIPC1;PRICKLE1;GSK3B;RNF144A;VCP;XPO1;ARIH1;CLU;RNF19A;CSNK1A1;COMMD1;RAD23B;ZYG11B;WAC;USP7;DESI1;DDRGK1;COP1;ARIH2;ANKIB1;CSNK1E;TRIM39;TLK2;RNF14
prerank,negative regulation of interferon-gamma production (GO:0032689),0.4547674989670182,1.0621874657065855,0.3668188736681887,0.8770135882083234,1.0,5/23,12.36%,INHBA;DDIT3;TLR4;RARA;ZC3H12A
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3877585274397145,1.0620146864296638,0.3790523690773067,0.8767632259830486,1.0,23/72,19.60%,PLAGL1;NDRG1;CRADD;CHEK2;PLK3;CDKN1B;MDM4;ATM;AURKA;PCBP4;USP10;ATRX;EP300;CNOT7;PIDD1;PML;CASP2;CARM1;TNKS1BP1;NBN;CDKN1A;CNOT4;E2F1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5133651796130945,1.0619406092987447,0.4119496855345912,0.8762555319088905,1.0,2/14,1.56%,ANK2;ATP1B1
prerank,retinoic acid metabolic process (GO:0042573),-0.4217444608178361,-1.0618472648689166,0.38817480719794345,0.7590179842791729,1.0,2/14,2.00%,ALDH1A2;CYP26B1
prerank,cellular defense response (GO:0006968),0.43443132419490116,1.0616287274146676,0.39492242595204513,0.8763812915724678,1.0,6/40,7.25%,LBP;PTK2B;ITGB1;ZNF148;BECN1;KLRC2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3917820618962738,1.060819891547599,0.3632911392405063,0.8777329975647057,1.0,6/78,8.41%,EGFR;PKD1;CCNA2;MNAT1;IPO7;CDKN1B
prerank,transition metal ion homeostasis (GO:0055076),-0.36768767281247927,-1.0605799791767467,0.3433734939759036,0.7610687568109797,1.0,5/28,7.01%,CP;B2M;PICALM;SLC40A1;FTL
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.40881054597437505,1.0604421512586872,0.3854033290653009,0.8779927675615598,1.0,8/59,3.33%,CDH1;HMCN1;PKD1;FAT2;MPZL2;NECTIN3;ITGB1;DSG2
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3563765708899793,-1.0604219669369448,0.3738019169329074,0.7600414895285734,1.0,14/32,22.02%,MAP2;NAV3;CLASP2;SNCA;STMN1;CAMSAP2;FKBP4;TUBB4A;STMN2;TPX2;CDH5;APC2;DYRK1A;CAMSAP1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.38972940992623306,-1.0601378637070893,0.376,0.7593454041360286,1.0,7/20,13.30%,BCL2;DCC;BCL2L1;FAS;BOK;CASP3;GSK3A
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.2779087102432154,-1.0595309167653446,0.29927007299270075,0.759582630437086,1.0,32/116,19.52%,LYN;ADCY5;ADCY1;PRKAR2B;GNG2;CALCRL;ADCY7;GGT5;PRKAR1B;MYH9;PRKACB;PRKAR1A;ADORA2A;CYSLTR1;CYSLTR2;PTH1R;RAMP2;ADM;ADCY2;PLCG1;ADCY4;HCK;PLK2;GGT1;FCGR1A;GPR176;RHBDF2;LHCGR;VIPR2;SELENOS;TSHR;RXFP1
prerank,prostanoid biosynthetic process (GO:0046457),-0.42691111158962847,-1.0594215006779308,0.39746835443037976,0.7584766628712785,1.0,8/15,18.72%,PTGDS;PTGS1;EDN1;PNPLA8;MIF;CD74;PTGES3;PTGS2
prerank,cristae formation (GO:0042407),-0.364031000595167,-1.059392011429595,0.3782991202346041,0.7571667860066751,1.0,10/27,19.76%,ATP5PF;ATP5F1B;ATP5F1E;ATP5F1A;ATP5MC1;ATP5F1D;CHCHD6;MICOS13;ATP5MC2;ATP5ME
prerank,neutrophil activation (GO:0042119),0.5262987778936773,1.058456438818372,0.43463497453310695,0.8825770038707058,1.0,1/12,2.04%,PRKCD
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3543641745186539,1.0583118524012824,0.39565217391304347,0.8822310921380832,1.0,44/182,16.31%,FOXP1;BMP4;SLC24A3;ITGB8;SMO;WWP2;KLF4;BMPR1A;FGF2;ZNF148;NOTCH2;LRPAP1;ATP2B4;LDLR;ESR1;CELF1;REL;MOV10;ID2;TNRC6C;ATOH8;NFKB1;RBMS3;CD46;AURKA;ATXN2;VEGFA;SMCR8;CCL3;CREB3L1;RB1;SNX12;DDRGK1;ZC3H12A;ANXA7;REST;CNOT7;MAP2K2;HINFP;XDH;AGO2;ADAM10;RIN3;YY1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.4405151925469793,-1.0582427491105253,0.3888888888888889,0.7588632110877197,1.0,3/13,11.81%,ENPP1;TPST1;SULT4A1
prerank,receptor catabolic process (GO:0032801),0.46850225912473203,1.0580602228026728,0.40923076923076923,0.882169758978051,1.0,7/24,13.30%,NEDD4;AP2A2;BECN1;AP2A1;KIF16B;SMURF1;SH3GLB1
prerank,natural killer cell activation (GO:0030101),0.46200702249555675,1.0579744839720118,0.4026946107784431,0.8816631019811111,1.0,3/23,6.34%,PBX1;CD2;NFIL3
prerank,positive regulation of developmental growth (GO:0048639),-0.32937952973434853,-1.057749710289896,0.33064516129032256,0.7587649950060461,1.0,16/49,16.06%,PLCB1;NEDD4L;SEMA7A;RIMS1;RIMS2;INSR;GHR;MAPT;SYT1;TWF2;RNF157;PPIB;LIMK1;MACF1;CPNE5;CDKL5
prerank,organophosphate biosynthetic process (GO:0090407),0.4315168783295401,1.0574459783239971,0.4019471488178025,0.8823584220874626,1.0,13/37,20.23%,FGF2;IP6K2;PNPO;PIP5K1A;NFS1;GNPAT;MBOAT1;PPIP5K2;MOCOS;IP6K1;IP6K3;LPCAT1;MOCS3
prerank,positive regulation of kinase activity (GO:0033674),0.37495249857775703,1.0574368098880949,0.3971797884841363,0.8816524279806783,1.0,12/107,6.37%,EGFR;RASSF2;MET;NTRK3;CCN1;PTK2B;LMO4;DDR2;FGFR1;RAP1A;EPHB3;ROR1
prerank,intracellular cholesterol transport (GO:0032367),0.5026390706367274,1.057392855441259,0.41679873217115687,0.8810462482286447,1.0,3/15,8.78%,LRP6;LDLR;STARD4
prerank,brain morphogenesis (GO:0048854),-0.4400920705181882,-1.0572812990310152,0.3825,0.7585705039760408,1.0,2/12,2.12%,SHANK3;CTNNA2
prerank,negative regulation of synaptic transmission (GO:0050805),-0.3763063792680874,-1.0569312128245427,0.38202247191011235,0.7581702688277927,1.0,9/23,32.01%,SLC24A2;SYT11;SLC30A1;PLK2;MTMR2;ACHE;SLC24A1;DRD2;SHANK2
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.46811365825355855,1.0568785743509344,0.39717425431711145,0.88162464858708,1.0,5/22,10.37%,RASSF2;PDGFC;RAP2C;PDGFA;VEGFA
prerank,response to peptide (GO:1901652),0.4356208095757339,1.0568555724535917,0.37625178826895567,0.8809509906922872,1.0,10/33,20.71%,ANXA1;IRS1;STAT3;ERBIN;MMP13;STAT5A;EIF2B2;STAT6;EIF2B3;STAT4
prerank,retinal metabolic process (GO:0042574),0.5157645492655919,1.05682222504,0.40268456375838924,0.8803101070320489,1.0,1/12,1.29%,CYP1B1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.5380438663175074,1.0567277269446118,0.4339622641509434,0.8798404120971788,1.0,1/10,4.50%,PDE6A
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.4884889215167788,1.0566992824367833,0.42857142857142855,0.8791844231029035,1.0,6/16,17.91%,MCM7;WRN;MCM2;RPA1;RECQL5;RAD51
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.37167337876336026,1.056335837694019,0.38028169014084506,0.8793599736775273,1.0,25/118,13.44%,BMPER;FMNL2;NEDD4;EFNA5;PID1;SIPA1L1;PHLDB2;ARHGAP44;GSK3B;FGF2;GDNF;EPHB3;PDLIM5;MARK2;NF1;PROK2;ERBB2;ZDHHC15;BCL9L;HTATIP2;ZMYM4;SH3D19;TANC2;ZRANB1;PAK2
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5070221256842649,1.0561821391135262,0.4242928452579035,0.879074725028502,1.0,2/15,1.66%,UST;DSE
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.35447254189161004,-1.055688086968035,0.38926174496644295,0.7599521920806974,1.0,9/32,10.07%,MCTP1;RIMS1;RIMS2;MEF2C;MCTP2;SYT11;SLC30A1;CAMK2A;SYN1
prerank,sterol metabolic process (GO:0016125),-0.30934172778934416,-1.0552561541926675,0.3424657534246575,0.75972962788456,1.0,11/60,7.73%,CYP7B1;APOE;CYP27A1;CYP26B1;PRKAG2;ABCA5;LIPA;PPARD;ABCA1;INSIG2;ABCG1
prerank,peptidyl-lysine dimethylation (GO:0018027),0.48725301846422964,1.0549330845320426,0.4212962962962963,0.8816274113430764,1.0,6/18,20.21%,SMYD2;SETD2;EHMT1;KMT2D;EHMT2;ASH1L
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.41692193233453184,-1.0549202968557894,0.3861111111111111,0.7592436331333134,1.0,4/15,8.38%,TNK2;DGKD;HIP1R;SNAP91
prerank,cellular response to organic cyclic compound (GO:0071407),0.3631625859914418,1.0548778690419558,0.3782559456398641,0.8810368178944261,1.0,26/141,12.37%,EGFR;CDH1;CYP1B1;EZR;IGFBP5;CTNNA1;DIAPH1;SLC26A6;RAP1A;NR4A3;CASP6;ESR1;RORA;GOLPH3;DMTN;LCOR;MYOG;JUP;P2RX4;ATP1A3;ATP1A1;AKAP9;CCL3;ARL6IP5;ZC3H12A;SPIDR
prerank,pyruvate metabolic process (GO:0006090),0.4134184996847862,1.054630187741958,0.4060446780551905,0.8809958909145645,1.0,6/52,8.56%,ME1;SLC16A1;NR4A3;PFKFB2;PFKFB1;GPI
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.39789242317481344,1.054526407635854,0.37088607594936707,0.8805342875219412,1.0,23/64,28.21%,MLLT3;ELOF1;CDK12;MNAT1;SETD2;AFF4;ELOA;NELFE;CTR9;ELP4;CDK13;ERCC3;CCNT1;RTF1;PAF1;ERCC2;EAF2;ADRM1;GTF2F2;GTF2H3;NCBP2;CCNT2;EAF1
prerank,positive regulation of macrophage migration (GO:1905523),0.48377124068446703,1.0543487071651167,0.4088669950738916,0.8802883133197608,1.0,4/19,11.16%,THBS1;CMKLR1;P2RX4;CCL3
prerank,negative regulation of viral life cycle (GO:1903901),-0.4124644115945074,-1.053835126111333,0.3915211970074813,0.7606745896777003,1.0,5/15,7.65%,LY6E;PPIA;IFITM1;BST2;IFITM3
prerank,regulation of cell differentiation (GO:0045595),0.3645348064878975,1.0534856950241294,0.4022346368715084,0.881794234309268,1.0,16/148,7.77%,ZFHX3;SIX1;NGF;DDX5;PHLDB2;SMOC1;FGFR1;KLF4;TGFBR1;DDX17;CREBBP;ISL1;GDNF;PTHLH;ID2;LTBP4
prerank,epidermis development (GO:0008544),0.4028160137568933,1.0532853602656054,0.4007731958762887,0.8815552606114077,1.0,9/56,8.73%,KRTDAP;DSP;GRHL1;EMP1;PTHLH;KRT14;CRABP2;SPRR1A;GRHL2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3499656998040282,1.0531707210610584,0.3813559322033898,0.881097254633131,1.0,44/248,11.46%,EGFR;TCF7L2;SOX9;LRP6;MLLT3;CTNND2;PTPRU;WNK1;WNT11;GLI3;GPC3;PLEKHA4;PRICKLE1;GSK3B;FZD7;TMEM198;VCP;TRPM4;SFRP4;UBE2B;TLE2;NOG;TLE6;UBR5;INVS;TBL1X;BAMBI;DDIT3;PSMB2;JUP;CSNK1A1;USP34;CSNK1G3;NFKB1;RBMS3;DACT1;TNKS2;DKK3;PSMC6;IGFBP6;EMD;PRDM15;USP47;RNF146
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.42616721419132064,1.052898076105929,0.3983402489626556,0.8811191206825937,1.0,5/39,7.30%,THBS1;ANO6;NFE2L2;PDCD4;IL10
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.4320172481501193,-1.0524707108310767,0.40554156171284633,0.7629405382412894,1.0,6/13,28.09%,NOS3;ALDH4A1;GLUD1;NOS2;NOS1;DAO
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.4141370832622448,-1.052452887423864,0.37027027027027026,0.7616110669950169,1.0,8/16,8.58%,IGF1;TGFBR3;NOTCH1;ERBB4;AKAP6;RBPJ;MEF2C;EDN1
prerank,response to growth factor (GO:0070848),0.42110539763339877,1.0522695132469384,0.4056737588652482,0.8820079067768333,1.0,9/41,12.50%,SHC1;KLF4;BMPR1A;TGFBR1;TGFBR2;ACVR1;EMD;ERBB2;CPNE3
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.497829175129602,1.0520383752724853,0.44308231173380036,0.8818548974250398,1.0,4/12,14.77%,PLK3;WAC;PRKDC;CCND1
prerank,regulation of type I interferon production (GO:0032479),0.3838159734109789,1.051922627508367,0.40024479804161567,0.8814488100660586,1.0,34/84,24.31%,TAX1BP1;CREBBP;POLR3D;MAVS;IRF1;IKBKE;NFKB1;NFKB2;MYD88;PRKDC;IFIH1;XRCC5;EP300;NPLOC4;DHX9;RNF135;OTUD5;ACOD1;POLR3K;POLR3A;POLR3F;DHX36;POLR3E;TRAF3;UFD1;TRIM25;STAT6;GPATCH3;POLA1;IRF3;TRAF3IP1;CRCP;RNF26;POLR3B
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.3233757114904865,-1.051804038256465,0.34256055363321797,0.7619472821348396,1.0,7/46,6.49%,SEMA6A;LYN;TIMP3;FBLN1;DAB2IP;SIRPA;SPRED1
prerank,tight junction assembly (GO:0120192),-0.32422205560132644,-1.0517618144903278,0.3925619834710744,0.7607161039381704,1.0,6/49,2.80%,PECAM1;PARD6G;CLDN5;ESAM;OCLN;F11R
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.46646635652106627,-1.051704527647706,0.3877068557919622,0.7594943333886733,1.0,5/10,25.61%,RPS6KA6;SP100;ING4;MUC1;HIPK2
prerank,histone acetylation (GO:0016573),0.3894930626843888,1.0515828722251097,0.3992443324937028,0.8815572224050765,1.0,40/69,30.86%,KAT6B;NAA40;CREBBP;TADA3;TRRAP;EP400;SGF29;CPA4;ZZZ3;BRCA2;PER1;KAT2A;BRD1;EP300;ATF2;KAT2B;EPC1;TRIM16;TAF12;BRD8;YEATS2;PHF20;PHF20L1;NAA50;DMAP1;KAT5;MAP3K7;JADE2;ING3;MORF4L2;HAT1;TADA2A;KAT14;TAF9;KAT6A;NAA60;TAF6L;TAF5;TADA1;BRPF1
prerank,negative regulation of cell development (GO:0010721),-0.37268464988934485,-1.0508227456746215,0.369281045751634,0.7605471745738083,1.0,3/25,4.43%,IGF1;B2M;NOTCH1
prerank,regulation of cell size (GO:0008361),0.4618084376626535,1.0504150134653656,0.43883792048929665,0.8839029091692423,1.0,7/23,13.21%,EZR;VAV2;RDX;RHOA;RARG;RAP1GAP2;MTOR
prerank,positive regulation of protein maturation (GO:1903319),-0.47013243684690453,-1.0503694239184336,0.43099273607748184,0.7603802126569215,1.0,2/11,5.81%,CCBE1;NKD2
prerank,cell-cell junction organization (GO:0045216),0.3856759562939964,1.0502260587280687,0.4017412935323383,0.883641873490572,1.0,9/79,3.33%,CDH1;CDH11;CTNND2;TGFB3;CXADR;NECTIN3;DSP;CTNNA1;DSG2
prerank,regulation of mitochondrial fission (GO:0090140),-0.377977911118652,-1.0501502168591437,0.35331230283911674,0.759591175955385,1.0,5/24,8.35%,DCN;KDR;INF2;MAPT;SPIRE1
prerank,generation of neurons (GO:0048699),0.3576507717714727,1.0500426861959173,0.41042345276872966,0.8834056718614275,1.0,28/190,9.35%,SIX1;MET;WNT9A;MARK1;CIT;WNT11;HES1;FGFR1;FGF13;DOCK7;FZD7;NRP1;ACSL3;NR4A2;ITM2C;PAFAH1B1;BHLHE40;WNT16;THOC2;ELP3;LHX2;FZD1;MARK2;SIX4;ATOH8;DISC1;MAP1B;CTF1
prerank,regulation of B cell activation (GO:0050864),-0.3752911477364518,-1.049919686893424,0.39886039886039887,0.7588297435724383,1.0,4/25,11.08%,AHR;SH3KBP1;TNIP2;SAMSN1
prerank,positive regulation of insulin secretion (GO:0032024),0.4231443468985967,1.0493333403702334,0.3945086705202312,0.8846054234908821,1.0,7/36,11.27%,TCF7L2;TRPM4;ISL1;CLTRN;AACS;MCU;CAPN10
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.42858920881367707,-1.0492469541684821,0.37467018469656993,0.7592607774001704,1.0,3/14,11.38%,TFRC;NECTIN2;RIF1
prerank,positive regulation of cell death (GO:0010942),0.40214563628394046,1.0489709035292312,0.40816326530612246,0.8848192256640112,1.0,12/59,12.36%,BMP4;MAP3K5;GSK3B;EIF4G1;LRP1;CLU;RIPK2;CELF1;CDKN1B;RARG;HTATIP2;ZC3H12A
prerank,positive regulation of cation channel activity (GO:2001259),-0.33733946644573265,-1.0485626673183264,0.35471698113207545,0.7597924109100688,1.0,9/40,10.80%,SHANK3;ANK3;TMSB4X;CALM1;AKAP6;ACTN2;CTSS;STAC;JPH2
prerank,protein O-linked glycosylation via serine (GO:0018242),0.5282217206225792,1.048314340106221,0.421875,0.8858328397080888,1.0,2/10,7.61%,GALNT13;POGLUT3
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.3389177623704869,-1.048057946619025,0.36271186440677966,0.7597285654971394,1.0,16/38,22.81%,PHLPP1;PPARA;DAG1;THEM4;ARRB2;SH2B3;AKT1;PHLDA3;RACK1;HYAL2;GPER1;INPP5K;TRIB3;EPHA2;PTPRJ;PLEKHA1
prerank,protein phosphorylation (GO:0006468),0.3376520131335785,1.047921489573477,0.38484848484848483,0.8861442923105902,1.0,77/478,11.42%,STK39;EGFR;BMP4;DCLK1;MAP3K5;GRK5;PKD1;MARK1;CCNA2;PTK2B;CAMK2D;CIT;ABI1;DDR2;WNK1;PRKCD;WNT11;ULK2;FGFR1;LIMK2;HIPK1;BMPR1A;GSK3B;TLK1;PRKCE;NEK7;ABL1;ERC1;BCR;TGFBR1;EFEMP1;CLK2;MKNK2;STK16;SGK3;TGFBR2;FRK;CDK12;EPHB3;BIRC6;MAP3K3;CDC25B;IKBKE;FAM20A;VRK3;GDF6;MARK2;CSNK1A1;CHEK2;TLR4;NLK;CSNK1G3;CHUK;RIPK3;AAK1;SIK3;IRAK3;ATM;AURKA;ACVR1;USP15;RARA;TOP1;PIM2;MARK3;SMAD2;SIK2;SRMS;CAB39;ERN2;CLSPN;MORC3;STRADA;MAPK12;MAST2;ERBB2;HTATIP2
prerank,cardiac ventricle morphogenesis (GO:0003208),0.4232390963080458,1.0476276210832964,0.40083217753120665,0.8862154973153948,1.0,6/41,6.32%,BMP4;BMPR1A;TGFBR2;ISL1;JAG1;GATA4
prerank,protein autophosphorylation (GO:0046777),0.35824824922687243,1.0474937547017837,0.4008958566629339,0.8858158675002952,1.0,28/157,11.42%,STK39;EGFR;GRK5;PTK2B;CAMK2D;DDR2;ULK2;FGFR1;GSK3B;ABL1;CLK2;MKNK2;STK16;CDK12;EPHB3;MAP3K3;MARK2;CHEK2;RIPK3;AAK1;ATM;AURKA;PIM2;MARK3;SIK2;SRMS;ERBB2;HTATIP2
prerank,regulation of astrocyte differentiation (GO:0048710),0.511295596210701,1.0469478233199117,0.4412751677852349,0.8864981603282517,1.0,4/12,7.56%,HES1;CLCF1;NOG;ID2
prerank,regulation of ERAD pathway (GO:1904292),0.5207337326296559,1.0466550865752777,0.4206773618538324,0.8865204049299353,1.0,3/11,9.76%,USP13;RNF185;USP25
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.42631925049296737,1.046596431028108,0.4076086956521739,0.8859861399645313,1.0,10/37,11.47%,TGFB3;IGFBP5;BMPR1A;FGF2;NR4A3;PDCD4;IL10;CDKN1B;JUN;HTR1B
prerank,negative regulation of anoikis (GO:2000811),-0.4203180383501167,-1.0461497697549755,0.4026315789473684,0.7633728862850745,1.0,4/14,6.25%,TLE1;BCL2;NOTCH1;PTK2
prerank,central nervous system myelination (GO:0022010),-0.4551790570812503,-1.0460533243538856,0.4155251141552511,0.762278880637453,1.0,9/11,33.68%,PLP1;TENM4;CNTNAP1;MYRF;ABCA2;SOX10;B4GALT6;B4GALT5;HES5
prerank,regulation of protein modification process (GO:0031399),-0.3188171999657498,-1.045652646794283,0.3707865168539326,0.7619133104867735,1.0,18/50,21.60%,LYN;PPP1R16B;GRM5;CCDC88A;PTK2;SPRED1;PPIB;CADM4;FNIP2;CCDC88C;CDH5;NDUFS4;HSPB1;ABCA2;PLXNB2;MT3;CCAR2;HPF1
prerank,regulation of DNA binding (GO:0051101),0.4184496290185187,1.0452691964417633,0.41301460823373176,0.8888139272112388,1.0,15/44,21.40%,NGF;SMO;HES1;MDFI;SKI;KDM1A;FOXC1;JUN;ZBTB7A;EGF;CPNE1;PPARG;E2F1;MAPK8;HJURP
prerank,negative regulation of epithelial cell migration (GO:0010633),0.4396681604970846,1.0451687639188807,0.4277286135693215,0.8883320613014903,1.0,2/33,0.27%,SLIT2;THBS1
prerank,establishment of vesicle localization (GO:0051650),0.4699826014426886,1.0450742286637495,0.4141732283464567,0.8878501396993136,1.0,6/18,16.99%,LIMK2;SPG11;F8A1;TMEM230;SYNJ1;IKBKG
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3590760615193746,1.044695991884902,0.4150513112884835,0.888111898121153,1.0,22/132,12.44%,SLC4A4;EZR;ADAM9;PRKCD;FOXO3;GSK3B;IRS1;PFKFB2;TPCN1;MOV10;DXO;RDX;DAGLB;PFKFB1;ZC3H18;DACT1;PIM2;MTDH;ATF6;SH3D19;ZC3H12A;TNFRSF1B
prerank,regulation of coagulation (GO:0050818),-0.45463704893404855,-1.044685756401567,0.41262135922330095,0.763129530966722,1.0,8/11,40.54%,HS3ST5;HRG;F2R;FOXA2;CAV1;GP1BA;F2RL1;F2
prerank,amino sugar biosynthetic process (GO:0046349),0.5105325020612638,1.0444109091928744,0.4350758853288364,0.8881577002061134,1.0,4/12,20.10%,NANP;RENBP;UAP1;GFPT1
prerank,cytoplasmic translational initiation (GO:0002183),0.4763963554921006,1.0443162443806702,0.4301765650080257,0.8876920502232535,1.0,8/17,23.32%,EIF4G1;EIF2D;EIF3A;EIF2S2;EIF4B;EIF2B3;DHX29;RBM4
prerank,regulation of proteolysis (GO:0030162),0.4104094134442173,1.044270659068965,0.4180645161290323,0.8870726131435628,1.0,9/48,15.46%,CYFIP2;PERP;LTBP4;FBXW11;DNAJC1;SERPINE2;TBC1D10A;SPOP;IST1
prerank,regulation of chemotaxis (GO:0050920),0.4357940612143166,1.0442275443890787,0.40988372093023256,0.886470775395806,1.0,4/30,8.71%,THBS1;PTPN2;MYCBP2;P2RX4
prerank,striated muscle cell development (GO:0055002),-0.43200292328242185,-1.0438613943052621,0.40714285714285714,0.763969869242536,1.0,3/14,7.04%,PGM5;LMOD1;TMOD1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.4176736023594014,1.0437431087884803,0.4156028368794326,0.8870079864323557,1.0,6/44,9.42%,BMP4;PRKCD;PDCD4;CBLC;IRAK3;NF1
prerank,sphingolipid catabolic process (GO:0030149),0.4828126740240606,1.0434938490177914,0.40894039735099336,0.8869542010357174,1.0,2/15,3.97%,ACER3;PDXDC1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.4329458606849531,1.0430080177492242,0.43373493975903615,0.8874653175334842,1.0,11/29,21.37%,TANK;IKBKE;TLR4;CHUK;UBE2D3;IKBKG;BIRC3;TLR6;TRAF3;LY96;IRF3
prerank,RNA 3'-end processing (GO:0031123),0.3914365709659152,1.042948793377281,0.41419354838709677,0.8869048146527467,1.0,29/69,28.50%,SRSF11;THOC2;SRSF5;SRSF6;U2AF2;SRRM1;TUT7;CASC3;CHTOP;TUT4;U2AF1L4;SRSF2;THOC5;ZC3H11A;TENT2;FIP1L1;CSTF1;NUDT21;CDC40;CPSF7;CPSF3;UPF3B;SRSF3;RBM8A;ALYREF;NCBP2;CLP1;CPSF4;SRSF7
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.37047287147825436,-1.0424432455115422,0.40672782874617736,0.7663220335889592,1.0,10/27,13.42%,DCN;CSGALNACT1;CHSY3;CHST3;PXYLP1;CHSY1;UGDH;CSPG5;XYLT2;NCAN
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.40473867451061474,1.042178942563556,0.4147339699863574,0.8882246376854988,1.0,13/48,16.36%,ELOF1;POLR1G;POLR1A;TAF1D;TAF1C;KAT2A;CHEK1;POLR1F;EP300;ZMIZ1;SF3B1;DDX21;KAT2B
prerank,regulation of actin filament-based process (GO:0032970),0.384518944702229,1.0420432648833533,0.4020100502512563,0.8878693187253303,1.0,16/70,9.67%,EZR;EFNA5;PRKCD;ARHGAP44;RHOBTB1;ABL1;FAM107A;LRP1;RHOQ;DMTN;ARHGAP17;PDGFA;RND3;RHOA;IQGAP1;MLST8
prerank,positive regulation of developmental process (GO:0051094),0.3518626067453995,1.0412193456251138,0.39608269858541895,0.8892523029322845,1.0,28/164,11.89%,BMP4;SOX9;BMP5;FOXD1;COBL;BMP1;PHLDB2;ZBTB16;FGFR1;BMPR1A;LMNA;NLRP5;TRPM4;FOXO6;TLE6;ISL1;GDNF;AGR2;DDHD1;SHANK1;NIBAN2;AURKA;ACVR1;VEGFA;MCU;ZDHHC15;MIEF1;CORO1C
prerank,vasoconstriction (GO:0042310),0.5165482611626455,1.041067479646146,0.42434782608695654,0.8889058043034219,1.0,1/11,0.88%,EDNRA
prerank,positive regulation of vasculogenesis (GO:2001214),-0.4615213612676229,-1.041024264352073,0.4200477326968974,0.768691960630944,1.0,3/10,4.96%,RAPGEF2;KDR;CD34
prerank,positive regulation of cell aging (GO:0090343),-0.4451731848420273,-1.041011537655174,0.4268292682926829,0.7673877300694967,1.0,3/11,9.85%,B2M;YPEL3;ABI3
prerank,RNA splicing (GO:0008380),0.37788907387110104,1.0404213480756968,0.4018801410105758,0.8898225479860951,1.0,40/95,27.79%,MBNL1;SNRNP48;SRSF11;CDK12;SYNCRIP;CELF3;FUS;TCERG1;SCAF11;SRRM1;PRPF3;SF3B2;SF3B1;RNPC3;PPIG;SRPK1;SNRNP40;SNRNP35;SCNM1;SRSF2;WBP4;PRPF18;TRA2B;NRDE2;DBR1;NOL3;ZCRB1;TARDBP;TXNL4A;DHX8;LSM4;RSRC1;SF3B3;SRPK2;DDX47;SMNDC1;RBM8A;PDCD7;PRPF6;NCBP2
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.44384762951410606,1.0400446434979225,0.41615853658536583,0.8900633401232784,1.0,6/26,11.16%,INHBA;PTPN2;TLR4;RARA;TCTA;CCL3
prerank,sphingolipid metabolic process (GO:0006665),-0.27797967955936237,-1.039887417029852,0.3356164383561644,0.7690596671512742,1.0,35/108,18.84%,ST6GALNAC3;PRKD1;ENPP2;CERS4;SGMS1;ACER2;ELOVL7;CERT1;UGCG;DEGS2;SMPD3;CERK;ELOVL6;CTSA;ESYT1;GAL3ST1;SERINC1;SPHK1;SPTSSA;SPNS2;HACD3;CERS1;ELOVL4;CERS2;HEXB;HACD2;SMPD1;ORMDL3;PSAP;ALDH3B1;PLPP2;CLN8;HACD1;ABCA2;GM2A
prerank,protein import into nucleus (GO:0006606),0.38759352981796014,1.0397142449579517,0.41448189762796506,0.8902428542087407,1.0,19/66,20.44%,PRICKLE1;NUP93;STAT3;E2F3;IPO7;KPNA1;RGPD1;TNPO2;RANBP2;NUP153;SEC13;KPNA4;NUP214;NUP188;NUP88;HEATR3;TNPO3;RAN;NUTF2
prerank,negative regulation of transport (GO:0051051),-0.31238832457100085,-1.0395628101493095,0.35655737704918034,0.768546187423904,1.0,9/51,7.45%,PRKD1;MCTP1;DYSF;NR1H3;SIRPA;BST2;SYT11;CTTNBP2NL;SNCA
prerank,actin cytoskeleton reorganization (GO:0031532),0.39242552998464036,1.0388758084376315,0.42191435768261965,0.8917352013745503,1.0,23/63,17.44%,EZR;PHACTR1;ANXA1;SIPA1L1;CXADR;PARVA;GSN;NRP1;ANTXR1;PIP5K1A;DMTN;RHOA;CTTN;MCU;MKLN1;CAPN10;CDC42BPG;GAB1;S1PR2;GPR65;CDC42BPA;PDLIM4;WHAMM
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.42965373566877463,1.0388589844265947,0.41291291291291293,0.8910734379803162,1.0,6/30,10.56%,BMP4;MLLT3;INHBA;TNFRSF13B;HOXB4;PRRC2C
prerank,positive regulation of sodium ion transport (GO:0010765),-0.44155103157672365,-1.0387558334950184,0.4049382716049383,0.7693893361054702,1.0,4/12,26.19%,ANK3;SCN4B;NOS1;PKP2
prerank,neuron projection fasciculation (GO:0106030),-0.45915407019547544,-1.0387403157970032,0.42142857142857143,0.7680913282647533,1.0,7/10,24.44%,CNTN4;EPHA4;RTN4;NRCAM;CDK5R1;AMIGO1;SEMA5A
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.4627407874181668,1.0382394150528287,0.4406528189910979,0.8919642915830623,1.0,9/20,27.36%,PAICS;AMPD3;PFAS;GMPS;AK4;AK3;GMPR2;AMPD2;ADSS2
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.42860023840123035,-1.0379693885716101,0.4151898734177215,0.7687523254375256,1.0,6/13,14.04%,ANK3;SLC8A1;CALM1;PDE4D;CASQ2;CALM3
prerank,transcription by RNA polymerase I (GO:0006360),0.4287340747770467,1.0378793180702435,0.40057636887608067,0.8921925829091713,1.0,14/34,27.70%,POLR1G;MNAT1;POLR1A;TAF1D;TAF1C;TTF1;POLR1F;ERCC3;UBTF;ERCC2;RRN3;GTF2H3;TAF1;POLR1H
prerank,regulation of actin filament depolymerization (GO:0030834),-0.44301699061174726,-1.037630310059036,0.40932642487046633,0.7682316920007525,1.0,2/12,9.54%,PLEKHH2;PLEK
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.4382982704129039,-1.0371430663955485,0.44768856447688565,0.766903179079285,1.0,2/13,3.34%,PLCB1;IL15RA
prerank,cellular response to interleukin-15 (GO:0071350),-0.4382982704129039,-1.0371430663955485,0.44768856447688565,0.766903179079285,1.0,2/13,3.34%,PLCB1;IL15RA
prerank,histone ubiquitination (GO:0016574),0.46181421136307566,1.0370882956492646,0.41680395387149916,0.8935425863575811,1.0,11/21,30.91%,UBE2B;WAC;CTR9;USP22;RNF8;UBE2N;HUWE1;PAF1;RNF20;UBE2A;DTX3L
prerank,organic hydroxy compound transport (GO:0015850),-0.33275856287115324,-1.037038284287522,0.36585365853658536,0.7658408813584296,1.0,5/36,6.17%,SLCO2B1;NCOA1;SLCO1C1;RBP4;SLC5A3
prerank,platelet degranulation (GO:0002576),0.36510402873172393,1.03623656040205,0.4013761467889908,0.8949846314301061,1.0,17/118,10.80%,THBS1;PCDH7;LHFPL2;CD109;TGFB3;FN1;CD9;FAM3C;SYTL4;VCL;CLU;SERPING1;PDGFA;GTPBP2;TIMP1;VEGFA;ITGB3
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.4666928945316088,1.0360490078332731,0.43449419568822556,0.8947664509321331,1.0,3/17,9.90%,ANK2;SNTA1;AKAP9
prerank,response to reactive oxygen species (GO:0000302),0.39619920934896385,1.03601650386949,0.4064516129032258,0.8941348678873742,1.0,6/54,10.62%,EGFR;ADAM9;COA8;PLK3;CHUK;JUN
prerank,lymphocyte proliferation (GO:0046651),-0.3840261139480992,-1.0356579616060655,0.4067796610169492,0.7681207052861594,1.0,7/22,18.72%,BCL2;MEF2C;CTPS1;PPP3CB;FLT3;CD40;PIK3CG
prerank,intracellular protein transport (GO:0006886),0.3380198731311838,1.0352611852930689,0.41898864809081526,0.8953736647851398,1.0,90/304,22.12%,PKD1;SGSM2;KIF13A;GIPC1;PRICKLE1;STX11;TLK1;NUP93;RAB43;LTBP2;TMED5;RAB6A;HERC2;AP3B1;STX5;HPS4;XPO1;STAT3;E2F3;IPO7;GRTP1;ARF3;RAB3GAP2;SEC16A;NSF;AP4E1;TNPO2;EGR2;AP2A1;STX8;EIF2D;C2CD5;EHD1;COPA;TBC1D2B;CTTN;TBC1D13;SEC31A;KATNB1;ARF4;STRADA;RANGRF;ARCN1;DESI1;STX19;TBC1D25;NUP153;CHP1;SEC13;SMURF1;BAG3;RAB24;TBC1D8B;TBC1D10A;GGA2;ARFIP1;ARFIP2;ARFGAP3;NUP214;SEC23IP;TBC1D5;SAR1B;SGSM3;NUP188;SNX31;SCFD2;XPO4;RAB21;AP4M1;AP3D1;NUP88;RAB5B;USO1;SNF8;SNX8;TBC1D17;SNX13;HEATR3;TNPO3;RAB5A;RAN;RAB1A;NUTF2;AP4B1;STX2;STXBP1;TMED3;SRPRA;RAB18;CAMSAP3
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.5116344897014835,1.0350628928967234,0.436426116838488,0.8951263040955142,1.0,6/12,19.73%,UPP2;TK1;TK2;CAD;DHODH;UMPS
prerank,adipose tissue development (GO:0060612),-0.4558158594494721,-1.034990936315335,0.40298507462686567,0.7686364600424997,1.0,4/11,20.69%,ARID5B;XBP1;DYRK1B;RORC
prerank,organelle assembly (GO:0070925),0.3368313434251899,1.0348655268680804,0.41188524590163933,0.89490625380695,1.0,120/384,24.41%,PKD1;BBS9;ABLIM3;EXOC4;MAPRE2;PARVA;GSN;ULK2;NEK7;RAB43;PDE6D;TMOD3;PTPDC1;DZIP1;WIPI2;ZFYVE1;HPS4;BECN1;PDCD6IP;RAB11FIP3;ATG3;PCM1;ARL3;EHD3;GBF1;ATAT1;CEP164;OCRL;EXOC5;CFAP70;CDC14A;DISC1;WDR35;TMEM231;CEP63;IFT46;EHD1;RB1CC1;GALNT11;CDS1;ATXN2;DYNC2I2;EHD2;PRRC2C;NCOR1;ARF4;CEP131;VPS37A;BIN2;CCDC66;ABCC4;TUBGCP6;ARMC9;PIBF1;RFX2;ATP6V0D1;CEP20;SSTR3;GORASP2;IFT52;IST1;AMBRA1;MKS1;CENPT;TUBGCP5;NUDCD3;NEK6;FAM161A;CEP89;KIF3B;TUBGCP4;HAUS2;DYNC2I1;VPS37B;INO80;TSG101;SMIM22;RBM14;LZTFL1;HYLS1;ATG2A;TEKT2;EIF2S1;SNF8;IQCB1;RILPL1;CIRBP;CSNK1D;POC1B;WDR45B;FUZ;DYNC2H1;RAB1A;IFT80;YTHDF2;CLUAP1;HGS;FLII;OFD1;UBAP2L;TRAPPC14;ULK1;FLNA;TRAF3IP1;DHX29;HAUS5;PLK4;TRAPPC6A;BBS2;FARP2;VTA1;CHMP4A;CHMP4B;YTHDF3;TMEM237;STX12;RAB7A;LSM4;MAK;POGZ
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.34355595813059325,-1.0348461437455923,0.41237113402061853,0.7677179877868695,1.0,9/31,19.95%,HSPA8;DAB2IP;OPTN;ERN1;TMBIM6;HSPA13;PACRG;ATXN3;HSPA9
prerank,"base-excision repair, gap-filling (GO:0006287)",0.4318797644253585,1.0348116601526836,0.43319268635724334,0.8943580646083912,1.0,10/35,24.04%,MPG;SMUG1;APEX1;POLB;RPA1;RFC1;TDG;POLD3;MBD4;RFC5
prerank,membrane lipid biosynthetic process (GO:0046467),0.39434557188944963,1.0341553201195632,0.4212548015364917,0.895320748109541,1.0,5/58,5.29%,ST3GAL4;ACER3;PLPP3;SGMS2;SPTSSB
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.4807767167505532,1.033456730713576,0.4207221350078493,0.8963755034214896,1.0,6/16,18.81%,ANK2;GBF1;SEC16A;DDRGK1;BCAP31;BCAP29
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4523240903280195,1.0328140867395703,0.4296520423600605,0.8973472800055208,1.0,3/24,3.07%,NT5E;EZR;ITGB1
prerank,cellular response to retinoic acid (GO:0071300),0.4148902338007811,1.0327705417374393,0.4240766073871409,0.896750955780239,1.0,5/42,3.34%,WNT9A;SOX9;PTK2B;WNT11;FZD7
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.358538591543281,1.0324873599003466,0.43132803632236094,0.8968343162166559,1.0,17/138,6.37%,EGFR;GUCY2C;MET;NTRK3;NGF;PTK2B;ABI1;DDR2;PTPRU;FGFR1;SHC1;POLR1G;PTPRF;FRK;TRIO;EPHB3;ROR1
prerank,protein K48-linked deubiquitination (GO:0071108),0.4452493729872468,1.0322586287992048,0.4206471494607088,0.8967301444885613,1.0,8/23,16.16%,USP34;USP25;OTUD7B;USP33;OTUD3;BAP1;VCPIP1;OTUD5
prerank,DNA damage checkpoint signaling (GO:0000077),0.432726527983507,1.0322411269589535,0.42415316642120765,0.8960830183403613,1.0,11/28,19.60%,CHEK2;RAD17;CEP63;ATM;CLSPN;CHEK1;HINFP;USP28;ATR;NBN;E2F1
prerank,negative regulation of phosphatase activity (GO:0010923),0.4488892727416982,1.0321848018592965,0.43425076452599387,0.8955527355802989,1.0,9/25,20.83%,GSK3B;CRY2;STYXL1;BOD1L1;CHP1;URI1;PPP1R36;TGFB2;PTPA
prerank,regulation of dendrite development (GO:0050773),0.40812899046526163,1.0313101936748432,0.38687150837988826,0.8970774225156598,1.0,5/37,3.23%,BMP5;MARK1;COBL;NEDD4;GSK3B
prerank,cellular sodium ion homeostasis (GO:0006883),-0.42512471528272044,-1.0311386631353836,0.4308510638297872,0.7758885043940796,1.0,5/15,4.72%,ATP1A2;ATP1B3;NEDD4L;SLC8A1;ATP1B2
prerank,carbohydrate homeostasis (GO:0033500),0.37956757308103367,1.0310992626331656,0.40875,0.8969386117796293,1.0,15/67,14.11%,TCF7L2;KCNB1;CRY2;IRS1;KLF7;PTPN2;STAT3;BACE2;MCU;SLC8B1;SELENOT;HNF4A;HNF1A;PAX6;ACSM2A
prerank,lamellipodium assembly (GO:0030032),0.44720473150145384,1.0310729535918808,0.4161676646706587,0.8962965802920358,1.0,8/26,7.04%,ABLIM3;ITGB1;SRGAP2;VCL;ABLIM2;GOLPH3;DMTN;ARHGEF6
prerank,development of primary male sexual characteristics (GO:0046546),0.41543449834227625,1.0309007715354974,0.42053445850914206,0.8960172925305876,1.0,6/34,9.80%,SOX9;LHFPL2;INHBA;GATA4;SIX4;GATA1
prerank,positive regulation of intracellular transport (GO:0032388),0.4232400802537912,1.0305495280511667,0.43597122302158275,0.8961813875401213,1.0,8/38,11.27%,NEDD4;BCAS3;PCM1;PLK3;EHD1;EHD2;CEP131;CAPN10
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.34295816218233355,-1.030250000000719,0.3945578231292517,0.776836290465666,1.0,4/35,5.03%,PAM;ACSS3;FAR2;GGT5
prerank,regulation of cell cycle process (GO:0010564),0.36739921131132686,1.029677181701834,0.4294187425860024,0.8976093388179275,1.0,28/104,21.82%,SOX9;KIF13A;TXLNG;BECN1;RAB11FIP3;CCDC8;SETD2;BIRC6;PLK3;KLHL13;AURKA;ENTR1;CEP85;SH3GLB1;CHEK1;PDXP;AHCTF1;CDK13;IHO1;KNSTRN;RMI2;CSNK2A2;CSNK2A1;YTHDF2;CDC42;CUL7;PRMT5;ZFYVE26
prerank,tRNA wobble uridine modification (GO:0002098),0.4907168412942973,1.029384985949557,0.42989214175654855,0.8976784904062829,1.0,9/14,30.11%,ELP3;MTO1;ALKBH8;ELP4;CTU2;MOCS3;GTPBP3;DPH3;URM1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3407426690103994,1.0291368496471667,0.4407484407484408,0.8976082800204334,1.0,45/308,10.37%,BMP4;SIX1;SOX9;FOXD1;ADRA1B;LBP;PDGFC;SMO;BMP1;TGFB3;ZBTB16;GRB10;ADRB2;INHBA;BMPR1A;FGF2;CMKLR1;LRPAP1;TGFBR1;NLRP5;TRPM4;ZBTB7B;TGFBR2;GCNT2;TSKU;NOG;LRP1;TLE6;GADD45G;GDNF;KDM1A;TGFB1I1;BAMBI;DECR1;EHMT1;IL10;SIX4;FOXC1;IL33;SCD;NIBAN2;ACVR1;HILPDA;SMAD2;VEGFA
prerank,glycoprotein catabolic process (GO:0006516),-0.3995934204281102,-1.0290778282137218,0.39037433155080214,0.7785234503049139,1.0,6/17,21.95%,ADAMTS9;ADAMTS12;STT3B;CTSL;NEU2;FBXO44
prerank,positive regulation of DNA binding (GO:0043388),0.42533150212416865,1.0288429839404563,0.4307479224376731,0.8976700859257483,1.0,9/31,17.93%,NGF;HES1;SKI;FOXC1;NIBAN2;RB1;TWIST1;EGF;PPARG
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.4584972354042569,-1.02871001166223,0.43316831683168316,0.7781922308294389,1.0,5/10,13.74%,NEXMIF;NOTCH1;NOTCH4;RGCC;PPM1F
prerank,transcription by RNA polymerase II (GO:0006366),0.3381986602705805,1.028657644414322,0.4082051282051282,0.8974561318100106,1.0,64/305,16.73%,NR3C2;RNMT;RARB;MLLT3;DDX5;HDAC9;ESR2;PRRX1;NOTCH2;ELOF1;NR2F1;NR4A3;NR4A2;ZBTB7B;CREBBP;CDK12;MNAT1;ESR1;MBD1;TBL1X;E2F3;RORA;SETD2;NFIX;AFF4;TEAD1;SCAF8;RXRA;NFKB1;NFYA;RBMX;MED27;RARG;TTF2;RARA;RPAP1;SNAPC2;NCOR1;CBFB;NABP1;TAF1C;ELOA;GTF2E1;NR6A1;NR4A1;NCOR2;NELFE;CTR9;HNF4A;LSM11;E2F2;HDAC10;ELP4;INTS8;TRIP11;ZBTB1;INTS5;CDK13;TAF4;DDX21;ERCC3;KAT2B;TAF12;WWTR1
prerank,cellular response to nitrogen compound (GO:1901699),0.4481568038722825,1.0285561162132728,0.42022116903633494,0.8970369271617873,1.0,5/20,12.57%,DDI2;ATP2B4;DDX11;SPIDR;ATRX
prerank,positive regulation of protein transport (GO:0051222),0.3859715780371619,1.0285018134294717,0.4122137404580153,0.896467516047747,1.0,15/67,12.46%,EZR;TGFB3;ADAM9;BMP6;UNC13B;ACSL3;SYTL4;BCAS3;PCM1;GOLPH3;CNST;PLK3;CEP131;ARHGEF5;CHP1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.4805333681142421,1.0283077714623317,0.44844517184942717,0.895554876487373,1.0,7/15,22.40%,TNRC6C;TOB1;PABPC1;CNOT7;AGO2;DHX36;NANOS2
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.4805333681142421,1.0283077714623317,0.44844517184942717,0.895554876487373,1.0,7/15,22.40%,TNRC6C;TOB1;PABPC1;CNOT7;AGO2;DHX36;NANOS2
prerank,regulation of translation (GO:0006417),0.34959357003503155,1.02814131766528,0.44258639910813824,0.8952873514788721,1.0,40/173,21.67%,THBS1;SAMD4A;EIF4G3;FOXO3;IGFBP5;NIBAN1;PAIP2;EIF4G1;SYNCRIP;LARP4B;ETF1;TOB1;GSPT1;ATXN2;ERBB2;EIF3E;EIF6;PRKDC;MTOR;EIF2AK4;DHX9;CNOT7;MTRF1;PLD1;EIF2B2;EIF4G2;MTIF2;PUM3;TRAP1;DHX36;FXR2;CAPRIN1;EIF4B;CIRBP;FMR1;LARP4;DDX1;RBM3;EIF2AK3;EPRS1
prerank,proteoglycan metabolic process (GO:0006029),0.4474495328349387,1.0281138356041155,0.4321167883211679,0.894664263411864,1.0,12/26,19.83%,HS3ST4;SULF1;CHST13;FOXL1;XYLT1;B3GALT6;CHST11;HPSE;CHST12;GAL3ST4;SULF2;B4GALT7
prerank,dopamine metabolic process (GO:0042417),-0.39147511068193996,-1.0279016705953103,0.42779291553133514,0.7790809045861806,1.0,5/18,7.88%,MOXD1;MAOB;MAOA;SNCA;COMT
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.4241131342945662,1.0263275301132466,0.4484304932735426,0.898429663854715,1.0,11/30,21.37%,TANK;IKBKE;TLR4;CHUK;UBE2D3;IKBKG;BIRC3;TLR6;TRAF3;LY96;IRF3
prerank,regulation of organelle organization (GO:0033043),0.37271784450078693,1.025735288987931,0.4184652278177458,0.8992148361719929,1.0,22/80,16.68%,CLIC4;EZR;CAPN2;DIAPH1;STX5;CLEC16A;MAVS;EHD3;GOLPH3;RDX;MARK2;CAPN6;ARMH3;AKAP9;ARHGEF5;TBC1D25;PAK2;PRMT6;EP300;SQSTM1;SAR1B;SCARB2
prerank,negative regulation of axon extension (GO:0030517),-0.3488050623919418,-1.0254683554522124,0.4006514657980456,0.78414802306731,1.0,11/30,12.79%,SEMA6A;SEMA7A;MAP2;SEMA6D;MAG;RTN4;SEMA5B;SEMA3G;SEMA6B;SEMA3B;TRIM46
prerank,gluconeogenesis (GO:0006094),-0.32479480313849973,-1.0246667751120333,0.4243421052631579,0.7849435988136755,1.0,13/39,21.28%,RBP4;PPARGC1A;GAPDH;PGAM1;PGM1;MDH1;ALDOC;ALDOA;GOT2;ENO2;ENO1;SLC25A13;SLC25A11
prerank,V(D)J recombination (GO:0033151),0.5142290453691725,1.0246303409178303,0.4537953795379538,0.9013364019025469,1.0,3/11,13.09%,DCAF1;TCF3;PRKDC
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5104681277868952,1.0246253025044614,0.4602076124567474,0.9006627186367323,1.0,2/11,7.40%,CAMK2D;CACNG6
prerank,protein O-linked mannosylation (GO:0035269),0.4685468001499272,1.0240246515064697,0.42902208201892744,0.9015009276783055,1.0,6/18,16.32%,TMTC1;LARGE1;B4GAT1;DPM1;LARGE2;POMGNT2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.4586534158427402,1.0238967320496966,0.43243243243243246,0.9011562109143731,1.0,4/19,6.08%,EXT1;HS6ST2;GLCE;XYLT1
prerank,cortical actin cytoskeleton organization (GO:0030866),0.45830116745355265,1.0235008685968618,0.43759630200308164,0.9014851328423831,1.0,4/20,10.47%,FMNL2;RHOQ;DLG1;NCKAP1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3705636957412819,-1.0234515843089742,0.4,0.7869130625324567,1.0,6/26,9.64%,DNAJC6;SGIP1;PICALM;FNBP1L;SNAP91;INPP5F
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.3589209281707418,-1.0233640104153443,0.43243243243243246,0.7858275904527287,1.0,4/25,3.41%,B2M;KIT;WNT5A;SLC7A5
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.3920909993623057,-1.0232680459107055,0.4297520661157025,0.7847816793697755,1.0,5/17,18.59%,APOE;FGF1;ABCG1;KPNB1;ABCA2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.43740207033689393,-1.0232485198155272,0.42424242424242425,0.7835054600413874,1.0,3/12,7.36%,IGF1R;INSR;SETX
prerank,glycerol metabolic process (GO:0006071),-0.4595042987843836,-1.0231357611277703,0.45823389021479716,0.7824871727983045,1.0,2/10,6.74%,GK;COQ2
prerank,regulation of neuron apoptotic process (GO:0043523),0.37250579609786577,1.0227781552600235,0.43058823529411766,0.9025942608282591,1.0,12/96,6.42%,SIX1;NGF;EGLN3;PTK2B;TGFB3;FOXO3;KCNB1;CLCF1;NFATC4;ISL1;GDNF;DDIT3
prerank,polarized epithelial cell differentiation (GO:0030859),0.49707375362486195,1.0227429376745676,0.4539363484087102,0.9020000533791817,1.0,7/13,22.12%,EZR;RHOA;SYNE4;MYO9A;SCRIB;CDC42;CAMSAP3
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3983832971647542,1.0225894602367045,0.42359249329758714,0.901696496655994,1.0,10/51,10.47%,DCLK1;NGF;SRGAP2;SNX2;TRIO;SHTN1;ANKRD27;NBL1;CTTN;NCKAP1
prerank,cardiac muscle cell development (GO:0055013),-0.37344645328299636,-1.0224810332912087,0.43103448275862066,0.7829093466185956,1.0,6/20,7.33%,SORBS2;PDGFRB;SLC8A1;MYH11;OBSL1;HEY2
prerank,regulation of presynapse organization (GO:0099174),0.4758373705707404,1.0218241554390421,0.4608,0.9022717286435606,1.0,3/18,8.16%,GPC6;EIF4G1;GPC4
prerank,regulation of presynapse assembly (GO:1905606),0.4758373705707404,1.0218241554390421,0.4608,0.9022717286435606,1.0,3/18,8.16%,GPC6;EIF4G1;GPC4
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.517671746709853,1.0216113371575744,0.43611584327086883,0.9014381458474706,1.0,2/10,4.54%,MPG;FTO
prerank,DNA dealkylation (GO:0035510),0.517671746709853,1.0216113371575744,0.43611584327086883,0.9014381458474706,1.0,2/10,4.54%,MPG;FTO
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.37449810879028667,1.021543180270923,0.4363411619283066,0.9009274204567737,1.0,7/76,6.64%,PLCE1;ADRA1B;GPR4;CMKLR1;AGTR1;ESR1;LPAR4
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.44397074434431644,-1.0215217756313315,0.4312796208530806,0.7840497654780014,1.0,5/11,29.59%,AKAP6;NOS1AP;TREM2;RNF207;LRRC55
prerank,Notch signaling pathway (GO:0007219),-0.30406952958472605,-1.0214712952328497,0.4027777777777778,0.7828529519031779,1.0,13/59,7.33%,SORBS2;MAML3;MAML2;NOTCH3;DTX4;NOTCH1;PLXND1;RBPJ;NOTCH4;BMP2;JAG2;DTX1;HEY2
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.4582152404773751,-1.021134164516088,0.4794188861985472,0.7824840423216737,1.0,2/10,10.93%,SACS;DNAJA4
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.4339373754339685,-1.020796901168159,0.4005037783375315,0.7821009258465921,1.0,6/12,27.78%,CXCL12;APP;JAM2;DOCK8;PYCARD;CCL5
prerank,histone H4 acetylation (GO:0043967),0.4011364065902794,1.0207407570465383,0.4444444444444444,0.9022056010825916,1.0,27/47,28.54%,NAA40;TADA3;TRRAP;EP400;KANSL2;ZZZ3;BRCA2;PER1;KANSL3;KANSL1;MSL1;HCFC1;EP300;ATF2;EPC1;TRIM16;BRD8;PHF20;OGT;DMAP1;MCRS1;JADE2;ING3;MORF4L2;HAT1;KMT2A;NAA60
prerank,regulation of gluconeogenesis (GO:0006111),0.4321617761019509,1.0206485157005967,0.4629080118694362,0.9017724460282104,1.0,8/27,16.33%,CLK2;PTPN2;NNMT;C1QTNF12;USP7;ERFE;EP300;GNMT
prerank,plasma membrane organization (GO:0007009),0.3776608549145198,1.0204289913204527,0.4232258064516129,0.9016271303587452,1.0,15/61,14.38%,AHNAK2;ANK2;DMKN;ANO6;SYTL4;PLSCR1;NSF;EHD2;BIN2;A4GALT;CAVIN2;TLCD1;PLSCR3;CXCR4;TLCD2
prerank,negative regulation of secretion (GO:0051048),-0.4597098362316404,-1.0201967322023182,0.43507972665148065,0.7823569263093858,1.0,7/10,29.92%,NR1H3;CD74;PTGER3;ERBB3;NRG1;VAMP8;VAMP3
prerank,actomyosin structure organization (GO:0031032),0.38316419679113584,1.0201879898893234,0.422029702970297,0.901544315968414,1.0,14/75,8.86%,EPB41L5;CIT;PHACTR1;CSRP3;EPB41L2;SORBS1;ITGB1;ITGB5;TMOD3;KRT19;CSRP2;SIX4;FRMD6;RHOA
prerank,primary miRNA processing (GO:0031053),0.5267998562510328,1.019927825525689,0.48426573426573427,0.9014955009850455,1.0,6/10,25.50%,SMAD2;DGCR8;PUS10;DROSHA;SRRT;HNRNPA2B1
prerank,positive regulation of glucose metabolic process (GO:0010907),0.47870413852362514,1.01984005476454,0.44594594594594594,0.9010303605088408,1.0,3/14,8.36%,IRS1;PTPN2;NNMT
prerank,regulation of synapse assembly (GO:0051963),-0.31990297595198813,-1.0197481781658564,0.38934426229508196,0.7821629420394994,1.0,11/46,8.84%,IL1RAPL1;NRXN1;ROBO2;GRID2;EPHB1;APP;MEF2C;SNCA;LRFN5;SRPX2;LRRC4B
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.48705258763674864,1.0197149269090973,0.4489112227805695,0.9006752584253078,1.0,5/14,14.99%,ENTPD6;NUDT5;ENTPD2;ENTPD7;NUDT15
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.32870013422951766,1.0196899059855073,0.45161290322580644,0.90005583259547,1.0,73/509,11.29%,F3;EGFR;THBS1;NR3C2;TCF7L2;MET;TNFAIP8L3;NTRK3;SOX9;NEDD4;ADRA1B;TCIM;PDGFC;TRAF3IP2;FN1;AKAP13;WNT11;NFAT5;ADRB2;FGFR1;ALPK1;SHC1;ITGB1;GAB2;FGF2;PIK3AP1;IRS1;STRN;TGFBR1;PDCD4;TAB3;GCNT2;CD80;BECN1;WNT16;IRAK4;ITGAV;ESR1;MAVS;ROR1;TRIM44;DDIT3;GOLPH3;RIPK2;MAP3K3;REL;IFI35;IKBKE;P2RX2;RRAGB;PDGFA;STYXL1;TLR4;BCAR3;P2RX4;RHOA;IQGAP1;CHUK;BCLAF1;LIMS1;USP15;MLST8;PLCG2;PIM2;MTDH;VEGFA;SMCR8;GOLT1B;MIER1;TNFSF11;CCL3;ERBB2;ITGB1BP1
prerank,positive regulation of protein secretion (GO:0050714),0.3776401158253453,1.0196523055991549,0.4211195928753181,0.8994616946960863,1.0,11/69,8.33%,TCF7L2;EZR;TGFB3;ADAM9;BMP6;UNC13B;SYTL4;ISL1;GOLPH3;AACS;TLR4
prerank,regulation of response to cytokine stimulus (GO:0060759),0.46321708571228637,1.0194127768288268,0.4500818330605565,0.8993754100769074,1.0,6/19,14.67%,KLF4;ELF1;MAVS;CBFB;IFIH1;DHX9
prerank,DNA recombination (GO:0006310),0.414786615473538,1.0191057012933051,0.4377745241581259,0.8994609868676975,1.0,12/37,21.89%,EXO1;WRN;IGHMBP2;RAD52;HDAC10;RPA1;RECQL5;RAD51;ERCC1;RAD51B;RAD51C;RAD50
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.3012511952211373,-1.01888267703845,0.3907563025210084,0.7830214838053803,1.0,15/54,18.92%,NSA2;RPL23A;RPL26;RPL35A;SNU13;RPL11;RPL7;NOC2L;NPM1;RPL14;RPL24;RPL10A;RPL3;RPL5;LAS1L
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.41144158677695963,-1.0188495548362932,0.40575916230366493,0.7818060223560013,1.0,7/15,24.16%,IQGAP2;ARPC4;ARPC5;ARPC3;ARPC5L;TRIM27;ARPC1A
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.45190716205059356,1.0185406321728476,0.44613050075872535,0.8995174378468981,1.0,9/21,27.34%,CHD1L;ERCC5;ERCC3;XPA;RPA1;ERCC1;CUL4A;ERCC2;GTF2H3
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.45190716205059356,1.0185406321728476,0.44613050075872535,0.8995174378468981,1.0,9/21,27.34%,CHD1L;ERCC5;ERCC3;XPA;RPA1;ERCC1;CUL4A;ERCC2;GTF2H3
prerank,mesenchyme morphogenesis (GO:0072132),0.469230884037525,1.018266725593758,0.4412751677852349,0.8995612466836933,1.0,7/17,10.17%,SOX9;BMPR1A;NOG;ISL1;MDM4;ACVR1;SMAD2
prerank,regulation of macrophage activation (GO:0043030),0.4267853054731083,1.018189173456178,0.4363103953147877,0.8990475782410858,1.0,5/30,9.58%,THBS1;LBP;TLR4;IL33;SHPK
prerank,apical protein localization (GO:0045176),-0.44830776525961025,-1.0181748128823398,0.44844124700239807,0.7822184671405936,1.0,4/10,6.09%,SHROOM2;ACTB;MAL;JAM3
prerank,apoptotic process (GO:0006915),0.34192558490376235,1.0177275577608145,0.44432432432432434,0.8995736711743046,1.0,47/203,17.71%,PLAGL1;CYFIP2;EGLN3;PTK2B;EFNA5;CIT;PRKCD;PAWR;ZBTB16;NOTCH2;PRKCE;MAGI3;RFK;PDCD4;CASP6;TGFBR2;CD2;PLSCR1;YARS1;IRF1;ARHGEF6;GDF6;PLK3;MCM2;BCLAF1;FEM1B;CDIP1;NCKAP1;BCL2L13;DIABLO;MYD88;MTOR;CHEK1;PLSCR3;CXCR4;EP300;TRADD;CDK11B;PIDD1;TRPC5;ERCC3;CASP2;IKBKG;AIFM2;MRPS30;PAK4;BNIP1
prerank,regulation of protein autophosphorylation (GO:0031952),-0.3269233449746065,-1.0177112987050323,0.40468227424749165,0.7821742048715012,1.0,7/36,4.43%,ENG;ERRFI1;PDGFD;EPHA7;ENPP1;RAP2A;CALM1
prerank,regulation of ion transport (GO:0043269),0.3715361341351003,1.0176853768238616,0.4362934362934363,0.8990022248080547,1.0,12/76,11.23%,KCNJ2;NEDD4;WNK1;KCNJ15;WWP2;GDNF;SYT8;P2RX4;ATP1A1;DRD3;ITGB3;PER1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.5037468011612638,1.0174102613990466,0.45307443365695793,0.8990080698801327,1.0,1/11,0.27%,THBS1
prerank,triglyceride metabolic process (GO:0006641),-0.31575543727351496,-1.0173533509004986,0.391304347826087,0.7818097304078524,1.0,9/48,15.52%,APOE;LPGAT1;GK;LPIN3;GPAM;FABP5;DGAT1;LPIN1;LPL
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.4369999242700051,1.0170851574824749,0.44763271162123386,0.8990941866411933,1.0,5/27,4.88%,TMEFF2;MET;ARAP1;PHLDB2;RHPN2
prerank,N-terminal protein amino acid modification (GO:0031365),0.48094263760535316,1.016951206757098,0.4539249146757679,0.8987611604740983,1.0,7/14,28.54%,NAA40;NAA15;METAP1D;NAA35;NAA50;METAP2;NAA60
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.40837156427433896,1.016877140177118,0.42155525238744884,0.898268317197916,1.0,12/40,18.33%,PTK2B;XPO1;CLU;COMMD1;RAD23B;DESI1;SMURF1;CCDC22;TRIM39;PML;CSNK2A2;CSNK2A1
prerank,regulation of hormone secretion (GO:0046883),0.48060988480152683,1.0166046398826245,0.43636363636363634,0.8982669206886226,1.0,1/15,1.91%,ANXA1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.45644655484305746,1.0164696050881927,0.4611727416798732,0.8979601351957787,1.0,7/21,11.47%,IGFBP5;BMPR1A;FGF2;NR4A3;IL10;JUN;HTR1B
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5214107538266068,1.0163152763624062,0.4757785467128028,0.8976856472181651,1.0,3/10,10.37%,KDM1A;DISC1;VEGFA
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.45467889303591114,-1.0158634693056647,0.43596059113300495,0.7843797707587652,1.0,2/10,2.43%,ZEB2;RAPGEF2
prerank,cellular response to cytokine stimulus (GO:0071345),0.32723400377319506,1.0158259746816247,0.44455747711088506,0.8982480014823678,1.0,51/416,10.39%,STK39;F3;SLC12A2;DPYSL3;SOX9;LBP;PID1;ANXA1;WNK1;TANK;FN1;NFAT5;IL22RA1;FOXO3;PTGIS;GRB10;YBX3;SHC1;ITGB1;NFE2L2;GSK3B;GAB2;FGF2;SLC26A6;CLCF1;PTPN2;CD80;IRAK4;STAT3;SYNCRIP;RORA;IRF1;IL10;SOCS2;TLR4;CDKN1B;CXCL2;FOXC1;RHOA;NFKB1;CHUK;CTF1;IRAK3;ERBIN;SHPK;RBMX;TIMP1;USP10;VEGFA;IL20RB;IL18BP
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5054679303589165,1.0154835178558455,0.4578096947935368,0.8984133195905595,1.0,3/10,17.70%,KLF4;IRAK3;PALM3
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.35352389228051107,1.0151124579597994,0.4361078546307151,0.8986690347941497,1.0,26/129,13.35%,EGFR;WNK1;GPC3;PLEKHA4;TMEM198;VCP;TRPM4;SFRP4;UBE2B;UBR5;TBL1X;BAMBI;PSMB2;JUP;USP34;CSNK1G3;NFKB1;DACT1;TNKS2;PSMC6;PRDM15;USP47;RNF146;PSMD11;CSNK1G1;PPM1A
prerank,smooth muscle cell differentiation (GO:0051145),0.4977556909138113,1.0149461519279404,0.44559585492227977,0.8984072250834967,1.0,2/12,5.39%,BMP4;MRTFA
prerank,embryonic axis specification (GO:0000578),0.4816376888183068,1.0148552233042991,0.4603174603174603,0.8979655625079703,1.0,2/15,2.16%,COBL;SMAD6
prerank,endomembrane system organization (GO:0010256),0.3439814707203106,1.014681261230731,0.44924406047516197,0.8977518245867966,1.0,58/178,23.08%,ARHGAP21;ATL3;GOLGB1;NUP93;RAB43;TMED5;ATL2;BCAS3;FBXW8;SPTSSB;RAB30;LMAN2L;GAK;GOLPH3;DOP1B;GBF1;CSNK1A1;SEC16A;ATP8B1;SUN3;WASHC5;PLEKHM2;SEC31A;SEC61A1;A4GALT;COG3;TLCD1;TLCD2;NPLOC4;SQSTM1;TRIP11;GORASP2;SEC23IP;HOOK3;LEMD2;TOR1B;ANXA8L1;ANXA8;BNIP1;AP3D1;ARFGEF1;TMCC1;CSNK1D;DYNC2H1;ZW10;RAB1A;WASHC4;CDC42;PLEKHF1;CUL7;VPS51;TMED3;EIF2AK3;HUWE1;HOOK2;TMEM170A;SUN2;SURF4
prerank,response to insulin (GO:0032868),-0.28000995956912944,-1.0144819300639185,0.425531914893617,0.7865947202813663,1.0,24/80,20.09%,TBC1D4;PIK3R1;SORT1;FOXO1;CPEB2;ENPP1;INSR;INSIG2;LPIN3;MYO5A;SLC25A33;GSK3A;AKT1;LPIN1;RAB15;DENND4C;RAB31;PDE3B;RAB13;SLC27A1;SELENOS;XBP1;SLC2A4;INPP5K
prerank,positive regulation of interferon-beta production (GO:0032728),0.4239191999884219,1.0141305011510011,0.4540229885057471,0.8984236075975227,1.0,11/33,18.27%,POLR3D;MAVS;RIPK2;IRF1;TLR4;IFIH1;DHX9;RNF135;TLR8;POLR3A;POLR3F
prerank,lipoprotein biosynthetic process (GO:0042158),-0.4437140132670169,-1.0140047567062702,0.4852216748768473,0.7865496687043888,1.0,2/11,3.53%,APOE;UGCG
prerank,regulation of stress fiber assembly (GO:0051492),0.3789664905802691,1.0135586297577692,0.44416562107904645,0.899153047016388,1.0,15/74,8.98%,TMEFF2;MET;SORBS3;ARAP1;TGFB3;WNT11;PHLDB2;ABL1;NRP1;TGFBR1;RHPN2;SLC9A1;ARHGEF10;RHOA;S100A10
prerank,muscle cell development (GO:0055001),-0.3402339351643127,-1.013384842433425,0.40189873417721517,0.7868381868228,1.0,10/30,9.74%,IGF1;ENG;SGCZ;DYSF;SLC8A1;MYH11;HEY2;MEGF10;RAMP2;EFEMP2
prerank,embryonic hemopoiesis (GO:0035162),-0.43114086783011907,-1.012629317501581,0.48578199052132703,0.7875887705081679,1.0,5/12,16.31%,KIT;KDR;TAL1;SH2B3;FLT3LG
prerank,cellular glucose homeostasis (GO:0001678),-0.32278443307423554,-1.0125127129340332,0.450354609929078,0.7865966685231791,1.0,9/41,7.77%,IGF1R;PIK3R1;FOXO1;PRKAA2;ZBTB20;HIF1A;PPARGC1A;ERN1;GAS6
prerank,positive regulation of neuron differentiation (GO:0045666),-0.3258407671963489,-1.0120788284521147,0.39849624060150374,0.7864101377068518,1.0,8/40,8.97%,TCF4;ZEB1;BRINP3;MEF2C;GPRC5B;BMP2;ZC4H2;PROX1
prerank,protein ubiquitination (GO:0016567),0.3237215773477899,1.0119788146269375,0.47076612903225806,0.9023594975146885,1.0,130/471,21.97%,FBXL7;WWP1;NEDD4;FBXO10;UBE4B;WWP2;NPEPPS;NFE2L2;RNF144A;FBXO40;RNF115;HERC2;RNF138;RNF185;VCP;FBXW8;KLHL22;UBE2B;ARIH1;UBR5;MKRN3;ATG3;TRIM44;CDC16;BIRC6;RNF19A;HIF3A;FBXL20;TRIP12;RNF114;PSMB2;ASB9;CBLC;BIRC7;ANAPC16;MYCBP2;RNF141;KLHL13;TRIM47;UBE2D3;RNF126;FBXW11;LRSAM1;TNKS2;COMMD1;UBE4A;PSMC6;UVSSA;TRIM7;TRIM26;WAC;USP7;RNF111;TRIM41;TRIM55;CBFB;FBXO17;RNF146;UBE2Z;ASB11;SPSB2;HECTD2;RNF122;ARIH2;RNF168;SMURF1;SH3RF3;FBXO4;PRKDC;ANKIB1;PSMD11;PEX13;CTR9;HERC6;UBE2S;CUL3;ERCC8;SPOP;RNF135;FANCL;CCDC22;PSMD1;UBE2K;ASB1;TRIM39;CUL1;CHFR;VCPIP1;RNF14;MKRN1;BFAR;UHRF2;BARD1;OS9;PSMD7;USP9X;BCL10;DTX3;UBE3C;PSMC1;USP22;MKRN2;FBXL19;FBXO25;TRIM35;PSMD14;CNOT4;RTF1;UBE2W;TRIM25;FBXL8;GAN;TSPAN17;TRPC4AP;RNF8;MIB1;FBXL4;UBE2N;KLHL18;RNF31;ANAPC11;NFX1;CUL7;RBCK1;PSMD3;DET1;PPIL2;CUL4A;HUWE1;RMND5A
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5102360462460749,1.011219142557149,0.47330960854092524,0.9035789281264672,1.0,2/10,3.53%,PRKCE;IRS1
prerank,DNA modification (GO:0006304),0.44503251520225307,1.0111682525255035,0.4424920127795527,0.9030144757809893,1.0,7/22,23.59%,MPG;SMUG1;PARP3;NEIL3;TDG;MBD4;PARP2
prerank,regulation of endocytosis (GO:0030100),-0.3004183372110642,-1.0108482933546183,0.4027777777777778,0.7884376382013748,1.0,12/61,8.10%,APOE;PRKD1;NEDD4L;MCTP1;PICALM;CDH13;RIT2;OPHN1;SYT11;SNCA;HIP1R;SPHK1
prerank,retrograde axonal transport (GO:0008090),0.4735393909001666,1.010760644628226,0.4645161290322581,0.9033335373323346,1.0,4/16,9.27%,PAFAH1B1;DLG2;KIF1C;FBXW11
prerank,regulation of cell development (GO:0060284),0.41581863214353826,1.0107462189590217,0.4461538461538462,0.9026955176196702,1.0,5/36,5.27%,HES1;HDAC9;DOCK7;NOTCH2;BHLHE40
prerank,regulation of phospholipase activity (GO:0010517),0.4966133928197108,1.0105230805862042,0.46219931271477666,0.902580961940844,1.0,2/10,5.58%,FGFR1;LRP1
prerank,anterior/posterior axis specification (GO:0009948),-0.4026317585911747,-1.0104607884055368,0.4300254452926209,0.7882592552011022,1.0,2/15,2.65%,WLS;TBX3
prerank,cytoskeleton organization (GO:0007010),0.3551755997374612,1.010286251314422,0.43902439024390244,0.9024780940928228,1.0,21/114,13.13%,MICAL2;PLCE1;FMNL2;MARK1;ARHGAP10;STRIP2;PPP2R3C;RHOBTB1;DIAPH1;DMTN;FGD6;RND3;RHOA;PCLO;SPRYD3;MAST2;CCL3;ZMYM4;SH3D19;CCL7;ZRANB1
prerank,keratan sulfate metabolic process (GO:0042339),0.4148611658664789,1.0102719746343531,0.4446022727272727,0.9018329248151642,1.0,5/31,6.56%,ST3GAL4;B3GNT2;HEXA;CHST5;B4GALT1
prerank,negative regulation of neuron differentiation (GO:0045665),0.44890046454100463,1.0102292427370823,0.44290123456790126,0.9012814832597708,1.0,3/22,3.23%,SOX9;HES1;GSK3B
prerank,acylglycerol metabolic process (GO:0006639),-0.32492338500835993,-1.0098215545688871,0.4519230769230769,0.7885827382651563,1.0,14/37,20.34%,APOE;DGKB;DGKI;GK;DGKD;ABHD12;DGKG;DGAT1;PGS1;LPL;PLAAT3;DGKE;DGKZ;APOC1
prerank,regulation of store-operated calcium entry (GO:2001256),0.5094522580506967,1.0095021189643634,0.4573502722323049,0.9024278238471635,1.0,4/10,15.14%,SLC8B1;HOMER2;HOMER1;GRAMD2A
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.35623651446046845,-1.0092743054035156,0.43613707165109034,0.788743345599584,1.0,6/24,14.55%,ERRFI1;PRKCH;ROCK2;CTSL;ETV4;MED1
prerank,response to interleukin-6 (GO:0070741),0.5107153563626925,1.009173042826975,0.4767025089605735,0.902571883497454,1.0,3/10,8.90%,PID1;PTGIS;NFKB1
prerank,maintenance of protein localization in organelle (GO:0072595),-0.3741663406695598,-1.0090497073351878,0.446524064171123,0.788026759948964,1.0,7/19,21.05%,TAPT1;ARL2BP;TAF3;HK2;AKT1;CHCHD10;BCL3
prerank,negative regulation of cytokine production (GO:0001818),0.34023202897631133,1.008919689435252,0.45805739514348787,0.9025175976540232,1.0,33/163,16.91%,THBS1;EZR;ANXA1;FN1;HDAC9;ANXA4;TAX1BP1;KLF4;INHBA;CMKLR1;PDCD4;MAVS;DDIT3;IKBKE;IL10;TLR4;IRAK3;RARA;INHBB;OTUD7B;HOMER2;ZC3H12A;IFIH1;PIBF1;NPTN;NPLOC4;RNF135;TLR8;ASB1;OTUD5;ACOD1;C5AR2;NLRP12
prerank,neuron fate commitment (GO:0048663),0.4794739460158111,1.0087136799003125,0.46275752773375595,0.9023372624692638,1.0,4/14,13.71%,TGFBR1;ISL1;ID2;PAX6
prerank,regulation of postsynapse organization (GO:0099175),-0.3422531877913284,-1.0084984262047674,0.45182724252491696,0.7882041746301011,1.0,9/28,13.40%,IL1RAPL1;SHANK3;PPFIA2;WNT5A;EPHA4;CFL1;ABI3;ARHGAP22;KIF1A
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.3831704249679461,1.008171600742355,0.4576271186440678,0.9029775765295623,1.0,20/52,26.88%,SAMD4A;PAN3;EXOSC7;TUT7;CNOT7;DCP1A;TUT4;TNKS1BP1;EXOSC1;LSM2;CNOT4;PNLDC1;CNOT11;SAMD4B;CNOT3;LSM4;RC3H2;EDC3;PARN;EXOSC4
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.43828211833381114,1.0079841688285713,0.4608433734939759,0.9027849552662228,1.0,6/23,16.94%,CCN3;IFI35;ZC3H12A;PPM1A;NLRP12;CPNE1
prerank,actin filament organization (GO:0007015),0.34823621203956434,1.007912353085443,0.4594594594594595,0.9023081206979613,1.0,22/151,9.44%,DPYSL3;BAIAP2L1;VILL;COBL;ABI1;GSN;SHROOM3;RHOBTB1;FAT1;TMOD3;NLRP5;TLE6;PLS1;DMTN;NEBL;DLG1;GAS2L2;ARHGAP17;SHROOM4;RND3;RHOA;GAS2
prerank,regulation of kinase activity (GO:0043549),0.3641947081628845,1.007315186214673,0.45787545787545786,0.903138342226088,1.0,7/89,2.85%,EGFR;PLCE1;MET;NTRK3;LMO4;DDR2;FGFR1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3841646960589553,1.0069738622250586,0.4664082687338501,0.9033245456405031,1.0,3/57,1.08%,MAP3K5;CYFIP2;PERP
prerank,DNA integrity checkpoint signaling (GO:0031570),0.4112046232673647,1.006153976871862,0.460545193687231,0.9046748697202027,1.0,13/36,21.99%,CHEK2;RAD17;CEP63;ATM;CLSPN;CDC45;CHEK1;HINFP;USP28;ATR;NBN;E2F1;RAD9B
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.4174479817378646,1.0058462748900798,0.4446043165467626,0.9047547209047134,1.0,13/32,27.70%,POLR1G;MNAT1;POLR1A;TAF1D;TAF1C;POLR1F;ERCC3;UBTF;ERCC2;RRN3;GTF2H3;TAF1;POLR1H
prerank,glucose homeostasis (GO:0042593),0.3642771949717297,1.0054299987053343,0.4559710494571773,0.9050525523449465,1.0,18/83,14.11%,TCF7L2;LRRC8D;KCNB1;CRY2;IRS1;KLF7;PTPN2;FOXK1;STAT3;BACE2;MCU;FOXK2;SLC8B1;SELENOT;HNF4A;HNF1A;PAX6;ACSM2A
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.517497420413482,1.0054226752366646,0.46059544658493873,0.9037392643651911,1.0,2/10,9.05%,AP2A2;AP2A1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.517497420413482,1.0054226752366646,0.46059544658493873,0.9037392643651911,1.0,2/10,9.05%,AP2A2;AP2A1
prerank,diol metabolic process (GO:0034311),-0.3820317663994811,-1.0049814913712662,0.45244956772334294,0.7960191049160271,1.0,9/19,20.69%,NOS3;DEGS2;CALM1;SPHK1;AKT1;GCH1;PLPP2;SPHK2;SGPP1
prerank,dephosphorylation (GO:0016311),0.34556825069132796,1.00493986225046,0.46360582306830905,0.9042449454974338,1.0,31/147,15.25%,PLPPR2;PTPN3;PPP3CA;PTPRU;PLPP3;ALPL;PPM1H;PTPRF;ACP3;PTPRA;DUSP5;PTPN21;DUSP16;DUSP11;FBXW11;PPEF2;PPP1R12A;PPP2R5C;DUSP10;PTPN9;PPP5C;PPP3CC;ILKAP;DAPP1;PPP4R2;PPM1A;PLPP1;PDXP;PPP4R1;SBF1;ACP4
prerank,protein K63-linked deubiquitination (GO:0070536),0.42300202008491566,1.004894576130584,0.44782608695652176,0.9036891152607083,1.0,10/31,19.04%,USP13;OTUD1;USP25;USP7;OTUD7B;USP33;UIMC1;ZRANB1;OTUD5;PSMD14
prerank,protein kinase A signaling (GO:0010737),0.48360200234708256,1.0048661266718661,0.4576271186440678,0.9031030574112281,1.0,2/12,7.72%,EZR;RDX
prerank,epithelium development (GO:0060429),0.3589953984163912,1.004841837796355,0.45454545454545453,0.9024951607877915,1.0,15/107,10.37%,SIX1;PKD1;SOX9;SMO;BDH2;MEOX2;ANXA4;EHF;CASP6;VCL;RIPK4;GRHL2;KANK2;DACT1;VEGFA
prerank,neurotransmitter transport (GO:0006836),0.3706376191153996,1.0047812390720128,0.4617314930991217,0.9019970222870226,1.0,2/73,0.30%,SLC38A2;SLC38A1
prerank,regulation of mRNA catabolic process (GO:0061013),0.34691396273575387,1.004611797576873,0.4584795321637427,0.9017421201637227,1.0,31/121,19.50%,SAMD4A;PRKCD;EIF4G1;XPO1;MOV10;PSMB2;PKP1;ZC3H14;PCBP4;PSMC6;APEX1;SERBP1;EXOSC7;PABPC1;ZC3H12A;PSMD11;PUM2;PRKCA;PUM1;CNOT7;MAPKAPK2;DCP1A;PSMD1;NUP214;EXOSC1;PSMD7;PSMC1;DHX36;FXR2;PSMD14;FMR1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.4999412753369036,1.0045592009965538,0.4796084828711256,0.9012248774814414,1.0,4/12,20.77%,B3GNT2;B4GAT1;B3GNT9;B3GNT6
prerank,carboxylic acid catabolic process (GO:0046395),0.4865195103543407,1.004052663552837,0.4657762938230384,0.9018535265581994,1.0,3/12,12.21%,PON3;ACOT8;RENBP
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.3751397609712417,-1.0037097657229215,0.4794871794871795,0.7980025066632594,1.0,5/19,9.28%,TJP1;NEXMIF;NOTCH1;NOTCH4;RGCC
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.4230836295175651,1.0033113892859886,0.4672754946727549,0.9030677306190847,1.0,12/27,25.75%,TAB3;IRAK4;TLR4;IRAK3;MYD88;TNIP1;TLR1;TLR6;LY96;CD36;TRAF6;MAP3K7
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5137471088960965,1.0028659045014157,0.46221441124780316,0.9035276455394178,1.0,3/10,7.72%,PRKCD;CD9;RDX
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.4663954007216602,1.0026870413577915,0.4793388429752066,0.9032868584652376,1.0,8/18,20.63%,USP15;PUM2;NPLOC4;PUM1;ANKRD17;BIRC3;UFD1;GPATCH3
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.48961681058845297,1.0025001522643575,0.474025974025974,0.9030908003959436,1.0,6/13,16.51%,BMP5;NFKB1;DKK3;ERLIN1;REST;CYP27B1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.43700388883017577,1.002317902112242,0.4572317262830482,0.902861956145902,1.0,7/23,13.97%,HDAC4;CLK2;PFKFB1;C1QTNF12;NCOR1;ERFE;EP300
prerank,regulation of chemokine production (GO:0032642),0.4072127985314522,1.0022242730988051,0.46206896551724136,0.9024246445731323,1.0,1/36,0.25%,FOXP1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.4759430489288665,1.002210823878654,0.47753743760399336,0.9018100920775176,1.0,2/13,6.10%,CD44;KDM1A
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.3885018899788714,-1.002201552464767,0.46321525885558584,0.8007004941667769,1.0,4/18,8.04%,SHANK3;NRXN1;CACNG4;CACNG7
prerank,oligodendrocyte development (GO:0014003),-0.4024779504841018,-1.002064634800735,0.4466501240694789,0.7997790842643088,1.0,10/15,33.68%,PLP1;CNTNAP1;MYRF;TPPP;SOX10;B4GALT6;EIF2B1;EIF2B5;B4GALT5;HES5
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.4124848546112543,-1.0019813230897658,0.43914081145584727,0.7987405943460906,1.0,4/14,6.67%,RAPGEF2;PRKAR2B;PRKAR1B;PRKAR1A
prerank,double-strand break repair via break-induced replication (GO:0000727),0.4882780379883112,1.00175836005293,0.46192052980132453,0.9022599164620191,1.0,3/12,12.77%,MCM7;MCM2;CDC45
prerank,insulin receptor signaling pathway (GO:0008286),0.37227465780604335,1.0015975123690735,0.46878980891719746,0.9019873727755734,1.0,18/69,16.10%,GRB10;SHC1;SORBS1;ATP6V0A4;GSK3B;SLC39A14;IRS1;FOXC2;PTPN2;RHOQ;IDE;BCAR3;C2CD5;TCIRG1;PIK3R3;ATP6V0D1;GAB1;ATP6V0E1
prerank,lipid transport (GO:0006869),0.3587910569950841,1.0015253136152593,0.463785046728972,0.9015175144527665,1.0,12/97,8.67%,SLCO3A1;ABCD3;TNFAIP8L3;SLCO2A1;LBP;PITPNC1;PITPNA;SLC27A3;LDLR;SLC10A2;ATP8B1;RXRA
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.4837265408962737,1.0014156803921077,0.4691151919866444,0.901112695915569,1.0,2/13,7.25%,GAB2;KLRC2
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3375507564022209,1.0013826240732713,0.48136315228966986,0.9005304832939078,1.0,43/198,15.25%,PLCE1;TNFAIP8L3;PLPPR2;PPP3CA;PLPP3;ALPL;LIMK2;PLCB3;IP6K2;INPP4A;PLCZ1;PLA2G4F;ACP3;STAT3;PFKFB2;PLA2G15;PFKP;NUDT4;DUSP5;OCRL;PLCD3;PFKFB1;GPI;DUSP16;SHPK;PLCG2;TOP1;NUDT5;NADK;DUSP10;LCAT;MTOR;PPIP5K2;PPM1A;PAK2;AGK;PLPP1;SYNJ1;PDXP;HTR2B;PLA2G2C;PLCD1;ACP4
prerank,negative regulation of transposition (GO:0010529),0.4705695986233658,1.001321697285657,0.49221183800623053,0.9000290717158378,1.0,5/16,20.39%,MOV10;TDRD9;TUT7;TUT4;TEX15
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.4489157508967566,1.0011217307957205,0.47987616099071206,0.8998696432169907,1.0,2/21,4.28%,GUCY2C;ADCY9
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.36371274155612676,1.000874747313921,0.46562123039806996,0.899839536948437,1.0,19/86,14.25%,MET;BAIAP2L1;CDC42EP5;PTK2B;PRKCE;CLIP1;NCK2;CLU;TOGARAM1;AKAP9;CTTN;NCKAP1;KATNB1;SLAIN2;RB1;FCHSD2;FCHSD1;WDR1;PDXP
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.4437551705581648,1.0006662336563452,0.4613003095975232,0.8996991169407257,1.0,7/21,20.75%,SMO;KIF7;EVC;ARMC9;TTC23;TEDC2;DLG5
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.44341203571464194,1.0006659798164599,0.4592476489028213,0.8990499833787193,1.0,6/22,14.35%,IRF1;CD46;CBFB;DUSP10;KAT2A;BCL6
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.47714310767896295,1.000608812857634,0.4440677966101695,0.8985343213744232,1.0,2/12,7.32%,TRPM4;CLTRN
prerank,monocyte chemotaxis (GO:0002548),-0.3404880237859048,-1.0004885249067992,0.47249190938511326,0.8014422703730509,1.0,5/32,10.15%,FLT1;IL6R;RPS19;TNFRSF11A;PTPRO
prerank,nuclear envelope organization (GO:0006998),0.4536517927868085,1.0003381414416712,0.47226386806596704,0.8985268412257021,1.0,8/20,22.93%,NUP93;TOR1AIP1;SUN3;EMD;LEMD2;TOR1B;TMEM170A;SUN2
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.2714401296354126,-1.000238857179841,0.44666666666666666,0.8008253850859511,1.0,12/90,7.42%,LEPR;IGF1R;ACSL1;PPARGC1B;ESRRG;GATM;EBF2;PRDM16;GJA1;PPARGC1A;ELOVL6;IL18
prerank,histone H2B ubiquitination (GO:0033523),0.5111734170277081,1.0001235326226852,0.47752808988764045,0.8984033843607253,1.0,6/10,30.91%,WAC;CTR9;RNF8;PAF1;RNF20;DTX3L
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.43747116988102125,-0.9995244248399684,0.4556354916067146,0.8013931368974236,1.0,3/10,14.55%,PRKCH;ETV4;MED1
prerank,lamellipodium organization (GO:0097581),0.4215932277506418,0.9990790148228705,0.45652173913043476,0.9002943093585529,1.0,8/29,7.04%,ABLIM3;ITGB1;SNX2;VCL;ABLIM2;GOLPH3;DMTN;ARHGEF6
prerank,chromatin remodeling (GO:0006338),0.35343630015431104,0.9986378746062295,0.4619105199516324,0.9006909525883952,1.0,28/100,19.19%,SOX9;HDAC4;ESR1;MYSM1;SRCAP;CHD1L;BAZ2B;TOP1;NUDT5;BPTF;BAZ1A;RB1;SMARCA4;ATRX;KAT2A;PBRM1;HCFC1;CHD3;KDM4D;BAZ2A;ZBTB1;ZBTB7A;KAT2B;INO80;SMARCC1;SATB2;EZH1;SMARCA5
prerank,regulation of calcium ion transport (GO:0051924),-0.2969637733811913,-0.9986306992146123,0.448,0.80247881981108,1.0,11/54,11.55%,MYLK;CACNA1D;EPB41;BCL2;ADRA2A;ATP2B1;CACNA2D1;TRPC6;CAMK2A;CD84;CAMK2B
prerank,translesion synthesis (GO:0019985),0.39682805870616494,0.9983937416672286,0.46630727762803237,0.9006374302019458,1.0,17/42,29.24%,REV3L;VCP;USP10;NPLOC4;POLE2;ZBTB1;RPA1;RFC1;REV1;UFD1;TRIM25;POLD3;RFC5;POLK;POLI;RCHY1;PRIMPOL
prerank,response to muscle stretch (GO:0035994),0.47443387699247974,0.9983441666046499,0.49216300940438873,0.9001095049527916,1.0,4/15,8.27%,CSRP3;GSN;DMD;SLC9A1
prerank,innate immune response in mucosa (GO:0002227),-0.44407064649070815,-0.9981747987029035,0.46352941176470586,0.8023542010338551,1.0,7/10,42.96%,DEFA6;RPL39;NOS2;CAMP;BPIFB1;DEFB1;LTF
prerank,purine-containing compound biosynthetic process (GO:0072522),0.4290048463421873,0.9981032189053777,0.47653958944281527,0.9000327694966023,1.0,8/25,24.66%,PRPS2;PAICS;ADA;AMPD3;GMPS;DGUOK;GMPR2;AMPD2
prerank,regulation of p38MAPK cascade (GO:1900744),-0.3260134536160939,-0.9979757642447479,0.4842105263157895,0.8015944736558134,1.0,6/35,8.10%,SASH1;PHLPP1;MFHAS1;DAB2IP;BMP2;SPHK1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3827732536801285,0.997919171254342,0.4573333333333333,0.899823628271778,1.0,17/52,21.97%,ABLIM3;NPEPPS;HPS4;SAE1;UBE2D3;HSPA1L;PPP3CC;ARIH2;SH3GLB1;BAP1;CSNK2A2;E2F1;MAPK8;RNF31;USP36;NMT1;HUWE1
prerank,positive regulation of signaling (GO:0023056),-0.32746938185607627,-0.9978471898977569,0.4597315436241611,0.8006510424405989,1.0,8/37,9.64%,WLS;RIMS1;GRIK2;RIMS2;SNCA;EDN1;SYT1;INPP5F
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.4106403162991497,-0.997837054969269,0.48402948402948404,0.7994194356622558,1.0,6/12,14.55%,CTSH;LMO2;CTSB;CTSS;CTSL;MED1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.4619694967733149,0.9977712878942822,0.45641838351822506,0.8995304516044622,1.0,5/16,8.14%,PDGFC;ABL1;NRP1;NR4A3;PDGFA
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.403311153313418,0.9975659993347583,0.4609164420485175,0.8993811095059135,1.0,5/42,8.71%,WARS2;EARS2;YARS1;CARS2;NARS2
prerank,actin filament polymerization (GO:0030041),0.4280342031217408,0.9972125436254783,0.4732394366197183,0.8996449272091633,1.0,7/29,13.02%,COBL;GSN;DIAPH1;FAM107A;WASHC5;MSRB2;PSTPIP1
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.3640646014359116,-0.9971602543839113,0.436046511627907,0.7998394277009314,1.0,6/23,8.58%,SASH1;PAK1;DAB2IP;RPS3;TNFRSF11A;EDN1
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.4231404827399218,0.9967689017135088,0.46597633136094674,0.9001158005421911,1.0,2/29,2.04%,SLIT2;PRKCD
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.2354268440481729,-0.9965023253152997,0.4857142857142857,0.8001705936820633,1.0,67/306,13.15%,APOE;RBMS1;RPS14;FUT9;PTMA;EEF1A1;RPL38;RPLP1;RPS9;RPL21;RPS13;RPL41;RPL37A;RPS21;RPLP2;EEF1B2;RPL27A;RPS19;RPL34;RPS29;RPS8;RPS3;RPS23;RPS5;RPS4X;RPL13;RPS16;RPL9;RPS15;RPS27;RPL30;DTX1;ALAS1;RPL37;RPL19;RPS11;RPS24;RPL18A;RPL18;RPS7;RPL23;RPL17;EIF4EBP2;RPS20;RPL22;RPL23A;RPL26;RPS25;RPS18;RPL35A;MRPL3;RPL11;RPL13A;RPL7;GAL3ST2;RPL36;RPL32;RPS17;BLM;RPL39;RPS2;RPL8;RPL14;POLR2G;ORC4;SET;RPL24
prerank,regulation of sister chromatid cohesion (GO:0007063),0.49168504346518976,0.9962274855834541,0.4702886247877759,0.9007814831316384,1.0,4/12,12.00%,HDAC8;DDX11;RB1;WAPL
prerank,regulation of anoikis (GO:2000209),-0.37610674760971363,-0.9960664824065131,0.45217391304347826,0.8000099919978205,1.0,4/19,6.25%,TLE1;BCL2;NOTCH1;PTK2
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.44281750269692927,0.99584717836024,0.47213622291021673,0.9010312049624494,1.0,5/20,11.16%,LBP;PRKCE;TLR4;MTDH;CCL3
prerank,protein heterotetramerization (GO:0051290),0.47844891924463895,0.9954627206892319,0.468013468013468,0.9013807502460058,1.0,1/13,1.11%,PKD1
prerank,camera-type eye morphogenesis (GO:0048593),0.5012384315482014,0.9951167635455169,0.4718543046357616,0.9015369415794514,1.0,4/10,10.37%,LRP6;SKI;NF1;VEGFA
prerank,regulation of vasculogenesis (GO:2001212),-0.40768554203786755,-0.9951040067287974,0.4506329113924051,0.8012630758840518,1.0,4/14,7.33%,RAPGEF2;KDR;CD34;HEY2
prerank,regulation of pH (GO:0006885),0.4824613694635671,0.994793892371524,0.4859038142620232,0.9016884970218026,1.0,3/11,8.94%,ATP6V0A4;SLC9A1;ATP1A4
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.3225828679246761,-0.9946979266236176,0.4368231046931408,0.8010925593556039,1.0,8/36,6.42%,SGMS1;BCL2;TPD52L1;DAPK2;PPIA;DAB2IP;RPS3;FAS
prerank,response to UV-B (GO:0010224),-0.4092895349790915,-0.9945018537089695,0.4599483204134367,0.8003037000387676,1.0,6/12,29.46%,CRIP1;MFAP4;MME;HYAL2;RELA;IL12A
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.416347687799102,-0.994148122461352,0.4651741293532338,0.7999297211547656,1.0,2/12,6.96%,INSIG2;TAPT1
prerank,protein processing (GO:0016485),0.35383402642048606,0.9940695430547084,0.47268408551068886,0.9028365543817826,1.0,20/102,16.55%,F3;PCSK5;PRSS12;DDI2;PHEX;MMP16;XPNPEP3;ASPRV1;MMP14;LONP2;ADAMTS3;OMA1;YME1L1;TMPRSS2;PITRM1;ECE1;PCSK7;PIDD1;ADAM10;CASP2
prerank,proton transmembrane transport (GO:1902600),-0.322329877330107,-0.9940602212117663,0.45454545454545453,0.7988980550654364,1.0,1/36,0.02%,ATP1A2
prerank,negative regulation of biosynthetic process (GO:0009890),-0.38936625733914687,-0.9930059536691962,0.4685714285714286,0.8003220195328725,1.0,6/16,19.26%,SLC30A10;PPARA;ABCB7;ASXL3;ABCD2;GPER1
prerank,negative regulation of immune response (GO:0050777),-0.25369111613482986,-0.9929654601681768,0.5050505050505051,0.7991863570132917,1.0,46/154,21.96%,LYN;ADCY5;ADCY1;PRKAR2B;GNG2;CALCRL;ADCY7;GGT5;PRKAR1B;MYH9;ENPP3;PRKACB;PRKAR1A;ADORA2A;CD300A;CYSLTR1;CYSLTR2;PTH1R;RAMP2;ADM;NMI;SAMSN1;ADCY2;PLCG1;HAVCR2;TYRO3;ADCY4;HCK;TRIM21;LYAR;PLK2;GGT1;FCGR1A;GPR176;RHBDF2;LHCGR;VIPR2;TSHR;RXFP1;SYK;SPI1;CD163;TREM2;CACTIN;TRIM27;TNFAIP3
prerank,cellular response to UV (GO:0034644),0.36478928351980067,0.9927963864703891,0.4781523096129838,0.9052265205591489,1.0,21/76,19.50%,NEDD4;PRKCD;CREBBP;KDM1A;TIMP1;USP47;CARD16;CHEK1;EP300;EIF2AK4;ZBTB1;YY1;XPA;USP28;ATR;INO80;CDKN1A;EIF2S1;DHX36;ERCC1;FMR1
prerank,positive regulation of dendritic spine development (GO:0060999),-0.36558707863387196,-0.9926354837008441,0.4689265536723164,0.7988092327330253,1.0,5/20,11.72%,SHANK3;APOE;LRP8;CAMK2B;CUX2
prerank,negative regulation of B cell proliferation (GO:0030889),-0.4335029214057188,-0.9926324320710154,0.494199535962877,0.7975789048783049,1.0,3/11,8.29%,LYN;TNFRSF21;CD300A
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3537016039895001,0.9926252137203728,0.4723203769140165,0.9050301516430678,1.0,13/100,6.37%,EGFR;NTRK3;SOX9;NEDD4;PDGFC;FN1;FGFR1;FGF2;PIK3AP1;BECN1;WNT16;PIP5K1A;ROR1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.40672946751179023,0.9923702963792684,0.4793388429752066,0.9049756226007982,1.0,4/37,3.63%,HMCN1;CXADR;NECTIN3;ALCAM
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.448470633859979,0.9922067577014505,0.4727838258164852,0.9047401308741575,1.0,11/20,32.24%,ADAM9;SPPL2A;NFKB1;ADAM10;MBTPS1;TRAF6;SPPL2B;TGFB1;ADAM17;PSEN1;MBTPS2
prerank,ethanol metabolic process (GO:0006067),0.4801876632218405,0.9921704029912249,0.4763458401305057,0.9041761094212406,1.0,2/12,4.64%,ADH7;SULT1A1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.383172236275301,0.992152344894998,0.48026315789473684,0.9035792192546053,1.0,17/55,16.40%,GPC6;GPC3;CD44;FGF2;HEXA;SPAM1;ARSB;GPC4;SLC9A1;NAGLU;SGSH;GLB1;CHP1;IDUA;SDC4;HPSE;BGN
prerank,prostaglandin metabolic process (GO:0006693),-0.34694464410879966,-0.9920176738990225,0.47305389221556887,0.7978993354822336,1.0,10/26,19.87%,PTGDS;PTGS1;EDN1;PNPLA8;HPGDS;MIF;CD74;PTGES3;PTGS2;GSTM1
prerank,histone lysine demethylation (GO:0070076),0.4308452563639854,0.9915381578977825,0.46213292117465227,0.9044635251861853,1.0,7/25,17.15%,JMJD1C;KDM1A;RIOX2;KDM3B;KDM4D;KDM2A;HR
prerank,regulation of neurotransmitter transport (GO:0051588),-0.3990978531464744,-0.9914599795134029,0.4973404255319149,0.7981500671140971,1.0,6/16,10.07%,MCTP1;RIMS1;MEF2C;MCTP2;CAMK2A;SYN1
prerank,toll-like receptor signaling pathway (GO:0002224),0.35707762145993216,0.9913813236118012,0.4747225647348952,0.9041917875944826,1.0,22/84,20.18%,SCARA3;LBP;PIK3AP1;TAB3;IRAK4;RIPK2;TLR4;CHUK;UBE2D3;IRAK3;PLCG2;MYD88;TNIP1;TLR1;MAPKAPK2;TLR8;IKBKG;BIRC3;BCL10;TLR6;TRAF3;LY96
prerank,protein sumoylation (GO:0016925),0.3869303355953102,0.990920072900037,0.47651006711409394,0.9046522591137937,1.0,16/49,23.75%,NUP93;TRPM4;PIAS2;SAE1;PIAS3;EGR2;RANBP2;NUP153;IFIH1;NUP214;NUP188;NUP88;PIAS1;NUP98;AAAS;NUP54
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.41498371698568803,0.9907957927032084,0.46734397677793904,0.9042982994131341,1.0,9/29,13.39%,ISL1;ESR1;STRN3;KANK2;CBFB;DNAAF4;DDRGK1;KMT2D;UBA5
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.37451036187864506,0.9905231439946037,0.48672566371681414,0.9043073178793837,1.0,13/67,10.80%,CYFIP2;PGF;PTK2B;ABI1;SULF1;VAV2;NRP1;NCK2;ITGAV;RHOA;VEGFA;NCKAP1;ITGB3
prerank,regulation of transforming growth factor beta production (GO:0071634),0.445462379079243,0.9903873352092105,0.47435897435897434,0.9040058472592154,1.0,4/18,9.13%,ITGB8;FN1;ITGAV;CD46
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.4324851316836717,0.9899417627855794,0.4745508982035928,0.9044301923940546,1.0,2/22,1.56%,ANK2;ATP1B1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.40559739879202084,-0.9898888345384395,0.48621553884711777,0.8010156234865248,1.0,4/13,6.03%,NOS3;PPARA;TMSB4X;PPARGC1A
prerank,microtubule-based transport (GO:0099111),0.4821895646690043,0.9898446154144837,0.49230769230769234,0.9040431808067295,1.0,4/12,11.32%,DYNC1I1;SPAG17;CCDC40;DNAAF4
prerank,positive regulation of viral genome replication (GO:0045070),-0.34163143228529885,-0.9897451970055215,0.46153846153846156,0.8002175936249772,1.0,11/29,19.30%,PPARA;PPIA;TOP2B;HACD3;NR5A2;ADARB1;TARBP2;ADAR;IFIT1;PPIE;DDX3X
prerank,nervous system development (GO:0007399),0.32353724687185825,0.9895274280796436,0.5229357798165137,0.9041403541659913,1.0,56/429,10.66%,WWP1;CDH1;PCDHB16;DCLK1;CRIM1;MET;MBNL1;PKD1;ZIC4;HDAC4;NGF;RBFOX2;PDGFC;SMO;EFNA5;FN1;HES1;ZBTB16;GSN;INHBA;ZIC1;FGF13;FGF2;NOTCH2;GLRB;ECRG4;NELL1;PMP22;TGFBR1;NOG;GLIS2;STAT3;GDNF;JAG1;PCDHB13;NTN5;ELP3;TEAD1;DMBX1;SOX14;NBL1;SNTG2;DAGLB;NAGLU;GRHL2;PCDHB9;EGR2;PCDHB3;DACT1;NF1;BTBD3;PCDHA1;ADGRG6;VEGFA;NCKAP1;FARP1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.38955763116729725,0.9894928640181937,0.48433420365535246,0.9035847547302326,1.0,8/50,14.85%,NXN;ABL1;HDAC8;U2AF2;USP4;CHP1;GTPBP4;SQSTM1
prerank,regulation of T cell cytokine production (GO:0002724),0.46122238430318274,0.9893468488669347,0.4721311475409836,0.903276137203869,1.0,2/15,4.92%,CD55;TRPM4
prerank,regulation of organelle assembly (GO:1902115),0.3672228751924596,0.9884918270734268,0.47631241997439183,0.9047090150199278,1.0,23/72,20.37%,EZR;GSN;RABEP2;NPRL3;PDCD6IP;ATG3;RDX;KIF9;SPICE1;ATXN2;TBC1D2B;TBC1D13;TBC1D10A;STIL;SDCCAG8;TBC1D5;SGSM3;CEP295NL;TSG101;TBC1D17;ODAD3;RAB5A;NPRL2
prerank,aerobic respiration (GO:0009060),-0.368420903856117,-0.9884125016775684,0.44050632911392407,0.8024798540514635,1.0,10/20,29.41%,UQCRH;UQCR10;ME3;ATP5F1D;MTFR2;UQCRB;UQCRC1;SDHC;BLOC1S1;UQCRC2
prerank,establishment of protein localization to membrane (GO:0090150),0.37091269209410394,0.9883576427189302,0.47126436781609193,0.904386987205273,1.0,20/66,21.16%,EGFR;NECTIN3;ATG3;ZDHHC11;RAB3GAP2;FRMPD1;PARD3;ZDHHC15;VPS37A;ZDHHC2;GOLGA7;GORASP2;SEC63;ZDHHC20;VPS37B;ZDHHC23;RABGEF1;ZDHHC12;NPC1;AFDN
prerank,amyloid fibril formation (GO:1990000),-0.2980685767348693,-0.9881398093747364,0.4470588235294118,0.8019253113885463,1.0,11/51,13.17%,B2M;TSPAN5;HSPG2;CST3;ITM2B;APP;SNCA;MAPT;UBC;APH1B;MFGE8
prerank,regulation of neuron migration (GO:2001222),-0.3450925113660837,-0.988011461902349,0.46226415094339623,0.8010017021383377,1.0,9/26,12.00%,SEMA6A;CTNNA2;RAPGEF2;NEXMIF;DAB2IP;ADGRG1;CAMK2A;CAMK2B;MDK
prerank,negative regulation of developmental growth (GO:0048640),-0.33361667318850774,-0.9876491905606358,0.47318611987381703,0.8006213146912907,1.0,7/30,9.72%,NKD1;MAP2;DCC;PTCH1;MAG;RTN4;SEMA3G
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.4427867838280897,0.9874966342900235,0.4802527646129542,0.9058047540766406,1.0,2/21,3.39%,FOXP1;ELF1
prerank,negative regulation of gene expression (GO:0010629),0.3183844338564144,0.9873171269026932,0.5230769230769231,0.9055751094057984,1.0,63/302,17.09%,FOXP1;BMP4;SLC24A3;SAMD4A;ITGB8;SMO;HDAC9;IGFBP5;WWP2;KLF4;BMPR1A;FGF2;ZNF148;NOTCH2;PAIP2;ATP2B4;ESR1;SYNCRIP;CELF1;REL;MOV10;DXO;IL10;ID2;TNRC6C;ATOH8;NFKB1;RBMS3;CD46;AURKA;TOB1;VEGFA;SMCR8;NCOR1;CCL3;EED;CREB3L1;RB1;SNX12;DDRGK1;ZC3H12A;NCOR2;ANXA7;NPTN;ZC3H12D;DNMT3A;REST;SUZ12;CNOT7;MAP2K2;HINFP;ASB1;DIS3L2;NUDT12;XDH;AGO2;ADAM10;YY1;KAT2B;EPC1;NLRP12;CPNE1;EMILIN1
prerank,negative regulation of binding (GO:0051100),0.3618089253470105,0.9872053896025456,0.49573690621193667,0.9052205846926392,1.0,19/81,14.20%,SMO;PRKCD;GSK3B;LRPAP1;BTAF1;MDFI;KDM1A;SLPI;DISC1;DACT1;AURKA;JUN;DDX11;ITGB1BP1;WAPL;USP33;CARD16;GTPBP4;CSNK1E
prerank,calcium import into the mitochondrion (GO:0036444),0.5115371971867406,0.9872053492658036,0.4747826086956522,0.9045866767201654,1.0,5/10,25.55%,MCUB;MCU;MICU3;MICU1;MICU2
prerank,glycolytic process (GO:0006096),-0.3362942691721122,-0.9871763252276253,0.465625,0.8006301298176185,1.0,11/28,20.62%,GAPDH;PGAM1;PGAM4;PGM1;ALDOC;HK2;PFKM;ALDOA;ENO2;ENO1;PFKL
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4966853554318085,0.9867435368647821,0.5113438045375218,0.9050239709613985,1.0,5/11,9.61%,TGFBR1;TGFBR2;GDF6;ACVR1;USP15
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.3422391911418838,-0.9867333872317204,0.4398826979472141,0.8005752854444242,1.0,5/29,6.69%,RPS14;RPS21;RPS19;RPS8;RPS16
prerank,mRNA splice site selection (GO:0006376),0.4053682554648558,0.9866713534868847,0.4676470588235294,0.9045499693330542,1.0,5/30,7.58%,LUC7L2;SRSF5;SRSF6;CELF1;CELF3
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.49399262137877653,0.9865210469573066,0.5,0.9042693207294383,1.0,1/11,1.07%,SCARA3
prerank,regulation of trophoblast cell migration (GO:1901163),0.46395486387861906,0.9862518901368943,0.483974358974359,0.904245084227295,1.0,4/14,16.14%,ARHGDIB;TIMP1;VEGFA;AGO2
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.3031390670536135,-0.9862382036077117,0.46511627906976744,0.800716863288837,1.0,11/46,8.61%,NOVA1;ALDH1A1;LGR4;NOVA2;PLCL1;NOTCH1;NR1H3;MAP2K6;RBPJ;PLCL2;ACVR2B
prerank,mitotic DNA replication (GO:1902969),0.4984604176698926,0.9859966936688186,0.5131348511383538,0.9042129540691034,1.0,4/10,20.79%,MCM2;CDC45;GINS3;POLA1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.29789630420394053,-0.9856823195762993,0.4940239043824701,0.8008551919230705,1.0,21/54,16.10%,APOE;PRKD1;NOS3;AKT3;ETS1;KDR;TMSB4X;MEF2C;HIF1A;GATA2;ANGPT2;ATP5F1B;RGCC;PRCP;NUS1;PLCG1;ATP5F1A;VASH1;ACVRL1;AKT1;CD40
prerank,protein alkylation (GO:0008213),0.4365401845080681,0.9852803768636584,0.4852941176470588,0.9052301675469224,1.0,11/22,27.59%,PRMT8;ETF1;GSPT1;PCMT1;METTL22;ETFBKMT;EEF1AKMT1;METTL21A;PRMT2;METTL21C;FAM98A
prerank,"DNA-templated transcription, termination (GO:0006353)",0.3657268880765983,0.9849846006932591,0.484394506866417,0.9052715223051371,1.0,33/68,32.89%,POLR1G;MNAT1;SCAF8;POLR1A;TTF2;TAF1D;TAF1C;TTF1;LSM11;POLR1F;ERCC3;POLR3K;MAZ;PRMT5;FIP1L1;CSTF1;UBTF;NUDT21;ERCC2;CPSF7;CPSF3;GTF2H3;POLR1H;NCBP2;CLP1;CPSF4;CDK7;SMN1;CSTF2T;POLR1C;CSTF3;SSU72;MTERF2
prerank,glycolipid metabolic process (GO:0006664),0.38902546400883103,0.9847156594952015,0.4830393487109905,0.9052804566087971,1.0,4/47,4.97%,ST3GAL4;ESYT3;HEXA;ESYT2
prerank,regulation of small molecule metabolic process (GO:0062012),-0.3292449614578421,-0.9841535467851162,0.4503311258278146,0.8035268384058993,1.0,3/28,2.98%,APOE;PPARA;PDK1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.33768061657296145,-0.9837178751376155,0.45768025078369906,0.8034524830839886,1.0,10/29,17.95%,APOE;PPARA;LPGAT1;NR1H3;ZBTB20;MFSD2A;SCARB1;AKT1;NR1H2;SLC27A1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.504976999350174,0.9835563592596845,0.4826989619377163,0.9074101858631571,1.0,2/10,6.08%,DSE;XYLT1
prerank,regulation of cellular response to heat (GO:1900034),0.3603100535657014,0.9835399658163788,0.4775561097256858,0.906818663070907,1.0,21/77,18.23%,CAMK2D;GSK3B;NUP93;CREBBP;HSPA1L;ATM;MLST8;RANBP2;HSPB8;NUP153;CHORDC1;SEC13;MTOR;BAG3;EP300;MAPKAPK2;NUP214;NUP188;RPA1;ATR;NUP88
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.4879861626027992,0.9834493218329675,0.5073891625615764,0.906401639828522,1.0,3/12,5.55%,ATP1B1;WNK1;DMD
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.3250761463761643,-0.9834351457804412,0.48172757475083056,0.8029601454532755,1.0,17/33,25.51%,TGFA;DGKD;CCDC88A;AFAP1L2;ADRA2A;HIP1R;HBEGF;HIP1;CNOT9;AGT;AKT1;NUP62;GPER1;PLAUR;PDE6G;DOK1;HAP1
prerank,regulation of wound healing (GO:0061041),0.3947518191214244,0.9832778702770942,0.4847222222222222,0.9061730961333059,1.0,7/42,6.68%,CD109;ANXA1;ITGB1;FGF2;PRKCE;DMTN;SRSF6
prerank,regulation of protein secretion (GO:0050708),0.34734750001862047,0.9832308940882828,0.5244186046511627,0.9056725315406791,1.0,15/119,7.58%,SLC12A2;CACNA1C;EZR;TGFB3;DISP1;ADAM9;KCNS3;KCNB1;BMP6;UNC13B;RAP1A;SYTL4;ITPR2;GOLPH3;P3H1
prerank,cellular protein localization (GO:0034613),0.32259339655621544,0.9831555249174001,0.5239085239085239,0.9052278072421129,1.0,68/285,19.14%,EGFR;ANK2;CSRP3;PTPRU;WNT11;SGSM2;KIF13A;CNTLN;STX11;TLK1;ID1;RAB43;TMED5;RAB6A;HERC2;AP3B1;WIPI2;STX5;VCL;DMD;RIC3;GRTP1;ARF3;RRAGB;RAB3GAP2;NSF;AP2A1;STX8;EIF2D;EHD1;COPA;TBC1D2B;CTTN;TBC1D13;SEC31A;ARF4;ZDHHC15;ARCN1;NIPBL;STX19;TBC1D25;USP4;COG3;SEC13;SMURF1;RAB24;TBC1D8B;NPHP1;TBC1D10A;GGA2;ARFIP1;ARFIP2;ARFGAP3;PIGU;SEC23IP;TBC1D5;SAR1B;SGSM3;SNX31;SCFD2;RAB21;AP4M1;AP3D1;RAB5B;USO1;SNX8;TBC1D17;SNX13
prerank,proteasomal protein catabolic process (GO:0010498),0.3299549257219432,0.9830232715326594,0.5190839694656488,0.9048974933884456,1.0,33/201,15.73%,WWP1;NEDD4;UBE4B;WWP2;NFE2L2;DDI2;RNF185;VCP;KLHL22;UBE2B;TBL1X;DDIT3;PSMB2;UBE2D3;RNF126;FBXW11;FEM1B;RAD23B;PSMC6;PPP2R5C;SPSB2;MTA1;COP1;RNF122;SMURF1;PSMD11;CUL3;ERCC8;SPOP;APPBP2;PSMD1;UBE2K;PML
prerank,peptidyl-tyrosine modification (GO:0018212),0.37855638886291426,0.9828506111030151,0.4665809768637532,0.9046684788601312,1.0,7/56,4.25%,EGFR;PTK2B;ABI1;DDR2;FGFR1;ABL1;EFEMP1
prerank,bile acid metabolic process (GO:0008206),-0.3275761681069459,-0.9826715780309316,0.49696969696969695,0.8037052063588501,1.0,7/27,21.44%,CYP7B1;CYP27A1;OSBPL1A;SCP2;CH25H;OSBPL7;SLC27A2
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3511301242223991,0.9822349295585031,0.5006002400960384,0.9054810923891038,1.0,18/98,12.46%,EGFR;KCNB1;SORBS1;ITGB1;PRKCE;ATP2B4;LRP1;PLS1;DLG1;AGR2;C2CD5;ERBB2;ITGB1BP1;RANGRF;MIEF1;PTPN9;PPP3CC;CHP1
prerank,negative regulation of angiogenesis (GO:0016525),0.35886359659215655,0.9822047439497117,0.5201900237529691,0.9049241727329677,1.0,8/84,5.23%,THBS1;SLC12A2;HOXA5;SEMA3E;SULF1;KLF4;ISM1;ATP2B4
prerank,hepaticobiliary system development (GO:0061008),0.4429196877044923,0.9816529011991612,0.49768875192604006,0.9056227206022412,1.0,5/20,11.69%,MET;COBL;NF1;PRKCSH;NIPBL
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3198275687822134,0.9813297404408797,0.5521472392638037,0.9057497319477652,1.0,46/390,6.99%,EGFR;ARHGEF28;MET;CYFIP2;NTRK3;NGF;PGF;RBFOX2;PDGFC;PTK2B;EFNA5;ABI1;DDR2;SIPA1L1;SULF1;GRB10;VAV2;ADRB2;UBASH3B;FGFR1;SHC1;SORBS1;ATP6V0A4;GSK3B;FGF2;SLC39A14;IRS1;AP2A2;FOXC2;POLR1G;NRP1;SPRED2;NR4A3;SHOC2;PTPN2;NCK2;NFATC4;FRK;STAT3;ITGAV;FLRT2;RHOQ;EPHB3;ROR1;IDE;HNRNPH1
prerank,insulin secretion (GO:0030073),0.4401192825820783,0.9813047186131355,0.4748427672955975,0.905193067215488,1.0,4/19,13.27%,ANXA1;CLTRN;SNX19;SELENOT
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4431815320261487,0.9809469001973607,0.49614791987673346,0.9054056673881108,1.0,6/20,14.92%,SMAD9;NFE2L2;CARF;VEGFA;EP300;RUNX2
prerank,calcium ion homeostasis (GO:0055074),0.35032815782893517,0.9806250161807191,0.5072992700729927,0.905562458801303,1.0,19/95,14.30%,SLC24A3;ANK2;ATP1B1;ATP2C2;CSRP3;STIM2;ATP2B4;SLC10A7;CASR;FAM20A;DRD3;TNNI3;CCL3;CCL1;SLC8B1;CCL7;RMDN3;NPTN;HTR2B
prerank,nuclear pore complex assembly (GO:0051292),0.48951366960905285,0.9806247428660102,0.4983164983164983,0.9049395044458878,1.0,5/10,22.91%,NUP93;NUP153;AHCTF1;NUP98;TMEM170A
prerank,dicarboxylic acid metabolic process (GO:0043648),0.3750742285035556,0.9806215136858605,0.4800531914893617,0.9043273582081925,1.0,10/52,19.93%,ME1;GCLC;ACOT8;FPGS;FOLR2;OGDH;NIT2;SLC19A1;SLC25A32;D2HGDH
prerank,histone H4-K16 acetylation (GO:0043984),0.4451641398619913,0.9803505463189375,0.4848024316109423,0.9043616907666475,1.0,10/19,27.65%,KANSL2;KANSL3;KANSL1;MSL1;HCFC1;PHF20;OGT;MCRS1;JADE2;KMT2A
prerank,UV-damage excision repair (GO:0070914),0.48138870989160143,0.9798954467765074,0.5060240963855421,0.9048041015446308,1.0,7/12,31.02%,XPA;INO80;ERCC1;POLA1;POLD3;XPC;CUL4B
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.4195390512439927,0.9796002563829458,0.4775888717156105,0.9048791986678996,1.0,9/22,23.57%,WDR43;DDX11;ERBB2;SMARCA4;MTOR;NOL11;EIF2AK3;WDR75;UBTF
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.35037944698300955,-0.9795891487483839,0.48265895953757226,0.8091017372203025,1.0,4/23,14.97%,BCL2;TFDP2;YWHAB;PPP3R1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.35037944698300955,-0.9795891487483839,0.48265895953757226,0.8091017372203025,1.0,4/23,14.97%,BCL2;TFDP2;YWHAB;PPP3R1
prerank,myoblast fusion (GO:0007520),0.48878040583606186,0.9787305385180277,0.5163511187607573,0.9063122707838673,1.0,3/12,6.00%,CD9;ADAM12;ADAMTS5
prerank,nuclear export (GO:0051168),0.36302590192323114,0.9786395316494386,0.5019305019305019,0.905910945840679,1.0,38/80,27.79%,PKD1;XPO1;SRSF11;THOC2;SRSF5;SRSF6;EGR2;U2AF2;STRADA;DESI1;NUP153;CHP1;SRRM1;SMURF1;CASC3;NUP214;CHTOP;NUP188;XPO4;U2AF1L4;SRSF2;THOC5;ZC3H11A;NXF1;RAN;WASHC4;NUTF2;XPO7;CDC40;RITA1;UPF3B;SRSF3;TGFB1;RBM8A;RAE1;ALYREF;NUP155;NCBP2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.396646869128295,0.9785465874806804,0.49130434782608695,0.9055264512942474,1.0,8/39,12.38%,EGFR;PTPN3;RNF115;PTPN2;CBLC;RNF126;ERBB2;EPS15L1
prerank,water transport (GO:0006833),-0.4189216911756984,-0.9781547244861635,0.4784688995215311,0.8114021445402089,1.0,2/12,7.82%,AQP11;AQP4
prerank,protein mannosylation (GO:0035268),0.4268084538579436,0.9778730938052871,0.49255952380952384,0.9064213768820374,1.0,6/22,16.32%,TMTC1;LARGE1;B4GAT1;DPM1;LARGE2;POMGNT2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3972054826495534,0.977513968020481,0.4664804469273743,0.9066972743983274,1.0,8/36,8.56%,TCF7L2;PPP3CA;WNT11;PLCB3;PDE6A;MOV10;TNRC6C;NLK
prerank,myeloid cell differentiation (GO:0030099),-0.3022876581483569,-0.9774675143872106,0.506896551724138,0.811923937521743,1.0,7/47,8.25%,LYN;MFHAS1;KIT;SNRK;RPS14;RPS19;TAL1
prerank,GTP metabolic process (GO:0046039),0.46399696607756197,0.9774165459972567,0.5121951219512195,0.9063243331425214,1.0,5/15,20.32%,RHOQ;ENTPD7;AK4;AK3;RAN
prerank,regulation of interferon-beta production (GO:0032648),0.39034516528243196,0.9772658809730744,0.4951590594744122,0.9060591988332192,1.0,15/46,19.21%,POLR3D;MAVS;RIPK2;IRF1;REL;TLR4;IFIH1;DHX9;RNF135;TLR8;YY1;POLR3A;POLR3F;PTPRS;TRAF3
prerank,keratan sulfate biosynthetic process (GO:0018146),0.41423867324051244,0.9772001180121019,0.4767616191904048,0.9055962037364528,1.0,4/26,6.56%,ST3GAL4;B3GNT2;CHST5;B4GALT1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.4521588398463135,0.9770132768987235,0.4813008130081301,0.9054101765629714,1.0,9/15,35.33%,ZC3H12A;ZC3H12D;ZC3H12C;LACTB2;DICER1;ZC3H12B;NYNRIN;POP1;RNASEH1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.3477453592478608,-0.9766418466263702,0.48746518105849584,0.8127376215241895,1.0,6/24,5.82%,VTN;EPN2;PRKCB;TMEM204;DAB2IP;HIF1A
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.3891447503981041,0.9762881047118461,0.48746518105849584,0.906416345318258,1.0,8/46,6.25%,TMEFF2;FN1;PARVA;NRP1;SRGAP2;ANTXR1;ITGAV;EPHB3
prerank,glycoprotein metabolic process (GO:0009100),0.3722847284643241,0.9762507606795219,0.5019815059445178,0.9058921035833415,1.0,19/53,20.77%,ST3GAL4;FUT8;LARGE1;GOLPH3;PRKCSH;FBXO17;MAN2A1;TNIP1;GANC;ST3GAL2;HPSE;OGA;ST8SIA2;GAL3ST4;MAN2B1;GANAB;B4GALT7;ENGASE;B3GNT6
prerank,cellular response to ionizing radiation (GO:0071479),0.3821983199973038,0.975779844816389,0.5113788487282463,0.9063759848925224,1.0,14/47,17.91%,TANK;KDM1A;WRN;ATM;NIPBL;SPIDR;XRCC5;KDM4D;TLK2;TNKS1BP1;ATR;INO80;CDKN1A;RAD51
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.32586384772158816,-0.9757523913078628,0.4642857142857143,0.8137363468043579,1.0,6/32,12.16%,DEFA6;PGLYRP1;RPS19;RPL30;GAPDH;RPL39
prerank,positive regulation of actin nucleation (GO:0051127),0.48368859518167223,0.9757365361615247,0.49072512647554806,0.9058637326740855,1.0,6/11,25.61%,GSN;NCKAP1;FCHSD2;WHAMM;BRK1;CYFIP1
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.3005377303771331,-0.9756842897001946,0.4925925925925926,0.812672956769053,1.0,7/48,13.08%,PDE4B;IL1R1;SLC7A5;PDE4D;IL18;TLR7;TLR3
prerank,leukotriene biosynthetic process (GO:0019370),-0.39712433755003046,-0.9755283908880823,0.5088607594936709,0.8118550335582737,1.0,7/14,25.60%,GGT5;LTA4H;GGT1;GGT7;PLA2G5;ALOX5AP;MGST3
prerank,regulation of axonogenesis (GO:0050770),0.3826642571344012,0.9754503663359921,0.5054347826086957,0.9059071845017062,1.0,8/51,8.86%,SLIT2;NGF;SIPA1L1;GSK3B;TIAM2;EPHB3;MARK2;RHOA
prerank,GPI anchor biosynthetic process (GO:0006506),0.41184675313444596,0.9754153767262163,0.4970501474926254,0.905381204122374,1.0,14/30,26.32%,PGAP2;PIGB;DPM1;PIGU;PIGL;GPAA1;PIGN;PIGT;PIGH;PGAP3;PIGQ;MPPE1;PIGK;PIGA
prerank,positive regulation of neurogenesis (GO:0050769),0.36554319600046814,0.974886225910457,0.5152671755725191,0.9059897015269234,1.0,8/68,8.88%,SLIT2;NGF;CUX1;TIAM2;FBXW8;KDM1A;RHOA;DISC1
prerank,mitotic nuclear division (GO:0140014),0.3641808977582035,0.9748451519394108,0.49047013977128334,0.9054608737409665,1.0,24/71,23.69%,SMC4;NDEL1;KLHL22;MISP;PPP2R2D;TOGARAM1;CHEK2;ARHGEF10;RHOA;SPICE1;SMC1A;PIBF1;UBE2S;STAG2;KIF3B;KNSTRN;INO80;STAG1;ZW10;RAN;OFD1;FLNA;AAAS;CHMP4B
prerank,cell cycle G2/M phase transition (GO:0044839),0.33267582695775827,0.9748088096153097,0.5028702640642939,0.9049278590570476,1.0,39/129,23.42%,FBXL7;CCNA2;PPP1R12B;SFI1;PAFAH1B1;MNAT1;PCM1;CDC25B;CEP164;CHEK2;PLK3;FBXW11;CEP63;AURKA;AKAP9;PPP1R12A;CEP131;FBXL6;CSNK1E;SDCCAG8;CUL1;CEP43;HAUS2;CEP57;KHDRBS1;CDKN1A;CEP70;CSNK1D;FBXL8;ARPP19;WEE1;OFD1;CNTRL;FBXL17;HAUS5;AKAP8L;PLK4;CDK2;CCNB1
prerank,negative regulation of chemokine production (GO:0032682),-0.39672704626210875,-0.974680681913276,0.4723618090452261,0.8127248065368774,1.0,3/14,6.36%,APOD;SIRPA;C1QTNF3
prerank,regulation of protein kinase C signaling (GO:0090036),-0.39604222977722653,-0.9745372842725852,0.4897435897435897,0.8119064760791953,1.0,8/14,20.41%,ADGRV1;WNT5A;DGKD;DGKG;FLT4;CD40;MYADM;SPHK2
prerank,protein secretion (GO:0009306),0.37354968228799695,0.9744649224597047,0.4961139896373057,0.9050999272043905,1.0,6/56,9.08%,PCSK5;ANXA1;TANGO6;LTBP2;GOLPH3;SNX19
prerank,error-prone translesion synthesis (GO:0042276),0.42871009902728635,0.9744219312319014,0.5015822784810127,0.9045895695345585,1.0,9/21,29.24%,REV3L;POLE2;RPA1;RFC1;REV1;RFC5;POLK;POLI;PRIMPOL
prerank,transport along microtubule (GO:0010970),0.48055903715803233,0.9742908643696061,0.49663299663299665,0.904279877301759,1.0,5/13,14.82%,ARHGAP21;SPG11;DYNC1I1;BAG3;COPG1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.2847454584267135,-0.9742555055791686,0.4798206278026906,0.8113883067986591,1.0,4/59,2.50%,ALDH1A2;CYP7B1;CYP27A1;GATM
prerank,regulation of potassium ion transport (GO:0043266),0.4107050950309278,0.9741028543041901,0.49712643678160917,0.9041201340665675,1.0,3/31,1.68%,FHL1;ANK2;PTK2B
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.2543107986527049,-0.9737651602902917,0.5203252032520326,0.8114979125291518,1.0,20/109,14.51%,PLCB1;INPP4B;PIK3R1;PDGFRB;PIP5K1B;LPGAT1;INPP5D;PLEKHA2;PIK3C2A;PIK3R6;BMX;PLEK;INPP5F;MTMR10;PTPN13;PLCG1;PIK3R5;CDIPT;CSF1R;PIP5K1C
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.31031843049665897,-0.9735441849849528,0.48880597014925375,0.8108884272608288,1.0,13/39,21.48%,MYO1B;PPFIA2;FNBP1L;MYO6;MYO5A;BICDL1;ACTN4;KIF1A;MYO5C;MYO1F;WASL;SYT4;TRAK2
prerank,regulation of inflammatory response (GO:0050727),0.32907355661990456,0.9735037027104958,0.5305676855895196,0.9048844121601519,1.0,29/190,12.67%,FOXP1;CCN3;ANXA1;MGLL;PRKCD;GPR4;PTGIS;KLF4;PIK3AP1;AGTR1;PDCD4;PTPN2;IL17RA;ISL1;RORA;CELF1;IFI35;IL10;DAGLB;TLR4;IL33;NLRP6;SHPK;CCL3;CCL1;MYD88;RB1;TNFRSF1B;TNIP1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3757090271582942,0.9731819474174576,0.5066844919786097,0.9050433680648398,1.0,10/47,12.36%,SIX1;ZBTB16;CMKLR1;TRPM4;ZBTB7B;ID2;CDS1;SYAP1;LRP5;ZC3H12A
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3586382730578963,0.9731376439589154,0.5055762081784386,0.9045410475051585,1.0,6/75,4.50%,PLCE1;GRK5;MGLL;SLC39A14;MRAP;PDE6A
prerank,microtubule nucleation (GO:0007020),0.4315413754508884,0.9730311543717662,0.48966613672496023,0.9041446295005413,1.0,7/19,19.65%,NDEL1;AKAP9;SLAIN2;TUBGCP6;TUBGCP5;TUBGCP4;CSNK1D
prerank,positive regulation of biosynthetic process (GO:0009891),0.3916991415989275,0.9729845862298775,0.514367816091954,0.9036366285850277,1.0,3/40,3.04%,BMP4;TGFB3;SORBS1
prerank,negative regulation of developmental process (GO:0051093),0.3620001137703597,0.9726560087680312,0.5208070617906684,0.9037785990392427,1.0,5/69,3.98%,BMP4;NFIB;SOX9;WNT11;KLF7
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.3146150035026811,-0.9723076008620349,0.4852459016393443,0.8127892794243338,1.0,5/32,10.33%,CDK14;CDK17;TFDP2;CDK15;BACH1
prerank,cellular response to lipid (GO:0071396),0.32427789348611114,0.9721992678815298,0.521311475409836,0.9042075967702359,1.0,25/191,9.58%,EGFR;WNT9A;SOX9;LBP;PTK2B;PID1;ADAM9;WNT11;FZD7;IRS1;PDCD4;CD80;ESR1;RORA;LCOR;MYOG;IL10;TLR4;CXCL2;RHOA;NFKB1;ATP1A3;ATP1A1;ATM;SHPK
prerank,mRNA destabilization (GO:0061157),0.3862421212967724,0.9719954172822709,0.5042372881355932,0.9040668315495864,1.0,15/38,24.47%,FTO;CELF1;MOV10;ZC3H12A;ZC3H12D;TUT7;PUM1;DIS3L2;TUT4;DHX36;YTHDF2;TARDBP;YTHDF3;RC3H2;ROCK1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.4009111075395354,0.9718655785634919,0.5240715268225584,0.9037817978049775,1.0,3/36,5.23%,EGFR;NPR3;ATP2B4
prerank,regulation of cellular component organization (GO:0051128),0.33972861566982493,0.9712221159155643,0.5243488108720272,0.9046228835583748,1.0,19/135,9.55%,PLCE1;SNCAIP;MLLT3;NEDD4;CAMK2D;STON1;ABL1;STON2;FAM107A;AGTR1;RAP1A;SGK3;LTBP4;SOCS2;ANGPTL7;RUFY1;DCUN1D5;IRAK3;AURKA
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.4369895376422043,0.9709661860149947,0.496875,0.9045979502451613,1.0,2/19,3.61%,THBS1;CMKLR1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4070596093378651,0.9708028961924091,0.4897959183673469,0.9043533343511297,1.0,3/33,4.65%,EZR;UBASH3A;PTPN2
prerank,glycerophospholipid metabolic process (GO:0006650),-0.26913359700260525,-0.9707764833403718,0.5230769230769231,0.815325806468933,1.0,10/75,9.54%,PLCB1;GPCPD1;PDGFRB;PLA1A;SERINC5;ENPP6;ABHD12;SERINC1;ABHD3;PLEK
prerank,T cell mediated immunity (GO:0002456),0.4808327673627225,0.9707745108750484,0.5056910569105691,0.9038084383466757,1.0,4/13,9.13%,CD55;GNL1;JAG1;CD46
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.46688008587455593,0.9706911800960893,0.511265164644714,0.903399940331979,1.0,2/13,5.02%,SIX1;ZBTB7B
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.47524925977051646,0.9700768126913131,0.5108877721943048,0.9042135632442023,1.0,3/12,15.88%,PAICS;PFAS;GMPS
prerank,response to lipopolysaccharide (GO:0032496),0.3296886184955651,0.9699097972485542,0.5306818181818181,0.9039926709759681,1.0,28/138,17.70%,FOXP1;LBP;ADAM9;SMAD6;PDCD4;CD80;SLPI;IL10;TLR4;CXCL2;RHOA;NFKB1;IRAK3;ERBIN;SHPK;TRIM41;MYD88;ZC3H12A;CARD16;TNFRSF1B;CTR9;SBNO2;MAPKAPK2;OTUD5;ACOD1;CYP27B1;BCL10;PALM3
prerank,positive regulation of ruffle assembly (GO:1900029),-0.40105117471459695,-0.9697972327956658,0.4975728155339806,0.8166603861259036,1.0,2/13,5.70%,EPS8;EPS8L2
prerank,vesicle coating (GO:0006901),0.3722650174384041,0.9690279463968249,0.5164835164835165,0.9041320135457898,1.0,24/61,20.99%,SEC24B;STX5;SEC16A;NSF;SEC23A;ANKRD28;PPP6R3;SEC31A;CNIH2;SEC13;SEC24D;CUL3;TRAPPC10;SEC22B;SEC23IP;SAR1B;USO1;CSNK1D;PPP6C;SEC24A;TRAPPC3;RAB1A;BET1;PPP6R1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3722650174384041,0.9690279463968249,0.5164835164835165,0.9041320135457898,1.0,24/61,20.99%,SEC24B;STX5;SEC16A;NSF;SEC23A;ANKRD28;PPP6R3;SEC31A;CNIH2;SEC13;SEC24D;CUL3;TRAPPC10;SEC22B;SEC23IP;SAR1B;USO1;CSNK1D;PPP6C;SEC24A;TRAPPC3;RAB1A;BET1;PPP6R1
prerank,COPII vesicle coating (GO:0048208),0.3722650174384041,0.9690279463968249,0.5164835164835165,0.9041320135457898,1.0,24/61,20.99%,SEC24B;STX5;SEC16A;NSF;SEC23A;ANKRD28;PPP6R3;SEC31A;CNIH2;SEC13;SEC24D;CUL3;TRAPPC10;SEC22B;SEC23IP;SAR1B;USO1;CSNK1D;PPP6C;SEC24A;TRAPPC3;RAB1A;BET1;PPP6R1
prerank,response to unfolded protein (GO:0006986),-0.2912378391889685,-0.9690027678638686,0.5271966527196653,0.8174636754792969,1.0,13/48,20.63%,HSPA8;DAB2IP;OPTN;ERN1;HSP90AB1;STT3B;TMBIM6;HSPA13;DNAJB5;PACRG;HSPB1;HSPA9;HSPE1
prerank,Ras protein signal transduction (GO:0007265),0.3375699845614368,0.968978922079579,0.5276211950394588,0.9036428960244375,1.0,26/137,12.11%,PLCE1;NTN1;CDC42EP5;CCNA2;ARHGDIB;NRAS;KRAS;MRAS;SHC1;FGF2;AGTR1;RAP1A;SHOC2;SHTN1;RAPGEF6;RAP2C;RHOA;G3BP2;ARHGAP5;NF1;GNA13;NCKAP1;JUN;TIAM1;RB1;RIT1
prerank,negative regulation of metabolic process (GO:0009892),-0.2874302260218845,-0.9689360478885938,0.5022222222222222,0.8164242667859891,1.0,11/54,8.61%,NOVA1;ALDH1A1;LGR4;NOVA2;PLCL1;NOTCH1;NR1H3;MAP2K6;RBPJ;PLCL2;ACVR2B
prerank,positive regulation of autophagy (GO:0010508),-0.2674106900578398,-0.9688914853955878,0.5303030303030303,0.8153143461048025,1.0,9/81,5.92%,RNF152;PRKD1;FOXO1;DCN;KDR;TRIM14;PRKAA2;PIK3C2A;OPTN
prerank,cochlea morphogenesis (GO:0090103),0.49713542526538046,0.9683439235707632,0.5093696763202725,0.9044661902287634,1.0,1/10,1.12%,SOX9
prerank,glycoprotein biosynthetic process (GO:0009101),0.35490864233798014,0.9679008393207813,0.5111940298507462,0.9048746043223329,1.0,20/79,18.08%,ST3GAL4;B3GNT2;CHST13;LARGE1;FOXL1;GCNT2;XYLT1;GOLPH3;MPI;B3GALT6;CHST11;COG3;TNIP1;MGAT1;ST3GAL2;DDOST;B3GNT9;CHST12;ST8SIA2;GAL3ST4
prerank,detection of visible light (GO:0009584),0.45275023829223493,0.9678980050987311,0.5180533751962323,0.9042772607337813,1.0,2/16,7.40%,RP1;CACNA1F
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.4535118541838228,0.9678709621303055,0.48976109215017066,0.9037219669265054,1.0,3/13,9.52%,DDX5;SPRED2;ATM
prerank,organelle organization (GO:0006996),0.31392190952125615,0.9675940176789903,0.5686868686868687,0.9037280983581374,1.0,70/388,16.34%,MICAL2;PLCE1;ABCD3;FMNL2;MARK1;ARHGAP21;ARHGAP10;STRIP2;ATL3;CXADR;VPS13C;PNPLA3;GOLGB1;DIAPH1;RAB43;TMED5;ATL2;BCAS3;FBXW8;SPTSSB;PDCD6IP;RAB30;LMAN2L;GAK;TMEM135;GOLPH3;DOP1B;DMTN;GBF1;CSNK1A1;GABPB1;SEC16A;FGD6;KIF9;ATP8B1;VPS13D;PLEKHM2;PCLO;HILPDA;NRF1;SEC31A;SPRYD3;MAST2;MTX2;CCL3;LONP2;ZMYM4;MTFR1;SEC61A1;SH3D19;COG3;WDR81;PPRC1;MTX3;CCL7;ZRANB1;YME1L1;HCFC1;NPLOC4;POLG2;TRIP11;GORASP2;NCKIPSD;BRWD1;CENPT;FAM161B;SEC23IP;FAM161A;SAR1B;TTC17
prerank,protein modification process (GO:0036211),0.3516142215217011,0.9674580923821136,0.5253164556962026,0.9034417050149124,1.0,28/76,23.47%,PLOD2;WWP2;ABL1;PHKA2;PHEX;ATG3;TGM3;CSNK1G3;UBE2D3;RIPK3;USP25;YES1;PRKDC;PPP4R2;UBE2S;BAP1;TGM1;GNMT;ST8SIA2;LOX;MAN2B1;TGM5;B4GALT7;PARP4;UBE2M;PIGH;FBXO11;GGCX
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.3578705159563691,0.9674236968622016,0.5141104294478528,0.902929245441151,1.0,8/72,6.99%,RBFOX2;FGFR1;FGF2;SPRED2;SHOC2;NOG;FLRT2;HNRNPH1
prerank,cellular copper ion homeostasis (GO:0006878),-0.3986571922074046,-0.9673904476250569,0.5024752475247525,0.8179401459527492,1.0,7/14,25.56%,APP;ATOX1;MT2A;SLC31A1;ATP7A;COX19;ABCB6
prerank,positive regulation of JNK cascade (GO:0046330),0.356228452436924,0.9668789872389403,0.5122850122850123,0.9035695211127511,1.0,6/70,5.68%,RASSF2;MAP3K5;PTK2B;FZD7;WNT16;GADD45G
prerank,positive regulation of TOR signaling (GO:0032008),0.3851712558122563,0.9667204974917595,0.49859943977591037,0.9033338294239204,1.0,9/40,12.61%,TELO2;KLHL22;CLEC16A;GOLPH3;RRAGB;SIK3;MLST8;SMCR8;SEC13
prerank,cardiac muscle contraction (GO:0060048),0.40185505113005915,0.9664812460233615,0.5289747399702823,0.9032689748260826,1.0,5/34,5.55%,ATP1B1;CAMK2D;CSRP3;GSN;DMD
prerank,ear morphogenesis (GO:0042471),0.43980105713545964,0.9658295934619817,0.49149922720247297,0.9040918516164412,1.0,3/20,5.56%,SIX1;ZIC1;NOG
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.46445285304035244,0.965728060991307,0.5129533678756477,0.9037277033804314,1.0,5/12,20.13%,TCERG1;RNF168;NELFE;RECQL5;RNF8
prerank,regulation of cell-substrate adhesion (GO:0010810),0.38630343060759414,0.9656663371628643,0.49594594594594593,0.9032683502689142,1.0,8/42,9.53%,VIT;FZD7;GCNT2;DMTN;AGR2;RHOA;NF1;LIMS1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.4824821692482096,0.965357921569459,0.506993006993007,0.9033403156745214,1.0,2/11,12.36%,ANXA1;ZC3H12A
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.4180276800656879,-0.9652466647090622,0.49612403100775193,0.8221338276946724,1.0,2/11,1.98%,SLC30A10;PPARA
prerank,iron ion homeostasis (GO:0055072),-0.2819693657140008,-0.9651423606140546,0.5412844036697247,0.821199458945174,1.0,11/58,12.97%,CP;B2M;PICALM;FTH1;TFRC;SLC40A1;FTL;ABCB7;BOLA2;ATP6AP1;SLC22A17
prerank,response to organonitrogen compound (GO:0010243),0.39155881058828196,0.9644175341860829,0.49213161659513593,0.9048606083662429,1.0,6/38,13.21%,GLRB;RNF185;VCP;DRD3;IRAK3;MTOR
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.33853446572230694,-0.9632113754389466,0.4868804664723032,0.8248940389140564,1.0,7/24,24.99%,DACH1;RPS3;BLM;ACVRL1;H1-0;DFFA;TERF2IP
prerank,response to tumor necrosis factor (GO:0034612),0.3487469707536151,0.9631099637092478,0.5291970802919708,0.907219268701438,1.0,17/91,16.21%,PID1;TANK;ADAM9;AFF3;YBX3;NFE2L2;CHUK;ERBIN;CCL3;CCL1;ZC3H12A;CCL7;TRADD;DHX9;ZFAND6;ADAM10;ACOD1
prerank,phosphorylation (GO:0016310),0.31179473647090844,0.9629759480166356,0.581799591002045,0.9069196985901629,1.0,75/384,14.99%,STK39;DCLK1;MAP3K5;GRK5;MARK1;PTK2B;CAMK2D;WNK1;PRKCD;WNT11;FGFR1;LIMK2;HIPK1;BMPR1A;GSK3B;TLK1;PRKCE;NEK7;ABL1;BCR;TGFBR1;CLK2;MKNK2;SGK3;TGFBR2;FRK;STAT3;CDK12;BIRC6;CDC25B;IKBKE;FAM20A;DGKA;MARK2;CSNK1A1;CHEK2;NLK;CHUK;AAK1;SIK3;IRAK3;ATM;AURKA;SHPK;ACVR1;RARA;TOP1;PIM2;MARK3;SIK2;ERN2;MORC3;STRADA;MAST2;ERBB2;NADK;CDKL2;CSK;PRKDC;PDK3;MTOR;PKN2;PAK2;CHEK1;PRKCA;AGK;CDC42BPG;DYRK2;CSNK1E;EIF2AK4;HTR2B;CDK11B;PPP4R1;CDK16;MAPKAPK2
prerank,response to thyroid hormone (GO:0097066),-0.3929466942208577,-0.9628494226725968,0.5244215938303342,0.8246155951490728,1.0,6/13,14.55%,CTSH;LMO2;CTSB;CTSS;CTSL;MED1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3689194413327643,0.9616794016046535,0.508,0.909200998089016,1.0,17/48,21.36%,HIPK1;ABL1;IKBKE;CHEK2;ATM;CDIP1;TNFRSF1B;PRKDC;EP300;DYRK2;PML;CASP2;USP28;MOAP1;E2F1;SNW1;MCL1
prerank,regulation of protein dephosphorylation (GO:0035304),-0.30630156740757825,-0.9616504440710817,0.527027027027027,0.8263702290534634,1.0,10/37,14.86%,MFHAS1;PPP1R16B;CALM1;PPIA;YWHAB;TIPRL;PPP2R5A;HSP90B1;CALM3;SMPD1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.43275055618309566,0.9615748319487427,0.5132605304212169,0.9088004427465629,1.0,3/20,6.52%,MET;MRAP;ADA
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.41140840115181,0.9615316482072293,0.5389048991354467,0.9083078908206276,1.0,7/30,15.74%,FHIT;GIPC1;WAC;USP7;DDRGK1;TRIM39;TLK2
prerank,regulation of insulin secretion (GO:0050796),0.3400792373224522,0.9614424698333436,0.5234093637454982,0.9079016520486616,1.0,20/101,14.94%,CCN3;TCF7L2;CACNA1C;EFNA5;KCNS3;KCNB1;IRS1;RAP1A;ISL1;ITPR2;AACS;MCU;LRP5;INHBB;CAPN10;SLC8B1;HNF4A;PRKCA;REST;CDK16
prerank,nucleotide-excision repair (GO:0006289),0.3410702642702933,0.9613972816436381,0.5365566037735849,0.907406942373291,1.0,32/101,27.60%,MNAT1;CHD1L;ERCC5;COMMD1;RAD23B;SLC30A9;UVSSA;USP7;RNF111;COPS7B;BRCA2;COPS5;SLX4;EP300;ERCC8;POLB;ERCC3;XPA;RPA1;ERCC1;RFC1;POLA1;POLD3;CUL4A;RFC5;ERCC2;COPS3;BRIP1;POLK;XPC;GTF2H3;COPS2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.45287440215059144,0.9613458876534688,0.508716323296355,0.906949548342378,1.0,7/16,20.04%,FOXK1;RORA;FOXK2;PDK3;SCARB2;GNB3;ADIPOR1
prerank,diacylglycerol metabolic process (GO:0046339),0.4232928528239206,0.9612985046935071,0.5039370078740157,0.9064683279891799,1.0,3/23,7.09%,PLCE1;PLA2G15;DGKA
prerank,negative regulation of defense response (GO:0031348),0.35322665521879365,0.9612935248795347,0.5138888888888888,0.9058860257121206,1.0,9/77,7.30%,CCN3;PRKCD;PTGIS;KLF4;PTPN2;TRAFD1;ISL1;RORA;IL10
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.44061589817285085,0.9612301665271119,0.5186991869918699,0.9054454382842237,1.0,5/17,10.02%,SPRED2;EIF4G1;DMTN;PARD3;PPEF2
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.3386984949845237,-0.9610153938911213,0.5160349854227405,0.8267943077329207,1.0,5/24,12.48%,LPGAT1;CDS2;GPAM;PNPLA8;PGS1
prerank,negative regulation of DNA replication (GO:0008156),0.4624223376119634,0.9607990136979415,0.499184339314845,0.9058024967329504,1.0,4/13,17.21%,RAD17;WAPL;GTPBP4;ATR
prerank,protein glycosylation (GO:0006486),0.33108491330644424,0.9603497277499798,0.5422374429223744,0.9061990160156634,1.0,30/125,20.85%,ST3GAL4;MGAT4C;FUT8;PLOD2;B3GNT2;LARGE1;GCNT2;MGAT3;B4GALT1;MPI;COG3;B4GAT1;DPM1;LARGE2;MGAT1;ST3GAL2;DDOST;POMGNT2;B3GNT9;MGAT5;OGA;TMEM165;ALG12;ST8SIA2;POFUT1;TUSC3;B4GALT7;GFPT1;B3GNT6;NPC1
prerank,protein complex oligomerization (GO:0051259),0.3473081523782241,0.9600173779765501,0.531442663378545,0.9063535710939602,1.0,22/85,17.58%,LRRC8D;ATL3;TMEM120A;ATL2;MPP2;PDCD6IP;EHD3;FUS;SLC9A1;G3BP2;PRMT8;RBMX;EHD1;MCU;CUTC;ZC3H12A;YME1L1;RNF135;HOMER1;ZBTB1;JMJD6;BCL10
prerank,regulation of defense response (GO:0031347),0.35699328301872935,0.9598348249027474,0.5294840294840295,0.9061760699767932,1.0,15/76,14.73%,FOXP1;ANXA1;MGLL;PIK3AP1;AGTR1;IRF1;CELF1;DAGLB;NLRP6;SHPK;ERAP1;MYD88;BCL6;RNF135;SBNO2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.45065436733588493,0.9597029156737064,0.5155763239875389,0.9059049160627712,1.0,4/17,8.41%,TGFB3;PDCD4;IL10;CDKN1B
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.43248985884817953,0.9591066207982516,0.5039246467817896,0.9066729262468493,1.0,3/20,4.50%,BMP4;TGFBR1;PDCD4
prerank,regulation of cholesterol transport (GO:0032374),-0.3556403828811208,-0.9587700466076466,0.4986301369863014,0.8311743158617338,1.0,7/20,20.34%,ABCA5;NR1H3;NUS1;ABCB4;NR1H2;ABCA2;APOC1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.4738907253408037,0.9586353524723686,0.511437908496732,0.907138409684752,1.0,3/13,5.84%,CD9;ITGB1;LDLR
prerank,regulation of phospholipase C activity (GO:1900274),0.44736544482561824,0.9586036799476166,0.49592169657422513,0.906615715995693,1.0,5/15,6.03%,NTRK3;FGFR1;FGF2;ABL1;ESR1
prerank,positive regulation of cellular process (GO:0048522),0.3085583107306152,0.9585612670167227,0.5995975855130785,0.9061152616406223,1.0,72/565,11.29%,EGFR;THBS1;BMP4;ACER3;ZFHX3;GRK5;NTRK3;SOX9;BMP5;HDAC4;LRP6;PGF;LBP;PPP3CA;PDGFC;PTK2B;TGFB3;FN1;PRKCD;HES1;KRAS;FGFR1;SHC1;BMP6;GAB2;FGF2;FZD7;IRS1;LMNA;GAREM1;TGFBR1;CLCF1;EIF4G1;TRPM4;TGFBR2;GCNT2;KLHL22;LRP1;ISL1;ITGAV;GDNF;PTHLH;BAMBI;RIPK2;CELF1;CDC25B;P2RX2;PDGFA;MMP14;TLR4;CDKN1B;P2RX4;CHRD;EGR2;RAB25;CTF1;BCLAF1;ATM;PARD3;RARA;HILPDA;TIMP1;VEGFA;PROK2;LRP5;CEP131;MVD;SMC5;USP47;ERBB2;CAPN10;ITGB1BP1
prerank,peptidyl-lysine methylation (GO:0018022),0.4171062932653281,0.9585302092414281,0.5363636363636364,0.9055898770304369,1.0,10/26,26.55%,SMYD2;SETD2;EHMT1;ETFBKMT;KMT5A;EHMT2;EEF1AKMT1;METTL21A;METTL21C;SETD6
prerank,regulation of neuron differentiation (GO:0045664),0.35604407306878494,0.9583983486223191,0.5375939849624061,0.9052824885698905,1.0,6/76,2.85%,ZFHX3;SIX1;VWC2;NGF;HES1;FGFR1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.410825454412836,0.9583850156073035,0.5182926829268293,0.9047186613768476,1.0,6/25,13.09%,FOXO3;INHBA;STAT3;GATA1;BRD1;PRKDC
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.32335311912139464,0.9583453114544587,0.5610561056105611,0.9042214156143453,1.0,52/184,24.46%,FZR1;PKD1;ANAPC5;SFI1;PAFAH1B1;PCM1;CDC16;PSMB2;ID2;CEP164;ANAPC16;CDC14A;CEP63;AURKA;AKAP9;PSMC6;CEP131;PSMD11;UBE2S;CUL3;CSNK1E;MAD2L1;PSMD1;SDCCAG8;CUL1;NEK6;ERCC3;CEP43;HAUS2;CEP57;PSMD7;INO80;PSMC1;CEP70;PSMD14;E2F1;CSNK1D;ZW10;KLHL18;ANAPC11;PSMD3;OFD1;ANAPC10;CNTRL;HAUS5;PLK4;RIOK2;CDK2;CCNB1;CDC20;ERCC2;PSMD12
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.3393763403041868,-0.9583302867493501,0.5030120481927711,0.8310295658357141,1.0,5/25,9.54%,ITPR1;CDH13;RIT2;MAPT;PLEK
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.32780765068102563,0.9575623879413295,0.5316455696202531,0.9053430809122204,1.0,18/128,10.88%,FBXL7;CCNA2;PPP1R12B;SFI1;PAFAH1B1;MNAT1;PCM1;CDC25B;CEP164;CHEK2;PLK3;FBXW11;CEP63;AURKA;AKAP9;PPP1R12A;CEP131;FBXL6
prerank,regulation of secretion (GO:0051046),-0.3914395211015318,-0.9574072790377702,0.5051546391752577,0.8320881490049026,1.0,4/13,8.47%,MYO6;SGK1;OAS2;KCNQ1
prerank,carnitine metabolic process (GO:0009437),0.4623387461523064,0.9573313867761474,0.507563025210084,0.9052795692062093,1.0,3/12,8.49%,TMLHE;CPT1C;ACADM
prerank,manganese ion transport (GO:0006828),-0.3951891092654124,-0.9570206950265852,0.5092592592592593,0.8318285469292291,1.0,6/14,9.13%,SLC30A10;TRPC3;SLC39A8;ATP2C1;TRPC4;TRPC6
prerank,negative regulation of cyclase activity (GO:0031280),-0.38733943066052057,-0.9569773269325499,0.5486284289276808,0.830765152377275,1.0,2/14,2.19%,GRM3;ADGRV1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.33521822067626644,0.9562890515216804,0.5462085308056872,0.9070696976561146,1.0,7/108,4.92%,F3;MAP3K5;NGF;EGLN3;GSN;CRADD;VCP
prerank,axoneme assembly (GO:0035082),0.403113575791669,0.955704614034353,0.5240112994350282,0.9077751753212848,1.0,5/30,11.12%,RP1;DNAAF3;TOGARAM1;SPAG17;CCDC40
prerank,positive regulation of protein deacetylation (GO:0090312),0.4518050246461726,0.955584758173026,0.540453074433657,0.9074403058598708,1.0,6/14,24.07%,ZBTB7B;NNMT;NIPBL;SAP30BP;AKAP8L;BRMS1
prerank,negative regulation of axonogenesis (GO:0050771),-0.32917189688684445,-0.955474344596665,0.5445544554455446,0.833280607497803,1.0,9/27,12.79%,MAP2;DCC;ARHGDIA;MAG;RTN4;LINGO1;SEMA3G;EFNB3;TRIM46
prerank,regulation of mRNA stability (GO:0043488),0.3266482712100052,0.9550167280681728,0.5417142857142857,0.9080930925733989,1.0,52/145,27.63%,SAMD4A;PRKCD;FTO;EIF4G1;XPO1;GDNF;FASTKD1;CELF1;PSMB2;FUS;ZC3H14;PCBP4;PSMC6;APEX1;SERBP1;EXOSC7;PABPC1;PSMD11;PUM2;PRKCA;PUM1;MAPKAPK2;DCP1A;PSMD1;THRAP3;NUP214;EXOSC1;PSMD7;PSMC1;DHX36;FXR2;PSMD14;CIRBP;FMR1;E2F1;TENT5D;YTHDF2;PSMD3;SAMD4B;YTHDF3;TAF15;RC3H2;PSMD12;ROCK1;TENT5C;PSMD4;PARN;EXOSC4;MEX3D;VIP;PSMD2;PSME3
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.3512164844841145,-0.9548695177098231,0.5102040816326531,0.8336117377478508,1.0,4/22,3.71%,CACNA1D;GRM3;ADGRV1;CAP2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3588789060974455,0.9541160900530133,0.5416149068322982,0.9095597169409675,1.0,13/69,9.85%,PLCE1;NGF;EZR;FGFR1;PLCB3;GAB2;IRS1;PIK3C2B;PLCZ1;PLCD3;RHOA;NF1;PI4KB
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.3928188567009952,-0.9536881540799135,0.5307125307125307,0.8353681294509953,1.0,2/13,2.19%,GRM3;ADGRV1
prerank,electron transport chain (GO:0022900),-0.38912395419914714,-0.9536471587812747,0.5223880597014925,0.8342751448514256,1.0,4/15,11.66%,SDHA;PPARGC1A;PDIA5;CYB561
prerank,cellular senescence (GO:0090398),0.3970348495625472,0.9536090182367183,0.5083969465648855,0.9100465198387059,1.0,6/27,17.83%,PRKCD;ECRG4;ID2;SMC5;PML;CDKN1A
prerank,translational termination (GO:0006415),0.339841372276775,0.9533035584821246,0.5429594272076372,0.9101178622718334,1.0,39/95,31.58%,MRPL33;MRPL48;MRRF;ETF1;GSPT1;MRPS27;MRPL32;MRPL14;MRPL40;GFM2;MRPS31;MTRF1;MRPL21;MRPL42;MRPS30;ABCE1;MRPL57;MRPS35;MRPS28;MRPL52;MRPL38;MRPS22;MTRF1L;MRPL10;MRPS10;MRPL36;MRPL20;MRPL47;MRPL11;MRPS7;MRPS2;MRPL23;MRPS18A;MRPL19;MRPS21;MRPL9;MRPS18C;MRPS34;MRPS16
prerank,mRNA 3'-end processing (GO:0031124),0.3528760876817452,0.9531927702120202,0.5380774032459426,0.9097738823441999,1.0,37/78,32.62%,SRSF11;THOC2;SRSF5;SRSF6;SCAF8;U2AF2;PABPC1;SRRM1;LSM11;CASC3;CHTOP;U2AF1L4;SRSF2;THOC5;ZC3H11A;TENT2;FIP1L1;PAF1;CSTF1;NUDT21;CDC40;CPSF7;CPSF3;UPF3B;SRSF3;RBM8A;ALYREF;NCBP2;CLP1;CPSF4;SRSF7;CPSF4L;MTPAP;CSTF2T;CSTF3;SSU72;DDX39A
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.26168865134334623,-0.9531259097926181,0.5224719101123596,0.8343974215262273,1.0,16/94,14.08%,PLCB1;IL1R1;RPS6KA5;PELI2;ST18;NOD1;BTRC;UBC;TNIP2;PSMB4;PSMB3;IRAK2;MAPK3;PSME2;PSMB8;PSMB10
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.4148408130975526,0.9530167802997049,0.5287187039764359,0.909555102258892,1.0,2/25,2.73%,EXT1;B3GNT2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.39641661965797964,0.9529672010212498,0.5260869565217391,0.908481424843556,1.0,15/32,27.84%,NUP93;RANBP2;NUP153;SEC13;NUP214;NUP188;NUP88;RAN;NUP98;SSB;AAAS;NUP54;RAE1;NUP155;XPOT
prerank,tRNA export from nucleus (GO:0006409),0.39641661965797964,0.9529672010212498,0.5260869565217391,0.908481424843556,1.0,15/32,27.84%,NUP93;RANBP2;NUP153;SEC13;NUP214;NUP188;NUP88;RAN;NUP98;SSB;AAAS;NUP54;RAE1;NUP155;XPOT
prerank,post-translational protein modification (GO:0043687),0.31023825879739547,0.9528514563756773,0.6055900621118012,0.9081513724352187,1.0,55/332,15.71%,FBXL7;BMP4;MSLN;FSTL1;PTP4A2;CCN1;FN1;FBXO10;GPC3;ZBTB16;IGFBP5;DCAF6;FBXO40;FBXW8;KLHL22;DNAJC3;CCDC8;HIF3A;FBXL20;PSMB2;ASB9;ASB16;KTN1;SOCS2;DCAF4;KLHL13;UBE2F;FBXW11;COMMD1;FEM1B;PSMC6;TIMP1;COPS7B;PRKCSH;FBXO17;CKAP4;ASB11;SPSB2;COPS5;LRRC41;COP1;FBXO4;PSMD11;RCN1;CUL3;DCAF5;ERCC8;BMP15;WDTC1;CCDC22;CALU;PSMD1;MXRA8;ASB1;CUL1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.4113817883081383,0.9526263566302078,0.526395173453997,0.9080433308340174,1.0,4/27,9.27%,MAP3K5;NFKB1;CHUK;FBXW11
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4505908909907448,0.9523575158214374,0.5223642172523961,0.9080744119910326,1.0,3/16,5.38%,SLC39A14;MRAP;ACP3
prerank,dendritic spine morphogenesis (GO:0060997),-0.38412451258583613,-0.9521497677744124,0.5408970976253298,0.8356222483703951,1.0,3/15,3.06%,DOCK10;SHANK3;EPHB1
prerank,telomere maintenance (GO:0000723),0.3697304077024676,0.9521304881261904,0.530446549391069,0.9079745337492305,1.0,16/50,22.27%,STN1;WRN;ATM;APEX1;SMC5;PRKDC;XRCC5;PARP3;RPA1;ATR;NBN;RAD51;SMC6;POLD3;RAD50;TEN1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.47498138989916605,0.9520412808368337,0.5208333333333334,0.9075785783776509,1.0,4/11,21.23%,YBX3;RIPK3;BIRC3;FZD9
prerank,C-terminal protein amino acid modification (GO:0018410),-0.41716721906878834,-0.9519043438658797,0.5298013245033113,0.8350504466947011,1.0,4/11,23.05%,AGBL4;ICMT;ATG12;LCMT1
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.33588008366499766,-0.9511400685333506,0.5445544554455446,0.8358407440880313,1.0,9/26,20.12%,APOE;HIF1A;NUS1;SCARB1;NOS1AP;AKT1;GCH1;ATP7A;CDH3
prerank,glycogen catabolic process (GO:0005980),0.44933454044179166,0.9507869664320967,0.5257234726688103,0.9097895261089636,1.0,4/15,9.91%,PYGB;PHKA2;PHKB;RB1CC1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.41469399414178176,-0.9506735192786202,0.5254988913525499,0.8358147294883016,1.0,4/10,16.72%,LYN;GHR;JAK3;STAT5B
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.3818496277240794,0.950587742378583,0.5303030303030303,0.9096535846555218,1.0,16/38,21.04%,BMP6;POLR3D;PLSCR1;IFI35;USP15;PUM2;PRKCA;DHX9;PUM1;TLR8;ACOD1;ANKRD17;POLR3F;ADAM8;LY96;AKIRIN2
prerank,negative regulation of blood coagulation (GO:0030195),0.3871261993420875,0.950508675425426,0.5351506456241033,0.9092460454101661,1.0,4/38,8.14%,F3;THBD;SERPING1;PDGFA
prerank,photoreceptor cell development (GO:0042461),0.4548691840303404,0.9504114476809391,0.5090016366612111,0.9088966607515481,1.0,3/14,10.37%,RP1;ARL3;VEGFA
prerank,female gonad development (GO:0008585),-0.35953080797434955,-0.9501539545604035,0.5473684210526316,0.8359062380620901,1.0,2/19,1.92%,NR2F2;KIT
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3136821991278126,0.9497875420998748,0.5661605206073753,0.909664533960143,1.0,23/190,11.23%,SLIT2;THBS1;CCN3;CIT;TANK;PHLPP2;NPRL3;ATP2B4;UBE2B;PDE10A;ESR1;RORA;DDIT3;IFI35;DRD3;NF1;PPEF2;MARK3;USP10;PPP2R5C;PRDM15;PER1;OTUD7B
prerank,glycerolipid metabolic process (GO:0046486),0.4650444796347759,0.949709417234334,0.5215231788079471,0.909259094098457,1.0,4/11,7.09%,PNPLA3;PIP5K1A;PLA2G15;DGKA
prerank,organophosphate catabolic process (GO:0046434),-0.4237052313070767,-0.9495136407725645,0.5221674876847291,0.8362887170470581,1.0,2/11,7.68%,ENPP2;ABHD12
prerank,skeletal muscle contraction (GO:0003009),-0.3587884818812775,-0.9493913464247895,0.5522388059701493,0.8354042010390547,1.0,10/19,39.09%,RCSD1;STAC;MYH14;STAC2;CCDC78;TCAP;TNNI2;STAC3;TNNC2;JSRP1
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.3983984479101741,-0.9492494273599514,0.5,0.8346010305000668,1.0,3/12,8.77%,APOE;PFDN5;PFDN2
prerank,negative regulation of stem cell differentiation (GO:2000737),0.4655598222888347,0.9491678323845524,0.5246179966044142,0.9098346763216892,1.0,3/12,14.51%,HES1;JAG1;REST
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.452887003213377,0.949117178993929,0.5397923875432526,0.909356965133162,1.0,5/13,20.13%,TCERG1;RNF168;NELFE;RECQL5;RNF8
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.45141333554915763,0.94869016148549,0.5008375209380235,0.90971318403551,1.0,5/13,16.14%,TNRC6C;TOB1;PABPC1;CNOT7;AGO2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.31690405544102646,-0.9483327396036362,0.5210355987055016,0.8357001929924746,1.0,8/31,18.15%,BCL2;TFDP2;HIP1R;YWHAB;BOK;GSK3A;PPP3R1;CHCHD10
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.37761856094054586,-0.9479515657652554,0.525,0.835461010018166,1.0,3/17,11.92%,BCL2;BCL2L1;BOK
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.4626096978135089,0.9479480779731839,0.5319488817891374,0.9107453394675492,1.0,4/13,20.77%,B3GNT2;B4GAT1;B3GNT9;B3GNT6
prerank,positive regulation of cell projection organization (GO:0031346),0.333825657122343,0.9478492424144408,0.5625730994152047,0.9103622665536059,1.0,17/115,8.86%,SLIT2;DPYSL3;NTRK3;NGF;PTK2B;CUX1;RAP1A;TIAM2;KIDINS220;FBXW8;ROR1;FZD1;P3H1;MARK2;ARSB;STYXL1;RHOA
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.32329087989986516,0.9477132629567223,0.5614430665163472,0.9100851309108547,1.0,29/149,15.98%,SLCO3A1;CARD14;EDA;ERC1;RAB7B;TAB3;STAT3;CLU;ROR1;RIPK2;RIPK4;TLR4;NFKB1;CHUK;RIPK3;IRAK3;MTDH;NFKB2;TNFSF11;MYD88;TRAF5;DDRGK1;CARD16;EP300;TRADD;DHX9;PIDD1;ZBTB7A;IL18RAP
prerank,lymphocyte chemotaxis (GO:0048247),0.38685504825925865,0.9475402193264097,0.5209235209235209,0.9099282197538553,1.0,1/34,0.49%,SLC12A2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.4221032774328286,0.947464100964692,0.5300462249614792,0.9095115148433058,1.0,2/24,1.68%,PKD1;PTK2B
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.31890441148675475,-0.947235804211676,0.5317220543806647,0.8360324639635928,1.0,4/32,2.05%,AUTS2;PIK3R1;ENPP2;OCLN
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.446193183117427,0.9471172709222473,0.5234899328859061,0.9096834075543319,1.0,4/14,12.19%,PPP3CA;PPTC7;PPP2R2D;PPP5C
prerank,membrane raft organization (GO:0031579),0.4490831454993718,0.9469264504189693,0.5025210084033613,0.9095060157768369,1.0,6/15,21.81%,ANXA2;S100A10;ABCA7;CLN3;NPC1;EMP2
prerank,muscle tissue morphogenesis (GO:0060415),0.4385327161643697,0.9464849282525959,0.5364667747163695,0.9099628121711152,1.0,1/16,0.28%,BMP4
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.44360500371081435,0.9461521093286102,0.5404120443740095,0.9101577255274803,1.0,4/16,15.88%,PAICS;AMPD3;PFAS;GMPS
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.44776647110624856,0.9461010359459624,0.5163934426229508,0.909690364946316,1.0,7/15,22.87%,PLCG2;DDRGK1;CUL3;DYRK3;KLHL18;PAF1;ATAD5
prerank,regulation of lamellipodium organization (GO:1902743),0.46180798579820603,0.9460946514269188,0.5161839863713799,0.9091311434909044,1.0,2/14,6.57%,CD44;DMTN
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.3561614898500565,-0.9460821500269401,0.5195195195195195,0.8375901471576728,1.0,3/21,3.14%,IGF1;KDR;CTSH
prerank,positive regulation of superoxide anion generation (GO:0032930),0.46297738913397984,0.9460137038237905,0.5283018867924528,0.9087397302849728,1.0,1/13,2.04%,PRKCD
prerank,protein homooligomerization (GO:0051260),0.3317079063907924,0.9460062103235247,0.5681293302540416,0.9081805111175099,1.0,15/114,9.86%,KCNJ2;DISP1;ATL3;TMEM120A;SCARA5;ATL2;TRPM4;MPP2;PDCD6IP;EHD3;FUS;G3BP2;PRMT8;RBMX;EHD1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.34505528908469696,0.9456417329574971,0.5314861460957179,0.9083818264681186,1.0,15/72,19.04%,CARD14;REL;PSMB2;CHUK;FBXW11;PSMC6;NFKB2;PSMD11;PSMD1;CUL1;BIRC3;PSMD7;PSMC1;TLR6;PSMD14
prerank,DNA methylation (GO:0006306),0.4169943220355024,0.9452587497579124,0.5342261904761905,0.9086548316163927,1.0,8/23,25.49%,EHMT1;ATRX;DNMT3A;BAZ2A;EHMT2;TEX15;DMAP1;ATF7IP
prerank,inositol phosphate metabolic process (GO:0043647),0.3741095386428111,0.9447751906210308,0.5317769130998703,0.9091412280615858,1.0,10/46,9.97%,PLCE1;PLCB3;FGF2;IP6K2;INPP4A;PLCZ1;NUDT4;OCRL;PLCD3;PLCG2
prerank,mitotic spindle assembly (GO:0090307),0.37938314471781565,0.944648988072118,0.5238744884038199,0.9088438030367418,1.0,14/42,22.95%,MISP;TOGARAM1;CHEK2;ARHGEF10;RHOA;SPICE1;SMC1A;PIBF1;STAG2;KIF3B;STAG1;OFD1;FLNA;AAAS
prerank,regulation of gene silencing by RNA (GO:0060966),0.36771598529175026,0.9443523015405958,0.5447154471544715,0.9082905285422811,1.0,16/50,23.75%,NUP93;EIF4G1;RANBP2;NUP153;SEC13;PUM2;PUM1;NUP214;AGO2;NUP188;NUP88;FMR1;NUP98;TNRC6A;AAAS;NUP54
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.36771598529175026,0.9443523015405958,0.5447154471544715,0.9082905285422811,1.0,16/50,23.75%,NUP93;EIF4G1;RANBP2;NUP153;SEC13;PUM2;PUM1;NUP214;AGO2;NUP188;NUP88;FMR1;NUP98;TNRC6A;AAAS;NUP54
prerank,limb development (GO:0060173),0.40535479437307076,0.944163750770641,0.5258493353028065,0.9081369872815055,1.0,4/28,5.56%,PCSK5;GLI3;SMOC1;NOG
prerank,ribosome assembly (GO:0042255),-0.29052616290770156,-0.9438639633549685,0.5894736842105263,0.8418196552608419,1.0,14/47,19.30%,RPS14;RPS19;RPS5;RPS15;RPS27;RPL23A;RPL11;NPM1;RPL24;MRPS11;RPL3;RPL5;RPS28;DDX3X
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.38095876591316036,-0.9438025142706327,0.5258215962441315,0.8407744942276597,1.0,2/13,3.80%,IGF1;INSR
prerank,ketone body metabolic process (GO:1902224),0.48065721083782154,0.9435990312472813,0.5339130434782609,0.908785719550942,1.0,2/10,7.85%,BDH2;AACS
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.451394205022813,0.943258852933441,0.534923339011925,0.9089394057100889,1.0,3/13,16.01%,PTGIS;NNMT;NUDT12
prerank,telomere maintenance via recombination (GO:0000722),0.47654701655643533,0.9429178417398058,0.5474956822107081,0.909090945948295,1.0,5/11,21.89%,SMC5;RAD51;ERCC1;SMC6;RAD50
prerank,mitochondrion transport along microtubule (GO:0047497),-0.392123823635639,-0.9427942000711398,0.5400516795865633,0.8421628503783192,1.0,2/13,8.14%,HIF1A;MAPT
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.4253003092385987,0.9422689975475889,0.5408496732026143,0.9099427079954983,1.0,4/16,5.55%,ANK2;CACNA1C;CAMK2D;DMD
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.40519307439118263,0.9422573520669107,0.5480480480480481,0.9093934542148713,1.0,5/27,11.08%,NFAT5;CD44;NR4A3;RHOA;TNFSF11
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.3401718755047301,-0.9419010210444763,0.5294117647058824,0.843262764856935,1.0,6/24,16.63%,AGBL4;TTLL7;TTLL11;TTLL5;TTLL4;CEP41
prerank,Rho protein signal transduction (GO:0007266),0.3700021057707183,0.9418845086899018,0.5502645502645502,0.9096463973994269,1.0,9/53,9.63%,NTN1;CDC42EP5;RHOJ;ARHGDIB;AGTR1;SHTN1;RHOA;ARHGAP5;GNA13
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3970840207196725,-0.9418778011620768,0.5514018691588785,0.8421408176813167,1.0,3/12,13.29%,ACSL1;FADS2;SCP2
prerank,brain development (GO:0007420),0.3262568501041393,0.9417275552198198,0.5735294117647058,0.9094108915521906,1.0,16/136,9.42%,SLC23A1;PBX3;ZFHX3;NFIB;ADGRL2;PBX1;ZIC1;TGFBR2;PAFAH1B1;DMBX1;SHROOM4;PAFAH1B2;GRHL2;EGR2;FBXW11;NF1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.35113299845451473,0.9416893430074121,0.5432569974554707,0.908927228422869,1.0,18/68,18.34%,LBP;RAB7B;IL17RA;ISL1;STAT3;MAVS;TLR4;IL33;PLCG2;MYD88;IFIH1;TLR1;DHX9;TWIST1;TLR8;BCL10;IL16;TLR6
prerank,synapse organization (GO:0050808),0.3291326057783872,0.9414698460622417,0.5919075144508671,0.9088214805126041,1.0,9/125,3.83%,CDH1;PCDHB16;GPC6;CTNND2;NEDD4;SEMA3E;UNC13B;CAST;PTPRF
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.4754026201018787,0.9413309665773959,0.5384615384615384,0.908566202973274,1.0,4/10,7.37%,SOX9;ZBTB16;GDF6;GDF5
prerank,protein export from nucleus (GO:0006611),0.3991991576550649,0.941011975099427,0.5404191616766467,0.908682900540446,1.0,14/27,23.71%,PKD1;XPO1;DUSP16;EGR2;STRADA;DESI1;CHP1;SMURF1;NUP214;XPO4;RAN;NUTF2;XPO7;STYX
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3585668511525783,0.9407515363873189,0.5509433962264151,0.9086868604888202,1.0,8/69,6.07%,SIX1;NGF;PTK2B;TGFB3;CLCF1;NFATC4;ISL1;GDNF
prerank,actin-myosin filament sliding (GO:0033275),-0.3031173303044364,-0.9407401008876826,0.5791245791245792,0.8425898958003237,1.0,6/38,8.30%,MYL6;TMOD1;TPM2;VIM;DES;ACTN2
prerank,muscle filament sliding (GO:0030049),-0.3031173303044364,-0.9407401008876826,0.5791245791245792,0.8425898958003237,1.0,6/38,8.30%,MYL6;TMOD1;TPM2;VIM;DES;ACTN2
prerank,negative regulation of receptor binding (GO:1900121),0.47404641004941106,0.9405808123688384,0.5274914089347079,0.9084884072293116,1.0,3/10,7.30%,PTPRF;NOG;IL10
prerank,long-chain fatty acid metabolic process (GO:0001676),0.34722090163313346,0.9402911590639835,0.5401554404145078,0.9085390151592712,1.0,9/64,11.36%,CYP1B1;MGLL;PNPLA3;ACSL3;SLC27A3;ACOT8;DAGLB;HACL1;ELOVL5
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.38594752618175227,0.9401465440575651,0.5463483146067416,0.908277608020772,1.0,18/36,26.51%,EHMT1;CBX5;EED;CHEK1;RNF2;SUZ12;RBBP8;EPC1;RRM2;EHMT2;RAD51;RBBP7;E2F1;YAF2;E2F6;MGA;RBBP4;PCGF6
prerank,membrane repolarization (GO:0086009),0.4447407478990126,0.9399616466016804,0.55,0.908084946317609,1.0,2/15,1.56%,KCNJ2;ATP1B1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.44486999290297335,0.9396737073001308,0.540765391014975,0.9081421619830493,1.0,3/14,9.94%,ANXA1;CD80;RARA
prerank,membrane depolarization during action potential (GO:0086010),0.4027462175729868,0.9395686195752516,0.5298621745788668,0.9078067123008219,1.0,3/26,3.30%,KCNJ2;CACNA1C;CACNA1G
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.332593068086751,-0.9395380753898057,0.5667655786350149,0.8443033165561131,1.0,6/25,10.80%,TMTC2;ANK3;SLC8A1;SNCA;GRIN1;JPH2
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.4165262676760098,0.9389911332445382,0.5345622119815668,0.9084715590710131,1.0,6/21,16.15%,ADAM9;SPPL2A;BACE2;RBMX;ERAP1;ADAM10
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.3754979290426584,0.9388450117211965,0.541374474053296,0.9082103649980018,1.0,6/43,9.16%,EGFR;PTPN3;RNF115;PTPN2;CBLC;RNF126
prerank,cellular response to amino acid starvation (GO:0034198),0.3504015714553693,0.9384118232251879,0.5670886075949367,0.90854018206388,1.0,23/71,21.52%,MAP3K5;DAPL1;NPRL3;RRAGB;ITFG2;MLST8;CASTOR2;SEC13;MTOR;SH3GLB1;TCIRG1;ATP6V0D1;EIF2AK4;ATF2;ATP6V0E1;SZT2;CDKN1A;EIF2S1;RHEB;ATP6V1H;NPRL2;MAPK8;EIF2AK3
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.3464790365905632,-0.9382798167006232,0.5555555555555556,0.8462493983533764,1.0,2/23,7.77%,IGF1;GAS6
prerank,negative regulation of protein binding (GO:0032091),0.34943861667733694,0.9381900257917316,0.5409836065573771,0.908467040486971,1.0,14/71,12.41%,PRKCD;ADRB2;GSK3B;LRPAP1;PTPRF;KDM1A;SLPI;DISC1;DACT1;AURKA;DDX11;ITGB1BP1;USP33;CARD16
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3392477828563867,0.9380842983776434,0.5708908406524467,0.9081362882399253,1.0,5/73,4.92%,F3;NGF;EGLN3;CRADD;VCP
prerank,positive regulation of hormone secretion (GO:0046887),-0.3718608210673992,-0.9380797863415178,0.5284974093264249,0.8455782124954069,1.0,3/17,8.58%,C1QTNF3;SPP1;EDN1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.4696750575717567,0.938039702532281,0.5308219178082192,0.9076845625096415,1.0,1/10,2.87%,ANO6
prerank,response to amino acid starvation (GO:1990928),0.34970610984112815,0.9377708755191517,0.5669191919191919,0.9076878272369003,1.0,23/72,21.52%,MAP3K5;DAPL1;NPRL3;RRAGB;ITFG2;MLST8;CASTOR2;SEC13;MTOR;SH3GLB1;TCIRG1;ATP6V0D1;EIF2AK4;ATF2;ATP6V0E1;SZT2;CDKN1A;EIF2S1;RHEB;ATP6V1H;NPRL2;MAPK8;EIF2AK3
prerank,positive regulation of response to external stimulus (GO:0032103),0.3242608811657162,0.9377518633284216,0.56601607347876,0.9071593257358881,1.0,30/128,18.77%,THBS1;GPR4;THBD;BMP6;AGTR1;PDCD4;IL17RA;POLR3D;PLSCR1;IFI35;TLR4;IL33;LRSAM1;USP15;CCL3;CCL1;TNIP1;PUM2;PRKCA;TRADD;DHX9;PUM1;TLR8;ACOD1;ANKRD17;ABCC1;NLRP12;POLR3F;IL16;ADAM8
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.44489714635144484,0.9374907585226744,0.5394736842105263,0.9071539377139124,1.0,5/15,18.34%,IL17RA;STAT3;TLR4;MYD88;TLR6
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.40856099606870183,0.9374077943766738,0.5327102803738317,0.9067519913625492,1.0,6/24,13.47%,NFE2L2;DDIT3;VEGFA;ATF6;CREB3L1;CREB3L3
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.46267913132902805,0.9369719315249184,0.532258064516129,0.9071278155412641,1.0,4/11,15.11%,DDX11;SMARCA4;MTOR;NOL11
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.32105717597244915,-0.9360340028631617,0.5483870967741935,0.8492851386892121,1.0,13/29,31.48%,NR1H3;DBI;PNPLA8;TMEM86B;NR1H2;PLAAT3;PLA2G4C;PLA2G5;PLBD1;PLA2G4E;PLB1;LPCAT3;PLA2G3
prerank,synaptic vesicle exocytosis (GO:0016079),-0.2970462960935004,-0.9359204837360967,0.55,0.8483687504183232,1.0,16/40,23.28%,UNC13C;RIMS1;RIMS2;SYT7;SNAP25;SNCA;SYT1;BLOC1S6;PIP5K1C;SYT10;RAB3A;CPLX1;SYT2;DOC2B;OTOF;SYT5
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.35073330068566255,-0.9358832068216422,0.5532467532467532,0.847284227986606,1.0,5/20,21.10%,NR2F2;MYOCD;HHEX;INCA1;CEBPA
prerank,positive regulation of transmembrane transport (GO:0034764),0.4482033455624882,0.9357291843934697,0.5325542570951586,0.9092781468548763,1.0,5/13,13.98%,ANO6;SLC26A6;NR4A3;C2CD5;AZIN1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.37538563903703215,0.9350821034122787,0.5484330484330484,0.9100771851494603,1.0,7/39,13.27%,TCF7L2;ISL1;AACS;MCU;TNFSF11;CAPN10;SELENOT
prerank,cell chemotaxis (GO:0060326),0.3558900735508897,0.9350731606431933,0.5549805950840879,0.9095363859729082,1.0,7/60,6.01%,CCN3;PRKCD;PARVA;NRP1;AGTR1;DEFB130A;PIP5K1A
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3448186353513487,0.9349941143986069,0.5551282051282052,0.9091354864693956,1.0,11/65,13.21%,EGLN3;NDRG1;PTGIS;NPEPPS;LMNA;RORA;MDM4;HILPDA;VEGFA;CARD16;MTOR
prerank,response to steroid hormone (GO:0048545),0.38890770454778345,0.9343980137064823,0.5582733812949641,0.9098322833899674,1.0,2/31,1.76%,THBS1;TGFB3
prerank,megakaryocyte differentiation (GO:0030219),-0.40464492250778267,-0.9336901706633111,0.550561797752809,0.8513450768145097,1.0,4/11,15.16%,KIT;TAL1;MED1;SH2B3
prerank,spliceosomal complex assembly (GO:0000245),0.36396071829260956,0.9336089450858962,0.5422818791946309,0.9109658081898733,1.0,19/46,28.23%,LUC7L2;SRSF5;SRSF6;CELF1;CELF3;SCAF11;GCFC2;SF3B1;SRPK1;DDX1;NOL3;TXNL4A;RBM5;LUC7L;CELF4;SRPK2;SNRNP200;PRPF6;KHDC4
prerank,negative regulation of neuron death (GO:1901215),0.3390260168368623,0.9334585593221163,0.5709219858156028,0.9107005542268265,1.0,10/93,6.07%,SIX1;NGF;PTK2B;TGFB3;GSK3B;CLCF1;EIF4G1;NFATC4;ISL1;GDNF
prerank,regulation of cellular respiration (GO:0043457),-0.37295204278107746,-0.9331319345286225,0.5639097744360902,0.8515403872547085,1.0,3/17,3.90%,CBFA2T3;IFNAR1;PRDM16
prerank,regulation of mRNA processing (GO:0050684),0.390193093865533,0.933016965433747,0.5494350282485876,0.9110689022611949,1.0,8/32,17.22%,SLTM;SON;RBM39;DHX9;CDK11B;JMJD6;KHDRBS1;SRPK1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.34023152521713973,-0.9329383703876871,0.5488126649076517,0.850839349009166,1.0,7/22,8.76%,PLA2R1;SPRED1;RPS15;RPL37;RPS7;RPL23;RPS20
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.2802894822450215,-0.9328578187433685,0.5748987854251012,0.8498441699854038,1.0,22/49,29.06%,SGMS1;BCL2;BCL2L1;DAPK2;BOK;NOC2L;BMF;NUPR1;RACK1;P4HB;DDX3X;NDUFA13;DNM1L;PMAIP1;PLAUR;PYCARD;CYLD;PINK1;BCL2L2;SIAH1;BCL2L11;SRC
prerank,neural crest cell migration (GO:0001755),0.38741348907078577,0.932732266619349,0.5611510791366906,0.9111018895258829,1.0,7/36,8.20%,SEMA3E;FN1;SEMA3D;SEMA3C;NRP1;GDNF;PITX2
prerank,sister chromatid segregation (GO:0000819),0.39766358597554463,0.932071968844999,0.5598227474150664,0.91199194870553,1.0,8/31,20.32%,SMC4;KLHL22;SMC1A;RB1;KNSTRN;INO80;ZW10;RAN
prerank,regulation of neuroblast proliferation (GO:1902692),0.4478287518225508,0.9320509531982686,0.5533661740558292,0.9114780713389464,1.0,4/15,10.37%,KDM1A;DISC1;NF1;VEGFA
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.40367634656201395,0.9317833678150998,0.5316265060240963,0.9115056616751553,1.0,3/22,7.30%,CYP1B1;HES1;IL10
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.34430662223749353,-0.9316425817764189,0.5523255813953488,0.8516146183664897,1.0,4/22,5.64%,LYN;MFHAS1;NR1H3;DAB2IP
prerank,nuclear pore organization (GO:0006999),0.44149189885628737,0.9316353548491693,0.5697865353037767,0.9112607437804854,1.0,6/14,23.75%,NUP93;NUP153;AHCTF1;NUP98;TMEM170A;NUP54
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.42971182428968546,0.9315909600849143,0.5594294770206022,0.910786982981856,1.0,2/17,3.72%,ADAM9;FOXC2
prerank,protein autoubiquitination (GO:0051865),0.3431324860169621,0.931361149435145,0.5528031290743155,0.9107280399385806,1.0,17/61,20.96%,WWP2;RNF115;RNF185;UBE2B;RNF141;UBE2D3;LRSAM1;RNF146;RNF122;SH3RF3;CUL3;ERCC8;BFAR;UHRF2;CNOT4;RNF8;NFX1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3419770419869035,0.9312753998639155,0.5676691729323309,0.910366132304251,1.0,20/76,19.78%,PRICKLE1;GSK3B;RNF144A;VCP;ARIH1;CLU;RNF19A;CSNK1A1;ZYG11B;DDRGK1;COP1;ARIH2;SMURF1;ANKIB1;CSNK1E;CCDC22;RNF14;PIAS1;CSNK1D;DVL1
prerank,positive regulation of immune effector process (GO:0002699),0.39055173464569354,0.9302890476991285,0.554093567251462,0.9118940030778476,1.0,3/27,9.13%,LBP;IL10;CD46
prerank,cyclooxygenase pathway (GO:0019371),-0.4137542082344084,-0.9299966020534693,0.5288683602771362,0.8543627045523361,1.0,6/10,18.72%,PTGDS;PTGS1;HPGDS;CBR1;PTGES3;PTGS2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.40590274601575393,0.9295583279924587,0.5582089552238806,0.9128963512455998,1.0,4/24,3.76%,SEMA3E;SEMA3D;SEMA3C;NRP1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.32007903665431814,0.9293712775878432,0.6008771929824561,0.912732480449154,1.0,41/151,21.26%,ST3GAL4;ACER3;PCSK5;PLPP3;SGMS2;INHBA;LARGE1;SPTSSB;DMD;GOLPH3;NANP;NFS1;TYW5;LPIN2;SLC44A3;TYW1;CDO1;ELOVL5;TNIP1;LCAT;KDSR;CHKB;MOCOS;PLPP1;GSTM4;ST3GAL2;CEPT1;GSTA2;GAL3ST4;GSTT1;CSNK2A2;CSNK2A1;CERS6;CERS5;PLA2G4A;LPCAT1;MOCS3;ARG1;B3GNT6;NMRAL1;HACD4
prerank,neuromuscular process (GO:0050905),0.4250853677887517,0.9292384328260229,0.555735056542811,0.9124480189647565,1.0,8/16,23.95%,STRA6;PAFAH1B1;MYCBP2;SHANK1;UBA5;CLN3;TIFAB;AGTPBP1
prerank,apical junction assembly (GO:0043297),0.36297646479755535,0.9292315208259198,0.5572916666666666,0.9119054059595504,1.0,15/53,14.09%,MPP7;CTNNA1;STRN;VCL;PDCD6IP;CLDN11;DLG1;CLDN16;PATJ;GRHL2;RHOA;PARD3;PKN2;PAK2;WDR1
prerank,modified amino acid transport (GO:0072337),-0.38387861039595117,-0.9290375892855238,0.5578406169665809,0.8555921572800068,1.0,2/15,0.33%,SLC6A13;SLC16A12
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.35876306415184356,-0.9288856472979385,0.5467032967032966,0.8547774156686789,1.0,2/18,5.86%,CORO2B;CEP120
prerank,Golgi to plasma membrane transport (GO:0006893),0.36212353832426886,0.9286870923751241,0.5510204081632653,0.9125079920808485,1.0,13/47,15.21%,STXBP6;EXOC4;KIF13A;ARL3;GOLPH3;EXOC5;NSF;RABEP1;COMMD1;GOPC;GGA2;GOLGA7;CCDC22
prerank,glucose metabolic process (GO:0006006),-0.2730960108977833,-0.9285108328163195,0.5783132530120482,0.8544959563879913,1.0,17/58,21.42%,APOD;RBP4;PPARD;PPARGC1A;GAPDH;PGAM1;PGM1;MDH1;ALDOC;ALDOA;GOT2;ENO2;ENO1;AKR1A1;SLC25A13;SLC25A11;DCXR
prerank,mononuclear cell differentiation (GO:1903131),0.40472671337016425,0.9284724841149483,0.5617283950617284,0.912419247532246,1.0,1/24,0.28%,BMP4
prerank,positive regulation of phospholipase activity (GO:0010518),0.40789267606641666,0.9282356789685074,0.5546875,0.9123362892400525,1.0,7/22,10.78%,NTRK3;FGFR1;FGF2;AGTR1;ESR1;GNA13;ARF4
prerank,RNA biosynthetic process (GO:0032774),0.3862410493344464,0.9281374749301279,0.565028901734104,0.9119993467091805,1.0,15/31,30.01%,TTF2;TTF1;PRIM2;TAF4;TAF12;PRIM1;NCOA6;SMARCA5;HELB;POLA1;PRMT5;GTF2B;TAF13;SMN1;TAF5
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.3471217768321898,-0.9280765746799434,0.5403225806451613,0.8543924645267995,1.0,4/18,6.89%,APOE;CTSC;VGLL4;CD81
prerank,regulation of hydrolase activity (GO:0051336),0.3436200989793092,0.9280540745726055,0.5675340768277571,0.9116350909120337,1.0,17/71,11.61%,EFNA5;SIPA1L1;VAV2;ARHGAP44;PAFAH1B1;ADAP1;EPHB3;RDX;OCRL;RAPGEF6;RAB3GAP2;FGD6;FBXW11;WRN;NF1;ITGB1BP1;ARHGEF5
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3262060517586082,0.9280263427911258,0.5788849347568209,0.9111321120261229,1.0,21/107,14.30%,SLC24A3;ANK2;ATP1B1;ATP2C2;CSRP3;SLC39A14;STIM2;ATP2B4;SLC10A7;CASR;DRD3;TNNI3;SLC30A9;CCL3;SLC39A13;CCL1;SLC8B1;CCL7;RMDN3;NPTN;HTR2B
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.4144751308084637,-0.9278222599596949,0.572429906542056,0.8538127278612412,1.0,2/10,10.13%,ENPP2;PNPLA8
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.3376290573783212,0.9276801165636049,0.5925465838509317,0.9113578839324123,1.0,17/85,14.20%,USP13;PRICKLE1;GSK3B;RNF144A;RNF185;VCP;ARIH1;CLU;RNF19A;CSNK1A1;PSMC6;ZYG11B;DDRGK1;COP1;ARIH2;ANKIB1;CSNK1E
prerank,negative regulation of DNA binding (GO:0043392),0.39472746536890185,0.9276407233573255,0.53954802259887,0.9108953103164562,1.0,8/28,19.60%,SMO;MDFI;KDM1A;GATA1;JUN;CPNE1;PER2;E2F1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3414186999588938,0.9274607329645381,0.5837628865979382,0.9107218118022148,1.0,11/75,11.96%,BMP4;LRP6;PRKCD;ABL1;IPO7;CBLC;CDKN1B;IRAK3;NF1;LRP5;RB1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.38878633311069605,-0.9271782161840753,0.5251798561151079,0.8541938981585265,1.0,2/12,3.80%,IGF1;INSR
prerank,cell proliferation in forebrain (GO:0021846),0.4778835922981058,0.927105225153953,0.5741710296684118,0.9109461649220253,1.0,2/10,6.05%,DOCK7;PCM1
prerank,icosanoid secretion (GO:0032309),0.44469515019029593,0.9269336393037619,0.5238095238095238,0.9107263890654057,1.0,3/12,12.43%,ANXA1;DRD3;ABCC4
prerank,intraciliary retrograde transport (GO:0035721),0.46036184867376373,0.9268651065655112,0.5527210884353742,0.9102998313667873,1.0,8/12,32.02%,WDR35;DYNC2I2;DYNC2I1;DYNC2H1;TTC21A;IFT43;TTC21B;IFT122
prerank,negative regulation of lyase activity (GO:0051350),-0.3657037613175821,-0.926735180093393,0.5769230769230769,0.8540294696965763,1.0,2/16,2.19%,GRM3;ADGRV1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3678730576929745,0.9267306590739323,0.5665236051502146,0.9100073511512641,1.0,12/38,16.91%,TANK;ESR1;RORA;USP10;PER1;OTUD7B;ZC3H12A;TNIP1;PPM1A;CCDC22;TRIM39;NLRP12
prerank,cellular response to nutrient levels (GO:0031669),0.34922190552088983,0.9265480758338681,0.550326797385621,0.9098393044543194,1.0,13/62,13.21%,KCNB1;FAM107A;WIPI2;EIF4G1;KLF10;ZFYVE1;VPS41;CLEC16A;RRAGB;WRN;INHBB;USP33;MTOR
prerank,negative regulation of glycolytic process (GO:0045820),0.4712447473143568,0.9263864594191292,0.5514834205933682,0.9090556778528838,1.0,3/10,10.75%,HDAC4;PFKFB1;NCOR1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.4712447473143568,0.9263864594191292,0.5514834205933682,0.9090556778528838,1.0,3/10,10.75%,HDAC4;PFKFB1;NCOR1
prerank,regulation of intracellular signal transduction (GO:1902531),0.29952490295086037,0.9263494878560785,0.698284561049445,0.9085920161028975,1.0,95/420,17.81%,EGFR;RASSF2;MOB3B;NTRK3;ARHGAP20;RHOJ;ARHGAP21;ARHGAP10;ARAP1;EZR;AKAP13;ARHGDIB;VAV2;USP2;HIPK1;ARHGAP44;CMKLR1;ARHGAP31;BCR;SRGAP2;SRGAP3;TIAM2;TELO2;SMYD2;ARAP2;TRIO;ITGAV;PIP5K1A;RHOQ;GATA4;DLG1;EXO1;ARHGEF6;EHMT1;RRAGB;OCRL;ARHGAP17;CHEK2;STYXL1;PLK3;MDM4;RHOA;STARD13;RAD17;ITFG2;WRN;ARHGAP5;ATM;AURKA;GNA13;MLST8;PLCG2;VEGFA;PPP2R5C;MYO9A;USP7;TNFSF11;ARHGEF5;TIAM1;TRAF5;CASTOR2;SOS2;ARHGAP40;MTOR;PAK2;CHEK1;CHD3;EP300;DYRK2;SQSTM1;PIDD1;PML;ZFAND6;RBBP8;TAF4;TMBIM4;KMT5A;TAF12;RPA1;NLRP12;NEK8;CPNE1;IKBKG;TOP3A;VRK2;ATR;BIRC3;BARD1;RMI2;NBN;PAK4;TRIP10;AKAP12;PRKAR2A;EHMT2
prerank,negative regulation of response to external stimulus (GO:0032102),0.32765237386144014,0.9257951772211491,0.5812274368231047,0.9091935326718267,1.0,13/105,9.39%,CCN3;CD109;PRKCD;PTGIS;KLF4;FGF2;PTPN2;TRAFD1;ISL1;RORA;IL10;DRD3;IRAK3
prerank,arachidonic acid secretion (GO:0050482),0.4606469941672894,0.9256343174266327,0.5519713261648745,0.9084319380092414,1.0,2/10,9.10%,ANXA1;DRD3
prerank,arachidonate transport (GO:1903963),0.4606469941672894,0.9256343174266327,0.5519713261648745,0.9084319380092414,1.0,2/10,9.10%,ANXA1;DRD3
prerank,T cell receptor signaling pathway (GO:0050852),-0.2343263848327545,-0.9254875090323564,0.6423357664233577,0.8558796590020226,1.0,23/138,14.11%,PDE4B;PIK3R1;PAK1;FYB1;RFTN1;INPP5D;TEC;TNFRSF21;PDE4D;PRKCQ;PAG1;MOG;BTRC;PAK3;THEMIS;PSMB4;PSMB3;PLCG1;ICOSLG;PSME2;PSMB8;PSMB10;MALT1
prerank,hexose biosynthetic process (GO:0019319),-0.2900959539294384,-0.9253732439035793,0.5665529010238908,0.8550005880073497,1.0,13/42,21.28%,RBP4;PPARGC1A;GAPDH;PGAM1;PGM1;MDH1;ALDOC;ALDOA;GOT2;ENO2;ENO1;SLC25A13;SLC25A11
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3508200719192672,0.925070290527088,0.5673575129533679,0.909079261607633,1.0,9/65,9.16%,EGFR;PTPN3;ARAP1;RNF115;PTPN2;AGR2;CBLC;BCAR3;RNF126
prerank,reticulophagy (GO:0061709),0.4581917142499585,0.9248401886684207,0.5551839464882943,0.9090148628335158,1.0,6/12,22.11%,ULK2;RB1CC1;DDRGK1;UBA5;ATG2A;ULK1
prerank,negative regulation of protein depolymerization (GO:1901880),-0.3236147998914738,-0.9247877754290178,0.5416666666666666,0.8552073507897087,1.0,3/24,4.67%,PLEKHH2;NAV3;CLASP2
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.3867797998895321,0.9247293950893809,0.581294964028777,0.9087056022883612,1.0,9/36,15.74%,FHIT;GIPC1;F8A1;USP25;WAC;USP7;DDRGK1;TRIM39;TLK2
prerank,neuron apoptotic process (GO:0051402),-0.3475028470223,-0.9246686246587131,0.5905044510385756,0.8543190221447056,1.0,5/19,7.78%,BCL2;TNFRSF21;APP;FAS;GAPDH
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.31367024029756796,-0.9239477300937742,0.6050156739811913,0.8548729699193377,1.0,7/29,11.27%,WNT5A;SAMHD1;IFNAR2;HSP90AB1;NLRC5;USP18;RNASEL
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.33763681788625577,0.9238062569153819,0.5780487804878048,0.9100691471071767,1.0,24/88,16.32%,VPS13A;STXBP6;EXOC4;VPS13C;GOLGB1;CLINT1;ARL3;DOP1B;GBF1;EXOC5;RABEP1;AP4E1;AP2A1;COMMD1;KIF16B;SNAP23;SH3D19;SCAMP2;GOPC;GOLGA7;PUM1;CCDC22;MON2;ACBD3
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.44309193806578995,0.9237375534432986,0.5740432612312812,0.909654420658491,1.0,2/13,1.22%,SOAT1;RAMP1
prerank,regulation of biomineral tissue development (GO:0070167),0.4042158954136806,0.9234973715778749,0.5471976401179941,0.9095966740037515,1.0,4/26,4.63%,SOX9;DDR2;SGMS2;TXLNG
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.36525578547317333,0.9234664815693381,0.5655853314527504,0.9091162036110569,1.0,6/41,11.36%,CYP1B1;MGLL;ACOT8;DAGLB;SCD;ELOVL5
prerank,regulation of interferon-gamma production (GO:0032649),-0.2609747625448474,-0.922934821350301,0.6244343891402715,0.8561381466885082,1.0,16/71,18.87%,PDE4B;IL1R1;SLC7A5;CD47;PDE4D;SIRPA;IL18;GAS6;AXL;TLR7;TLR3;HAVCR2;VSIR;FZD5;NR1H4;CD276
prerank,regulation of adaptive immune response (GO:0002819),-0.35339441570738833,-0.9225999758052964,0.5850144092219021,0.8557915897303306,1.0,7/18,23.55%,AHR;ADCY7;IL6ST;SAMSN1;IRF7;TRIM27;PYCARD
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.4203648246708422,-0.9225563600786743,0.5698198198198198,0.8547226860692383,1.0,4/10,18.94%,LPGAT1;NR1H3;NR1H2;ABCD2
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.4601013315980656,0.9222919159486662,0.5522648083623694,0.911058453405325,1.0,4/12,28.29%,FDX1;STARD3NL;AKR1B1;STAR
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.3102468754899919,-0.9221884847168804,0.5742574257425742,0.854527153195219,1.0,10/31,13.40%,SHANK3;PPFIA2;EPHA4;LRP8;CFL1;ABI3;CAMK2B;CUX2;NGEF;KIF1A
prerank,peptide metabolic process (GO:0006518),0.3373645571206496,0.9221487219682777,0.559850374064838,0.9108055914373717,1.0,16/75,18.09%,PCSK5;NPEPPS;CPQ;DMD;MGAT3;IDE;MMACHC;GSR;NLN;BACE2;ERAP1;GSTM4;CARNMT1;DPEP1;GSTA2;GSTT1
prerank,histone H4-K5 acetylation (GO:0043981),0.439264799064144,0.9220646835371794,0.5856443719412724,0.9098808619482935,1.0,8/15,26.65%,KANSL2;KANSL3;KANSL1;HCFC1;PHF20;OGT;MCRS1;JADE2
prerank,histone H4-K8 acetylation (GO:0043982),0.439264799064144,0.9220646835371794,0.5856443719412724,0.9098808619482935,1.0,8/15,26.65%,KANSL2;KANSL3;KANSL1;HCFC1;PHF20;OGT;MCRS1;JADE2
prerank,mitotic recombination (GO:0006312),0.4435214524367327,0.9217495618114118,0.5634266886326195,0.9100054346523194,1.0,6/15,21.89%,SMC5;RAD52;RAD51;ERCC1;SMC6;RAD50
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.33950582320238043,-0.9214523544075324,0.5870206489675516,0.8551243747752626,1.0,6/25,10.51%,EPHA4;OPHN1;HSP90AB1;RPS7;RPL23;RPL11
prerank,anterograde axonal transport (GO:0008089),0.37469677258947365,0.9213836464408015,0.5787965616045845,0.9102110146180795,1.0,9/37,17.88%,AP3B1;KIF1B;DLG2;KIF1C;KIF3B;RAB27B;RAB21;AP3S1;AP3D1
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.38503970943985266,-0.9212889239069766,0.5661764705882353,0.8543028456105835,1.0,6/12,24.80%,MAOA;DDC;SMS;ATP7A;SLC22A3;SLC29A4
prerank,regulation of extracellular matrix organization (GO:1903053),-0.37664772189521817,-0.9210108925264965,0.5482093663911846,0.8538345347419733,1.0,5/15,10.18%,AEBP1;TIE1;NOTCH1;EFEMP2;FGFR4
prerank,cardiac myofibril assembly (GO:0055003),0.43206118522028575,0.9207863231182273,0.5553745928338762,0.9109290005810772,1.0,3/15,6.57%,CSRP3;MEF2A;NEBL
prerank,sphingolipid biosynthetic process (GO:0030148),-0.26801672047740543,-0.9206314275141463,0.6122448979591837,0.8536139771623693,1.0,23/71,17.91%,PRKD1;CERS4;SGMS1;ACER2;ELOVL7;CERT1;DEGS2;ELOVL6;SPHK1;ST8SIA1;SPTSSA;SPNS2;HACD3;CERS1;ELOVL4;CERS2;HACD2;ST8SIA5;SMPD1;ALDH3B1;PLPP2;CLN8;HACD1
prerank,ncRNA transcription (GO:0098781),0.44665165373489674,0.9204369760585212,0.5590682196339434,0.9111115049468135,1.0,2/13,10.54%,POLR1G;SNAPC2
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.464343032787948,0.9203105605287422,0.5355871886120996,0.9108046331528269,1.0,5/11,19.50%,STAT3;PUM2;DHX9;PUM1;FMR1
prerank,COPII-coated vesicle budding (GO:0090114),0.3491008513832679,0.9199497605414849,0.6130592503022975,0.9109845213723895,1.0,30/68,26.34%,SEC24B;STX5;SEC16A;NSF;SEC23A;ANKRD28;PPP6R3;SEC31A;CNIH2;SEC13;SEC24D;CUL3;TRAPPC10;SEC22B;SEC23IP;SAR1B;USO1;CSNK1D;PPP6C;SEC24A;TRAPPC3;RAB1A;BET1;PPP6R1;TRAPPC6A;MIA3;TRAPPC9;TBC1D20;AREG;PEF1
prerank,metanephric mesenchyme development (GO:0072075),0.4691196187271519,0.9196964107429896,0.5664939550949913,0.9109801304481384,1.0,2/10,8.09%,SIX1;SIX4
prerank,vesicle organization (GO:0016050),-0.28401773708887057,-0.9195920635740933,0.594488188976378,0.8549168357624173,1.0,9/46,17.23%,SORT1;FNBP1L;SRGN;CD34;DNM1;AKTIP;EPS15;DNAJC13;EXOC8
prerank,negative regulation of macroautophagy (GO:0016242),0.39907332022117015,0.9188512988231049,0.5583832335329342,0.912146753618585,1.0,13/26,25.27%,CLEC16A;TMEM39A;SMCR8;SMG1;MTOR;SEC22B;NRBP2;USP36;RUBCN;CHMP4A;CHMP4B;LZTS1;PHF23
prerank,mitochondrial translational termination (GO:0070126),0.33049451089912485,0.9187877745491525,0.5741857659831122,0.911733268400928,1.0,36/88,31.58%,MRPL33;MRPL48;MRRF;MRPS27;MRPL32;MRPL14;MRPL40;GFM2;MRPS31;MTRF1;MRPL21;MRPL42;MRPS30;MRPL57;MRPS35;MRPS28;MRPL52;MRPL38;MRPS22;MTRF1L;MRPL10;MRPS10;MRPL36;MRPL20;MRPL47;MRPL11;MRPS7;MRPS2;MRPL23;MRPS18A;MRPL19;MRPS21;MRPL9;MRPS18C;MRPS34;MRPS16
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.42686544318933306,0.9186851932396403,0.5464926590538336,0.911397963211607,1.0,5/15,16.14%,TNRC6C;TOB1;PABPC1;CNOT7;AGO2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3305679279812448,-0.9185832582056944,0.5930232558139535,0.8561099830706718,1.0,8/24,19.18%,NR1H3;BCL2L1;AQP11;TMBIM6;RACK1;NR1H2;SELENOS;XBP1
prerank,negative regulation of bone mineralization (GO:0030502),0.4514245291274971,0.9184520969283108,0.5691318327974276,0.9113237065931008,1.0,3/13,11.16%,PTK2B;TRPM4;CCL3
prerank,regulation of GTPase activity (GO:0043087),0.3138188103196373,0.9176404577283153,0.6485587583148559,0.9125027378134167,1.0,34/177,11.68%,ARAP1;EFNA5;WNK1;WNT11;SGSM2;SIPA1L1;MAPRE2;VAV2;ITGB1;ARHGAP44;GSK3B;SRGAP2;NDEL1;SNX18;RAP1A;BCAS3;ADAP1;EPHB3;RDX;OCRL;RAPGEF6;RGP1;RAB3GAP2;FGD6;BCAR3;S100A10;NF1;LIMS1;CCL3;ERBB2;ITGB1BP1;CCL1;ARHGEF5;ASAP3
prerank,receptor metabolic process (GO:0043112),0.3553414208678051,0.9176070620729219,0.5773195876288659,0.9120352505486596,1.0,7/53,6.39%,RAMP1;NEDD4;CD9;ITGB1;BECN1;LRP1;EHD3
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3318627479322791,0.9172331854579239,0.5731414868105515,0.9123027366323694,1.0,12/87,12.78%,RBFOX2;CD44;FGFR1;FGF2;SPRED2;SHOC2;FLRT2;HNRNPH1;KIF16B;ITGB1BP1;FGF22;NR4A1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.41135433530759447,0.9171222340609085,0.5703245749613601,0.9119637873445645,1.0,2/18,4.67%,MET;CCDC125
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.3876859435895774,0.917055288330047,0.5779411764705882,0.9115674917350309,1.0,13/29,31.02%,MNAT1;CHD1L;ERCC5;RAD23B;ERCC3;XPA;RPA1;CUL4A;ERCC2;XPC;GTF2H3;CDK7;CUL4B
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.4132188261873754,0.9168746950544258,0.5700787401574803,0.9113896345460208,1.0,10/22,26.86%,GSK3B;CRY2;STYXL1;BOD1L1;MGAT5;PTPA;LGALS3;ROCK1;FKBP1B;IKBKB
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.3214551696236681,-0.916784885755401,0.5762195121951219,0.8591654378327781,1.0,16/25,25.51%,RBPJ;DGKD;CCDC88A;AFAP1L2;HIP1R;RTN4;HIP1;CNOT9;AGT;AKT1;NUP62;GPER1;PLAUR;PDE6G;DOK1;HAP1
prerank,cellular response to leucine starvation (GO:1990253),0.46794494242405926,0.9159572323872781,0.5660377358490566,0.9126902168691768,1.0,3/10,14.27%,RRAGB;MTOR;EIF2AK4
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.39414439691763453,-0.9155150212716067,0.5644028103044496,0.8610434828644241,1.0,1/10,1.71%,RAPGEF3
prerank,regulation of cell-cell adhesion (GO:0022407),0.3690263338142973,0.9154160904098754,0.5698478561549101,0.9132754165319745,1.0,5/39,6.52%,CDH1;EFNA5;EPHB3;JAG1;ADA
prerank,cardiac atrium morphogenesis (GO:0003209),-0.3607961493101347,-0.9153220415338508,0.5800524934383202,0.8603780057309863,1.0,5/16,8.97%,ENG;NOTCH1;BMP2;HEY2;PROX1
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.3489199681742373,-0.9152285290672275,0.581081081081081,0.8594525366564303,1.0,6/19,20.23%,DDO;ALDH7A1;ASPA;GOT2;AASS;GCDH
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.41962787728435036,0.9151320350111172,0.5603864734299517,0.9122494269586116,1.0,8/20,25.84%,KLHL22;ATM;MAD2L1;ZW10;TEX14;CDC20;BUB3;TTK
prerank,spindle assembly checkpoint signaling (GO:0071173),0.41962787728435036,0.9151320350111172,0.5603864734299517,0.9122494269586116,1.0,8/20,25.84%,KLHL22;ATM;MAD2L1;ZW10;TEX14;CDC20;BUB3;TTK
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.41962787728435036,0.9151320350111172,0.5603864734299517,0.9122494269586116,1.0,8/20,25.84%,KLHL22;ATM;MAD2L1;ZW10;TEX14;CDC20;BUB3;TTK
prerank,positive regulation of cell growth (GO:0030307),0.3257934298848015,0.9146807691078185,0.616945107398568,0.9126236503038843,1.0,23/96,19.88%,EGFR;NTN1;NGF;TGFBR1;EIF4G1;KLHL22;SHTN1;MMP14;USP47;ERBB2;ZFYVE27;SMURF1;EIF4G2;ADAM10;CEP43;DDX49;INO80;DNPH1;CSNK2A1;GOLGA4;BRAT1;ISLR2;TGFB2
prerank,negative regulation of cellular component organization (GO:0051129),0.34019058934364743,0.9145604703018527,0.5822942643391521,0.9123223925373815,1.0,9/74,10.37%,TMEFF2;BMP6;GSK3B;ISL1;CLU;RDX;LRSAM1;IRAK3;VEGFA
prerank,cellular iron ion homeostasis (GO:0006879),-0.2670989593162879,-0.9139744798071726,0.6198347107438017,0.8612282605837694,1.0,9/55,12.97%,CP;FTH1;TFRC;SLC40A1;FTL;ABCB7;BOLA2;ATP6AP1;SLC22A17
prerank,second-messenger-mediated signaling (GO:0019932),-0.2535734626273927,-0.9135828818568518,0.6630434782608695,0.8609990508905576,1.0,13/82,8.58%,APOE;CCR9;NOS3;MCTP1;GUCY1B1;RYR2;NDNF;DGKD;MCTP2;GUCY1A1;CHRM3;SPHK1;EDN1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.43413792073123697,0.9134881123956009,0.5636942675159236,0.9139726877501498,1.0,4/15,21.17%,USP46;CLN3;ZDHHC12;STXBP1
prerank,histone H3-K36 demethylation (GO:0070544),-0.4047467672587155,-0.9131707250437396,0.5721040189125296,0.8608230783600608,1.0,2/10,7.36%,KDM7A;KDM2B
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.31054609210803863,0.9130514039543075,0.6314631463146315,0.914375764321968,1.0,23/161,10.57%,TCF7L2;SOX9;LRP6;MLLT3;PTPRU;WNT11;GLI3;PRICKLE1;GSK3B;SFRP4;TLE2;NOG;TLE6;INVS;DDIT3;PSMB2;CSNK1A1;RBMS3;DACT1;DKK3;PSMC6;IGFBP6;EMD
prerank,long-term memory (GO:0007616),-0.33418286565969735,-0.9130301238109895,0.5721925133689839,0.8599984654954131,1.0,3/19,5.66%,APOE;RASGRF1;SGK1
prerank,receptor internalization (GO:0031623),0.3632811204222599,0.9125979696825514,0.5875486381322957,0.9147832473505016,1.0,5/44,5.58%,RAMP1;NEDD4;CD9;ITGB1;LRP1
prerank,negative regulation of response to wounding (GO:1903035),0.4185075237321286,0.9124711482783326,0.5780254777070064,0.9144991158341055,1.0,2/19,3.27%,CD109;FGF2
prerank,regulation of autophagosome assembly (GO:2000785),0.3824241014830473,0.9121986858167551,0.5714285714285714,0.9145341629075385,1.0,18/33,28.65%,NPRL3;RAB3GAP2;TMEM39A;LRSAM1;SMCR8;SH3GLB1;SEC22B;RAB5A;NPRL2;PIP4K2A;CHMP4A;CHMP4B;PHF23;RAB3GAP1;PIKFYVE;IFT88;RALB;FEZ2
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.2991031842661282,-0.9119782945298958,0.5808580858085809,0.8613099968407125,1.0,8/30,20.63%,HSPA8;ERO1A;HSPA13;PTGES3;CHCHD4;DNAJB5;HSPA9;HSPE1
prerank,negative regulation of TOR signaling (GO:0032007),-0.3025743799007766,-0.9115811639724929,0.6029411764705882,0.8610794446654751,1.0,12/36,22.94%,RNF152;PRKAA2;SPAAR;TNFAIP8L1;SH3BP4;GSK3A;TMEM127;DEPTOR;MINAR1;DDIT4;CASTOR1;SESN1
prerank,positive regulation of innate immune response (GO:0045089),0.38463534598675925,0.9115181153059598,0.5887573964497042,0.9153910914369235,1.0,10/30,18.77%,LBP;POLR3D;MAVS;PLSCR1;IFI35;DHX9;TLR8;UBE2K;POLR3F;ADAM8
prerank,plasma membrane invagination (GO:0099024),0.389247392261489,0.9110585297961274,0.5859154929577465,0.915817718169392,1.0,5/29,12.09%,GULP1;GSN;SNX18;RHOA;BIN2
prerank,snRNA metabolic process (GO:0016073),0.41693056180119215,0.911048333487375,0.5571658615136876,0.9153030006715143,1.0,10/17,33.39%,ZCCHC8;INTS8;INTS5;INTS6;INTS1;INTS9;INTS2;INTS3;INTS7;MEPCE
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.45998918889948653,0.9110468133886159,0.5726495726495726,0.9142279712057169,1.0,1/10,2.04%,PRKCD
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.45998918889948653,0.9110468133886159,0.5726495726495726,0.9142279712057169,1.0,1/10,2.04%,PRKCD
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.3400258087752481,0.9108948580852768,0.5833333333333334,0.9140042629048359,1.0,18/69,23.35%,UBE4B;RNF185;VCP;ANKZF1;UBE4A;PSMC6;FBXO17;UBXN4;ERLIN1;NPLOC4;OS9;EDEM2;UFD1;TRIM25;ECPAS;FAF2;HERPUD1;FBXO27
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.44885179784427764,0.9107497445168707,0.5878378378378378,0.9137632107528032,1.0,4/11,11.16%,P2RX2;P2RX4;PLCG2;CCL3
prerank,regulation of translational initiation (GO:0006446),0.34556065213623166,0.910445819771881,0.5879332477535302,0.9138458540883293,1.0,21/63,23.70%,EIF4G3;PAIP2;NCK2;EIF4G1;DNAJC3;EIF3E;EIF2AK4;EIF2B2;EIF4G2;AGO2;KHDRBS1;MTIF2;EIF4B;FMR1;YTHDF2;NCK1;DDX1;EIF2AK3;CDC123;RBM4;YTHDF3
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.4098595873921347,0.9104288784365622,0.5714285714285714,0.913341384967391,1.0,3/20,2.46%,SEMA3E;SEMA3D;SEMA3C
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.4475904043326132,0.9100799565238199,0.5738255033557047,0.9134841792877807,1.0,3/12,11.83%,STX11;SNAP23;STX19
prerank,glycogen metabolic process (GO:0005977),0.3809452393026894,0.9098753338186633,0.5859598853868195,0.913377859493163,1.0,5/27,8.79%,PYGB;GSK3B;PPP1R3C;PHKA2;PHKB
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.44675910893568216,0.9096611037679099,0.5868852459016394,0.9132692429228334,1.0,4/13,9.13%,FSTL1;NOG;NBL1;CD46
prerank,mammary gland development (GO:0030879),-0.33258852217714685,-0.9095085948104958,0.5826558265582655,0.8647202810093434,1.0,4/21,6.00%,WNT4;TBX3;ERBB4;NOTCH4
prerank,cell cycle checkpoint signaling (GO:0000075),0.4569959901547942,0.9089018821680884,0.571900826446281,0.9143011783237178,1.0,6/12,21.07%,NABP1;CHFR;PRCC;ZWILCH;ZW10;WEE1
prerank,microtubule bundle formation (GO:0001578),0.3637120493282047,0.9084822565971992,0.5918635170603674,0.9146287025000936,1.0,8/42,12.46%,RP1;CLIP1;GAS2L2;TOGARAM1;CAPN6;CCDC40;CCDC66;CHP1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.3384140968494187,0.9084575386332163,0.5947955390334573,0.9141418622874342,1.0,7/67,4.25%,EGFR;PTK2B;ABI1;DDR2;FGFR1;ABL1;EFEMP1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.4374513618850495,0.908416325830884,0.5815126050420169,0.9136936396004701,1.0,4/13,20.10%,RENBP;UAP1;SLC35A3;GFPT1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.32469102801060923,-0.9077781568780573,0.6034985422740525,0.8675672554691777,1.0,5/23,12.35%,PARP14;NR1H3;HSP90AB1;NLRC5;STAT1
prerank,negative regulation of proteolysis (GO:0045861),0.37116437686145065,0.9076524538790589,0.5899581589958159,0.9147899124751543,1.0,9/34,15.25%,PTPN3;TIMP2;GAS1;IL10;TIMP1;DNAJC1;SNX12;SERPINE2;ACP4
prerank,alpha-amino acid catabolic process (GO:1901606),-0.3067146208149061,-0.9075483344503068,0.6165644171779141,0.8669808873525447,1.0,5/29,16.87%,DDO;ALDH4A1;SARDH;CBS;GOT2
prerank,receptor-mediated endocytosis (GO:0006898),0.31810033749394107,0.9073867947476484,0.6242905788876277,0.914774352873796,1.0,21/132,10.22%,RAMP1;LRP6;NEDD4;PDLIM7;CD9;ADRB2;COLEC11;ITGB1;AP2A2;IGF2R;LRP1;GAK;LDLR;CLTB;HPX;GPR107;AP4E1;AP2A1;FCHO2;PI4KB;CTTN
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.39554827268442927,-0.9070636797950853,0.5961995249406176,0.8669927684471039,1.0,1/11,3.94%,AHR
prerank,regulation of embryonic development (GO:0045995),-0.29767530091294997,-0.9068847569820339,0.6351351351351351,0.866264538310926,1.0,10/34,15.78%,PLCB1;INSR;CLASP2;SOX17;CFL1;DAG1;NR2C2;WDPCP;RBM19;RPS6KA6
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.3362558724254748,-0.9065961416748785,0.6089385474860335,0.8658079640225614,1.0,12/21,36.77%,PAG1;SAMSN1;DUSP3;JAK3;TNFAIP3;LAPTM5;FOXJ1;LST1;FGL1;IL4I1;TNFAIP8L2;FCGR2B
prerank,regulation of programmed cell death (GO:0043067),0.3072952112548894,0.9064451629755967,0.6409978308026031,0.9161339824477419,1.0,30/161,17.21%,ACER3;PERP;SOX9;NDRG1;FBXO10;CRADD;ABL1;VCP;CASP6;CREBBP;CLU;GAS1;KANK2;RIPK3;WRN;RBM25;ATM;RARG;APEX1;HTATIP2;DDX42;OMA1;PLSCR3;TMEM219;BCL6;PIDD1;ZBTB7A;CASP2;AIFM2;BIRC3
prerank,positive regulation of GTPase activity (GO:0043547),0.3054637973085108,0.9062893616429077,0.6594827586206896,0.9159405132992227,1.0,43/188,14.15%,NTRK3;ARAP1;WNT11;SGSM2;SIPA1L1;MAPRE2;ITGB1;GSK3B;DOCK7;BCR;SRGAP2;NDEL1;SNX18;RAP1A;TIAM2;CCDC125;BCAS3;PIP5K1A;GRTP1;RAPGEF6;RGP1;BCAR3;ARHGEF10;S100A10;NF1;LIMS1;TBC1D2B;TBC1D13;CCL3;ERBB2;CCL1;ARHGEF5;ASAP3;TIAM1;TBC1D25;CORO1C;ARHGAP42;RAP1GAP2;CCL7;SIPA1L2;TBC1D8B;RSU1;TBC1D10A
prerank,positive regulation of cellular metabolic process (GO:0031325),0.3283197095311251,0.906140197421343,0.6009501187648456,0.9156942781339833,1.0,9/98,5.03%,THBS1;PID1;ANXA2;KLF4;INHBA;AGTR1;EIF4G1;SFRP4;TGFBR2
prerank,regulation of mitochondrial fusion (GO:0010635),0.45495163521716786,0.9060772092771053,0.5906040268456376,0.915273800192648,1.0,1/11,1.83%,PID1
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.34810707516117767,-0.9057076457560569,0.5774278215223098,0.8667334473886682,1.0,2/16,3.80%,IGF1R;INSR
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.3376871063772159,-0.9054025740074219,0.6056338028169014,0.8663208855265969,1.0,6/17,17.39%,CLDN5;F11R;S1PR3;ROCK2;TNFRSF1A;CDH5
prerank,regulation of interleukin-17 production (GO:0032660),-0.3002529837864676,-0.9053014152426161,0.5821917808219178,0.8654201733900931,1.0,5/31,8.10%,RFTN1;SLC7A5;PRKCQ;IL18;SPHK1
prerank,regulation of mitochondrion organization (GO:0010821),0.3512931328983601,0.9051088359911644,0.5867346938775511,0.9166624511470567,1.0,14/47,23.98%,PID1;GSK3B;GOLPH3;OMA1;PLSCR3;PRMT6;EP300;SQSTM1;SREBF1;CSNK2A2;USP36;PARL;RHOT1;MIEF2
prerank,protein homotrimerization (GO:0070207),0.4308982982290482,0.9049352449247752,0.5951219512195122,0.915950402626586,1.0,2/14,3.83%,DISP1;SCARA5
prerank,protein trimerization (GO:0070206),0.4308982982290482,0.9049352449247752,0.5951219512195122,0.915950402626586,1.0,2/14,3.83%,DISP1;SCARA5
prerank,regulation of fatty acid oxidation (GO:0046320),0.4218225148648654,0.9043724520162185,0.5865384615384616,0.9165232597490329,1.0,2/16,4.34%,SOX9;NR4A3
prerank,long-chain fatty acid transport (GO:0015909),-0.30660277556079996,-0.9041499016833403,0.6290322580645161,0.8668552177199802,1.0,7/30,10.41%,ACSL1;APOE;PRKAG2;PRKAA2;ACACB;MFSD2A;FABP5
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.3778738896220008,-0.9037674142407591,0.579746835443038,0.8666388006116159,1.0,5/13,14.83%,IL18;GAS6;AXL;LAMP1;TYROBP
prerank,regulation of gene silencing by miRNA (GO:0060964),0.3402316821681247,0.9035752684541096,0.6040868454661558,0.9176103183190268,1.0,19/62,23.75%,NUP93;EIF4G1;STAT3;RANBP2;NUP153;SEC13;PUM2;DHX9;PUM1;NUP214;AGO2;NUP188;PPARG;NUP88;FMR1;NUP98;TNRC6A;AAAS;NUP54
prerank,regulation of cellular protein metabolic process (GO:0032268),0.35375508836799746,0.9030423988587745,0.6013888888888889,0.918127570472609,1.0,8/47,9.97%,FOXO3;KLF4;INHBA;AGTR1;EIF4G1;CNDP1;NFKB1;ATXN2
prerank,regulation of response to external stimulus (GO:0032101),0.31773099045083764,0.9029015518473026,0.6290322580645161,0.9178997900961313,1.0,19/121,14.73%,FOXP1;CD55;ANXA1;MGLL;PIK3AP1;AGTR1;PDE6A;IRF1;CELF1;DAGLB;P2RX4;NLRP6;SHPK;ERAP1;MYD88;CXCR4;BCL6;RNF135;SBNO2
prerank,mitotic cell cycle phase transition (GO:0044772),0.300036509912981,0.9026870952801198,0.6684841875681571,0.9178184382793413,1.0,57/203,23.69%,FBXL7;CCNA2;INHBA;PPP1R12B;SFI1;PAFAH1B1;MNAT1;PCM1;E2F3;CDC16;CDC25B;PPP2R2D;CEP164;CHEK2;PLK3;CDKN1B;FBXW11;CEP63;AURKA;ACVR1;AKAP9;GSPT1;PIM2;PPP1R12A;CEP131;FBXL6;RB1;CDKN3;UBE2S;CUL3;CSNK1E;CCND1;SDCCAG8;HINFP;CUL1;CEP43;HAUS2;CEP57;KHDRBS1;CDKN1A;CEP70;E2F1;CSNK1D;FBXL8;PPP6C;ARPP19;WEE1;OFD1;CUL4A;CCNG1;CNTRL;FBXL17;HAUS5;PLK4;CDK2;CCNB1;CHMP4B
prerank,negative regulation of translational initiation (GO:0045947),0.4382607212770586,0.9025937406020612,0.568760611205433,0.9174935152539367,1.0,7/13,27.04%,PAIP2;EIF3E;EIF2AK4;AGO2;FMR1;RBM4;EIF2AK1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.40870438654744456,0.9020329969165827,0.5726210350584308,0.918083232162596,1.0,5/16,9.87%,SOX9;LTBP3;GATA4;FOXC1;HOXB4
prerank,oligosaccharide metabolic process (GO:0009311),0.35271713964288914,0.9010994697614451,0.6038514442916093,0.9194705874278454,1.0,2/46,1.55%,ST3GAL4;FUT8
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.37796590098537175,0.9005910559697274,0.5890804597701149,0.9199915411439803,1.0,12/31,15.07%,EZR;DLG2;PDCD6IP;DLG1;MARK2;RHOA;SYNE4;ERBIN;PARD3;MYO9A;WDR1;SYNJ2BP
prerank,DNA-dependent DNA replication (GO:0006261),0.31332387604855927,0.900376216215886,0.627906976744186,0.9198883092185697,1.0,40/128,27.63%,REV3L;PSMB2;MCM7;WRN;MCM2;MCMBP;PSMC6;BAZ1A;CDC45;PSMD11;PRIM2;POLG2;POLB;POLE2;PSMD1;DDX21;RPA1;RECQL5;PSMD7;GINS3;PSMC1;RAD51;PRIM1;RFC1;PSMD14;TOPBP1;HELB;POLA1;PSMD3;POLD3;CDK2;NOC3L;RFC5;PSMD12;PSMD4;SRPK2;ORC3;CDK2AP1;PSMD2;PSME3
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.38826402807865124,0.9003216186734995,0.5964653902798233,0.9194598553460319,1.0,5/27,10.77%,MARK1;GSK3B;NDEL1;DISC1;MBOAT1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.35188372674349333,-0.9002993394194306,0.6166219839142091,0.8735059489269826,1.0,5/16,23.44%,CLDN5;CLDN1;CLDN10;CLDN14;CLDN18
prerank,heart contraction (GO:0060047),0.3574241930117013,0.8998631788961009,0.6151685393258427,0.9198629765157912,1.0,4/41,5.55%,SGCD;ATP1B1;CSRP3;DMD
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.29855190745006477,-0.8998093364207751,0.6222910216718266,0.8734972850402235,1.0,1/31,0.08%,PLCB1
prerank,mRNA stabilization (GO:0048255),0.3669515341917006,0.8995154706241866,0.5789473684210527,0.9200366655944117,1.0,13/40,20.20%,YBX3;GDNF;SYNCRIP;FUS;PABPC1;MYD88;ANGEL2;DHX9;MAPKAPK2;THRAP3;CIRBP;E2F1;TENT5D
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3278184385134592,0.8992064294082327,0.6178960096735188,0.9201082513733159,1.0,11/85,12.18%,PIEZO2;ATP6V0A4;COL11A1;TBL1X;ROR1;P2RX2;P2RX4;CDC14A;SLC52A3;NIPBL;HOMER2
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.40693325519701606,0.8991745281064052,0.5862619808306709,0.9196490933094313,1.0,8/21,25.84%,KLHL22;ATM;MAD2L1;ZW10;TEX14;CDC20;BUB3;TTK
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.39432457951724537,-0.8990668491394778,0.5933806146572104,0.8740369668137554,1.0,5/10,24.40%,ATP5F1A;ATP5MC1;ATP5F1D;ATP5MC2;ATP5MC3
prerank,regulated exocytosis (GO:0045055),0.30496020696289033,0.8989690473035046,0.651564185544768,0.9195005825739556,1.0,22/173,10.80%,THBS1;PCDH7;LHFPL2;CD109;TGFB3;FN1;CD9;FAM3C;SYTL4;VCL;CLU;DNAJC5;CLTRN;SYT8;ARHGAP17;SERPING1;PDGFA;GTPBP2;PCLO;TIMP1;VEGFA;ITGB3
prerank,regulation of platelet aggregation (GO:0090330),-0.35539976319766464,-0.8989306306869795,0.5753424657534246,0.8732289331126476,1.0,4/17,5.69%,LYN;PRKG1;F11R;PRKCQ
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.42028475888407685,0.8986949895570764,0.5753205128205128,0.9194920428551703,1.0,3/16,15.90%,RAET1E;PLEKHM2;LYST
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.4262142125743887,0.8981680013100595,0.5880452342487884,0.9200055285708565,1.0,4/15,8.27%,CAMK2D;MEF2A;NR4A3;SLC9A1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.3237601335902803,-0.8979439136229308,0.6450704225352113,0.8743001565957907,1.0,6/24,13.41%,ITPR1;RYR2;HTR2C;HTR2A;ERO1A;CCL19
prerank,tRNA modification (GO:0006400),0.33861816779303333,0.8978050164283468,0.625,0.9202023043600672,1.0,32/62,35.74%,TYW5;MTO1;TYW1;ELP5;ALKBH8;TRMT13;PUS10;METTL6;CTU2;TRMT10A;TARBP1;TRDMT1;METTL1;MOCS3;SSB;PUSL1;QTRT1;THADA;GTPBP3;PUS7;URM1;THUMPD2;FTSJ1;TRMT12;METTL2B;METTL2A;TRMT44;ALKBH1;WDR4;TRMT61B;DUS2;TRMT6
prerank,positive regulation of stem cell proliferation (GO:2000648),0.42135890583029434,0.8977380147746497,0.5677830940988836,0.9197877646821688,1.0,2/17,6.10%,LTBP3;KDM1A
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3875476574873433,0.897437350470413,0.5853658536585366,0.9198526767359799,1.0,8/21,18.49%,MED13;BCLAF1;JUN;HNF1A;MED14;TWIST1;MED24;DHX36
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.4415752536967733,0.8973157321621736,0.5767918088737202,0.9195598237861664,1.0,3/11,9.50%,SOAT1;ITM2C;BACE2
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.464304653752512,0.8970398532215703,0.5877192982456141,0.9196129352785666,1.0,6/10,27.68%,TLR4;MYD88;TLR6;MIA3;CD36;TICAM1
prerank,regulation of macrophage differentiation (GO:0045649),-0.35386355040446843,-0.8968685731957341,0.5763546798029556,0.8756608173008772,1.0,2/15,3.49%,IL34;CSF1
prerank,regulation of biosynthetic process (GO:0009889),-0.38095933211828914,-0.8967809642341898,0.5957446808510638,0.8747609058711346,1.0,6/11,36.33%,SNCA;SLC25A33;SPHK2;MID1IP1;GSTP1;CCN6
prerank,I-kappaB phosphorylation (GO:0007252),0.4555068089752055,0.8966535421665448,0.5890652557319224,0.9198372195285043,1.0,3/10,9.07%,ERC1;TLR4;CHUK
prerank,protein ADP-ribosylation (GO:0006471),-0.3111348145735176,-0.8966484225037299,0.6018808777429467,0.8739192077033793,1.0,9/28,21.60%,PARP14;ART3;PARP16;TIPARP;PARP8;PARP11;SIRT5;PARP10;HPF1
prerank,mitochondrial translation (GO:0032543),0.31584697997733885,0.8962158109539816,0.6261574074074074,0.92016724400187,1.0,40/104,31.58%,MRPL33;EARS2;MRPL48;MRRF;MRPS27;MTIF3;MRPL32;MRPL14;MRPL40;GFM2;MRPS31;MTRF1;NOA1;MRPL21;MRPL42;MTIF2;MRPS30;MRPL57;MRPS35;MRPS28;MRPL52;MRPL38;MRPS22;MTRF1L;MRPL10;MRPS10;MRPL36;MRPL20;MRPL47;MRPL11;MRPS7;MRPS2;MRPL23;MRPS18A;MRPL19;MRPS21;MRPL9;MRPS18C;MRPS34;MRPS16
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.4121422148477592,0.8961079146013652,0.5813609467455622,0.9198494336026499,1.0,2/17,3.88%,NFE2L2;VNN1
prerank,establishment of protein localization to organelle (GO:0072594),0.3324401141716324,0.8959809726738943,0.6173469387755102,0.9195633360109496,1.0,18/72,20.44%,PRICKLE1;NUP93;STAT3;E2F3;IPO7;TNPO2;LRSAM1;ZDHHC15;NUP153;SEC13;NUP214;NUP188;NUP88;HEATR3;TNPO3;TSPAN17;RAN;NUTF2
prerank,nucleocytoplasmic transport (GO:0006913),-0.27814122494600874,-0.8959650413187763,0.6515151515151515,0.874309269890876,1.0,11/40,23.08%,ATXN1;BACH2;ANP32A;NPM1;SNRPG;MALT1;DDX20;NUP205;RBM15B;PHAX;NXT2
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.2575762542608449,-0.8958379068500173,0.694300518134715,0.8734477547768023,1.0,24/70,26.67%,ENPP2;SLC44A1;NR1H3;LPIN3;DBI;ABHD3;PNPLA8;MFSD2A;SLC44A2;CHKA;TMEM86B;LPIN1;NR1H2;SLC27A1;PLAAT3;PCYT1B;PLA2G4C;PLA2G7;PLA2G5;PEMT;ACHE;PLBD1;PLA2G4E;PLB1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.27479566667545313,-0.8957383447337072,0.623574144486692,0.8725481475393878,1.0,10/44,19.50%,CYP7B1;CYP27A1;PRKAG2;INSIG2;OSBPL1A;ALOX12;SCP2;CH25H;SC5D;OSBPL7
prerank,iron ion transmembrane transport (GO:0034755),0.448710241738258,0.8954875372815673,0.609375,0.92002832331498,1.0,2/10,3.83%,SLC39A14;SCARA5
prerank,regulation of exosomal secretion (GO:1903541),0.4026573308997482,0.8950753551553096,0.5828220858895705,0.9203450762602079,1.0,8/19,23.94%,PDCD6IP;SDC4;TSG101;SNF8;SDC1;HGS;ATP9A;RAB7A
prerank,C4-dicarboxylate transport (GO:0015740),0.421789852655268,0.8945269671763918,0.5930599369085173,0.9209118269316535,1.0,1/14,1.34%,LRRC8D
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.33725324236987514,0.8941704453482785,0.622568093385214,0.921076048541308,1.0,16/59,21.29%,TANK;ERC1;TAB3;RIPK2;REL;TLR4;CHUK;IRAK1BP1;TRADD;TLR8;IKBKG;BIRC3;BCL10;LY96;RNF31;RBCK1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.2637937932994288,-0.8930553912606197,0.6605504587155964,0.8774948886768116,1.0,14/63,16.10%,BCL2;VCAM1;TFRC;MEF2C;CD81;VAV3;CD38;IL18;IL6ST;MIF;CCL19;CD74;JAK3;CD40
prerank,cranial nerve development (GO:0021545),-0.3895201028668712,-0.8929553814558884,0.6122448979591837,0.8766113331838357,1.0,2/11,4.40%,CHD7;SALL1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.42339306296651236,0.8928265362441061,0.5888157894736842,0.9231958497906134,1.0,4/14,16.45%,USP15;PUM2;PUM1;ANKRD17
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.42194443119918745,0.8926680626068119,0.5672913117546848,0.9229718942002609,1.0,5/14,31.26%,FUS;MRNIP;WDR48;RAD51AP1;ACTR2
prerank,positive regulation of MAPK cascade (GO:0043410),0.29703782306975196,0.8924593676264682,0.6911764705882353,0.9228430431187787,1.0,17/245,4.33%,BMPER;EGFR;TNFAIP8L3;NTRK3;ADRA1B;PDGFC;PTK2B;CD44;ADRB2;FGFR1;MID1;SHC1;FGF2;NOTCH2;NRP1;GAREM1;RAP1A
prerank,positive regulation of exosomal secretion (GO:1903543),0.42348512077627154,0.8922850913752433,0.5966666666666667,0.9226831331781358,1.0,7/15,23.94%,PDCD6IP;SDC4;TSG101;SNF8;SDC1;HGS;RAB7A
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.39763777798098077,-0.8922048823669294,0.610705596107056,0.877119446755187,1.0,3/10,5.82%,VTN;PRKCB;HIF1A
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.4355901518740693,0.8920204140171014,0.5904605263157895,0.9226563958134131,1.0,4/14,14.99%,YBX3;MYD88;ANGEL2;MAPKAPK2
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3613280229696401,0.8918601724217008,0.5959302325581395,0.9224444318155244,1.0,7/35,13.09%,HOXA5;FOXO3;INHBA;STAT3;GATA1;BRD1;PRKDC
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3524527883776659,0.8917941615073526,0.6193820224719101,0.9220657787239049,1.0,15/45,25.61%,FOXO3;GCNT2;ZC3H7A;ATXN2;PER1;PUM2;TDRD7;PUM1;PUM3;LARP4;MATR3;RBM3;NUDT21;RBM4B;CYFIP1
prerank,mRNA metabolic process (GO:0016071),0.3193681802287891,0.8916458769260651,0.6181384248210023,0.9218320687789343,1.0,24/90,22.77%,DDX5;SON;SRSF11;SRSF5;CELF1;DXO;U2AF2;TCERG1;SCAF11;LSM11;ZC3H12D;PRPF3;KIN;SF3B2;DIS3L2;NUDT12;SRSF2;LSM2;PRPF18;YTHDF2;ALKBH5;SSB;NANOS2;AKAP8L
prerank,establishment of mitotic spindle localization (GO:0040001),0.3851152506294331,0.8915862845434519,0.5937961595273265,0.9214207288136002,1.0,9/28,21.28%,ITGB1;NDEL1;PAFAH1B1;MISP;FBXW11;MAD2L1;SPDL1;ZW10;GPSM2
prerank,ribosomal large subunit assembly (GO:0000027),-0.3106034545006161,-0.8914389184784144,0.6124260355029586,0.8776958305683221,1.0,10/24,28.97%,RPL23A;RPL11;FASTKD2;RPL24;RPL3;RPL5;RPLP0;RRS1;DDX28;RSL24D1
prerank,T cell homeostasis (GO:0043029),0.4474743900030645,0.8914370424614542,0.6035087719298246,0.9212023204812759,1.0,2/10,9.15%,PPP2R3C;RIPK3
prerank,macrophage activation involved in immune response (GO:0002281),0.42825525835973605,0.891337807111837,0.5889070146818923,0.9208715622039821,1.0,4/13,14.73%,LBP;IFI35;PLCG2;SBNO2
prerank,myelin assembly (GO:0032288),0.45573002452611944,0.8912193323359472,0.6095406360424028,0.9205634517340722,1.0,2/10,3.86%,CD9;PMP22
prerank,cytokine-mediated signaling pathway (GO:0019221),0.28687835934444883,0.8907437637786284,0.7852822580645161,0.9209498431846624,1.0,72/532,13.48%,F3;TNFRSF11B;CARD14;EDA;LBP;PTK2B;CAMK2D;TRAF3IP2;ANXA1;FN1;ANXA2;PRKCD;IL17RE;IL22RA1;FOXO3;CD44;GRB10;PITPNA;MID1;SHC1;ITGB1;GAB2;FGF2;IRS1;IP6K2;CLCF1;PDCD4;TAB3;CD80;IL17RA;IRAK4;STAT3;RORA;RIPK2;IRF1;MAP3K3;IFI35;PSMB2;IL10;SOCS2;CDKN1B;CXCL2;FOXC1;NFKB1;CHUK;TNFRSF13B;IL33;FBXW11;CTF1;IRAK3;LIMS1;PSMC6;TIMP1;CDIP1;VEGFA;IL20RB;IL18BP;TRIM26;CAPZA1;TNFSF11;CCL3;CCL1;MYD88;TRAF5;TNFRSF1B;SMARCA4;IL5;CSK;CCL7;PSMD11;PAK2;CTR9
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.35750534241800197,-0.8907042035743831,0.6195372750642674,0.8782142339767821,1.0,6/16,17.34%,ACE;PRCP;ADM;KLK2;GSK3A;GPR37L1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.31093838434890153,-0.8906434578934994,0.6461538461538462,0.8772530978887523,1.0,11/25,26.32%,CEMIP;AKAP6;SNCA;PLCG1;TRPC1;APLNR;GPER1;CX3CL1;F2R;RAMP3;CASQ1
prerank,axonogenesis (GO:0007409),0.29766185067523493,0.8905760271268399,0.7127882599580713,0.9207526878199115,1.0,23/237,6.27%,SLIT3;SLIT2;EZR;EFNA5;SEMA3E;UNC5C;SEMA3D;SEMA3C;ULK2;PDLIM7;GRB10;SPTAN1;SHC1;GAB2;DOCK7;NOTCH2;NRP1;KLF7;SHTN1;ISL1;GDNF;EPHB3;PTPRA
prerank,mitotic spindle organization (GO:0007052),0.3100153890346083,0.8905193669193405,0.6677814938684504,0.9203363362987084,1.0,60/153,29.43%,NDEL1;CLIP1;VCP;TBCE;PAFAH1B1;XPO1;MISP;TOGARAM1;CHEK2;ARHGEF10;RHOA;SPICE1;DYNC1I1;AURKA;RANBP2;SMC1A;SEC13;PIBF1;DCTN6;MAD2L1;STIL;RMDN1;STAG2;NEK9;CENPT;AHCTF1;NEK6;KIF3B;DYNC1LI2;CENPQ;STAG1;SPDL1;ZWILCH;ZW10;RAN;PTPA;NUP98;GPSM2;OFD1;FLNA;SUN2;AAAS;KIF2C;CCNB1;CDC20;SKA2;MECP2;BUB3;TTK;PCNT;CENPU;SPC24;CEP192;WDR62;KIF18A;CENPL;CENPK;CENPC;CCDC61;MAD1L1
prerank,DNA packaging (GO:0006323),0.416059084986467,0.8904244608571403,0.5803858520900321,0.9200011569728224,1.0,6/16,28.40%,CHAF1B;AIFM1;CHAF1A;RBBP4;HAT1;KAT6A
prerank,regulation of MAP kinase activity (GO:0043405),0.3180112779241636,0.8902567120404739,0.6326781326781327,0.9198148089894281,1.0,15/92,11.24%,EGFR;BMP4;PDGFC;PRKCD;FGFR1;FGF2;CDK12;CBLC;PDGFA;IRAK3;NF1;PPEF2;VEGFA;TNFSF11;ERBB2
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3314160584559044,0.8896877102548901,0.6256218905472637,0.9204114006244204,1.0,10/72,11.59%,SLIT2;PRKCD;FGF13;HDGFL3;LDLR;CLU;SHANK1;KANK4;KATNB1;LIMA1
prerank,regulation of actin filament-based movement (GO:1903115),0.4468735751329558,0.8894270865675038,0.591304347826087,0.9204042567207196,1.0,1/10,1.52%,ANK2
prerank,tRNA transport (GO:0051031),0.36678545114490024,0.8893852089182839,0.5985714285714285,0.9199694403450547,1.0,16/35,27.84%,NUP93;RANBP2;NUP153;SEC13;NUP214;NUP188;NUP88;RAN;NUP98;SSB;AAAS;NUP54;TOMM20;RAE1;NUP155;XPOT
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.3814249606095119,-0.8891784921869613,0.6075949367088608,0.8794432515945341,1.0,5/12,15.26%,PPARA;FUT9;MDK;ASS1;AKT1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.4374708241717434,0.8890245257807738,0.6104347826086957,0.9201503240155062,1.0,4/13,12.78%,KPNA1;RGPD1;RANBP2;KPNA4
prerank,bone development (GO:0060348),0.35806841929032585,0.8889304321115401,0.5988779803646563,0.9198134705443305,1.0,7/39,7.58%,LRP6;AKAP13;SULF1;SFRP4;SKI;SLC10A7;P3H1
prerank,negative regulation of MAPK cascade (GO:0043409),0.3209622311322448,0.8889115024898352,0.64875,0.9193372021660748,1.0,15/87,12.67%,BMP4;EZR;PRKCD;SPRED2;PTPN2;DLG1;CBLC;TLR4;IRAK3;NF1;PPEF2;PRDM15;ITGB1BP1;DUSP10;TNIP1
prerank,intracellular sterol transport (GO:0032366),-0.37118989059815066,-0.8877151960595451,0.6143617021276596,0.8816055871075197,1.0,3/13,9.77%,ABCA1;ABCG1;NPC2
prerank,regulation of protein targeting to membrane (GO:0090313),0.3746044948609299,0.8875886925963192,0.5925925925925926,0.9215067619657524,1.0,7/28,12.46%,KCNB1;DMTN;C2CD5;ERBB2;ITGB1BP1;MIEF1;CHP1
prerank,DNA strand elongation (GO:0022616),0.39746144142116774,0.8869547972314833,0.6006240249609984,0.922235030426022,1.0,6/18,21.89%,MCM7;GINS3;NBN;POLA1;POLD3;RAD50
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.36888950862144065,-0.8869178280584588,0.585427135678392,0.8822816334341201,1.0,3/14,9.40%,RPS3;CD81;NECTIN2
prerank,adherens junction organization (GO:0034332),0.34708521418015004,0.8859323375957167,0.6266666666666667,0.92369051023508,1.0,7/48,9.01%,CDH1;CDH11;NECTIN3;CTNNA1;VCL;JUP;PVR
prerank,protein targeting to lysosome (GO:0006622),0.39994552521283433,0.8856429499267172,0.6128048780487805,0.9237082868938897,1.0,13/20,35.03%,NEDD4;CLU;SCARB2;AP4M1;HGS;RAB7A;GNPTAB;LAMP2;SORL1;ZFYVE16;AP3M1;GCC2;NCOA4
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.3129807642481832,0.8854612698488811,0.6666666666666666,0.9235506296695228,1.0,19/113,13.30%,TRABD2B;MPP7;GSK3B;UNC13B;EIF4G1;VCP;ESR1;CLU;CLTRN;TLR4;CHD1L;ERCC5;ATM;PSMC6;VEGFA;MYD88;SPIDR;IL5;SH3GLB1
prerank,regulation of viral genome replication (GO:0045069),-0.26711453568965277,-0.8851080181239389,0.684931506849315,0.8851475211197778,1.0,19/56,21.01%,PPARA;PPIA;IFITM1;BST2;IFITM3;OAS2;PROX1;HACD3;RNASEL;NR5A2;ADARB1;TARBP2;ADAR;IFIT1;PPIE;DDX3X;PARP10;BANF1;OASL
prerank,heme catabolic process (GO:0042167),0.4222598933809615,0.8850670102327548,0.5876623376623377,0.9232706579329489,1.0,2/14,6.40%,ABCG2;HMOX2
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.4222598933809615,0.8850670102327548,0.5876623376623377,0.9232706579329489,1.0,2/14,6.40%,ABCG2;HMOX2
prerank,embryonic heart tube development (GO:0035050),0.43263997718156777,0.8846145114283342,0.6105769230769231,0.9236330686064838,1.0,4/14,10.95%,HES1;PITX2;ACVR1;MEGF8
prerank,cellular glucan metabolic process (GO:0006073),0.4340262443311725,0.884609142314633,0.5983739837398374,0.9231246081249713,1.0,3/11,8.79%,GSK3B;PPP1R3C;PHKB
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.28963422659439914,-0.8845168608314724,0.6387959866220736,0.8853546458830065,1.0,3/34,3.41%,RBP4;WNT5A;SLC7A5
prerank,regulation of establishment of protein localization (GO:0070201),-0.37137398946372635,-0.8844818710121641,0.5936739659367397,0.8843042492879407,1.0,2/13,5.86%,CORO2B;CEP120
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.23627902129706746,-0.8840015350598772,0.708994708994709,0.8842822758718814,1.0,33/87,28.72%,IMMP2L;NDUFB9;NDUFAF4;SLC25A33;NDUFA8;NDUFC1;UQCC2;NDUFB11;NDUFAF8;COA3;PET100;NDUFB3;NDUFA1;NDUFB8;NDUFA3;SCO1;CHCHD4;COX18;NDUFS4;COX17;NDUFA11;NDUFA13;NDUFB7;COX20;FOXRED1;NDUFA6;COX19;SDHAF3;NDUFA2;NDUFA10;NDUFS6;NDUFV3;BCS1L
prerank,regulation of JNK cascade (GO:0046328),0.31365160841502376,0.883549951476125,0.6651108518086347,0.9247082519962427,1.0,14/101,11.98%,EGFR;RASSF2;MAP3K5;PTK2B;FZD7;WNT16;GADD45G;KLHL31;DACT1;NCOR1;PER1;COPS5;DUSP10;TRAF5
prerank,mitotic chromosome condensation (GO:0007076),0.3773913041965329,0.8834186847934211,0.6138328530259366,0.9244504170075909,1.0,8/26,23.42%,SMC4;RB1;NCAPH2;KMT5A;CSNK2A2;CSNK2A1;AKAP8L;CCNB1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.3825428018829396,0.8832327221564193,0.5987558320373251,0.9243114762997969,1.0,4/24,10.69%,MAP7D3;FGF13;HDGFL3;KATNB1
prerank,activation of adenylate cyclase activity (GO:0007190),0.36099484809056953,0.8830426889031293,0.6054131054131054,0.9241871471540821,1.0,3/35,4.28%,EDNRA;ADRB2;ADCY9
prerank,regulation of steroid biosynthetic process (GO:0050810),0.43706159710301207,0.8828456991591344,0.5880398671096345,0.9240467755269005,1.0,1/11,1.17%,BMP5
prerank,regulation of gastrulation (GO:0010470),-0.3585778308886367,-0.8826439450304694,0.6020151133501259,0.886126580792884,1.0,6/14,18.13%,TENM4;CLASP2;OSR1;DAG1;RACK1;LHX1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.36730732415992107,-0.8825505870916945,0.5986394557823129,0.8852128781896621,1.0,4/13,17.20%,NR1H3;AQP11;NUPR1;NR1H2
prerank,purine ribonucleotide transport (GO:0015868),0.405340949778013,0.8825120812164918,0.5924170616113744,0.9241479944276101,1.0,1/16,1.34%,LRRC8D
prerank,apoptotic nuclear changes (GO:0030262),-0.31182782132370646,-0.8820334866553841,0.6203703703703703,0.8852502387869119,1.0,10/24,24.09%,CECR2;BLCAP;CASP3;ACVR1C;KPNB1;FOXL2;GPER1;TOP2A;H1-0;DFFA
prerank,negative regulation of secretion by cell (GO:1903531),-0.28018242485961525,-0.8818121316700881,0.6498316498316499,0.8846368323086322,1.0,7/38,9.70%,IL1RAPL1;APOE;GRM7;NOTCH1;SYT11;SNCA;SLC30A1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.3752830612055059,0.8816078793823439,0.6092124814264487,0.925440006691841,1.0,3/27,1.98%,PDGFC;DDR2;FN1
prerank,membrane fusion (GO:0061025),-0.28294960173552147,-0.8815070603611382,0.6766666666666666,0.8842137747446006,1.0,3/33,3.34%,DNM3;RIMS1;DYSF
prerank,cellular response to exogenous dsRNA (GO:0071360),0.43753616105545606,0.8815000757518181,0.6009933774834437,0.9251376253041097,1.0,8/12,34.77%,MAVS;IFIH1;DHX9;COLEC12;RALB;ZCCHC3;CGAS;MUL1
prerank,ribosomal small subunit assembly (GO:0000028),-0.34658758042772564,-0.8808134605870885,0.6148148148148148,0.8846895699290173,1.0,5/16,7.17%,RPS14;RPS19;RPS5;RPS15;RPS27
prerank,negative regulation of hydrolase activity (GO:0051346),-0.2759583560435197,-0.8807113579554847,0.6370370370370371,0.8837914255126703,1.0,10/49,12.38%,CPEB2;MAP2;F11R;LRCH1;CST3;DAB2IP;GMIP;CAMK2A;SH3BP4;EGLN1
prerank,steroid biosynthetic process (GO:0006694),-0.25828066068079997,-0.879791014468023,0.6877828054298643,0.8846774168445315,1.0,10/56,19.50%,CYP7B1;CYP27A1;PRKAG2;INSIG2;OSBPL1A;SCP2;CH25H;SC5D;SRD5A1;OSBPL7
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.3661203588718092,-0.8796373337934639,0.639686684073107,0.8839036971854283,1.0,2/13,7.40%,RNF152;SPAAR
prerank,pre-miRNA processing (GO:0031054),-0.35659320667774397,-0.8794098856344313,0.640506329113924,0.8832988223729358,1.0,5/14,18.18%,LIN28B;AGO4;TARBP2;ADAR;AGO1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.3103168685915945,0.8792849649187998,0.6482122260668973,0.9289036684510394,1.0,22/104,18.74%,LRP6;CCNA2;ADRB2;ABL1;TELO2;CDK12;MNAT1;CDKN1B;RHOA;PPEF2;SYAP1;CAB39;LRP5;RB1;CDKN3;GTPBP4;CCND1;MAP2K2;TSG101;CDKN1A;CCNT1;SNF8
prerank,regulation of interleukin-1 beta production (GO:0032651),0.3265945417188857,0.879102491437571,0.6462324393358876,0.9287466489267492,1.0,9/66,12.41%,FOXP1;ISL1;STAT3;RIPK2;TLR4;CCL3;MYD88;ZC3H12A;CARD16
prerank,regulation of cation channel activity (GO:2001257),0.3180114919956283,0.8790440223535977,0.6473489519112207,0.9283450124338393,1.0,10/89,6.66%,ANK2;PTK2B;CAMK2D;AHNAK;SLMAP;ITGB1;FGF13;DLG2;DMD;DLG1
prerank,regulation of mitotic nuclear division (GO:0007088),-0.2678055685119851,-0.8787023866629762,0.6899563318777293,0.8836877205835119,1.0,9/55,9.28%,IGF1;TGFA;PDGFRB;INSR;BMP7;OBSL1;CDK5RAP2;EDN1;RGCC
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3796251558531871,0.8786694194940755,0.6098654708520179,0.9285799284263375,1.0,11/26,29.09%,SETD2;KMT2D;SETD5;CTR9;ETFBKMT;KMT5B;WDR82;OGT;METTL21C;KMT2A;SETD1B
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.34289013221989006,-0.8785007974876856,0.6363636363636364,0.8830375246497982,1.0,13/18,43.06%,DCP2;RUVBL1;RUVBL2;CCT8;NOP10;SHQ1;NHP2;CCT7;CCT2;CCT4;EXOSC10;CCT3;DKC1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.32724441826000694,0.8784880973324759,0.6362467866323908,0.928392858683366,1.0,13/70,11.96%,TMEFF2;FN1;PARVA;NRP1;SRGAP2;ANTXR1;ITGAV;EPHB3;GRHL2;RHOA;RAB25;ITGB3;RB1
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.360895942580396,-0.8784705089087392,0.6666666666666666,0.8820150254559941,1.0,2/14,6.44%,ENPP1;ENPP3
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.4385589812424432,0.8783019954160276,0.6016806722689075,0.9282197977228024,1.0,3/12,14.52%,PIBF1;ERLIN1;WDTC1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.4498748072171713,0.8781802549591253,0.6112084063047285,0.9279302654044446,1.0,2/10,10.04%,ESR1;PSMC6
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.35917692103174176,-0.877616307385595,0.6172248803827751,0.8827328394438205,1.0,4/14,18.72%,OSMR;IL6ST;PTGER3;PTGS2
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.3370518068463167,0.877523279427944,0.6326530612244898,0.928705955149196,1.0,8/54,14.85%,NXN;HDAC8;PIAS3;U2AF2;USP4;CHP1;GTPBP4;SQSTM1
prerank,JNK cascade (GO:0007254),0.3490415287164345,0.8772468021012098,0.6034236804564908,0.9287322077187109,1.0,4/40,7.04%,MAP3K5;TAB3;RIPK2;ARHGEF6
prerank,replicative senescence (GO:0090399),0.4143735882502009,0.8770926542814608,0.5771812080536913,0.9285117222645513,1.0,5/12,17.21%,WNT16;CHEK2;ATM;CHEK1;ATR
prerank,response to light stimulus (GO:0009416),0.33857193603535485,0.8769788709770084,0.6284584980237155,0.928216936674316,1.0,11/55,20.49%,UBE4B;CRY2;UBE2B;ERCC5;USP1;UVSSA;ERCC8;ERCC3;REV1;CIRBP;MAPK8
prerank,microtubule anchoring at centrosome (GO:0034454),0.4394421369278223,0.8764402668048815,0.5812274368231047,0.9287649422253135,1.0,2/10,6.05%,NIN;PCM1
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3555593993867291,-0.8760975173928799,0.6143617021276596,0.8849511335232406,1.0,1/15,0.42%,LEF1
prerank,positive regulation of heart rate (GO:0010460),0.4094768483218144,0.8757750482524719,0.6074313408723748,0.9295649389069235,1.0,2/17,4.92%,ADRA1B;TRPM4
prerank,regulation of osteoclast differentiation (GO:0045670),0.36052559395407147,0.8755496977242226,0.6092619392185239,0.9294767211551913,1.0,6/33,13.21%,UBASH3B;TLR4;TCTA;TNFSF11;CCL3;MTOR
prerank,cellular response to hexose stimulus (GO:0071331),0.37975599913641356,0.8755489713688286,0.6070336391437309,0.9289634920599336,1.0,4/23,3.93%,KCNB1;SLC39A14;UNC13B;SLC26A6
prerank,protein localization to kinetochore (GO:0034501),0.4260395766693145,0.8748816501200412,0.6262295081967213,0.9297357454758504,1.0,7/14,29.13%,CENPT;SPDL1;ZWILCH;ZW10;BUB3;TTK;CHAMP1
prerank,regulation of cytokine production (GO:0001817),-0.22742840517502702,-0.874536779037108,0.8088235294117647,0.8871948241689599,1.0,27/126,15.86%,CADM1;LYN;RPS6KA5;PLA2R1;LGR4;DTX4;SRGN;CD47;SIRPA;C1QTNF3;SYT11;AFAP1L2;ADRA2A;ATP2B1;GAPDH;MOG;RGCC;ACE2;MIF;BCL6B;ICOSLG;LURAP1;AGT;BTN3A3;TRIM21;NLRP4;TRIM56
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.27995488602413116,-0.8743274589379616,0.7095709570957096,0.8865602921084871,1.0,7/37,8.10%,CEMIP;PRKAG2;CALM1;BMP7;APP;SPRED1;SPHK1
prerank,homotypic cell-cell adhesion (GO:0034109),0.35189947920725245,0.8742149696601768,0.6417910447761194,0.9304579935268935,1.0,10/39,14.70%,FN1;PLPP3;UBASH3B;VCL;CLIC1;GATA1;ITGB3;DSC2;GNAS;CEACAM5
prerank,positive regulation of bone resorption (GO:0045780),-0.3817044544168411,-0.8738644125703179,0.6264775413711584,0.886490438940628,1.0,5/11,20.26%,TNFRSF11A;SPP1;ATP6AP1;PLEKHM1;SYK
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.2806993787591176,-0.8738163457601813,0.6928838951310862,0.8855247373149914,1.0,16/42,24.42%,IL6R;DEFA6;OPTN;RPS19;RPL30;GSDMD;ADGRB1;CHGA;SELP;TREM2;ROMO1;PYCARD;MR1;NOS2;AQP1;MPEG1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.30595606508795936,-0.8736815050687593,0.6585365853658537,0.8847490265012775,1.0,10/26,23.43%,LGR4;TLR3;TYRO3;LRRC14;GPS2;BIRC2;IRF7;TREM2;CACTIN;SMPDL3B
prerank,negative regulation of organelle assembly (GO:1902116),0.36067712767195254,0.8736739283037825,0.6262482168330956,0.9309778080277558,1.0,14/35,25.27%,LIMK2;STYXL1;TMEM39A;SMCR8;KAT2A;SEC22B;KAT2B;CDK10;CEP97;RBM14;SMAD4;CHMP4A;CHMP4B;PHF23
prerank,positive regulation of growth (GO:0045927),0.32635851939687616,0.8735023109977151,0.6396396396396397,0.9307988529244393,1.0,16/64,18.56%,EGFR;TGFBR1;EIF4G1;KLHL22;AGR2;MMP14;USP47;ERBB2;EIF4G2;ADAM10;CEP43;DDX49;INO80;DNPH1;CSNK2A1;BRAT1
prerank,neuromuscular process controlling balance (GO:0050885),-0.36757199514577577,-0.8730481912496149,0.6338383838383839,0.8850473526855124,1.0,2/12,4.32%,NRXN1;PCDH15
prerank,presynapse organization (GO:0099172),-0.395636311106613,-0.8730240379297628,0.638095238095238,0.8839984707328681,1.0,2/10,7.59%,WNT5A;LRRTM3
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.3790303656033129,0.8725856998793102,0.6296851574212894,0.9320242724626681,1.0,6/26,11.84%,MET;CLIP1;TOGARAM1;AKAP9;KATNB1;SLAIN2
prerank,cellular response to interleukin-12 (GO:0071349),-0.27623188986594227,-0.8724062958085719,0.69140625,0.884155363124049,1.0,12/48,15.51%,PLCB1;CNN2;CD47;PPIA;SIRPA;LMNB1;CFL1;BOLA2;MIF;PSME2;TALDO1;LCP1
prerank,histone H2A acetylation (GO:0043968),0.4063912212273272,0.8720365556983806,0.6206896551724138,0.9325697333163745,1.0,8/16,27.35%,NAA40;TRRAP;EP400;EPC1;BRD8;DMAP1;ING3;MORF4L2
prerank,mRNA processing (GO:0006397),0.28878276120372276,0.8719455959274738,0.7455497382198953,0.9322465705894193,1.0,99/287,28.50%,RNMT;DDX5;SON;SNRNP48;RBM6;SRSF11;MNAT1;THOC2;SRSF5;SYNCRIP;SRRM2;SRSF6;CELF1;HNRNPH1;FUS;USP49;RBMX;U2AF2;TCERG1;ZCCHC8;DDX42;PABPC1;SCAF11;SRRM1;SNRNP70;SNRPB2;GCFC2;DHX9;PRPF3;GPKOW;HNRNPM;KIN;SF3B2;SF3B1;CASC3;CHTOP;U2SURP;RNPC3;ERCC3;PRCC;ESS2;SNRNP40;U2AF1L4;RBM14;SNRNP35;SRSF2;LSM2;THOC5;LSM8;ZC3H11A;WBP4;SNW1;PNN;PRPF18;SRSF12;TRA2B;ALKBH5;DBR1;FIP1L1;ZCRB1;PRPF40B;AKAP8L;SRRT;RNGTT;CSTF1;RBM4;TXNL4A;RBM5;NUDT21;DHX8;ERCC2;LSM4;SUGP1;RSRC1;RBM4B;CDC40;PPIL1;GTF2F2;CPSF7;HNRNPA2B1;CHERP;HNRNPUL1;CPSF3;SF3B3;UPF3B;SNRNP200;SMNDC1;RAMAC;SRSF3;RBM8A;ALYREF;GTF2H3;PDCD7;PRPF6;NCBP2;PRKACA;CLP1;CPSF4;SRSF7
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.4320925331866491,0.8715434032481414,0.6169064748201439,0.932474594193078,1.0,4/10,17.11%,TUT7;DIS3L2;CHFR;TUT4
prerank,T cell activation involved in immune response (GO:0002286),-0.3705101017352732,-0.8714674518124423,0.6343283582089553,0.8850790925919041,1.0,3/12,15.51%,MDK;CD74;LCP1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.35930893194197033,0.8713680236833546,0.6116373477672531,0.9323123866264214,1.0,19/38,29.25%,UBN1;CABIN1;ATRX;HIRA;CENPT;CENPQ;RBBP7;SMARCA5;HJURP;IPO4;RBBP4;CENPU;NASP;CENPX;HAT1;CENPL;CENPK;CENPC;CENPW
prerank,regulation of G0 to G1 transition (GO:0070316),0.3542604740947019,0.8709806531937456,0.634965034965035,0.9325754006931823,1.0,18/38,26.51%,EHMT1;CBX5;EED;CHEK1;RNF2;SUZ12;RBBP8;EPC1;RRM2;EHMT2;RAD51;RBBP7;E2F1;YAF2;E2F6;MGA;RBBP4;PCGF6
prerank,global genome nucleotide-excision repair (GO:0070911),0.3721885974871841,0.8709593824975466,0.6294642857142857,0.9320999699810534,1.0,10/26,27.34%,CHD1L;RAD23B;RNF111;ERCC3;XPA;ERCC1;CUL4A;ERCC2;XPC;GTF2H3
prerank,selective autophagy (GO:0061912),0.33488246971884933,0.8707841665942269,0.65,0.9319189117076325,1.0,23/56,27.32%,ULK2;BECN1;DYNC1I1;ACBD5;ATM;RB1CC1;DDRGK1;WDR81;UBA5;SQSTM1;AMBRA1;DYNC1LI2;NBR1;ATG2A;UBE2N;ULK1;RAB7A;LGALS8;UBE2V1;PCNT;USP30;ATG5;IFT88
prerank,TOR signaling (GO:0031929),-0.30200496160599016,-0.870687138428526,0.6605504587155964,0.885668291268557,1.0,7/26,15.26%,PRR5L;CCDC88A;EIF4EBP2;TIPRL;EIF4EBP1;RICTOR;AKT1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.39160868695306417,0.870324181979748,0.6186708860759493,0.9322447629518807,1.0,2/17,6.10%,CD44;KDM1A
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.2783925887489059,-0.8700599069845383,0.6655948553054662,0.8859399823728518,1.0,5/37,5.82%,APOD;PPARA;ADCY7;SIRPA;HIF1A
prerank,regulation of urine volume (GO:0035809),-0.3917789507969525,-0.8698864418889942,0.6300448430493274,0.8852132013324442,1.0,6/10,28.90%,NPR1;ADM;HYAL2;INPP5K;HAS2;TFAP2B
prerank,zinc ion transmembrane transport (GO:0071577),-0.3191160233590085,-0.8694451691117602,0.6428571428571429,0.8850715047541835,1.0,7/22,17.34%,SLC30A10;SLC39A10;SLC39A8;SLC30A1;SLC30A4;SLC39A1;SLC39A7
prerank,organonitrogen compound catabolic process (GO:1901565),0.3331285749855203,0.8693256917222988,0.6360052562417872,0.9336546557836444,1.0,10/57,13.21%,NPEPPS;CPQ;PDXDC1;PLA2G15;IDE;LRSAM1;GADL1;ERAP1;RENBP;MTOR
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.35339089512721444,0.8692608784204543,0.6376811594202898,0.933250039123883,1.0,11/33,23.23%,TELO2;STN1;ANKRD28;PPP6R3;RPA1;TNKS1BP1;RAD51;RFC1;PPP6C;RAD50;CDK2
prerank,ribosomal subunit export from nucleus (GO:0000054),0.42195880612580977,0.868811611575063,0.6143344709897611,0.9336228281888933,1.0,6/13,20.32%,XPO1;LTV1;EIF6;ABCE1;NUP88;RAN
prerank,ceramide metabolic process (GO:0006672),0.339497511929175,0.8687503870332751,0.6223118279569892,0.9332220740260276,1.0,5/49,6.36%,ACER3;PLPP3;SGMS2;SPTSSB;PLA2G15
prerank,negative regulation of protein localization to membrane (GO:1905476),0.385999720373234,0.8687169134797716,0.6261261261261262,0.9327685082575253,1.0,5/24,11.29%,PID1;MRAP;RHOQ;DMTN;ITGB1BP1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.34732055791916083,0.8686091444033747,0.6373779637377964,0.9324654807769563,1.0,17/40,33.28%,WRN;BOD1L1;DDX11;ATRX;MCM9;ATR;SMARCAL1;RAD51;FANCM;EXD2;FAM111A;ALYREF;CENPX;PRIMPOL;RFWD3;NUCKS1;TONSL
prerank,proteoglycan biosynthetic process (GO:0030166),0.3683396233488002,0.8684433386364462,0.6409883720930233,0.932309914713879,1.0,7/31,11.00%,EXT1;CHST13;GLCE;FOXL1;XYLT1;B3GALT6;CHST11
prerank,cardiac muscle cell differentiation (GO:0055007),0.38898782295311896,0.8682883450865454,0.6376811594202898,0.9320764700846677,1.0,4/21,10.37%,AKAP13;CXADR;ACVR1;VEGFA
prerank,adenine nucleotide transport (GO:0051503),0.3993814608952167,0.8682717568518178,0.6210691823899371,0.9315956959939766,1.0,1/17,1.34%,LRRC8D
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.3891000745685023,0.8682158048557853,0.6204620462046204,0.9311730731568357,1.0,9/19,29.05%,MTOR;PRDX5;ZNF76;POLR3F;DHX36;ICE2;TENM1;AR;CHD8
prerank,ERAD pathway (GO:0036503),0.3166110987819494,0.8681184301870151,0.656479217603912,0.9308587595491601,1.0,20/83,23.97%,UBE4B;USP13;RNF185;VCP;ANKZF1;UBE4A;PSMC6;FBXO17;UBXN4;ERLIN1;NPLOC4;OS9;UFD1;TRIM25;ECPAS;UGGT2;FAF2;HERPUD1;FBXO27;POMT2
prerank,cellular response to virus (GO:0098586),0.3577654564576908,0.8679578675728834,0.6244725738396625,0.9306678146847456,1.0,9/30,24.00%,VWCE;GBF1;CHUK;ZC3H12A;IFIH1;RRP1B;FMR1;IRF3;LGALS8
prerank,positive regulation of lipid storage (GO:0010884),0.38380909240001837,0.867615471211053,0.6302250803858521,0.9307856015470304,1.0,5/21,12.36%,IKBKE;NFKB1;EHD1;HILPDA;ZC3H12A
prerank,GPI anchor metabolic process (GO:0006505),0.37380357568008227,0.8674361436855816,0.6345565749235474,0.9306230910628814,1.0,11/26,26.32%,PGAP2;PIGB;DPM1;PIGU;PIGL;PIGN;PIGH;PGAP3;PIGQ;MPPE1;PIGA
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.2931106177109959,-0.867362801250952,0.6339285714285714,0.8883954814346869,1.0,7/25,20.63%,HSPA8;ERO1A;HSPA13;PTGES3;DNAJB5;HSPA9;HSPE1
prerank,cellular response to gamma radiation (GO:0071480),0.39724000277001886,0.8672860195728125,0.6398104265402843,0.9303875142966744,1.0,6/17,17.21%,KDM1A;WRN;ATM;XRCC5;TLK2;ATR
prerank,negative regulation of GTPase activity (GO:0034260),-0.31648723222944986,-0.8670113238040973,0.6455331412103746,0.8880716618146156,1.0,10/22,20.66%,CPEB2;F11R;LRCH1;DAB2IP;GMIP;SH3BP4;RASA4;PLXNB3;HRAS;GPSM1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.33794450366600787,-0.8669569029330809,0.6641221374045801,0.8871303884530365,1.0,1/16,0.60%,AUTS2
prerank,regulation of superoxide anion generation (GO:0032928),0.41773195269400254,0.866889437283955,0.6213921901528013,0.9306364648088111,1.0,2/14,12.04%,PRKCD;AATF
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.4115643094326768,0.8666402025252559,0.6180327868852459,0.9306161264348778,1.0,9/15,32.24%,VCP;NPLOC4;OS9;UFD1;FAF2;HERPUD1;SEC61B;SYVN1;SEL1L
prerank,hemidesmosome assembly (GO:0031581),-0.37527742413928794,-0.8659879662006572,0.6508728179551122,0.8881525615794947,1.0,4/11,14.71%,ITGA6;DST;LAMC2;LAMC1
prerank,cellular protein-containing complex assembly (GO:0034622),-0.21476375834016065,-0.8659714522393084,0.7927927927927928,0.8871160778996267,1.0,30/159,16.94%,TCF4;FMOD;SGIP1;PICALM;IMMP2L;RPL38;PIK3C2A;PDE4DIP;SNCA;HIP1R;HSP90AB1;MAPT;RTN4;HIP1;DNAI4;HOPX;COX7A2;NSG1;POMP;BIN1;CYBA;CASQ2;EIF4H;ANLN;PTGES3L;EPS15;GPX4;PTGES3;CHCHD4;HIGD1B
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3035920285023145,-0.8659341150849192,0.6563380281690141,0.8861212178770353,1.0,6/26,13.41%,ITPR1;RYR2;HTR2C;HTR2A;ERO1A;CCL19
prerank,membrane lipid metabolic process (GO:0006643),-0.30811519226215445,-0.8655418011905225,0.654320987654321,0.8858277602889105,1.0,5/22,8.10%,ST3GAL6;CERK;GAL3ST1;SERINC1;SPHK1
prerank,immunoglobulin mediated immune response (GO:0016064),-0.3776993602647096,-0.8655267206890433,0.64,0.8847888779980617,1.0,2/10,13.49%,CD81;CD74
prerank,vascular process in circulatory system (GO:0003018),-0.3668163178205476,-0.8654763113568379,0.634032634032634,0.8827875608201277,1.0,5/13,11.65%,NOS3;NPR1;ACE;ACE2;ROCK2
prerank,regulation of tube diameter (GO:0035296),-0.3668163178205476,-0.8654763113568379,0.634032634032634,0.8827875608201277,1.0,5/13,11.65%,NOS3;NPR1;ACE;ACE2;ROCK2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.43503048827811375,0.8653907123872806,0.6162988115449916,0.9325251567042799,1.0,3/11,14.51%,NR4A3;IL10;REST
prerank,response to peptide hormone (GO:0043434),0.3431710553193528,0.8653774853309459,0.6570644718792867,0.9320422580498332,1.0,5/43,5.81%,ANXA1;IGFBP5;IRS1;ZBTB7B;STAT3
prerank,regulation of microglial cell activation (GO:1903978),-0.35256086276135096,-0.8653254318834152,0.6242937853107344,0.882038310373045,1.0,6/15,21.57%,SYT11;GRN;SPHK1;TTBK1;CX3CL1;TREM2
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.381657454638209,-0.8652712444129288,0.6222222222222222,0.8811154764960604,1.0,4/10,15.16%,PARP14;INPP5F;NF2;SH2B3
prerank,response to retinoic acid (GO:0032526),0.3293978778038317,0.8652414546108593,0.6743295019157088,0.9317908173794758,1.0,9/59,9.94%,WNT9A;SOX9;PTK2B;WNT11;FZD7;RXRA;ATM;RARG;RARA
prerank,multivesicular body assembly (GO:0036258),0.3564462126016674,0.8650504805487376,0.6401137980085349,0.9316368024791393,1.0,10/30,23.69%,PDCD6IP;VPS37A;IST1;VPS37B;TSG101;SNF8;HGS;VTA1;CHMP4A;CHMP4B
prerank,positive regulation of hydrolase activity (GO:0051345),0.2998147029169308,0.8645966849018767,0.7093922651933702,0.9320150378840867,1.0,25/137,11.68%,ARAP1;WNT11;SGSM2;MAPRE2;ITGB1;GSK3B;SRGAP2;NDEL1;SNX18;RAP1A;BCAS3;RAPGEF6;RGP1;BCAR3;RHOA;S100A10;RIPK3;WRN;NF1;LIMS1;MAPK12;CCL3;ERBB2;CCL1;ASAP3
prerank,negative regulation of JUN kinase activity (GO:0043508),0.4466567561699797,0.8645371912596612,0.6344086021505376,0.9316254636242742,1.0,2/10,11.95%,PDCD4;DUSP10
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.37573633019783004,-0.86415988485023,0.6402877697841727,0.8823400556117916,1.0,6/11,34.16%,PRKCQ;MALT1;NFKBID;IL12RB1;CARD9;IL23A
prerank,autophagosome organization (GO:1905037),0.34092124422112524,0.8636777234479461,0.6410958904109589,0.9327725192947,1.0,15/50,26.50%,ULK2;RAB43;WIPI2;BECN1;ATG3;RB1CC1;AMBRA1;ATG2A;WDR45B;RAB1A;ULK1;STX12;RAB7A;ATG7;ATG5
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.39086286719619123,-0.8636249098998235,0.639225181598063,0.8824090011385352,1.0,3/10,6.57%,APOE;ABCA1;PRKACB
prerank,mitochondrial protein processing (GO:0034982),0.4258620704196414,0.863578352337357,0.6228668941979523,0.9324518804879106,1.0,7/11,27.99%,PMPCB;OMA1;YME1L1;IMMP1L;SPG7;STOML2;MIPEP
prerank,lymphocyte differentiation (GO:0030098),0.31935645432752113,0.8635681184162679,0.654639175257732,0.9319764552142561,1.0,8/68,7.30%,HDAC4;PBX1;HDAC9;ITGB1;CLCF1;PTPN2;NFIL3;IL10
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.41964678880440426,0.8628376905017362,0.6350245499181669,0.9328449400882981,1.0,7/13,29.66%,ALG13;ALG14;ALG12;ALG3;DPAGT1;ALG9;MPDU1
prerank,tRNA metabolic process (GO:0006399),-0.33410187773758027,-0.8627324408396486,0.6585365853658537,0.8831690302098835,1.0,6/17,25.25%,DARS2;POP5;POP7;SARS1;DTD1;RPP21
prerank,mitotic cytokinesis (GO:0000281),0.3366220052777271,0.8623740797112455,0.6338582677165354,0.9332475855596928,1.0,7/47,12.29%,CIT;SNX18;SON;PDCD6IP;ARL3;TTC19;CNTROB
prerank,cellular response to cAMP (GO:0071320),0.3643189430712396,0.8622632157334803,0.6572637517630465,0.9329307387926393,1.0,6/30,9.90%,EZR;IGFBP5;SLC26A6;RAP1A;DMTN;AKAP9
prerank,lipid modification (GO:0030258),0.3475805808692359,0.8620948033525545,0.6473029045643154,0.932756180075946,1.0,5/37,10.77%,PLPPR2;PLPP3;DGKA;MBOAT4;MBOAT1
prerank,regulation of microtubule nucleation (GO:0010968),-0.39111447930362064,-0.8620922243359319,0.6488372093023256,0.8834555529571454,1.0,2/10,11.42%,PAK1;ARHGEF7
prerank,import into nucleus (GO:0051170),0.3206232669052908,0.8620259990195477,0.6625615763546798,0.9323757100553022,1.0,17/73,20.44%,PRICKLE1;NUP93;STAT3;E2F3;IPO7;TNPO2;HTATIP2;NUP153;SEC13;NUP214;NUP188;GEMIN8;NUP88;HEATR3;TNPO3;RAN;NUTF2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.3958886538186598,0.86147392264364,0.6251993620414673,0.9328960843984104,1.0,2/17,3.16%,CD55;BMP6
prerank,toxin transport (GO:1901998),0.4344606730003392,0.8611174273437827,0.6270566727605119,0.9330398493615567,1.0,3/10,16.15%,ANTXR1;ANTXRL;ADAM10
prerank,ncRNA metabolic process (GO:0034660),0.3499058441140187,0.861106725848865,0.6570644718792867,0.9325538923757384,1.0,10/37,20.32%,DDX17;ZCCHC8;DGCR8;TDRD9;TUT7;AGO2;TDRD12;TUT4;DROSHA;RAN
prerank,telomere organization (GO:0032200),0.33951536068332194,0.8606824726319787,0.6624825662482566,0.9328704595142616,1.0,12/43,21.89%,STN1;WRN;ATM;APEX1;PRKDC;XRCC5;PARP3;RPA1;ATR;NBN;POLD3;RAD50
prerank,regulation of rRNA processing (GO:2000232),0.39887290730398267,0.860235384883297,0.6336134453781512,0.9332602131960323,1.0,6/16,23.07%,WDR43;KAT2B;YTHDF2;USP36;WDR75;RIOK2
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3467322111411737,0.8601510220142842,0.6368715083798883,0.9329013011119496,1.0,11/44,11.61%,SORBS3;TGFB3;WNT11;ABL1;NRP1;TGFBR1;ARHGEF10;RHOA;S100A10;ITGB1BP1;ARHGEF5
prerank,negative regulation of histone methylation (GO:0031061),-0.3918464219336401,-0.8600241335573495,0.6511627906976745,0.8866564966898692,1.0,3/10,19.70%,JARID2;MTF2;AASS
prerank,regulation of protein kinase A signaling (GO:0010738),0.37934398124660285,0.8599091953985121,0.6217054263565891,0.9328482560513061,1.0,2/20,2.73%,TCIM;ADRB2
prerank,cellular response to oxidative stress (GO:0034599),0.30073442437152803,0.8598508007390195,0.7036172695449242,0.9324665948677643,1.0,14/118,11.32%,EGFR;PRKCD;FOXO3;NFE2L2;ABL1;WNT16;GPX8;MGAT3;VKORC1L1;GSR;CHUK;CCS;JUN;RAD52
prerank,cellular response to lectin (GO:1990858),0.3053481458208584,0.8597451011429426,0.6825775656324582,0.9316733945134592,1.0,22/104,17.86%,PRKCD;NRAS;KRAS;TAB3;CREBBP;MUC6;PSMB2;KLRC2;NFKB1;CHUK;FBXW11;PLCG2;PSMC6;PSMD11;PAK2;EP300;PSMD1;CUL1;IKBKG;PSMD7;BCL10;PSMC1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3053481458208584,0.8597451011429426,0.6825775656324582,0.9316733945134592,1.0,22/104,17.86%,PRKCD;NRAS;KRAS;TAB3;CREBBP;MUC6;PSMB2;KLRC2;NFKB1;CHUK;FBXW11;PLCG2;PSMC6;PSMD11;PAK2;EP300;PSMD1;CUL1;IKBKG;PSMD7;BCL10;PSMC1
prerank,regulation of response to oxidative stress (GO:1902882),-0.36687221293896916,-0.859736976451193,0.6403940886699507,0.8862538231941214,1.0,4/11,25.69%,MCTP1;STOX1;GGT7;PINK1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.30650168728448374,-0.85941081152566,0.6988304093567251,0.8858730182389833,1.0,12/24,26.09%,BCL2;CXCL12;BCL2L1;TPT1;MIF;CD74;TRIAP1;ING2;CCAR2;MUC1;SNAI2;TRIM32
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.2990714566988332,0.8592209139543868,0.7030716723549488,0.9321330491923674,1.0,35/124,21.63%,TCF7L2;PPP3CA;WNT11;PLCB3;PRICKLE1;FZD7;AP2A2;PDE6A;SFRP4;MOV10;PSMB2;FZD1;TNRC6C;NLK;RHOA;AP2A1;PSMC6;DAAM1;TIAM1;SMURF1;PSMD11;NFATC1;PSMD1;CELSR3;AGO2;PSMD7;PSMC1;PSMD14;DVL1;FZD2;CDC42;FZD9;FZD3;PSMD3;SFRP5
prerank,regulation of protein localization (GO:0032880),-0.2506090446038373,-0.8591845969580224,0.748898678414097,0.8852358428377576,1.0,12/58,16.33%,PICALM;MAP2;RABGAP1L;TRIM14;HSP90AB1;TRIM46;MMD;PPM1F;WDPCP;TRIM21;RACK1;CTSD
prerank,regulation of AMPA receptor activity (GO:2000311),-0.305030020130191,-0.8590532145182552,0.6486486486486487,0.8844716899334293,1.0,10/25,23.72%,SHANK3;MEF2C;CACNG4;CACNG7;GSG1L;SHISA9;RELN;CNIH3;SHISA8;CACNG8
prerank,nitric oxide metabolic process (GO:0046209),0.4126772435255122,0.8590449459079114,0.639344262295082,0.9319451552338593,1.0,1/14,1.29%,CYP1B1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.382265827714469,0.8585400486880381,0.6343042071197411,0.9323448240443047,1.0,4/18,14.73%,LBP;IFI35;PLCG2;SBNO2
prerank,negative regulation of biomineral tissue development (GO:0070168),0.39036188290807694,0.8583180728926112,0.6162079510703364,0.9322601252948097,1.0,3/21,4.92%,SOX9;PTK2B;TRPM4
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.35520296838297727,-0.8582469549958903,0.6684636118598383,0.885062861530042,1.0,11/15,43.06%,RUVBL1;RUVBL2;CCT8;NOP10;SHQ1;NHP2;CCT7;CCT2;CCT4;CCT3;DKC1
prerank,triglyceride biosynthetic process (GO:0019432),-0.32642416288810294,-0.8580735402256221,0.6447368421052632,0.8843456329186514,1.0,6/18,15.41%,LPGAT1;GK;LPIN3;GPAM;DGAT1;LPIN1
prerank,lipid droplet organization (GO:0034389),0.3799831594253927,0.8580734123836122,0.6355421686746988,0.9322464348307242,1.0,9/22,26.00%,PNPLA3;ZFYVE1;CDS1;HILPDA;SMIM22;RAB18;FAF2;BSCL2;RAB3GAP1
prerank,negative regulation of platelet activation (GO:0010544),0.40132544026224487,0.8580653587530844,0.6080645161290322,0.9317565382036245,1.0,4/16,8.14%,PRKCD;CD9;THBD;PDGFA
prerank,regulation of cell motility (GO:2000145),0.30465935661842686,0.8580319014707023,0.701123595505618,0.931319744252513,1.0,12/121,7.70%,EGFR;NTN1;LMO4;FGF2;ABL1;LMNA;DIAPH1;CCDC125;SGK3;MGAT3;MEMO1;CCDC25
prerank,glutathione derivative metabolic process (GO:1901685),-0.32702709338157965,-0.8580263251443422,0.6756756756756757,0.8823664672324851,1.0,12/20,34.52%,HPGDS;GSTA4;ESD;MGST1;GSTK1;AKR1A1;GSTM1;GSTA3;MGST3;GSTM2;GSTZ1;GSTP1
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.32702709338157965,-0.8580263251443422,0.6756756756756757,0.8823664672324851,1.0,12/20,34.52%,HPGDS;GSTA4;ESD;MGST1;GSTK1;AKR1A1;GSTM1;GSTA3;MGST3;GSTM2;GSTZ1;GSTP1
prerank,neuron development (GO:0048666),0.29614532213182765,0.8578436617909944,0.7261219792865362,0.9311622068070319,1.0,12/141,6.22%,VSX1;PBX3;NEDD4;PBX1;WNK1;RP1;GSK3B;DOCK7;HDGFL3;THOC2;GDNF;ARL3
prerank,nucleoside salvage (GO:0043174),0.4264195942450574,0.8576017133788906,0.6334459459459459,0.931092189256382,1.0,3/10,15.63%,UPP2;TK1;TK2
prerank,autophagosome assembly (GO:0000045),0.3384466744222552,0.8575450477653824,0.6666666666666666,0.9307012092403182,1.0,16/52,26.50%,ULK2;RAB43;WIPI2;BECN1;ATG3;RB1CC1;SMURF1;AMBRA1;ATG2A;WDR45B;RAB1A;ULK1;STX12;RAB7A;ATG7;ATG5
prerank,nitric oxide biosynthetic process (GO:0006809),0.4176691122071133,0.8573104713316206,0.6455906821963394,0.930643110653397,1.0,1/13,1.29%,CYP1B1
prerank,histone mRNA catabolic process (GO:0071044),0.40745879805280005,0.8571322419201469,0.6472545757071547,0.9304879275572457,1.0,9/15,31.17%,ATM;TUT7;TUT4;TENT2;SSB;ERI1;EXOSC4;MTPAP;XRN1
prerank,polyol metabolic process (GO:0019751),0.33872008322239006,0.8566671807499527,0.6536964980544747,0.9308956182854919,1.0,9/46,9.97%,PLCE1;PLCB3;IP6K2;INPP4A;PLCZ1;NUDT4;OCRL;PLCD3;PLCG2
prerank,positive regulation of cytokine production (GO:0001819),0.2804147150206589,0.8566532961934246,0.7803590285110876,0.9304228712007084,1.0,43/292,15.37%,F3;FOXP1;CYP1B1;LBP;ANXA1;SULF1;RAB7B;ZBTB7B;CD80;IL17RA;CREBBP;CD2;ISL1;STAT3;POLR3D;MAVS;GATA4;RORA;DDIT3;RIPK2;IRF1;IL10;TLR4;NFKB1;CD46;IL33;RARA;PLCG2;HILPDA;NFKB2;CCL1;MYD88;KAT2A;PRKDC;IFIH1;PIBF1;XRCC5;EP300;HTR2B;TLR1;DHX9;TWIST1;TLR8
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.33862395202891893,0.8565072394444332,0.6537433155080213,0.9301804314158428,1.0,4/45,2.89%,CAMK2D;PRKCD;CD44;MID1
prerank,regulation of catabolic process (GO:0009894),0.3923107054352475,0.8564788104892113,0.6494522691705791,0.9297250937834264,1.0,7/18,23.72%,ITGB1;CHEK2;ZDHHC2;SNF8;HGS;FAP;ODC1
prerank,positive regulation of cilium assembly (GO:0045724),-0.3336552035816175,-0.8562202463915842,0.6528189910979229,0.8849802544928659,1.0,3/18,6.96%,CEP120;CCDC88A;TAPT1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3199099150428252,0.8561174047172199,0.6833541927409261,0.9299033145861516,1.0,7/73,4.34%,CYFIP2;ABI1;PRKCD;VAV2;PRKCE;ABL1;NR4A3
prerank,neutrophil degranulation (GO:0043312),0.2774739337202954,0.8560302106172878,0.8314720812182741,0.9295674540424781,1.0,74/425,16.37%,CD55;ANXA2;ANXA3;PRKCD;DSP;CD44;GSN;TMC6;NRAS;PYGB;SPTAN1;ANO6;STOM;RAB44;AP2A2;DIAPH1;VNN1;IGF2R;RAB6A;RAP1A;UBR4;VCP;BRI3;VCL;ACP3;DNAJC3;FRK;TIMP2;ITGAV;HMOX2;B4GALT1;DNAJC5;CRACR2A;PTGES2;SLPI;CYSTM1;PKP1;JUP;DERA;ARSB;RAP2C;GPI;PAFAH1B2;RHOA;NFKB1;IQGAP1;KCMF1;CAB39;SNAP23;CKAP4;AMPD3;GLB1;BIN2;TNFRSF1B;CPNE3;OLR1;ATP11A;TMEM179B;PSMD11;TOM1;XRCC5;RAB24;TCIRG1;GOLGA7;PLD1;PSMD1;IST1;DDOST;HPSE;RAB4B;ADAM10;CDK13;NIT2;CLEC5A
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.36622324668188194,0.855886048717389,0.6498470948012233,0.9293314852499878,1.0,5/26,10.73%,EFNA5;KLF7;TRPM4;CLTRN;LRP5
prerank,cellular lipid catabolic process (GO:0044242),0.3646462990987139,0.8558671088524492,0.6259314456035767,0.9288764695053942,1.0,5/27,9.54%,CYP1B1;PLA2G15;ACOT8;ACBD5;LPIN2
prerank,axonal fasciculation (GO:0007413),-0.36113851793988355,-0.8555911266321099,0.6348039215686274,0.885245686287971,1.0,7/12,24.44%,CNTN4;EPHA4;RTN4;NRCAM;CDK5R1;AMIGO1;SEMA5A
prerank,neutrophil mediated immunity (GO:0002446),0.2772290731505867,0.8553138655549136,0.8314720812182741,0.9294118250533168,1.0,75/432,16.37%,CD55;ANXA2;ANXA3;PRKCD;DSP;CD44;GSN;TMC6;NRAS;PYGB;SPTAN1;ANO6;STOM;RAB44;AP2A2;DIAPH1;VNN1;IGF2R;RAB6A;RAP1A;UBR4;VCP;BRI3;VCL;ACP3;DNAJC3;FRK;IRAK4;TIMP2;ITGAV;HMOX2;B4GALT1;DNAJC5;CRACR2A;PTGES2;SLPI;CYSTM1;PKP1;JUP;DERA;ARSB;RAP2C;GPI;PAFAH1B2;RHOA;NFKB1;IQGAP1;KCMF1;CAB39;SNAP23;CKAP4;AMPD3;GLB1;BIN2;TNFRSF1B;CPNE3;OLR1;ATP11A;TMEM179B;PSMD11;TOM1;XRCC5;RAB24;TCIRG1;GOLGA7;PLD1;PSMD1;IST1;DDOST;HPSE;RAB4B;ADAM10;CDK13;NIT2;CLEC5A
prerank,glucan catabolic process (GO:0009251),0.40440131190714657,0.8551032085805141,0.6568627450980392,0.9293124760112084,1.0,3/15,8.79%,PYGB;PHKA2;PHKB
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.419635654645132,0.8550925958790494,0.6051282051282051,0.9288389896718388,1.0,5/11,32.72%,RENBP;UAP1;GFPT1;GNPDA1;AMDHD2
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.376253913133726,0.8550560448320667,0.6204724409448819,0.928417012256177,1.0,1/24,0.44%,PLCE1
prerank,hemopoiesis (GO:0030097),0.30371329276029135,0.8549612794754257,0.7092288242730721,0.9281023741339349,1.0,10/87,7.30%,BMP4;MFAP5;ZBTB16;HIPK1;INHBA;NOTCH2;MKNK2;TGFBR2;JAG1;IL10
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3039840814664658,0.8549039635767537,0.6917562724014337,0.9277294477672604,1.0,22/105,17.86%,PRKCD;NRAS;KRAS;TAB3;CREBBP;MUC6;PSMB2;KLRC2;NFKB1;CHUK;FBXW11;PLCG2;PSMC6;PSMD11;PAK2;EP300;PSMD1;CUL1;IKBKG;PSMD7;BCL10;PSMC1
prerank,negative regulation of catalytic activity (GO:0043086),-0.30043762635443994,-0.8545169390803735,0.6829971181556196,0.8863502231167661,1.0,9/24,26.75%,NOTCH1;NES;CAMK2A;IFIT1;MT3;CAND1;CCAR2;NOS1;PLN
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.3690126110237321,-0.8543926681737711,0.648989898989899,0.8855864843323529,1.0,3/11,11.86%,PAK1;RAC1;STMN1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.2661270295025826,-0.8543758236138428,0.7094339622641509,0.884578962081263,1.0,14/43,21.96%,IGF1;CD34;SIRPA;SYT11;GAS6;HAVCR2;VSIR;NR1H4;SELENOS;CHRNA7;CX3CL1;CACTIN;TRIM27;TNFAIP3
prerank,mitotic nuclear membrane organization (GO:0101024),0.3293612100434812,0.8542053640551518,0.6736292428198434,0.9280246303073589,1.0,15/51,23.69%,NUP93;LMNA;LBR;EMD;SEC13;CC2D1B;IST1;AHCTF1;NUP188;LEMD2;RAN;NUP98;CCNB1;CHMP4A;CHMP4B
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.3293612100434812,0.8542053640551518,0.6736292428198434,0.9280246303073589,1.0,15/51,23.69%,NUP93;LMNA;LBR;EMD;SEC13;CC2D1B;IST1;AHCTF1;NUP188;LEMD2;RAN;NUP98;CCNB1;CHMP4A;CHMP4B
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.36409020641280954,-0.8541553417376523,0.6414634146341464,0.8840079232511494,1.0,2/12,10.49%,CYP26B1;CALR
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.38563600295655964,0.8541546175725195,0.6328502415458938,0.9276441327022585,1.0,2/17,5.95%,ANK2;SNTA1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.2722940478125075,-0.8541225341492578,0.7286821705426356,0.8830533768069638,1.0,14/41,21.96%,IGF1;CD34;SIRPA;SYT11;GAS6;HAVCR2;VSIR;NR1H4;SELENOS;CHRNA7;CX3CL1;CACTIN;TRIM27;TNFAIP3
prerank,response to cytokine (GO:0034097),0.29448468713631054,0.8541079423359483,0.7413213885778276,0.9272454498214077,1.0,30/141,16.91%,DPYSL3;HDAC4;PID1;ANXA1;ADAM9;NFAT5;COL3A1;AFF3;PTPN2;STAT3;TIMP2;PLSCR1;SETD2;REL;IKBKE;RHOA;IRAK3;TIMP1;IL18BP;MYD88;PTPN9;PRKCA;CXCR4;IFNLR1;MAPKAPK2;PML;DDOST;ADAM10;CYP27B1;NLRP12
prerank,copper ion transport (GO:0006825),-0.37085125241597705,-0.8541020900161268,0.6586538461538461,0.8820793995407451,1.0,7/11,24.63%,ATOX1;SLC31A1;STEAP3;COX17;ATP7A;STEAP2;STEAP4
prerank,neutrophil activation involved in immune response (GO:0002283),0.2764441993640098,0.8538033880022581,0.8367139959432048,0.9272870573268553,1.0,74/428,16.37%,CD55;ANXA2;ANXA3;PRKCD;DSP;CD44;GSN;TMC6;NRAS;PYGB;SPTAN1;ANO6;STOM;RAB44;AP2A2;DIAPH1;VNN1;IGF2R;RAB6A;RAP1A;UBR4;VCP;BRI3;VCL;ACP3;DNAJC3;FRK;TIMP2;ITGAV;HMOX2;B4GALT1;DNAJC5;CRACR2A;PTGES2;SLPI;CYSTM1;PKP1;JUP;DERA;ARSB;RAP2C;GPI;PAFAH1B2;RHOA;NFKB1;IQGAP1;KCMF1;CAB39;SNAP23;CKAP4;AMPD3;GLB1;BIN2;TNFRSF1B;CPNE3;OLR1;ATP11A;TMEM179B;PSMD11;TOM1;XRCC5;RAB24;TCIRG1;GOLGA7;PLD1;PSMD1;IST1;DDOST;HPSE;RAB4B;ADAM10;CDK13;NIT2;CLEC5A
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.414058191954542,0.8537636194619465,0.6258169934640523,0.926868231939966,1.0,6/13,20.12%,SEC16A;TMEM30B;BCAP31;SAR1B;EDEM2;TM9SF4
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.31426534975541737,0.8532087533425252,0.6862275449101797,0.9274143536637395,1.0,7/75,5.23%,THBS1;HOXA5;SEMA3E;SULF1;KLF4;ISM1;ATP2B4
prerank,regulation of amyloid-beta clearance (GO:1900221),0.39428344302266666,0.8527115989236799,0.6282051282051282,0.9278415130622821,1.0,3/16,6.35%,LRPAP1;LRP1;CLU
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.3456756659014041,0.8525799450541178,0.661849710982659,0.9275697350170147,1.0,7/34,12.15%,UBASH3B;PTPRF;PTPN2;DUSP5;DUSP16;DUSP10;PTPN9
prerank,cellular response to lipopolysaccharide (GO:0071222),0.300294068514062,0.85246624918706,0.6871165644171779,0.9272906141061819,1.0,19/101,13.48%,LBP;ADAM9;PRKCE;PDCD4;CD80;IL10;TLR4;CXCL2;RHOA;NFKB1;SHPK;MTDH;TRIM41;CCL3;MYD88;ZC3H12A;CARD16;TNFRSF1B;CTR9
prerank,N-glycan processing (GO:0006491),-0.3208997484772461,-0.8523173312202681,0.6213872832369942,0.8844896438938027,1.0,5/18,8.57%,ST8SIA4;MAN1C1;ST8SIA6;MAN2A2;ST8SIA1
prerank,regulation of oxidoreductase activity (GO:0051341),0.41470230046508305,0.851547608397123,0.6387959866220736,0.9284317978918709,1.0,1/13,3.58%,ABL1
prerank,mitotic sister chromatid segregation (GO:0000070),0.30357377785699075,0.8512541114993183,0.7216867469879518,0.928464460420153,1.0,27/98,24.41%,SMC4;KLHL22;BECN1;PDCD6IP;SMC1A;NIPBL;RB1;PIBF1;CUL3;DIS3L2;NCAPH2;KMT5A;KNSTRN;INO80;CSNK2A2;CSNK2A1;SPDL1;ZW10;RAN;AKAP8L;TEX14;KIF2C;CCNB1;CHMP4A;CHMP4B;NAA50;POGZ
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.35513831313870575,0.8510361721153847,0.6834030683403068,0.9283697650697088,1.0,10/37,18.33%,FHIT;GIPC1;WAC;USP7;DDRGK1;TRIM39;PML;TLK2;CSNK2A2;CSNK2A1
prerank,response to axon injury (GO:0048678),0.3897568230363153,0.8508497732261885,0.6317460317460317,0.9282142603985749,1.0,1/18,0.85%,DPYSL3
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.3937549909260343,0.8507358582696798,0.6521060842433697,0.9279366218817681,1.0,10/18,34.68%,CDC25B;CCND1;RAD51B;RAD51C;CCNB1;MECP2;DTL;BRD4;RAB11A;FBXO5
prerank,positive regulation of macroautophagy (GO:0016239),0.33093902155940963,0.8504601318279498,0.6729222520107239,0.9279602407674123,1.0,12/48,17.39%,ADRB2;RAB3GAP2;PAFAH1B2;LRSAM1;VPS13D;HSPB8;WAC;SMCR8;SH3GLB1;BAG3;IKBKG;SCOC
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.31227874627540575,-0.850390208883557,0.6744186046511628,0.8872216064967592,1.0,2/21,1.98%,SLC30A10;PPARA
prerank,negative regulation of hippo signaling (GO:0035331),0.41795482287984764,0.8503794250593151,0.627147766323024,0.9276064685484828,1.0,2/12,10.12%,CIT;MARK3
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.36172366742448814,0.8500515870733932,0.6337209302325582,0.9277257491416968,1.0,13/29,27.31%,GDNF;PKP1;FUS;PABPC1;THRAP3;CIRBP;FMR1;E2F1;TENT5D;NBAS;TAF15;TENT5C;VIP
prerank,lipoprotein catabolic process (GO:0042159),-0.3741456957379868,-0.8496671346235063,0.6482412060301508,0.8876553828961514,1.0,2/11,5.51%,APOE;NOTUM
prerank,lipid homeostasis (GO:0055088),-0.2560646784575274,-0.8494323104300219,0.7942386831275721,0.8870933720329088,1.0,16/57,21.57%,APOE;NR1H3;PRKAA2;ZBTB20;ABCA1;ABCG1;PNPLA8;ABCB4;ORMDL3;CLN8;ABCA2;XBP1;DDX3X;CEBPA;USF2;TREM2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.2552464863917084,-0.8492170257487496,0.7261410788381742,0.886538046229081,1.0,21/55,24.17%,BCL2;TPD52L1;BCL2L1;DAB2IP;TNFSF10;RPS3;FAS;WWOX;BOK;BMF;AGT;NUPR1;RACK1;TNFSF12;HYAL2;GPER1;DNM1L;PMAIP1;PYCARD;G0S2;CYLD
prerank,cellular response to starvation (GO:0009267),0.2919923119463003,0.8484554868144342,0.7429218573046432,0.9300969604451481,1.0,38/147,20.49%,MAP3K5;FOXO3;DAPL1;WIPI2;KLF10;NPRL3;ZFYVE1;BECN1;VPS41;CLEC16A;RRAGB;ITFG2;WRN;MLST8;SIK2;INHBB;USP33;ZC3H12A;CASTOR2;SEC13;MTOR;SH3GLB1;TCIRG1;ATP6V0D1;EIF2AK4;ATF2;ATP6V0E1;SREBF1;SZT2;EHMT2;CDKN1A;GAS2L1;EIF2S1;RHEB;ATP6V1H;WDR45B;NPRL2;MAPK8
prerank,hexose metabolic process (GO:0019318),-0.2650619264377848,-0.8484240855316199,0.7403508771929824,0.8871377751192866,1.0,16/39,31.16%,APOD;PPARD;PGM1;ALDOC;ALDOA;PMM2;AKR1A1;DCXR;KHK;FUCA1;CHST1;GALT;ALDOB;TFAP2B;FUCA2;GALM
prerank,negative regulation of autophagosome assembly (GO:1902902),0.4063019349931638,0.8465932072996589,0.6533333333333333,0.932980694362138,1.0,7/13,28.65%,TMEM39A;SMCR8;SEC22B;CHMP4A;CHMP4B;PHF23;FEZ2
prerank,endothelial cell differentiation (GO:0045446),0.4279109814804132,0.846424272348283,0.6271186440677966,0.9327837877851849,1.0,2/12,6.28%,FSTL1;JAG1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.41000308811632824,0.8462556478926275,0.6331058020477816,0.9325995433540811,1.0,2/12,6.05%,NIN;PCM1
prerank,endosome organization (GO:0007032),0.34011556028060785,0.8458161470500049,0.680998613037448,0.9329107500626103,1.0,13/41,24.31%,EEA1;WASHC5;CORO1C;SQSTM1;HOOK3;ANXA8L1;ANXA8;TMCC1;WASHC4;PLEKHF1;HOOK2;RNF26;PHETA2
prerank,determination of left/right symmetry (GO:0007368),0.345367318849382,0.8455550881860263,0.6620689655172414,0.9328900087313262,1.0,11/36,22.07%,SMO;PITX2;GALNT11;MEGF8;CCDC40;DNAAF4;STIL;KIF3B;ODAD3;OFD1;ODAD2
prerank,regulation of TORC1 signaling (GO:1903432),0.3478863933565103,0.8454813526686816,0.649645390070922,0.9325340558528736,1.0,9/33,12.39%,TELO2;KLHL22;CLEC16A;RRAGB;ITFG2;SIK3;ATM;SMCR8;CASTOR2
prerank,maturation of 5.8S rRNA (GO:0000460),0.3813274256874715,0.8452306999310963,0.6310679611650486,0.9324962400397717,1.0,9/17,22.44%,C1D;MPHOSPH6;EIF6;RPF1;PRKDC;RRP15;WDR12;URB1;FTSJ3
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.35249673624254435,0.8451316284256063,0.6621417797888386,0.9321851563679039,1.0,5/29,5.86%,NGF;SHC1;NOTCH2;SHOC2;ITGAV
prerank,vacuolar acidification (GO:0007035),0.36743587088391133,0.8447674609074597,0.6519685039370079,0.9323521659583212,1.0,6/21,19.94%,ATP6V0A4;TCIRG1;ATP6V0D1;ATP6V0E1;ATP6V1H;CLN3
prerank,mRNA catabolic process (GO:0006402),0.32600094310406286,0.8441856663636899,0.6685236768802229,0.9328864474074693,1.0,12/44,22.40%,DDX5;DXO;ZC3H12D;TUT7;THRAP3;DIS3L2;NUDT12;TUT4;LSM2;YTHDF2;NBAS;NANOS2
prerank,genitalia development (GO:0048806),0.41017932131271456,0.8440445202261009,0.637901861252115,0.9326565403697502,1.0,2/12,4.11%,PKD1;STRA6
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.3242625682983503,-0.8437820709464497,0.6631016042780749,0.8952661494611271,1.0,6/18,15.26%,PPARA;PAG1;DUSP3;ASS1;JAK3;AKT1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.36793837424459286,-0.8433775378947898,0.675609756097561,0.8949929635713691,1.0,4/10,41.71%,ARRB2;CX3CR1;FCGR2B;KLRC1
prerank,regulation of establishment of planar polarity (GO:0090175),0.3064171438249866,0.8432915849536309,0.7050183598531212,0.9335781892898148,1.0,24/88,21.30%,WNT11;PRICKLE1;FZD7;AP2A2;PSMB2;FZD1;RHOA;AP2A1;DACT1;PSMC6;DAAM1;TIAM1;SMURF1;PSMD11;PSMD1;CELSR3;PSMD7;PSMC1;PSMD14;DVL1;FZD2;CDC42;FZD3;PSMD3
prerank,RNA stabilization (GO:0043489),0.34792685198080875,0.8432168951661669,0.6414285714285715,0.933219944852239,1.0,15/33,27.31%,GDNF;FUS;PABPC1;THRAP3;DHX36;TRDMT1;CIRBP;E2F1;TENT5D;TENT2;NAF1;TAF15;TENT5C;PARN;VIP
prerank,granulocyte differentiation (GO:0030851),-0.32460410248717686,-0.8429568740557879,0.6885245901639344,0.8948232770069909,1.0,3/18,8.25%,LEF1;CBFA2T3;TAL1
prerank,neurotrophin signaling pathway (GO:0038179),0.37630900941477874,0.8428223089103402,0.6740157480314961,0.9334532849983668,1.0,3/21,4.54%,NGF;RAP1A;KIDINS220
prerank,calcium ion import (GO:0070509),0.3582020320609299,0.8427494281946987,0.6710526315789473,0.9331040896222706,1.0,6/28,10.64%,CACNA1C;CACNA1G;CASR;CACNA1F;MCUB;MCU
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.4206448916406791,0.8426750359584811,0.6602254428341385,0.9327557958740343,1.0,4/13,16.70%,HES1;PIGU;MGAT5;EGF
prerank,ncRNA export from nucleus (GO:0097064),0.34820114288799486,0.8425295773399032,0.6784140969162996,0.9325255997287063,1.0,16/36,27.84%,NUP93;RANBP2;NUP153;SEC13;NUP214;NUP188;NUP88;RAN;NUP98;SSB;AAAS;NUP54;RAE1;NUP155;NCBP2;XPOT
prerank,regulation of synapse organization (GO:0050807),-0.29190149185252373,-0.8419708503506828,0.7217125382262997,0.8957339333169786,1.0,5/26,5.39%,IL1RAPL1;CTNNA2;WNT5A;EPHA4;MEF2C
prerank,cellular response to arsenic-containing substance (GO:0071243),0.38399475345006445,0.8418785771430621,0.6237942122186495,0.9331978083793822,1.0,4/15,18.49%,MKNK2;VCP;ZC3H12A;DHX36
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.28796286067430216,0.8418630510156654,0.7388392857142857,0.9327356189801976,1.0,46/148,24.04%,USP2;HIPK1;SMYD2;EXO1;EHMT1;CHEK2;PLK3;MDM4;RAD17;WRN;ATM;AURKA;MLST8;PPP2R5C;USP7;MTOR;CHEK1;CHD3;EP300;DYRK2;PML;RBBP8;TAF4;KMT5A;TAF12;RPA1;TOP3A;ATR;BARD1;RMI2;NBN;EHMT2;CSNK2A2;CSNK2A1;RBBP7;TOPBP1;PHF20;PAK1IP1;PRMT5;RAD50;RAD9B;CCNG1;CDK2;PIP4K2A;TAF15;RFC5
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.36785095895066106,0.8417845342868835,0.6466973886328725,0.9323989761365357,1.0,1/22,1.42%,CD55
prerank,tRNA methylation (GO:0030488),0.34642352643153324,0.8415997027678132,0.6709770114942529,0.9322558178598764,1.0,19/34,35.21%,MTO1;ALKBH8;TRMT13;METTL6;TRMT10A;TARBP1;TRDMT1;DALRD3;METTL1;TRMT1L;THADA;GTPBP3;THUMPD2;FTSJ1;TRMT12;METTL2B;METTL2A;TRMT44;TRMT61B
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.3479943018253485,0.8410347181776566,0.6859623733719248,0.9327830670284121,1.0,4/33,7.30%,TCF7L2;NFE2L2;CAST;IL10
prerank,regulation of steroid metabolic process (GO:0019218),-0.29982720317782996,-0.8410171378605983,0.6755162241887905,0.8965526904174964,1.0,5/23,20.69%,APOE;ABCG1;NR1H4;ABCA2;RORC
prerank,positive regulation of viral life cycle (GO:1903902),-0.29861815912774875,-0.8409821272369946,0.6986666666666667,0.8955862415946926,1.0,5/22,19.06%,LGALS1;AXL;CD74;TYRO3;P4HB
prerank,negative regulation of blood pressure (GO:0045776),-0.3524940911320925,-0.840927492847053,0.6787564766839378,0.8946774768326767,1.0,7/13,32.47%,NOS3;PRCP;GPR37L1;NOS2;NOS1;DRD2;BMPR2
prerank,intermediate filament organization (GO:0045109),0.39123312285340683,0.840901690595116,0.6612111292962357,0.9325589327684503,1.0,3/17,7.38%,DSP;KRT14;PKP1
prerank,regulation of immune response (GO:0050776),0.288788252108714,0.8406488973560682,0.734006734006734,0.9325476843796663,1.0,16/135,14.70%,FOXP1;CXADR;COL3A1;ITGB1;RAET1E;SPPL2A;PLSCR1;IRF1;PVR;RIPK3;TREML1;ERAP1;CSK;GPR108;BCL6;RNF135
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.37386747032318024,-0.8405775423506652,0.6618004866180048,0.8943620985550316,1.0,2/10,7.42%,PRKCZ;IL18
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.40925050644734856,0.8405080582056781,0.6486486486486487,0.9323222984073942,1.0,2/13,3.27%,FGFR1;FGF2
prerank,triglyceride catabolic process (GO:0019433),0.37668389019128834,0.8405017441849334,0.6672025723472669,0.931849396677664,1.0,1/19,3.51%,PNPLA3
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.39454839722700163,0.8404502891308585,0.6645264847512039,0.9314470459858305,1.0,2/15,6.10%,CD44;KDM1A
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3461193445606298,0.8402767375473761,0.6760961810466761,0.9312722920668576,1.0,22/37,32.68%,PCM1;WDR35;IFT46;DYNC2I2;CEP131;TRIP11;IFT52;KIF3B;DYNC2I1;DYNC2H1;IFT80;CLUAP1;TRAF3IP1;IFT88;IFT43;TTC21B;IFT74;IFT27;IFT122;KIFAP3;IFT22;KIF17
prerank,peptide hormone secretion (GO:0030072),0.3668505202017833,0.8400425859341972,0.6838995568685377,0.9312040377447613,1.0,3/26,9.08%,ANXA1;LTBP4;SNX19
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.3037705611459349,0.840012317573456,0.7295980511571255,0.9307599257457628,1.0,17/86,19.04%,EGLN3;NFE2L2;CREBBP;DDIT3;HIF3A;PSMB2;PSMC6;VEGFA;PSMD11;BAG3;CHEK1;EP300;PSMD1;PSMD7;INO80;PSMC1;PSMD14
prerank,regulation of autophagy (GO:0010506),0.28022760436980804,0.8397727041313294,0.7879781420765027,0.930711220429116,1.0,37/216,14.30%,MET;NEDD4;EXOC4;EIF4G3;FOXO3;USP13;DAPL1;GSK3B;ABL1;FOXK1;EIF4G1;TAB3;KLHL22;STAT3;DDIT3;TPCN1;IL10;RRAGB;WDR41;ATM;MLST8;RB1CC1;SNX32;PIM2;USP10;MTDH;SMCR8;FOXK2;ATF6;CISD2;USP33;ZC3H12A;MTOR;SH3GLB1;EP300;ATP6V0D1;HTR2B
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.32288941017112893,-0.8396804392481542,0.684931506849315,0.89497860808092,1.0,1/18,0.70%,LYN
prerank,positive regulation of tissue remodeling (GO:0034105),-0.37182182018210247,-0.8394302300572615,0.655011655011655,0.894441445948805,1.0,3/10,19.98%,IL18;ROCK2;HRG
prerank,regulation of cholesterol esterification (GO:0010872),-0.37606336866767565,-0.8392337540760593,0.6847058823529412,0.8938237563678013,1.0,5/10,20.34%,APOE;ABCG1;AGT;ABCA2;APOC1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.4026166559651901,0.8392115520674526,0.6414141414141414,0.931200270291629,1.0,4/13,10.37%,SEMA3E;NRP1;TGFBR2;VEGFA
prerank,nuclear membrane reassembly (GO:0031468),0.3223269341052165,0.8390891575132245,0.7054263565891473,0.9309317251989894,1.0,15/54,23.69%,NUP93;LMNA;LBR;EMD;SEC13;CC2D1B;IST1;AHCTF1;NUP188;LEMD2;RAN;NUP98;CCNB1;CHMP4A;CHMP4B
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.30024326352378866,0.8386961833609096,0.7177033492822966,0.9311531802687314,1.0,16/101,11.24%,EGFR;PKD1;TCIM;PDGFC;ADRB2;FGFR1;FGF2;TELO2;ATP2B4;PDGFA;RHOA;SYAP1;VEGFA;CAB39;TNFSF11;ERBB2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.2826292450496577,-0.8382076251047474,0.7278481012658228,0.8947378426312772,1.0,17/31,25.19%,SYT7;SYT11;SYT12;ADRA2A;SYT1;SYT13;CACNA1I;SYT10;SYT9;SYT6;SYT15;SYT2;DOC2B;SYT4;SYT5;SYT17;DOC2A
prerank,regulation of lipid metabolic process (GO:0019216),0.30306040769876175,0.8377122159929961,0.7160194174757282,0.9324257830761176,1.0,23/88,20.04%,TNFAIP8L3;CHD9;CREBBP;TBL1X;RORA;ID2;RXRA;NFYA;SCD;NCOR1;MVD;NCOR2;HNF4A;PLPP1;HMGCR;GNB3;CARM1;SREBF1;PPARG;NCOA6;ABCA7;FDPS;ADIPOR1
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.3791479675969764,0.8375128690710052,0.6575121163166397,0.9322826532003519,1.0,1/17,0.28%,BMP4
prerank,regulation of actomyosin structure organization (GO:0110020),0.40946031894589163,0.8372289464783356,0.6342281879194631,0.9323338738857588,1.0,3/13,11.68%,AKAP13;SLC9A1;ASAP3
prerank,positive regulation of neuron death (GO:1901216),0.3318362662811937,0.8369824404955828,0.6993377483443709,0.9323206953205444,1.0,8/46,11.16%,MAP3K5;FOXO3;GSK3B;CLU;DDIT3;TLR4;NF1;CCL3
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.33520596075930226,0.8368072727623808,0.6813793103448276,0.9321464811050065,1.0,8/42,10.37%,PTK2B;GSK3B;ABL1;NRP1;JUP;S100A10;LIMS1;VEGFA
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.3494794619670301,0.8363088419435611,0.6642228739002932,0.9325812496253423,1.0,3/28,6.42%,MAP3K5;TMEM117;DDIT3
prerank,regulation of hemopoiesis (GO:1903706),0.4198285810663227,0.8361321492526005,0.6409807355516638,0.9324299122570403,1.0,3/10,11.22%,CREBBP;MYSM1;CBFB
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.3048903754001425,-0.8360905892548349,0.7013698630136986,0.8977261411756605,1.0,3/22,12.66%,NR2F2;MYOCD;HHEX
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.34093503501554595,-0.8359765248807013,0.6810126582278481,0.8969121253784195,1.0,5/14,24.79%,BCL2L1;TMBIM6;SELENOS;XBP1;CREB3
prerank,regulation of phosphate metabolic process (GO:0019220),0.38414928213934363,0.8344590807328623,0.6676970633693973,0.9349152289764457,1.0,5/16,17.23%,SMG6;MCM7;RAD17;GNB3;BARD1
prerank,endocytic recycling (GO:0032456),0.3259060894906833,0.8340119144649505,0.6893333333333334,0.9352274993770952,1.0,22/50,25.52%,RAB11FIP3;ANKRD27;EHD3;EHD1;EHD2;ENTR1;SNX12;CCDC22;SNX31;SNF8;WASHC1;VPS52;VPS51;SNX4;RAB35;VPS53;CMTM6;RAB11B;RAB7A;SNX17;VPS26C;VPS29
prerank,cellular response to hypoxia (GO:0071456),0.2865948817388564,0.8339086581617183,0.7611428571428571,0.9349207626009408,1.0,25/126,19.04%,EGLN3;NDRG1;PTGIS;NPEPPS;LMNA;CREBBP;RORA;HIF3A;PSMB2;PLK3;MDM4;HILPDA;PSMC6;VEGFA;CARD16;PSMD11;MTOR;EP300;TWIST1;PSMD1;PSMD7;PSMC1;AK4;ADAM8;PSMD14
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.3835877842040016,0.8335370977929042,0.6328358208955224,0.9350885825535412,1.0,3/18,5.62%,PTK2B;BCAS3;SHTN1
prerank,histone H3 acetylation (GO:0043966),0.32979845232919863,0.8334536861284464,0.6923076923076923,0.9347726986825594,1.0,24/40,30.86%,KAT6B;TADA3;SGF29;BRCA2;PER1;KAT2A;BRD1;KAT2B;TRIM16;TAF12;YEATS2;PHF14;LDB1;MAP3K7;JADE2;TADA2A;KAT14;TAF9;KAT6A;NAA60;TAF6L;TAF5;TADA1;BRPF1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.35859326905309064,0.8331153854519411,0.6835820895522388,0.9348911942340066,1.0,5/28,11.84%,MET;CLIP1;TOGARAM1;AKAP9;SLAIN2
prerank,blood circulation (GO:0008015),0.32671121572807416,0.8330126584140094,0.6972972972972973,0.9346016593170406,1.0,10/49,13.64%,SGCD;MEOX2;GCLC;AGTR1;SERPING1;TNNI3;ELN;ITGB1BP1;OLR1;SCPEP1
prerank,positive regulation of lyase activity (GO:0051349),-0.3400833819511337,-0.8328712888498143,0.6772486772486772,0.9015653199239682,1.0,2/14,1.96%,CACNA1D;NOS3
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.346886511848208,-0.8324942114261508,0.6675257731958762,0.9012565945885227,1.0,3/14,5.33%,PRKD1;LOXL3;CD63
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.37793991104303404,0.8319078155674987,0.6671732522796353,0.9361013311023526,1.0,3/20,6.13%,PID1;MRAP;RHOQ
prerank,regulation of protein neddylation (GO:2000434),-0.3668659328487169,-0.8316253960346721,0.6877729257641921,0.9018744434384685,1.0,5/10,17.85%,HIF1A;RPL11;DCUN1D3;EPAS1;RPL5
prerank,positive regulation of protein ubiquitination (GO:0031398),0.30307565589673463,0.8313590769504169,0.7106227106227107,0.9365958019605262,1.0,24/80,25.40%,PRICKLE1;FAM107A;KDM1A;RIPK2;BIRC7;MYCBP2;DCUN1D5;COMMD1;MTA1;FBXO4;CUL3;BIRC3;BCL10;FANCM;DCUN1D2;DCUN1D1;DCUN1D4;UBE2N;HUWE1;TSPYL5;SMAD7;ARRDC3;PHF23;TRAF6
prerank,positive regulation of peptidase activity (GO:0010952),0.38108671914660514,0.8312552201296433,0.656298600311042,0.9362894635755994,1.0,4/20,12.35%,TANK;VCP;MAPK12;DDRGK1
prerank,cardiac ventricle development (GO:0003231),0.36953873529993897,0.8308645230080748,0.6755485893416928,0.9364982218402765,1.0,5/20,8.46%,HES1;STRA6;GATA4;TMEM65;MDM4
prerank,presynapse assembly (GO:0099054),-0.33034487670235063,-0.8304546522343107,0.6859504132231405,0.9029543563956013,1.0,3/16,7.59%,IL1RAPL1;WNT5A;LRRTM3
prerank,oogenesis (GO:0048477),-0.33455572689336155,-0.8304496726845232,0.6759493670886076,0.9019338623043484,1.0,5/15,20.78%,FMN2;MDK;NANOS3;TRIP13;METTL3
prerank,DNA replication initiation (GO:0006270),0.3378316438429598,0.830156833872092,0.685472496473907,0.9372402848080227,1.0,11/37,23.40%,MCM7;MCM2;CDC45;PRIM2;POLE2;RPA1;PRIM1;TOPBP1;POLA1;CDK2;NOC3L
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.2965067174951899,0.8299666079953044,0.7401668653158522,0.9370886276338382,1.0,8/93,7.25%,RASSF2;MAP3K5;PTK2B;MID1;FZD7;WNT16;GADD45G;GDF6
prerank,regulation of vacuole organization (GO:0044088),0.3782387555472862,0.8293194176023952,0.6881889763779527,0.9377521369832784,1.0,2/20,4.86%,ANXA2;NPRL3
prerank,Golgi ribbon formation (GO:0090161),0.4006463745450777,0.8287326709603703,0.6417910447761194,0.9383559558687442,1.0,4/13,15.32%,TMED5;GOLPH3;VTI1A;TRIP11
prerank,epithelial cell morphogenesis (GO:0003382),0.3832941766435713,0.8282807661624132,0.6788079470198676,0.9386600292319596,1.0,3/17,9.32%,MET;GRHL2;RAB25
prerank,mitochondrial translational elongation (GO:0070125),0.297169545557836,0.8281906557643336,0.7195704057279236,0.9383326769591075,1.0,33/88,31.58%,MRPL33;MRPL48;MRPS27;MRPL32;MRPL14;MRPL40;GFM2;MRPS31;MRPL21;MRPL42;MRPS30;MRPL57;MRPS35;MRPS28;MRPL52;MRPL38;MRPS22;MRPL10;MRPS10;MRPL36;MRPL20;MRPL47;MRPL11;MRPS7;MRPS2;MRPL23;MRPS18A;MRPL19;MRPS21;MRPL9;MRPS18C;MRPS34;MRPS16
prerank,dendrite morphogenesis (GO:0048813),0.34151068736504886,0.827475337477152,0.6951871657754011,0.9391009988735781,1.0,8/35,10.66%,CTNND2;PHACTR1;MEF2A;KLF7;EPHB3;SHANK1;BTBD3;FARP1
prerank,regulation of glucose metabolic process (GO:0010906),0.33758339001905546,0.8273680983826068,0.7062841530054644,0.9388142445181161,1.0,8/34,16.88%,IRS1;FOXK1;RORA;USP7;FOXK2;PDK3;GNMT;GNB3
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.41511685020589206,0.8271144035487068,0.6908783783783784,0.9387984478720395,1.0,2/11,6.10%,CD44;KDM1A
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.300633459032408,0.8269345998365054,0.7158536585365853,0.9386066926582911,1.0,23/85,21.30%,WNT11;PRICKLE1;FZD7;AP2A2;PSMB2;FZD1;RHOA;AP2A1;PSMC6;DAAM1;TIAM1;SMURF1;PSMD11;PSMD1;CELSR3;PSMD7;PSMC1;PSMD14;DVL1;FZD2;CDC42;FZD3;PSMD3
prerank,cellular polysaccharide catabolic process (GO:0044247),0.38418490064679955,0.8264089857015694,0.6741935483870968,0.9390640699544476,1.0,3/16,8.79%,PYGB;PHKA2;PHKB
prerank,melanosome organization (GO:0032438),0.35146941142792476,0.8261536977449682,0.6747720364741642,0.9390507942627377,1.0,6/26,17.88%,KIF13A;AP3B1;HPS4;PMEL;LYST;AP3D1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.39197099332630725,0.8252988090531647,0.6715927750410509,0.9400907221799242,1.0,3/15,12.58%,ENTPD6;ENTPD2;ENTPD7
prerank,regulation of protein localization to cell surface (GO:2000008),-0.2778638672991059,-0.8251379486563412,0.7532467532467533,0.910857633092418,1.0,5/33,8.30%,NEDD4L;PICALM;GPM6B;HSP90AB1;ACTN2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3088239672725822,0.8250622309851745,0.7296620775969962,0.9400292338171339,1.0,6/71,3.58%,CYFIP2;ABI1;PRKCD;VAV2;PRKCE;ABL1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.30948658626642533,0.8248832980925472,0.7236180904522613,0.9398635388403409,1.0,6/70,3.58%,CYFIP2;ABI1;PRKCD;VAV2;PRKCE;ABL1
prerank,response to interferon-beta (GO:0035456),-0.30390214000193466,-0.8248819794012446,0.7348703170028819,0.9103197027428319,1.0,6/22,12.35%,IFITM1;BST2;AIM2;IFITM3;IFNAR2;STAT1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.34763813337027694,0.8246733288962325,0.6681547619047619,0.9397388604454658,1.0,9/29,24.93%,ABL1;DCUN1D5;FEM1B;DCUN1D2;DCUN1D1;DCUN1D4;UBE2N;SMAD7;ARRDC3
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.35565988711516955,0.8245348635439667,0.6940993788819876,0.9394960124134549,1.0,9/26,15.45%,GSK3B;ATP2B4;SLC9A1;PLCG2;HOMER2;CHP1;RCAN1;DYRK2;LMCD1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.35071672077215155,0.8245214579588688,0.689900426742532,0.9390410039925425,1.0,2/30,3.23%,BMP5;GSK3B
prerank,regulation of cell adhesion (GO:0030155),0.2854193152902369,0.8244374380654664,0.7497142857142857,0.9387145677375688,1.0,19/129,14.04%,ZFHX3;PPP3CA;PTK2B;EFNA5;ARHGDIB;GPR4;ABL1;ITGAV;EPHB3;CHRD;ATM;PPP1R12A;VEGFA;ERBB2;ITGB1BP1;ZDHHC2;PRKCA;CXCR4;RSU1
prerank,RNA transport (GO:0050658),0.3057302072443715,0.8243248155693291,0.7022900763358778,0.9384302730066715,1.0,20/71,19.85%,SIDT2;TGFBR2;SRSF11;THOC2;SRSF5;SRSF6;ATXN2;U2AF2;NUP153;SRRM1;CASC3;NUP214;CHTOP;NUP188;U2AF1L4;SRSF2;THOC5;ZC3H11A;FMR1;NXF1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.3816667390920304,0.8243057441152836,0.6875,0.9379853744771203,1.0,4/18,12.92%,MISP;MMP14;STX8;ZDHHC2
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.3953637442046427,0.8243034002739147,0.6791171477079796,0.9375153423757195,1.0,3/13,11.92%,PIK3AP1;IRAK4;MYD88
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.41396234910828017,0.8242043290585638,0.6712095400340715,0.9372018174754095,1.0,2/10,6.52%,WNK1;ADA
prerank,positive regulation of protein kinase activity (GO:0045860),0.28428837642853194,0.8241368025326821,0.7828054298642534,0.9368364509468012,1.0,20/148,10.88%,RASSF2;CCN1;PTK2B;DDR2;PRKCD;ADRB2;RAP1A;TELO2;TGFBR2;CLU;MARK2;RHOA;IQGAP1;RIPK3;SYAP1;VEGFA;CAB39;CLSPN;ITGB3;STRADA
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.4161291100942394,0.8234230020036847,0.6684027777777778,0.937623570286305,1.0,2/10,11.22%,ZBTB7B;CBFB
prerank,regulation of cellular component size (GO:0032535),0.3446799530433373,0.8231726439723757,0.6987087517934003,0.9375595305281266,1.0,6/30,13.21%,EZR;VAV2;RDX;RARG;RAP1GAP2;MTOR
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.3769718138923356,0.8231273578318961,0.6749611197511665,0.9371612055342035,1.0,3/20,6.13%,PID1;MRAP;RHOQ
prerank,"transcription, DNA-templated (GO:0006351)",0.27843224686498486,0.8224570766256342,0.8134328358208955,0.9378511931678327,1.0,41/207,19.60%,RNMT;MLLT3;DDX5;FOXO3;MEF2A;NR4A2;ZBTB7B;MNAT1;MBD1;NFIX;AFF4;NFKB1;NFYA;RBMX;TTF2;RPAP1;SNAPC2;CBFB;TAF1C;PPP5C;ELOA;TTF1;GTF2E1;NELFE;CTR9;BAZ2A;TRIP11;HOXD3;TAF4;DDX21;ERCC3;POLR3K;EPC1;TAF12;CREBL2;POLR3A;CCNT1;NCOA6;SMARCA5;RTF1;E2F1
prerank,RNA catabolic process (GO:0006401),0.317533935343008,0.8222633628267205,0.6893333333333334,0.9377096153846587,1.0,13/46,22.60%,SIDT2;DXO;PABPC4;EXOSC7;ZC3H12D;RNASEH2A;DIS3L2;NUDT12;RNASE6;LSM2;YTHDF2;NANOS2;RNASE3
prerank,protein-containing complex subunit organization (GO:0043933),0.2891042022402838,0.8222512340878054,0.7479674796747967,0.9372603357840047,1.0,13/109,11.10%,REPS2;SOX9;PTK2B;HES1;CREBBP;MNAT1;DMTN;TEAD1;MDM4;SHANK1;PARD3;CAPZA1;MATN1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.26805358367211907,-0.8221605154562142,0.7770897832817337,0.9142708850726287,1.0,12/37,22.49%,BCL2;BCL2L1;RPS3;RPS7;BOK;BMF;NUPR1;RACK1;NACC2;MSX1;DNM1L;PMAIP1
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.3497123204754638,-0.8219854457885656,0.7302798982188295,0.9135323624263099,1.0,4/12,18.59%,CLCN2;KPNB1;H6PD;ABCA2
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.36113561208348677,0.8217302260771406,0.6854460093896714,0.9376800034943338,1.0,8/23,27.60%,RAD23B;COPS7B;COPS5;XPA;CUL4A;COPS3;XPC;COPS2
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.3967282009028587,0.8217276245964764,0.6738768718801996,0.937211969862379,1.0,1/12,1.69%,CAMK2D
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.290449964285414,0.8214109399489833,0.7408312958435208,0.9372885526572803,1.0,17/95,14.73%,LBP;ADAM9;PDCD4;CD80;IL10;TLR4;CXCL2;RHOA;NFKB1;SHPK;TRIM41;MYD88;ZC3H12A;CARD16;TNFRSF1B;CTR9;SBNO2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.3630451188333967,0.8213038613658139,0.6846153846153846,0.9370163158995499,1.0,2/20,2.87%,NT5E;ANO6
prerank,protein targeting to membrane (GO:0006612),0.2996638406867434,0.8211032251401996,0.7335766423357665,0.9368802524089989,1.0,29/83,25.58%,ABCD3;PXMP2;ATG3;ZDHHC11;ACBD5;PARD3;ZDHHC15;SEC61A1;VPS37A;ZDHHC2;PEX13;GOLGA7;SEC63;ZDHHC20;VPS37B;ABCD1;ZDHHC23;RABGEF1;ZDHHC12;SRPRA;PEX2;SLC25A17;SIL1;GET3;CHMP4A;CHMP4B;PEX26;ZDHHC24;SRP19
prerank,positive regulation of dephosphorylation (GO:0035306),-0.2773365127110369,-0.8208526264971909,0.7735849056603774,0.9145761571960833,1.0,8/27,17.39%,PPP1R16B;CALM1;PPIA;BMP2;PPP2R5A;CALM3;SMPD1;CDH5
prerank,negative regulation of cell adhesion (GO:0007162),0.30801411626731917,0.8208259098201542,0.7220125786163522,0.9368594194600576,1.0,7/72,6.57%,CDH1;CYP1B1;ARHGDIB;FZD7;GCNT2;JAG1;DMTN
prerank,platelet aggregation (GO:0070527),0.33952858812278347,0.8208253935573061,0.6866295264623955,0.9363898626689278,1.0,6/33,10.80%,FN1;UBASH3B;VCL;CLIC1;GATA1;ITGB3
prerank,cellular response to fluid shear stress (GO:0071498),0.3987537372047226,0.8207979297629088,0.6632825719120136,0.9359704972762233,1.0,2/12,3.21%,KLF4;NFE2L2
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.3030294104763714,-0.8206383491698861,0.7185792349726776,0.9139152402500712,1.0,5/21,9.97%,MFHAS1;PPP1R16B;PPP4R4;YWHAB;TIPRL
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3780138315134283,0.8206380403258499,0.6842105263157895,0.935779323370057,1.0,2/18,3.88%,NFE2L2;VNN1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.35961996130219726,0.8205608717768267,0.6568047337278107,0.9354507120427589,1.0,5/22,8.71%,CAMK2D;MEF2A;NR4A3;SLC9A1;P2RX4
prerank,purine-containing compound salvage (GO:0043101),0.39418546346424915,0.8203579222816224,0.6762360446570973,0.9353168756199478,1.0,5/12,24.66%,ADA;AMPD3;DGUOK;GMPR2;AMPD2
prerank,negative regulation of viral process (GO:0048525),-0.23882921446848565,-0.8203532958749707,0.8200836820083682,0.9134228263820741,1.0,22/57,28.35%,TRIM14;PPIA;IFITM1;BST2;TRIM62;IFITM3;OAS2;PROX1;RNASEL;STAT1;TRIM21;IFIT1;PARP10;BANF1;OASL;TRIM27;RSAD2;IFITM2;TRIM32;TRIM8;CCL5;TRIM6
prerank,neuron projection morphogenesis (GO:0048812),0.28402159495418033,0.8201398117000072,0.7624861265260822,0.93520591607468,1.0,22/137,10.66%,DCLK1;NGF;CTNND2;DOCK7;ALCAM;SRGAP2;MEF2A;KLF7;TRIO;SHTN1;ISL1;ANKRD27;EPHB3;NBL1;SHANK1;IQGAP1;MAP1B;PARD3;BTBD3;CTTN;NCKAP1;FARP1
prerank,fluid transport (GO:0042044),0.3972706998087524,0.8200101976165619,0.6717687074829932,0.9349705607551033,1.0,2/12,9.93%,SLC26A6;AQP6
prerank,activation of GTPase activity (GO:0090630),0.2947421433731243,0.8192139084023173,0.7575757575757576,0.9358115503881691,1.0,25/89,16.48%,NTRK3;SGSM2;SIPA1L1;DOCK7;BCR;TIAM2;CCDC125;BCAS3;PIP5K1A;GRTP1;ARHGEF10;TBC1D2B;TBC1D13;ARHGEF5;TIAM1;TBC1D25;CORO1C;ARHGAP42;RAP1GAP2;SIPA1L2;TBC1D8B;TBC1D10A;TBC1D5;SGSM3;GPR65
prerank,regulation of histone methylation (GO:0031060),0.393252506873879,0.819076592734556,0.6930860033726813,0.9355812887336145,1.0,7/13,22.79%,NNMT;CTCFL;CTR9;CHTOP;NSD1;PAF1;MTHFR
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.3302320184420693,-0.8190446116250749,0.7057291666666666,0.9147749939775665,1.0,6/15,19.29%,RYR2;SRP14;SPCS3;ZFAND2A;SEC61G;SPCS1
prerank,regulation of axon extension (GO:0030516),0.3322626853335439,0.8189735380747055,0.6983471074380165,0.9352914183346366,1.0,4/37,5.62%,NTN1;GSK3B;ABL1;SHTN1
prerank,protein tetramerization (GO:0051262),0.3049485786186039,0.818666146052244,0.726474278544542,0.9353292395480536,1.0,2/67,1.11%,KCNJ2;PKD1
prerank,regulation of stem cell differentiation (GO:2000736),0.29329467166748546,0.8186325823618781,0.7616707616707616,0.9349130113867795,1.0,28/89,27.65%,HES1;BMPR1A;ABL1;GDNF;JAG1;PSMB2;GATA1;HOXB4;PSMC6;CBFB;TCF3;PRKDC;PSMD11;PSMD1;PSMD7;PSMC1;PSMD14;YTHDF2;PSMD3;GATA3;NUDT21;PSMD12;LDB1;PSMD4;EIF2AK2;PSMD2;PSME3;KMT2A
prerank,myelination (GO:0042552),0.31978339920401644,0.8186016000067311,0.7129629629629629,0.9345131658854607,1.0,8/46,10.26%,ACER3;MARVELD1;PMP22;SKI;ARHGEF10;NF1;PARD3;ADGRG6
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.3152267452914074,-0.8185387507487764,0.7294429708222812,0.9146160071107929,1.0,2/17,4.41%,CTNNA2;WASF3
prerank,alanine transport (GO:0032328),-0.3619188523263614,-0.8184882926048433,0.6852678571428571,0.9136781505110044,1.0,4/10,23.62%,SLC6A6;SLC6A17;SLC36A2;SLC7A10
prerank,MAPK cascade (GO:0000165),0.2708428548931568,0.8182901238592557,0.83125,0.9345991970288241,1.0,37/295,11.24%,EGFR;MET;MAP3K5;SOX9;PTPN3;NRAS;KRAS;MRAS;SPTAN1;FGFR1;SHC1;FGF13;FGF2;IRS1;MEF2A;PDE6D;SHOC2;DLG2;ITGAV;GDNF;PTPRA;IL17RD;DLG1;MAP3K3;PSMB2;DUSP5;ABHD17B;PDGFA;NFKB1;CHUK;FBXW11;NF1;PSMC6;MARK3;MAPK12;CCL3;ERBB2
prerank,cellular protein catabolic process (GO:0044257),-0.2394764914343554,-0.8181215416088906,0.8636363636363636,0.9132786146702435,1.0,12/59,15.81%,CTSC;CTSH;ADAMTS12;DAB2IP;CTSB;CTSZ;CTSS;LGMN;CTSL;MALT1;AFG1L;MYLIP
prerank,negative regulation of translation (GO:0017148),0.29505745110762166,0.8177353731454198,0.7691358024691358,0.9350798148597806,1.0,24/87,24.47%,SAMD4A;IGFBP5;FTO;PAIP2;SYNCRIP;CELF1;TOB1;EIF3E;EIF2AK4;PUM1;CNOT7;AGO2;DHX36;FXR2;CAPRIN1;FMR1;YTHDF2;EIF2AK3;EPRS1;NANOS2;SAMD4B;RBM4;YTHDF3;ROCK1
prerank,acetyl-CoA metabolic process (GO:0006084),-0.32783118376512393,-0.8173650539997498,0.7142857142857143,0.9135993264831789,1.0,3/15,13.46%,ACACB;ACSS1;ACLY
prerank,synaptic vesicle transport (GO:0048489),0.401019276793988,0.817276359486852,0.6745762711864407,0.935408232499769,1.0,3/11,14.23%,SPG11;TMEM230;SYNJ1
prerank,stem cell differentiation (GO:0048863),0.3260190446084979,0.8172680337937843,0.6934812760055479,0.9349626717343605,1.0,7/39,14.72%,LRP6;MLLT3;SETD2;HOXB4;PSMD11;HTR2B;PUM1
prerank,pore complex assembly (GO:0046931),0.37467369213670393,0.817018290524897,0.6719745222929936,0.9349445207645092,1.0,8/19,22.91%,ANO6;NUP93;NUP153;AHCTF1;ADAM10;AFDN;NUP98;TMEM170A
prerank,RNA destabilization (GO:0050779),0.3711620161599038,0.816789595472679,0.6599378881987578,0.9348596272715144,1.0,9/18,27.02%,FTO;CELF1;DXO;ZC3H18;PUM1;YTHDF2;YTHDF3;ROCK1;MEX3D
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.34527309368042763,-0.8165192430512543,0.6718346253229974,0.9140987011998426,1.0,5/13,21.01%,OAS2;IL6ST;STAT1;CRLF1;OASL
prerank,positive regulation of cyclase activity (GO:0031281),-0.3263082136815776,-0.8163066159138779,0.7277628032345014,0.9134203895410574,1.0,2/14,1.96%,CACNA1D;NOS3
prerank,regulation of interleukin-6 production (GO:0032675),0.2919384969645454,0.8157100110619011,0.7505938242280285,0.9362346082232265,1.0,24/96,18.34%,LBP;RAB7B;IL17RA;ISL1;STAT3;MAVS;IL10;TLR4;IL33;IRAK3;PLCG2;MYD88;ZC3H12A;IFIH1;TLR1;DHX9;MAPKAPK2;TWIST1;TLR8;C5AR2;NLRP12;BCL10;IL16;TLR6
prerank,regulation of protein ubiquitination (GO:0031396),0.29037261204954273,0.8153377756942074,0.7514384349827388,0.9364015702646467,1.0,22/108,20.47%,NXN;PRICKLE1;FAM107A;TGFBR1;HDAC8;RIPK2;BIRC7;MYCBP2;COMMD1;U2AF2;USP4;CHP1;FBXO4;GTPBP4;CUL3;SQSTM1;BIRC3;BCL10;PER2;WASHC1;DCUN1D1;UBE2N
prerank,primary alcohol metabolic process (GO:0034308),0.3497510671092938,0.8151253967445932,0.6795069337442219,0.9362971069830031,1.0,2/25,2.13%,CYP1B1;ADH7
prerank,long-term synaptic potentiation (GO:0060291),0.36272001430532486,0.8149972250653204,0.6940993788819876,0.9360523159635259,1.0,5/21,14.04%,PTK2B;MPP2;NFATC4;NPTN;GRIN2C
prerank,response to muramyl dipeptide (GO:0032495),0.39449156809265973,0.8143230254128052,0.6792452830188679,0.9368189872235477,1.0,3/12,10.90%,RIPK2;ERBIN;TRIM41
prerank,snRNA 3'-end processing (GO:0034472),0.3623429301374096,0.814225921965386,0.7056910569105691,0.9365173464994825,1.0,10/19,33.32%,EXOSC7;INTS8;INTS5;INTS6;INTS1;INTS2;EXOSC4;EXOSC2;EXOSC3;INTS7
prerank,peptidyl-arginine modification (GO:0018195),-0.32282452773103865,-0.8141310107328606,0.7111650485436893,0.9162642039700257,1.0,10/15,35.73%,ART3;PRMT1;KRTCAP2;PRMT7;PADI2;PARK7;ART1;PADI1;PADI4;ART4
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.3836868949568851,0.8137898150493281,0.6804635761589404,0.9367733130159878,1.0,3/15,10.50%,ADAM9;EHD1;EHD2
prerank,response to histamine (GO:0034776),-0.3637335005912593,-0.813536640787932,0.6616915422885572,0.9162846121203281,1.0,3/10,7.85%,GABRB1;GABRB2;GABRB3
prerank,regulation of T cell proliferation (GO:0042129),0.30708013066164863,0.8134480706192136,0.7270375161707633,0.9368822231665055,1.0,13/61,21.65%,ANXA1;NCK2;CD80;IL10;CD46;RIPK3;TNFRSF1B;SDC4;IL23R;ARG1;DLG5;NCK1;LGALS3
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.3725512613640685,0.8132708304854852,0.6910197869101978,0.9366955201986835,1.0,3/18,10.83%,COX16;COA8;SCO2
prerank,multivesicular body organization (GO:0036257),0.33471316398722556,0.8130165805419828,0.7132667617689016,0.9366444174839978,1.0,10/31,23.69%,PDCD6IP;VPS37A;IST1;VPS37B;TSG101;SNF8;HGS;VTA1;CHMP4A;CHMP4B
prerank,regulation of fibroblast proliferation (GO:0048145),0.3195769803075635,0.8125334349000629,0.7183288409703504,0.9370167763437394,1.0,8/45,10.71%,PDGFC;DDR2;FN1;SKI;PDGFA;NF1;EMD;MORC3
prerank,histone H2A ubiquitination (GO:0033522),0.3718825648731078,0.8125267988562678,0.6786296900489397,0.9365638044793907,1.0,5/17,20.13%,UBE2B;RNF168;RNF2;PCGF1;RNF8
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.3490312149549546,0.8124258968436259,0.6978527607361963,0.9362669047686557,1.0,2/22,6.99%,NFE2L2;PSMB2
prerank,apoptotic DNA fragmentation (GO:0006309),-0.3144342633378592,-0.8114958551882949,0.7090909090909091,0.9187968583634707,1.0,4/16,14.89%,CECR2;CASP3;KPNB1;FOXL2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.3526693290491518,0.8112764615671703,0.6843657817109144,0.9377532319441262,1.0,3/24,4.34%,PID1;COQ10B;NR4A3
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3451143578102507,0.8109870683441532,0.717948717948718,0.9377792138701374,1.0,10/29,18.91%,ZC3H7A;SMAD2;DGCR8;PUM2;PUS10;TUT7;PUM1;AGO2;TUT4;DROSHA
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.307132677469139,-0.8104177576028901,0.6982758620689655,0.9196609577813818,1.0,3/18,8.35%,DCN;KDR;SPIRE1
prerank,positive regulation of T cell differentiation (GO:0045582),0.3296824408853737,0.8102278017803541,0.7305475504322767,0.9385342492972215,1.0,12/36,22.14%,GLI3;VNN1;GLI2;CD46;DUSP10;BCL6;ZMIZ1;ZBTB1;ADAM8;IL23R;NKAP;GATA3
prerank,cellular response to inorganic substance (GO:0071241),-0.2978203687234798,-0.8101509347836273,0.696236559139785,0.9191017765627845,1.0,5/21,13.91%,FOXO1;GUCY1B1;KCNC2;BLM;NSMCE3
prerank,serine family amino acid metabolic process (GO:0009069),0.3797159824265399,0.8101231864538272,0.6959459459459459,0.9382456206143843,1.0,2/16,11.01%,GCLC;CDO1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.31408556937943655,-0.8100501101948545,0.7236842105263158,0.9182794235575438,1.0,6/18,15.50%,VCAM1;SLC39A8;ITGA4;JAM2;GCNT1;ADD2
prerank,monocarboxylic acid metabolic process (GO:0032787),0.2831780981466986,0.8100120041081553,0.7915234822451317,0.9379618573184423,1.0,7/117,5.14%,ME1;SLC5A6;SLC16A1;ADH7;VNN1;ACSL3;CYP2S1
prerank,ovarian follicle development (GO:0001541),0.38550115947324737,0.809977862789233,0.6894308943089431,0.937558311819717,1.0,4/13,15.86%,INHBA;VEGFA;INHBB;EIF2B2
prerank,receptor signaling pathway via STAT (GO:0097696),0.3491179057906235,0.8099479214277738,0.680365296803653,0.9371449939902341,1.0,9/25,20.71%,PKD1;CLCF1;STAT3;SOCS2;CTR9;STAT5A;PIAS1;STAT6;STAT4
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.35505110432399234,0.809899302893648,0.7037593984962406,0.9367615606344131,1.0,9/23,21.07%,PLK3;NABP1;CHEK1;CHFR;PRCC;ZWILCH;ZFYVE19;ZW10;WEE1
prerank,energy reserve metabolic process (GO:0006112),0.36678347629481134,0.8095598517133122,0.6980568011958147,0.936877854339327,1.0,3/19,3.25%,PID1;GSK3B;PPP1R3C
prerank,regulation of immunoglobulin production (GO:0002637),0.35265833857283074,0.8093902644075059,0.6917293233082706,0.936712748028294,1.0,3/23,8.56%,CLCF1;IL10;GPI
prerank,peptide catabolic process (GO:0043171),0.35392491194351655,0.8092744712164617,0.669195751138088,0.936451889062264,1.0,7/23,15.91%,NPEPPS;CPQ;XPNPEP1;IDE;ERAP1;ECE1;DPEP1
prerank,telomere maintenance via telomerase (GO:0007004),0.3350078256676836,0.8087795316724082,0.7105263157894737,0.9367928695449432,1.0,9/28,23.23%,TELO2;ANKRD28;PPP6R3;RPA1;TNKS1BP1;RFC1;PPP6C;RAD50;CDK2
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.28416647062314027,-0.8086629293027019,0.7704918032786885,0.9196684356648295,1.0,9/27,21.96%,SIRPA;C1QTNF3;SYT11;GAS6;CD200;ARRB1;SELENOS;CX3CL1;TNFAIP3
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.3187655441370855,-0.8081233164463234,0.7051282051282052,0.919665442288193,1.0,6/18,21.10%,ST18;IL6R;IL6ST;STAT1;SPI1;CEBPA
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.3378622845037795,0.808008439289567,0.6929698708751794,0.937617181878082,1.0,5/30,10.17%,FSTL1;SFRP4;LTBP4;DKK3;SMAD2
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.2843164432549767,-0.8078987987775168,0.7523809523809524,0.919062580693695,1.0,1/25,0.18%,IGF1
prerank,cellular response to insulin stimulus (GO:0032869),0.2814818254732372,0.8069742628012535,0.7704728950403691,0.9388926967440515,1.0,22/124,14.01%,HDAC9;GRB10;SHC1;SORBS1;ATP6V0A4;GSK3B;SLC39A14;IRS1;FOXC2;PTPN2;RHOQ;IDE;BCAR3;LPIN2;C2CD5;SYAP1;INHBB;CAPN10;PRKDC;TCIRG1;PIK3R3;ATP6V0D1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.36231925120693814,0.8066207271532019,0.6938775510204082,0.9390227977779553,1.0,8/20,22.86%,CELF1;MOV10;TNRC6C;EIF6;CNOT7;AGO2;NRDE2;TNRC6A
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.3461425589308415,0.8064813291944906,0.7014925373134329,0.9388054888939419,1.0,6/24,12.46%,KCNB1;C2CD5;ERBB2;ITGB1BP1;MIEF1;CHP1
prerank,mesoderm formation (GO:0001707),0.3690943093436805,0.8063313303929077,0.6849757673667205,0.9385818150252003,1.0,3/17,10.80%,ITGB1;SMAD2;ITGB3
prerank,mitotic sister chromatid cohesion (GO:0007064),0.37646033754805436,0.8060450016465731,0.677938808373591,0.938602635880427,1.0,6/16,24.41%,SMC1A;NIPBL;RB1;DSCC1;NAA50;POGZ
prerank,positive regulation of reproductive process (GO:2000243),0.34381815854092834,0.805883464912703,0.7312138728323699,0.9383843352608946,1.0,4/31,10.79%,LHFPL2;INHBA;VEGFA;INHBB
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.297539466605911,-0.8055958971217363,0.7420382165605095,0.9220430132515446,1.0,5/23,14.92%,CADM1;PIK3R6;NECTIN2;LAMP1;ARRB2
prerank,cardiocyte differentiation (GO:0035051),0.40531195179344903,0.8055677386597379,0.6848381601362862,0.9384345369639079,1.0,1/10,1.99%,AKAP13
prerank,regulation of primary metabolic process (GO:0080090),0.2809425286110281,0.8054674898170879,0.7888631090487239,0.9381422963412572,1.0,31/126,20.04%,TNFAIP8L3;CHD9;CREBBP;LDLR;TBL1X;PSMB2;ID2;RXRA;NFYA;SCD;PSMC6;NCOR1;MVD;NCOR2;PSMD11;HNF4A;AZIN1;PLPP1;HMGCR;PSMD1;CARM1;SREBF1;PSMD7;NQO1;PSMC1;PPARG;NCOA6;PSMD14;ABCA7;FDPS;ADIPOR1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3335686157599139,0.8053952358327642,0.7034883720930233,0.9377968370475335,1.0,4/35,8.56%,CYP1B1;HES1;IL10;NLK
prerank,regulation of fat cell differentiation (GO:0045598),0.29678391613259814,0.8051568216746577,0.7557997557997558,0.9377397912634161,1.0,11/74,10.73%,ZFPM2;ZBTB16;CMKLR1;FTO;TRPM4;TRIO;RORA;ID2;CDS1;SYAP1;LRP5
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.32616929121018157,0.8051386966998537,0.7225352112676057,0.9373081322864284,1.0,13/37,27.34%,CHD1L;ERCC5;ERCC3;XPA;RPA1;ERCC1;RFC1;POLD3;CUL4A;RFC5;ERCC2;POLK;GTF2H3
prerank,stress-activated MAPK cascade (GO:0051403),0.30405574779452615,0.804563030327928,0.7302631578947368,0.9377947130734341,1.0,8/61,11.70%,MAP3K5;TAB3;RIPK2;ARHGEF6;NFKB1;CHUK;FBXW11;MAP2K4
prerank,cellular amino acid catabolic process (GO:0009063),-0.2207827300711256,-0.8045042624316628,0.9,0.9228221847562217,1.0,27/87,28.09%,DDO;NOS3;ALDH7A1;ASPA;BCKDHB;ALDH4A1;QDPR;IVD;SARDH;MCCC2;CBS;GOT2;ECHS1;BCKDHA;AASS;GCDH;GLDC;GLUD1;NOS2;SHMT2;HAL;NOS1;HSD17B10;BCKDK;ABAT;ALDH5A1;DAO
prerank,positive regulation of receptor internalization (GO:0002092),-0.29736878054678717,-0.8044606979315126,0.7223880597014926,0.9218846540855681,1.0,6/22,15.49%,INSR;CD63;ARRB1;NTF3;ARRB2;GREM1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.2498710981422558,-0.8042243749490845,0.7854406130268199,0.9212911920149901,1.0,13/45,18.12%,WNT5A;APP;AIM2;GSDMD;P2RX7;CCL19;MALT1;TYROBP;LPL;FZD5;GBP5;HSPB1;CASP1
prerank,male gonad development (GO:0008584),0.3253261931495146,0.8038670410102681,0.7025495750708215,0.9384808170455797,1.0,5/34,9.80%,SOX9;INHBA;GATA4;SIX4;GATA1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.3521819751923289,0.8036473960186158,0.7071005917159763,0.9383742033427808,1.0,11/25,27.69%,SCAF11;SRRM1;PRPF3;SF3B1;SNRNP40;TRA2B;DBR1;TXNL4A;SF3B3;SMNDC1;PRPF6
prerank,membrane protein proteolysis (GO:0033619),0.3287820790854637,0.8032021533026559,0.7346938775510204,0.9386728355911259,1.0,16/37,27.10%,ADAM9;SPPL2A;NFKB1;BACE2;RBMX;ERAP1;CLPP;ADAM10;RET;MBTPS1;PARL;SPPL3;TRAF6;SPPL2B;NAPSA;TGFB1
prerank,positive regulation of T cell activation (GO:0050870),-0.2304933099512215,-0.8030097993585245,0.8114754098360656,0.9223643646289057,1.0,15/62,20.21%,VCAM1;TFRC;CD47;PRKCQ;SIRPA;CD81;RHOH;IL6ST;MDK;CCL19;JAK3;DOCK8;CD276;XBP1;CCL2
prerank,positive regulation of organelle assembly (GO:1902117),-0.2517628408325537,-0.8029796522647806,0.8068181818181818,0.9213947661077062,1.0,5/44,6.96%,ASAP1;CNOT6L;CEP120;CCDC88A;TAPT1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.3832410170053409,0.8028766590519365,0.6655791190864601,0.9387307252825249,1.0,2/15,5.58%,DDR2;LRP1
prerank,nucleoside phosphate catabolic process (GO:1901292),0.3861883784326,0.8028524301054686,0.7085427135678392,0.9383129173878343,1.0,5/13,14.99%,ENTPD6;ENTPD2;SMPDL3A;ENTPD7;NUDT15
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.34810159797595064,-0.8023400821077319,0.7432762836185819,0.9214540147265541,1.0,8/11,43.06%,CCT8;WRAP53;TERF1;CCT7;CCT2;CCT4;CCT3;DKC1
prerank,cholesterol transport (GO:0030301),0.3226895825623842,0.8022977198386675,0.7096336499321574,0.9387734662832283,1.0,7/45,13.08%,SOAT1;TSKU;LDLR;CLU;STARD4;LIMA1;LCAT
prerank,cell-substrate junction assembly (GO:0007044),0.3374137594798549,0.802165509518153,0.7222222222222222,0.9385152740436128,1.0,8/33,13.03%,FN1;SORBS1;BCR;PIP5K1A;KRT14;CTTN;PLEC;TRIP6
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.3498228812201372,0.8019316997548096,0.7040498442367601,0.9384641810245441,1.0,11/22,31.78%,ERI3;EXOSC7;KRI1;WDR12;URB1;FTSJ3;ERI1;ERI2;EXOSC2;PES1;EXOSC3
prerank,positive regulation of transferase activity (GO:0051347),0.2760661327706537,0.801373160861037,0.8070776255707762,0.9388933743663131,1.0,8/142,3.50%,EGFR;MET;NTRK3;LMO4;DDR2;FGFR1;KLF4;NEK7
prerank,regulation of mRNA polyadenylation (GO:1900363),0.36957374499180323,0.8006469467083198,0.6921850079744817,0.9396210871434155,1.0,8/17,27.79%,ZC3H14;NELFE;CTR9;CCNT1;NUDT21;CPSF7;RNF20;NCBP2
prerank,cellular response to oxygen levels (GO:0071453),-0.3498968747865546,-0.8004671807813348,0.708433734939759,0.9236964720813498,1.0,2/10,12.75%,CPEB4;ATP6AP1
prerank,amide biosynthetic process (GO:0043604),0.31466579435141384,0.8004251910959489,0.7403462050599201,0.9395334361460939,1.0,5/47,7.09%,PCSK5;SGMS2;SPTSSB;DMD;NANP
prerank,negative regulation of cell communication (GO:0010648),0.35849650524760657,0.8002737198781533,0.721875,0.9393125817822524,1.0,4/21,10.29%,UBASH3B;HHIP;ACVR1;SRMS
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.2917737287897826,-0.8002527595566743,0.7280701754385965,0.9230545211405916,1.0,4/22,14.26%,ALDH1A2;LGMN;CUBN;CBR1
prerank,tRNA aminoacylation (GO:0043039),0.3280617293124375,0.7998408131225069,0.739251040221914,0.9395426987924218,1.0,2/37,6.62%,WARS2;YARS1
prerank,protein K48-linked ubiquitination (GO:0070936),-0.23945598378731497,-0.7994791099973114,0.8451882845188284,0.9233511226085489,1.0,7/54,11.85%,RNF152;NEDD4L;UBE2E2;RFFL;KLHL3;ZNRF1;HACE1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.3450517636321781,-0.7994065616633482,0.7323943661971831,0.9224647586714038,1.0,4/12,12.39%,SLC5A3;GRIN1;CYBA;ADGRB1
prerank,response to cAMP (GO:0051591),0.32569872263823163,0.7990551916420456,0.7154582763337893,0.940367804348318,1.0,5/37,6.57%,EZR;IGFBP5;SLC26A6;RAP1A;DMTN
prerank,intracellular lipid transport (GO:0032365),0.35931340988451954,0.7989206573998253,0.7104851330203443,0.9401368596260091,1.0,1/21,0.92%,ABCD3
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.32532789655031763,0.7986005732019177,0.7256011315417256,0.940195204282969,1.0,3/35,4.67%,MET;ARHGAP44;CCDC125
prerank,ruffle organization (GO:0031529),-0.3124378690776404,-0.7981957305326192,0.7552083333333334,0.9234707843585188,1.0,8/16,22.81%,RAC1;PLEK;CSF1R;CORO1B;AIF1L;ARF6;INPP5K;PLEKHA1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.2797974106375563,0.7978403154900975,0.7702227432590856,0.9409873039769717,1.0,24/109,17.86%,PPP3CA;VAV2;SHC1;GAB2;NR4A3;TAB3;PSMB2;NFKB1;CHUK;FBXW11;PLCG2;PSMC6;JUN;MAP2K4;NFATC3;PSMD11;PAK2;NFATC1;PSMD1;CUL1;IKBKG;PSMD7;BCL10;PSMC1
prerank,cholesterol efflux (GO:0033344),0.35585729481512196,0.7973621087096606,0.715372907153729,0.9413004915548863,1.0,2/20,5.28%,SOAT1;TSKU
prerank,RNA metabolic process (GO:0016070),-0.20788838236855742,-0.7972416911234812,0.959349593495935,0.9240075748947902,1.0,32/127,20.87%,RBPMS;NOVA1;RBMS1;ATXN1;APOBEC1;ADARB2;HNRNPA0;ELAVL4;SETX;METTL14;AGO4;RNASEL;CELF2;FASTKD2;POLR2G;HNRNPH3;ADARB1;ADAR;TFIP11;DDX20;PABPN1;PCBP3;PCBP1;RNASE4;AGO1;DDX54;POLR2K;DDX3X;NUFIP1;RNASEH2B;METTL3;MTREX
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3470118155396965,0.7968089883625623,0.7263464337700145,0.9417412196153214,1.0,4/27,9.10%,GPR4;AGTR1;LPAR4;DRD3
prerank,regulation of lipid kinase activity (GO:0043550),-0.3493782033666729,-0.7966558392574719,0.7281323877068558,0.9239665897175035,1.0,3/11,13.67%,PIK3R1;PPP2R5A;RBL1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.31847476610813213,0.7966367326844682,0.7378917378917379,0.9415615813146612,1.0,6/41,8.42%,PTPRU;PLPP3;CD44;GCNT2;IL10;DENND6A
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.2946508929288677,0.796322077919735,0.783375314861461,0.9415991405443234,1.0,21/72,27.60%,MNAT1;ERCC5;UVSSA;USP7;COPS7B;COPS5;EP300;ERCC8;ERCC3;XPA;RPA1;ERCC1;RFC1;POLD3;CUL4A;RFC5;ERCC2;COPS3;POLK;GTF2H3;COPS2
prerank,regulation of viral release from host cell (GO:1902186),0.3461740052193808,0.7956882025831026,0.7046875,0.9422106266524694,1.0,7/21,21.42%,TRIM26;PML;VPS37B;TSG101;TRIM35;TRIM25;MID2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.27576913719232565,-0.7954482166234493,0.8179012345679012,0.9249515681748013,1.0,6/26,13.08%,MFHAS1;NR1H3;RTN4;NINJ1;CYBA;TLR3
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.36165808839886915,0.7950145735180618,0.7125193199381762,0.9428469421522357,1.0,8/21,25.35%,CDC25B;CCND1;DYRK3;RAD51B;RAD51C;ATAD5;CCNB1;MECP2
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.371637990676559,0.7949843027076335,0.7006369426751592,0.9424484144548295,1.0,6/17,23.05%,VCP;NPLOC4;OS9;UFD1;FAF2;HERPUD1
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.39338805415521816,0.7948774290320832,0.696969696969697,0.9421662918921496,1.0,2/12,3.37%,PTK2B;NOTCH2
prerank,presynaptic endocytosis (GO:0140238),0.34912455942210663,0.7948323873734306,0.7174887892376681,0.9417853982606508,1.0,5/24,14.23%,STON1;STON2;SYT8;FCHO2;SYNJ1
prerank,B cell activation (GO:0042113),0.2954473456047017,0.794379086002899,0.767175572519084,0.9420709755356379,1.0,9/68,12.66%,HDAC4;HDAC9;ITGB1;CLCF1;PTPN2;IL10;PLCG2;DCAF1;TCF3
prerank,negative regulation of reproductive process (GO:2000242),0.36058097284753443,0.7939227076025336,0.7104,0.9423706973233171,1.0,2/17,2.32%,ARHGDIB;SULF1
prerank,coenzyme A metabolic process (GO:0015936),-0.32124722460336264,-0.7937487145017011,0.712468193384224,0.9267243936822493,1.0,3/14,13.46%,PANK1;ACOT7;ACLY
prerank,axonemal dynein complex assembly (GO:0070286),0.34352105211806416,0.79340253945822,0.7242424242424242,0.9427943768785626,1.0,4/27,11.32%,DNAAF3;DNAH8;CCDC40;DNAAF4
prerank,regulation of secretion by cell (GO:1903530),0.3111290024828779,0.7933358316143148,0.7573726541554959,0.942450176429092,1.0,6/54,10.19%,SNCAIP;DISP1;ANXA1;P3H1;NSF;DNAJC1
prerank,postreplication repair (GO:0006301),0.3095145210789519,0.7932205659009766,0.7550744248985115,0.9421837620469655,1.0,17/45,29.65%,VCP;UBE2B;USP10;ZBTB1;NSMCE1;RPA1;RFC1;REV1;TRIM25;UBE2N;POLD3;RFC5;UBE2V1;POLK;POLI;PRIMPOL;UBE2A
prerank,leukotriene metabolic process (GO:0006691),-0.29751758476002266,-0.7927330885406444,0.7246376811594203,0.9273620261913837,1.0,7/19,25.60%,GGT5;ALOX12;LTA4H;GGT1;PLA2G5;ALOX5AP;MGST3
prerank,negative regulation of intracellular protein transport (GO:0090317),0.34990324168878156,0.7920722044668914,0.7085271317829457,0.9436118643517044,1.0,5/22,17.23%,MDFIC;DMTN;ITGB1BP1;CHP1;BARD1
prerank,glycerolipid catabolic process (GO:0046503),0.36220496355780407,0.7919924075873409,0.7061538461538461,0.9432856243078315,1.0,7/19,20.14%,MGLL;PLA2G4F;ABHD6;LYPLA2;GDPD3;ABHD2;PLA2G4A
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.2966292328263072,-0.7918673467310472,0.7927170868347339,0.9277489266457479,1.0,3/19,12.77%,MAOB;CYBA;PRDX4
prerank,positive regulation of glial cell differentiation (GO:0045687),0.3640548460542185,0.7918614849032659,0.7014218009478673,0.943057368528738,1.0,7/17,13.94%,HES1;CLCF1;ID2;EGR2;TNFRSF1B;CXCR4;SERPINE2
prerank,DNA conformation change (GO:0071103),0.36751887855546694,0.7918223711301521,0.7074721780604134,0.9426682767235439,1.0,7/17,28.40%,ABL1;TOP1;ERCC3;TOP3A;TOP1MT;HAT1;KAT6A
prerank,protein acylation (GO:0043543),-0.2502865984785588,-0.791693770600189,0.8464285714285714,0.9270412379157876,1.0,6/38,10.76%,ZDHHC14;FOXO1;ZDHHC1;ZDHHC17;SPHK1;ZDHHC9
prerank,negative regulation of viral release from host cell (GO:1902187),0.3757673455421686,0.7916219932102931,0.7021996615905245,0.942515824080837,1.0,4/13,21.42%,TRIM26;PML;TRIM35;MID2
prerank,regulation of cardiac muscle contraction (GO:0055117),0.32728154611664273,0.7915728943001423,0.7342657342657343,0.9421352861988793,1.0,6/34,12.36%,ANK2;ATP1B1;SLC9A1;P2RX4;TNNI3;ZC3H12A
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3299835164363584,0.7914862656373393,0.7559171597633136,0.9418253805203738,1.0,4/33,6.52%,CYP1B1;ADAM9;FOXC2;ADA
prerank,response to amino acid (GO:0043200),-0.25812015229529506,-0.790952955864822,0.8262295081967214,0.9272681276992394,1.0,11/31,19.41%,SPAAR;GRIN1;GLRA1;CPEB4;SLC38A9;GLRA3;SH3BP4;TMBIM6;LAMTOR2;XBP1;CPEB3
prerank,regulation of nervous system development (GO:0051960),0.3271795027861373,0.7906670613086135,0.7323162274618585,0.9426889741764645,1.0,9/37,22.78%,HES1;DOCK7;BHLHE40;TNFRSF1B;HEYL;PER2;YTHDF2;HES3;HES7
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.3013479925757673,0.7906483062960883,0.7470817120622568,0.9422673729845651,1.0,14/56,20.18%,LBP;ALPK1;TAB3;IRAK4;TLR4;PLCG2;MYD88;TLR1;MAPKAPK2;TLR8;BCL10;TLR6;TRAF3;LY96
prerank,positive regulation of interleukin-10 production (GO:0032733),0.3370280092523522,0.790456548095227,0.7044776119402985,0.942126841904506,1.0,5/30,13.54%,STAT3;TLR4;CD46;PLCG2;PIBF1
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.32183297353230184,0.7904220084455349,0.7272727272727273,0.941725668605571,1.0,13/36,23.94%,NECTIN3;KIF13A;GOLPH3;NSF;GGA2;GOLGA7;GORASP2;GOLGA4;RILPL1;AFDN;BBS2;SYS1;RAB7A
prerank,error-free translesion synthesis (GO:0070987),0.3435847966067471,0.7903403435572786,0.7345679012345679,0.9413944847639496,1.0,6/22,19.33%,VCP;NPLOC4;RPA1;RFC1;REV1;UFD1
prerank,interstrand cross-link repair (GO:0036297),0.3033924990118718,0.7902767095226042,0.746971736204576,0.9410576963121148,1.0,16/53,21.05%,VCP;USP1;SLX4;RNF168;MCM9;FANCL;XPA;RPA1;ATR;RAD51;FANCM;ERCC1;NEIL3;WDR48;RNF8;FAAP24
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.36114027710554214,0.7901873675135274,0.7129186602870813,0.9407483548457198,1.0,3/18,6.42%,USP13;RNF185;DDIT3
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.34503670471813264,0.7890562257105092,0.712241653418124,0.942115838929653,1.0,3/21,9.90%,ANK2;SNTA1;AKAP9
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.33971049153551186,0.7888926653314574,0.7202380952380952,0.9419284816022928,1.0,9/24,16.19%,SEC24B;IDE;SEC23A;SEC31A;ERAP1;SEC13;SEC24D;BCAP31;SAR1B
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.2903082148597374,0.7888256301551038,0.7754077791718946,0.9415777989442388,1.0,16/72,18.78%,TAX1BP1;HIPK1;ELF1;PTPN2;SPPL2A;TRIM44;CHUK;IRAK3;CBFB;TRADD;IKBKG;VRK2;BIRC3;ABCE1;PALM3;PIAS1
prerank,cellular respiration (GO:0045333),-0.2443197313239012,-0.7886743601863309,0.808955223880597,0.9299769707141873,1.0,19/41,29.41%,SDHA;PPARGC1A;UQCRH;UQCR10;ME3;CYCS;ATP5F1D;NDUFS4;MTFR2;COX10;COX4I2;SLC25A13;ETFRF1;UQCRB;UQCRC1;SDHC;MTLN;BLOC1S1;UQCRC2
prerank,neural tube development (GO:0021915),0.3692620512476658,0.7886499936628867,0.705229793977813,0.9414174580279888,1.0,3/15,9.40%,PKD1;GRHL2;DACT1
prerank,replication fork processing (GO:0031297),0.3166706750991233,0.7884932302184591,0.735632183908046,0.9412070845907882,1.0,10/38,20.20%,WRN;BOD1L1;DDX11;BRCA2;ATRX;ATR;SMARCAL1;RAD51;FANCM;EXD2
prerank,T cell activation (GO:0042110),0.29162691081986364,0.7884249448351403,0.7934093789607097,0.940865606663942,1.0,7/69,6.52%,PPP3CA;CXADR;CD44;PTPN2;NCK2;CD2;ADA
prerank,negative regulation of cilium assembly (GO:1902018),0.38473472139745146,0.7884095333119555,0.6711864406779661,0.9404413827994847,1.0,3/12,18.00%,LIMK2;CDK10;CEP97
prerank,defense response to tumor cell (GO:0002357),0.40302152172081285,0.7883610044249564,0.6912751677852349,0.9400730806634566,1.0,2/10,9.09%,KLF4;RBMS3
prerank,regulation of receptor recycling (GO:0001919),0.3638946772087173,0.7876431896790017,0.698051948051948,0.9407265687604122,1.0,4/16,14.30%,ANXA2;NSF;KIF16B;ECE1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.3107962802561042,0.7873718747817716,0.751412429378531,0.9407388848945857,1.0,16/44,24.47%,FTO;CELF1;MOV10;TNRC6C;TOB1;PABPC1;ZC3H12A;PUM1;CNOT7;AGO2;DHX36;YTHDF2;NANOS2;TNRC6A;YTHDF3;ROCK1
prerank,negative regulation of immune effector process (GO:0002698),0.38010546796289174,0.7873002462899117,0.7068062827225131,0.9404067808774222,1.0,1/13,1.42%,CD55
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.32876014714595164,-0.7872504309404116,0.7443037974683544,0.9312453745292043,1.0,4/13,17.98%,ADHFE1;IDH2;GOT2;PHYH
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.3487078283137692,0.7871315687227723,0.7299270072992701,0.9402284803650671,1.0,7/24,21.36%,FOXO3;DDIT3;NF1;CCL3;TFAP2A;TGFB2;MCL1
prerank,negative regulation of bone remodeling (GO:0046851),0.3920210031301464,0.7870613505484505,0.7104377104377104,0.9398959535396869,1.0,1/11,2.83%,UBASH3B
prerank,sulfur amino acid metabolic process (GO:0000096),0.3386342750678844,0.7870122309943397,0.6930232558139535,0.9395245492354573,1.0,5/24,17.99%,GCLC;GADL1;CDO1;DPEP1;ADO
prerank,negative regulation of transferase activity (GO:0051348),0.33060290210745114,0.7869524622135418,0.7380952380952381,0.9391667184952593,1.0,3/28,8.41%,GSK3B;ABL1;CDKN1B
prerank,inner dynein arm assembly (GO:0036159),0.39922804262164857,0.7868698834412009,0.6962457337883959,0.938856213914473,1.0,2/10,11.32%,CCDC40;DNAAF4
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.34100010167588973,-0.7866001402926315,0.7377450980392157,0.9312399971603947,1.0,4/12,12.78%,PARP16;TIPARP;PARP8;PARP11
prerank,dendritic cell migration (GO:0036336),-0.3191194152713589,-0.786227811833587,0.75,0.9308200611219505,1.0,4/16,18.72%,EPS8;CCL19;CCR5;PIK3CG
prerank,cellular response to interleukin-6 (GO:0071354),0.3401236286713804,0.7853606922694545,0.7171875,0.9407597054019157,1.0,6/26,14.73%,PID1;PTGIS;STAT3;NFKB1;CTR9;SBNO2
prerank,regulation of execution phase of apoptosis (GO:1900117),0.3868105139383404,0.7850784041329315,0.7117750439367311,0.9407514218558221,1.0,2/11,12.36%,PTGIS;ZC3H12A
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.3253486045444386,-0.7848759795492778,0.7340153452685422,0.9319337884189247,1.0,4/13,20.21%,KDR;EDN1;SELENOS;CCL2
prerank,neuron projection organization (GO:0106027),0.3680758065188797,0.7848414919711616,0.714975845410628,0.9406791195290247,1.0,3/15,8.94%,GSK3B;PLS1;ATP1A3
prerank,regulation of protein-containing complex assembly (GO:0043254),0.27754210632497367,0.784809156844762,0.8039673278879813,0.940287392455679,1.0,14/110,13.97%,TRABD2B;MPP7;GSN;GSK3B;VCP;ISL1;CLU;KIF9;VEGFA;RB1;SPIDR;SH3GLB1;HCFC1;EP300
prerank,regulation of interleukin-2 production (GO:0032663),0.3045891829475794,0.784611431910047,0.7549295774647887,0.9401709434493865,1.0,5/43,12.18%,EZR;ANXA1;CD80;PLCG2;HOMER2
prerank,protein acetylation (GO:0006473),0.3223492740031608,0.7842351654131543,0.7291361639824304,0.9403391434272381,1.0,16/30,28.54%,NAA40;CREBBP;EP300;KAT2B;NAA15;DSCC1;NAA35;NAA50;NAT10;GTF2B;KAT5;ESCO1;NAA80;HAT1;KAT6A;NAA60
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.3566146910923237,0.7840481411602688,0.7174959871589085,0.9401993641798505,1.0,3/18,11.16%,TLR4;TCTA;CCL3
prerank,positive regulation of response to stimulus (GO:0048584),0.3159137815014343,0.7840469650366491,0.7583798882681564,0.9397569179286868,1.0,11/40,19.88%,PRKCD;CD80;MAVS;BCLAF1;IFIH1;DHX9;HOMER1;NSMCE1;FXR2;FMR1;TGFB2
prerank,regulation of myoblast fusion (GO:1901739),0.38353995199216606,0.7840375550401391,0.7145359019264448,0.9393280482374271,1.0,3/11,10.50%,MYOG;EHD1;EHD2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.3698801562927803,0.7835885969048105,0.7269789983844911,0.9395708607201195,1.0,3/15,12.44%,ADAM9;SH3D19;TNFRSF1B
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.28319952090278483,-0.7826028799258795,0.7506925207756233,0.9346011628847241,1.0,6/21,17.39%,CYP26B1;PPARD;LPIN3;AGXT;LPIN1;NUDT19
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.29359457386580984,-0.7825697934980761,0.7863501483679525,0.9336402725850566,1.0,4/20,18.59%,APOE;KPNB1;NR1H4;ABCA2
prerank,defense response to bacterium (GO:0042742),0.27383721419801865,0.7824558952454979,0.8136792452830188,0.9409138593808525,1.0,8/105,8.33%,LBP;ANXA3;PRKCD;SHC1;DEFB130A;MAVS;SLPI;TLR4
prerank,heme biosynthetic process (GO:0006783),0.34990170168625867,0.7824508420349447,0.7511380880121397,0.9404762905577982,1.0,8/22,24.68%,ABCG2;NFE2L1;FLVCR1;UROS;COX15;PPOX;ATP5IF1;FXN
prerank,snRNA processing (GO:0016180),0.35987806254315724,0.782397309637461,0.7252032520325203,0.9401237763659794,1.0,8/16,33.32%,INTS8;INTS5;INTS6;INTS1;INTS9;INTS2;INTS3;INTS7
prerank,RNA processing (GO:0006396),0.26735138506529676,0.7821716188877367,0.8507625272331155,0.9400550613176729,1.0,66/176,28.07%,MBNL1;SON;DDX17;SNRNP48;RBM6;SRSF11;CDK12;SRSF5;SYNCRIP;CELF1;HNRNPH1;CELF3;RBM39;PABPC4;FUS;DUSP11;U2AF2;TCERG1;ZCCHC8;SCAF11;SRRM1;TUT7;PRPF3;KIN;SF3B2;SF3B1;RNPC3;PPIG;TUT4;SRPK1;SNRNP40;SNRNP35;SCNM1;SRSF2;DROSHA;WBP4;TSEN54;PRPF18;ALKBH5;NRDE2;RBM3;NOL3;TENT2;ZCRB1;FASTKD5;AKAP8L;RNGTT;RBM4;TARDBP;RBM5;NUDT21;DHX8;LSM4;RSRC1;HNRNPA2B1;HNRNPUL1;SF3B3;SRPK2;DDX47;RBM8A;PDCD7;PRPF6;NCBP2;PRKACA;BICD1;CLP1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.3250656183184377,0.7821223212788304,0.7681365576102418,0.9396860673808107,1.0,14/35,30.73%,NEK7;TNKS2;ATM;FBXO4;XRCC5;ATR;DHX36;MAP3K4;NAF1;HNRNPA2B1;PARN;MAPK15;ACD;CCT6A
prerank,chromosome condensation (GO:0030261),0.32518473313594826,0.781642368083206,0.7430939226519337,0.9399931186033408,1.0,11/36,23.42%,SMC4;ERN2;RB1;DFFB;NCAPH2;KMT5A;CSNK2A2;CSNK2A1;AIFM1;AKAP8L;CCNB1
prerank,protein transport (GO:0015031),0.2538873824078658,0.7813175656736844,0.9030927835051547,0.9400779912279138,1.0,72/332,19.28%,RAMP1;SGSM2;KIF13A;ATP6V0A4;STX11;TLK1;TANGO6;RAB43;LTBP2;TMED5;RAB6A;HERC2;AP3B1;STX5;LRP1;LMAN2L;SLC10A7;CLU;GOLPH3;GRTP1;ARF3;RAB3GAP2;NSF;RUFY1;AP2A1;STX8;EIF2D;LRSAM1;EHD1;COPA;TBC1D2B;CTTN;TBC1D13;SEC31A;ARF4;ARCN1;ARL6IP5;STX19;TBC1D25;SEC13;SCAMP2;TOM1;RAB24;TCIRG1;TBC1D8B;ATP6V0D1;TBC1D10A;GGA2;ARFIP1;GOLGA7;ARFIP2;COPG1;ARFGAP3;SEC23IP;TBC1D5;ATP6V0E1;SAR1B;SGSM3;KIF3B;SNX31;SCFD2;RAB21;AP4M1;AP3D1;PPARG;RAB5B;GOLGA4;USO1;SNX8;TBC1D17;SNX13;ATP6V1H
prerank,positive regulation of viral process (GO:0048524),-0.22895838572318222,-0.7811165904116121,0.8723404255319149,0.9349264466169133,1.0,15/60,19.30%,PPARA;PPIA;HACD3;AXL;NELFCD;NR5A2;POLR2G;TYRO3;ADARB1;TARBP2;ADAR;IFIT1;POLR2K;PPIE;DDX3X
prerank,protein import into peroxisome matrix (GO:0016558),-0.3332845124388434,-0.7809232380532255,0.7427884615384616,0.9342544206635041,1.0,2/12,10.25%,PEX5L;PEX6
prerank,fatty acid transmembrane transport (GO:1902001),0.35562224957288713,0.7806911972209387,0.7329192546583851,0.9405985903796281,1.0,1/19,0.92%,ABCD3
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.30963861396343856,0.7804996742345928,0.7593360995850622,0.9404526860113763,1.0,6/38,8.71%,PTGIS;KLF4;ATP2B4;CLU;TLR4;P2RX4
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.2899583496818747,0.7800623341031986,0.7874519846350833,0.9407151640179584,1.0,6/70,5.86%,NGF;HIPK1;CRADD;INHBA;GSK3B;ITGAV
prerank,histone H2A monoubiquitination (GO:0035518),-0.3068833891260479,-0.779659219052993,0.7875647668393783,0.9352046824508419,1.0,2/17,7.36%,PCGF5;KDM2B
prerank,negative regulation of interleukin-2 production (GO:0032703),0.3504880299095371,0.7795849586172234,0.7181964573268921,0.9410292504998978,1.0,1/18,1.71%,EZR
prerank,cellular biogenic amine catabolic process (GO:0042402),0.40135435047565626,0.7793957347989684,0.75,0.9408722083051935,1.0,1/10,1.70%,SMOX
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.3008493085801349,-0.7793378681386998,0.7950138504155124,0.9346993747258017,1.0,7/18,22.68%,ADAMTS9;SAMHD1;STT3B;AOAH;NEU2;FBXO44;FUCA1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.3078484281490203,0.7785767395069045,0.768918918918919,0.9416778434401453,1.0,11/47,14.52%,PTGIS;CLK2;ATP2B4;NFKB1;C1QTNF12;ERFE;MPV17L;ZC3H12A;ERLIN1;EP300;WDTC1
prerank,protein localization to condensed chromosome (GO:1903083),0.38581326989437054,0.7784459871326761,0.7062706270627063,0.9414330507786248,1.0,6/12,29.13%,SPDL1;ZWILCH;ZW10;BUB3;TTK;CHAMP1
prerank,protein localization to cell junction (GO:1902414),0.34526472830597904,0.7779288719637725,0.7349397590361446,0.941800872526485,1.0,6/22,13.44%,DSP;BSN;NPHS1;SHANK1;PCLO;PAK2
prerank,regulation of tau-protein kinase activity (GO:1902947),0.39830753912257033,0.7779166863236017,0.7109243697478992,0.9413734922362914,1.0,2/10,11.96%,CLU;RB1
prerank,protein-DNA complex assembly (GO:0065004),0.27323055633226945,0.7775534468737648,0.8348946135831382,0.9414766523150778,1.0,23/116,19.19%,SOX9;CHAF1B;KAT6B;MNAT1;PSMB2;MCM7;CHD1L;ERCC5;MCM2;RAD23B;PSMC6;ATRX;PSMD11;PSMD1;ERCC3;XPA;RPA1;PSMD7;PSMC1;RAD51;NAP1L2;PSMD14;SMARCA5
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.39108251343685496,0.7772143520976329,0.7023411371237458,0.9411482102866825,1.0,1/10,7.40%,CACNA1F
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.39108251343685496,0.7772143520976329,0.7023411371237458,0.9411482102866825,1.0,1/10,7.40%,CACNA1F
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.3276164041600919,0.7771716485033255,0.7340267459138187,0.9407730879710972,1.0,6/29,13.99%,PKD1;CLCF1;STAT3;SOCS2;CTR9;STAT5A
prerank,pinocytosis (GO:0006907),-0.3452605253451661,-0.7769588979367555,0.7518072289156627,0.9372734458180246,1.0,6/10,33.03%,DOCK2;AHSG;PYCARD;PPT1;MAPKAPK3;SNX5
prerank,phospholipid transport (GO:0015914),0.30390443793503974,0.776619010135625,0.7701453104359313,0.941183117296739,1.0,9/52,12.71%,TNFAIP8L3;PITPNC1;PITPNA;ATP10A;LDLR;ATP8B1;TMEM30B;ATP9B;ATP11A
prerank,negative regulation of receptor internalization (GO:0002091),0.3832517270598228,0.7764612031892208,0.7353896103896104,0.9409920226529178,1.0,5/12,21.66%,LRPAP1;ATXN2;RIN3;DLG4;ANKRD13D
prerank,neuron projection extension (GO:1990138),0.32512918052783474,0.7760273337236725,0.7617728531855956,0.9412280792771476,1.0,6/32,9.03%,ULK2;ALCAM;NRP1;SPG11;IQGAP1;MAP1B
prerank,cellular response to UV-A (GO:0071492),-0.32956181991728273,-0.775703768584081,0.7530562347188264,0.9381501779777036,1.0,9/11,41.37%,CERS1;MME;MMP2;MMP3;OPN3;MMP1;OPN5;MMP9;OPN1SW
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.31192891161387404,-0.774989027249517,0.7893333333333333,0.9382106549481722,1.0,3/14,14.83%,CSF1;ATP6AP1;TYROBP
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.2568259226112067,0.7744109165243171,0.8800834202294057,0.9432321849270774,1.0,90/264,28.50%,DDX5;DDX17;SNRNP48;RBM6;SRSF11;SRSF5;SYNCRIP;SRRM2;SRSF6;HNRNPH1;FUS;USP49;RBMX;U2AF2;ZCCHC8;DDX42;PABPC1;SCAF11;SRRM1;SNRNP70;SNRPB2;GCFC2;DHX9;PRPF3;GPKOW;HNRNPM;SF3B2;SF3B1;CASC3;U2SURP;RNPC3;CDK13;PRCC;SRPK1;ESS2;SNRNP40;U2AF1L4;RBM14;SNRNP35;GEMIN8;SCNM1;SRSF2;LSM2;LSM8;WBP4;SNW1;PNN;SRSF12;TRA2B;DDX1;DBR1;PRMT5;FIP1L1;ZCRB1;PRPF40B;SRRT;CSTF1;RBM4;TXNL4A;RBM5;NUDT21;DHX8;LSM4;SUGP1;RSRC1;RBM4B;CDC40;PPIL1;CELF4;GTF2F2;CPSF7;HNRNPA2B1;CHERP;HNRNPUL1;CPSF3;SF3B3;SRPK2;UPF3B;SNRNP200;SMNDC1;SRSF3;RBM8A;ALYREF;PDCD7;TGS1;PRPF6;NCBP2;CLP1;CPSF4;SRSF7
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.35690177130087736,0.7743796522516883,0.7216666666666667,0.942846373321373,1.0,7/16,30.52%,MOV10;ZC3H12A;ZC3H12D;DHX36;TARDBP;ZFP36L2;KHSRP
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.32759047266687313,-0.7740429316802052,0.751937984496124,0.9386461723774293,1.0,2/13,6.50%,DDO;ASPA
prerank,neutrophil migration (GO:1990266),-0.23421380191282595,-0.7739854507610461,0.8853754940711462,0.9377355354759015,1.0,13/58,21.48%,PECAM1;PDE4B;BSG;PPIA;EDN1;PPIB;CCL19;PIP5K1C;PIK3CG;CX3CL1;CCL2;SYK;PRTN3
prerank,neural crest cell differentiation (GO:0014033),0.35201084233606544,0.7738673100498888,0.7204301075268817,0.9432376378996619,1.0,1/18,1.37%,LRP6
prerank,maturation of SSU-rRNA (GO:0030490),-0.25509372679950854,-0.7735610451176912,0.8328267477203647,0.937380508348517,1.0,8/34,18.27%,RPS14;RPS19;RPS8;RPS16;SNU13;MRPS11;RPS28;TSR3
prerank,negative regulation of RNA metabolic process (GO:0051253),0.34104775570697443,0.7735035849615042,0.7246376811594203,0.9433678289999246,1.0,6/18,21.24%,ESR1;NCOR1;ZC3H12A;NCOR2;KAT2B;NRDE2
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.27046034986741047,0.7733180101193488,0.8350634371395617,0.9432180796905506,1.0,24/119,15.18%,PLEKHA4;FGF2;TTC7A;PIK3C2B;IP6K2;INPP4A;MTMR12;PIP5K1A;ARF3;OCRL;SOCS2;RUFY1;PI4KB;CDS1;PLCG2;PGAP2;PIGB;DPM1;SMG1;PIK3R3;SYNJ1;SBF1;PITPNM3;PIGU
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.26057322083664425,-0.7732537911175774,0.7933130699088146,0.9368668012157239,1.0,9/28,21.57%,CTSC;DAB2IP;PTK2;ECSCR;NUPR1;OSBPL7;PSMC5;PSMC3;TREM2
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.266241401215032,-0.7730252191584281,0.8396501457725948,0.9362489887548194,1.0,11/28,25.47%,NOD1;MAP2K6;LACC1;UBC;IRAK2;RPS27A;OTULIN;TNFAIP3;TAB1;CYLD;RELA
prerank,response to leucine (GO:0043201),0.3925986914326998,0.7727676165877929,0.7301038062283737,0.9431884706922913,1.0,2/10,13.21%,KLHL22;MTOR
prerank,cellular response to leucine (GO:0071233),0.3925986914326998,0.7727676165877929,0.7301038062283737,0.9431884706922913,1.0,2/10,13.21%,KLHL22;MTOR
prerank,anterograde synaptic vesicle transport (GO:0048490),0.3567317575410099,0.7726175229302207,0.7357594936708861,0.9425422512373683,1.0,3/15,17.88%,AP3B1;AP3S1;AP3D1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.3567317575410099,0.7726175229302207,0.7357594936708861,0.9425422512373683,1.0,3/15,17.88%,AP3B1;AP3S1;AP3D1
prerank,positive regulation of cellular component organization (GO:0051130),0.2738773039020302,0.7721145730677947,0.820185614849188,0.9428964095289236,1.0,10/107,6.35%,TRABD2B;TGFB3;GPC3;MPP7;ATP10A;GSK3B;TGFBR1;VCP;LRP1;CLU
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.33461394685352003,0.7720185232350826,0.7532846715328467,0.942612570829513,1.0,3/26,6.32%,NFE2L2;VNN1;GATA4
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.33136313879977974,-0.7712110282207627,0.7142857142857143,0.9359439266584726,1.0,2/11,11.56%,PANK1;ACOT7
prerank,coenzyme A biosynthetic process (GO:0015937),-0.33136313879977974,-0.7712110282207627,0.7142857142857143,0.9359439266584726,1.0,2/11,11.56%,PANK1;ACOT7
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.33136313879977974,-0.7712110282207627,0.7142857142857143,0.9359439266584726,1.0,2/11,11.56%,PANK1;ACOT7
prerank,regulation of necroptotic process (GO:0060544),0.3401668275935517,0.7710118059979839,0.7563527653213752,0.9436837710083446,1.0,3/23,9.15%,YBX3;PDCD6IP;RIPK3
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2796243100596448,0.7702799941552928,0.8096385542168675,0.9443501762962874,1.0,20/88,21.65%,TRABD2B;MPP7;GSK3B;VCP;PDCD6IP;CLU;VEGFA;SPIDR;SLX4;SH3GLB1;PRKCA;SDC4;EMILIN1;TSG101;ERCC1;SNF8;CDC42EP2;SDC1;HGS;LGALS3
prerank,nuclear membrane organization (GO:0071763),0.34875322220887356,0.769974197343854,0.7135922330097088,0.9443935459002322,1.0,6/19,23.69%,TOR1AIP1;EMD;TOR1B;AKAP8L;TARDBP;CHMP4B
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.3334925242067275,0.7697684606145809,0.7453416149068323,0.944246886574465,1.0,6/24,10.37%,MAPRE2;ABL1;NRP1;S100A10;LIMS1;VEGFA
prerank,positive regulation of viral transcription (GO:0050434),0.33494340434805503,0.7696665428510284,0.7417417417417418,0.9439530345758173,1.0,4/25,18.44%,MDFIC;NELFE;DHX9;CCNT1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.36695734479164444,0.7689766390297649,0.7462437395659433,0.9445688349735908,1.0,5/15,27.04%,TLR4;MYD88;TLR6;CD36;EIF2AK2
prerank,sensory perception of taste (GO:0050909),0.3956728089134386,0.7685258725068979,0.7302158273381295,0.9448165628981766,1.0,3/10,24.09%,TAS1R3;PKD2L1;CD36
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.3342441875013078,0.7682647679720924,0.7385714285714285,0.9447769785963167,1.0,3/22,9.10%,AHNAK;DMD;DRD3
prerank,cardiac cell development (GO:0055006),0.39429775466623257,0.7682549430619741,0.7323232323232324,0.9443583317823822,1.0,3/11,10.37%,CXADR;JAG1;VEGFA
prerank,positive regulation of nervous system process (GO:0031646),-0.29691923251544033,-0.7680869354259073,0.7844827586206896,0.9395157411206413,1.0,3/18,4.61%,RIMS1;RIMS2;TENM4
prerank,rRNA transcription (GO:0009303),0.35657780309229237,0.7670126164289937,0.7617504051863857,0.9457779006666333,1.0,1/17,3.73%,POLR1G
prerank,positive regulation of cellular protein localization (GO:1903829),-0.21894224078368765,-0.7667333588925579,0.9365853658536586,0.9404757988256728,1.0,9/69,9.05%,TFRC;CARD10;PRKAA2;CCDC88A;SLC5A3;SYT11;HSP90AB1;MAPT;RTN4
prerank,histone H3-K4 methylation (GO:0051568),0.3323886940067236,0.7663331853676298,0.7469512195121951,0.9463623381604267,1.0,13/26,37.80%,KMT2C;KMT2D;CTR9;WDR82;OGT;KMT2A;SETD1B;ASH2L;PAXIP1;TET2;DPY30;WDR5;SETD4
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.32825513307030685,0.7660390389687772,0.75,0.9463588264055637,1.0,5/28,14.43%,NGF;CRADD;DIABLO;BAG3;TRADD
prerank,cellular response to calcium ion (GO:0071277),0.28541990285782715,0.7659248443634721,0.8164313222079589,0.9460879601676899,1.0,10/67,12.50%,CLIC4;CAMK2D;MEF2A;DMTN;SYT8;IQGAP1;PLCG2;CARF;CPNE3;ADD1
prerank,negative regulation of cell activation (GO:0050866),-0.3168562961283588,-0.7654871545396854,0.7572559366754618,0.9413429852920022,1.0,4/14,11.26%,APOE;NOS3;PDGFRA;CD200
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.334408530607107,0.7654581834250103,0.7455621301775148,0.9463599106269633,1.0,10/24,28.16%,ABCG2;NFE2L1;FLVCR1;UROS;COX15;PPOX;ATP5IF1;FXN;SUCLA2;RSAD1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.34961462985159797,0.7653884666965417,0.7323717948717948,0.9460326336995529,1.0,3/18,8.43%,GSK3B;RAP1A;SLC4A8
prerank,phospholipid translocation (GO:0045332),0.3229551278720788,0.7652320057627857,0.7676470588235295,0.9458303480418628,1.0,8/28,13.84%,ATP10A;ANO6;PLSCR1;ATP8B1;TMEM30B;ATP9B;ATP11A;PLSCR3
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.38386452524539594,0.7648579267266575,0.7414721723518851,0.9459650410880149,1.0,5/11,24.95%,ELOF1;CHEK1;ZMIZ1;ZMIZ2;ARID1A
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.2950452182463702,0.764653025137664,0.7885350318471338,0.9458585435732014,1.0,7/56,9.70%,CIT;SNX18;SON;PDCD6IP;ARL3;RHOA;TTC19
prerank,maturation of LSU-rRNA (GO:0000470),-0.2739341463413445,-0.7642143903219151,0.8070175438596491,0.9422044464215968,1.0,10/26,26.62%,NSA2;SNU13;RPL7;RPL10A;NIFK;LAS1L;RPL7A;RPL35;ZNHIT6;NHP2
prerank,pseudouridine synthesis (GO:0001522),0.35935385962263366,0.763652857413419,0.7450331125827815,0.9469531200016681,1.0,7/13,31.28%,PUS10;PUS7L;PUSL1;TRUB2;PUS7;GAR1;RPUSD2
prerank,axonal transport (GO:0098930),0.30768405185360587,0.7634802163211427,0.7629733520336606,0.9467783353886656,1.0,8/36,17.88%,AP3B1;KIF1B;PAFAH1B1;FBXW11;KIF3B;RAB21;AP3S1;AP3D1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.3767114929961017,0.7632546133929005,0.7658862876254181,0.946671610838562,1.0,2/12,6.10%,CD44;KDM1A
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.33897063738878075,-0.7619215889610726,0.7662650602409639,0.9445283320171007,1.0,3/10,12.90%,APOD;SNCA;NDRG4
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.35998173438471137,0.76185851322479,0.7368421052631579,0.9483376242005453,1.0,1/15,2.04%,PRKCD
prerank,regulation of macroautophagy (GO:0016241),0.26873994262588036,0.7616063065878843,0.8307873090481787,0.9482748735712913,1.0,25/105,20.81%,NEDD4;EXOC4;CLEC16A;RRAGB;PAFAH1B2;MLST8;RB1CC1;SNX32;WAC;SMCR8;TBC1D25;SMG1;MTOR;SH3GLB1;ATP6V0D1;ATP6V0E1;IKBKG;SCOC;NRBP2;RHEB;ATP6V1H;CAPN1;CLN3;MAPK8;USP36
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.3448966557968908,0.7611116017857862,0.7456,0.9485578479766972,1.0,2/18,6.35%,SLC2A13;CLU
prerank,regulation of phosphatase activity (GO:0010921),0.3327647552286501,0.7610854934749741,0.7644376899696048,0.9481647114662489,1.0,8/24,20.99%,RIPK3;PPP6R2;PPP6R3;CHP1;URI1;PPP1R36;PTPA;PPP6R1
prerank,outer dynein arm assembly (GO:0036158),0.367871477474723,0.7609370639374222,0.7524916943521595,0.9479415315197167,1.0,7/14,33.20%,DNAH8;DNAAF4;ODAD3;ODAD2;ODAD1;DNAL1;DNAH5
prerank,glutamate metabolic process (GO:0006536),0.3460125067460744,0.7609242129327627,0.7238095238095238,0.9475225213018555,1.0,2/19,12.26%,GCLC;FPGS
prerank,negative regulation of protein transport (GO:0051224),0.33353712845277983,0.7607122800973044,0.7681818181818182,0.9473982860737591,1.0,6/25,15.31%,WWP2;DRD3;SNX12;CSK;SERGEF;HMGCR
prerank,positive regulation of cellular component movement (GO:0051272),0.3352078384830487,0.7600727416725108,0.7411242603550295,0.9479071463794784,1.0,4/24,10.37%,NTN1;TGFBR1;CCDC25;VEGFA
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.30647651115363167,0.7597189496620004,0.8053977272727273,0.9480320480801686,1.0,15/42,30.13%,VCP;WRN;USP10;ZBTB1;RPA1;RFC1;REV1;TRIM25;POLA1;POLD3;RFC5;POLK;POLI;PRIMPOL;CDKN2D
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.3351459839786974,0.7595414682501321,0.7622699386503068,0.9478784460901182,1.0,8/22,27.34%,CHD1L;RAD23B;ERCC3;XPA;CUL4A;ERCC2;XPC;GTF2H3
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.31625510068062723,0.7594249265544921,0.7544581618655692,0.9476158530110602,1.0,5/33,8.41%,TGFB3;IGFBP5;PDCD4;IL10;CDKN1B
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.3029764380733833,0.7592393716895421,0.8011363636363636,0.9474706094524686,1.0,15/41,24.51%,NUP93;RANBP2;NUP153;EIF6;SEC13;EP300;NUP214;ZBTB7A;NUP188;SCARB2;NUP88;NUP98;AAAS;NUP54;OGT
prerank,P-body assembly (GO:0033962),0.3738480062085072,0.7588887475325449,0.7216828478964401,0.9475331784039207,1.0,4/12,30.39%,ATXN2;LSM4;EDC3;DYNC1H1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.3541860999386329,0.7587475554511605,0.7512038523274478,0.947303656016442,1.0,1/15,1.41%,NGF
prerank,regulation of leukocyte migration (GO:0002685),0.3572772683220699,0.7586485529886854,0.7585669781931464,0.9470050226875217,1.0,2/16,10.37%,ANXA1;VEGFA
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3530113502025009,0.7576407736355021,0.7572815533980582,0.9480495470656365,1.0,2/16,4.92%,PID1;VCP
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.29227374488387753,0.7574122919823039,0.8013333333333333,0.9479638003595838,1.0,18/51,31.17%,NEK7;SMG6;STN1;TNKS2;ATM;FBXO4;XRCC5;ATR;MAP3K4;TEN1;NAF1;NAT10;PARN;PINX1;MAPK15;ACD;CCT6A;XRN1
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.34054824904904535,-0.7570415472962431,0.8009708737864077,0.9503619098931898,1.0,5/10,18.26%,CORO2B;MAPT;NDFIP2;PPM1F;SNX3
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.34553969111530836,0.7562595373311366,0.7713841368584758,0.9492480476558873,1.0,5/19,15.68%,PPP2R3C;MMP14;PRKDC;ZMIZ1;ZBTB1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.29247890248789044,0.7560152510687221,0.8061497326203209,0.9491811319056658,1.0,11/54,17.21%,TAX1BP1;HIPK1;PTPN2;SPPL2A;CHUK;CARD16;TRADD;UBE2K;CPNE1;IKBKG;BIRC3
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.2951599911402695,0.7551660596903348,0.7658402203856749,0.9499757519811174,1.0,8/40,19.04%,PID1;ABL1;VCP;ARL6IP5;RNF122;ABCD1;PYCR1;SLC25A36
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.35490697795107623,0.7549317063764371,0.7495934959349594,0.9498855220801663,1.0,4/16,8.27%,CAMK2D;MEF2A;NR4A3;SLC9A1
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.23855777114720655,-0.7545950522849815,0.8527397260273972,0.9527541032015174,1.0,3/42,4.38%,CECR2;ACTB;SMARCA2
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.2708352271409973,0.7533659812280545,0.8233861144945189,0.951794094440076,1.0,9/88,10.19%,SAMD4A;IGFBP5;NELL1;PAIP2;SYNCRIP;RGP1;NFKB1;TOB1;DNAJC1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3384203393695625,0.7529671254198623,0.7598116169544741,0.9519399247872837,1.0,6/20,19.67%,TGFBR1;DCUN1D5;ZMIZ1;WASHC1;DCUN1D2;DCUN1D1
prerank,motile cilium assembly (GO:0044458),0.37402338236009075,0.7526883209930793,0.747008547008547,0.9519142045023045,1.0,4/12,23.09%,DNAAF3;CCDC40;RSPH9;RSPH6A
prerank,positive regulation of behavior (GO:0048520),0.3804224471423849,0.7525287285193155,0.7342419080068143,0.9517007376469818,1.0,2/10,4.34%,STRA6;NR4A3
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.3605901968606468,0.7519452847622359,0.7265238879736409,0.9521115161963243,1.0,2/13,9.41%,NEDD4;NIBAN2
prerank,magnesium ion transport (GO:0015693),0.3692750275819262,0.7517859800814378,0.7451327433628319,0.951918789554672,1.0,4/12,19.41%,CNNM4;NIPAL2;MRS2;TUSC3
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.3660555937479667,0.7516742469582423,0.7512605042016807,0.9516610766781847,1.0,2/12,5.76%,CD80;ISL1
prerank,negative regulation of B cell activation (GO:0050869),0.33199218659819196,0.7513151785300058,0.7604501607717041,0.9517386273060743,1.0,5/21,9.52%,INHBA;IL10;ID2;TNFRSF13B;ATM
prerank,regulation of cellular amide metabolic process (GO:0034248),0.31156529442788716,0.7512860929687408,0.8088235294117647,0.9513571143762299,1.0,2/32,2.21%,PRKCD;FOXO3
prerank,negative regulation of T cell activation (GO:0050868),-0.2465335611301107,-0.751215300375676,0.8436482084690554,0.956585380674175,1.0,6/35,14.82%,RIPOR2;TNFRSF21;PAG1;DUSP3;HAVCR2;JAK3
prerank,fatty acid metabolic process (GO:0006631),0.26434591778761235,0.7508904057259514,0.8664302600472813,0.9514721843332725,1.0,23/115,19.11%,ABCD3;PNPLA3;ACSL3;PON3;SLC27A3;PLA2G15;ACOT8;CPT1C;ACADM;ACBD5;LPIN2;ACOT12;GNPAT;HACL1;ACSM2A;ACSM2B;ANGPTL3;PPARG;ALKBH7;ACOT11;NAAA;NDUFAB1;PER2
prerank,defense response to protozoan (GO:0042832),-0.3218526853878683,-0.750884225757086,0.7672209026128266,0.9560517885487312,1.0,2/12,5.60%,GBP4;GBP7
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.3313764619799563,-0.7500371792334752,0.7927710843373494,0.9561292939184969,1.0,5/11,17.95%,NR1H3;MFSD2A;SCARB1;NR1H2;SLC27A1
prerank,negative regulation by host of viral transcription (GO:0043922),0.35655177056393983,0.7499870404062444,0.7520938023450586,0.9523246171392812,1.0,3/12,14.51%,JUN;CCL3;REST
prerank,nucleic acid-templated transcription (GO:0097659),0.3032362408278799,0.7498891594407099,0.7843406593406593,0.9520369019887028,1.0,11/42,23.33%,MEF2A;NR4A2;PPP5C;BAZ2A;HOXD3;EPC1;CREBL2;POLR3A;E2F1;THAP1;DRG1
prerank,pentose-phosphate shunt (GO:0006098),0.3791599253432962,0.7492874177581081,0.7599337748344371,0.9524712863701559,1.0,3/11,14.12%,DERA;SHPK;RPIA
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.36859461158649715,0.7485606432270177,0.7487520798668885,0.9530627580086446,1.0,3/11,27.18%,IL10;CIITA;JAK2
prerank,regulation of dephosphorylation (GO:0035303),-0.289914868636848,-0.748435688629853,0.814621409921671,0.9572761441657355,1.0,8/15,32.57%,PPP1R16B;SMG7;INPP5K;MTMR2;MTMR3;SRC;SMG5;CDK5RAP3
prerank,regulation of innate immune response (GO:0045088),0.2869115112106037,0.7482451381587348,0.8132295719844358,0.9530959898367202,1.0,15/57,18.77%,TRAFD1;POLR3D;PLSCR1;IRF1;IFI35;IRAK3;ERAP1;DHX9;RNF135;TLR8;ACOD1;BIRC3;ABCE1;POLR3F;ADAM8
prerank,regulation of acute inflammatory response (GO:0002673),-0.2859772088064603,-0.7480477225340677,0.8142076502732241,0.9567831775883955,1.0,2/18,10.62%,OSMR;IL6ST
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.3063780692543401,0.7476326850284702,0.7893982808022922,0.9535358425931028,1.0,7/36,11.95%,EZR;DLG1;KLHL31;DACT1;NCOR1;PER1;DUSP10
prerank,protein homotetramerization (GO:0051289),0.2915262476363138,0.747173479816797,0.8087071240105541,0.9537601642062972,1.0,2/49,4.92%,KCNJ2;TRPM4
prerank,aromatic amino acid family metabolic process (GO:0009072),0.38209809393268046,0.747162856537723,0.7380530973451327,0.9533424390068691,1.0,4/10,26.78%,IYD;KYAT1;ASRGL1;PCBD1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.33468210529225123,0.746643508902728,0.7615262321144675,0.9536505696553937,1.0,6/18,23.57%,WDR43;ERBB2;EIF2AK3;FLNA;WDR75;UBTF
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.34145081749946365,-0.7466074758849223,0.7541371158392435,0.9578293199146792,1.0,2/10,11.38%,JARID2;RIF1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.346720482240106,0.7465304929760526,0.743801652892562,0.9533688872600267,1.0,5/15,24.20%,CHEK2;RAD17;ATF2;RAD9B;MDC1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.32870202959554784,-0.7464848293979539,0.7971360381861575,0.9570045904064575,1.0,1/10,2.13%,PCGF5
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.3659451424484646,0.7460750077933112,0.7512437810945274,0.953587289546212,1.0,2/12,4.34%,IRS1;NR4A3
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.32734450762455825,0.7460711643185863,0.783359497645212,0.9531643426262518,1.0,5/22,13.35%,DUSP5;DUSP16;DUSP10;PPP5C;PPM1A
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.35333009312490726,0.7459732932755071,0.7531446540880503,0.9528683671991538,1.0,2/15,10.29%,SMOX;SRM
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.2899098781033081,0.7459375071728592,0.8177014531043593,0.9524865971883921,1.0,14/53,20.38%,PKD1;XPO1;F8A1;COMMD1;RAD23B;PSMC6;DNAAF4;DESI1;DDRGK1;NUDT15;PSMD14;FMR1;RHBDF1;TMF1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.3146299401243161,0.7448528405916254,0.7798449612403101,0.9535652281764265,1.0,3/25,9.97%,ANXA1;CD80;PLCG2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.3688815077411228,0.7443817941131472,0.7263681592039801,0.9538021065075818,1.0,3/11,8.71%,LMNA;ATP2B4;P2RX4
prerank,carbohydrate catabolic process (GO:0016052),-0.23856595269897302,-0.744276797371527,0.8874172185430463,0.9589088710774173,1.0,13/38,21.15%,GAPDH;PGAM1;PGAM4;PGM1;ALDOC;HK2;MAN2C1;PFKM;ALDOA;ENO2;ENO1;PFKL;NEU2
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.3378594548496367,-0.7439271063026018,0.7911832946635731,0.9583651785490266,1.0,4/10,24.99%,RIF1;TFIP11;DCLRE1B;TERF2IP
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.2688224615045064,-0.7437993730228482,0.7982954545454546,0.9575212775567409,1.0,6/22,20.41%,WNT5A;SLC7A5;LACC1;BTK;TRIL;SPHK2
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.3152044117931121,0.7437602690298599,0.8116788321167884,0.9542478273378728,1.0,7/32,18.62%,NEK7;TNKS2;ATM;FBXO4;XRCC5;ATR;MAP3K4
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.25487288939909336,-0.7433871130683652,0.8742331288343558,0.9570311191223337,1.0,4/30,14.84%,DACH1;DCP2;CERS1;ACVRL1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.30883662570972303,-0.7433199389715333,0.835820895522388,0.9561125230646196,1.0,5/14,18.99%,RFFL;GAS6;GPS2;CCDC3;TRAIP
prerank,protein N-linked glycosylation (GO:0006487),0.2761093041397074,0.7431898748477236,0.8207070707070707,0.9546323162920939,1.0,16/66,21.06%,MGAT4C;FUT8;ALG13;MGAT3;B4GALT1;DPM1;MGAT1;ALG14;DDOST;MGAT5;TMEM165;ALG12;TUSC3;B4GALT7;GFPT1;UGGT2
prerank,membrane organization (GO:0061024),0.24815928786167635,0.7427788038605235,0.9142550911039657,0.954781135363064,1.0,30/227,13.30%,EGFR;REPS2;ANK2;ADRB2;STX11;STON2;AP2A2;NUP93;IGF2R;PDCD6IP;GAK;LDLR;TOR1AIP1;CLTB;OCRL;RABEP1;SUN3;AP2A1;AAK1;FCHO2;CTTN;EMD;GAPVD1;SNAP23;CORO1C;A4GALT;EPS15L1;CHP1;TLCD1;SH3GLB1
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.36607953736170573,0.7426392209640242,0.7703826955074875,0.9545698017857532,1.0,4/13,20.12%,RIC3;RANGRF;ABCA7;TM9SF4
prerank,regulation of multicellular organismal development (GO:2000026),0.32613023172288186,0.742468447259028,0.7735562310030395,0.9543836996152782,1.0,9/25,22.14%,MYSM1;TRIP12;EHMT1;NIPBL;KAT2A;HPSE;DHX36;TDG;GATA3
prerank,telomere capping (GO:0016233),0.3433837950158479,0.7421438746400788,0.7766497461928934,0.9544160849969068,1.0,5/16,22.27%,STN1;PRKDC;NBN;RAD50;TEN1
prerank,positive regulation of protein depolymerization (GO:1901881),-0.3222191942588892,-0.7419179039129634,0.7862407862407862,0.9569118559186219,1.0,4/11,16.77%,NES;PLEK;TRPV4;STMN2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.33443035597489085,0.7415487787186819,0.7672281776416539,0.9548190953313787,1.0,1/20,1.17%,BMP5
prerank,negative regulation of kinase activity (GO:0033673),0.27904110141072275,0.7415222816479254,0.8252933507170795,0.9544312158815589,1.0,12/62,16.73%,LRP6;UBASH3B;CDKN1B;NF1;SMCR8;ITGB1BP1;CEP85;RB1;CHP1;PAK2;CEP43;WWTR1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.36818433471546047,0.7414848241775835,0.7567084078711985,0.9540608115299988,1.0,3/11,17.71%,ATL2;VCPIP1;BNIP1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.3142720655172618,0.7408833778878617,0.7847730600292826,0.9545402466893018,1.0,9/30,18.71%,DSE;CHST13;HEXA;ARSB;CHST11;IDUA;BGN;CHST12;CHPF2
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.3540204325351689,0.7408815903067388,0.7444253859348199,0.9541150892450575,1.0,5/12,23.69%,SEC61A1;SEC63;GET3;CHMP4A;CHMP4B
prerank,positive regulation of telomere capping (GO:1904355),0.34539339490754173,0.7407427947286387,0.7746031746031746,0.9538724509600719,1.0,2/17,9.43%,NEK7;TNKS2
prerank,endoderm development (GO:0007492),0.35383560476244835,0.74060763967828,0.7727272727272727,0.953642967864904,1.0,3/13,10.93%,GATA4;DUSP5;KIF16B
prerank,regulation of macrophage cytokine production (GO:0010935),0.3561042362194093,0.739754414823752,0.7603305785123967,0.9544214839491595,1.0,3/13,9.97%,TGFB3;IRAK3;PLCG2
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.21700091514958042,-0.7395379505917725,0.9241071428571429,0.9589501723591652,1.0,15/61,21.03%,PPARA;PRKAG2;FGFR4;PSMB4;PSMB3;PSME2;PSMB8;PSMB10;SIRT5;NR1H4;PDK2;PDK4;PSMC5;PSMD9;PSMC3
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.2171823284766482,-0.7393994444043692,0.9259259259259259,0.9581406669259102,1.0,22/62,26.09%,BCL2;CXCL12;BCL2L1;PPIA;TPT1;HYOU1;NOC2L;TMBIM6;AKT1;HSPB1;SELENOS;XBP1;DDX3X;ENO1;NME5;NDUFA13;CCAR2;PLAUR;CREB3;SNAI2;PINK1;TRIM32
prerank,mitochondrial transport (GO:0006839),-0.22751894497936143,-0.7386922143679178,0.9260869565217391,0.9580370216124872,1.0,18/53,28.72%,BCL2;BCL2L1;TIMM17A;TOMM7;STARD3;TMEM14A;COX18;MFN2;TOMM40;ABCB10;TOMM22;SLC25A13;PMAIP1;MFF;SLC25A4;TMEM14C;SLC25A31;BCS1L
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.2480282276516158,-0.7376643764831329,0.875,0.9583388484598788,1.0,3/31,8.29%,LYN;TNFRSF21;CD300A
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.3139470605558986,0.7372375975458588,0.8169642857142857,0.9575528496819419,1.0,4/25,8.71%,KLF4;CLU;TLR4;P2RX4
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.23443667759725556,-0.7357567394379183,0.9227799227799228,0.9597667389246121,1.0,13/46,19.95%,PLCB1;CNN2;PPIA;LMNB1;CFL1;BOLA2;MIF;PSME2;TALDO1;LCP1;HNRNPDL;P4HB;HSPA9
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.3325093276826553,0.7355249439141285,0.7758346581875993,0.9595116303865336,1.0,5/19,10.37%,ABL1;NRP1;S100A10;LIMS1;VEGFA
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.34876190341716606,0.7354777523847544,0.7811501597444089,0.9591430479325783,1.0,4/14,16.87%,AGR2;COPS5;DDRGK1;BFAR
prerank,regulation of cellular catabolic process (GO:0031329),0.27402845391910813,0.7347937023303166,0.8686605981794538,0.9596613789012505,1.0,12/62,13.97%,USP13;ABL1;DDIT3;RRAGB;WDR41;ATM;USP10;SMCR8;CISD2;LONP2;USP33;EP300
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.3662786334741312,0.7346926293685294,0.7842465753424658,0.9593737049683118,1.0,1/11,2.48%,GSN
prerank,regulation of telomerase activity (GO:0051972),0.2883292048903512,0.7342322667568292,0.8340136054421768,0.9595768596902213,1.0,5/45,9.52%,KLF4;NEK7;SMG6;GRHL2;ATM
prerank,eosinophil chemotaxis (GO:0048245),0.35182695382217577,0.7340651764402331,0.7652892561983471,0.958933323264305,1.0,3/14,13.07%,CCL3;CCL1;CCL7
prerank,eosinophil migration (GO:0072677),0.35182695382217577,0.7340651764402331,0.7652892561983471,0.958933323264305,1.0,3/14,13.07%,CCL3;CCL1;CCL7
prerank,cellular response to interleukin-1 (GO:0071347),0.25049669516388773,0.733997015538789,0.8913294797687862,0.9586041647680896,1.0,28/143,17.86%,SOX9;TANK;PTGIS;TAB3;IRAK4;RIPK2;MAP3K3;PSMB2;NFKB1;CHUK;FBXW11;IRAK3;RBMX;PSMC6;USP10;CCL3;CCL1;MYD88;ZC3H12A;CCL7;PSMD11;SQSTM1;PSMD1;CUL1;ACOD1;IKBKG;PSMD7;PSMC1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3559176475942559,0.7337043680019915,0.7512437810945274,0.958566359524922,1.0,2/13,8.86%,NFAT5;RHOA
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.26047124822727497,0.7332933637782331,0.9017341040462428,0.9586922076762029,1.0,45/125,28.79%,NDEL1;CLIP1;TBCE;PAFAH1B1;XPO1;SETD2;DYNC1I1;AURKA;RANBP2;SEC13;DCTN6;MAD2L1;STIL;RMDN1;NEK9;CENPT;AHCTF1;NEK6;KIF3B;DYNC1LI2;CENPQ;SPDL1;ZWILCH;ZW10;RAN;PTPA;NUP98;GPSM2;SUN2;KIF2C;CCNB1;CDC20;SKA2;MECP2;BUB3;TTK;PCNT;TACC3;CENPU;SPC24;WDR62;KIF18A;CENPL;CENPK;CENPC
prerank,regulation of metal ion transport (GO:0010959),0.3396935877447576,0.7331393126011155,0.7470686767169179,0.9584857965249466,1.0,3/16,6.66%,ANK2;CASR;DLG1
prerank,renal filtration (GO:0097205),0.3633073818404106,0.7331048641776303,0.7454242928452579,0.9581064515479716,1.0,3/10,13.77%,SULF1;XPNPEP3;TBC1D8B
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.24596462978629793,-0.7329461186891191,0.86,0.9622619021118094,1.0,9/32,19.31%,SLC44A1;LPIN3;ABHD3;MFSD2A;SLC44A2;CHKA;LPIN1;SLC27A1;PCYT1B
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.2855647735851228,-0.7326624103519452,0.8391089108910891,0.9616170429820113,1.0,6/16,21.84%,PARP14;INPP5F;NF2;SH2B3;BCL3;LEPROT
prerank,proteasome assembly (GO:0043248),0.3651602293102102,0.7324415284498988,0.7610921501706485,0.9585880560484596,1.0,5/11,25.47%,PSMD11;PSMG2;PSMG1;ADRM1;PSMD4
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.35636998905069844,0.732354756469736,0.7907742998352554,0.9582713980349856,1.0,4/13,17.23%,MDFIC;NUP153;CHP1;BARD1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.24137820988317082,0.7322855424385469,0.9215686274509803,0.9579353020651525,1.0,57/208,21.42%,TRAF3IP2;TANK;AKAP13;ALPK1;TAB3;IRAK4;ESR1;MAVS;RORA;ROR1;RIPK2;MAP3K3;REL;IKBKE;RHOA;CHUK;PLCG2;PIM2;USP10;MTDH;GOLT1B;MIER1;PER1;OTUD7B;MYD88;TRAF5;PPP5C;ZC3H12A;CARD16;TNIP1;PPM1A;HTR2B;TRADD;SQSTM1;S100B;CCDC22;TRIM39;PIDD1;ZFAND6;NEK6;DDX21;ANKRD17;NLRP12;CPNE1;IKBKG;BIRC3;BCL10;TLR6;DHX36;SLC20A1;TRAF3;TRIM25;UBE2N;RNF31;DDX1;RBCK1;MID2
prerank,histone monoubiquitination (GO:0010390),0.3209596415316676,0.7317282098658644,0.7904761904761904,0.9582462815093011,1.0,5/24,15.09%,WAC;RNF168;CTR9;RNF2;PCGF1
prerank,granulocyte chemotaxis (GO:0071621),0.28237221824474323,0.7311220513635246,0.8657534246575342,0.958686649583465,1.0,7/55,13.07%,ANXA1;CXADR;GBF1;CXCL2;CCL3;CCL1;CCL7
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.32711368356033743,0.7307980514623258,0.7848297213622291,0.9587103273634932,1.0,6/21,11.89%,EFNA5;VCL;PTPRA;SLC9A1;RHOA;CORO1C
prerank,regulation of centrosome cycle (GO:0046605),0.3216834214911891,0.7305364360861389,0.7848484848484848,0.9586570783741968,1.0,3/21,10.81%,PDCD6IP;AURKA;CEP131
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.34377868627508507,0.7304857982177146,0.7662337662337663,0.9583023381600132,1.0,6/14,22.48%,ETNK1;LPIN2;CHKB;CEPT1;ETNPPL;ETNK2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.36878372928423075,0.7301402690794258,0.7576853526220615,0.9583549688039021,1.0,3/10,14.30%,PARD3;PLPP1;HTR2B
prerank,serine family amino acid catabolic process (GO:0009071),-0.32720021508707015,-0.7301294541301647,0.8109339407744874,0.9637035030889859,1.0,5/10,34.44%,CBS;GLDC;SHMT2;DAO;THNSL2
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.279026270970942,-0.7300755634013834,0.8076923076923077,0.9627817743343965,1.0,1/17,2.24%,LPGAT1
prerank,regulation of cellular localization (GO:0060341),0.284226366760987,0.7290872113750543,0.8351351351351352,0.9593154816651452,1.0,4/46,6.10%,CAMK2D;EFNA5;GSN;KDM1A
prerank,filopodium assembly (GO:0046847),0.34178752982063854,0.7284992778815594,0.7987321711568938,0.9596916036916322,1.0,3/16,8.08%,EZR;SRGAP2;FGD6
prerank,intestinal lipid absorption (GO:0098856),0.3720683451582339,0.7284469444675568,0.7724957555178268,0.9593416011081087,1.0,5/11,26.41%,LDLR;LIMA1;CEL;CD36;SOAT2
prerank,synaptic vesicle membrane organization (GO:0048499),0.3310090920936141,0.7278284702914272,0.75,0.9597438594083915,1.0,5/17,21.01%,STX11;SNAP23;STX19;AP3D1;STX2
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.22785302092558873,-0.7277477479408515,0.9021739130434783,0.9645141503949477,1.0,7/40,13.85%,DEFA6;PGLYRP1;GBP4;GBP7;GSDMD;RPL39;CHGA
prerank,myofibril assembly (GO:0030239),0.2912075495635224,0.7275896351382242,0.8128415300546448,0.959630079365371,1.0,5/42,8.09%,CSRP3;TMOD3;KRT19;CSRP2;SIX4
prerank,oligodendrocyte differentiation (GO:0048709),0.3314494343608078,0.7275339305482019,0.7712519319938176,0.9592805677412455,1.0,1/19,1.12%,SOX9
prerank,regulation of microtubule polymerization (GO:0031113),0.29463919209311124,0.727449577789909,0.8247566063977747,0.9589628255300082,1.0,6/40,11.84%,MET;ABL1;CLIP1;TOGARAM1;AKAP9;SLAIN2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.3045051744517756,-0.7271125219070934,0.8,0.9643412611653788,1.0,4/13,23.05%,CDK5RAP2;ANAPC15;XRCC3;LCMT1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.24293107296293687,0.7270129871257636,0.9417989417989417,0.9591143328907689,1.0,79/241,28.50%,DDX5;SNRNP48;RBM6;SRSF11;SRSF5;SYNCRIP;SRRM2;SRSF6;HNRNPH1;FUS;USP49;RBMX;U2AF2;ZCCHC8;DDX42;PABPC1;SRRM1;SNRNP70;SNRPB2;GCFC2;DHX9;PRPF3;GPKOW;HNRNPM;SF3B2;SF3B1;CASC3;U2SURP;RNPC3;PRCC;ESS2;SNRNP40;U2AF1L4;RBM14;SNRNP35;SRSF2;LSM2;LSM8;WBP4;SNW1;PNN;SRSF12;TRA2B;DBR1;FIP1L1;ZCRB1;PRPF40B;SRRT;CSTF1;RBM4;TXNL4A;RBM5;NUDT21;DHX8;LSM4;SUGP1;RSRC1;RBM4B;CDC40;PPIL1;GTF2F2;CPSF7;HNRNPA2B1;CHERP;HNRNPUL1;CPSF3;SF3B3;UPF3B;SNRNP200;SMNDC1;SRSF3;RBM8A;ALYREF;PDCD7;PRPF6;NCBP2;CLP1;CPSF4;SRSF7
prerank,regulation of protein processing (GO:0070613),0.32158441105977276,0.7265584543723732,0.8085758039816233,0.9593007840363237,1.0,7/21,19.94%,GAS1;TNP2;SNX12;SERPINE2;ACP4;ADAM8;CLN3
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.24976391364739,0.7265522585652354,0.9068255687973997,0.9588882849688392,1.0,42/172,20.52%,PLEKHA4;FGF2;PNPLA3;PIK3C2B;INPP4A;MTMR12;ETNK1;PIP5K1A;PLSCR1;ARF3;DGKA;OCRL;DDHD1;RUFY1;LPIN2;SLC44A3;PI4KB;CDS1;PLCG2;GNPAT;CPNE3;LCAT;CHKB;AGK;PIK3R3;SYNJ1;SBF1;PLD1;PITPNM3;CEPT1;HDHD5;CPNE1;LCLAT1;CSNK2A2;CSNK2A1;VAC14;GPAT3;CLN3;PLA2G4A;LPCAT1;RAB5A;TAMM41
prerank,cellular macromolecule catabolic process (GO:0044265),0.28282764148642936,0.7262046730106211,0.8282967032967034,0.9589408573715851,1.0,10/49,18.42%,SIDT2;IDE;PABPC4;CHEK2;FBXO17;EXOSC7;RNASEH2A;DFFB;OGA;RNASE6
prerank,sphingoid metabolic process (GO:0046519),0.36898173211085095,0.7258284522289169,0.7922297297297297,0.9590306892913955,1.0,4/12,18.84%,PLPP3;KDSR;PLPP1;NAAA
prerank,inner mitochondrial membrane organization (GO:0007007),-0.22130601332705693,-0.7256551836379727,0.9222614840989399,0.965023817926574,1.0,15/47,24.40%,ATP5PF;ATP5F1B;ATP5F1E;ATP5F1A;ATP5MC1;ATP5F1D;CHCHD6;MICOS13;ATP5MC2;ATP5ME;HSPA9;MTX1;NDUFA13;ROMO1;ATP5MC3
prerank,prostanoid metabolic process (GO:0006692),-0.30010640153807777,-0.7239778620007693,0.8081841432225064,0.9659966685253277,1.0,2/13,12.36%,PTGS1;HPGDS
prerank,regulation of JUN kinase activity (GO:0043506),0.3023905480620031,0.7239606647322698,0.8306569343065694,0.9610908690567688,1.0,5/33,11.95%,MAP3K5;PDCD4;PPEF2;ARHGEF5;DUSP10
prerank,mitochondrial membrane organization (GO:0007006),-0.23715326354384728,-0.7236288935417283,0.9090909090909091,0.965404636562052,1.0,11/32,25.15%,BCL2;BCL2L1;CHCHD6;MICOS13;MFN2;HSPA9;MTX1;MFN1;PMAIP1;SLC25A4;RCC1L
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.33932570516592997,0.7234777031447707,0.7990580847723705,0.9613264948343917,1.0,2/15,3.53%,PRKCE;IRS1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.3087215730574829,0.7233769483881906,0.8340807174887892,0.9610435013476194,1.0,4/26,8.71%,KLF4;CLU;TLR4;P2RX4
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.34374255184686636,0.722895448726716,0.7922077922077922,0.9612598664643562,1.0,6/16,26.32%,PIGB;PIGL;PIGN;PIGH;PIGQ;PIGA
prerank,positive regulation of cell killing (GO:0031343),-0.30841835266737827,-0.7226373924953851,0.7933673469387755,0.965534923241683,1.0,3/13,12.21%,WNT5A;RAC1;CYBA
prerank,cellular response to ATP (GO:0071318),-0.2982387263175241,-0.7223712278619112,0.8009592326139089,0.9648709206790766,1.0,4/14,16.61%,P2RY1;P2RX7;HSP90B1;RYR3
prerank,regulation of interleukin-10 production (GO:0032653),-0.2265898717439005,-0.7221800416765944,0.934931506849315,0.9641130046923609,1.0,24/44,39.34%,TNFRSF21;CD47;CD34;PRKCZ;JAK3;TYROBP;VSIR;DLL1;SYK;PYCARD;TSLP;CD28;HSPD1;TRIB2;HMGB1;INAVA;IL23A;FOXP3;FCGR2B;IRF4;LILRA5;CD274;F2RL1;IL12B
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.3074701820464532,-0.7216922208670087,0.8349282296650717,0.9636977126339017,1.0,12/12,69.28%,CCT8;WRAP53;CCT7;CCT2;CCT4;CCT3;DKC1;CCT5;GNL3L;GNL3;TCP1;CCT6A
prerank,innate immune response (GO:0045087),0.2376313468183007,0.7204545100781139,0.9445037353255069,0.9640526577984271,1.0,45/217,19.61%,LBP;PTK2B;COLEC11;ALPK1;VNN1;ANKHD1;FRK;IRAK4;MAVS;RIPK2;SETD2;REL;SLPI;KLRC2;ZDHHC11;TLR4;CLPB;CHUK;TREML1;PLCG2;SRMS;TRIM26;CAPZA1;MYD88;YES1;IFIH1;IFNLR1;RNF135;S100B;TLR8;TRIM39;PML;CLEC5A;ANKRD17;CYP27B1;IKBKG;SRPK1;BCL10;POLR3A;PPARG;RNASE6;TTC4;TRIM35;CIITA;TRIM25
prerank,protein oxidation (GO:0018158),0.36454702074001266,0.7198021357343646,0.7796610169491526,0.9644925706056381,1.0,4/11,23.00%,LOXL1;LOXL4;LOX;TMX3
prerank,rRNA 3'-end processing (GO:0031125),0.35832991858323315,0.7195253617478383,0.7724957555178268,0.9644272951873958,1.0,2/10,11.57%,ERI3;EXOSC7
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.2619939271459273,-0.7194665309696889,0.882183908045977,0.9652844094852693,1.0,4/23,14.89%,CECR2;CASP3;KPNB1;FOXL2
prerank,establishment of spindle localization (GO:0051293),0.3393115286944358,0.7194182738233577,0.7727272727272727,0.9641462817601101,1.0,2/14,5.64%,NLRP5;TLE6
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.2920194927144963,-0.7191011390114106,0.85995085995086,0.9647286646735594,1.0,2/14,10.86%,ERN1;CPSF6
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.35977389017950906,0.7183451670525987,0.7653910149750416,0.9651828295048878,1.0,2/10,6.19%,TSKU;PLS1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.3324030923823652,0.7182722545839753,0.799347471451876,0.9648464708383313,1.0,5/16,20.61%,PRKDC;KDM4D;SHLD1;PARP3;KMT5B
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.33753454152847095,0.7170659145095947,0.7906976744186046,0.9660248734242922,1.0,3/15,7.21%,FGFR1;CELF1;MFRP
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.2609881151913316,0.7168365551504335,0.8858895705521472,0.9659043101756102,1.0,22/83,20.79%,INHBA;MNAT1;E2F3;PLK3;CDKN1B;ACVR1;GSPT1;PIM2;RB1;CDKN3;CDC45;CUL3;CCND1;CDK16;HINFP;CUL1;RRM2;KHDRBS1;CDKN1A;E2F1;PPP6C;POLA1
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.29769122415511795,-0.716583743554835,0.8080568720379147,0.9666417686497489,1.0,3/12,7.65%,LY6E;IFITM1;IFITM3
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.31905340431391627,0.7165070370003984,0.8062992125984252,0.9658955851252903,1.0,5/20,13.97%,CLK2;C1QTNF12;NCOR1;ERFE;EP300
prerank,cholesterol homeostasis (GO:0042632),0.2694598911714102,0.7164921273982847,0.8652392947103275,0.9654939401811464,1.0,10/64,13.58%,SOAT1;HDAC9;TSKU;LDLR;RORA;EHD1;LRP5;LIMA1;LCAT;HNF4A
prerank,RNA interference (GO:0016246),0.3343459690686594,0.7161695201675846,0.820919175911252,0.9654786229203323,1.0,5/17,21.24%,CELF1;DHX9;AGO2;DROSHA;NRDE2
prerank,icosanoid biosynthetic process (GO:0046456),-0.3161718332027543,-0.716109329279684,0.8317757009345794,0.9662124623362811,1.0,4/10,25.60%,LTA4H;PLA2G5;ALOX5AP;MGST3
prerank,Fc receptor signaling pathway (GO:0038093),0.24986409756108302,0.7149260498749513,0.8976744186046511,0.9666830844993991,1.0,23/110,17.86%,PPP3CA;VAV2;SHC1;GAB2;TAB3;PSMB2;NFKB1;CHUK;FBXW11;PLCG2;PSMC6;JUN;MAP2K4;NFATC3;PSMD11;PAK2;NFATC1;PSMD1;CUL1;IKBKG;PSMD7;BCL10;PSMC1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.30705383967708005,0.7148565644885402,0.8009404388714734,0.9663556791409754,1.0,2/24,5.55%,CAMK2D;DMD
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.2594787335178154,0.7145822456691922,0.8813131313131313,0.9662650778968843,1.0,25/73,27.65%,ABL1;PSMB2;FOXC1;GATA1;PSMC6;CBFB;TCF3;PRKDC;PSMD11;PSMD1;KITLG;PSMD7;PSMC1;DHX36;PSMD14;YTHDF2;PSMD3;GATA3;PSMD12;LDB1;PSMD4;EIF2AK2;PSMD2;PSME3;KMT2A
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.32108530751248254,0.7145763897954746,0.8030075187969925,0.9658501625093422,1.0,12/20,27.10%,FOXC1;NIBAN2;RB1;DDRGK1;PAX6;EP300;TWIST1;GATA3;GTF2B;POU4F1;TRAF6;TGFB1
prerank,Notch signaling involved in heart development (GO:0061314),0.3578550266799383,0.7140958557126553,0.7942664418212478,0.966029544711815,1.0,3/11,9.95%,NOTCH2;JAG1;GALNT11
prerank,nuclear body organization (GO:0030575),-0.29927077149969206,-0.7136463429162794,0.8115577889447236,0.9679945865430396,1.0,1/12,2.36%,ETS1
prerank,focal adhesion assembly (GO:0048041),0.32217244546430535,0.7128840388656066,0.8024316109422492,0.9671346704272041,1.0,5/21,13.03%,SORBS1;BCR;PIP5K1A;CTTN;TRIP6
prerank,organelle fission (GO:0048285),-0.25189875737706247,-0.712874616415214,0.8869047619047619,0.9678700905393243,1.0,3/24,9.06%,DNM3;DNM1;SEC16B
prerank,cilium-dependent cell motility (GO:0060285),-0.26267596170126856,-0.712688226507788,0.8842975206611571,0.9671002909347628,1.0,7/22,29.79%,CFAP44;CFAP54;DNAH3;EFHC2;CCDC39;TEKT5;EFHC1
prerank,embryonic digit morphogenesis (GO:0042733),0.32594590035887794,0.7125369597535949,0.7950310559006211,0.9671903266890649,1.0,3/18,5.56%,GLI3;CREBBP;NOG
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.25320804193733043,0.7122316543180587,0.876979293544458,0.967146399135099,1.0,24/94,22.82%,SFI1;PAFAH1B1;PCM1;CEP164;CEP63;AKAP9;CEP131;NPHP1;CSNK1E;SDCCAG8;MKS1;CEP89;CEP43;HAUS2;CEP57;C2CD3;CEP97;IQCB1;CEP70;CSNK1D;OFD1;CNTRL;HAUS5;PLK4
prerank,copper ion homeostasis (GO:0055070),-0.27375477593353287,-0.7114970091526404,0.8453865336658354,0.9674059470730372,1.0,4/17,11.16%,APP;ATOX1;MT2A;SLC31A1
prerank,regulation of T cell differentiation (GO:0045580),0.29285167958088615,0.7107307538642009,0.8376068376068376,0.9686952803689541,1.0,6/33,15.68%,ABL1;CD2;CBFB;KAT2A;ZMIZ1;ZBTB1
prerank,amyloid-beta metabolic process (GO:0050435),0.3257713162044586,0.710442012571333,0.8041733547351525,0.9686295856553923,1.0,3/16,9.50%,MGAT3;IDE;BACE2
prerank,phosphate ion homeostasis (GO:0055062),0.36227334433838665,0.7104350300168863,0.8110367892976589,0.9682162548079936,1.0,2/10,7.31%,SFRP4;SLC34A2
prerank,lipid droplet formation (GO:0140042),0.36632097379452455,0.7094248088188854,0.8055077452667814,0.9690527265289312,1.0,3/10,17.65%,ZFYVE1;CDS1;SMIM22
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.2599115146643968,0.7092257331254744,0.8823529411764706,0.9688844974888441,1.0,23/70,27.65%,ABL1;PSMB2;FOXC1;GATA1;PSMC6;CBFB;TCF3;PRKDC;PSMD11;PSMD1;PSMD7;PSMC1;PSMD14;YTHDF2;PSMD3;GATA3;PSMD12;LDB1;PSMD4;EIF2AK2;PSMD2;PSME3;KMT2A
prerank,synaptic vesicle localization (GO:0097479),0.33808277107301266,0.7088475750168854,0.8103161397670549,0.9689567423691912,1.0,3/13,14.23%,SPG11;TMEM230;SYNJ1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.2924727261375727,0.7083514300096109,0.8286516853932584,0.9691627309287802,1.0,4/36,7.30%,ADRB2;ITGB1;NRP1;IL10
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.3428448263938799,0.7074155085246789,0.7904085257548845,0.9698864786847601,1.0,3/13,14.82%,ELOF1;CHEK1;ZMIZ1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.30897217623646706,0.7069582032404605,0.8188622754491018,0.9700425356480636,1.0,2/22,4.85%,EDEM3;RNF185
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.29314734942249565,-0.7068531726903781,0.8543689320388349,0.9714934295516645,1.0,2/13,7.33%,TMSB4X;HEY2
prerank,negative regulation of RNA splicing (GO:0033119),0.31804033562355766,0.7067710925895807,0.8277511961722488,0.9698634797310168,1.0,6/19,20.62%,SRSF6;PCBP4;RBMX;U2AF2;SFSWAP;SRSF12
prerank,regulation of receptor internalization (GO:0002090),0.29522463772477275,0.7060692823107575,0.8223495702005731,0.9703255561002646,1.0,11/35,21.66%,LRPAP1;SFRP4;ATXN2;VEGFA;MKLN1;TBC1D5;RIN3;EGF;FMR1;DLG4;ANKRD13D
prerank,positive regulation of double-strand break repair (GO:2000781),0.28290019189938875,0.7051925183588494,0.8523206751054853,0.9709610714828432,1.0,10/39,20.61%,FUS;DDX11;SPIDR;PRKDC;KDM4D;MRNIP;SHLD1;PARP3;WDR48;KMT5B
prerank,heterocycle biosynthetic process (GO:0018130),0.3388228820541873,0.7051012993492961,0.7961476725521669,0.9706524224576194,1.0,4/14,20.23%,NFS1;MOCOS;PYCR1;MOCS3
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.27353406362897786,-0.7050573361445913,0.8378378378378378,0.9724740489994066,1.0,6/17,26.58%,LPGAT1;PLAAT3;PLA2G4C;PLA2G5;PLBD1;PLA2G4E
prerank,organelle fusion (GO:0048284),0.31685274325531665,0.7050153746905602,0.8260211800302572,0.9703292684699707,1.0,6/22,26.31%,EEA1;MIEF1;SPG7;MIEF2;MIGA1;USP30
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.3185697704648969,0.7046811994418766,0.8241590214067278,0.9703478055192842,1.0,5/20,18.91%,ZC3H7A;PUM2;PUM1;AGO2;DROSHA
prerank,response to gamma radiation (GO:0010332),0.304503554379756,0.7044407840087412,0.8242424242424242,0.9702075474598062,1.0,6/24,17.21%,KDM1A;WRN;ATM;XRCC5;TLK2;ATR
prerank,C21-steroid hormone metabolic process (GO:0008207),0.3163957650199447,0.7043470898359554,0.8315467075038285,0.9699078063763198,1.0,1/20,4.28%,FDX1
prerank,erythrocyte development (GO:0048821),-0.3068061787799886,-0.7040605789729459,0.8287671232876712,0.9726280296267656,1.0,5/10,18.05%,ALAS1;MED1;SH2B3;LYAR;ABCB10
prerank,positive regulation of cell cycle process (GO:0090068),0.2525242703492206,0.7039226236081536,0.8871165644171779,0.9699957678026928,1.0,15/91,14.78%,CIT;GIPC1;PRKCE;PLSCR1;CDC25B;CDC14A;RHOA;DRD3;AURKA;LRP5;DDX11;ATRX;PKN2;CUL3;MAD2L1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3186927977019123,-0.7038525751700917,0.8232445520581114,0.9718638355505639,1.0,8/10,47.77%,CCT8;WRAP53;CCT7;CCT2;CCT4;CCT3;DKC1;CCT5
prerank,inorganic ion transmembrane transport (GO:0098660),-0.29972951377433305,-0.7029124808015842,0.8400954653937948,0.971856304496159,1.0,3/12,17.74%,ABCC9;KCNJ8;ABCC8
prerank,regulation of microtubule depolymerization (GO:0031114),0.30433071572516734,0.7028938407589399,0.8140929535232384,0.9708363166474073,1.0,4/25,10.69%,FGF13;HDGFL3;MAP1B;KATNB1
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.29480238272173914,0.7028233472511242,0.8325925925925926,0.9705054380898098,1.0,7/30,14.63%,KIF13A;GOLPH3;SEC16A;NSF;KRT18;GGA2;GOLGA7
prerank,sterol homeostasis (GO:0055092),0.2645088384625193,0.7027299618834425,0.8888888888888888,0.9701980530341603,1.0,13/65,17.78%,SOAT1;HDAC9;TSKU;LDLR;RORA;EHD1;LRP5;LIMA1;LCAT;HNF4A;PLA2G12B;ABCD1;ANGPTL3
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.2831062859157683,0.7021404880647408,0.8577464788732394,0.9705047750066018,1.0,13/39,27.34%,CHD1L;ERCC5;ERCC3;XPA;RPA1;ERCC1;RFC1;POLD3;CUL4A;RFC5;ERCC2;POLK;GTF2H3
prerank,positive regulation of defense response (GO:0031349),0.2518666097454141,0.701788743055062,0.9082007343941249,0.9705187131136381,1.0,21/89,18.77%,GPR4;AGTR1;PDCD4;IL17RA;POLR3D;PLSCR1;IFI35;TLR4;IL33;LRSAM1;CCL3;CCL1;TNIP1;TRADD;DHX9;TLR8;ABCC1;NLRP12;POLR3F;IL16;ADAM8
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.26298834560412476,-0.7010927618056246,0.8760563380281691,0.9728205611113404,1.0,2/19,4.57%,SLCO1C1;APP
prerank,glutathione metabolic process (GO:0006749),0.28444468789887367,0.7008359682225641,0.8516949152542372,0.9712885814062444,1.0,7/38,18.09%,GCLC;MMACHC;GSR;GSTM4;DPEP1;GSTA2;GSTT1
prerank,lipid biosynthetic process (GO:0008610),0.2616083969879223,0.7008272644743251,0.8987341772151899,0.9708815905764463,1.0,16/77,21.86%,ABCD3;PIP5K1A;AGPS;SCD;GNPAT;PDSS2;MBOAT1;MVD;ACSM2A;ACSM2B;HMGCR;SREBF1;NDUFAB1;LPCAT1;CYP19A1;MCAT
prerank,lipid translocation (GO:0034204),0.31062537954882724,0.7006957954073967,0.8307926829268293,0.9706370531431148,1.0,8/21,19.31%,ATP10A;ATP8B1;TMEM30B;ATP9B;ATP11A;ABCC1;RFT1;ABCA7
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.3528836083475955,0.7003576928951992,0.7933450087565674,0.970641562172535,1.0,1/11,4.32%,AGTR1
prerank,placenta development (GO:0001890),-0.2968868051523695,-0.7001107147897945,0.8272506082725061,0.9728696320798581,1.0,5/12,28.92%,PTK2;E2F7;ADAM19;E2F8;SOD1
prerank,ncRNA catabolic process (GO:0034661),0.29383817503180126,0.6996578131679172,0.8438880706921944,0.9710585382783697,1.0,12/28,32.48%,ERN2;ZCCHC8;EXOSC7;DIS3L2;TUT4;PARN;EXOSC4;NUDT16L1;EXOSC2;XRN1;EXOSC3;DIS3
prerank,positive regulation of inflammatory response (GO:0050729),0.2505518811476794,0.698687575237905,0.910411622276029,0.9718656552748278,1.0,18/86,18.77%,LBP;GPR4;AGTR1;PDCD4;IL17RA;IFI35;TLR4;IL33;CCL3;CCL1;TNIP1;CREB3L3;TRADD;DHX9;ABCC1;NLRP12;IL16;ADAM8
prerank,positive regulation of myelination (GO:0031643),0.34604800541649927,0.6980848522296236,0.8049586776859504,0.9721768270571343,1.0,3/11,12.44%,EGR2;PARD3;TNFRSF1B
prerank,regulation of keratinocyte proliferation (GO:0010837),0.30094250491810026,0.6975448228302105,0.8540031397174255,0.9724228518448803,1.0,3/22,6.68%,NOTCH2;KLF9;SRSF6
prerank,cellular response to glucose stimulus (GO:0071333),0.2892514410595005,0.6974383814370562,0.8441176470588235,0.972147189478925,1.0,6/30,13.27%,KCNB1;SLC39A14;UNC13B;CLTRN;PDK3;SELENOT
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.3165009632566457,0.6973560687060942,0.8166915052160953,0.9718326924903387,1.0,6/19,24.66%,ADA;AMPD3;DGUOK;POLD3;GMPR2;AMPD2
prerank,regulation of exocytosis (GO:0017157),0.27847971422137197,0.6972695248970657,0.86593707250342,0.9715104773103846,1.0,4/46,8.13%,STXBP6;ANXA1;SYTL4;NSF
prerank,negative regulation of signaling (GO:0023057),0.30098692084130585,0.6969295148247058,0.8463855421686747,0.9715363327769934,1.0,4/25,10.29%,UBASH3B;HHIP;ACVR1;SRMS
prerank,regulation of histone modification (GO:0031056),0.3331733365456884,0.6967754128764702,0.8003442340791739,0.9713156222386918,1.0,5/13,22.79%,NNMT;SETD5;UBE2N;AKAP8L;MTHFR
prerank,protein targeting (GO:0006605),0.2434109756966912,0.6966702576574816,0.9167616875712656,0.971018421705261,1.0,33/118,23.26%,GIPC1;LTBP2;HPS4;ATG3;ZDHHC11;AP4E1;PARD3;KATNB1;HACL1;ZDHHC15;LONP2;SEC61A1;VPS37A;ZDHHC2;TIMM23;PITRM1;GOLGA7;BCAP31;SEC63;TIMM17B;ZFAND6;ZDHHC20;VPS37B;SRPRB;AP4M1;ZDHHC23;RABGEF1;ZDHHC12;AP4B1;SRPRA;DNAJC19;TOMM34;TRAK1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.29613416225051625,0.6959556455577286,0.8441558441558441,0.9714622451458871,1.0,3/30,6.57%,PRKCD;PTPN2;DMTN
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.3074508819283158,-0.6959238151244536,0.8397129186602871,0.9750978741827432,1.0,11/11,69.28%,CCT8;CCT7;CCT2;CCT4;CCT3;DKC1;LARP7;CCT5;MEPCE;TCP1;CCT6A
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.3074508819283158,-0.6959238151244536,0.8397129186602871,0.9750978741827432,1.0,11/11,69.28%,CCT8;CCT7;CCT2;CCT4;CCT3;DKC1;LARP7;CCT5;MEPCE;TCP1;CCT6A
prerank,neutrophil chemotaxis (GO:0030593),-0.21155231133141564,-0.6958719217771512,0.9813432835820896,0.9741831066302581,1.0,11/53,20.26%,PDE4B;BSG;PPIA;EDN1;PPIB;CCL19;PIP5K1C;PIK3CG;CX3CL1;CCL2;SYK
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.23820072857187588,-0.6954167841574844,0.9074626865671642,0.9736648846454533,1.0,5/29,13.35%,CXCL12;GAS6;LGMN;CALR;JAM2
prerank,respiratory chain complex IV assembly (GO:0008535),0.3128956935408064,0.6948731533118024,0.8449848024316109,0.9723206418296174,1.0,3/21,10.83%,COX16;COA8;SCO2
prerank,regulation of neuron projection arborization (GO:0150011),-0.27886927029312286,-0.6938496565324828,0.8702702702702703,0.9742771284503624,1.0,4/15,16.62%,WNT5A;MFSD2A;MACF1;GRIP1
prerank,secondary alcohol metabolic process (GO:1902652),0.278302459753127,0.6937561909113826,0.8458333333333333,0.9732132730829831,1.0,6/42,13.08%,SOAT1;FDX1;TSKU;RXRA;EBP;LCAT
prerank,cellular amide metabolic process (GO:0043603),0.24671024722599522,0.6933688985101258,0.9231692677070829,0.9732409873670116,1.0,15/102,14.11%,SLC5A6;PLPP3;VNN1;PLA2G15;ACOT8;NLN;NNMT;ACOT12;ACOT9;FPGS;FOLR2;ACOT13;PLPP1;ACSM2A;ACSM2B
prerank,folic acid-containing compound metabolic process (GO:0006760),0.3066281791117842,0.6930688271928622,0.8416801292407108,0.9732072003417492,1.0,8/19,33.47%,FPGS;FOLR2;SLC19A1;SLC25A32;MTHFR;MTHFD2L;SLC46A1;MTRR
prerank,microtubule anchoring (GO:0034453),-0.29705798024890795,-0.6929343354767076,0.8448275862068966,0.9742026801882724,1.0,2/12,10.31%,CLASP2;DAG1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.2860850517148168,0.6924241826027477,0.8403483309143687,0.9735536442449974,1.0,9/29,23.23%,TELO2;ANKRD28;PPP6R3;RPA1;TNKS1BP1;RFC1;PPP6C;RAD50;CDK2
prerank,mRNA methylation (GO:0080009),-0.2727882104437082,-0.6920161994431007,0.8493506493506493,0.9741357529497948,1.0,5/15,31.10%,METTL14;METTL3;ZC3H13;METTL8;METTL16
prerank,regulation of Golgi organization (GO:1903358),0.3200508380987809,0.6919507461704936,0.8333333333333334,0.9736810481040556,1.0,8/17,24.70%,STX5;EHD3;ARMH3;AKAP9;MAP2K2;RBSN;CAMSAP3;STX18
prerank,regulation of defense response to virus (GO:0050688),0.33641694072348455,0.6916035641158165,0.8205980066445183,0.973645349342859,1.0,7/14,29.96%,IFNLR1;DHX9;TRAF3;TRAF3IP1;RNF26;PPM1B;ILRUN
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.3370624618173092,0.6907731674307662,0.8042071197411004,0.9741991214124324,1.0,3/11,19.46%,GATA4;REST;LANCL1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.2721271495782263,-0.6891227546018335,0.8632707774798928,0.976060540964058,1.0,1/17,0.70%,LYN
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.2744700547826969,-0.6887714601874567,0.8810126582278481,0.9754565607674559,1.0,6/15,22.53%,NR1H3;MFSD2A;SCARB1;NR1H2;SLC27A1;C3
prerank,Golgi to lysosome transport (GO:0090160),0.3466132038371442,0.6887300903595404,0.8160535117056856,0.9761836845983357,1.0,5/11,19.94%,GAK;EHD3;AP4M1;RBSN;CLN3
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.29112056572028994,0.6885105823633217,0.8442503639010189,0.975621685123359,1.0,6/29,14.11%,ACOT8;ACOT12;ACOT9;ACOT13;ACSM2A;ACSM2B
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.29112056572028994,0.6885105823633217,0.8442503639010189,0.975621685123359,1.0,6/29,14.11%,ACOT8;ACOT12;ACOT9;ACOT13;ACSM2A;ACSM2B
prerank,histone exchange (GO:0043486),0.2819592659478223,0.6881617921372121,0.8413793103448276,0.9756011021570262,1.0,17/37,29.25%,SRCAP;VPS72;CENPT;CENPQ;RBBP7;SMARCA5;RNF8;HJURP;DMAP1;RBBP4;CENPU;NASP;CENPX;CENPL;CENPK;CENPC;CENPW
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.29065187640143186,0.687273261424576,0.8668596237337193,0.9762145407155937,1.0,1/30,0.92%,ABCD3
prerank,transferrin transport (GO:0033572),-0.22855171983447214,-0.6868757300645177,0.9298245614035088,0.9763084395108577,1.0,10/33,20.15%,TFRC;LMTK2;ATP6AP1;ATP6V1D;STEAP3;ATP6V0C;ATP6V0E2;ATP6V1F;ATP6V1E1;ATP6V0D2
prerank,cellular response to interferon-gamma (GO:0071346),0.24942354392180782,0.6856524694193857,0.917189460476788,0.9776822697858667,1.0,11/88,11.58%,CAMK2D;PRKCD;CD44;MID1;SLC26A6;SYNCRIP;IRF1;TLR4;TRIM26;CCL3;CCL1
prerank,glycosphingolipid metabolic process (GO:0006687),0.2772140848934047,0.685523715756569,0.8659058487874465,0.9774085939632606,1.0,4/42,4.97%,ESYT3;LARGE1;HEXA;ESYT2
prerank,negative regulation of fat cell differentiation (GO:0045599),0.2868085604260973,0.6852562884881453,0.8652482269503546,0.9773208411961353,1.0,3/34,6.37%,ZFPM2;TRIO;RORA
prerank,negative regulation of cellular metabolic process (GO:0031324),0.2773404351916321,0.6846579644474171,0.864406779661017,0.9776123017381927,1.0,12/37,21.66%,LRPAP1;ITGAV;NFKB1;ATXN2;NCOR1;ITGB3;AATF;TFAP2A;RIN3;TRAP1;DLG4;ANKRD13D
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2887915688858781,0.6835062977339355,0.856093979441997,0.978483850374541,1.0,12/29,32.48%,EXOSC7;CNOT7;DCP1A;EXOSC1;LSM2;LSM4;EDC3;EXOSC4;EXOSC2;CNOT8;EXOSC3;DIS3
prerank,folic acid metabolic process (GO:0046655),0.3048401487739311,0.6831275204895018,0.8401305057096248,0.9785051780124073,1.0,10/18,37.04%,FPGS;FOLR2;SLC19A1;SLC25A32;MTHFR;MTHFD2L;SLC46A1;MTRR;PM20D2;DHFR
prerank,protein catabolic process (GO:0030163),-0.19954996280951195,-0.6823278481030152,0.9708333333333333,0.9796382085066654,1.0,4/59,5.64%,APOE;ADAMTS9;HSPA8;DAB2IP
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.27382221794134975,-0.6820755816344305,0.8880597014925373,0.9788875811642833,1.0,6/14,28.10%,ABCG1;APH1B;DYRK1A;ADAM19;NCSTN;PSENEN
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.24926773617748846,0.6819261048488798,0.912826899128269,0.9790790752386214,1.0,22/78,24.62%,AP2A2;SEC24B;KLC1;AP2A1;DYNC1I1;SEC23A;SEC31A;CAPZA1;SEC13;SEC24D;DCTN6;SAR1B;KIF3B;DYNC1LI2;DCTN5;SEC24A;AP1S1;CAPZA2;DCTN4;KIF2C;RAB7A;AP2B1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.24926773617748846,0.6819261048488798,0.912826899128269,0.9790790752386214,1.0,22/78,24.62%,AP2A2;SEC24B;KLC1;AP2A1;DYNC1I1;SEC23A;SEC31A;CAPZA1;SEC13;SEC24D;DCTN6;SAR1B;KIF3B;DYNC1LI2;DCTN5;SEC24A;AP1S1;CAPZA2;DCTN4;KIF2C;RAB7A;AP2B1
prerank,cellular response to dsRNA (GO:0071359),0.3232191129091749,0.6817937971587088,0.8603174603174604,0.9788104478679603,1.0,3/15,14.67%,MAVS;IFIH1;DHX9
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.24353039163417042,0.6816124986908016,0.9192166462668299,0.9785911847901765,1.0,22/82,23.23%,SFI1;PAFAH1B1;PCM1;CEP164;CEP63;AURKA;AKAP9;CEP131;CSNK1E;SDCCAG8;CEP43;HAUS2;CEP57;CEP70;CSNK1D;DYRK3;OFD1;CNTRL;HAUS5;PLK4;ATAD5;CDK2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.2728156236668694,0.6816014204654273,0.8813793103448276,0.9781870488744252,1.0,9/39,18.32%,TTC7A;PIK3C2B;IP6K2;SOCS2;PI4KB;SMG1;PIK3R3;IP6K1;IP6K3
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.34489260902080504,0.6811776175173976,0.8088495575221238,0.9782698161129014,1.0,1/10,3.21%,NFE2L2
prerank,striated muscle cell differentiation (GO:0051146),0.3156109409636899,0.6809951384391261,0.8471138845553822,0.9780506233305142,1.0,2/16,5.80%,AKAP13;SKI
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.3553336953814693,0.68096001851089,0.8645833333333334,0.9776704432715644,1.0,2/10,9.25%,TLR4;IL33
prerank,lipoprotein transport (GO:0042953),-0.2987282748169199,-0.6806354305165203,0.8461538461538461,0.9791700867754839,1.0,2/10,7.93%,PRKCB;ZDHHC17
prerank,negative regulation of T cell proliferation (GO:0042130),0.28618917542653766,0.6805158797175871,0.8437025796661608,0.9777493841816144,1.0,7/28,23.30%,CD80;IL10;SDC4;SCRIB;ARG1;DLG5;GLMN
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.30469554680854327,0.6800964157807556,0.850609756097561,0.9778120670123687,1.0,1/21,1.41%,NGF
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.28290909620697124,0.679758803012013,0.85383502170767,0.9777583445885475,1.0,3/30,6.35%,CD44;KDM1A;CLU
prerank,gene silencing by miRNA (GO:0035195),0.2853662785321706,0.6797057016746649,0.8716119828815977,0.9774025424613701,1.0,11/32,23.32%,ZC3H7A;MOV10;TNRC6C;EIF6;PUM2;PUM1;CNOT7;AGO2;RAN;TNRC6A;RBM4
prerank,positive regulation of immune response (GO:0050778),0.25278066462648113,0.6794921191625226,0.8970398970398971,0.9772305999170731,1.0,13/64,21.04%,POLR3D;PLSCR1;IFI35;IL10;CD46;EIF2AK4;DHX9;TLR8;POLR3F;ADAM8;TGFB2;IL23R;AKIRIN2
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.2505194752894085,-0.6791358178938907,0.8663101604278075,0.9795316674604932,1.0,8/19,33.86%,GSK3A;FZD5;CAMKK2;DNM1L;PINK1;HTRA2;FBXO7;PARK7
prerank,aminoglycan metabolic process (GO:0006022),0.3464611689594719,0.6777264239205424,0.8059964726631393,0.978825460742839,1.0,3/10,19.83%,XYLT1;B3GALT6;B4GALT7
prerank,cobalamin metabolic process (GO:0009235),0.3090521432399062,0.6774003257689519,0.84688995215311,0.9787674706164048,1.0,7/17,27.19%,MMACHC;ABCC1;CD320;MMAB;MMADHC;CTRC;LMBRD1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.3369031870128663,0.6772369299299605,0.8344370860927153,0.9785532661805606,1.0,4/11,27.79%,BARD1;DHX36;PAF1;NCBP2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.3148777079590682,0.6768997347242479,0.8288854003139717,0.9785185642315433,1.0,1/18,1.83%,DDR2
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3043219027002967,0.6767757069052197,0.8311111111111111,0.9782483862036443,1.0,4/21,14.12%,DERA;GPI;SHPK;RPIA
prerank,sterol biosynthetic process (GO:0016126),-0.2270472341994704,-0.6760218546146659,0.9351535836177475,0.9813546722174855,1.0,7/33,17.75%,PRKAG2;INSIG2;ACLY;HSD17B7;CH25H;ACAT2;SC5D
prerank,negative regulation of JNK cascade (GO:0046329),0.2813618281132185,0.6751095018858964,0.8861671469740634,0.9796201749889767,1.0,6/31,11.95%,PDCD4;KLHL31;DACT1;NCOR1;PER1;DUSP10
prerank,myeloid dendritic cell activation (GO:0001773),0.3259068986801042,0.674671852949461,0.8255613126079447,0.9796626308376211,1.0,1/12,5.03%,TGFBR2
prerank,regulation of viral transcription (GO:0046782),-0.21748763526834697,-0.6746380994847608,0.9581881533101045,0.9816293510907953,1.0,8/39,18.45%,TRIM14;TRIM62;IFITM3;NELFCD;POLR2G;TARBP2;TRIM21;POLR2K
prerank,necroptotic process (GO:0070266),0.31605179026126895,0.674595566879345,0.8580542264752791,0.9793291545939574,1.0,3/16,9.15%,TRPM7;TLR4;RIPK3
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.3048470258202318,0.6736496768136954,0.8394276629570747,0.9799773187603471,1.0,9/18,36.10%,RNF185;OS9;EDEM2;UGGT2;MAN1B1;SYVN1;SEL1L;RNF5;RNF103
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.31940837665959515,0.6728449350349647,0.8580441640378549,0.980433447691511,1.0,5/13,24.23%,DDRGK1;BFAR;ABCA7;NCK1;PTPN1
prerank,cellular response to chemical stress (GO:0062197),0.24001698704269406,0.6726782981528964,0.936094674556213,0.9801970773697183,1.0,12/96,12.36%,LRRC8D;FOXO3;NFE2L2;ABL1;GPX8;MGAT3;VKORC1L1;GSR;ATM;CCS;RAD52;ZC3H12A
prerank,macrophage chemotaxis (GO:0048246),-0.3059659601319281,-0.672236412893662,0.863849765258216,0.9827722949741492,1.0,5/10,27.78%,TAFA4;EDNRB;CCL2;CXCL17;CCL5
prerank,nuclear transport (GO:0051169),-0.25893592300071366,-0.6720572441628727,0.9104859335038363,0.9819582800527709,1.0,6/16,23.08%,ANP32A;NPM1;NUP205;RBM15B;BANF1;NXT2
prerank,acyl-CoA metabolic process (GO:0006637),0.27948163343433774,0.6715833367973119,0.8705547652916074,0.9809662461871358,1.0,13/35,28.33%,ACOT8;ACOT12;ACOT9;ACOT13;ACSM2A;ACSM2B;OGDH;ACOT11;SUCLG2;ACOT6;HMGCS1;SUCLA2;MCEE
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.34028871065073985,0.6710874123801421,0.856175972927242,0.9810775727225816,1.0,2/11,9.10%,ADRB2;DRD3
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.2825847577564434,0.6709190118522723,0.875,0.9808399263308348,1.0,7/30,21.06%,FUT8;DPM1;MGAT1;DDOST;MGAT5;TUSC3;UGGT2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.32778353166489416,0.6707016012639625,0.8224956063268892,0.9806611085692207,1.0,2/10,9.90%,DLGAP4;AKAP9
prerank,nuclear membrane disassembly (GO:0051081),0.31892993010234305,0.6706045497396707,0.8576214405360134,0.9803378843207068,1.0,6/14,23.42%,CNEP1R1;PRKCA;NEK9;NEK6;AKAP8L;CCNB1
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.27911266368755544,-0.6698323266565047,0.8671875,0.9829137638288853,1.0,4/12,21.57%,IL18;TTBK1;NUPR1;TREM2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.2667977375009558,0.6697885285235111,0.9058988764044944,0.9808098770844145,1.0,14/41,24.51%,NUP93;RANBP2;NUP153;EIF6;SEC13;EP300;NUP214;ZBTB7A;NUP188;NUP88;NUP98;AAAS;NUP54;OGT
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.31984160983976356,0.6693709274305222,0.835,0.9808472997269211,1.0,2/14,5.76%,CD80;ISL1
prerank,peptidyl-asparagine modification (GO:0018196),0.2804584512708549,0.6689818007905084,0.8778735632183908,0.9808712506556694,1.0,7/31,21.06%,FUT8;DPM1;MGAT1;DDOST;MGAT5;TUSC3;UGGT2
prerank,cellular response to radiation (GO:0071478),0.26702768147639305,0.668516419075393,0.8994413407821229,0.98096278812127,1.0,7/40,17.91%,TANK;SPIDR;KDM4D;TNKS1BP1;INO80;CDKN1A;RAD51
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.33833804876053025,0.6682901445848437,0.8520408163265306,0.9807856684506772,1.0,2/11,11.89%,CD44;CORO1C
prerank,spermatid development (GO:0007286),-0.219966995528022,-0.6679985034783238,0.9462025316455697,0.9834670074406595,1.0,12/32,32.83%,NECTIN2;JAM2;CDYL;TDRD5;NME5;ING2;YTHDC2;DPY19L2;CCDC63;RSPH1;SOX30;ZMYND15
prerank,glucan biosynthetic process (GO:0009250),-0.28532881995460635,-0.6676285745442885,0.8727735368956743,0.9818666888561423,1.0,3/12,11.13%,GBE1;PGM1;PGM2L1
prerank,glycogen biosynthetic process (GO:0005978),-0.28532881995460635,-0.6676285745442885,0.8727735368956743,0.9818666888561423,1.0,3/12,11.13%,GBE1;PGM1;PGM2L1
prerank,negative regulation of double-strand break repair (GO:2000780),0.2759976677857745,0.6669645995743244,0.8837209302325582,0.9818232972833593,1.0,6/30,19.48%,UBR5;TRIP12;TWIST1;SHLD1;RMI2;HELB
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.3206645413336666,0.6669591309185262,0.8510998307952623,0.9814174306673972,1.0,7/13,31.50%,FIP1L1;NUDT21;CPSF7;NCBP2;CPSF4;CPSF4L;CSTF2T
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.28567990563215334,0.6668513592512939,0.8706766917293233,0.981125258326538,1.0,3/26,6.50%,ALPK1;TAB3;RIPK2
prerank,sensory perception of smell (GO:0007608),-0.2940807231184483,-0.6666595125391459,0.8712871287128713,0.9817316291150207,1.0,11/11,70.62%,SYT10;DRD2;OMP;ADCY3;OBP2B;GFY;SLC24A4;MKKS;UBR3;BEST2;BBS4
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.28154956446755786,0.6665007624855083,0.8755622188905547,0.9811040559567281,1.0,4/28,9.03%,MAPRE2;ABL1;GAS2L2;MAP1B
prerank,cellular response to pH (GO:0071467),0.3050271785882709,0.6659913444169286,0.8747913188647746,0.9812376302470505,1.0,6/17,30.81%,SLC9A1;CHP1;RAB11B;PKD2L1;MCOLN1;GPR68
prerank,regulation of exit from mitosis (GO:0007096),0.2726436905177491,0.6658781278594031,0.8916323731138546,0.980960159397324,1.0,11/38,25.45%,ANAPC5;CDC16;ANAPC16;CDC14A;UBE2S;MAD2L1;ZW10;ANAPC11;ANAPC10;CDC20;BUB3
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.26574213022604315,-0.6658672100631667,0.8839506172839506,0.9814898803633094,1.0,5/15,17.85%,RPS7;RPL23;RPL11;LIMK1;RPL5
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.2842974080009445,-0.6656287994890437,0.8676844783715013,0.9807134558649214,1.0,2/12,8.11%,EPHB1;HSP90AB1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.3039120139749009,-0.6653180688993393,0.8704156479217604,0.9800127216056636,1.0,6/10,26.18%,RUVBL1;PIH1D1;RUVBL2;NUFIP1;SHQ1;ZNHIT6
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.2974880327250587,-0.6652596485365705,0.8438287153652393,0.9791136257817069,1.0,5/10,30.94%,CALM1;CALM3;GNB5;GPR35;DRD2
prerank,regulation of spindle assembly (GO:0090169),0.28365068385897674,0.6651177115014998,0.8651162790697674,0.9813355606225832,1.0,10/25,34.10%,PDCD6IP;CEP97;GPSM2;DRG1;CHMP4B;SENP6;DYNC1H1;RNF4;CHMP3;CHMP2B
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.2988706537373645,-0.6649600420030685,0.8537170263788969,0.9784031682783935,1.0,1/10,6.67%,PRKAR1A
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.2959660088451219,0.6648359964766036,0.8597285067873304,0.9812249345137902,1.0,4/23,9.51%,DSG2;ISL1;ID2;TNNI3
prerank,lipoprotein localization (GO:0044872),-0.28401327101287444,-0.6641767756578912,0.8740740740740741,0.9781162158126679,1.0,2/11,7.93%,PRKCB;ZDHHC17
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.24873181567225885,0.663857851019547,0.9248407643312102,0.9818528083588092,1.0,21/67,20.93%,RABEP2;ATG3;DMTN;RDX;ATP8B1;P2RX4;TBC1D2B;TBC1D13;TBC1D10A;PLD1;SDCCAG8;TBC1D5;SGSM3;ABITRAM;FXR2;TBC1D17;ODAD3;FMR1;RAB5A;MYO10;CDC42
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.2947588543035792,-0.663434753962158,0.8514851485148515,0.9777451163395959,1.0,2/10,9.54%,ACTN2;PLEK
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.2817429566829298,0.6633936210024396,0.8621745788667687,0.981910298604412,1.0,8/26,23.42%,ANAPC5;CDC16;RB1;CUL3;NEK6;ANAPC11;RIOK2;CCNB1
prerank,regulation of centriole replication (GO:0046599),0.3083515993268224,0.6630745668454597,0.8594249201277955,0.9818280305887603,1.0,6/17,18.03%,SPICE1;KAT2A;STIL;KAT2B;CEP295NL;RBM14
prerank,regulation of cilium movement (GO:0003352),0.33583489214823425,0.662782629888777,0.8293075684380032,0.9817126423565732,1.0,4/10,29.02%,CCDC40;ODAD2;CFAP43;DNAH11
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.30306022367571683,0.6627208163767158,0.8610223642172524,0.9813672793334827,1.0,4/18,21.45%,MCM7;GINS3;POLA1;POLD3
prerank,purine ribonucleotide metabolic process (GO:0009150),0.24621111248907807,0.6616689470412006,0.926489226869455,0.9820558004213175,1.0,14/68,18.68%,SULT1A1;RHOQ;PTHLH;ACOT8;ACOT12;ACOT9;AMPD3;ENTPD7;ACOT13;ACSM2A;ACSM2B;AK4;AK3;ACOT11
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.27506216062080385,0.6611182258708126,0.8884057971014493,0.9822241514919283,1.0,13/31,32.48%,EXOSC7;CNOT7;DCP1A;DIS3L2;EXOSC1;LSM2;LSM4;EDC3;EXOSC4;EXOSC2;CNOT8;EXOSC3;DIS3
prerank,endodermal cell fate commitment (GO:0001711),-0.29586389736443974,-0.6608002140011988,0.8512195121951219,0.978955539165229,1.0,1/10,4.89%,SOX17
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.2770015233420128,-0.6603051604286836,0.8762376237623762,0.9784071721262284,1.0,1/12,5.44%,APOBEC1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.28276318823571195,0.6600967372146233,0.8811728395061729,0.9828514989223891,1.0,8/24,31.17%,STN1;TNKS2;SLX4;TEN1;NAT10;PINX1;ACD;XRN1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2241445292162567,0.6598356296371354,0.9648924122310306,0.9827092568455754,1.0,41/158,21.42%,TRAF3IP2;AKAP13;ALPK1;TAB3;IRAK4;MAVS;ROR1;RIPK2;MAP3K3;REL;IKBKE;RHOA;CHUK;PIM2;MTDH;GOLT1B;MIER1;MYD88;TRAF5;PPP5C;CARD16;PPM1A;HTR2B;TRADD;S100B;CCDC22;NEK6;DDX21;ANKRD17;IKBKG;BIRC3;BCL10;TLR6;DHX36;SLC20A1;TRIM25;UBE2N;RNF31;DDX1;RBCK1;MID2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.2990470624129932,0.6596827834426883,0.8661654135338346,0.9824777040521024,1.0,10/21,29.16%,MCUB;MCU;SLC8B1;FATE1;BCAP31;MICU3;MICU1;MICU2;PDZD8;ANXA6
prerank,macroautophagy (GO:0016236),0.2314212851770076,0.6586597656004042,0.9519450800915332,0.9830861124672238,1.0,30/118,24.26%,WIPI2;VCP;ZFYVE1;BECN1;VPS41;ATG3;LIX1L;ACBD5;RB1CC1;VPS37A;TCIRG1;HDAC10;SQSTM1;AMBRA1;TBC1D5;VPS37B;NBR1;TSG101;CSNK2A2;CSNK2A1;SNF8;ATG4B;CLN3;HGS;ULK1;PIP4K2A;VTA1;CHMP4A;CHMP4B;TOMM20
prerank,zinc ion transport (GO:0006829),0.29699311874658607,0.658399829323411,0.8700475435816165,0.9829551196482643,1.0,4/21,11.37%,SLC39A14;SLC39A11;SLC30A9;SLC39A13
prerank,positive regulation of histone modification (GO:0031058),-0.21878804139023705,-0.6583382848795118,0.9125874125874126,0.9790314945110584,1.0,9/33,20.67%,RPS6KA5;PPARGC1A;MAPK3;ARRB1;APLNR;CTBP1;RUVBL2;SART3;ING2
prerank,stress granule assembly (GO:0034063),0.29190286120737396,0.6580915647760117,0.8419405320813772,0.9828439886935879,1.0,10/20,30.39%,ATXN2;PRRC2C;EIF2S1;CIRBP;YTHDF2;UBAP2L;YTHDF3;BICD1;CSDE1;DYNC1H1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.24227070748968596,0.6578381493616444,0.9528535980148883,0.9826870221798547,1.0,13/74,19.04%,EGLN3;NFE2L2;CREBBP;HIF3A;PSMB2;PSMC6;VEGFA;PSMD11;EP300;PSMD1;PSMD7;PSMC1;PSMD14
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.26937890796949193,-0.6576916242355402,0.9130434782608695,0.9786070876994509,1.0,1/13,2.06%,PRR5L
prerank,regulation of cellular amine metabolic process (GO:0033238),0.25026497020859007,0.6575126377756594,0.9066666666666666,0.9826335882813942,1.0,16/50,27.63%,PSMB2;PSMC6;PSMD11;AZIN1;PSMD1;PSMD7;NQO1;PSMC1;PSMD14;PSMD3;ODC1;PSMD12;OAZ2;PSMD4;PSMD2;PSME3
prerank,establishment of melanosome localization (GO:0032401),-0.24967524681051084,-0.657252881906594,0.9093406593406593,0.9779772468380438,1.0,7/19,25.76%,SHROOM2;MYO5A;BLOC1S6;BBS7;RAB27A;MREG;BBS5
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.2583115201686344,0.6565712467063712,0.8996036988110965,0.9831638997511405,1.0,18/50,30.13%,CCNA2;MNAT1;CDKN1B;CDKN3;GTPBP4;CCND1;CDKN1A;CCNT1;CCNG1;CCNB1;CCND3;CCNE2;CCNF;CCNT2;CDKN2C;GADD45A;CDK7;CDKN2D
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.24258703888986657,0.6564069974542524,0.951715374841169,0.9829101100483766,1.0,20/72,24.75%,DXO;CHD1L;ERCC5;ZC3H12A;DCP1A;ERCC3;XPA;IHO1;RPA1;RNASE6;ERCC1;RFC1;EXD2;DDX1;POLD3;RAD50;CUL4A;RFC5;ERCC2;EDC3
prerank,female gamete generation (GO:0007292),-0.22683512471430342,-0.6560284629948848,0.9253731343283582,0.9780223292531723,1.0,7/29,20.78%,DIAPH2;FMN2;SPO11;MDK;NANOS3;TRIP13;METTL3
prerank,indolalkylamine catabolic process (GO:0046218),0.33128295254833046,0.6547740789868237,0.8375634517766497,0.9841319275171561,1.0,10/10,66.89%,KYAT1;TDO2;IDO2;HAAO;KMO;ACMSD;IDO1;KYNU;IL4I1;AADAT
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.2610593385725245,-0.6547348932591568,0.8955223880597015,0.9780243635599265,1.0,8/16,35.78%,ACSS1;ACLY;GCDH;DIP2A;PPT1;PPCS;SLC25A1;HSD17B8
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.2437730145116485,0.6536335471482593,0.9448621553884712,0.9848734157420074,1.0,25/69,30.65%,SNAPC2;NABP1;GTF2E1;INTS8;INTS5;SNAPC5;CCNT1;ICE2;INTS6;POU2F1;INTS1;SRRT;INTS9;GTF2B;GTF2F2;INTS2;TAF13;GTF2A2;NCBP2;CCNT2;SNAPC4;TAF9;CDK7;TAF5;INTS3
prerank,cellular response to glucose starvation (GO:0042149),0.2632618687369981,0.6534251957823434,0.9106145251396648,0.9846710409465623,1.0,6/41,13.30%,FOXO3;BECN1;ITFG2;SIK2;ZC3H12A;SH3GLB1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.2290025717245946,-0.6530221488216481,0.927536231884058,0.9783536581557206,1.0,8/24,24.17%,NOD1;MAP2K6;UBC;IRAK2;RPS27A;TNFAIP3;TAB1;CYLD
prerank,lysosome localization (GO:0032418),0.2648604451183121,0.6525878397988764,0.9004267425320057,0.9851103877103065,1.0,4/37,9.83%,NDEL1;NR4A3;SYTL4;PLEKHM2
prerank,lytic vacuole organization (GO:0080171),0.2745301460994018,0.65200595693237,0.899135446685879,0.9852563202282874,1.0,13/32,28.47%,HPS4;ACP3;ARSB;MTOR;ACP4;HOOK3;MBTPS1;CLN3;HOOK2;GAA;TFEB;GNPTAB;ZKSCAN3
prerank,sulfur amino acid catabolic process (GO:0000098),0.3271540914800758,0.6519530903768174,0.8610108303249098,0.9849013731422926,1.0,2/10,17.99%,GADL1;ADO
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3115015904717347,0.6517576507866664,0.8659966499162479,0.9846920550733502,1.0,1/13,4.03%,BMS1
prerank,mitochondrion distribution (GO:0048311),0.31691690169588577,0.6517121093378452,0.8510998307952623,0.9843175530128524,1.0,1/12,3.95%,MEF2A
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.23720514330326647,0.6516258654388616,0.948339483394834,0.9840023009101745,1.0,22/79,24.62%,AP2A2;SEC24B;KLC1;AP2A1;DYNC1I1;SEC23A;SEC31A;CAPZA1;SEC13;SEC24D;DCTN6;SAR1B;KIF3B;DYNC1LI2;DCTN5;SEC24A;AP1S1;CAPZA2;DCTN4;KIF2C;RAB7A;AP2B1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.27920279725702224,-0.6515953172042034,0.8776978417266187,0.9785081250721203,1.0,5/11,28.08%,ENPP3;SLC19A3;SLC25A19;DCK;THTPA
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.2411432721573339,-0.6514432418651497,0.936231884057971,0.977696668001914,1.0,4/21,12.00%,TOX;NES;PROX1;MDK
prerank,glucose catabolic process to pyruvate (GO:0061718),0.28415481924097724,0.6513255468629296,0.878419452887538,0.9834916415414323,1.0,4/24,11.08%,FOXK1;PFKP;GPI;FOXK2
prerank,canonical glycolysis (GO:0061621),0.28415481924097724,0.6513255468629296,0.878419452887538,0.9834916415414323,1.0,4/24,11.08%,FOXK1;PFKP;GPI;FOXK2
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.30832562371173633,0.6512623130083198,0.8615136876006442,0.9831421421934994,1.0,3/16,9.01%,RAET1E;KLRC2;PVR
prerank,rRNA modification (GO:0000154),-0.2361830539975851,-0.651129688478906,0.9250720461095101,0.9770365555717834,1.0,10/21,35.23%,TSR3;BUD23;NOP10;TFB2M;NHP2;FBL;TRMT112;DIMT1;FBLL1;TFB1M
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.31697346880979976,0.64998838259295,0.8647746243739566,0.9839497478594974,1.0,4/12,16.12%,CNEP1R1;PRKCA;NEK9;NEK6
prerank,regulation of vesicle-mediated transport (GO:0060627),0.23238422460075653,0.6499618058939749,0.948502994011976,0.9835602831079228,1.0,19/91,18.39%,STON1;ABL1;STON2;NRP1;ITGAV;GAS1;NSF;RUFY1;RAB25;USP7;SNX12;ARFGAP1;PLD1;MAP2K2;RAB4B;RAB21;MBTPS1;RAB5B;BET1L
prerank,regulation of mitotic spindle assembly (GO:1901673),0.2907431560827005,0.6494838485418372,0.8744038155802861,0.9836091146601805,1.0,4/19,23.69%,PDCD6IP;CEP97;DRG1;CHMP4B
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.2876492856864068,0.6489244467392195,0.8593508500772797,0.9837571336478702,1.0,3/21,10.69%,FGF13;HDGFL3;KATNB1
prerank,protein localization to lysosome (GO:0061462),0.27842932701723105,0.6483584512723432,0.8831360946745562,0.9839199299141524,1.0,1/28,1.49%,NEDD4
prerank,miRNA mediated inhibition of translation (GO:0035278),0.3180379164196806,0.6476642546777263,0.8595890410958904,0.9837755405979955,1.0,5/11,23.32%,TNRC6C;EIF6;AGO2;TNRC6A;RBM4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.3180379164196806,0.6476642546777263,0.8595890410958904,0.9837755405979955,1.0,5/11,23.32%,TNRC6C;EIF6;AGO2;TNRC6A;RBM4
prerank,cellular response to amino acid stimulus (GO:0071230),0.2679405568926782,0.6473977275794764,0.9090909090909091,0.9836188265373027,1.0,5/33,13.21%,CAPN2;KLHL22;RRAGB;CASTOR2;MTOR
prerank,translational elongation (GO:0006414),0.2286290305016802,0.6468394504762095,0.9535962877030162,0.983728712521484,1.0,36/101,31.58%,MRPL33;MRPL48;GTPBP2;MRPS27;MRPL32;MRPL14;MRPL40;GFM2;MRPS31;MRPL21;MRPL42;MRPS30;MRPL57;MRPS35;MRPS28;MRPL52;MRPL38;EEF2K;MRPS22;MRPL10;MRPS10;MRPL36;MRPL20;MRPL47;MRPL11;MRPS7;MRPS2;MRPL23;MRPS18A;MRPL19;LTN1;MRPS21;MRPL9;MRPS18C;MRPS34;MRPS16
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.30227068088637393,0.6461333717808196,0.8706624605678234,0.9839595814873398,1.0,3/17,9.01%,RAET1E;KLRC2;PVR
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.29061110686839886,0.6461039536996488,0.8662613981762918,0.9835834440062459,1.0,4/18,10.71%,SKI;NF1;EMD;MORC3
prerank,snRNA transcription (GO:0009301),0.24026621270316506,0.6452057302341412,0.9549436795994993,0.983998402740705,1.0,25/70,30.65%,SNAPC2;NABP1;GTF2E1;INTS8;INTS5;SNAPC5;CCNT1;ICE2;INTS6;POU2F1;INTS1;SRRT;INTS9;GTF2B;GTF2F2;INTS2;TAF13;GTF2A2;NCBP2;CCNT2;SNAPC4;TAF9;CDK7;TAF5;INTS3
prerank,positive regulation of secretion (GO:0051047),0.3250681939877246,0.6451757204173663,0.8741496598639455,0.9836195883124217,1.0,1/11,4.40%,ACSL3
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.2492117772630605,-0.6445306218724559,0.9166666666666666,0.9809685586326542,1.0,1/19,1.26%,APOE
prerank,regulation of neurogenesis (GO:0050767),0.24896640526301062,0.6445107574104898,0.9193954659949622,0.9838679359260618,1.0,14/55,23.87%,HES1;DOCK7;BHLHE40;PCM1;PAX6;REST;HOOK3;HEYL;PER2;SNW1;YTHDF2;HES3;HES7;NUMB
prerank,regulation of DNA damage checkpoint (GO:2000001),0.3315383734275057,0.6429689546708797,0.8454545454545455,0.9848834235976334,1.0,3/10,21.03%,FEM1B;THOC5;WDR76
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.19311273933919454,-0.642673869200295,0.9822222222222222,0.9813210423818458,1.0,13/53,21.09%,CALCRL;CHRM2;HTR2C;CHRM3;HTR2A;AGT;HRH1;LHCGR;TSHR;CCL2;LPAR3;HTR1F;NPY
prerank,lysosome organization (GO:0007040),0.2620101852475242,0.6424671602217442,0.9087136929460581,0.9849225524908128,1.0,16/36,30.34%,HPS4;ACP3;ARSB;MTOR;ACP4;HOOK3;TMEM165;MBTPS1;CLN3;HOOK2;GAA;TFEB;GNPTAB;ZKSCAN3;TPP1;VPS33A
prerank,plasma membrane tubulation (GO:0097320),0.30672414358249966,0.6413774372149591,0.8691910499139415,0.9855398621305107,1.0,4/13,17.44%,EHD2;BIN2;CAVIN2;WHAMM
prerank,positive regulation of ATPase activity (GO:0032781),0.2555172202548775,0.639778993863904,0.9093333333333333,0.9866241272978096,1.0,3/41,6.58%,ATP1B1;TOR1AIP1;PLSCR1
prerank,receptor clustering (GO:0043113),0.2696809106973197,0.6392968091122194,0.9198813056379822,0.986670536465435,1.0,10/27,23.94%,DLG2;DLG1;ITGB1BP1;SYNJ2BP;DVL1;SCRIB;DLG4;FLNA;LRP4;NRXN2
prerank,regulation of nuclear division (GO:0051783),0.28699424983917843,0.6389899351181972,0.8788819875776398,0.9865637531735747,1.0,5/20,21.67%,CCDC8;PDXP;CDK13;CUL7;PRMT5
prerank,macrophage migration (GO:1905517),0.3070333516442809,0.6379806268257379,0.8731218697829716,0.9870702700197729,1.0,2/13,11.16%,P2RX4;CCL3
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.29436142157478357,0.6370717557167049,0.8922345483359746,0.987501125868381,1.0,16/16,70.59%,RIPK3;IL23R;KLRD1;CYRIB;FADD;AGER;LILRB1;CEACAM1;PTPRC;XCL1;KLRC1;IL12B;IL23A;IL12RB1;IL12A;STX7
prerank,protein destabilization (GO:0031648),0.26678981250761896,0.6366360661555773,0.9001367989056087,0.9874693493457075,1.0,5/32,14.03%,GSN;CREBBP;FBXW11;EP300;CUL3
prerank,negative regulation of protein kinase activity (GO:0006469),0.22855574145615343,0.6364713449504316,0.963985594237695,0.9872052862982785,1.0,17/88,16.73%,LRP6;UBASH3B;ABL1;CDKN1B;NF1;SMCR8;LRP5;ITGB1BP1;CEP85;CORO1C;DUSP10;RB1;CHP1;PAK2;ACP4;CEP43;WWTR1
prerank,epithelial cell development (GO:0002064),-0.23544519025763658,-0.6357206929370085,0.9297297297297298,0.985196968563852,1.0,2/20,7.09%,WNT5B;ACTA2
prerank,positive regulation of exocytosis (GO:0045921),0.2619842212227906,0.6356854963349173,0.9034090909090909,0.9874873614939953,1.0,13/35,24.77%,SYTL4;PDCD6IP;EXPH5;SDC4;RAB27B;TSG101;SNF8;RAB5A;SDC1;HGS;RAB7A;RAB2B;STXBP5
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.28269106968391283,0.6344574788888724,0.8982785602503912,0.988169301169291,1.0,2/19,5.09%,CUX1;FBXW8
prerank,negative regulation by host of viral process (GO:0044793),0.3148001877540255,0.6342222627829344,0.8556149732620321,0.9879833215221507,1.0,2/10,14.27%,ZC3H12A;EIF2AK4
prerank,phospholipid homeostasis (GO:0055091),0.3111579315869121,0.6342052717370996,0.8598425196850393,0.9875955011317038,1.0,5/11,23.38%,TLCD1;HNF4A;TLCD2;ANGPTL3;FABP3
prerank,vitamin D metabolic process (GO:0042359),-0.26354536810792306,-0.6339344742382598,0.9076212471131639,0.9854203906067547,1.0,2/13,11.67%,LGMN;CUBN
prerank,protein prenylation (GO:0018342),-0.2762365051468742,-0.6338055765656812,0.8835443037974684,0.9845635024652155,1.0,10/10,72.40%,PTAR1;FNTB;CHML;RCE1;AIPL1;FNTA;RABGGTA;PGGT1B;RABGGTB;CHM
prerank,regulation of aerobic respiration (GO:1903715),-0.2573642570024032,-0.6319473990737602,0.9052369077306733,0.984846497117811,1.0,7/15,25.69%,CBFA2T3;SLC25A33;COX7A2;UQCC2;ATP7A;SHMT2;PINK1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.2734491768034935,0.6317328295746807,0.8877245508982036,0.9893430183291504,1.0,5/23,18.47%,MTMR12;OCRL;PIP4P2;SYNJ1;MTMR11
prerank,mRNA modification (GO:0016556),-0.23291457286432163,-0.6306489830363845,0.9292035398230089,0.984747241153288,1.0,22/22,76.75%,METTL14;METTL3;TRUB1;ZC3H13;METTL8;METTL16;TRMT10C;DKC1;CBLL1;PUS1;NSUN2;PUS3;TRMT61A;CMTR1;TRMT6;TRMT61B;RPUSD2;VIRMA;PCIF1;PUS7;WTAP;TRUB2
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.2937341655049515,0.6302327375597816,0.8793706293706294,0.9901891008324182,1.0,3/15,12.53%,ATL2;RTN3;ZFYVE27
prerank,modulation by host of viral genome replication (GO:0044827),0.29970269207979455,0.6295643895467554,0.8694214876033057,0.9903597619589383,1.0,5/13,27.64%,ZC3H12A;EIF2AK4;FMR1;TBC1D20;VAPA
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.233151271406948,0.6288517541636358,0.9573400250941029,0.9905786999597564,1.0,19/71,24.19%,CAPN2;DDI2;VCP;PDCD6IP;IDE;ZYG11B;OTUD7B;ZRANB1;OMA1;YME1L1;CLPP;CHFR;USP9X;UBE2W;RNF123;FBXL17;FAP;CHMP4B;NR1D1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.290714804672185,0.6281580763877332,0.8916666666666667,0.9907579008206385,1.0,2/17,11.58%,ANO6;CCL1
prerank,histone mRNA metabolic process (GO:0008334),0.27133040277441445,0.6280699809383892,0.9017857142857143,0.9904182746615359,1.0,12/27,31.17%,ATM;LSM11;TUT7;TUT4;TENT2;SSB;ERI1;CPSF3;EXOSC4;NCBP2;MTPAP;XRN1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.30638348565268103,0.6255377290817669,0.8787375415282392,0.9921452355367947,1.0,3/13,18.40%,BCAP31;OS9;EDEM2
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.24724239064574446,-0.6250716343450198,0.914364640883978,0.9873795427620693,1.0,1/16,3.94%,AHR
prerank,histone lysine methylation (GO:0034968),0.257405361489127,0.6247693863817066,0.9284692417739628,0.9923735985041885,1.0,10/33,32.37%,SMYD2;KMT2D;PRDM5;EHMT2;WDR82;SETD6;KMT2A;SETD1B;ASH2L;PAXIP1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.3064161980137728,0.6246506388940358,0.8932874354561101,0.9920610394479273,1.0,3/12,17.76%,WDR18;NBN;TICRR
prerank,tetrapyrrole metabolic process (GO:0033013),0.2830682753176891,0.6245881872149759,0.9031746031746032,0.9917054765039337,1.0,7/18,27.19%,MMACHC;ABCC1;CD320;MMAB;MMADHC;CTRC;LMBRD1
prerank,synaptic vesicle recycling (GO:0036465),0.26219317708489753,0.6238748773557494,0.9192634560906515,0.9918699284916151,1.0,4/31,9.70%,STON1;STON2;SYT8;FCHO2
prerank,ribonucleoprotein complex assembly (GO:0022618),0.2129799528089167,0.6234219678437459,0.9787709497206704,0.991831560575769,1.0,44/132,28.23%,RPSA;LUC7L2;SRSF5;SRSF6;CELF1;CELF3;EIF2D;EIF6;EIF3A;SCAF11;BRIX1;PRKDC;XRCC5;GCFC2;DHX9;SF3B1;EIF2S2;NLE1;SRPK1;GEMIN8;EIF4B;PRPF18;DDX1;PRMT5;NOL3;NAF1;DHX29;TXNL4A;RBM5;MDN1;NUDT21;LSM4;LUC7L;MRPL20;CELF4;CPSF7;SRPK2;SNRNP200;RAMAC;TGS1;PRPF6;CLP1;MRPS7;KHDC4
prerank,protein palmitoylation (GO:0018345),-0.20881303450504912,-0.6224018347001937,0.9688473520249221,0.9880453386565826,1.0,5/30,13.81%,ZDHHC14;ZDHHC1;ZDHHC17;ZDHHC9;SELENOK
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.2502767499651776,-0.6212316062958059,0.941025641025641,0.9878479486047157,1.0,3/15,10.12%,SAMHD1;NLRC5;USP18
prerank,mitotic cytokinetic process (GO:1902410),0.2779280198282615,0.6212036557348479,0.8958652373660031,0.9932282301398592,1.0,3/20,12.29%,PDCD6IP;RHOA;CNTROB
prerank,positive regulation of isotype switching (GO:0045830),-0.24519698589735178,-0.6207543128650936,0.9310344827586207,0.9871965611849878,1.0,4/15,20.32%,TFRC;RIF1;CD40;SHLD3
prerank,protein insertion into ER membrane (GO:0045048),-0.20293120574205767,-0.6205343173361411,0.9781818181818182,0.9863868693005496,1.0,11/37,23.58%,APP;MMGT1;CYB5A;UBE2J2;TRAM1;SEC61G;SERP1;SGTA;EMC7;OTOF;EMC6
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.25525539247266404,-0.6198853550683177,0.9166666666666666,0.9858472965073034,1.0,1/15,2.61%,HECW2
prerank,negative regulation of interferon-beta production (GO:0032688),0.30973163622833527,0.6191952431461973,0.8839590443686007,0.9944405316894258,1.0,5/10,28.75%,REL;YY1;PTPRS;PPM1B;RELB
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.26329337520844065,0.6188622295310499,0.9097633136094675,0.9943035100830452,1.0,11/27,31.97%,CTPS2;GSR;RRM2;AK4;AK9;AK1;NUDT13;AK5;AK6;CMPK1;DTYMK
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.2659357476715676,0.6187422857755526,0.8992592592592593,0.993997340082723,1.0,4/25,11.08%,FOXK1;PFKP;GPI;FOXK2
prerank,positive regulation of rRNA processing (GO:2000234),0.3104379651966773,0.618524880446492,0.875438596491228,0.9937642877565561,1.0,3/10,23.07%,WDR43;WDR75;RIOK2
prerank,melanosome localization (GO:0032400),-0.23199811210331497,-0.6184990733842172,0.936231884057971,0.9857424721440154,1.0,7/21,25.76%,SHROOM2;MYO5A;BLOC1S6;BBS7;RAB27A;MREG;BBS5
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.2776299180112531,-0.6183787486691479,0.8891625615763546,0.9848828388340397,1.0,2/10,19.01%,SNCA;MT3
prerank,programmed necrotic cell death (GO:0097300),0.2856418861546537,0.6179784171889577,0.875993640699523,0.9938098064501019,1.0,5/18,20.18%,TRPM7;TLR4;RIPK3;ALKBH7;LY96
prerank,regulation of transposition (GO:0010528),0.30221608387218274,0.6173157242266247,0.8768472906403941,0.9939234956156727,1.0,13/13,69.80%,TDRD9;TEX15;PIWIL4;SIRT7;PIWIL2;AICDA;PIWIL1;BTBD18;UBR2;MYBL1;DDX4;SMYD5;SPOCD1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.27485713478809926,0.6172158730296867,0.9185185185185185,0.9936045905739745,1.0,8/23,22.19%,KIF1B;KIF1C;F8A1;DYNC1I1;HOOK3;MAP6;MYO10;HOOK2
prerank,glutamine family amino acid metabolic process (GO:0009064),0.2556293731741441,0.6171434628294895,0.9149855907780979,0.993261693303637,1.0,6/33,18.24%,GCLC;FPGS;KYAT1;CAD;NIT2;PYCR1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.31341765516366094,0.6160260307701337,0.8670120898100173,0.9937294631527374,1.0,2/10,18.91%,AGO2;DROSHA
prerank,vasodilation (GO:0042311),0.3047033185868324,0.6160116092404991,0.8985270049099836,0.993339166676006,1.0,1/13,2.73%,ADRB2
prerank,regulation of protein acetylation (GO:1901983),0.30348943410815765,0.6159639261617565,0.8894472361809045,0.9929742420865583,1.0,1/12,3.23%,GSK3B
prerank,positive regulation of telomerase activity (GO:0051973),0.25395721215774436,0.6158193744879423,0.9219653179190751,0.992668888306334,1.0,3/33,8.73%,KLF4;NEK7;GRHL2
prerank,chondroitin sulfate catabolic process (GO:0030207),0.29545209960001517,0.6147235389940936,0.9054054054054054,0.9931119402203956,1.0,4/13,16.40%,HEXA;ARSB;IDUA;BGN
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.2425357774093554,-0.6131748814157844,0.9420654911838791,0.9869673661580941,1.0,7/16,34.21%,TOP2B;EME2;TOP2A;MUS81;EME1;CENPS;RMI1
prerank,glycine metabolic process (GO:0006544),0.2967474465201892,0.6130966180892116,0.8873483535528596,0.9939750690780726,1.0,3/12,20.35%,GCAT;DLD;SDSL
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.23824813668525738,0.6121703412050213,0.950863213811421,0.994257551880558,1.0,14/52,22.85%,SHC1;LMNA;DNAJC3;ERN2;SEC31A;DDX11;ADD1;ATP6V0D1;ARFGAP1;SRPRB;GFPT1;CUL7;SRPRA;DNAJB11
prerank,mitochondrial fusion (GO:0008053),0.28111006475832834,0.6121217684844171,0.9059011164274322,0.993886741583551,1.0,7/18,30.46%,MIEF1;SPG7;MIEF2;MIGA1;STOML2;USP30;BAX
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.27312793028352306,0.6118726805437174,0.9055727554179567,0.9936778686399361,1.0,1/20,1.69%,CAMK2D
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.29891968315080364,0.610943116586945,0.8860971524288107,0.9939946928679501,1.0,4/13,14.67%,MAVS;TRIM44;IFIH1;DHX9
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.30616528773139756,0.6107661873250688,0.8986254295532646,0.9937305825500536,1.0,4/10,27.79%,DHX36;PAF1;NUDT21;NCBP2
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.22233140814831082,-0.6103282117404681,0.946524064171123,0.9876425580866035,1.0,7/21,24.79%,BCL2L1;BOK;TMBIM6;SELENOS;XBP1;PMAIP1;CREB3
prerank,regulation of cytoplasmic translation (GO:2000765),0.28611827525088496,0.6095589411976241,0.8858520900321544,0.9942206396642523,1.0,4/14,19.50%,YBX3;DHX9;DHX36;FMR1
prerank,negative regulation of viral genome replication (GO:0045071),-0.1948999424929718,-0.6095401542569533,0.9739776951672863,0.9871446625320586,1.0,12/40,22.58%,IFITM1;BST2;IFITM3;OAS2;PROX1;RNASEL;IFIT1;PARP10;INPP5K;BANF1;OASL;RSAD2
prerank,regulation of protein metabolic process (GO:0051246),0.2418023675034317,0.6093318535004684,0.9514824797843666,0.9940098891209607,1.0,13/44,22.10%,KLF4;LDLR;CNDP1;LTBP4;CHEK2;ZDHHC2;SPOP;SNF8;TRAF3;ABCA7;MAPK8;HGS;PARL
prerank,phagosome maturation (GO:0090382),0.24627057874954764,0.6074330168050402,0.939521800281294,0.9950245374403489,1.0,6/35,19.28%,ATP6V0A4;RAB43;TCIRG1;ATP6V0D1;ATP6V0E1;ATP6V1H
prerank,regulation of centrosome duplication (GO:0010824),0.25022658837795736,0.6066158583849278,0.9248554913294798,0.9952113501758808,1.0,9/29,26.58%,PDCD6IP;SPICE1;CEP131;STIL;CEP295NL;CHMP4B;NAT10;FBXW5;CCNF
prerank,negative regulation of hormone secretion (GO:0046888),0.30491813979306687,0.6063519235151836,0.8902877697841727,0.9950100101072872,1.0,1/10,5.46%,RAB11FIP3
prerank,termination of RNA polymerase II transcription (GO:0006369),0.2505999198732076,0.605927966358798,0.9351585014409222,0.9949317469034616,1.0,15/33,32.55%,SCAF8;TTF2;LSM11;MAZ;FIP1L1;CSTF1;NUDT21;CPSF7;CPSF3;NCBP2;CLP1;CPSF4;CSTF2T;CSTF3;SSU72
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.2577025736224869,0.6058660521576266,0.9273570324574961,0.9945866461150991,1.0,15/27,36.65%,ZC3H12A;ZC3H12D;ZC3H12C;RNASE6;LACTB2;CPSF3;PARN;XRN1;CSTF3;DICER1;ZC3H12B;NYNRIN;POP1;RNASEH1;TOE1
prerank,negative regulation of innate immune response (GO:0045824),0.25127226734253655,0.6057579168815914,0.9298998569384835,0.9942600790873081,1.0,8/34,16.21%,PTPN2;TRAFD1;SERPING1;IRAK3;USP15;FAM3A;CNOT7;ACOD1
prerank,protein lipidation (GO:0006497),0.22687486035553922,0.60365077667447,0.9570871261378413,0.9953945341006399,1.0,22/59,26.73%,WIPI2;HHAT;PGAP2;ZDHHC15;PIGB;ZDHHC2;DPM1;PIGU;ZDHHC20;PIGL;ZDHHC23;PIGN;WDR45B;ZDHHC12;PIGH;PGAP3;PIGQ;MPPE1;ATG7;PIGA;ATG5;ZDHHC5
prerank,renal absorption (GO:0070293),0.30683539521349,0.6035616987703563,0.8998272884283247,0.9950712216388772,1.0,1/10,2.48%,GSN
prerank,alpha-amino acid metabolic process (GO:1901605),-0.18356689496105313,-0.6033269613296374,0.9890510948905109,0.9896484684670754,1.0,13/45,22.96%,ASPA;ASPG;KYAT3;ASS1;NOX4;DDAH2;ASNS;CBS;GOT2;ATP7A;SLC25A13;PYCR2;GLUD1
prerank,cholesterol metabolic process (GO:0008203),0.22681180614522745,0.6024595877236059,0.967741935483871,0.9954352770828317,1.0,12/68,19.31%,SOAT1;FDX1;TSKU;RXRA;LBR;MVD;EBP;LCAT;HMGCR;ANGPTL3;OSBPL5;FDPS
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.3001067101876845,0.6018549333257018,0.8966725043782837,0.9954353256230049,1.0,11/11,70.01%,PARN;EXOSC4;EXOSC2;EXOSC3;EXOSC5;TENT4B;LARP7;DKC1;EXOSC10;FBLL1;FBL
prerank,establishment of protein localization to extracellular region (GO:0035592),0.24420808513918568,0.6018217783221927,0.9486823855755895,0.9950560697857218,1.0,3/39,6.49%,TANGO6;LTBP2;GOLPH3
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.28265085875805684,0.601341405768015,0.9176090468497576,0.9949809365174155,1.0,4/16,17.16%,LDLR;DAGLB;CNEP1R1;SREBF1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.21587521326083836,-0.5996940086355425,0.9565217391304348,0.99056942110939,1.0,2/23,7.11%,CALM1;NMT2
prerank,regulation of ATP metabolic process (GO:1903578),0.22859900752026888,0.5985293923475512,0.9635627530364372,0.9965695759451411,1.0,17/54,24.51%,NUP93;RANBP2;NUP153;EIF6;SEC13;EP300;NUP214;ZBTB7A;NUP188;ABCD1;NUP88;AK4;NUP98;ATP5IF1;AAAS;NUP54;OGT
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.2736511297140659,0.5981472706898726,0.9278033794162827,0.996429790244291,1.0,2/18,11.81%,GSK3B;MPV17L
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.24054475558945368,0.5978624627597809,0.9384203480589023,0.9962194208489454,1.0,10/46,22.31%,PNPLA3;DGKA;DDHD1;GNPAT;PLD1;LCLAT1;GPAT3;PLA2G4A;LPCAT1;ABHD5
prerank,intracellular protein transmembrane transport (GO:0065002),0.23608009434368038,0.5978474148305069,0.9462809917355371,0.995829038805695,1.0,12/42,24.53%,C2CD5;SEC61A1;TIMM23;SEC63;TIMM17B;AIFM1;DNAJC19;PEX2;PEX7;GRPEL2;TOMM20;PEX26
prerank,positive regulation of interleukin-1 production (GO:0032732),0.23173131106528055,0.5978464693467332,0.9721854304635762,0.995432359565754,1.0,11/51,18.34%,ISL1;STAT3;RIPK2;TLR4;CCL3;MYD88;TLR8;TRIM16;NLRP12;IL16;TLR6
prerank,positive regulation of cellular respiration (GO:1901857),0.2987782752806057,0.596853759786002,0.9048442906574394,0.995724349724953,1.0,2/11,14.33%,VCP;IFNLR1
prerank,cellular response to acid chemical (GO:0071229),0.2544603973245779,0.5968175171048272,0.927007299270073,0.9953598122205878,1.0,4/27,13.21%,CAPN2;RRAGB;VEGFA;MTOR
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.2808260832677889,0.5957468305085782,0.8985507246376812,0.9956631508175412,1.0,4/14,17.61%,IRS1;LONP2;TWIST1;ABCD1
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.24117414607388019,-0.5950221330391611,0.912718204488778,0.9919553444050062,1.0,7/16,25.69%,SLC25A33;COX7A2;UQCC2;NUPR1;ATP7A;SHMT2;PINK1
prerank,protein-DNA complex disassembly (GO:0032986),-0.23404996440131093,-0.5949612722039439,0.9463414634146341,0.9910536159721418,1.0,3/16,13.07%,RPL23;SMARCD1;SET
prerank,positive regulation of histone deacetylation (GO:0031065),0.2926838027020153,0.5945846368786086,0.8923611111111112,0.9960474966294522,1.0,3/12,11.69%,ZBTB7B;VEGFA;NIPBL
prerank,phasic smooth muscle contraction (GO:0014821),0.2986590588606202,0.5943403744438627,0.889273356401384,0.9958015880015361,1.0,2/10,14.30%,GDNF;HTR2B
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.27624099621863735,0.5941377740179882,0.9298245614035088,0.995534034072792,1.0,7/17,29.13%,RB1;SPDL1;ZWILCH;ZW10;BUB3;TTK;CHAMP1
prerank,regulation of stem cell population maintenance (GO:2000036),0.26759018172746196,0.5939900219423003,0.9202551834130781,0.9952460965664419,1.0,3/18,14.51%,WDR43;KAT2A;REST
prerank,protein autoprocessing (GO:0016540),-0.22674319626832046,-0.5939342120037998,0.9466292134831461,0.9906691309857182,1.0,4/17,18.12%,CASP4;CTSL;MYRF;CASP1
prerank,leukocyte tethering or rolling (GO:0050901),0.2769130002131147,0.59319931600589,0.9265905383360522,0.9953516349572616,1.0,2/17,6.49%,ITGB1;GOLPH3
prerank,regulation of cell projection organization (GO:0031344),0.2813695029676567,0.592507062228917,0.9093799682034976,0.9954085189933973,1.0,2/13,10.48%,MOV10;MYO9A
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.2958782911236113,0.5924793131619887,0.9099099099099099,0.9950321028512394,1.0,5/10,32.79%,ACADM;ETFA;ETFDH;ACADVL;ACADS
prerank,negative regulation of cholesterol transport (GO:0032375),0.2944314044493439,0.5899832618815365,0.884083044982699,0.9962698658988177,1.0,1/10,8.90%,NFKB1
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.24869298574496063,-0.5899817968801372,0.9261904761904762,0.9916126874470859,1.0,1/12,4.13%,ACTB
prerank,sterol transport (GO:0015918),0.27158658141662556,0.5882256287074202,0.9177215189873418,0.996989453856072,1.0,5/19,24.09%,LDLR;LCAT;OSBPL5;NPC1;CD36
prerank,regulation of isotype switching (GO:0045191),0.27461489935297484,0.5879192521034435,0.9247135842880524,0.9967940899754184,1.0,4/14,20.61%,IL10;SHLD1;PARP3;KMT5B
prerank,tRNA 5'-end processing (GO:0099116),-0.22662341002432923,-0.5872564022741594,0.9639175257731959,0.991931924786325,1.0,10/15,41.64%,POP5;POP7;RPP21;HSD17B10;PRORP;RPP25L;RPP25;RPP40;TRMT10C;RPP14
prerank,steroid metabolic process (GO:0008202),0.21744871504292668,0.586990821495165,0.9675405742821473,0.9969788654586079,1.0,3/72,4.64%,CYP1B1;FDX1;SULT1A1
prerank,steroid catabolic process (GO:0006706),-0.26084811811828257,-0.5836253750610825,0.9453302961275627,0.9926568004796099,1.0,8/10,43.43%,SPP1;HSD17B11;HSD11B1;HSD17B14;CYP24A1;FGF23;YWHAH;HSD17B6
prerank,nucleus organization (GO:0006997),0.23023633101441549,0.5828836531818666,0.9594594594594594,0.9990655326940449,1.0,12/47,23.75%,NUP93;PDCD6IP;SUN3;LEMD2;PITPNB;USP36;NUP98;TMEM170A;SUN2;CHMP4A;CHMP4B;NUP54
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.2489466284331112,-0.5814168893194389,0.946078431372549,0.9927450290893313,1.0,1/12,5.69%,PRKCQ
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.2257691424368904,0.5812534225728329,0.9796472184531886,0.9996363287911234,1.0,15/48,24.51%,NUP93;RANBP2;NUP153;EIF6;SEC13;EP300;NUP214;ZBTB7A;NOA1;NUP188;NUP88;NUP98;AAAS;NUP54;OGT
prerank,transcription preinitiation complex assembly (GO:0070897),0.2856049109209293,0.579735663416565,0.907563025210084,1.0,1.0,5/12,27.51%,TAF12;GTF2B;GTF2A2;TAF1;TAF7L
prerank,aggrephagy (GO:0035973),0.24586759618419643,0.5797036139907319,0.9450222882615156,0.9997795083858273,1.0,10/27,27.32%,DYNC1I1;ACBD5;WDR81;SQSTM1;DYNC1LI2;UBE2N;UBE2V1;PCNT;ATG5;IFT88
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.2930586877851275,0.5774038799767505,0.9118165784832452,1.0,1.0,1/11,6.22%,MAVS
prerank,positive regulation of chromatin organization (GO:1905269),0.2837488620189038,0.577077568843414,0.9175257731958762,1.0,1.0,3/12,20.47%,MIER1;ATRX;UBE2N
prerank,RNA methylation (GO:0001510),0.21721915265843506,0.5760217238952983,0.9750328515111695,1.0,1.0,29/60,35.74%,MTO1;ALKBH8;TRMT13;METTL6;TRMT10A;TARBP1;TRDMT1;METTL1;FTSJ3;WTAP;MRM2;THADA;TGS1;GTPBP3;NSUN4;METTL5;PCIF1;THUMPD2;FTSJ1;VIRMA;TRMT12;NOP2;METTL2B;METTL2A;MEPCE;TRMT44;NSUN3;TRMT61B;TRMT6
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.20782630040792335,0.575975894609364,0.9839704069050554,1.0,1.0,5/84,6.35%,SAMD4A;IGFBP5;PAIP2;SYNCRIP;CLU
prerank,mitochondrial genome maintenance (GO:0000002),0.2908021891577585,0.5758003854923095,0.9003322259136213,1.0,1.0,4/11,22.16%,MEF2A;TOP3A;SLC25A36;MPV17
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.2501586694965147,0.5747452170121101,0.9388059701492537,1.0,1.0,8/25,21.66%,LRPAP1;ITGAV;ATXN2;ITGB3;NEU3;RIN3;DLG4;ANKRD13D
prerank,phosphatidic acid metabolic process (GO:0046473),0.23051603613305435,0.5745120377658521,0.9651474530831099,1.0,1.0,10/48,22.31%,PNPLA3;DGKA;DDHD1;GNPAT;PLD1;LCLAT1;GPAT3;PLA2G4A;LPCAT1;ABHD5
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.21812204120532586,0.5742855957441598,0.9736147757255936,0.9997816691755518,1.0,16/53,27.63%,PSMB2;PSMC6;PSMD11;AZIN1;PSMD1;PSMD7;NQO1;PSMC1;PSMD14;PSMD3;ODC1;PSMD12;OAZ2;PSMD4;PSMD2;PSME3
prerank,dendritic cell chemotaxis (GO:0002407),0.2781663091753066,0.5739303110707767,0.9192245557350566,0.9995928215730236,1.0,2/14,13.85%,TRPM4;CXCR4
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.257595560187886,0.5732218576331118,0.9291338582677166,0.999594492990772,1.0,4/19,20.10%,MPI;RENBP;UAP1;GFPT1
prerank,response to exogenous dsRNA (GO:0043330),0.26248118289925476,0.5727160948252604,0.9490740740740741,0.9994875401367818,1.0,4/18,14.67%,MAVS;IRAK3;IFIH1;DHX9
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.24774205141103092,0.5720580513966478,0.9478390461997019,0.9994855780865284,1.0,8/27,22.48%,ETNK1;PLA2G15;LPIN2;CHKB;CEPT1;NAAA;ETNPPL;ETNK2
prerank,fatty acid biosynthetic process (GO:0006633),0.2162102392671756,0.5701988975348149,0.9817945383615084,1.0,1.0,12/63,21.86%,ABCD3;SCD;ELOVL5;ACSM2A;ACSM2B;GSTM4;ABCD1;NDUFAB1;ABHD2;TECR;HACD4;MCAT
prerank,negative regulation of DNA recombination (GO:0045910),-0.17536881930272888,-0.5692898294953104,0.9963503649635036,0.9969729507157967,1.0,12/43,29.63%,RIF1;BLM;POLR2G;POLR2K;SHLD3;H1-0;TERF2IP;SMCHD1;UBQLN4;TERF1;POLR2L;RADX
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.26979323476485595,0.5689048451989059,0.9315525876460768,1.0,1.0,5/14,25.82%,DDX18;WDR12;URB1;FTSJ3;ZNHIT3
prerank,regulation of cell aging (GO:0090342),0.28429126371228475,0.5675455849942359,0.9226713532513181,1.0,1.0,1/11,3.84%,LMNA
prerank,positive regulation of DNA recombination (GO:0045911),0.23879093046883954,0.5668547587443559,0.9504643962848297,1.0,1.0,12/27,34.51%,FUS;MRNIP;SHLD1;WDR48;KMT5B;ERCC2;RAD51AP1;ACTR2;PAXIP1;KMT5C;ZCWPW1;HMCES
prerank,regulation of cilium assembly (GO:1902017),0.2138998050739901,0.564770768266756,0.9923566878980892,1.0,1.0,16/62,20.70%,LIMK2;RABEP2;ATG3;TBC1D2B;TBC1D13;ENTR1;TBC1D10A;SDCCAG8;TBC1D5;SGSM3;CDK10;CEP97;TBC1D17;ODAD3;FUZ;ARHGAP35
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.20989191891039224,0.5633715636661379,0.9882659713168188,1.0,1.0,13/67,19.04%,ITGB5;ITGAV;PSMB2;CHUK;PSMC6;SNAP23;PSMD11;PSMD1;SEC22B;IKBKG;PSMD7;PSMC1;PSMD14
prerank,positive regulation of immunoglobulin production (GO:0002639),0.23056534776300644,0.5626060787823289,0.9538239538239538,1.0,1.0,6/31,20.61%,CLCF1;IL10;GPI;SHLD1;TNFRSF4;KMT5B
prerank,hydrogen peroxide catabolic process (GO:0042744),0.2751644380511883,0.561302535797335,0.9393442622950819,1.0,1.0,4/11,29.75%,PRDX5;PXDN;PRDX2;PRDX3
prerank,maintenance of protein location in nucleus (GO:0051457),-0.209273805728862,-0.5599577727821383,0.9805013927576601,0.9996367751815372,1.0,5/20,21.05%,ARL2BP;TAF3;SP100;CHCHD10;BCL3
prerank,mitotic metaphase plate congression (GO:0007080),0.21505456471986698,0.5588743968158926,0.978494623655914,1.0,1.0,16/51,29.43%,BECN1;PDCD6IP;PIBF1;CUL3;RMDN1;SPDL1;ZW10;KIF2C;CCNB1;CHMP4A;CHMP4B;KIF18A;PINX1;CENPC;CHAMP1;MAD1L1
prerank,regulation of myelination (GO:0031641),-0.1914620248224776,-0.5567583096280482,0.9876543209876543,0.9998222423813938,1.0,2/25,4.61%,TNFRSF21;TENM4
prerank,cilium movement (GO:0003341),0.21666040036401069,0.5551151047943399,0.9788359788359788,1.0,1.0,11/47,23.09%,CFAP70;SPAG17;CCDC40;DNAAF4;TEKT2;RSPH9;ODAD3;ODAD2;CAMSAP3;SPEF1;RSPH6A
prerank,tryptophan catabolic process (GO:0006569),0.2759399912121022,0.5538540623281937,0.9192751235584844,1.0,1.0,11/11,72.43%,KYAT1;TDO2;IDO2;HAAO;KMO;ACMSD;IDO1;KYNU;IL4I1;AADAT;AFMID
prerank,phagolysosome assembly (GO:0001845),-0.23115433353448978,-0.5536367356443771,0.9580246913580247,0.9999761939585605,1.0,6/12,27.36%,SYT7;RAB39A;RAB20;PLA2G5;ARL8B;CORO1A
prerank,rRNA catabolic process (GO:0016075),0.25578672859814466,0.5521067174129388,0.9606557377049181,1.0,1.0,7/16,32.48%,ERN2;EXOSC7;EXOSC4;EXOSC2;XRN1;EXOSC3;DIS3
prerank,autophagosome maturation (GO:0097352),0.23090027773817867,0.5520141061124585,0.9602941176470589,1.0,1.0,3/32,8.84%,WIPI2;VCP;LIX1L
prerank,protein targeting to mitochondrion (GO:0006626),0.2147989906403392,0.5515869723305119,0.9722589167767504,1.0,1.0,16/52,27.99%,SAMM50;PMPCB;TIMM23;AGK;PITRM1;BCAP31;TIMM17B;IMMP1L;AIFM1;DNAJC19;TOMM34;GRPEL2;TOMM20;HSPA4;TIMM9;MIPEP
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.23100804046075465,0.5511079952750099,0.9566517189835575,1.0,1.0,6/28,20.61%,PRKDC;KDM4D;MRNIP;SHLD1;PARP3;KMT5B
prerank,phagosome acidification (GO:0090383),0.2340312833594041,0.5479458978696189,0.9712121212121212,1.0,1.0,5/26,19.28%,ATP6V0A4;TCIRG1;ATP6V0D1;ATP6V0E1;ATP6V1H
prerank,protein localization to phagophore assembly site (GO:0034497),0.27347390325746845,0.5474072937642782,0.9433333333333334,1.0,1.0,1/11,4.77%,WIPI2
prerank,regulation of response to interferon-gamma (GO:0060330),0.2610006035152228,0.5467378353042551,0.9292929292929293,1.0,1.0,1/14,4.65%,PTPN2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.24889083787600833,0.5466995318607635,0.9594813614262561,1.0,1.0,3/18,11.32%,SPAG17;CCDC40;DNAAF4
prerank,receptor recycling (GO:0001881),0.27107846697715243,0.5464465813716953,0.9102112676056338,1.0,1.0,3/10,24.31%,EHD3;RAB11B;PHETA2
prerank,lipoxygenase pathway (GO:0019372),0.2589716756030327,0.5459190723671568,0.9478827361563518,1.0,1.0,1/14,5.60%,PON3
prerank,cardiolipin metabolic process (GO:0032048),0.2668737995470679,0.5456327707094605,0.9254237288135593,1.0,1.0,4/13,20.52%,PLSCR3;LCLAT1;PLA2G4A;TAMM41
prerank,cellular response to interferon-beta (GO:0035458),0.2590695117859026,0.5452572855674173,0.9446308724832215,1.0,1.0,3/14,16.21%,IRF1;UBE2K;ACOD1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.21195566926821238,-0.5437435252272964,0.9816272965879265,1.0,1.0,5/17,25.99%,MMGT1;SGTA;EMC7;EMC6;GET4
prerank,mucosal immune response (GO:0002385),-0.21738947843811424,-0.5426036925601423,0.9786666666666667,1.0,1.0,2/15,12.16%,DEFA6;RPL39
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.26977327429946596,0.5426011518327638,0.9180327868852459,1.0,1.0,2/11,14.23%,OCRL;SYNJ1
prerank,inositol phosphate dephosphorylation (GO:0046855),0.26977327429946596,0.5426011518327638,0.9180327868852459,1.0,1.0,2/11,14.23%,OCRL;SYNJ1
prerank,isotype switching (GO:0045190),0.27305988133058773,0.5412268720667567,0.9322638146167558,1.0,1.0,4/10,33.77%,RNF168;RNF8;EXOSC3;LIG4
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.2470892083386516,0.5399019796218661,0.9450726978998385,1.0,1.0,5/16,27.79%,SFSWAP;WBP4;SRSF12;SNRNP200;NCBP2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.25830764142117807,0.5397786081637078,0.9496527777777778,1.0,1.0,3/13,18.59%,NRP1;PLXNA2;PLXNB1
prerank,positive regulation of catalytic activity (GO:0043085),0.22092109725107073,0.5397017029270135,0.9707446808510638,1.0,1.0,5/37,15.94%,ABL1;BCAS3;WRN;XRCC5;CHTOP
prerank,regulation of TOR signaling (GO:0032006),0.20240425775760268,0.5396543446533841,0.9896507115135834,1.0,1.0,8/67,12.61%,TELO2;NPRL3;GOLPH3;RRAGB;ITFG2;MLST8;SMCR8;SEC13
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.24383240567636222,0.5391776711514642,0.9450726978998385,1.0,1.0,3/20,14.11%,ACSL3;SCD;ACSM2A
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.2429006322696423,0.5390571070266453,0.9646697388632872,1.0,1.0,7/22,20.79%,ZDHHC11;ZDHHC15;ZDHHC2;GOLGA7;ZDHHC20;ZDHHC23;ZDHHC12
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.2429006322696423,0.5390571070266453,0.9646697388632872,1.0,1.0,7/22,20.79%,ZDHHC11;ZDHHC15;ZDHHC2;GOLGA7;ZDHHC20;ZDHHC23;ZDHHC12
prerank,lysine catabolic process (GO:0006554),0.2625691941735653,0.5380488288325522,0.9564489112227805,1.0,1.0,6/12,28.90%,HYKK;OGDH;DLD;SLC25A21;PIPOX;PHYKPL
prerank,lysine metabolic process (GO:0006553),0.2625691941735653,0.5380488288325522,0.9564489112227805,1.0,1.0,6/12,28.90%,HYKK;OGDH;DLD;SLC25A21;PIPOX;PHYKPL
prerank,inositol phosphate catabolic process (GO:0071545),0.26241668529869383,0.5380373417017729,0.9108589951377634,1.0,1.0,2/12,14.23%,OCRL;SYNJ1
prerank,regulation of lymphocyte activation (GO:0051249),-0.22786732240354207,-0.5373475156626143,0.9601769911504425,1.0,1.0,4/12,29.66%,PAG1;THEMIS2;CCL5;CRTAM
prerank,mitochondrion organization (GO:0007005),0.18418875427505407,0.5351799080280948,0.9988801791713325,1.0,1.0,22/165,15.82%,PID1;CXADR;VPS13C;MEF2A;GABPB1;VPS13D;SAMM50;NRF1;MTX2;MIEF1;MTFR1;WDR81;PPRC1;MTX3;OMA1;YME1L1;TIMM23;HCFC1;PITRM1;POLG2;BCAP31;TIMM17B
prerank,antibacterial humoral response (GO:0019731),-0.20655453836332,-0.5341789930216071,0.9705882352941176,1.0,1.0,2/16,12.16%,DEFA6;RPL39
prerank,myelin maintenance (GO:0043217),0.26779973607643515,0.5334640283481663,0.9307958477508651,1.0,1.0,3/10,17.61%,CLU;CXCR4;ABCD1
prerank,regulation of T cell activation (GO:0050863),0.21240740566884175,0.5324555753741141,0.9928469241773963,1.0,1.0,5/42,12.70%,ABL1;CD2;TNFSF11;TNFRSF1B;KAT2A
prerank,melanosome transport (GO:0032402),0.24473504813609726,0.5318274429123913,0.9673405909797823,1.0,1.0,1/18,3.29%,MLPH
prerank,pigment granule transport (GO:0051904),0.24473504813609726,0.5318274429123913,0.9673405909797823,1.0,1.0,1/18,3.29%,MLPH
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.2380490384344296,-0.5310749950492881,0.9610983981693364,1.0,1.0,3/10,23.58%,MMGT1;EMC7;EMC6
prerank,determination of bilateral symmetry (GO:0009855),0.23070887426300374,0.5309434269742711,0.9641255605381166,1.0,1.0,7/24,22.07%,PITX2;GALNT11;DNAAF4;STIL;KIF3B;ODAD3;ODAD2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.2655736782577558,0.5300283438585249,0.9510603588907015,1.0,1.0,4/13,20.62%,USP4;PRPF3;LSM2;SRSF12
prerank,gas transport (GO:0015669),-0.2430512843777669,-0.5287466471660929,0.9553990610328639,1.0,1.0,6/10,33.89%,CA2;AQP1;MYC;MB;NGB;RHAG
prerank,rRNA pseudouridine synthesis (GO:0031118),0.2655061157451062,0.5276789727486965,0.9433333333333334,1.0,1.0,5/10,31.28%,RPUSD4;NAF1;RPUSD1;GAR1;RPUSD2
prerank,regulation of lymphocyte migration (GO:2000401),-0.23629525158256737,-0.5273039856375966,0.9782082324455206,1.0,1.0,3/10,21.10%,JAM2;AKT1;WASL
prerank,regulation of mitotic spindle organization (GO:0060236),0.21377962198238376,0.5268713329694448,0.9817415730337079,1.0,1.0,13/35,34.10%,PDCD6IP;PARP3;CEP97;GPSM2;DRG1;CHMP4B;TACC3;RAE1;BORA;DYNC1H1;DCTN1;CHMP3;CHMP2B
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.2505779097293727,0.5256816468179029,0.9693548387096774,1.0,1.0,7/14,35.44%,TSEN54;DDX1;CLP1;CPSF4;TRPT1;RTCB;TSEN2
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.23567287112699742,-0.5256678947354745,0.9565217391304348,1.0,1.0,4/10,22.71%,HK2;PFKM;PFKL;GFPT2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.19400813042052487,0.5253359701476302,0.998719590268886,1.0,1.0,13/70,19.04%,ITGB5;ITGAV;PSMB2;CHUK;PSMC6;SNAP23;PSMD11;PSMD1;SEC22B;IKBKG;PSMD7;PSMC1;PSMD14
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.2041164628377842,-0.5252495371980345,0.9972527472527473,0.9994627112686668,1.0,7/19,37.62%,POLR2G;POLR2K;TERF2IP;TERF1;POLR2L;POLR2F;POLR2J
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.2041164628377842,-0.5252495371980345,0.9972527472527473,0.9994627112686668,1.0,7/19,37.62%,POLR2G;POLR2K;TERF2IP;TERF1;POLR2L;POLR2F;POLR2J
prerank,DNA catabolic process (GO:0006308),0.2640763291695438,0.5251598151777873,0.9584055459272097,1.0,1.0,11/11,73.61%,DFFB;REXO4;DNASE1L1;DNASE1L3;DNASE1L2;DNASE1;SETMAR;FBH1;ISG20;XRN2;MUS81
prerank,defense response to fungus (GO:0050832),0.24357534577888895,0.5243806898770192,0.9619047619047619,1.0,1.0,3/17,17.58%,PLCG2;FAM3A;BCL10
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.2535106855967051,0.5239996499036464,0.9419568822553898,1.0,1.0,4/13,20.12%,SEC16A;TMEM30B;SAR1B;TM9SF4
prerank,methylguanosine-cap decapping (GO:0110156),-0.23430975694435316,-0.5224964593449993,0.9592326139088729,0.9992760424099927,1.0,6/10,39.79%,DCP2;PATL2;LSM1;EDC4;DCP1B;DCPS
prerank,kinetochore organization (GO:0051383),-0.21550858138293297,-0.5206202746263131,0.9638242894056848,0.9988396911182351,1.0,8/13,37.84%,CENPA;DLGAP5;NUF2;CENPF;NDC80;CDT1;CENPE;CENPH
prerank,branched-chain amino acid catabolic process (GO:0009083),0.23079479982964426,0.5170117665177512,0.9649122807017544,1.0,1.0,2/20,8.57%,AUH;HIBCH
prerank,branched-chain amino acid metabolic process (GO:0009081),0.23079479982964426,0.5170117665177512,0.9649122807017544,1.0,1.0,2/20,8.57%,AUH;HIBCH
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.2176573560827036,0.5166813825029177,0.9910846953937593,1.0,1.0,3/29,9.01%,RAET1E;KLRC2;PVR
prerank,regulation of spindle organization (GO:0090224),0.23367539406812143,0.5139772578085001,0.9590551181102362,1.0,1.0,9/18,32.25%,PARP3;GPSM2;TACC3;RAE1;SENP6;BORA;DYNC1H1;DCTN1;RNF4
prerank,mitochondrial gene expression (GO:0140053),0.20532858439099705,0.5139266366545931,0.9919246298788694,1.0,1.0,18/42,34.96%,FOXO3;GFM2;NOA1;MRPL57;MRPS28;FASTKD5;MRPL47;MRPS7;MRPS2;MRPL23;MRPS18A;MRPS21;MRPS34;MRPS16;NDUFA7;PTCD3;GATC;QRSL1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.23094468554565611,0.5122750385227156,0.9772036474164134,1.0,1.0,2/23,10.77%,PLA2G4F;MBOAT1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.2508977270273637,0.5121190673478844,0.964824120603015,1.0,1.0,6/12,32.34%,RMDN1;KIF2C;CENPC;CHAMP1;MAD1L1;SEH1L
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.2547545615231933,0.5118304398329001,0.9643463497453311,1.0,1.0,1/11,7.48%,TAS1R3
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.1811293786921538,-0.5111324505345914,0.9851190476190477,1.0,1.0,1/25,1.81%,SORT1
prerank,modulation by host of symbiont process (GO:0051851),0.21251065526353882,0.5106123161429602,0.9772403982930299,1.0,1.0,11/31,23.56%,JUN;CCL3;SMARCA4;EP300;REST;CCNT1;RRP1B;SNW1;CHD1;SAP30BP;TARDBP
prerank,lymphocyte migration (GO:0072676),0.20826811238904744,0.5066457314566659,0.9781659388646288,1.0,1.0,7/32,22.36%,CCL3;CCL1;CCL7;RET;ADAM8;GATA3;CCL15
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.2553481710199853,0.5046165383575465,0.968476357267951,1.0,1.0,3/10,24.51%,USP7;GNMT;OGT
prerank,regulation of intracellular transport (GO:0032386),0.20490596093550592,0.5034537793790661,0.9848484848484849,1.0,1.0,10/38,24.23%,NDEL1;GAS1;CAPN10;GRIPAP1;NUP214;RAB11B;AAAS;RBM4;ATP9A;PTPN1
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.15923531006024727,-0.503238934996024,0.9961832061068703,1.0,1.0,21/46,38.77%,HK2;TIMM17A;TOMM7;AKT1;CHCHD4;MFN2;TOMM40;TOMM22;ROMO1;MFF;RALA;PINK1;TOMM40L;FBXO7;HSPD1;GRPEL1;TOMM20L;HK1;TOMM5;TIMM13;TIMM44
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.21587525148440762,0.503034795048654,0.9827338129496402,1.0,1.0,13/29,29.25%,CENPT;CENPQ;RBBP7;SMARCA5;HJURP;RBBP4;CENPU;NASP;CENPX;CENPL;CENPK;CENPC;CENPW
prerank,CENP-A containing chromatin organization (GO:0061641),0.21587525148440762,0.503034795048654,0.9827338129496402,1.0,1.0,13/29,29.25%,CENPT;CENPQ;RBBP7;SMARCA5;HJURP;RBBP4;CENPU;NASP;CENPX;CENPL;CENPK;CENPC;CENPW
prerank,protein import into mitochondrial matrix (GO:0030150),0.2281974653399195,0.5026865210613264,0.9731437598736177,1.0,1.0,5/18,24.26%,TIMM23;TIMM17B;DNAJC19;GRPEL2;TOMM20
prerank,regulation of cytoplasmic transport (GO:1903649),0.24529068450555142,0.5017923119903099,0.9643435980551054,1.0,1.0,3/11,23.65%,USP7;MAP2K2;ATP9A
prerank,phosphate ion transport (GO:0006817),0.23403768280932996,0.5014373348435229,0.9669291338582677,1.0,1.0,3/16,18.79%,SLC34A2;SLC25A14;SLC20A1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.200979468826521,-0.5004250895231903,0.9814323607427056,1.0,1.0,15/15,79.93%,ERN1;TSEN15;FAM98B;TSEN34;RTRAF;CPSF1;ZBTB8OS;CSTF2;TSEN2;RTCB;TRPT1;CPSF4;CLP1;DDX1;TSEN54
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.22162482416459195,-0.49992855854979373,0.9722863741339491,0.9999798401495797,1.0,3/10,28.52%,MFSD2A;MTMR2;MTMR3
prerank,RNA polyadenylation (GO:0043631),0.21923044620195548,0.499065660632482,0.9717868338557993,1.0,1.0,10/26,32.55%,SCAF8;PABPC1;TENT2;FIP1L1;PAF1;CPSF3;CLP1;MTPAP;CSTF3;SSU72
prerank,mRNA polyadenylation (GO:0006378),0.21923044620195548,0.499065660632482,0.9717868338557993,1.0,1.0,10/26,32.55%,SCAF8;PABPC1;TENT2;FIP1L1;PAF1;CPSF3;CLP1;MTPAP;CSTF3;SSU72
prerank,tetrahydrofolate metabolic process (GO:0046653),0.24409992467988947,0.49783203153052863,0.9582608695652174,1.0,1.0,10/10,75.61%,MTHFR;MTHFD2L;TYMS;DHFR;MTHFD2;MTHFD1;SHMT1;MTHFD1L;MTHFS;SHMT2
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.22539026876699086,0.4974040333189992,0.981679389312977,1.0,1.0,4/20,19.70%,CLU;PSMG2;PSMG1;BBS12
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.24663938357026055,0.49170916283167837,0.9679144385026738,1.0,1.0,1/11,5.81%,STAT3
prerank,negative regulation of defense response to virus (GO:0050687),-0.22439116244037158,-0.4913326683581555,0.9716312056737588,1.0,1.0,10/10,77.58%,TARBP2;TSPAN6;PCBP2;C1QBP;ITCH;MUL1;ILRUN;PPM1B;RNF26;TRAF3IP1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.2451107495965501,0.48916064300004325,0.9556737588652482,1.0,1.0,3/10,20.63%,NPLOC4;UFD1;GPATCH3
prerank,phagosome-lysosome fusion (GO:0090385),0.24498733139493353,0.48848590025113414,0.979381443298969,1.0,1.0,1/10,4.86%,RAB7B
prerank,rRNA methylation (GO:0031167),0.21030150753768861,0.48509865282833675,0.9748427672955975,1.0,1.0,22/22,79.00%,METTL15;FTSJ3;MRM1;MRM2;NSUN4;METTL5;NOP2;NSUN3;MRM3;ZCCHC4;MTERF4;NSUN5;TFB1M;FBLL1;DIMT1;TRMT112;METTL16;FBL;TFB2M;FDXACB1;BUD23;EMG1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.19241627362611263,-0.48506372035209216,0.9796954314720813,1.0,1.0,4/13,31.46%,BOLA2;YAE1;GLRX5;ISCA2
prerank,tRNA processing (GO:0008033),0.18355705080852966,0.4846414985276106,0.9987277353689568,1.0,1.0,24/61,35.74%,TYW5;ELP5;CTU2;TRMT10A;TRDMT1;METTL1;TSEN54;DDX1;SSB;QTRT1;PTCD1;FARS2;CLP1;CPSF4;URM1;FTSJ1;TRPT1;RTCB;KARS1;POP1;WDR4;ELAC2;TSEN2;TRMT6
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.21181418027455481,0.4840272386212359,0.9866071428571429,1.0,1.0,6/24,19.05%,EED;DNMT3A;SUZ12;EPC1;RBBP7;TASOR
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.24947285304227318,0.48284871913025007,0.9642857142857143,1.0,1.0,3/10,23.42%,KNSTRN;CDC42;CCNB1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.204970173974147,0.48140919154923634,0.9818181818181818,1.0,1.0,4/26,16.21%,TRAFD1;IRAK3;CARD16;ACOD1
prerank,intracellular pH reduction (GO:0051452),0.19701494369414282,0.4809181475725306,0.9956521739130435,1.0,1.0,5/33,19.28%,ATP6V0A4;TCIRG1;ATP6V0D1;ATP6V0E1;ATP6V1H
prerank,DNA biosynthetic process (GO:0071897),0.2270333643591524,0.4807596868246433,0.9746835443037974,1.0,1.0,3/16,21.45%,WRN;POLA1;POLD3
prerank,peptidyl-methionine modification (GO:0018206),0.23743092238695512,0.4807112349401169,0.9550949913644214,1.0,1.0,4/12,28.54%,NAA15;METAP1D;METAP2;NAA60
prerank,homocysteine metabolic process (GO:0050667),-0.20550985041993952,-0.4800415757743657,0.9855072463768116,1.0,1.0,2/11,16.48%,NOX4;CBS
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.23820555838351803,0.4797999119303695,0.9686985172981878,1.0,1.0,1/11,11.22%,CBFB
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.2421415955876059,0.47927842249559083,0.9714795008912656,1.0,1.0,3/10,24.33%,ZC3H12A;RC3H2;SMAD7
prerank,regulation of endocytic recycling (GO:2001135),0.23886490704876712,0.47351543391009565,0.9822695035460993,1.0,1.0,4/11,23.65%,EHD1;EHD2;RAB11B;ATP9A
prerank,RNA modification (GO:0009451),0.1786093057207984,0.47126721544947986,0.9960835509138382,1.0,1.0,18/54,31.42%,TYW5;ELP5;CTU2;JMJD6;TRDMT1;PUS7L;METTL1;SSB;FTSJ3;QTRT1;NAT10;MRM2;PARN;NSUN4;PUS7;URM1;FTSJ1;NOP2
prerank,chromatin remodeling at centromere (GO:0031055),0.19958873440006825,0.4708642045329997,0.995702005730659,1.0,1.0,13/31,29.25%,CENPT;CENPQ;RBBP7;SMARCA5;HJURP;RBBP4;CENPU;NASP;CENPX;CENPL;CENPK;CENPC;CENPW
prerank,homologous chromosome segregation (GO:0045143),-0.1733057577130246,-0.46998825452331855,0.9941002949852508,1.0,1.0,1/20,6.05%,FMN2
prerank,meiosis I (GO:0007127),0.2069225453860169,0.46754946437233286,0.9955423476968797,1.0,1.0,23/23,79.34%,TDRD9;SYCP3;FOXJ3;FOXJ2;ZSCAN21;ZCWPW1;HSF2BP;BRDT;PTTG1;MEIOB;BTBD18;MEIOC;MEI1;DNMT3L;CCNA1;SGO1;MEIKIN;MYBL1;MOV10L1;DDX4;BCL2L11;SLC25A31;ING2
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.19218891289775886,0.4650930437505771,0.9912152269399708,1.0,1.0,9/31,24.53%,TIMM23;TIMM17B;AIFM1;DNAJC19;PEX2;PEX7;GRPEL2;TOMM20;PEX26
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.19310691192165233,-0.4644345745863951,1.0,1.0,1.0,13/13,80.71%,BMF;PMAIP1;BCL2L11;VDAC2;BNIP3L;BAD;BLOC1S2;RTL10;RHOT2;BAX;RHOT1;BNIP3;MOAP1
prerank,piRNA metabolic process (GO:0034587),0.21268283499003152,0.46270760906448116,0.9904912836767037,1.0,1.0,18/19,69.21%,TDRD9;TDRD12;TEX15;MAEL;PIWIL4;EXD1;PIWIL2;PLD6;PIWIL1;TDRD1;BTBD18;GPAT2;ASZ1;HENMT1;MYBL1;MOV10L1;DDX4;FKBP6
prerank,negative regulation of centrosome duplication (GO:0010826),0.2321928093391646,0.46233024934206596,0.9792027729636048,1.0,1.0,3/11,18.03%,KAT2A;KAT2B;RBM14
prerank,midbody abscission (GO:0061952),0.21000818780572447,0.4612355806573234,0.9800307219662059,1.0,1.0,1/17,5.41%,PDCD6IP
prerank,steroid hormone biosynthetic process (GO:0120178),0.1955694898954111,0.45948421814828877,0.9942028985507246,1.0,1.0,7/29,28.29%,FDX1;STARD3NL;CYP19A1;DHCR7;HSD17B2;AKR1B1;STAR
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.2114863766086386,0.45445772877077983,0.9820554649265906,1.0,1.0,5/16,23.69%,SNF8;TMEM50B;VTA1;CHMP4A;CHMP4B
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.1915551595366525,-0.4522328782568748,0.9908256880733946,1.0,1.0,4/11,37.05%,BLM;TIMELESS;FBH1;GMNN
prerank,heterochromatin assembly (GO:0031507),-0.16575244331316755,-0.4518576835515439,0.9919786096256684,1.0,1.0,11/20,40.97%,MBD2;SMCHD1;ZNFX1;SUV39H1;H3-3A;HMGA2;SIRT2;BEND3;CDKN2A;HELLS;CENPV
prerank,synaptonemal complex organization (GO:0070193),0.2094793784161737,0.4500176192204695,0.9841521394611727,1.0,1.0,1/15,8.47%,P3H4
prerank,synaptonemal complex assembly (GO:0007130),0.2094793784161737,0.4500176192204695,0.9841521394611727,1.0,1.0,1/15,8.47%,P3H4
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.1855087035756927,0.4466010071719315,0.991304347826087,1.0,1.0,29/29,81.48%,P3H4;IHO1;ANKRD31;RAD21L1;RNF212B;ZCWPW1;SIRT7;MEI4;REC8;MEIOB;PRDM9;SYCE3;SYCE1;RNF212;KASH5;SYCE2;SYCP1;TERB1;BAG6;TERB2;HORMAD1;MAJIN;RAD21;TEX11;SYCP2;STAG3;TEX12;TRIP13;FANCD2
prerank,transcription by RNA polymerase III (GO:0006383),0.19274998707720176,0.44465250504713527,0.9984848484848485,1.0,1.0,11/27,31.95%,SNAPC2;POLR3K;SNAPC5;ICE2;CRCP;SNAPC4;POLR3GL;GTF3C3;GTF3C1;GTF3C2;GTF3A
prerank,regulation of programmed necrotic cell death (GO:0062098),0.19844955409143472,0.4441163806769958,0.993920972644377,1.0,1.0,2/20,9.15%,PDCD6IP;RIPK3
prerank,male meiosis I (GO:0007141),0.20683159613211094,0.4440460401787387,0.9827586206896551,1.0,1.0,16/16,79.34%,TDRD9;SYCP3;FOXJ3;FOXJ2;ZSCAN21;HSF2BP;BRDT;BTBD18;MEIOC;DNMT3L;CCNA1;MYBL1;MOV10L1;DDX4;SLC25A31;ING2
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.22050867732530147,0.44258162833219045,0.9863247863247864,1.0,1.0,7/11,38.36%,AGK;TIMM9;TIMM29;TIMM22;TIMM10;TIMM10B;TIMM8B
prerank,pre-replicative complex assembly (GO:0036388),0.16619540058996954,0.44247183617317887,0.9986772486772487,1.0,1.0,15/64,27.63%,PSMB2;MCM7;MCM2;PSMC6;PSMD11;PSMD1;PSMD7;PSMC1;PSMD14;PSMD3;PSMD12;PSMD4;ORC3;PSMD2;PSME3
prerank,ESCRT complex disassembly (GO:1904896),0.21610595028872723,0.4379556393968595,0.9884488448844885,1.0,1.0,10/10,78.40%,IST1;VTA1;CHMP2B;CHMP5;VPS4B;CHMP2A;VPS4A;CHMP1B;CHMP1A;CHMP7
prerank,ESCRT III complex disassembly (GO:1904903),0.21610595028872723,0.4379556393968595,0.9884488448844885,1.0,1.0,10/10,78.40%,IST1;VTA1;CHMP2B;CHMP5;VPS4B;CHMP2A;VPS4A;CHMP1B;CHMP1A;CHMP7
prerank,centromere complex assembly (GO:0034508),0.17713260577739234,0.4307032537886952,0.9986013986013986,1.0,1.0,14/36,29.25%,CENPT;CENPQ;RBBP7;SMARCA5;HJURP;POGZ;RBBP4;CENPU;NASP;CENPX;CENPL;CENPK;CENPC;CENPW
prerank,positive regulation of mitochondrial translation (GO:0070131),0.2045983769765169,0.4306184414338375,0.9888535031847133,1.0,1.0,4/14,24.02%,MRPS27;RPUSD4;TRUB2;MPV17L2
prerank,secondary alcohol biosynthetic process (GO:1902653),0.17966141547088177,0.426982727283837,0.9927953890489913,1.0,1.0,6/30,23.03%,LBR;MVD;EBP;HMGCR;FDPS;DHCR7
prerank,negative regulation of ATPase activity (GO:0032780),0.19499981554454188,0.4266221668742707,0.9949832775919732,1.0,1.0,6/16,35.41%,TNNI3;ATP5IF1;THADA;TSC1;PPIF;PXK
prerank,positive regulation of translational initiation (GO:0045948),0.1881863144138196,0.41857942151505295,0.9891135303265941,1.0,1.0,5/18,23.70%,MTOR;KHDRBS1;YTHDF2;CDC123;YTHDF3
prerank,sensory perception of chemical stimulus (GO:0007606),0.19832480241297457,0.4181143206341982,0.996742671009772,1.0,1.0,6/15,37.88%,GNAS;CD36;BBS4;BEST2;UBR3;MKKS
prerank,tRNA 5'-leader removal (GO:0001682),0.20001255571598997,0.41664916504783184,0.9918300653594772,1.0,1.0,13/13,80.02%,RPP38;SSB;POP1;RPP30;POP4;RPP14;RPP40;RPP25;RPP25L;PRORP;RPP21;POP7;POP5
prerank,phosphate ion transmembrane transport (GO:0035435),-0.17558066541117387,-0.41638315743577636,0.9949748743718593,1.0,1.0,12/12,82.46%,XPR1;SLC25A11;SLC37A3;SLC20A2;SLC25A10;SLC37A4;SLC25A30;SLC37A2;SLC37A1;SLC25A3;SLC20A1;SLC25A14
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.17275580665411175,-0.4151724547737252,1.0,1.0,1.0,12/12,82.74%,GRN;PPT1;CLN6;ATP6AP2;CCDC115;LRRK2;TMEM9;CLN5;VPS33A;TMEM199;CLN3;TMEM165
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.20880826572617306,0.41440538176479474,0.9891696750902527,1.0,1.0,3/10,25.20%,ATRX;INO80;STOML2
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.1468730904207247,-0.40981126495006787,0.9939759036144579,1.0,1.0,6/23,22.78%,BMF;COX18;NDUFA13;TOMM22;PMAIP1;ROMO1
prerank,peptidyl-amino acid modification (GO:0018193),0.20418282522179157,0.4027831129852947,0.9892086330935251,1.0,1.0,3/10,25.49%,FKBP10;METAP1D;METAP2
prerank,metallo-sulfur cluster assembly (GO:0031163),0.17950855480601735,0.39974568551679696,0.9935897435897436,1.0,1.0,3/22,17.96%,NFS1;NFU1;NUBP2
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.16881206495576165,0.39809627121751895,0.99860529986053,1.0,1.0,5/31,20.73%,NFS1;MOCOS;PYCR1;MOCS3;CYP19A1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.16631644611780166,-0.39377028465936154,0.9948051948051948,1.0,1.0,6/13,34.16%,NECTIN2;MR1;STX7;IL12A;IL12RB1;IL23A
prerank,B cell mediated immunity (GO:0019724),-0.1756563472687825,-0.3931089247452036,1.0,1.0,1.0,6/10,46.84%,CD74;CARD9;SLA2;FCGR2B;CD19;MSH2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.1721156204654546,0.39235449315927085,0.9968992248062015,1.0,1.0,6/24,26.10%,POLB;RPA1;RFC1;POLD3;RFC5;POLK
prerank,covalent chromatin modification (GO:0016569),-0.15797166062843915,-0.39199474794664524,1.0,0.9999463683511953,1.0,3/14,21.45%,MBD2;MT3;HLCS
prerank,cholesterol biosynthetic process (GO:0006695),0.16150444607267467,0.38744754874415366,0.995768688293371,1.0,1.0,5/31,19.31%,LBR;MVD;EBP;HMGCR;FDPS
prerank,nucleosome disassembly (GO:0006337),0.18408604868934558,0.3859488840697928,0.9949664429530202,1.0,1.0,5/14,29.11%,SMARCA4;SMARCC1;ARID1A;SMARCD2;SMARCC2
prerank,chromatin disassembly (GO:0031498),0.18408604868934558,0.3859488840697928,0.9949664429530202,1.0,1.0,5/14,29.11%,SMARCA4;SMARCC1;ARID1A;SMARCD2;SMARCC2
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.19897062515691694,0.38551065516587074,0.996415770609319,1.0,1.0,10/10,80.12%,OS9;YOD1;SVIP;DERL2;UBAC2;UBE2G2;DERL3;INSIG1;UBE2J1;ERLEC1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.177457797840136,0.38329227568931856,0.9951456310679612,1.0,1.0,4/16,26.11%,SHLD1;RMI2;HELB;POLQ
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.17165971852900405,0.38266747461031814,0.9983974358974359,1.0,1.0,6/19,31.17%,STN1;TEN1;NAT10;PINX1;ACD;XRN1
prerank,tryptophan metabolic process (GO:0006568),0.1904462996673154,0.3821094841302164,0.993322203672788,0.9998433241734953,1.0,11/11,80.97%,KYAT1;TDO2;IDO2;HAAO;KMO;ACMSD;IDO1;KYNU;IL4I1;AADAT;ATP7A
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.15112701701513154,-0.37591091493080575,1.0,0.9994971577198082,1.0,15/15,84.91%,QDPR;AADAT;GSTZ1;IL4I1;KYNU;IDO1;ACMSD;KMO;FAH;TAT;HAAO;HGD;IDO2;TDO2;KYAT1
prerank,regulation of lipid catabolic process (GO:0050994),0.17227122984715024,0.3751953013981452,0.9968652037617555,0.9998452109768886,1.0,6/19,28.96%,LONP2;ABCD1;ANGPTL3;TYSND1;BSCL2;PRKAA1
prerank,regulation of mitochondrial translation (GO:0070129),0.16449111161132315,0.36823691317892543,1.0,0.9997871938543658,1.0,10/21,36.29%,MRPS27;RPUSD4;TRUB2;MPV17L2;MALSU1;FASTKD3;MTG2;ALKBH1;NSUN3;RPUSD3
prerank,B cell activation involved in immune response (GO:0002312),0.16990305700124986,0.3495478385767002,1.0,1.0,1.0,2/13,20.13%,RNF168;RNF8
prerank,spliceosomal snRNP assembly (GO:0000387),0.12845824949698167,0.31461754201376496,1.0,1.0,1.0,38/38,87.18%,USP4;PRPF3;GEMIN8;LSM2;SRSF12;PRMT5;LSM4;TGS1;PRPF6;SMN1;SNUPN;SNRPD2;SNRPD1;SNRPE;CD2BP2;SNRPD3;SART1;GEMIN5;PRPF8;COIL;GEMIN2;PRPF31;GEMIN4;GEMIN6;PRPF19;STRAP;SNRPC;SNRPB;GEMIN7;SNRPF;CLNS1A;PRMT7;SART3;WDR77;DDX20;SRSF10;SNRPG;AAR2
prerank,iron-sulfur cluster assembly (GO:0016226),0.13571514382614913,0.30782338579760504,1.0,0.9998962602802371,1.0,3/24,17.96%,NFS1;NFU1;NUBP2
